Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"6SH1",,"X-RAY DIFFRACTION",2.3,46.42,"VAPOR DIFFUSION",,"Potassium nitrate, sodium bromide, Bis-Tris propane, PEG 3350",291.15,"10.1002/1873-3468.13602",,"6SH1",161.11,"2.1","2.1","Crystal structure of substrate-free human neprilysin E584D.","GICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHDITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6SH1"
"6SHC",,"X-RAY DIFFRACTION",5.34,76.97,"VAPOR DIFFUSION",7.5,"9% MPD, 0.1M Hepes pH7.5",293,"10.7554/eLife.50793",,"6SHC",41.01,"3.55","3.55","Crystal structure of human IRE1 luminal domain Q105C","STVTLPETLLFVSTLDGSLHAVSKRTGSIKWTLKEDPVLQVPTHVEEPAFLPDPNDGSLYTLGSKNNEGLTKLPFTIPELVCASPSRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSLSPSTSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVAFYVWQREGLRKVMHINVAVETLRYLTFMSGEVGRITKWKYPFPKETEAKSKLTPTLYVGKYSTSLYASPSMVHEGVAVVPRGSTLPLLEGPQTDGVTIGDKGESVITPSTDVKFDPGLKSKNKLNYLRNYWLLIGHHETPLSASTKMLERFPNNLPKHRENV","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6SHC"
"6SHH",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, HANGING DROP",,"2.9 M ammonium sulphate, 0.1 M HEPES, pH 8.5, 0.5- 2 % PEG 3350",277,"10.1021/acs.jmedchem.9b01806",,"6SHH",207.42,"2","2","Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","6SHH"
"6SHI",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.9 M ammonium sulphate, 0.1 M HEPES, pH 8.5, 0.5- 2 % PEG 3350",277,"10.1021/acs.jmedchem.9b01806",,"6SHI",206.92,"1.85","1.85","Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","6SHI"
"6SHK",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 4000, Ph 7, 200 mM Zinc",298,,,"6SHK",4.96,"1.992","1.992","High resolution structure of the antimicrobial peptide Dermcidin from human","SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL","Homo sapiens","DCD, AIDD, DSEP","Dermcidin","1","6SHK"
"6SHO",,"X-RAY DIFFRACTION",4.03,69.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M  NaCitrate pH 6.5, 0.1 M BisTris Propane and 20% PEG3500",293.15,"10.1107/S2053273319011446",,"6SHO",32.96,"3.20008450383","3.20008450383","SAD structure of Human Survivin recovered by continuous rotation data collection and multivariate analysis of Friedel pairs","MGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","BIRC5, API4, IAP4","Baculoviral IAP repeat-containing protein 5","1","6SHO"
"6SHR",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M tri-sodium citrate pH 5.6, 20 % (v/v) isopropanol and 20 % (w/v) PEG 4000",293,,,"6SHR",7.57,"1.745","1.745","X-RAY CRYSTAL STRUCTURE OF CELL-FREE PROTEIN SYNTHESIS (CFPS) PRODUCED SDF1-A","LSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1","1","6SHR"
"6SHS","4.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12683-8",,"6SHS",52.03,"4.4",,"Abeta fibril (Morphology I)","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6SHS"
"6SHZ",,"X-RAY DIFFRACTION",2.5,50.82,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT.",293,"10.1021/acschembio.9b00748",,"6SHZ",49.21,"1.24","1.24","p53 cancer mutant Y220C","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNN","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SHZ"
"6SI0",,"X-RAY DIFFRACTION",2.46,50.07,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of PK9323 in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.1021/acschembio.9b00748","LEK","6SI0",50.23,"1.53","1.53","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9323","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SI0"
"6SI1",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, SITTING DROP",7.2,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT.",293,"10.1021/acschembio.9b00748",,"6SI1",49.75,"1.44","1.44","p53 cancer mutant Y220H","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPHEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SI1"
"6SI2",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT.",293,"10.1021/acschembio.9b00748",,"6SI2",49.44,"1.5","1.5","p53 cancer mutant Y220S","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPSEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SI2"
"6SI3",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of PK9301 in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.1021/acschembio.9b00748","LEB","6SI3",50.18,"1.4","1.4","p53 cancer mutant Y220S in complex with small-molecule stabilizer PK9301","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPSEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SI3"
"6SI4",,"X-RAY DIFFRACTION",2.49,50.6,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT, 2 mM PK9323.",293,"10.1021/acschembio.9b00748","LEK","6SI4",49.9,"1.8","1.8","p53 cancer mutant Y220S in complex with small-molecule stabilizer PK9323","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPSEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SI4"
"6SJH",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, SITTING DROP",5,"Na-acetate, PEG 400, PGA",277,,,"6SJH",66.95,"1.5","1.5","Structure of the PRY-SPRY domain of human Trim16L/Trim70","GSHMSTREQFLQYVHDITFDPDTAHKYLQLQEENRKVTNTTPWEHPYPDLPSRFLHWRQVLSQQSLYLHRYYFEVEIFGAGTYVGLTCKGIDRKGEERNSCISGNNFSWSLQWNGKEFTAWYSDMETPLKAGPFRRLGVYIDFPGGILSFYGVEYDTMTLVHKFACKFSEPVYAAFWLSKKENAIRIVDL","Homo sapiens","TRIM16L, TRIM70","Tripartite motif-containing protein 16-like protein","1","6SJH"
"6SJU",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.9 M ammonium sulphate, 0.1 M HEPES, pH 8.5, 0.5- 2 % PEG 3350",277,"10.1021/acs.jmedchem.9b01806",,"6SJU",209.12,"1.97","1.97","Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","6SJU"
"6SK9",,"X-RAY DIFFRACTION",2.88,57.33,"VAPOR DIFFUSION, SITTING DROP",,"50 mM Hepes, pH 7.5, 300 mM sodium chloride, 10 mM sodium phosphate, 5 mM dithiothreitol and 5% glycerol",279,"10.1042/BCJ20200128","F9N","6SK9",33.24,"2","2","Nek2 bound to purine compound 51","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","Serine/threonine-protein kinase Nek2","1","6SK9"
"6SKB",,"X-RAY DIFFRACTION",1.71,27.95,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.126675",,"6SKB",96.55,"1.84","1.84","Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A","MPMLSAIVLYVLLAAAAHSAFAAMVHHHHHHSAGLVPRGSGKETAAAKFERQHMDSASGGGDDDDKLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGDYPCGSKERPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6SKB"
"6SKC",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.126675",,"6SKC",49.41,"2.18","2.18","Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNYPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6SKC"
"6SKD",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.126675",,"6SKD",49.71,"2.26","2.26","Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNYPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6SKD"
"6SKH",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4,
2 % (w/v) PEG 3350,
100 mM Tris-HCl, pH 8.0",293,,,"6SKH",84.33,"1.58","1.58","X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a inhibitor sulfamide inhibitor GluAsp","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAMEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6SKH"
"6SL6",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M Ammonium citrate tribasic pH 7.0, 20% w/v Polyethylene glycol 3,350",277,"10.1016/j.celrep.2020.03.076",,"6SL6",28.18,"1.67","1.67","p53 charged core","MGSSHHHHHHSSGRENLYFQGHMPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLGKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPIKTIIRLEDSSGNLLGLDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNGS","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6SL6"
"6SLH",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Bis-Tris pH 6.5, 15% PEG 3350, 250 mM MgCl2",293,"10.1107/S2053230X20001193",,"6SLH",151.62,"1.89","1.89","Conformational flexibility within the small domain of human serine racemase.","MDAQYDISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGALNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQAYGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGVKSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQTVSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSVHHHHHH","Homo sapiens","SRR","Serine racemase","1","6SLH"
"6SLR",,"X-RAY DIFFRACTION",2.96,58.45,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 30% PEG6000",293,,,"6SLR",27.91,"2.38","2.38","Structure of saposin B in complex with atovaquone","GASGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCD","Homo sapiens","PSAP, GLBA, SAP1","Prosaposin","1","6SLR"
"6SLZ",,"X-RAY DIFFRACTION",2.05,39.95,"VAPOR DIFFUSION, SITTING DROP",,"0.2M NH4 formate, 20% w/v PEG 3350",295,,,"6SLZ",58.52,"2.2","2.2","Crystal structure of human ROR gamma LBD in complex with a (quinolinoxymethyl)benzamide inverse agonist","GSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6SLZ"
"6SM1",,"X-RAY DIFFRACTION",3.77,67.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, 0.2 M CaCl2, 28% PEG 400",293,"10.7554/eLife.52300",,"6SM1",12.37,"1.55","1.55","Wild type immunoglobulin light chain (WT-1)","MGQSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTLYVFGTGTKVTVLG","Homo sapiens","IGLV2-14","Immunoglobulin lambda variable 2-14","1","6SM1"
"6SM2",,"X-RAY DIFFRACTION",4.16,70.44,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M sodiumcitrate, 0.5 M (NH4)2SO4, 1.0 M Li2SO4",293,"10.7554/eLife.52300",,"6SM2",23.53,"2.5","2.5","Mutant immunoglobulin light chain causing amyloidosis (Pat-1)","QSALTQPASVSGSLGQSITISCTGSSNDFGDYNYVSWYQQHPGKAPKLMIYDVDNRPSGVSNRFSGSKSGNTASLTISGVLAEDEADYFCSSYTSSSTLYVFGSGTKVTVLG","Homo sapiens",,"Pat-1","1","6SM2"
"6SM8",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, SITTING DROP",6,"27% (m/v) PEG6000, 0.1 M MES/NaOH pH 6.0 and 5 mM DTT",277,"10.1021/acs.jmedchem.9b01392","LKT","6SM8",70.45,"1.85","1.85","Human jak1 kinase domain in complex with inhibitor","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6SM8"
,,,,,,,,,,,,,,,,"DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","2","6SM8"
"6SMA",,"X-RAY DIFFRACTION",2.4,48,"VAPOR DIFFUSION, SITTING DROP",7.2,"24% PEG Smear Broad
0.1 M Tris-HCl pH 7.2
0.1 M KSCN
0.1M NaBr",293.15,"10.1021/acschembio.0c00090",,"6SMA",74.15,"2.59","2.59","Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELANE, ELA2","Neutrophil elastase","1","6SMA"
"6SMB",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, SITTING DROP",,"27% (m/v) PEG6000, 0.1 M MES/NaOH pH 6.0 and 5 mM DTT",277,"10.1021/acs.jmedchem.9b01392","LKQ","6SMB",70.32,"2.04","2.04","Human jak1 kinase domain in complex with inhibitor","DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6SMB"
"6SNK",,"X-RAY DIFFRACTION",1.83,32.75,"EVAPORATION",6.5,"30% P550MME_P20K, 0.1M Morpheus buffer 1, 0.12M Morpheus alcohols (condition D1 of Morpheus screen from Molecular Dimensions",298,"10.1074/jbc.RA120.014865",,"6SNK",44.27,"2.2","2.2","Crystal structure of the Collagen VI alpha3 N2 domain","EKKKADIVFLLDGSINFRRDSFQEVLRFVSEIVDTVYEDGDSIQVGLVQYNSDPTDEFFLKDFSTKRQIIDAINKVVYKGGRHANTKVGLEHLRVNHFVPEAGSRLDQRVPQIAFVITGGKSVEDAQDVSLALTQRGVKVFAVGVRNIDSEEVGKIASNSATAFRVGNVQELSELSEQVLETLHDAMHETLCPGVTDAAK","Homo sapiens","COL6A3","Collagen alpha-3(VI) chain","1","6SNK"
"6SNO",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",,"KCl, MgCl2, Na cacodylate pH 6.5 and PEG4000",298.15,"10.1038/s41598-020-62548-0",,"6SNO",64.45,"2.7","2.7","Crystal structures of human PGM1 isoform 2","GAMGSDFEEWISGTYRKMEEGPLPLLTFATAPYHDQKPGTSGLRKKTYYFEEKPCYLENFIQSIFFSIDLKDRQGSSLVVGGDGRYFNKSAIETIVQMAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","6SNO"
"6SNP",,"X-RAY DIFFRACTION",2.26,45.51,"VAPOR DIFFUSION, HANGING DROP",,"Magnesium chloride, Polyethylene glycol monomethyl ether 550",298.15,"10.1038/s41598-020-62548-0",,"6SNP",64.07,"2.75","2.75","Crystal structures of human PGM1 isoform 2","GAMGSDFEEWISGTYRKMEEGPLPLLTFATAPYHDQKPGTSGLRKKTYYFEEKPCYLENFIQSIFFSIDLKDRQGSSLVVGGDGRYFNKSAIETIVQMAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","6SNP"
"6SNQ",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, HANGING DROP",,"KCl, MgCl2, Na cacodylate pH 6.5 and PEG4000",298.15,"10.1038/s41598-020-62548-0",,"6SNQ",64.45,"2.7","2.7","Crystal structures of human PGM1 isoform 2","GAMGSDFEEWISGTYRKMEEGPLPLLTFATAPYHDQKPGTSGLRKKTYYFEEKPCYLENFIQSIFFSIDLKDRQGSSLVVGGDGRYFNKSAIETIVQMAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","6SNQ"
"6SNZ",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8K 10%, Imodazole 0.1M, Calcium acetate 0.2M",293,"10.1016/j.jsb.2019.10.006",,"6SNZ",73.09,"2.6","2.6","Crystal structure of lamin A coil1b tetramer","GSESEEVVSREVSGIKAAYEAELGDARKTLDSVAKERARLQLELSKVREEFKELKARNTKKEGDLIAAQARLKDLEALLNSKEAALSTALSEKRTLEGELHDLRGQVAKLEAALGEAKKQLQDEMLRRVDAENRLQTMKEELDFQKNIYSEELRETKRRH","Homo sapiens","LMNA, LMN1","Prelamin-A/C","1","6SNZ"
"6SO0",,"SOLUTION NMR",,,,,,,"10.1021/acsomega.9b03043",,"6SO0",6.2,,,"NMR solution structure of the family 14 carbohydrate binding module (CBM14) from human chitotriosidase","GSPTFCQGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWNGLVPR","Homo sapiens","CHIT1","Chitotriosidase-1","1","6SO0"
"6SP1",,"X-RAY DIFFRACTION",4.65,73.54,"VAPOR DIFFUSION, HANGING DROP",,"ammonium acetate",277,"10.1021/acsmedchemlett.9b00594",,"6SP1",65.3,"2.57","2.57","KEAP1 IN COMPLEX WITH COMPOUND 6","GSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6SP1"
"6SP4",,"X-RAY DIFFRACTION",2.62,53.15,"VAPOR DIFFUSION, HANGING DROP",,"ammonium acetate",277,"10.1021/acsmedchemlett.9b00594",,"6SP4",194.58,"2.59","2.59","KEAP1 IN COMPLEX WITH COMPOUND 23","GSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6SP4"
"6SPA",,"X-RAY DIFFRACTION",4.35,71.75,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl",293,"10.1038/s42003-020-0826-3",,"6SPA",96.96,"1.65","1.65","A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 IN C2 SPACE GROUP","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6SPA"
"6SPH",,"X-RAY DIFFRACTION",4.3,71.4,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl",293,"10.1038/s42003-020-0826-3",,"6SPH",98.43,"2.25","2.25","A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 WITH EBSELEN BOND IN C2 SPACE GROUP","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6SPH"
"6SPI",,"X-RAY DIFFRACTION",4.25,71.06,"VAPOR DIFFUSION, HANGING DROP",7.6,"100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate",293,"10.1038/s42003-020-0826-3",,"6SPI",198.25,"2.8","2.8","A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4","MATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6SPI"
"6SPJ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.6,"2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl",293,"10.1038/s42003-020-0826-3",,"6SPJ",101.93,"1.97","1.97","A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 1","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6SPJ"
"6SPK",,"X-RAY DIFFRACTION",4.38,71.89,"VAPOR DIFFUSION, HANGING DROP",7.6,"2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl",293,"10.1038/s42003-020-0826-3",,"6SPK",101.47,"2.77","2.77","A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 6","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6SPK"
"6SPV",,"X-RAY DIFFRACTION",2.73,54.86,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M calcium acetate; 0.1 M sodium cacodylate; 40% v/v PEG 400",277,"10.1016/j.bpj.2020.06.018",,"6SPV",21.18,"2.04","2.04","Crystal structure of PDZ1-2 from PSD-95","GPNGTEGEMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNA","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6SPV"
"6SQ0",,"X-RAY DIFFRACTION",2,38.48,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, magnesium chloride",293,"10.1021/acsmedchemlett.9b00370","LRQ","6SQ0",58.25,"1.77","1.77","ERa_L536S (L536S/C381S/C471S,C530S) in complex with a bridged tetracyclic indole (compound 8)","GSHMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6SQ0"
"6SQE",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, SITTING DROP",,"0.2M MgCl2, 25% PEG 3350, 0.1M BisTris pH 5.5",277.15,,,"6SQE",14.87,"1.506","1.506","Crystal structure of CREBBP bromodomain complexed with KD341","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6SQE"
"6SQF",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MES pH 6.5, 12% PEG 20000",277.15,,,"6SQF",14.79,"2.006","2.006","Crystal structure of CREBBP bromodomain complexed with LB32A","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6SQF"
"6SQM",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, SITTING DROP",,"8% Ethylene glycol, 0.1M HEPES pH 7.5, 10% PEG 8000",277.15,,,"6SQM",44.14,"1.8","1.8","Crystal structure of CREBBP bromodomain complexed with LA36","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6SQM"
"6SQT",,"X-RAY DIFFRACTION",2.95,58.33,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M ammonium sulfate, 0.2 M tri-potassium citrate",293,"10.1016/j.jsb.2020.107480",,"6SQT",34.14,"1.84","1.84","Structure of the U1A variant A1-98 Y31H/Q36R/F56W triple mutant","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAWVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","6SQT"
"6SQU",,"X-RAY DIFFRACTION",2.28,45.98,"VAPOR DIFFUSION, SITTING DROP",,"0.17 M Ammonium sulfate, 25.5 % PEG 4000, 15 % glycerol",289,"10.1021/acs.jmedchem.0c01944",,"6SQU",73.28,"2.27","2.27","Crystal structure of human SHIP2 catalytic domain in complex with 1,2,4 Dimer","SMDEPDMISVFIGTWNMGSVPPPKNVTSWFTSKGLGKTLDEVTVTIPHDIYVFGTQENSVGDREWLDLLRGGLKELTDLDYRPIAMQSLWNIKVAVLVKPEHENRISHVSTSSVKTGIANTLGNKGAVGVSFMFNGTSFGFVNCHLTSGNEKTARRNQNYLDILRLLSLGDRQLNAFDISLRFTHLFWFGDLNYRLDMDIQEILNYISRKEFEPLLRVDQLNLEREKHKVFLRFSEEEISFPPTYRYERGSRDTYAWHKQKPTGVRTNVPSWCDRILWKSYPETHIICNSYGCTDDIVTSDHSPVFGTFEVGVTSQ","Homo sapiens","INPPL1, SHIP2","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2","1","6SQU"
"6SQV",,"X-RAY DIFFRACTION",5.02,75.48,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M ammonium sulfate, 0.2 M tri-potassium citrate",293,"10.1016/j.jsb.2020.107480",,"6SQV",45.99,"2.45","2.45","Structure of the U1A variant A1-98 Y31H/Q36R/R70W","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALWSMQGFPFYDKPMRIQYAKTDSDIIAKMW","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","6SQV"
"6SR7",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, SITTING DROP",7,"2.2 M ammonium sulfate, 0.2 M tri-potassium citrate",293,"10.1016/j.jsb.2020.107480",,"6SR7",45.69,"1.86","1.86","Structure of the U1A variant A1-98 Y31H/Q36R/K98W","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMW","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","6SR7"
"6SRE",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, SITTING DROP",7.4,"10mM NaBorate, 760mM NaCitrate",277,"10.1002/1873-3468.13877",,"6SRE",109.18,"1.39","1.39","Crystal Structure of Human Prolidase S202F variant expressed in the presence of chaperones","GPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKIFSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPF","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6SRE"
"6SRF",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, SITTING DROP",7.4,"10mM NaBorate, 690-760mM NaCitrate",277,"10.1002/1873-3468.13877",,"6SRF",109.08,"1.847","1.847","Crystal Structure of Human Prolidase G278N variant expressed in the presence of chaperones","GPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMDGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6SRF"
"6SRG",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION",7.4,"10mM NaBorate, 690-760mM NaCitrate",277,"10.1002/1873-3468.13877",,"6SRG",110.16,"2.558","2.558","Crystal Structure of Human Prolidase G448R variant expressed in the presence of chaperones","MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGRVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6SRG"
"6SRH",,"X-RAY DIFFRACTION",2.68,54.14,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0 -- 1.4M ammonium sulfate -- 0.2M sodium/potassium tartrate",277,,,"6SRH",72.5,"1.25","1.25","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6SRH"
"6SRR",,"X-RAY DIFFRACTION",2.28,45.98,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Sodium citrate, 20 % w/v PEG 3000",289,"10.1021/acs.jmedchem.0c01944",,"6SRR",72.49,"2.45","2.45","Crystal structure of human SHIP2 catalytic domain","SMDEPDMISVFIGTWNMGSVPPPKNVTSWFTSKGLGKTLDEVTVTIPHDIYVFGTQENSVGDREWLDLLRGGLKELTDLDYRPIAMQSLWNIKVAVLVKPEHENRISHVSTSSVKTGIANTLGNKGAVGVSFMFNGTSFGFVNCHLTSGNEKTARRNQNYLDILRLLSLGDRQLNAFDISLRFTHLFWFGDLNYRLDMDIQEILNYISRKEFEPLLRVDQLNLEREKHKVFLRFSEEEISFPPTYRYERGSRDTYAWHKQKPTGVRTNVPSWCDRILWKSYPETHIICNSYGCTDDIVTSDHSPVFGTFEVGVTSQ","Homo sapiens","INPPL1, SHIP2","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2","1","6SRR"
"6SRV",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, SITTING DROP",,"200 mM NH4Cl
20% PEG3350",291,"10.1080/19420862.2020.1801230",,"6SRV",97.43,"2.4","2.4","Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021144","GAHSEVQLLESGGGLVQPGGSLRLSCAASGFTFRYDYHVWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLRADLGLYMDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHAA","Homo sapiens",,"Fab C0021144 heavy chain (IgG1)","1","6SRV"
,,,,,,,,,,,,,,,,"GVHSQSVLTQPPSVSAAPGQKVTVSCSGSSSNIGNHHVSWYQQLPGTAPKLLIYDTTVLSSGVPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDELTSNLVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab C0021144 light chain (IgG1)","2","6SRV"
"6SRX",,"X-RAY DIFFRACTION",2.44,49.49,"VAPOR DIFFUSION, SITTING DROP",5,"100 mM NaAcO pH 5.0
20% PEG6000
200 mM LiCl",291,"10.1080/19420862.2020.1801230",,"6SRX",95.88,"1.9","1.9","Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021158","GAHSEVQLLESGGGLVQPGGSLRLSCAASGFTFRYEVAAWVRQAPGKGLEWVSAISGPIPKGYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLRADLGLYMDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHAA","Homo sapiens",,"Fab C0021158 heavy chain (IgG1)","1","6SRX"
,,,,,,,,,,,,,,,,"GVHSQSVLTQPPSVSAAPGQKVTISCSGSSSNIGNHYVSWYQQLPGTAPKLLIYDNSERTAGVPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDELTSNLVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab C0021158 light chain (IgG1)","2","6SRX"
"6SS0",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM SPG pH 7.0
25% PEG1500

PACT A4
SPG: succinic acid, phosphate, glycine",291,"10.1080/19420862.2020.1801230",,"6SS0",96.74,"1.7","1.7","Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021181","GAHSEVQLLESGGGLVRPGGSLRLSCAASEFTFRYDYHVWVRQAPGKGLEWVSAISGSGGSTYYADSVKSRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLRADLGLYMDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHAA","Homo sapiens",,"Fab C0021181 heavy chain (IgG1)","1","6SS0"
,,,,,,,,,,,,,,,,"GVHSQSVLTQPPSVSAAPGQKVAVSCSGSSSNIGSHYVSWYQQLPGTAPKLLIYDNSERTSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDELTSNLVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab C0021181 light chain (IgG1)","2","6SS0"
"6SS5",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES pH 7.5
70% MPD",291,"10.1073/pnas.1919565117",,"6SS5",48.65,"1.78","1.78","Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0020187","GAHSEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLRADLGLYMDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHAA","Homo sapiens",,"Fab C0020187 heavy chain (IgG1)","1","6SS5"
,,,,,,,,,,,,,,,,"GVHSQSVLTQPPSVSAAPGQKVTISCSGSSSNIGNHYVSWYQQLPGTAPKLLIYDNSERPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSALVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab C0020187 light chain (IgG1)","2","6SS5"
"6SSB",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",293,,,"6SSB",35.33,"2.08","2.08","syk in complex with compound 30","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6SSB"
"6SSJ","2.75","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13786-y",,"6SSJ",27.57,"2.75",,"Human endogenous retrovirus (HML2) mature capsid assembly, T=1 icosahedron","PVTLEPMPPGEGAQEGEPPTVEARYKSFSIKMLKDMKEGVKQYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVRRNRAANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVRAICLRAWEKIQDPGSACPSFNTVRQGSKEPYPDFVARLQDVAQKSIADEKARKVIVELMAYENANPECQSAIKPLKGKVPAGSDVISEYVKACDGIGGAMHKAMLMAQLE","Homo sapiens","ERVK-24","Endogenous retrovirus group K member 24 Gag polyprotein","1","6SSJ"
"6SSK","3.18","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13786-y",,"6SSK",248.13,"3.18",,"Human endogenous retrovirus (HML2) mature capsid assembly, D5 capsule","PVTLEPMPPGEGAQEGEPPTVEARYKSFSIKMLKDMKEGVKQYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVRRNRAANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVRAICLRAWEKIQDPGSACPSFNTVRQGSKEPYPDFVARLQDVAQKSIADEKARKVIVELMAYENANPECQSAIKPLKGKVPAGSDVISEYVKACDGIGGAMHKAMLMAQLE","Homo sapiens","ERVK-24","Endogenous retrovirus group K member 24 Gag polyprotein","1","6SSK"
"6SSL","3.77","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13786-y",,"6SSL",248.13,"3.77",,"Human endogenous retrovirus (HML2) mature capsid assembly, D6 capsule","PVTLEPMPPGEGAQEGEPPTVEARYKSFSIKMLKDMKEGVKQYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVRRNRAANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVRAICLRAWEKIQDPGSACPSFNTVRQGSKEPYPDFVARLQDVAQKSIADEKARKVIVELMAYENANPECQSAIKPLKGKVPAGSDVISEYVKACDGIGGAMHKAMLMAQLE","Homo sapiens","ERVK-24","Endogenous retrovirus group K member 24 Gag polyprotein","1","6SSL"
"6SSM","4.34","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13786-y",,"6SSM",82.71,"4.34",,"Human endogenous retrovirus (HML2) mature capsid assembly, T=3 icosahedron","PVTLEPMPPGEGAQEGEPPTVEARYKSFSIKMLKDMKEGVKQYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVRRNRAANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVRAICLRAWEKIQDPGSACPSFNTVRQGSKEPYPDFVARLQDVAQKSIADEKARKVIVELMAYENANPECQSAIKPLKGKVPAGSDVISEYVKACDGIGGAMHKAMLMAQLE","Homo sapiens","ERVK-24","Endogenous retrovirus group K member 24 Gag polyprotein","1","6SSM"
"6SSO",,"X-RAY DIFFRACTION",2,38.53,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium cacodylate, pH 7 and 1.6 M sodium acetate",297,,,"6SSO",15.7,"1.211","1.211","EDN mutant L45H","MKPPQFTWAQWFETQHINMTSQQCTNAMQVINNYQRRCKNQNTFLHTTFANVVNVCGNPNMTCPSNKTRKNCHHSGSQVPLIHCNLTTPSPQNISNCRYAQTPANMFYIVACDNRDQRRDPPQYPVVPVHLDRII","Homo sapiens","RNASE2, EDN, RNS2","Non-secretory ribonuclease","1","6SSO"
"6SSR",,"X-RAY DIFFRACTION",2.77,55.62,"LIPIDIC CUBIC PHASE",5.5,"0.1M MES
0.4M Lithium citrate
40% PEG 400",298,"10.1038/s41467-021-21924-8",,"6SSR",52.4,"3.8","3.8","Crystal structure of Human Microsomal Glutathione S-Transferase 2 at 3.8 Angstroms resolution","MHHHHHHAGNSILLAAVSILSACQQSYFALQVGKARLKYKVTPPAVTGSPEFERVFRAQQNCVEFYPIFIITLWMAGWYFNQVFATCLGLVYIYGRHLYFWGYSEAAKKRITGFRLSLGILALLTLLGALGIANSFLDEYLDLNIAKKLRRQF","Homo sapiens","MGST2, GST2","Microsomal glutathione S-transferase 2","1","6SSR"
"6SSS",,"X-RAY DIFFRACTION",3.01,59.19,"LIPIDIC CUBIC PHASE",4.5,"0.1M Sodium acetate pH 4.5
0.4M Sodium sulfate
0.1M Potassium thiocyanate
17% PEG 400",298,"10.1038/s41467-021-21924-8",,"6SSS",107.41,"2.498","2.498","Crystal structure of Human Microsomal Glutathione S-Transferase 2","MHHHHHHAGNSILLAAVSILSACQQSYFALQVGKARLKYKVTPPAVTGSPEFERVFRAQQNCVEFYPIFIITLWMAGWYFNQVFATCLGLVYIYGRHLYFWGYSEAAKKRITGFRLSLGILALLTLLGALGIANSFLDEYLDLNIAKKLRRQF","Homo sapiens","MGST2, GST2","Microsomal glutathione S-transferase 2","1","6SSS"
"6SST","3.4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48907",,"6SST",144.76,"3.4",,"cryo-em structure of alpha-synuclein fibril polymorph 2B","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6SST"
"6SSU",,"X-RAY DIFFRACTION",3.32,62.9,"LIPIDIC CUBIC PHASE",5.5,"0.1M MES pH 5.5
0.4M Lithium citrate
0.1M Sodium nitrate
20% PEG 400",298,"10.1038/s41467-021-21924-8",,"6SSU",53.79,"2.499","2.499","Crystal structure of Human Microsomal Glutathione S-Transferase 2 in complex with co-substrate Glutathione","MHHHHHHAGNSILLAAVSILSACQQSYFALQVGKARLKYKVTPPAVTGSPEFERVFRAQQNCVEFYPIFIITLWMAGWYFNQVFATCLGLVYIYGRHLYFWGYSEAAKKRITGFRLSLGILALLTLLGALGIANSFLDEYLDLNIAKKLRRQF","Homo sapiens","MGST2, GST2","Microsomal glutathione S-transferase 2","1","6SSU"
"6SSW",,"X-RAY DIFFRACTION",3.16,61.11,"LIPIDIC CUBIC PHASE",5.5,"0.1M MES pH 5.5
0.4M Lithium citrate
0.1M Sodium malonate
20% PEG 400",298,"10.1038/s41467-021-21924-8",,"6SSW",53.46,"3","3","Crystal structure of Human Microsomal Glutathione S-Transferase 2 in complex with an Inhibitor Glutathione sulfonic acid","MHHHHHHAGNSILLAAVSILSACQQSYFALQVGKARLKYKVTPPAVTGSPEFERVFRAQQNCVEFYPIFIITLWMAGWYFNQVFATCLGLVYIYGRHLYFWGYSEAAKKRITGFRLSLGILALLTLLGALGIANSFLDEYLDLNIAKKLRRQF","Homo sapiens","MGST2, GST2","Microsomal glutathione S-transferase 2","1","6SSW"
"6SSX","2.98","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48907",,"6SSX",144.76,"2.98",,"cryo-em structure of alpha-synuclein fibril polymorph 2A","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6SSX"
"6ST3",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% PEG 4000, Sitting drop (300 nl), protein-to-well ratio, 1:2, 293K",293,"10.1002/cmdc.201900557","LUW","6ST3",53.05,"2.426","2.426","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with 4-hydroxy-N-(4-phenoxybenzyl)-2-(1H-pyrazol-1-yl)pyrimidine-5-carboxamide","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGE","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6ST3"
"6STF",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Sodium Cacodylate, 0.2 M MgAc2, 20% PEG8000",293,"10.1042/BCJ20190664",,"6STF",105.97,"2.4","2.4","Human Rab8a phosphorylated at Ser111 in complex with GDP","MDYLFKLLLIGDSGVGKTCVLFRFSEDAFNSTFISTIGIDFKIRTIELDGKRIKLQIWDTAGQERFRTITTAYYRGAMGIMLVYDITNEKSFDNIRNWIRNIEEHASADVEKMILGNKCDVNDKRQVSKERGEKLALDYGIKFMETSAKANINVENAFFTLARDIKAKMDKKHHHHHH","Homo sapiens","RAB8A, MEL, RAB8","Ras-related protein Rab-8A","1","6STF"
"6STG",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCl, 30% PEG300",293,"10.1042/BCJ20190664",,"6STG",42.67,"2.5","2.5","Human Rab8a phosphorylated at Ser111 in complex with GPPNP","MDYLFKLLLIGDSGVGKTCVLFRFSEDAFNSTFISTIGIDFKIRTIELDGKRIKLQIWDTAGQERFRTITTAYYRGAMGIMLVYDITNEKSFDNIRNWIRNIEEHASADVEKMILGNKCDVNDKRQVSKERGEKLALDYGIKFMETSAKANINVENAFFTLARDIKAKMDKKHHHHHH","Homo sapiens","RAB8A, MEL, RAB8","Ras-related protein Rab-8A","1","6STG"
"6STK",,"X-RAY DIFFRACTION",1.97,37.67,"VAPOR DIFFUSION, SITTING DROP",,"15% glycerol, 25.5% PEG 4000, 85mM acetate buffer pH 4.6, 0.17 M ammonium acetate",291,"10.1074/jbc.RA120.013891",,"6STK",15.79,"1.52","1.52","Crystal structure of the CC-chemokine 5 (CCL5) E66S mutation","SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLSMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","1","6STK"
"6STS",,"X-RAY DIFFRACTION",3.74,67.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"3.6 M ammonium sulphate, 10% glycerol",291,"10.1074/jbc.RA120.013087",,"6STS",30.92,"3","3","Human myelin protein P2 mutant R30Q","GMSNKFLGTWKLVSSENFDDYMKALGVGLATQKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6STS"
"6SUB",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M BICINE, pH 9, 1 M lithium chloride, 20% (w/v) polyethylene glycol 6000",293,"10.1038/s41467-020-17076-w",,"6SUB",34.1,"1.72","1.72","Human PTPRU D1 domain, reduced form","MGSSHHHHHHTGGTHPAVRVADLLQHINQMKTAEGYGFKQEYESFFEGWDATKKKDKVKGSRQEPMPAYDRHRVKLHPMLGDPSADYINANYIDGYHRSNHFIATQGPKPEMVYDFWRMVWQEHCSSIVMITKLVEVGRVKCSRYWPEDSDTYGDIKIMLVKTETLAEYVVRTFALERRGYSARHEVRQFHFTAWPEHGVPYHATGLLAFIRRVKASTPPDAGPIVIHCSAGTGRTGCYIVLDVMLDMAECEGVVDIYNCVKTLCSRRVNMIQTEEQYIFIHDAILEACLCGETTIP","Homo sapiens","PTPRU, FMI, PCP2, PTPRO","Receptor-type tyrosine-protein phosphatase U","1","6SUB"
"6SUC",,"X-RAY DIFFRACTION",2.69,54.21,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M BICINE, pH 9, 1 M lithium chloride, 20% (w/v) polyethylene glycol 6000",293,"10.1038/s41467-020-17076-w",,"6SUC",34.03,"1.97","1.97","Human PTPRU D1 domain, oxidised form","MGSSHHHHHHTGGTHPAVRVADLLQHINQMKTAEGYGFKQEYESFFEGWDATKKKDKVKGSRQEPMPAYDRHRVKLHPMLGDPSADYINANYIDGYHRSNHFIATQGPKPEMVYDFWRMVWQEHCSSIVMITKLVEVGRVKCSRYWPEDSDTYGDIKIMLVKTETLAEYVVRTFALERRGYSARHEVRQFHFTAWPEHGVPYHATGLLAFIRRVKASTPPDAGPIVIHCSAGTGRTGCYIVLDVMLDMAECEGVVDIYNCVKTLCSRRVNMIQTEEQYIFIHDAILEACLCGETTIP","Homo sapiens","PTPRU, FMI, PCP2, PTPRO","Receptor-type tyrosine-protein phosphatase U","1","6SUC"
"6SUG",,"X-RAY DIFFRACTION",1.99,37.82,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",298,"10.1016/j.bioorg.2020.104144",,"6SUG",32.32,"1.21","1.21","Crystal structure of transthyretin in complex with 3-deoxytolcapone, a tolcapone analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6SUG"
"6SUH",,"X-RAY DIFFRACTION",1.88,33.89,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",298,"10.1016/j.bioorg.2020.104144",,"6SUH",32.38,"1.26","1.26","Crystal structure of human transthyretin in complex with 3-O-methyltolcapone, a tolcapone analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6SUH"
"6SUK",,"X-RAY DIFFRACTION",2.41,48.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M NH4Cl, 22% PEG3350",291,"10.1021/acs.jmedchem.0c00441","FT8","6SUK",81.74,"1.75","1.75","Crystal structure of Neprilysin in complex with Omapatrilat.","YDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6SUK"
"6SUO",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, magnesium chloride",293,"10.1021/acsmedchemlett.9b00370","LVH","6SUO",58.22,"1.74","1.74","ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6)","GSHMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6SUO"
"6SUU",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa387",,"6SUU",10.32,,,"NMR structure of KRAS32R G9T conformer G-quadruplex within KRAS promoter region","AGGGCGGTTTGGGAAGAGGGAAGAGGGGGAGG","Homo sapiens",,"KRAS32R G9T","1","6SUU"
"6SVC",,"SOLUTION NMR",,,,,,,"10.1002/anie.202008734",,"6SVC",4.11,,,"Protein allostery of the WW domain at atomic resolution: apo structure","SKLPPGWEKRMSRNSGRVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","6SVC"
"6SVE",,"SOLUTION NMR",,,,,,,"10.1002/anie.202008734",,"6SVE",4.11,,,"Protein allostery of the WW domain at atomic resolution: pCdc25C bound structure","SKLPPGWEKRMSRNSGRVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","6SVE"
"6SVH",,"SOLUTION NMR",,,,,,,"10.1002/anie.202008734",,"6SVH",4.11,,,"Protein allostery of the WW domain at atomic resolution: FFpSPR bound structure","SKLPPGWEKRMSRNSGRVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","6SVH"
"6SVK",,"X-RAY DIFFRACTION",2.01,38.83,"VAPOR DIFFUSION, SITTING DROP",6.4,"48% M1K3350 (12% w/v PEG 1000, 12% w/v PEG 3350, and 12% v/v MPD, original solution Molecular Dimensions), 1,25% NPS (3.75 mM sodium nitrate, 3.75 mM sodium phosphate dibasic, and 3.75 mM ammonium sulfate; original solution MolecularDimensions), 0.1M MMT buffer (pH 6.4) (0.02 M DL-malic acid, 0.04 M MES monohydrate, 0.04 M Tris)",277.15,"10.1038/s41467-019-13343-7",,"6SVK",31.81,"1.604","1.604","human Myeloid-derived growth factor (MYDGF)","VSEPTTVAFDVRPGGVVHSFSHNVGPGDKYTCMFTYASQGGTNEQWQMSLGTSEDHQHFTCTIWRPQGKSYLYFTQFKAEVRGAEIEYAMAYSKAAFERESDVPLKTEEFEVTKTAVAHRPGAFKAELSKLVIVAKASRTEL","Homo sapiens","MYDGF, C19orf10","Myeloid-derived growth factor","1","6SVK"
"6SVM",,"X-RAY DIFFRACTION",3.22,61.8,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.75, 0.2 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6SVM",157.32,"2.481","2.481","Crystal structure of human GFAT-1 in complex with Glucose-6-Phosphate, L-Glu, and UDP-GalNAc","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6SVM"
"6SVO",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.75, 0.2 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6SVO",156.22,"2.328","2.328","Crystal structure of human GFAT-1 in complex with Glucosamine-6-Phosphate and L-Glu","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6SVO"
"6SVP",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 9.0, 0.2 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6SVP",157.32,"2.531","2.531","Crystal structure of human GFAT-1 in complex with Glucose-6-Phosphate, L-Glu, and UDP-GlcNAc","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6SVP"
"6SVQ",,"X-RAY DIFFRACTION",3.27,62.44,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.75, 0.35 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6SVQ",156.2,"2.717","2.717","Crystal structure of human GFAT-1 G461E after UDP-GlcNAc soaking","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCEVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate-aminotransferase [isomerizing] 1","1","6SVQ"
"6SVS",,"X-RAY DIFFRACTION",3.44,64.28,"VAPOR DIFFUSION, HANGING DROP",,"The crystallization drop included 1.5 ul of MALAT1_th11 RNA and 1 ul reservoir solution containing 50 mM sodium cacodylate pH 6.0-6.3, 200 mM calcium acetate, and 2.5 M sodium chloride. Crystals were cryoprotected by stepwise addition of crystallization solution supplemented with glycerol until the final concentration of 20% glycerol was reached.",292,"10.1093/nar/gkz1222",,"6SVS",51.58,"2.5","2.5","Crystal Structure of U:A-U-rich RNA triple helix with 11 consecutive base triples","GAAGGUUUUUCUUUUUCCUGAAGGCGAAAGUCUUCAGGUUUUUCUUUUUGGCCUUUCUUAAAAAAAAAAAAAGAAAA","Homo sapiens",,"RNA (79-mer)","1","6SVS"
"6SVY",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NH4Cl, 22 % w/v PEG3350",291,"10.1021/acs.jmedchem.0c00441",,"6SVY",81.4,"2.6","2.6","Crystal structure of Neprilysin in complex with Sampatrilat-ASP.","YDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6SVY"
"6SW3",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"8% Ethylene Glycol (V/V), 0.1 M HEPES pH 7.5, 10% PEG 8000 (W/V)",277.15,,,"6SW3",28.59,"1.2","1.2","Crystal structure of CREBBP bromodomain L1109W mutant","SMRKKIFKPEELRQALMPTLEALYRQDPESWPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens",,"cDNA FLJ57039, highly similar to CREB-binding protein","1","6SW3"
"6SW5",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM NaF, 20 % PEG 3350 and 15 % ethylene glycol",298,"10.1107/S2059798320006002",,"6SW5",175.77,"2.35","2.35","Crystal structure of the human S-adenosylmethionine synthetase 1 (ligand-free form)","MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF","Homo sapiens","MAT1A, AMS1, MATA1","S-adenosylmethionine synthase isoform type-1","1","6SW5"
"6SW6",,"X-RAY DIFFRACTION",2.3,46.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM NaF, 20 % PEG 3350 and 15 % ethylene glycol",298,"10.1107/S2059798320006002",,"6SW6",87.37,"2.85","2.85","Crystal structure R264H mutant of the human S-adenosylmethionine synthetase 1","MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGHKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF","Homo sapiens","MAT1A, AMS1, MATA1","S-adenosylmethionine synthase isoform type-1","1","6SW6"
"6SWM",,"X-RAY DIFFRACTION",2.29,46.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"28-31% PEG4000, 0.2 M Sodium acetate, 0.1 M Tris pH 8.5-9.0",296,"10.1039/c8cc08562e",,"6SWM",58.33,"2.77","2.77","selenol bound carbonic anhydrase I","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6SWM"
"6SWN",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2M NaI, 0.1M BTP, 20C",298,"10.1126/science.aaz8455",,"6SWN",15.82,"1.28","1.28","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH iBET-BD1 (GSK778)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SWN"
"6SWO",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 300, 0.1M MES buffer",298,"10.1126/science.aaz8455",,"6SWO",14.07,"1.601","1.601","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD1 (GSK778)","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6SWO"
"6SWP",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 300, 0.1M MES buffer pH6.",298,"10.1126/science.aaz8455",,"6SWP",13.97,"1.604","1.604","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH iBET-BD2 (GSK046)","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6SWP"
"6SWQ",,"X-RAY DIFFRACTION",2.14,42.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"25%w/v PEG1500, 0.1M SPG buffer, pH 6",298,"10.1126/science.aaz8455",,"6SWQ",15.7,"1.601","1.601","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH iBET-BD2 (GSK046)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SWQ"
"6SWS",,"X-RAY DIFFRACTION",3.56,65.49,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.3 M NaH2PO4, 0.7M K2HPO4,0.1M sodium acetate pH4.5",298,"10.4049/jimmunol.1901210",,"6SWS",62.37,"3","3","The DBB dimerization domain of B-cell adaptor for PI3K (BCAP) is required for down regulation of inflammatory signalling through the Toll-like receptor pathway","SNAMVVQPDRIRCGAETTVYVIVRCKLDDRVATEAEFSPEDSPSVRMEAKVENEYTISVKAPNLSSGNVSLKIYSGDLVVCETVISYYTDMEEIGNLLSNAANPVEFMCQAFK","Homo sapiens","PIK3AP1, BCAP","Phosphoinositide 3-kinase adapter protein 1","1","6SWS"
"6SX3",,"SOLUTION NMR",,,,,,,"10.1002/chem.201904923",,"6SX3",10.34,,,"Intercalation of heterocyclic ligand between quartets in G-rich tetrahelical structure","GGGAGCGAGGGAGCGAGGGAGCGAGGGAGCG","Homo sapiens",,"VK2","1","6SX3"
"6SX9",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, HANGING DROP",8,"1.5 M sodium citrate, 0.1 M Tris pH 8.0",296,,,"6SX9",29.81,"1.43","1.43","Crystal structure of carbonic anhydrase 2 with 4-(2-chlorophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SX9"
"6SXW",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",,"0.1M tris pH 8.5 -- 2.6M ammonium sulfate",277,,,"6SXW",8.64,"2.751","2.751","Crystal structure of the first RRM domain of human Zinc finger protein 638 (ZNF638)","SVLLITELPEDGCTEEDVRKLFQPFGKVNDVLIVPYRKEAYLEMEFKEAITAIMKYIETTPLTIKGKSVKICVP","Homo sapiens","ZNF638, NP220, ZFML","Zinc finger protein 638","1","6SXW"
"6SXX",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2 M Potassium thiocyanate, 5% EtGly",277,,,"6SXX",28.95,"2.01","2.01","Crystal structure of the bromodomain of human CREBBP in complex with ACA007","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREBBP","1","6SXX"
"6SY1",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION",8.5,"20% PEG3350 -- 10% ethylene glycol -- 0.1M bis-tris-propane pH 8.5 -- 0.2M sodium formate",293,"10.1107/S205225252000696X",,"6SY1",202.78,"1.87","1.87","Crystal structure of the human 2-oxoadipate dehydrogenase DHTKD1 (E1)","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","6SY1"
"6SY2",,"SOLUTION NMR",,,,,,,"10.1002/pro.3820",,"6SY2",5.29,,,"Structure of the BRK domain of the SWI/SNF chromatin remodelling complex subunit BRG1 reveals a potential role in protein-protein interactions","SQMSDLPVKVIHVESGKILTGTDAPKAGQLEAWLEMNPGYEVAPRSDSE","Homo sapiens","SMARCA4, BAF190A, BRG1, SNF2B, SNF2L4","Transcription activator BRG1","1","6SY2"
"6SYB",,"X-RAY DIFFRACTION",2.08,40.8,"VAPOR DIFFUSION, HANGING DROP",8,"1.5 M sodium citrate, 50 mM Tris pH 8.0",296,,,"6SYB",29.83,"1.6","1.6","Crystal structure of carbonic anhydrase 2 with (3aR,4S,9bS)-4-(2-chloro-4-hydroxyphenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SYB"
"6SYG",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",,"20% w/v PEG 3350, 2% v/v Tacsimate, 0.1M Bis-Tris, pH 6.8",292,"10.1085/jgp.201912505",,"6SYG",15.07,"1.5","1.5","Crystal structure of the Cyclic Nucleotide-Binding Homology Domain of the human KCNH2 channel","GAMGRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRD","Homo sapiens","Kcnh2, Erg, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","6SYG"
"6SYP",,"X-RAY DIFFRACTION",3.38,63.56,"VAPOR DIFFUSION, SITTING DROP",4.8,"32% PEG 400
0.2M KSCN
0.2M NaBr
0.1M acetate 4.8",293,,,"6SYP",44.04,"1.8","1.8","Human DHODH bound to inhibitor IPP/CNRS-A017","MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase","1","6SYP"
"6SYS",,"X-RAY DIFFRACTION",2.1,41.49,"VAPOR DIFFUSION, HANGING DROP",8,"1.5 M sodium citrate, 50 mM Tris pH 8.0",296,,,"6SYS",30.13,"1.3","1.3","Crystal structure of (3aR,4S,9bS)-4-(4-hydroxyphenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide with carbonic anhydrase 2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6SYS"
"6SYW",,"X-RAY DIFFRACTION",2.16,43.2,"VAPOR DIFFUSION, SITTING DROP",5,"PEG 6000, DTT, diammonium hydrogen citrate, NADP+",291,,,"6SYW",37.1,"0.93","0.93","human Aldose Reductase in complex with SAR25","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","aldose reductase","1","6SYW"
"6SYZ",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M1E","6SYZ",42.75,"2.28","2.28","Crystal structure of YTHDC1 with fragment 1 (DHU_DC1_141)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SYZ"
"6SZ1",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M0W","6SZ1",42.73,"1.75","1.75","Crystal structure of YTHDC1 with fragment 2 (DHU_DC1_140)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZ1"
"6SZ2",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894",,"6SZ2",42.57,"1.52","1.52","Crystal structure of YTHDC1 with fragment 3 (DHU_DC1_149)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZ2"
"6SZ3",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894",,"6SZ3",42.74,"1.28","1.28","Crystal structure of YTHDC1 with fragment 4 (DHU_DC1_158)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZ3"
"6SZ7",,"X-RAY DIFFRACTION",2.02,39.08,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M1Q","6SZ7",42.75,"2.31","2.31","Crystal structure of YTHDC1 with fragment 5 (DHU_DC1_066)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZ7"
"6SZ8",,"X-RAY DIFFRACTION",2.02,39.12,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M1Z","6SZ8",42.6,"1.47","1.47","Crystal structure of YTHDC1 with fragment 6 (DHU_DC1_034)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZ8"
"6SZE",,"X-RAY DIFFRACTION",3.75,67.24,"VAPOR DIFFUSION, HANGING DROP",7,"100mM buffer (Mes or Hepes pH6.8-7.5), 12-28% PEG 400, 50-250mM CaCl2, 0-200mM NaCl",293,"10.1021/acsmedchemlett.9b00141",,"6SZE",71.81,"2.94","2.94","RIP2 Kinase Catalytic Domain complex with 5-Amino-1-Phenylpyrazole-4-Carboxamide.","GMNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6SZE"
"6SZF",,"SOLUTION NMR",,,,,,,"10.3390/ph14080732",,"6SZF",4.52,,,"Solution structure of the amyloid beta-peptide (1-42)","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6SZF"
"6SZJ",,"X-RAY DIFFRACTION",3.78,67.5,"VAPOR DIFFUSION, HANGING DROP",7,"100mM buffer (Mes or Hepes pH6.8-7.5), 12-28% PEG 400, 50-250mM CaCl2, 0-200mM NaCl",298,"10.1021/acsmedchemlett.9b00141",,"6SZJ",71.98,"2.53","2.53","RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.","GMNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6SZJ"
"6SZL",,"X-RAY DIFFRACTION",2,38.42,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M3E","6SZL",42.7,"1.45","1.45","Crystal structure of YTHDC1 with fragment 7 (DHU_DC1_021)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZL"
"6SZM",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, SITTING DROP",5.5,"2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,"10.1021/acs.jmedchem.0c01199",,"6SZM",71.76,"1.42","1.42","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6SZM"
"6SZN",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","YZM","6SZN",42.67,"1.47","1.47","Crystal structure of YTHDC1 with fragment 8 (DHU_DC1_006)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZN"
"6SZP",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, SITTING DROP",,"reservoir: 0.1M MES pH 6.0 + 30% PEG6000
drop: 1+1 (v/v)
cryo protectant: reservoir + 20%(v/v) glycerol",277.15,"10.1021/acs.jmedchem.9b01230","M3B","6SZP",32.94,"1.76","1.76","High resolution crystal structure of human DDAH-1 in complex with N-(4-Aminobutyl)-N'-(2-Methoxyethyl)guanidine","MRGSHHHHHHGSMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH1, DDAH","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1","1","6SZP"
"6SZQ",,"X-RAY DIFFRACTION",2.14,42.66,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M NaAc, 0.1M Tris pH 8,5, 30% PEG4000,
cryo: reservoir+20% glycerol",277.15,"10.1021/acs.jmedchem.9b01230",,"6SZQ",195.41,"2.412","2.412","Crystal structure of human DDAH-1","MRGSHHHHHHGSMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH1, DDAH","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1","1","6SZQ"
"6SZR",,"X-RAY DIFFRACTION",1.97,37.49,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M3Z","6SZR",42.76,"1.64","1.64","Crystal structure of YTHDC1 with fragment 9 (DHU_DC1_107)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6SZR"
"6SZT",,"X-RAY DIFFRACTION",2.02,38.98,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M4Q","6SZT",43.01,"1.5","1.5","Crystal structure of YTHDC1 with fragment 10 (DHU_DC1_076)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6SZT"
"6SZX",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M4K","6SZX",43.05,"1.17","1.17","Crystal structure of YTHDC1 with fragment 11 (DHU_DC1_128)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6SZX"
"6SZY",,"X-RAY DIFFRACTION",1.94,36.67,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M5N","6SZY",42.61,"1.79","1.79","Crystal structure of YTHDC1 with fragment 12 (DHU_DC1_150)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6SZY"
"6T01",,"X-RAY DIFFRACTION",1.99,38.11,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M4B","6T01",42.97,"1.5","1.5","Crystal structure of YTHDC1 with fragment 13 (DHU_DC1_153)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6T01"
"6T02",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M5E","6T02",43.43,"1.1","1.1","Crystal structure of YTHDC1 with fragment 15 (DHU_DC1_169)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T02"
"6T03",,"X-RAY DIFFRACTION",2.02,39.05,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","MZY","6T03",42.71,"1.5","1.5","Crystal structure of YTHDC1 with fragment 16 (DHU_DC1_017)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T03"
"6T04",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M3H","6T04",42.66,"1.5","1.5","Crystal structure of YTHDC1 with fragment 17 (DHU_DC1_042)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6T04"
"6T05",,"X-RAY DIFFRACTION",2.02,39.09,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M6H","6T05",42.84,"1.5","1.5","Crystal structure of YTHDC1 with fragment 18 (DHU_DC1_048)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T05"
"6T06",,"X-RAY DIFFRACTION",1.95,36.92,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M5H","6T06",42.6,"2.4","2.4","Crystal structure of YTHDC1 with fragment 19 (DHU_DC1_045)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T06"
"6T07",,"X-RAY DIFFRACTION",1.99,38.05,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M45","6T07",42.66,"1.5","1.5","Crystal structure of YTHDC1 with fragment 20 (DHU_DC1_134)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6T07"
"6T08",,"X-RAY DIFFRACTION",2,38.57,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M5B","6T08",42.78,"1.41","1.41","Crystal structure of YTHDC1 with fragment 21 (DHU_DC1_131)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T08"
"6T09",,"X-RAY DIFFRACTION",1.98,37.96,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894",,"6T09",42.88,"1.75","1.75","Crystal structure of YTHDC1 with fragment 24 (PSI_DC1_003)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T09"
"6T0A",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M58","6T0A",42.98,"2.02","2.02","Crystal structure of YTHDC1 with fragment 25 (PSI_DC1_005)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0A"
"6T0C",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M4E","6T0C",42.86,"2.03","2.03","Crystal structure of YTHDC1 with fragment 26 (DHU_DC1_198)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0C"
"6T0D",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M4N","6T0D",42.82,"1.43","1.43","Crystal structure of YTHDC1 with fragment 27 (DHU_DC1_256)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0D"
"6T0O",,"X-RAY DIFFRACTION",1.95,36.89,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894",,"6T0O",43.03,"1.71","1.71","Crystal structure of YTHDC1 with fragment 14 (ACA_DC1_004)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0O"
"6T0X",,"X-RAY DIFFRACTION",1.97,37.68,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M6W","6T0X",42.86,"1.36","1.36","Crystal structure of YTHDC1 with fragment 22 (ACA_DC1_001)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0X"
"6T0Z",,"X-RAY DIFFRACTION",1.98,37.82,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M75","6T0Z",42.98,"1.43","1.43","Crystal structure of YTHDC1 with fragment 23 (ACA_DC1_005)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T0Z"
"6T10",,"X-RAY DIFFRACTION",1.99,38.25,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M6Z","6T10",43.21,"1.48","1.48","Crystal structure of YTHDC1 with fragment 28 (DHU_DC1_176)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T10"
"6T11",,"X-RAY DIFFRACTION",1.99,38.28,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","O2A","6T11",42.88,"1.49","1.49","Crystal structure of YTHDC1 with fragment 29 (DHU_DC1_218)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T11"
"6T12",,"X-RAY DIFFRACTION",2.02,39.1,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acschembio.9b00894","M78","6T12",42.92,"1.46","1.46","Crystal structure of YTHDC1 with fragment 30 (DHU_DC1_220)","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6T12"
"6T13",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M ammonium sulfate
0.1M Tris 
17.5% PEG MME 5000",293,"10.1002/anie.202013890",,"6T13",243.18,"1.85","1.85","CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE IN COMPLEX WITH A PYRROLOPYRAZINE","MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6T13"
"6T1I",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M sodium chloride, 0.1 M bis-tris pH 6.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1I",19.21,"1.8","1.8","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 1","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1I"
"6T1J",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 6.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1J",19.07,"1.97","1.97","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 2","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1J"
"6T1L",,"X-RAY DIFFRACTION",2.18,43.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2M sodium chloride, 0.1 M bis-tris pH 6.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1L",19.23,"2","2","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with piperazine-urea derivative 3","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1L"
"6T1M",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 5.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1M",19.02,"1.85","1.85","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 4","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1M"
"6T1N",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M sodium chloride, 0.1M bis-tris pH 5.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1N",19.03,"1.95","1.95","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 5","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1N"
"6T1O",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 0.2M sodium chloride, 0.1M HEPES pH 7.5",293.15,"10.1021/acsmedchemlett.9b00460",,"6T1O",19,"1.9","1.9","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with benzimidazole-amide derivative 6","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6T1O"
"6T1R","9.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0332-9",,"6T1R",318.98,"9.8",,"Pseudo-atomic model of a 16-mer assembly of reduced recombinant human alphaA-crystallin (non domain swapped configuration)","MDVTIQHPWFKRTLGPFYPSRLFDQFFGEGLFEYDLLPFLSSTISPYYRQSLFRTVLDSGISEVRSDRDKFVIFLDVKHFSPEDLTVKVQDDFVEIHGKHNERQDDHGYISREFHRRYRLPSNVDQSALSCSLSADGMLTFCGPKIQTGLDATHAERAIPVSREEKPTSAPSS","Homo sapiens","CRYAA, CRYA1, HSPB4","Alpha-crystallin A chain","1","6T1R"
"6T1S",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2 M LiSO4,  BisTris 0.1M pH 6.5",290,,,"6T1S",32.49,"1.65","1.65","PPAR mutant","GSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRISQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6T1S"
"6T27",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5: 15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5, 20% (w/v) PEG 6000",291,,,"6T27",36.98,"1.11","1.11","Structure of Human Aldose Reductase Mutant L301A with a Citrate Molecule Bound in the Anion Binding Pocket","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6T27"
"6T28",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",5.9,"0,1M NaCit, pH 5.9
2,05M AmmSO4
0,1M Na/K tartrate",293,"10.1021/acs.jmedchem.9b01803",,"6T28",43.84,"1.55","1.55","Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)","MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLDSSNASVSSSLSLASQKDCLAPSTLCSFISSSSGVSGVGAERRPRPTTVTAVHSGSK","Homo sapiens","CAMK1D, CAMKID","Calcium/calmodulin-dependent protein kinase type 1D","1","6T28"
"6T29",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5.9,"0,1M NaCit, pH 5.9
2,05M AmmSO4
0,1M Na/K tartrate",293,"10.1021/acs.jmedchem.9b01803",,"6T29",44.11,"1.484","1.484","Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)","MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLDSSNASVSSSLSLASQKDCLAPSTLCSFISSSSGVSGVGAERRPRPTTVTAVHSGSK","Homo sapiens","CAMK1D, CAMKID","Calcium/calmodulin-dependent protein kinase type 1D","1","6T29"
"6T2G",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa387",,"6T2G",10.32,,,"NMR structure of KRAS32R G25T conformer G-quadruplex within KRAS promoter region","AGGGCGGTGTGGGAAGAGGGAAGATGGGGAGG","Homo sapiens",,"KRAS32R G25T","1","6T2G"
"6T2H",,"X-RAY DIFFRACTION",1.93,36.12,"EVAPORATION",4.2,"1.5M Ammonium sulfate 0.1 M Sodium citrate pH4.2",300,"10.1016/j.bmcl.2019.126751",,"6T2H",45.7,"1.41","1.41","Furano[2,3-d]prymidine amides as Notum inhibitors","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6T2H"
"6T2K",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5M Ammonium sulfate 0.1 M Sodium citrate pH4.2",300,"10.1016/j.bmcl.2019.126751",,"6T2K",44.82,"1.38","1.38","Furano[2,3-d]prymidine amides as Notum inhibitors","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6T2K"
"6T2W",,"X-RAY DIFFRACTION",2.47,50.24,"VAPOR DIFFUSION",5.5,"16% PEG3350, 0.15 M Ammonium Sulfate, 0.1 M PCTP pH 5.5",277,"10.1021/acs.jmedchem.9b01684","M9T","6T2W",38.1,"1.7","1.7","Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)","QKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLSPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","6T2W"
"6T3B",,"X-RAY DIFFRACTION",2.25,45.33,"VAPOR DIFFUSION",8,"20 % PEG3350, 0.175 M ammonium sulfate, 0.001 M TCEP, 0.1 M Hepes pH 8.0",293,"10.1021/acs.jmedchem.9b01684",,"6T3B",111.11,"3.01","3.01","Crystal structure of PI3Kgamma with a dihydropurinone inhibitor (compound 4)","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6T3B"
"6T3C",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION",8,"20 % PEG3350, 0.175 M ammonium sulfate, 0.001 M TCEP, 0.1 M Hepes pH 8.0",293,"10.1021/acs.jmedchem.9b01684",,"6T3C",111.11,"2.62","2.62","Crystal structure of PI3Kgamma in complex with DNA-PK inhibitor AZD7648","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6T3C"
"6T3I",,"SOLUTION NMR",,,,,,,"10.3390/cells10010192",,"6T3I",9.68,,,"Solution structure of the HRP2 IBD","AASPSVEEKLQKLHSEIKFALKVDSPDVKRCLNALEELGTLQVTSQILQKNTDVVATLKKIRRYKANKDVMEKAAEVYTRLKSRGS","Homo sapiens","HDGFL2, HDGF2, HDGFRP2, HRP2, UNQ785/PRO1604","Hepatoma-derived growth factor-related protein 2","1","6T3I"
"6T3O",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.1 M citrate/phosphate buffer pH 5.4, 30 % PEG3350",291,"10.1080/21505594.2021.1920251",,"6T3O",15.44,"1.8","1.8","Crystal structure of the human myomesin domain 10","MGSSHHHHHHSSGLVPRGSHMKSELAVEILEKGQVRFWMQAEKLSGNAKVNYIFNEKEIFEGPKYKMHIDRNTGIIEMFMEKLQDEDEGTYTFQLQDGKATNHSTVVLVGDVFKKLQKEAEFQRQEWIRKQG","Homo sapiens","MYOM1","Myomesin-1","1","6T3O"
"6T3P",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0: 15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 20% (w/v) PEG 6000
Soaking-buffer: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 25% PEG 6000",291,,,"6T3P",37.49,"0.97","0.97","Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAALSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6T3P"
"6T4B",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Sodium bromide, 0.1M Bis-Tris propane 6.5, 20% PEG 3350",293,"10.1016/j.isci.2020.101159",,"6T4B",44.86,"2.55","2.55","CRYSTAL STRUCTURE OF HUMAN TDP-43 N-TERMINAL DOMAIN AT 2.55 A RESOLUTION","MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKD","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","6T4B"
"6T4G",,"X-RAY DIFFRACTION",3.01,59.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4G",31.45,"1.93","1.93","ROR(gamma)t ligand binding domain in complex with cholesterol and allosteric ligand FM26","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4G"
"6T4I",,"X-RAY DIFFRACTION",2.96,58.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M MgCl2 + 6% PEG6K + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4I",31.44,"1.84","1.84","ROR(gamma)t ligand binding domain in complex with cholesterol and allosteric ligand MRL871","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4I"
"6T4J",,"X-RAY DIFFRACTION",2.76,55.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4J",31.45,"1.79","1.79","ROR(gamma)t ligand binding domain in complex with desmosterol and allosteric ligand FM26","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4J"
"6T4K",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M MgCl2 + 6% PEG6K + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4K",31.53,"1.89","1.89","ROR(gamma)t ligand binding domain in complex with desmosterol and allosteric ligand MRL871","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4K"
"6T4N",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1016/j.bpj.2020.08.037","F1A","6T4N",29.93,"1.4","1.4","Human Carbonic anhydrase II bound by 2,4,6-trimethylbenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6T4N"
"6T4O",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1016/j.bpj.2020.08.037","MJ2","6T4O",29.78,"1.133","1.133","Human Carbonic anhydrase II bound by 3,5-dimethylbenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6T4O"
"6T4P",,"X-RAY DIFFRACTION",2.06,40.17,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1016/j.bpj.2020.08.037","MHK","6T4P",29.94,"1.75","1.75","Human Carbonic anhydrase II bound by napthalene-1-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6T4P"
"6T4T",,"X-RAY DIFFRACTION",2.76,55.51,"VAPOR DIFFUSION, SITTING DROP",,"none - crystallized in storage buffer upon evaporation",293,"10.1073/pnas.2021287118",,"6T4T",29.23,"1.62","1.62","ROR(gamma)t ligand binding domain in complex with 20-alpha-hydroxycholesterol and allosteric ligand FM26","LTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4T"
"6T4U",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, SITTING DROP",,"none - crystallized in storage buffer upon evaporation",293,"10.1073/pnas.2021287118",,"6T4U",29.01,"2","2","ROR(gamma)t ligand binding domain in complex with 20-alpha-hydroxycholesterol and allosteric ligand MRL871","TEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4U"
"6T4W",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, SITTING DROP",,"none - crystallized in storage buffer upon evaporation",293,"10.1073/pnas.2021287118",,"6T4W",29.09,"1.71","1.71","ROR(gamma)t ligand binding domain in complex with 20-alpha-hydroxycholesterol and allosteric ligand Glenmark","TEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4W"
"6T4X",,"X-RAY DIFFRACTION",2.76,55.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4X",31.47,"1.48","1.48","ROR(gamma)t ligand binding domain in complex with 25-hydroxycholesterol and allosteric ligand FM26","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4X"
"6T4Y",,"X-RAY DIFFRACTION",2.93,57.95,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T4Y",31.45,"1.95","1.95","ROR(gamma)t ligand binding domain in complex with 25-hydroxycholesterol and allosteric ligand MRL871","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T4Y"
"6T50",,"X-RAY DIFFRACTION",3.01,59.16,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M MgCl2 + 6% PEG6K + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6T50",31.44,"1.87","1.87","ROR(gamma)t ligand binding domain in complex with 25-hydroxycholesterol and allosteric ligand Glenmark","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6T50"
"6T51",,"SOLUTION NMR",,,,,,,"10.1007/s12104-017-9793-0",,"6T51",7.06,,,"NMR structure of KRAS22RT G-quadruplex forming within KRAS promoter region at physological temperature","AGGGCGGTGTGGGAATAGGGAA","Homo sapiens",,"KRAS22RT","1","6T51"
"6T5B",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, SITTING DROP",,"50mM HEPES pH 7.4, 100mM NaCl, 2mM MgSO4",293,"10.1021/acs.jmedchem.9b01720",,"6T5B",20.43,"1.37","1.37","KRasG12C ligand complex","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLIREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6T5B"
"6T5C",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1016/j.bpj.2020.08.037",,"6T5C",30.07,"1.22","1.22","Human Carbonic anhydrase II bound by anthracene-9-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6T5C"
"6T5G",,"X-RAY DIFFRACTION",2.14,42.48,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0:
15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% /w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 20% (w/v) PEG 6006",291,,,"6T5G",36.98,"1.28","1.28","Structure of Human Aldose Reductase Mutant L300A with a Citrate Molecule Bound in the Anion Binding Pocket","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAALSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6T5G"
"6T5J",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 0.15 M MgCl2, and 30% PEG3350",290,"10.1038/s41589-020-0592-z","MKB","6T5J",38.29,"1.6","1.6","Structure of NUDT15 in complex with inhibitor TH1760","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Probable 8-oxo-dGTP diphosphatase NUDT15","1","6T5J"
"6T5P",,"X-RAY DIFFRACTION",2.06,40.34,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 30% PEG4000",291,"10.1016/j.bpj.2020.08.037","VD8","6T5P",121.38,"1.5","1.5","Human Carbonic anhydrase XII bound by 3,5-Di-tert-butylbenzenesulfonamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6T5P"
"6T5Q",,"X-RAY DIFFRACTION",2,38.57,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 26% PEG4000",291,"10.1016/j.bpj.2020.08.037","MKQ","6T5Q",120.98,"1.8","1.8","Human Carbonic anhydrase XII bound by 3,5-diphenylbenzenesulfonamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6T5Q"
"6T5U",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, SITTING DROP",7.4,"50mM HEPES, 100mM NaCl, 2mM MgSO4",293,"10.1021/acs.jmedchem.9b01720",,"6T5U",40.05,"1.72","1.72","KRasG12C ligand complex","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, hCG_14731, KRAS2, RASK2","V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b","1","6T5U"
"6T5V",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",,"50mM HEPES
100mM NaCl 
2mM MgSO4",293,"10.1021/acs.jmedchem.9b01720",,"6T5V",20.2,"1.31","1.31","KRasG12C ligand complex","MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6T5V"
"6T6A",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"31% PEG 400, 0.2 M lithium sulfate and 0.1 M tris, pH 7.5",277.15,"10.3390/molecules24224090",,"6T6A",171.24,"2.8","2.8","Crystal structure of DYRK1A complexed with KuFal319 (compound 11)","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6T6A"
"6T6B",,"X-RAY DIFFRACTION",2.58,52.26,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG 3350, 0.15 M sodium citrate and 0.1 M tris, pH 8.0",293.15,"10.1021/acs.jmedchem.9b01786",,"6T6B",32.2,"2.8","2.8","Crystal structure of PPARgamma in complex with compound 16 (MF27)","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6T6B"
"6T6D",,"X-RAY DIFFRACTION",2.92,57.9,"VAPOR DIFFUSION, SITTING DROP",4.9,"0.1M citrate pH 4.9, 1M ammonium sulfate, 0.2M sodium/potassium tartrate",277,"10.1021/acs.jmedchem.0c00395",,"6T6D",140.82,"2.56","2.56","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6T6D"
"6T6F",,"X-RAY DIFFRACTION",2.34,47.41,"VAPOR DIFFUSION, SITTING DROP",5.5,"28% PEG3350 -- 0.1M bis-tris pH 5.5 -- 0.2M ammonium acetate",293,,,"6T6F",74.16,"1.97","1.97","Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 8 (CS275)","SMSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLD","Homo sapiens","CAMK1D, CAMKID","Calcium/calmodulin-dependent protein kinase type 1D","1","6T6F"
"6T6R",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, SITTING DROP",4,"PACT condition D1 (0.1M MMT, pH 4.0, 25% PEG 1500), MMT = DL-malic acid, MES monohydrate, Tris",293,"10.1021/acs.jmedchem.9b02123",,"6T6R",107.13,"1.67","1.67","Human endoplasmic reticulum aminopeptidase 1 (ERAP1) in complex with (4aR,5S,6R,8S,8aR)-5-(2-(Furan-3-yl)ethyl)-8-hydroxy-5,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid","MVFLPLKWSLATMSFLLSSLLALLTVSTPSWCQSTEASPKRSDGTPFPWNKIRLPEYVIPVHYDLLIHAQLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGQLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALQSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASIGSGGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGQLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLERMENLYFQ","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","Endoplasmic reticulum aminopeptidase 1","1","6T6R"
"6T7H",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, SITTING DROP",,"18 % w/v PEG 4000 
0.1 M Tris pH 9.0 
0.3 M Sodium acetate trihydrate 
20 % v/v Ethylene glycol",293,"10.1039/d0sc01944e",,"6T7H",69.67,"2.32","2.32","Crystal structure of Thrombin in complex with macrocycle N14-PR4-A","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","6T7H"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","6T7H"
"6T7P",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG10000, 200 mM Sodium phosphate (monobasic), corresponds to Nextal condition #87 from PEG series",293,"10.1021/acs.jmedchem.0c00279","MU8","6T7P",28.92,"1.416","1.416","human plasmakallikrein protease domain in complex with active site directed inhibitor","IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKA","Homo sapiens","KLKB1, KLK3","Plasma kallikrein","1","6T7P"
"6T7Q",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0: 15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 20% (w/v) PEG 6000
Soaking-buffer: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 25% (w/v) PEG 6000",291,,,"6T7Q",37.14,"1.01","1.01","Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6T7Q"
"6T7U",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM TRIS-HCl
1.6 M Sodium Citrate",290,"10.1016/j.ejmech.2020.112460","X33","6T7U",29.52,"1.2","1.2","Carborane inhibitor of Carbonic Anhydrase IX","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVVFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6T7U"
"6T81",,"X-RAY DIFFRACTION",2.05,39.87,"VAPOR DIFFUSION, SITTING DROP",,"0.1M sodium bicine (pH 9) and 2M sodium malonate (pH 7)",291,"10.1016/j.bpj.2020.08.037","MUE","6T81",29.79,"0.98","0.98","Human Carbonic anhydrase II bound by 2-Naphthalenesulfonamide.","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6T81"
"6T8N",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M citrate pH 5.5
1.2M ammonium sulfate
0.4M sodium/potassium tartrate",277,,,"6T8N",70.86,"1.77","1.77","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K3007","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6T8N"
"6T8P",,"X-RAY DIFFRACTION",2.54,51.63,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium iodide",293,"10.1016/j.bmcl.2020.127060","MVT","6T8P",104.82,"2.02","2.02","HKATII IN COMPLEX WITH LIGAND (2R)-N-benzyl-1-[6-methyl-5-(oxan-4-yl)-7-oxo-6H,7H-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide","MSYYHHHHHHDYDIPTTENLYFQGAMEMNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","6T8P"
"6T8Q",,"X-RAY DIFFRACTION",4.39,72,"VAPOR DIFFUSION, SITTING DROP",,"PEG 400, cadmium chloride, sodium acetate",293,"10.1016/j.bmcl.2020.127060",,"6T8Q",52.44,"2.51","2.51","HKATII IN COMPLEX WITH LIGAND (2R)-N-benzyl-1-[6-methyl-5-(oxan-4-yl)-7-oxo-6H,7H-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide","MSYYHHHHHHDYDIPTTENLYFQGAMEMNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","6T8Q"
"6T8U",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",,"2.4M AMMONIUM SULPHATE, 0.1 M SODIUM ACETATE PH 4.6",298,"10.1021/acs.jmedchem.9b01870",,"6T8U",100.61,"2.84","2.84","Complement factor B in complex with 5-Bromo-3-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-7-methyl-1H-indol-4-amine","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6T8U"
"6T8V",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 0.1M HEPES PH 7.5, 5 mM inhibitor",298,"10.1021/acs.jmedchem.9b01870",,"6T8V",67.25,"2.29","2.29","Complement factor B in complex with (S)-5,7-Dimethyl-4-((2-phenylpiperidin-1-yl)methyl)-1H-indole","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6T8V"
"6T8W",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 0.1M BIS-TRIS PH 6.5, 0.2M        
AMMONIUM SULFATE, 0.1 MM ZNCL2, 1 mM inhibitor",298,"10.1021/acs.jmedchem.9b01870",,"6T8W",67.16,"1.7","1.7","Complement factor B in complex with (-)-4-(1-((5,7-Dimethyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6T8W"
"6T8X",,"X-RAY DIFFRACTION",3.39,63.74,"VAPOR DIFFUSION, SITTING DROP",6,"1.3M NaMalonate, 0.1M Hepes pH6.0, 0.5% jeffamine ED2003",295,,,"6T8X",226.44,"2.81","2.81","Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide","MGSSHHHHHHSSGENLYFQGSQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQEPLHT","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","6T8X"
"6T9C",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M Sodium Citrate, 0.15 M Tris",293,"10.1021/acs.jmedchem.0c00048",,"6T9C",69.5,"1.95","1.95","Crystal structure of the complex between PPARgamma LBD and the ligand NV1346 (3a)","MGSSHHHHHHSSGLVPRGSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6T9C"
"6T9N","2.96","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.11.005",,"6T9N",276.89,"2.96",,"CryoEM structure of human polycystin-2/PKD2 in UDM supplemented with PI(4,5)P2","MPRVAWAERLVRGLRGLWGTRLMEESSTNREKYLKSVLRELVTYLLFLIVLCILTYGMMSSNVYYYTRMMSQLFLDTPVSKTEKTNFKTLSSMEDFWKFTEGSLLDGLYWKMQPSNQTEADNRSFIFYENLLLGVPRIRQLRVRNGSCSIPQDLRDEIKECYDVYSVSSEDRAPFGPRNGTAWIYTSEKDLNGSSHWGIIATYSGAGYYLDLSRTREETAAQVASLKKNVWLDRGTRATFIDFSVYNANINLFCVVRLLVEFPATGGVIPSWQFQPLKLIRYVTTFDFFLAACEIIFCFFIFYYVVEEILEIRIHKLHYFRSFWNCLDVVIVVLSVVAIGINIYRTSNVEVLLQFLEDQNTFPNFEHLAYWQIQFNNIAAVTVFFVWIKLFKFINFNRTMSQLSTTMSRCAKDLFGFAIMFFIIFLAYAQLAYLVFGTQVDDFSTFQECIFTQFRIILGDINFAEIEEANRVLGPIYFTTFVFFMFFILLNMFLAIINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDAENLYFQ","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","6T9N"
"6T9O","3.39","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.11.005",,"6T9O",270.93,"3.39",,"CryoEM structure of human polycystin-2/PKD2 in UDM supplemented with PI(3,5)P2","MPRVAWAERLVRGLRGLWGTRLMEESSTNREKYLKSVLRELVTYLLFLIVLCILTYGMMSSNVYYYTRMMSQLFLDTPVSKTEKTNFKTLSSMEDFWKFTEGSLLDGLYWKMQPSNQTEADNRSFIFYENLLLGVPRIRQLRVRNGSCSIPQDLRDEIKECYDVYSVSSEDRAPFGPRNGTAWIYTSEKDLNGSSHWGIIATYSGAGYYLDLSRTREETAAQVASLKKNVWLDRGTRATFIDFSVYNANINLFCVVRLLVEFPATGGVIPSWQFQPLKLIRYVTTFDFFLAACEIIFCFFIFYYVVEEILEIRIHKLHYFRSFWNCLDVVIVVLSVVAIGINIYRTSNVEVLLQFLEDQNTFPNFEHLAYWQIQFNNIAAVTVFFVWIKLFKFINFNRTMSQLSTTMSRCAKDLFGFAIMFFIIFLAYAQLAYLVFGTQVDDFSTFQECIFTQFRIILGDINFAEIEEANRVLGPIYFTTFVFFMFFILLNMFLAIINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDAENLYFQ","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","6T9O"
"6T9P",,"X-RAY DIFFRACTION",3.17,61.21,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate",293,"10.1042/BCJ20200192",,"6T9P",62.33,"2.7","2.7","Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1R)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6T9P"
"6T9Q",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION",,"200mM Sodium formate
18% PEG3350",292,"10.15252/embj.2019104185",,"6T9Q",7.88,"1.15","1.15","Crystal structure of the second, C-terminal repeat of the DNA-binding domain of human TImeless","DPGTHIVLWTGDQELELQRLFEEFRDSDDVLGHIMKNITAKRSRARIVDKLLALGLVAERRELYKKR","Homo sapiens","TIMELESS, TIM, TIM1, TIMELESS1","Protein timeless homolog","1","6T9Q"
"6T9S",,"X-RAY DIFFRACTION",3.17,61.21,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1042/BCJ20200192",,"6T9S",62.33,"2.7","2.7","Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6T9S"
"6T9T",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION",,"100 mM Sodium acetate pH 4.6, 2 M Sodium formate, protein concentration 7 mg/ml",291,,,"6T9T",27.14,"1.69","1.69","Matriptase in complex with the synthetic inhibitor (S)-3-(3-(4-(3-(tert-butyl)ureido)piperidin-1-yl)-2-((3'-fluoro-4'-(hydroxymethyl)-[1,1'-biphenyl])-3-sulfonamido)-3-oxopropyl)benzimidamide (MI-1904)","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","6T9T"
"6T9Z",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, HANGING DROP",,"50 mM TRIS-HCl
1.6 M Sodium Citrat",290,"10.1016/j.ejmech.2020.112460","MYW","6T9Z",29.59,"1.12","1.12","Nidocarborane inhibitor of Carbonic Anhydrase IX","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6T9Z"
"6TA0",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Bis Tris propane, 200 mM sodium malonate, 22% PEG3350, 10 mM nicotinic acid, 10 mM PRPP",277,,,"6TA0",115.21,"1.58","1.58","Human NAMPT in complex with nicotinic acid and phosphoribosyl pyrophosphate","MRGSHHHHHHGSMNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6TA0"
"6TA2",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Bis Tris propane, 20 mM sodium potassium phosphate, 22% PEG3350, 10 mM NAMN",281,,,"6TA2",115.02,"1.68","1.68","Human NAMPT in complex with nicotinic acid mononucleotide and phosphate","MRGSHHHHHHGSMNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6TA2"
"6TAC",,"X-RAY DIFFRACTION",2.42,49.19,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Bis Tris propane, 200 mM NaF, 16% PEG3350, 10 mM Nam, 10 mM PRPP, 6 mM MgCl2",277,,,"6TAC",112.78,"1.6","1.6","Human NAMPT deletion mutant in complex with nicotinamide mononucleotide, pyrophosphate, and Mg2+","MRGSHHHHHHGSMNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6TAC"
"6TAM",,"X-RAY DIFFRACTION",2.06,40.21,"VAPOR DIFFUSION, SITTING DROP",6.9,"100 mM MES pH 6.9 and 34% PEG 4000",293,"10.1002/cmdc.201900727",,"6TAM",20.2,"1.64","1.64","X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 3)","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6TAM"
"6TAN",,"X-RAY DIFFRACTION",2.06,40.15,"VAPOR DIFFUSION, SITTING DROP",6.3,"100 NANOLITER COVALENTLY MODIFIED KRAS (CONCENTRATION 18.8 MG/ML, IN 0.02 M HEPES PH 7.5, 0.15 M NACL, 0.001 M MGCL2) ADDED TO 100 NANOLITER RESERVOIR (0.1 M NA-MES PH 6.3, 31 % PEG 4000)",293,"10.1002/cmdc.201900727",,"6TAN",20.2,"1.16","1.16","X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 17)","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6TAN"
"6TAV",,"X-RAY DIFFRACTION",3.67,66.47,"VAPOR DIFFUSION, SITTING DROP",,"Equivolumetric drops consisting of 0.2M tribasic ammonium citrate, pH6.4, 15% (w/v) polyethylene glycol 3350, plus 0.05M sodium fluoride as an additive, and protein solution at 4.9 absorption units at lambda=280nm yielded a single large well-shaped monocrystal after several months. This crystal could not be reproduced despite extensive trials.",293,,,"6TAV",666.2,"4.2","4.2","Crystal structure of endopeptidase-induced alpha2-macroglobulin","MGKNKLLHPSLVLLLLVLLPTDASVSGKPQYMVLVPSLLHTETTEKGCVLLSYLNETVTVSASLESVRGNRSLFTDLEAENDVLHCVAFAVPKSSSNEEVMFLTVQVKGPTQEFKKRTTVMVKNEDSLVFVQTDKSIYKPGQTVKFRVVSMDENFHPLNELIPLVYIQDPKGNRIAQWQSFQLEGGLKQFSFPLSSEPFQGSYKVVVQKKSGGRTEHPFTVEEFVLPKFEVQVTVPKIITILEEEMNVSVCGLYTYGKPVPGHVTVSICRKYSDASDCHGEDSQAFCEKFSGQLNSHGCFYQQVKTKVFQLKRKEYEMKLHTEAQIQEEGTVVELTGRQSSEITRTITKLSFVKVDSHFRQGIPFFGQVRLVDGKGVPIPNKVIFIRGNEANYYSNATTDEHGLVQFSINTTNVMGTSLTVRVNYKDRSPCYGYQWVSEEHEEAHHTAYLVFSPSKSFVHLEPMSHELPCGHTQTVQAHYILNGGTLLGLKKLSFYYLIMAKGGIVRTGTHGLLVKQEDMKGHFSISIPVKSDIAPVARLLIYAVLPTGDVIGDSAKYDVENCLANKVDLSFSPSQSLPASHAHLRVTAAPQSVCALRAVDQSVLLMKPDAELSASSVYNLLPEKDLTGFPGPLNDQDNEDCINRHNVYINGITYTPVSSTNEKDMYSFLEDMGLKAFTNSKIRKPKMCPQLQQYEMHGPEGLRVGFYESDVMGRGHARLVHVEEPHTETVRKYFPETWIWDLVVVNSAGVAEVGVTVPDTITEWKAGAFCLSEDAGLGISSTASLRAFQPFFVELTMPYSVIRGEAFTLKATVLNYLPKCIRVSVQLEASPAFLAVPVEKEQAPHCICANGRQTVSWAVTPKSLGNVNFTVSAEALESQELCGTEVPSVPEHGRKDTVIKPLLVEPEGLEKETTFNSLLCPSGGEVSEELSLKLPPNVVEESARASVSVLGDILGSAMQNTQNLLQMPYGCGEQNMVLFAPNIYVLDYLNETQQLTPEIKSKAIGYLNTGYQRQLNYKHYDGSYSTFGERYGRNQGNTWLTAFVLKTFAQARAYIFIDEAHITQALIWLSQRQKDNGCFRSSGSLLNNAIKGGVEDEVTLSAYITIALLEIPLTVTHPVVRNALFCLESAWKTAQEGDHGSHVYTKALLAYAFALAGNQDKRKEVLKSLNEEAVKKDNSVHWERPQKPKAPVGHFYEPQAPSAEVEMTSYVLLAYLTAQPAPTSEDLTSATNIVKWITKQQNAQGGFSSTQDTVVALHALSKYGAATFTRTGKAAQVTIQSSGTFSSKFQVDNNNRLLLQQVSLPELPGEYSMKVTGEGCVYLQTSLKYNILPEKEEFPFALGVQTLPQTCDEPKAHTSFQISLSVSYTGSRSASNMAIVDVKMVSGFIPLKPTVKMLERSNHVSRTEVSSNHVLIYLDKVSNQTLSLFFTVLQDVPVRDLKPAIVKVYDYYETDEFAIAEYNAPCSKDLGNA","Homo sapiens","A2M, CPAMD5, FWP007","Alpha-2-macroglobulin","1","6TAV"
"6TAZ",,"SOLUTION NMR",,,,,,,"10.15252/embj.2019104185",,"6TAZ",16.36,,,"Timeless couples G quadruplex detection with processing by DDX11 during DNA replication","DPSRRAPTWSPEEEAHLRELYLANKDVEGQDVVEAILAHLNTVPRTRKQIIHHLVQMGLADSVKDFQRKGTHIVLWTGDQELELQRLFEEFRDSDDVLGHIMKNITAKRSRARIVDKLLALGLVAERRELYKKRQKKLASS","Homo sapiens","TIMELESS, TIM, TIM1, TIMELESS1","Protein timeless homolog","1","6TAZ"
"6TBE",,"X-RAY DIFFRACTION",2.83,56.52,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammoniumnitrat and 20% w/v PEG 3350",293.15,"10.1021/acs.jmedchem.0c01564",,"6TBE",14.77,"1.67008040045","1.67008040045","LC3A in complex with (3R,4S,5R,6R)-5-hydroxy-6-((4-hydroxy-3-(4-hydroxy-3-isopentylbenzamido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate","GAMDRPFKQRRSFADRCKEVQQIRDQHPSKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELVKIIRRRLQLNPTQAFFLLVNQHSMVSVSTPIADIYEQEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3A","Microtubule-associated proteins 1A/1B light chain 3A","1","6TBE"
"6TC2",,"X-RAY DIFFRACTION",1.95,36.94,"BATCH MODE",5.82,"12.78 mg/mL insulin, 0.77 mM zinc acetate, 40 mM p-coumaric acid, 3.2%(w/v) PEG-1000, 10 mM sodium thiocyanate, 0.4 M phosphate mixture (Na2HPO4, KH2PO4), pH = 5.82",298,"10.1107/S205979832001195X",,"6TC2",145.17,"1.36","1.36","Monoclinic human insulin in complex with p-coumaric acid","MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","6TC2"
"6TCM",,"X-RAY DIFFRACTION",3.57,65.58,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.085M Tris pH8.5, 42.5% MPD, 15% glycerol and 0.17M ammonium phosphate",291,"10.1107/S2053230X20001466",,"6TCM",49.64,"1.85","1.85","Crystal structure of the omalizumab Fab - crystal form I","DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab","1","6TCM"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab","2","6TCM"
"6TCN",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1M phosphate-citrate pH4.2, 20% PEG 1000 and 0.2M lithium sulphate. Cryoprotected with 0.1M sodium acetate pH4.6, 25% PEG 4000 and 18% ethylene glycol.",291,"10.1107/S2053230X20001466",,"6TCN",98.2,"2.3","2.3","Crystal structure of the omalizumab Fab - crystal form II","DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab","1","6TCN"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab","2","6TCN"
"6TCO",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350 and 0.2M sodium sulphate. Crystals were cryoprotected with 20% PEG 3350, 0.2M magnesium sulphate and 18% ethylene glycol.",291,"10.1107/S2053230X20001466",,"6TCO",98.85,"1.8","1.8","Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form I","DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNAPQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab Leu158Pro light chain mutant","1","6TCO"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab Leu158Pro light chain mutant","2","6TCO"
"6TCP",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 4000, 0.2M magnesium sulphate and 10% glycerol. Crystals were cryoprotected in 20% PEG 4000, 0.2M magnesium sulphate and 18% glycerol.",291,"10.1107/S2053230X20001466",,"6TCP",196.49,"2.5","2.5","Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form II","DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNAPQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab Leu158Pro light chain mutant","1","6TCP"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab Leu158Pro light chain mutant","2","6TCP"
"6TCQ",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH7 and 20% PEG 4000. Crystals were cryoprotected with 12% PEG 400 and 17% glycerol",291,"10.1107/S2053230X20001466",,"6TCQ",48.79,"2.05","2.05","Crystal structure of the omalizumab Fab Ser81Arg and Gln83Arg light chain mutant","EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant","1","6TCQ"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISRLRPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant","2","6TCQ"
"6TCR",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH7, 20% PEG 4000 and 0.15M ammonium sulphate. Crystals were cryoprotected with 0.1M HEPES pH7.5, 20% PEG 4000, 0.1M ammonium sulphate and 15% ethylene glycol",291,"10.1107/S2053230X20001466",,"6TCR",49.28,"1.45","1.45","Crystal structure of the omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant","EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant","1","6TCR"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISRLRPEDFATYYCQQSHEDPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNAPQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant","2","6TCR"
"6TCS",,"X-RAY DIFFRACTION",3.14,60.79,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M tri-sodium citrate pH5.6, 15% PEG 4000 and 0.2M ammonium sulphate. Crystals were cryoprotected with 0.1M tri-sodium citrate pH5.6, 30% PEG 4000 and 0.2M ammonium sulphate",291,"10.1107/S2053230X20001466",,"6TCS",29.7,"2.3","2.3","Crystal structure of the omalizumab scFv","DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGCGTKVEIKRTGGGGSGGGGSGGGGSGGGGSEVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKCLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSSENLYFQGSGGGGSHHHHHHHHHH","Homo sapiens",,"Omalizumab scFv","1","6TCS"
"6TCU",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION, HANGING DROP",,"18% (w/v) PEG8000
0.13 M NaCl
0.1 M Tris Acetate pH 8.0",277,"10.1021/acsmedchemlett.9b00633","N1Q","6TCU",40.89,"2.14","2.14","Glycogen synthase kinase-3 beta (GSK3b) in complex with ligand 1","GAMSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQA","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6TCU"
"6TD4",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 % PEG 3350, 0.1 M HEPES pH 7.5",293,,,"6TD4",13.97,"1.71","1.71","IRF4 DNA-binding domain surface entropy mutant apo structure","GPMGHMGNGKLRQWLIDQIDSGKYPGLVWENAAASIFRIPWKHAGKQDYNREEDAALFKAWALFKGKFREGIDKPDPPTWKTRLRSALNKSNDFEELVERSQLDISDPYKVYRIVPEGALE","Homo sapiens","IRF4, MUM1","Interferon regulatory factor 4","1","6TD4"
"6TD8",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0:
15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 20% (w/v) PEG 6000
Soaking-buffer: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 25% (w/v) PEG 6000",291,,,"6TD8",37.14,"0.97","0.97","Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6TD8"
"6TDC",,"X-RAY DIFFRACTION",2.46,49.9,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium Nitrate, 20% w/v PEG3350",277,,,"6TDC",33.84,"2.328","2.328","PPAR gamma ligand binding domain in complex with MRL-871","MGSSHHHHHHSSGLVPRGSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6TDC"
"6TE2",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, SITTING DROP",8.5,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01  ml  reservoir solution  +  0.02  ml  CK2alpja' (mutant Cys336Ser) /inhibitor MB002 mixture  (0.180  ml  6  mg/ml CK2alpha-'Cys336Ser,  0.5  M  NaCl,  25  mM  Tris/HCl,  pH  8.5,  mixed  and  pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the 2-aminothiazole-type inhibitor 17 by extensive crystal soaking.",293,"10.1021/acs.jmedchem.0c00587",,"6TE2",43.18,"0.922","0.922","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the 2-aminothiazole-type inhibitor 17","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6TE2"
"6TE3",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 mM FeCl2, 500 mM MnCl2, 1 mM UDP",277,,,"6TE3",84.02,"2.3","2.3","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6TE3"
"6TE5",,"X-RAY DIFFRACTION",2.57,52.13,"VAPOR DIFFUSION",,"Sodium Malonate 2.4M pH 7.0",293.15,"10.1021/acs.jmedchem.9b01910",,"6TE5",114.49,"3.25","3.25","Crystal structure of human Aldehyde dehydrogenase 1A3 in complex with LQ43 inhibitor compound","MATANGAVENGQPDRKPPALPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLGDKNP","Homo sapiens","ALDH1A3, ALDH6","Aldehyde dehydrogenase family 1 member A3","1","6TE5"
"6TE6",,"X-RAY DIFFRACTION",3.5,64.87,"VAPOR DIFFUSION",,"1.28 M Na/K-tartrate
0.1 M Hepes pH 6.6",293,"10.1021/acsmedchemlett.9b00452","N4W","6TE6",77.85,"1.98","1.98","Crystal structure of Dot1L in complex with an inhibitor (compound 3).","GPGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPG","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","6TE6"
"6TEC",,"X-RAY DIFFRACTION",3.36,63.42,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 uM FeCl2, 500 uM MnCl2, 1 mM UDP-Xylose",277,,,"6TEC",84.53,"2.4","2.4","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Xylose","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6TEC"
"6TEI",,"X-RAY DIFFRACTION",3.05,59.66,"VAPOR DIFFUSION, SITTING DROP",,"reservoir composition: 30 % (w/v) PEG8000, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5;
crystallization drop composition before equilibration: 0.01  ml  reservoir solution plus 0.02 ml enzyme stock solution (6 mg/ml enzyme, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5); the 2-aminothiazole-type inhibitor 17 was introduced by extensive soaking",293,"10.1021/acs.jmedchem.0c00587",,"6TEI",84.25,"1.756","1.756","Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the 2-aminothiazole-type inhibitor 17","MGSSHHHHHHSQDPMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TEI"
"6TEL",,"X-RAY DIFFRACTION",3.52,65.1,"VAPOR DIFFUSION",,"1.28 M K/Na tartrate
0.1 M Hepes pH 7.0",293,"10.1021/acsmedchemlett.9b00452","N4Z","6TEL",78.27,"2.19","2.19","Crystal structure of Dot1L in complex with an inhibitor (compound 10).","GPGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPG","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","6TEL"
"6TEN",,"X-RAY DIFFRACTION",3.53,65.11,"VAPOR DIFFUSION",,"1.5 M Li sulfate
0.1 M Hepes pH 7.0",293,"10.1021/acsmedchemlett.9b00452","N5K","6TEN",78.39,"2.21","2.21","Crystal structure of Dot1L in complex with an inhibitor (compound 11).","GPGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPG","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","6TEN"
"6TES",,"X-RAY DIFFRACTION",3.36,63.37,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 uM FeCl2, 500 uM MnCl2, 1 mM UDP-Glucuronic Acid",277,,,"6TES",84.45,"2.2","2.2","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Glucuronic Acid","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6TES"
"6TEU",,"X-RAY DIFFRACTION",3.36,63.41,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 uM FeCl2, 500 uM MnCl2",277,,,"6TEU",83.96,"3","3","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Val80Lys mutant - Cocrystal with Fe2+, Mn2+","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDKARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3","1","6TEU"
"6TEW",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"RESERVOIR COMPOSITION: 28 % (W/V) PEG6000, 0.9 M LICL, 0.1 M, TRIS/HCL, PH 8.5; CRYSTALLIZATION DROP COMPOSITION PRIOR TO EQUILIBRATION: 0.01 ML RESERVOIR SOLUTION PLUS 0.02 ML CK2ALPHA' (MUTANT CYS336SER)/INHIBITOR MB002 MIXTURE (0.180 ML 6 MG/ML CK2ALPHA-'CYS336SER, 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5, MIXED AND PRE-EQUILIBRATED WITH 0.02 ML 10 MM MB002 IN DIMETHYL SULFOXIDE); the inhibitor MB002 was replaced by extensive soaking with the 2-aminothiazole-type inhibitor 27; VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1021/acs.jmedchem.0c00587",,"6TEW",43.37,"1.082","1.082","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the 2-aminothiazole-type inhibitor 27","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6TEW"
"6TEX",,"X-RAY DIFFRACTION",3.35,63.24,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 uM FeCl2, 500 uM MnCl2, 1 mM UDP-Glucose",277,,,"6TEX",84.36,"2.3","2.3","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Val80Lys mutant - Cocrystal with Fe2+, Mn2+, UDP-Glucose","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDKARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3","1","6TEX"
"6TEZ",,"X-RAY DIFFRACTION",3.31,62.87,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 500 uM FeCl2, 500 uM MnCl2, 1 mM UDP-Glucuronic Acid",277,,,"6TEZ",84.54,"2.7","2.7","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Val80Lys mutant - Cocrystal with Fe2+, Mn2+, UDP-Glucuronic Acid","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDKARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3","1","6TEZ"
"6TF6",,"X-RAY DIFFRACTION",2.03,39.3,"VAPOR DIFFUSION, HANGING DROP",,"20 MG/ML GALECTIN-3C, 100MM NACL, 30 % W/V PEG 4000, 0.4 M NASCN, 10 MM BETA-MERCAPTOETHANOL, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 4.5 MM LIGAND",300,"10.3390/molecules24244554",,"6TF6",16.37,"1.5","1.5","Human galectin-3c in complex with a galactose derivative","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6TF6"
"6TF7",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, HANGING DROP",,"20 MG/ML GALECTIN-3C, 100MM NACL, 30 % W/V PEG 4000, 0.4 M NASCN, 10 MM BETA-MERCAPTOETHANOL, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 4.5 MM LIGAND",300,"10.3390/molecules24244554",,"6TF7",16.45,"1.4","1.4","Human galectin-3c in complex with a galactose derivative","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6TF7"
"6TFP",,"X-RAY DIFFRACTION",3.45,64.31,"VAPOR DIFFUSION, SITTING DROP",,"3.5 M sodium formate",293,"10.1021/acs.jmedchem.9b01916",,"6TFP",162.65,"2","2","BTK in complex with LOU064, a potent and highly selective covalent inhibitor","GPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6TFP"
"6TFU",,"X-RAY DIFFRACTION",2.3,46.52,"VAPOR DIFFUSION, HANGING DROP",,"32.5 % PEG3350, 100 mM MgSO4, 3 % ethylen glycole 7.2 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TFU",77.29,"2","2","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14d","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TFU"
"6TFV",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole 7.0 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TFV",77.65,"1.5","1.5","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18b","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TFV"
"6TFW",,"X-RAY DIFFRACTION",2.29,46.19,"VAPOR DIFFUSION, HANGING DROP",,"30 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole 7.0 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TFW",77.7,"2","2","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18d","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TFW"
"6TFY",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION, HANGING DROP",,"30 % PEG3350, 100 mM MgSO4, 3 % ethylen glycole 7.0 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TFY",77.55,"1.7","1.7","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18c","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TFY"
"6TFZ",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, HANGING DROP",,"30 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole 7.5 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TFZ",77.76,"1.8","1.8","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 19","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TFZ"
"6TG0",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 100 mM MgSO4, 3 % ethylen glycole 7.0 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TG0",77.71,"1.5","1.5","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21a","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TG0"
"6TG1",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 100 mM MgSO4, 2 % ethylen glycole 7.0 mg/mL EGFR T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.0c00870",,"6TG1",77.95,"1.6","1.6","Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6TG1"
"6TG4",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine, pH = 9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TG4",55.65,"2.76","2.76","Tankyrase 2 in complex with an inhibitor (OM-1700)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TG4"
"6TGK",,"X-RAY DIFFRACTION",2.65,53.67,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M CaCl
0.1 M Sodiumacetat 
30% PEG400",293,"10.1002/pro.3832",,"6TGK",12.22,"1.3","1.3","Domain swapped E6AP C-lobe dimer","LDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYA","Homo sapiens","UBE3A, E6AP, EPVE6AP, HPVE6A","Ubiquitin-protein ligase E3A","1","6TGK"
"6TGU",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"RESERVOIR COMPOSITION: 28 % (W/V) PEG6000, 0.9 M LICL, 0.1 M, TRIS/HCL, PH 8.5; CRYSTALLIZATION DROP COMPOSITION PRIOR TO EQUILIBRATION: 0.01 ML RESERVOIR SOLUTION PLUS 0.02 ML CK2ALPHA' (MUTANT CYS336SER)/INHIBITOR MB002 MIXTURE (0.180 ML 6 MG/ML CK2ALPHA-'CYS336SER, 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5, MIXED AND PRE-EQUILIBRATED WITH 0.02 ML 10 MM MB002 IN DIMETHYL SULFOXIDE); THE INHIBITOR MB002 WAS REPLACED BY EXTENSIVE SOAKING WITH THE 2-AMINOTHIAZOLE-TYPE INHIBITOR Cl-OH-3",293,"10.1021/acs.jmedchem.0c00587",,"6TGU",43.66,"0.833","0.833","Crystal structure of human protein kinase CK2alpha'(CSNK2A2 gene product) in complex with the 2-aminothiazole-type inhibitor Cl-OH-3","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6TGU"
"6TGW",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG-3350
0.24 M sodium malonate pH 7.0
10 mM TCEP-hydrochloride",293.15,"10.1038/s42003-021-02949-7",,"6TGW",228.86,"2.8","2.8","Crystal structure of human Aldehyde dehydrogenase 1A3 in complex with a selective inhibitor","MATANGAVENGQPDRKPPALPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLGDKNP","Homo sapiens","ALDH1A3, ALDH6","Aldehyde dehydrogenase family 1 member A3","1","6TGW"
"6TGY","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-14343-8",,"6TGY",13.7,"3.5",,"Cryo-EM structure of p62-PB1 filament (L-type)","MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMV","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","6TGY"
"6TH3","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-14343-8",,"6TH3",41.11,"4",,"Cryo-EM structure of p62-PB1 filament (S-type)","MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMV","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","6TH3"
"6THA",,"X-RAY DIFFRACTION",3.83,67.87,"VAPOR DIFFUSION, HANGING DROP",,"42-46 % polyethylene glycol 400, 100-200 mM MgCl2 and 100 mM Mops pH 7.4",290.15,"10.26508/lsa.202000858",,"6THA",55.57,"2.4","2.4","Crystal structure of human sugar transporter GLUT1 (SLC2A1) in the inward conformation","MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQVLVPR","Homo sapiens","SLC2A1, GLUT1","Solute carrier family 2, facilitated glucose transporter member 1","1","6THA"
"6THP",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.5, 25% W/V PEG 3350, 2 mM MGCL2, 0.2 M Ammoniumacetate",293,"10.1021/acsmedchemlett.9b00578",,"6THP",161.73,"2.54","2.54","Neprilysin in complex with the inhibitor (R)-4-(1-carboxy-3-(3'-chlorobiphenyl-4-yl)propan-2-ylamino)-4-oxobutanoic acid","GICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6THP"
"6THW",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",,"AMS 0.1 M Hepes  & 
Protein Buffer:  25 mM HEPES pH 7.5, 1 mM EDTA, 1 mM TCEP, 5% Glycerol, 150 mM NaCl",298,"10.1016/j.bmc.2020.115815","NBK","6THW",69.93,"2.44","2.44","IRAK4 in complex with inhibitor","GENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6THW"
"6THX",,"X-RAY DIFFRACTION",2.68,54.17,"VAPOR DIFFUSION, HANGING DROP",,"25 mM HEPES pH 7.5, 1 mM EDTA, 1 mM TCEP, 5% Glycerol, 150 mM NaCl",298,"10.1016/j.bmc.2020.115815","N9Z","6THX",69.94,"1.99","1.99","IRAK4 in complex with inhibitor","GENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6THX"
"6THZ",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG8K, 0.2 M NaAc 0.1 M Mes pH 6.4  
Protein Buffer:  25 mM HEPES pH 7.5, 1 mM EDTA, 1 mM TCEP, 5% Glycerol, 150 mM NaCl",298,"10.1016/j.bmc.2020.115815","NB5","6THZ",70.27,"2.38","2.38","IRAK4 IN COMPLEX WITH inhibitor","GENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6THZ"
"6TI5",,"SOLID-STATE NMR",,,,,,,"10.1039/d0cc02463e",,"6TI5",69.37,,,"A New Structural Model of Abeta(1-40) Fibrils","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6TI5"
"6TI6",,"SOLID-STATE NMR",,,,,,,"10.1039/d0cc02463e",,"6TI6",70.85,,,"Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrils","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6TI6"
,,,,,,,,,,,,,,,,"DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","2","6TI6"
"6TI7",,"SOLID-STATE NMR",,,,,,,"10.1039/d0cc02463e",,"6TI7",70.85,,,"Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrils","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6TI7"
,,,,,,,,,,,,,,,,"DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","2","6TI7"
"6TI8",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, HANGING DROP",,"2.7 M AMS 0.1 M Hepes pH 7.1-7.7  
Protein Buffer:  25 mM HEPES pH 7.5, 1 mM EDTA, 1 mM TCEP, 5% Glycerol, 150 mM NaCl",298,"10.1016/j.bmc.2020.115815","NBW","6TI8",140.34,"2.32","2.32","IRAK4 IN COMPLEX WITH inhibitor","GENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6TI8"
"6TI9",,"X-RAY DIFFRACTION",2.14,42.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"Protein: 4.93 mg/mL, Tris pH 8.0, 150mM NaCl. Precipitant: 24% PEG 600, 0.2M imidazole malate pH 5.5.",293,"10.1016/j.bmc.2020.115673",,"6TI9",28.65,"1.45","1.45","Human transthyretin (TTR) complexed with (E)-3-(((3,5-dibromo-2-hydroxybenzylidene)amino)oxy)propanoic acid.","GGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6TI9"
"6TIA",,"X-RAY DIFFRACTION",2.58,52.39,"VAPOR DIFFUSION, HANGING DROP",,"2.7 M AMS 0.1 M Hepes pH 7.1-7.7  
Protein Buffer:  50mM HEPES pH 7.5, 300 mM NaCl, 0,02% OG, 1 mM TCEP, 10% Glycerol",298,"10.1016/j.bmc.2020.115815",,"6TIA",73.87,"2.52","2.52","IRAK4 IN COMPLEX WITH inhibitor","GENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6TIA"
"6TIQ",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2019.11.015",,"6TIQ",31.88,,,"Refined solution NMR structure of hVDAC-1 in detergent micelles","MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQALEHHHHHH","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","6TIQ"
"6TIR",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2019.11.015",,"6TIR",32.54,,,"NOE based model of hVDAC-1 bound to beta-NADH in detergent micelles","MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQALEHHHHHH","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","6TIR"
"6TJJ",,"X-RAY DIFFRACTION",3.25,62.15,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.1 M (NH4)2SO4, 0.19 M guanidine HCl, 0.04 M KCl, 0.1 M Na acetate, pH 4.6",293,"10.1107/S205979832000501X",,"6TJJ",115.31,"1.59","1.59","Structure of Cerezyme at pH 4.6","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6TJJ"
"6TJK",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M Na2SO4, 14% (v/v) PEG3350, 0.1 M bis-tris-propane pH 7.0",293,"10.1107/S205979832000501X",,"6TJK",117.67,"1.56","1.56","Crystal Structure of Recombinant GBA in Complex with Bis-Tris Propane","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","Lysosomal acid glucosylceramidase","1","6TJK"
"6TJN",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, SITTING DROP",,"Protein: 4.93 mg/mL, Tris pH 8.0, 150mM NaCl. Reservoir: 24% PEG 600, 0.2 Imidazole Malate pH 5.5.",293,"10.1016/j.bmc.2020.115673",,"6TJN",28.09,"1.702","1.702","Human transthyretin (TTR) complexed with (E)-3-(((4-hydroxybenzylidene)amino)oxy)propanoic acid","GGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6TJN"
"6TJO","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2043-0",,"6TJO",137.76,"3.2",,"Cryo-EM structure of TypeI tau filaments extracted from the brains of individuals with Corticobasal degeneration","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6TJO"
"6TJQ",,"X-RAY DIFFRACTION",2.43,49.36,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Na2SO4, 14% (v/v) PEG3350, 0.25 M HEPES pH 7.0",293,"10.1107/S205979832000501X",,"6TJQ",58.46,"1.41","1.41","Crystal Structure of Recombinant GBA in Complex with 2-Deoxy-2-fluoro-beta-D-glucopyranoside","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6TJQ"
"6TJX","3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2043-0",,"6TJX",275.52,"3",,"Cryo-EM structure of TypeII tau filaments extracted from the brains of individuals with Corticobasal degeneration","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6TJX"
"6TKB",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, SITTING DROP",6,"PEG 8000, cacodylate",293,"10.1126/sciimmunol.abm3723",,"6TKB",97.13,"2","2","ChiLob 7/4 H2 HC-C224S F(ab')2","EVQLQQSGPDLVKPGASVKISCKTSGYTFTEYIMHWVKQSHGKSLEWIGGIIPNNGGTSYNQKFKDKATMTVDKSSSTGYMELRSLTSEDSAVYYCTRREVYGRNYYALDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKSCVECPPC","Homo sapiens",,"Chilob 7/4 H2 heavy chain C224S","1","6TKB"
,,,,,,,,,,,,,,,,"DIQMTQTTSSLSASLGDRVTITCSASQGINNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSNLPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Chilob 7/4 H2 kappa chain","2","6TKB"
"6TKC",,"X-RAY DIFFRACTION",3.17,61.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000, HEPES",293,"10.1126/sciimmunol.abm3723",,"6TKC",48.56,"2.3","2.3","ChiLob 7/4 H2 HC-C225S F(ab')2","EVQLQQSGPDLVKPGASVKISCKTSGYTFTEYIMHWVKQSHGKSLEWIGGIIPNNGGTSYNQKFKDKATMTVDKSSSTGYMELRSLTSEDSAVYYCTRREVYGRNYYALDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCSVECPPC","Homo sapiens",,"Chilob 7/4 H2 heavy chain C225S","1","6TKC"
,,,,,,,,,,,,,,,,"DIQMTQTTSSLSASLGDRVTITCSASQGINNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSNLPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Chilob 7/4 H2 kappa chain","2","6TKC"
"6TKD",,"X-RAY DIFFRACTION",3.05,59.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000, ammonium sulphate",293,"10.1126/sciimmunol.abm3723",,"6TKD",48.56,"1.9","1.9","ChiLob 7/4 H2 HC-C228S F(ab')2","EVQLQQSGPDLVKPGASVKISCKTSGYTFTEYIMHWVKQSHGKSLEWIGGIIPNNGGTSYNQKFKDKATMTVDKSSSTGYMELRSLTSEDSAVYYCTRREVYGRNYYALDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVESPPC","Homo sapiens",,"Chilob 7/4 H2 heavy chain C228S","1","6TKD"
,,,,,,,,,,,,,,,,"DIQMTQTTSSLSASLGDRVTITCSASQGINNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSNLPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Chilob 7/4 H2 kappa chain","2","6TKD"
"6TKE",,"X-RAY DIFFRACTION",3.09,60.14,"VAPOR DIFFUSION, SITTING DROP",6,"PEG 4000, cacodylate",293,"10.1126/sciimmunol.abm3723",,"6TKE",48.55,"2.35","2.35","ChiLob 7/4 H2 HC-C224S Kappa LC-C214S F(ab')2","EVQLQQSGPDLVKPGASVKISCKTSGYTFTEYIMHWVKQSHGKSLEWIGGIIPNNGGTSYNQKFKDKATMTVDKSSSTGYMELRSLTSEDSAVYYCTRREVYGRNYYALDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKSCVECPPC","Homo sapiens",,"ChiLob 7/4 H2 heavy chain C224S","1","6TKE"
,,,,,,,,,,,,,,,,"DIQMTQTTSSLSASLGDRVTITCSASQGINNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSNLPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGES","Homo sapiens",,"ChiLob 7/4 H2 kappa chain C214S","2","6TKE"
"6TKF",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION, SITTING DROP",,"PEG 1000, PEG 3350, MPD, MOPS/HEPES-Na",293,"10.1126/sciimmunol.abm3723",,"6TKF",48.55,"2.18","2.18","ChiLob 7/4 H2 HC-C225S KappaLC-C214S F(ab')2","EVQLQQSGPDLVKPGASVKISCKTSGYTFTEYIMHWVKQSHGKSLEWIGGIIPNNGGTSYNQKFKDKATMTVDKSSSTGYMELRSLTSEDSAVYYCTRREVYGRNYYALDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCSVECPPC","Homo sapiens",,"ChiLob 7/4 H2 Heavy chain C225S","1","6TKF"
,,,,,,,,,,,,,,,,"DIQMTQTTSSLSASLGDRVTITCSASQGINNYLNWYQQKPDGTVKLLIYYTSSLHSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSNLPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGES","Homo sapiens",,"ChiLob 7/4 H2 Kappa light chain C214S","2","6TKF"
"6TKM",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine, pH = 9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKM",55.75,"2.7","2.7","Tankyrase 2 in complex with an inhibitor (OM-1800)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKM"
"6TKN",,"X-RAY DIFFRACTION",2.17,43.3,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine pH=9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKN",55.62,"2.5","2.5","Tankyrase 2 in complex with an inhibitor (OM-1000)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKN"
"6TKP",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine, pH = 9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKP",55.78,"2.4","2.4","Tankyrase 2 in complex with an inhibitor (OM-1900)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKP"
"6TKQ",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine pH=9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKQ",55.71,"2.5","2.5","Tankyrase 2 in complex with an inhibitor (OM-2700)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKQ"
"6TKR",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG6000, Bicine pH=9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKR",55.75,"2.75","2.75","Tankyrase 2 in complex with an inhibitor (OM-1704)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKR"
"6TKS",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",,"7.5-25% PEG 6000, Bicine, pH=9.0",295.15,"10.1021/acs.jmedchem.0c00208",,"6TKS",55.75,"2.5","2.5","Tankyrase 2 in complex with an inhibitor (OM-1720)","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6TKS"
"6TKV",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Carboxilic acids
0.1 M Buffer system 3 pH 8.5 
30% Precipitant mix 1 
(Molecular Dimensions).",291,"10.1038/s41467-020-14794-z",,"6TKV",111.37,"1.95","1.95","Crystal structure of the human FUT8 in complex with GDP and a biantennary complex N-glycan","GLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAE","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6TKV"
,,,,,,,,,,,,,,,,"LGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEK","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","2","6TKV"
"6TL1",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 0.1 M NaPi,, 0.1 M KPi, 2 M NaCl",291,"10.1038/s41467-020-18761-6",,"6TL1",49.74,"2.03","2.03","Crystal structure of the TASOR pseudo-PARP domain","KALFQPLTPGSREFEDVVNILHSSYLEPTSVTNFNYRRACLVHNELLEKEFTEKRRELKFDGRLDKELSESYAFLMVDRYQVQTICEKGLHVGQSKITILGSPSMGVYLSRYADLLQANPLDTGAMGDVVIFKIMKGKIKSIYDPMGVKSLDPTPKHECHVSKNANRITSLLAYRAYELTQYYFYEYGFDELRRRPRHVCPYAVVSFTYKDDIQ","Homo sapiens","TASOR, C3orf63, FAM208A, KIAA1105","Protein TASOR","1","6TL1"
"6TL5",,"X-RAY DIFFRACTION",3.42,64.04,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K",294,,,"6TL5",114.25,"2.21","2.21","Three dimensional structure of human carbonic anhydrase IX in complex with sulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFQQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6TL5"
"6TL6",,"X-RAY DIFFRACTION",3.45,64.33,"VAPOR DIFFUSION, SITTING DROP",4.5,"CRYSTALLIZATION CONDITIONS: 1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K",294,,,"6TL6",114.02,"2.15","2.15","Three dimensional structure of human carbonic anhydrase IX in complex with sulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFQQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6TL6"
"6TL7",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 2000MME, 0.15M KBr, pH 6.4-7.1",277,,,"6TL7",30.88,"1.11","1.11","CRYSTAL STRUCTURE OF LECTIN-LIKE OX-LDL RECEPTOR 1 (P212121)","GSHMPCPQDWIWHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLSRRNPSYPWLWEDGSPLMPHLFRVRGAVSQTYPSGTCAYIQRGAVYAENCILAAFSICQKKANLRAQ","Homo sapiens","OLR1, CLEC8A, LOX1","Oxidized low-density lipoprotein receptor 1","1","6TL7"
"6TL9",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 7.5, 30% PEG MME 2000 and 0.15 M KBr",277,,,"6TL9",124.28,"2.734","2.734","CRYSTAL STRUCTURE OF LECTIN-LIKE OX-LDL RECEPTOR 1 IN COMPLEX WITH BI-0115","GSHMPCPQDWIWHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLSRRNPSYPWLWEDGSPLMPHLFRVRGAVSQTYPSGTCAYIQRGAVYAENCILAAFSICQKKANLRAQ","Homo sapiens","OLR1, CLEC8A, LOX1","Oxidized low-density lipoprotein receptor 1","1","6TL9"
"6TLA",,"X-RAY DIFFRACTION",2.45,49.89,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES pH 6, 20% PEG6000, 0.2 M LiCl",277,,,"6TLA",50.93,"2.16","2.16","CRYSTAL STRUCTURE OF LECTIN-LIKE OX-LDL RECEPTOR 1 (C 1 2 1)","GSHMNLQETLKRVANCSAPCPQDWIWHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLSRRNPSYPWLWEDGSPLMPHLFRVRGAVSQTYPSGTCAYIQRGAVYAENCILAAFSICQKKANLRAQ","Homo sapiens","OLR1, CLEC8A, LOX1","Oxidized low-density lipoprotein receptor 1","1","6TLA"
"6TLE",,"X-RAY DIFFRACTION",2.22,44.73,"VAPOR DIFFUSION, HANGING DROP",5.8,"PEG3350, NaNO3 and MES pH 5.8",277.15,,,"6TLE",82.81,"1.75","1.75","Human Eg5 motor domain mutant E344K","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLKETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6TLE"
"6TLF",,"X-RAY DIFFRACTION",4.49,72.64,"VAPOR DIFFUSION, HANGING DROP",9,"40 % wt/vol PEG 4000, 600mM ammonium sulfate, 100 mM Tris-HCl, pH 9.0",281,"10.1021/acschembio.0c00039",,"6TLF",31.63,"2.9","2.9","human 14-3-3 sigma isoform in complex with IMP","MSYYHHHHHHDYDIPTTENLYFQGAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAGEEGGEAPQEPQS","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","6TLF"
"6TLG",,"X-RAY DIFFRACTION",4.49,72.64,"VAPOR DIFFUSION, HANGING DROP",9,"40 % wt/vol PEG 4000, 600mM ammonium sulfate, 100 mM Tris-HCl, pH 9.0",281,"10.1021/acschembio.0c00039",,"6TLG",31.87,"2.4","2.4","Ligand-free state of human 14-3-3 sigma isoform","MSYYHHHHHHDYDIPTTENLYFQGAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAGEEGGEAPQEPQS","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","6TLG"
"6TLL",,"X-RAY DIFFRACTION",2.68,54.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLL",47.46,"1.88","1.88","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (tBBT)","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLL"
"6TLM",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, SITTING DROP",,"1.6M AmSO4 + 0.1M Tris (pH=8.5)",293,"10.1002/cmdc.202000044","MJE","6TLM",30.95,"2.321","2.321","ROR(gamma)t ligand binding domain in complex with allosteric ligand compound 13 (Glenmark)","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6TLM"
"6TLO",,"X-RAY DIFFRACTION",2.75,55.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLO",47.09,"1.69","1.69","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6-TRIBROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLO"
"6TLP",,"X-RAY DIFFRACTION",2.66,,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLP",46.79,"1.93","1.93","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLP"
"6TLQ",,"X-RAY DIFFRACTION",2.76,55.51,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6TLQ",31.61,"1.761","1.761","ROR(gamma)t ligand binding domain in complex with cholesterol and allosteric ligand Glenmark","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6TLQ"
"6TLR",,"X-RAY DIFFRACTION",2.72,,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLR",46.89,"1.64","1.64","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,7-DIBROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLR"
"6TLS",,"X-RAY DIFFRACTION",3.14,54.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLS",47.14,"1.46","1.46","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,6-DIBROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLS"
"6TLT",,"X-RAY DIFFRACTION",2.93,58,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6M AmSO4 + 0.1M Tris",293,"10.1073/pnas.2021287118",,"6TLT",31.42,"2.11","2.11","ROR(gamma)t ligand binding domain in complex with desmosterol and allosteric ligand Glenmark","GSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6TLT"
"6TLU",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLU",46.86,"1.81","1.81","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5-DIBROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLU"
"6TLV",,"X-RAY DIFFRACTION",2.73,54.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLV",46.81,"1.67","1.67","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5-BROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLV"
"6TLW",,"X-RAY DIFFRACTION",3.16,61.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M sodium HEPES/MOPS buffer pH 7.5, 20 mM sodium formate, 20 mM ammonium acetate, 20 mM sodium citrate tribasic dihydrate, 20 mM sodium potassium tartrate tetrahydrate, 20 mM sodium oxamate, 20% polyethylene glycol 550 monomethyl ester, 10% polyethylene glycol 20000",290,"10.1021/acs.jpcb.0c10264",,"6TLW",46.55,"1.73","1.73","HUMAN CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4-BROMOBENZOTRIAZOLE","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQLEHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6TLW"
"6TM2","2.95","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.09.021",,"6TM2",307.96,"2.95",,"Human MUC2 AAs 21-1397","SELQTEGRTRYHGRNVCSTWGNFHYKTFDGDVFRFPGLCDYNFASDCRGSYKEFAVHLKRGPGQAEAPAGVESILLTIKDDTIYLTRHLAVLNGAVVSTPHYSPGLLIEKSDAYTKVYSRAGLTLMWNREDALMLELDTKFRNHTCGLCGDYNGLQSYSEFLSDGVLFSPLEFGNMQKINQPDVVCEDPEEEVAPASCSEHRAECERLLTAEAFADCQDLVPLEPYLRACQQDRCRCPGGDTCVCSTVAEFSRQCSHAGGRPGNWRTATLCPKTCPGNLVYLESGSPCMDTCSHLEVSSLCEEHRMDGCFCPEGTVYDDIGDSGCVPVSQCHCRLHGHLYTPGQEITNDCEQCVCNAGRWVCKDLPCPGTCALEGGSHITTFDGKTYTFHGDCYYVLAKGDHNDSYALLGELAPCGSTDKQTCLKTVVLLADKKKNAVVFKSDGSVLLNQLQVNLPHVTASFSVFRPSSYHIMVSMAIGVRLQVQLAPVMQLFVTLDQASQGQVQGLCGNFNGLEGDDFKTASGLVEATGAGFANTWKAQSTCHDKLDWLDDPCSLNIESANYAEHWCSLLKKTETPFGRCHSAVDPAEYYKRCKYDTCNCQNNEDCLCAALSSYARACTAKGVMLWGWREHVCNKDVGSCPNSQVFLYNLTTCQQTCRSLSEADSHCLEGFAPVDGCGCPDHTFLDEKGRCVPLAKCSCYHRGLYLEAGDVVVRQEERCVCRDGRLHC","Homo sapiens","MUC2, SMUC","Mucin-2","1","6TM2"
,,,,,,,,,,,,,,,,"RQIRLIGQSCTAPKIHMDCSNLTALATSKPRALSCQTLAAGYYHTECVSGCVCPDGLMDDGRGGCVVEKECPCVHNNDLYSSGAKIKVDCNTCTCKRGRWVCTQAVCHGTCSIYGSGHYITFDGKYYDFDGHCSYVAVQDYCGQNSSLGSFSIITENVPCGTTGVTCSKAIKIFMGRTELKLEDKHRVVIQRDEGHHVAYTTREVGQYLVVESSTGIIVIWDKRTTVFIKLAPSYKGTVCGLCGNFDHRSNNDFTTRDHMVVSSELDFGNSWKEAPTCPDVSTNPEPCSLNPHRRSWAEKQCSILKSSVFSICHSKVDPKPFYEACVHDSCSCDTGGDCECFCSAVASYAQECTKEGACVFWRTPDLCPIFCDYYNPPHECEWHYEPCGNRSFETCRTINGIHSNISVSYLEGCYPRCPKDRPIYEEDLKKCVTADKCGCYVEDTHYP","Homo sapiens","MUC2, SMUC","Mucin-2","2","6TM2"
,,,,,,,,,,,,,,,,"PGASVPTEETCKSCVCTNSSQVVCRPEEGKILNQTQDGAFCYWEICGPNGTVEKHFNICSITTRPSTLTTFTTITLPTTPTSFTTTTTTTTPTSSTVLSTTPKLCCLWSDWINEDHPSSGSDDGDRETFDGVCGAPEDIECRSVKDPHLSLEQHGQKVQCDVSVGFICKNEDQFGNGPFGLCYDYKIRVNCCWPMDKCITHHHHHH","Homo sapiens","MUC2, SMUC","Mucin-2","3","6TM2"
"6TM6",,"X-RAY DIFFRACTION",2.01,38.95,"VAPOR DIFFUSION, HANGING DROP",,"100 mM citrate/phosphate buffer, pH 4.4, with 15% ethanol and 1% PEG 1K",293,"10.1016/j.cell.2020.09.021",,"6TM6",10.9,"1.63","1.63","MUC2 CysD1 domain","ALCCLWSDWINEDHPSSGSDDGDRETFDGVCGAPEDIECRSVKDPHLSLEQLGQKVQCDVSVGFICKNEDQFGNGPFGLCYDYKIRVNCCWPMDKCA","Homo sapiens","MUC2, SMUC","Mucin-2","1","6TM6"
"6TM7",,"X-RAY DIFFRACTION",4.56,73.05,"VAPOR DIFFUSION, HANGING DROP",9,"40 % wt/vol PEG 4000, 600mM ammonium sulfate, 100 mM Tris-HCl, pH 9.0",281,"10.1021/acschembio.0c00039",,"6TM7",62.81,"3","3","Human 14-3-3 sigma isoform in complex with PLP","MSYYHHHHHHDYDIPTTENLYFQGAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAGEEGGEAPQEPQS","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","6TM7"
"6TMD",,"X-RAY DIFFRACTION",1.97,37.53,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.2 M ammonium acetate, 0.1 M Bis-tris pH 5.7, 31% w/v PEG 3350",294,,,"6TMD",28.51,"1.5","1.5","Crystal structure of KANK2 ankyrin repeats mutant (A670V)","GIDPFTEEEIRMELSPDLISACLALEKYLDNPNALTERELKVAYTTVLQEWLRLACRSDAHPELVRRHLVTFRAMSARLLDYVVNIADSNGNTVLHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVALDAGQSEIASMLYSRMNIK","Homo sapiens","KANK2, ANKRD25, KIAA1518, MXRA3, SIP","KN motif and ankyrin repeat domain-containing protein 2","1","6TMD"
"6TMP",,"X-RAY DIFFRACTION",3.23,61.92,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M Sodium acetate pH 5.8
0.125 M Magnesium chloride",277,,,"6TMP",45.44,"2.076","2.076","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","GSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6TMP"
"6TMQ",,"X-RAY DIFFRACTION",3.3,62.75,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M Sodium acetate pH 5.8
0.125 M Magnesium chloride",277,,,"6TMQ",45.49,"2.112","2.112","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","GSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6TMQ"
"6TMZ",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M Sodium acetate pH 5.8
0.125 M Magnesium chloride",277,,,"6TMZ",45.44,"2.71","2.71","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","GSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6TMZ"
"6TN0",,"X-RAY DIFFRACTION",3.23,61.89,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M Sodium acetate pH 5.8
0.125 M Magnesium chloride",277,,,"6TN0",45.28,"1.905","1.905","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","GSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6TN0"
"6TN1",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Mg formate, 19% (v/v) PEG3350",293,"10.1107/S205979832000501X",,"6TN1",58.02,"0.98","0.98","Unliganded Crystal Structure of Recombinant GBA","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","Lysosomal acid glucosylceramidase","1","6TN1"
"6TN2",,"X-RAY DIFFRACTION",3.19,61.39,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.1 M Sodium acetate pH 5.8
0.125 M Magnesium chloride",277,,,"6TN2",45.41,"1.768","1.768","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","GSAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6TN2"
"6TN4",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG3350,
0.1 M sodium cacodylate pH 6.5,
0.2 M MgCl2",277,,,"6TN4",26.11,"1.274","1.274","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","HMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6TN4"
"6TN5",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG3350,
0.1 M sodium cacodylate pH 6.5,
0.2 M MgCl2",277,,,"6TN5",26.25,"1.165","1.165","Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures","HMDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6TN5"
"6TN7",,"X-RAY DIFFRACTION",1.93,36.24,"VAPOR DIFFUSION, SITTING DROP",7.4,"16% PEG 8000, 40 mM KH2PO4, 20% glycerol",293,"10.1016/j.bbrep.2021.100975",,"6TN7",11.36,"1.67","1.67","Crystal structure of the human Arc C-lobe","GAMGTLSREAIQRELDLPQKQGEPLDQFLWRKRDLYQTLYVDADEEEIIQYVVGTLQPKLKRFLRHPLPKTLEQLIQRGMEVQDDLEQAAEPAGPHL","Homo sapiens","ARC, KIAA0278","Activity-regulated cytoskeleton-associated protein","1","6TN7"
"6TN8",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M ammonium sulfate, 10%(v/v) dioxane, 0.1M MES pH 6.5",277,,"5U6","6TN8",35.62,"1.63","1.63","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound BI-9564","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6TN8"
"6TN9",,"X-RAY DIFFRACTION",3.22,61.84,"VAPOR DIFFUSION, HANGING DROP",,"25% GLYCEROL, 1.2 M AS, 0.1 M",295,"10.1021/acs.jmedchem.9b02035",,"6TN9",34.21,"2.6","2.6","X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16","GSNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6TN9"
"6TNB",,"X-RAY DIFFRACTION",3.64,66.23,"VAPOR DIFFUSION, HANGING DROP",6.54,"1.2M Ammonium sulphate, 100mM sodium cacodylate pH 6.54m 25% glycerol",293,"10.1021/acs.jmedchem.9b02035",,"6TNB",34.45,"2.65","2.65","X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41","GSNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6TNB"
"6TNC",,"X-RAY DIFFRACTION",3.17,61.16,"VAPOR DIFFUSION, HANGING DROP",,"1 M AMMONIUMSULFATE, 25%                  GLYCEROL, 0.1 M MES PH 6.5",298,"10.1021/acs.jmedchem.9b02035","O23","6TNC",34.28,"2.3","2.3","X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46","GSNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6TNC"
"6TND",,"X-RAY DIFFRACTION",3.65,66.33,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 3350, 180mM Magnesium formate, 25% glycerol",295,"10.1021/acs.jmedchem.9b02035",,"6TND",34.33,"2.58","2.58","X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79","GSNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6TND"
"6TO7",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","SUV","6TO7",92.94,"2.26","2.26","Crystal structure of the Orexin-1 receptor in complex with suvorexant at 2.29 A resolution","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TO7"
"6TOD",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",6.3,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787",,"6TOD",94.73,"2.11","2.11","Crystal structure of the Orexin-1 receptor in complex with EMPA","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQTVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TOD"
"6TOJ",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 microliter of BCL6-BTB at 10 mg/mL plus 1.5 microliter of a crystallisation solution consisting of 0.1 M Tris pH 7.5 and 0.80 M Na/K Tartrate, against 300 microliter of crystallisation solution.",291,"10.1021/acs.jmedchem.9b02076","NQQ","6TOJ",17.13,"1.85","1.85","Crystal structure of human BCL6 BTB domain in complex with compound 17a","GPGLDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6TOJ"
"6TOL",,"X-RAY DIFFRACTION",3.3,62.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 microliter of BCL6-BTB at 10 mg/mL plus 1.5 microliter of a crystallisation solution consisting of 0.1 M Tris pH 7.5 and 0.80 M Na/K Tartrate, against 300 microliter of crystallisation solution.",291,"10.1021/acs.jmedchem.9b02076","NQW","6TOL",17.55,"1.64","1.64","Crystal structure of human BCL6 BTB domain in complex with compound 25a","GPGLDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6TOL"
"6TOM",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 microliter of BCL6-BTB at 10 mg/mL plus 1.5 microliter of a crystallisation solution consisting of 0.1 M Tris pH 7.5 and 0.80 M Na/K Tartrate, against 300 microliter of crystallisation solution.",291,"10.1021/acs.jmedchem.9b02076","NQZ","6TOM",17.19,"1.9","1.9","Crystal structure of human BCL6 BTB domain in complex with compound 1","GPGLDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6TOM"
"6TOR",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 100 mM Bis Tris propane pH 7.0, 200 mM ammonium sulfate, and 3% MPD.",298,"10.1107/S2053230X20002988",,"6TOR",112.56,"2.05","2.05","human O-phosphoethanolamine phospho-lyase","MCELYSKRDTLGLRKKHIGPSCKVFFASDPIKIVRAQRQYMFDENGEQYLDCINNVAHVGHCHPGVVKAALKQMELLNTNSRFLHDNIVEYAKRLSATLPEKLSVCYFTNSGSEANDLALRLARQFRGHQDVITLDHAYHGHLSSLIEISPYKFQKGKDVKKEFVHVAPTPDTYRGKYREDHADSASAYADEVKKIIEDAHNSGRKIAAFIAESMQSCGGQIIPPAGYFQKVAEYVHGAGGVFIADEVQVGFGRVGKHFWSFQMYGEDFVPDIVTMGKPMGNGHPVACVVTTKEIAEAFSSSGMEYFNTYGGNPVSCAVGLAVLDIIENEDLQGNAKRVGNYLTELLKKQKAKHTLIGDIRGIGLFIGIDLVKDHLKRTPATAEAQHIIYKMKEKRVLLSADGPHRNVLKIKPPMCFTEEDAKFMVDQLDRILTVLEEAMGTKTESVTSENTPCKTKMLKEAHIELLRDSTTDSKENPSRKRNGMCTDTHSLLSKRLKT","Homo sapiens","ETNPPL, AGXT2L1","Ethanolamine-phosphate phospho-lyase","1","6TOR"
"6TOS",,"X-RAY DIFFRACTION",3.78,67.47,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787",,"6TOS",87.95,"2.13","2.13","Crystal structure of the Orexin-1 receptor in complex with GSK1059865","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TOS"
"6TOT",,"X-RAY DIFFRACTION",3.79,67.52,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","NRK","6TOT",81.94,"2.22","2.22","Crystal structure of the Orexin-1 receptor in complex with lemborexant","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TOT"
"6TP3",,"X-RAY DIFFRACTION",4.08,69.82,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787",,"6TP3",90.46,"3.04","3.04","Crystal structure of the Orexin-1 receptor in complex with daridorexant","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TP3"
"6TP4",,"X-RAY DIFFRACTION",4.16,70.4,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","NRZ","6TP4",79.98,"3.011","3.011","Crystal structure of the Orexin-1 receptor in complex with ACT-462206","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TP4"
"6TP5",,"X-RAY DIFFRACTION",3.4,62.47,"VAPOR DIFFUSION, SITTING DROP",9,"Well solution: 0.1 M Tris-HCl pH 9, 22% Tert-butanol, 1 mM N-oxalylglycine
Protein solution: 10 mM Tris-HCl pH 7.8, 0.1 M NaCl, 0.1 M Glycine, 2 mM CaCl2, 0.02 mM FeSO4",277,"10.1074/jbc.RA120.016542",,"6TP5",102.37,"2.25","2.25","Crystal structure of human Transmembrane prolyl 4-hydroxylase","HHHHHHDESSDPGPQHRVQGPGPEPTLGPLTRLEGIKVGHERKVQLVTDRDHFIRTLSLKPLLFEIPGFLTDEECRLIIHLAQMKGLQRSQILPTEEYEEAMSTMQVSQLDLFRLLDQNRDGHLQLREVLAQTRLGNGWWMTPESIQEMYAAIKADPDGDGVLSLQEFSNMDLRDFHKYMRSHKAESSELVRNSHHTWLYQGEGAHHIMRAIRQRVLRLTRLSPEIVELSEPLQVVRYGEGGHYHAHVDSGPVYPETICSHTKLVANESVPFETSCRYMTVLFYLNNVTGGGETVFPVADNRTYDEMSLIQDDVDLRDTRRHCDKGNLRVKPQQGTAVFWYNYLPDGQGWVGDVDDYSLHGGCLVTRGTKWIANNWINVDPSRARQALFQQEMARLAREGGTDSQPEWALDRAYRDARVEL","Homo sapiens","P4HTM, PH4","Transmembrane prolyl 4-hydroxylase","1","6TP5"
"6TP6",,"X-RAY DIFFRACTION",3.87,68.24,"VAPOR DIFFUSION, SITTING DROP",4.3,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","NT5","6TP6",89.37,"2.338","2.338","Crystal structure of the Orexin-1 receptor in complex with filorexant","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TP6"
"6TPD",,"X-RAY DIFFRACTION",2.77,55.57,"VAPOR DIFFUSION, HANGING DROP",,"2.1M Na Malonate pH 6.0/6.5, 0.1M glycine pH 8.2",277,"10.1021/acs.jmedchem.0c00359","QZ8","6TPD",34.18,"1.99","1.99","Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity","TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6TPD"
"6TPE",,"X-RAY DIFFRACTION",2.38,48.43,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00359",,"6TPE",67.78,"2.87","2.87","Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity","EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6TPE"
"6TPF",,"X-RAY DIFFRACTION",2.48,50.51,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00359","NTQ","6TPF",67.94,"2.31","2.31","Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity","EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6TPF"
"6TPK",,"X-RAY DIFFRACTION",4.13,70.19,"LIPIDIC CUBIC PHASE",,"ADA, PEG400, NaH2PO4, TCEP",293.15,"10.1126/sciadv.abb5419",,"6TPK",57.15,"3.2","3.2","Crystal structure of the human oxytocin receptor","NEALARVEVAVLCLILLLALSGNACVLLALHTTRQKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQLVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTARLAVLATWLGCLVVSAPQVHIFSLREVADGVFDCWAVFIRPWGPKAYITWITLAVYIVPVIVLATCYGLIAFKIWQNLRLKTAAAAAAEAPEGAAAGDGGRVALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDANAPKEASAFIIVMLLASLNCCCKPWIYMLFMGHLFHGIDCSFWCCNESYLTGSRDERKKSLLSKFGMDEGVTFMFIGRFDRGQKGVDVLLKAIEILSSKKEFQEMRFIIIGKGDPELEGWARSLEEKHGNVKVITEMLSREFVRELYGSVDFVIIPSYFEPFGLVALEAMCLGAIPIASAVGGLRDIITNETGILVKAGDPGELANAILKALELSRSDLSKFRENCKKRAMSFS","Homo sapiens","OXTR","Oxytocin receptor","1","6TPK"
"6TPT",,"X-RAY DIFFRACTION",3.16,61.08,"VAPOR DIFFUSION",6.5,"0.2 M Sodium fluoride, 0.1 M Bis-tris propane pH 6.5, and 20% PEG3350",277,"10.1107/S2059798320003885",,"6TPT",21.9,"3.2","3.2","Crystal structures of FNIII domain three and four of the human leucocyte common antigen-related protein, LAR","PAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDED","Homo sapiens","PTPRF, LAR","Receptor-type tyrosine-protein phosphatase F","1","6TPT"
"6TPU",,"X-RAY DIFFRACTION",2.22,44.72,"VAPOR DIFFUSION",7,"1.8 M Ammonium citrate tribasic pH 7.0",277,"10.1107/S2059798320003885",,"6TPU",43.83,"1.55","1.55","Crystal structures of FNIII domain three and four of the human leucocyte common antigen-related protein, LAR","GAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDED","Homo sapiens","PTPRF, LAR","Receptor-type tyrosine-protein phosphatase F","1","6TPU"
"6TPV",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, SITTING DROP",8.3,"0.2 M Sodium citrate tribasic dihydrate pH 8.3, 20 % PEG 3,350",277,"10.1107/S2059798320003885",,"6TPV",45.53,"1.8","1.8","Crystal structures of FNIII domain one and two of the human leucocyte common antigen-related protein, LAR","MHHHHHHENLYFQGPKPPIDLVVTETTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQAPSSPPRRVQARMLSASTMLVQWEPPEEPNGLVRGYRVYYTPDSRRPPNAWHKHNTDAGLLTTVGSLLPGITYSLRVLAFTAVGDGPPSPTIQVKTQQGVP","Homo sapiens","PTPRF, LAR","Receptor-type tyrosine-protein phosphatase F","1","6TPV"
"6TPW",,"X-RAY DIFFRACTION",3.63,66.09,"EVAPORATION",,"0.2 M Ammonium sulfate and 30% PEG8000",277,"10.1107/S2059798320003885",,"6TPW",44.71,"2.9","2.9","Crystal structures of FNIII domain one through four of the human leucocyte common antigen-related protein ( LAR)","MHHHHHHENLYFQGPKPPIDLVVTETTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQAPSSPPRRVQARMLSASTMLVQWEPPEEPNGLVRGYRVYYTPDSRRPPNAWHKHNTDAGLLTTVGSLLPGITYSLRVLAFTAVGDGPPSPTIQVKTQQGVPAQPADFQAEVESDTRIQLSWLLPPQERIIMYELVYWAAEDEDQQHKVTFDPTSSYTLEDLKPDTLYRFQLAARSDMGVGVFTPTIEARTAQSTPSAPPQKVMCVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDED","Homo sapiens","PTPRF, LAR","Receptor-type tyrosine-protein phosphatase F","1","6TPW"
"6TPX",,"X-RAY DIFFRACTION",1.9,35.21,"VAPOR DIFFUSION",,"20% PEG6000, 0.2M NH4Cl, 0.1M tris pH8",293,"10.1021/acs.jmedchem.9b01670",,"6TPX",15.72,"1.48","1.48","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1-((1-acetylpiperidin-4-yl)methyl)-2-(4-hydroxy-3,5-dimethylphenyl)-N-methyl-1H-benzo[d]imidazole-5-carboxamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6TPX"
"6TPY",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",,"0.1M BTP pH8.5, 20% PEG3350",293,"10.1021/acs.jmedchem.9b01670",,"6TPY",15.62,"1.8","1.8","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-dimethyl-5-(1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6TPY"
"6TPZ",,"X-RAY DIFFRACTION",1.89,34.76,"VAPOR DIFFUSION, SITTING DROP",,"of 0.1 PCTP pH 8.0, 25% v/v PEG1500",293,"10.1021/acs.jmedchem.9b01670",,"6TPZ",15.65,"1.299","1.299","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1H)-one","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6TPZ"
"6TQ1",,"X-RAY DIFFRACTION",2,38.57,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Hepes pH 7.0, 24-28% PEG3350, 0.2M (NH4)2SO4",293,"10.1021/acs.jmedchem.9b01670",,"6TQ1",55.24,"1.9","1.9","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1H-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1H)-one","MGSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6TQ1"
"6TQ2",,"X-RAY DIFFRACTION",2.01,38.8,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.0, 24-28% PEG3350, 0.2M (NH4)2SO4",293,"10.1021/acs.jmedchem.9b01670",,"6TQ2",55.37,"2.26","2.26","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5-(4-(4-fluorophenyl)-1H-imidazol-5-yl)-1-methylpyridin-2(1H)-one","MGSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6TQ2"
"6TQ4",,"X-RAY DIFFRACTION",3.75,67.16,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787",,"6TQ4",90.16,"2.299","2.299","Crystal structure of the Orexin-1 receptor in complex with Compound 16","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TQ4"
"6TQ6",,"X-RAY DIFFRACTION",3.88,68.28,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787",,"6TQ6",89.8,"2.546","2.546","Crystal structure of the Orexin-1 receptor in complex with Compound 14","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TQ6"
"6TQ7",,"X-RAY DIFFRACTION",3.86,68.09,"VAPOR DIFFUSION, SITTING DROP",5.2,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","NVK","6TQ7",89.91,"2.6636","2.6636","Crystal structure of the Orexin-1 receptor in complex with SB-334867","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TQ7"
"6TQ9",,"X-RAY DIFFRACTION",3.94,68.77,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M TRISODIUM CITRATE
50mM SODIUM CHLORIDE
50mM LITHIUM SULPHATE
15-34% PEG400",284,"10.1021/acs.jmedchem.9b01787","NVN","6TQ9",82.21,"2.655","2.655","Crystal structure of the Orexin-1 receptor in complex with SB-408124","AASEDEFLRYLWRDYLYPKQYAWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFLVNLSLADVLATAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRALGSILGIWAVSLAIMVPQAAVMECSSVLPELAARTRAFSVCDERWADDLAPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSAEVKQMRARRKTAKMLMVVVLVFALCYLPISVLNVLKRVFGMFRQASDREAVYAAFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSWWLPGLAAAHHHHHHHHH","Homo sapiens","HCRTR1","Orexin receptor type 1","1","6TQ9"
"6TQI",,"X-RAY DIFFRACTION",2.25,45.5,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG 400, 5 mM spermine, 50 mM 2-(N-morpholino)ethanesulfonic acid (MES)",285,"10.1093/nar/gkaa439",,"6TQI",2.68,"2.95","2.95","I-MOTIF STRUCTURE FORMED FROM THE C STRAND OF A HUMAN TELOMERE FRAGMENT","TAACCCTAA","Homo sapiens",,"DNA (5'-*TP*AP*AP*CP*CP*CP*TP*AP*A-3')","1","6TQI"
"6TQK","3.35","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020106807",,"6TQK",188.75,"3.35",,"Cryo-EM of native human uromodulin (UMOD)/Tamm-Horsfall protein (THP) filament.","DTSEARWCSECHSNATCTEDEAVTTCTCQEGFTGDGLTCVDLDECAIPGAHNCSANSSCVNTPGSFSCVCPEGFRLSPGLGCTDVDECAEPGLSHCHALATCVNVVGSYLCVCPAGYRGDGWHCECSPGSCGPGLDCVPEGDALVCADPCQAHRTLDEYWRSTEYGEGYACDTDLRGWYRFVGQGGARMAETCVPVLRCNTAAPMWLNGTHPSSDEGIVSRKACAHWSGHCCLWDASVQVKACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCKSNNGRWHCQCKQDFNITDISLLEHRLECGANDMKVSLGKCQLKSLGFDKVFMYLSDSRCSGFNDRDNRDWVSVVTPARDGPCGTVLTRNETHATYSNTLYLADEIIIRDLNIKINFACSYPLDMKVSLKTALQPMVSALNIRVGGTGMFTVRMALFQTPSYTQPYQGSSVTLSTEAFLYVGTMLDGGDLSRFALLMTNCYATPSSNATDPLKYFIIQDRCPHTRDSTIQVVENGESSQGRFSVQMFRFAGNYDLVYLHCEVYLCDTMNEKCKPTCSGTRF","Homo sapiens","UMOD","Uromodulin","1","6TQK"
"6TQL","3.96","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020106807",,"6TQL",104.33,"3.96",,"Cryo-EM of elastase-treated human uromodulin (UMOD)/Tamm-Horsfall protein (THP) filament","SVEGTCEECSIDEDCKSNNGRWHCQCKQDFNITDISLLEHRLECGANDMKVSLGKCQLKSLGFDKVFMYLSDSRCSGFNDRDNRDWVSVVTPARDGPCGTVLTRNETHATYSNTLYLADEIIIRDLNIKINFACSYPLDMKVSLKTALQPMVSALNIRVGGTGMFTVRMALFQTPSYTQPYQGSSVTLSTEAFLYVGTMLDGGDLSRFALLMTNCYATPSSNATDPLKYFIIQDRCPHTRDSTIQVVENGESSQGRFSVQMFRFAGNYDLVYLHCEVYLCDTMNEKCKPTCSGTRF","Homo sapiens","UMOD","Uromodulin","1","6TQL"
"6TQT",,"X-RAY DIFFRACTION",1.97,37.54,"VAPOR DIFFUSION, SITTING DROP",4.2,"40% PEG 300, 0.1 M Sodium Phosphate Citrate pH 4.2",293,"10.15252/embj.2019104369",,"6TQT",24.52,"1.5","1.5","The crystal structure of the MSP domain of human MOSPD2.","MISNEEQTPLLKKINPTESTSKAEENEKVDSKVKAFKKPLSVFKGPLLHISPAEELYFGSTESGEKKTLIVLTNVTKNIVAFKVRTTAPEKYRVKPSNSSCDPGASVDIVVSPHGGLTVSAQDRFLIMAAEMEQSSGTGPAELTQFWKEVPRNKVMEHRLRCHTVESSKPNTLTLKDNAFNMSDKTSEDICLQLSRLLESNRKLEDQVQRHHHHHH","Homo sapiens","MOSPD2","Motile sperm domain-containing protein 2","1","6TQT"
"6TR0",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1913483117",,"6TR0",22.34,,,"Solution structure of U2AF2 RRM1,2","AMVGSQMTRQARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGMSENPSVYVPGVVSTVVPDSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNA","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","6TR0"
"6TR2",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz1235",,"6TR2",7.29,,,"Pre-folded structures govern folding pathways of human telomeric G-quadruplexes","TAGGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","6TR2"
"6TR5",,"X-RAY DIFFRACTION",2,38.46,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5 M ammonium sulphate 
0.1 M sodium citrate pH 4.2",300,"10.1111/jpi.12630","ML1","6TR5",45.1,"1.509","1.509","Melatonin-Notum complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6TR5"
"6TR6",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5 M ammonium sulphate 
0.1 M sodium citrate pH 4.2.",300,"10.1111/jpi.12630","ASE","6TR6",45.05,"1.35","1.35","N-acetylserotonin-Notum complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6TR6"
"6TR7",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5 M ammonium sulphate 
0.1 M sodium citrate pH 4.2",300,"10.1111/jpi.12630","HWH","6TR7",45.55,"1.47","1.47","N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide-Notum complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6TR7"
"6TR9",,"X-RAY DIFFRACTION",3.69,66.63,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TR9",20.66,"2.46","2.46","Crystal structure of human L ferritin (HuLf) triple variant E60A-E61A-E64A","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAAAKRAGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TR9"
"6TRJ",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, SITTING DROP",,"0.1M DL-Glutamic acid monohydrate; 0.1M
DL-Alanine; 0.1M Glycine; 0.1M DL-Lysine
monohydrochloride; 0.1M DL-Serine; 0.1 M Tris (base); BICINE pH 8.5; 20% v/v Glycerol; 10% w/v PEG 4000 (Morpheus Molecular Dimensions condition H11)",291,,,"6TRJ",10.52,"1.3","1.3","LEDGF/p75 IBD dimer","SNAASETSMDSRLQRIHAEIKNSLKIDNLDVNRCIEALDELASLQVTMQQAQKHTEMITTLKKIRRFKVSQVIMEKSTMLYNKFKNMFLVG","Homo sapiens","PSIP1, DFS70, LEDGF, PSIP2","PC4 and SFRS1-interacting protein","1","6TRJ"
"6TRL",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG3350, NaNO3, MES",277.15,,,"6TRL",82.89,"2.2","2.2","Human Eg5 motor domain mutant Y82F","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVFRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6TRL"
"6TRX",,"X-RAY DIFFRACTION",4.24,70.99,"VAPOR DIFFUSION, HANGING DROP",6.75,"0.46 M Na citrate pH 6.75",277,"10.1107/S1600576721003551",,"6TRX",313.75,"3.2","3.2","Crystal structure of DPP8 in complex with 1G244","GAMGSMWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","6TRX"
"6TRY",,"X-RAY DIFFRACTION",2.57,52.12,"VAPOR DIFFUSION",,"0.4 M sodium malonate, pH 7.0",293.15,"10.1021/acsmedchemlett.9b00686",,"6TRY",114.38,"2.9","2.9","Crystal structure of human Aldehyde dehydrogenase 1A3 in complex with MF13 inhibitor compound","MATANGAVENGQPDRKPPALPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLGDKNP","Homo sapiens","ALDH1A3, ALDH6","Aldehyde dehydrogenase family 1 member A3","1","6TRY"
"6TS0",,"X-RAY DIFFRACTION",3.73,66.98,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TS0",20.51,"2.2","2.2","Crystal structure of human L ferritin (HuLf) triple variant E60A-E61A-E64A Fe(III)-loaded for 30 minutes","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAAAKRAGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TS0"
"6TS1",,"X-RAY DIFFRACTION",3.69,66.64,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TS1",20.6,"2.2","2.2","Crystal structure of human L ferritin (HuLf) triple variant E60A-E61A-E64A Fe(III)-loaded for 60 minutes","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAAAKRAGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TS1"
"6TS4",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulfate, 0.1 M BIS-TRIS pH5.5, 25% w/v Polyethylene glycol 3350",277,"10.1021/acs.jmedchem.0c00279","J7B","6TS4",27.9,"1.17","1.17","Coagulation factor XI protease domain in complex with active site inhibitor","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDAGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","6TS4"
"6TS5",,"X-RAY DIFFRACTION",2.27,45.84,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulfate, 0.1 M BIS-TRIS pH5.5, 25% w/v Polyethylene glycol 3350
Protein at 18mg/ml in 50mM Tris/HCl pH7.4 100mM NaCl",277,"10.1021/acs.jmedchem.0c00279","NW2","6TS5",27.75,"1.29","1.29","Coagulation factor XI protease domain in complex with active site inhibitor","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","6TS5"
"6TS6",,"X-RAY DIFFRACTION",2.26,45.6,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulfate, 0.1 M BIS-TRIS pH5.5, 25% w/v Polyethylene glycol 3350",277,"10.1021/acs.jmedchem.0c00279","NW5","6TS6",27.82,"1.33","1.33","Coagulation factor XI protease domain in complex with active site inhibitor","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","6TS6"
"6TS7",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, SITTING DROP",,"25% w/v PEG 3350, Sodium acetate trihydrate pH 4.5",277,"10.1021/acs.jmedchem.0c00279",,"6TS7",27.23,"2.63","2.63","Coagulation factor XI protease domain in complex with active site inhibitor","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","6TS7"
"6TSA",,"X-RAY DIFFRACTION",3.76,67.3,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TSA",21.06,"2.18","2.18","Crystal structure of human L ferritin (HuLf) Fe(III)-loaded for 30 minutes","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TSA"
"6TSE",,"X-RAY DIFFRACTION",2.05,39.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2, 500mM NaCl",298,,,"6TSE",40.68,"1.41","1.41","Crystal Structure of 1-methylindoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6TSE"
"6TSF",,"X-RAY DIFFRACTION",3.59,65.72,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TSF",20.94,"2.09","2.09","Crystal structure of human L ferritin (HuLf) Fe(III)-loaded for 60 minutes","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TSF"
"6TSG",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, SITTING DROP",,"33% PEG 3350 and 0.15 M sodium citrate",293.15,"10.1021/acs.jmedchem.9b02150",,"6TSG",32.42,"2.98","2.98","Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG) in complex with TETRAC","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6TSG"
"6TSJ",,"X-RAY DIFFRACTION",3.7,66.79,"VAPOR DIFFUSION, SITTING DROP",4.6,"80 mM cadmium nitrate, 80 mM ammonium sulfate, 200 mM sodium acetate, pH 4.6",293,"10.1002/chem.202000064",,"6TSJ",20.79,"2.3","2.3","Crystal structure of human L ferritin (HuLf) Fe(III)-loaded for 15 minutes","MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD","Homo sapiens","FTL","Ferritin light chain","1","6TSJ"
"6TSZ",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M citrate pH 5.9, 15% 2 propanol, 6% PEG4K",277,"10.1016/j.str.2020.07.016",,"6TSZ",35.03,"1.9","1.9","The ULK4 Pseudokinase Domain Bound To ATPgammaS","GSHHHHHHSSGTENLYFQENFILYEEIGRGSKTVVYKGRRKGTINFVAILCTDKCKRPEITNWVRLTREIKHKNIVTFHEWYETSNHLWLVVELCTGGSLKTVIAQDENLPEDVVREFGIDLISGLHHLHKLGILFCDISPRKILLEGPGTLKFSNFCLAKVEGENLEEFFALVAAEEGGGDNGENVLKKSMKSRVKGSPVYTAPEVVRGADFSISSDLWSLGCLLYEMFSGKPPFFSESISELTEKILCEDPLPPIPKDSSRPKASSDFINLLDGLLQRDPQKRLTWTRLLQHSFWKKAFAGAD","Homo sapiens","ULK4","Serine/threonine-protein kinase ULK4","1","6TSZ"
"6TT1",,"X-RAY DIFFRACTION",2.8,56.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1042/BCJ20200060",,"6TT1",149.97,"1.8","1.8","Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with 33RE.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQTWSNIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMEQLVVVHHEMGHIQYFLQYKDLPVSLREGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALDKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6TT1"
"6TT2",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2, 500mM NaCl",298,,,"6TT2",40.04,"1.36","1.36","The PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6TT2"
"6TT3",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30 % PEG550MME/PEG20000",289,"10.1042/BCJ20200060",,"6TT3",150.71,"1.7","1.7","Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with SG6.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQTWSNIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMEQLVVVHHEMGHIQYFLQYKDLPVSLREGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALDKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6TT3"
"6TT4",,"X-RAY DIFFRACTION",3.12,60.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1042/BCJ20200060",,"6TT4",150.98,"1.8","1.8","Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with omapatrilat.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQTWSNIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMEQLVVVHHEMGHIQYFLQYKDLPVSLREGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALDKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6TT4"
"6TT5",,"X-RAY DIFFRACTION",1.91,35.76,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350
0.3 M Ammonium Chloride",277.15,"10.1093/nar/gkab693",,"6TT5",42.33,"1.5","1.5","Crystal structure of DCLRE1C/Artemis","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","6TT5"
"6TTF","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.drudis.2019.12.006",,"6TTF",241.58,"3.2",,"PKM2 in complex with Compound 5","MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6TTF"
"6TTH","2.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.drudis.2019.12.006",,"6TTH",241.16,"2.6",,"PKM2 in complex with L-threonine","MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6TTH"
"6TTI","2.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.drudis.2019.12.006",,"6TTI",241.78,"2.5",,"PKM2 in complex with Compound 6","MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6TTI"
"6TTQ","2.7","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.drudis.2019.12.006",,"6TTQ",241.4,"2.7, 2.7",,"PKM2 in complex with Compound 10","MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6TTQ"
"6TU9",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES pH 7.2, 12% PEG20K",277,"10.1016/j.molcel.2020.06.018",,"6TU9",71.96,"1.94","1.94","The ROR1 Pseudokinase Domain Bound To Ponatinib","MSMLNAYKPKSKAKELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDYNNPQQWMEFQQEASLMAELHHPNIVCLLGAVTQEQPVCMLFEYINQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWNEIPSRRPRFKDIHVRLRSWEGLHHHHHH","Homo sapiens","ROR1, NTRKR1","Inactive tyrosine-protein kinase transmembrane receptor ROR1","1","6TU9"
"6TUA",,"X-RAY DIFFRACTION",3,59.06,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M lithium sulfate, 0.1 M HEPES 7.5",293,"10.1016/j.molcel.2020.06.018",,"6TUA",36.57,"2.38","2.38","The RYK Pseudokinase Domain","SITSSLGYPTLRIEKNDLRSVTLLEAKGKVKDIAISRERITLKDVLQEGTFGRIFHGILIDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLLPITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSYLARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLVNNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVMACCWALDPEERPKFQQLVQCLTEFHAALGAYV","Homo sapiens","RYK, JTK5A","Tyrosine-protein kinase RYK","1","6TUA"
"6TUB",,"SOLID-STATE NMR",,,,,,,"10.1038/s41594-020-00515-z",,"6TUB",20.82,,,"Beta-endorphin amyloid fibril","YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE","Homo sapiens","POMC","Beta-endorphin","1","6TUB"
"6TUC",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, DTT, diammonium hydrogen citrate, NADP+",291,,,"6TUC",37.18,"1.06","1.06","Human Aldose Reductase in complex with ALR25","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","aldose reductase","1","6TUC"
"6TUF",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, DTT, diammonium hydrogen citrate, NADP+",291,,,"6TUF",37.2,"1.15","1.15","Human Aldose Reductase in complex with ALR43","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","aldose reductase","1","6TUF"
"6TUH",,"X-RAY DIFFRACTION",2.23,44.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2",298,,,"6TUH",80.98,"2.25","2.25","The PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPSFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6TUH"
"6TUL",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM MMT (D/L-malic acid, MES, tris)
25% PEG1500",291,"10.1080/19420862.2020.1801230",,"6TUL",48.94,"2.25","2.25","Structure of the arginase-2-inhibitory human antigen-binding fragment Fab C0021177","GAHSEVQLLESGGGLVQPGGSLRLSCAASGFTFRYEVAAWVRQAPGKGLEWVSAISGPAPKGYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLRADLGLYMDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHAA","Homo sapiens",,"Fab C0021177 heavy chain (IgG1)","1","6TUL"
,,,,,,,,,,,,,,,,"GVHSQSELTQPPTASAAPGQKVTISCSGSSSNIGNHYVSWYQQLPGTAPKLLIYDTTVLSSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDELTSNLVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab C0021177 light chain (IgG1)","2","6TUL"
"6TUR",,"X-RAY DIFFRACTION",2.87,57.21,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350, 100 mM Citric acid pH 3.5",295,"10.1093/nar/gkaa688",,"6TUR",163.91,"2.9","2.9","human XPG, Apo1 form","MGVQGLWKLLECSGRQVSPEALEGKILAVDISIWLNQALKGVRDRHGNSIENPHLLTLFHRLCKLLFFRIRPIFVFDGDAPLLKKQTLVKRRQRKDLASSDSRKTTEKLLKTGTLKAQKQQQERIAATVTGQMFLESQELLRLFGIPYIQAPMEAEAQCAILDLTDQTSGTITDDSAIWLFGARHVYRNFFNKNKFVEYYQYVDFHNQLGLDRNKLINLAYLLGSDYTEGIPTVGCVTAMEILNEFPGHGLEPLLKFSEWWHEAQKNPKIRPNPHDTKVKKKLRTLQLTPGFPNPAVAEAYLKPVVDDSKGSFLWGKPDLDKIREFCQRYFGWNRTKTDESLFPVLKQLDAQQTQ","Homo sapiens","ERCC5, ERCM2, XPG, XPGC","DNA repair protein complementing XP-G cells,DNA repair protein complementing XP-G cells","1","6TUR"
,,,,,,,,,,,,,,,,,"Homo sapiens","ERCC5, ERCM2, XPG, XPGC"
"6TUS",,"X-RAY DIFFRACTION",3.06,59.76,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350, 100 mM Bis-Tris pH 6.5, 200 mM Amm. Sulfate.",295,"10.1093/nar/gkaa688",,"6TUS",82.41,"2.5","2.5","human XPG, Apo2 form","MGVQGLWKLLECSGRQVSPEALEGKILAVDISIWLNQALKGVRDRHGNSIENPHLLTLFHRLCKLLFFRIRPIFVFDGDAPLLKKQTLVKRRQRKDLASSDSRKTTEKLLKTGTLKAQKQQQERIAATVTGQMFLESQELLRLFGIPYIQAPMEAEAQCAILDLTDQTSGTITDDSAIWLFGARHVYRNFFNKNKFVEYYQYVDFHNQLGLDRNKLINLAYLLGSDYTEGIPTVGCVTAMEILNEFPGHGLEPLLKFSEWWHEAQKNPKIRPNPHDTKVKKKLRTLQLTPGFPNPAVAEAYLKPVVDDSKGSFLWGKPDLDKIREFCQRYFGWNRTKTDESLFPVLKQLDAQQTQA","Homo sapiens","ERCC5, ERCM2, XPG, XPGC","DNA repair protein complementing XP-G cells,DNA repair protein complementing XP-G cells","1","6TUS"
,,,,,,,,,,,,,,,,,"Homo sapiens","ERCC5, ERCM2, XPG, XPGC"
,,,,,,,,,,,,,,,,"MGVQGLWKLLECSGRQVSPEALEGKILAVDISIWLNQALKGVRDRHGNSIENPHLLTLFHRLCKLLFFRIRPIFVFDGDAPLLKKQTLVKRRQRKDLASSDSRKTTEKLLKTGTLKAQKQQQERIAATVTGQMFLESQELLRLFGIPYIQAPMEAEAQCAILDLTDQTSGTITDDSAIWLFGARHVYRNFFNKNKFVEYYQYVDFHNQLGLDRNKLINLAYLLGSDYTEGIPTVGCVTAMEILNEFPGHGLEPLLKFSEWWHEAQKNPKIRPNPHDTKVKKKLRTLQLTPGFPNPAVAEAYLKPVVDDSKGSFLWGKPDLDKIREFCQRYFGWNRTKTDESLFPVLKQLDAQQTQ","Homo sapiens","ERCC5, ERCM2, XPG, XPGC","DNA repair protein complementing XP-G cells,DNA repair protein complementing XP-G cells","2","6TUS"
,,,,,,,,,,,,,,,,,"Homo sapiens","ERCC5, ERCM2, XPG, XPGC"
"6TUZ",,"X-RAY DIFFRACTION",2,38.51,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5 M Ammonium sulphate
0.1 M sodium citrate pH4.2",300,"10.1038/s42003-020-01286-5","TEP","6TUZ",46,"1.24","1.24","Theophylline-Notum complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6TUZ"
"6TV4",,"X-RAY DIFFRACTION",1.93,36.25,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium citrate pH 4.2",300,"10.1038/s42003-020-01286-5","CFF","6TV4",45.75,"1.53","1.53","CFF-Notum complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6TV4"
"6TVE",,"X-RAY DIFFRACTION",2.42,49.19,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Tris pH 7.8, PEG6000, 100 mM Gly-Pro, 10 % DMSO. The Gly-Pro dipeptide was added as part of fragment screening experiment but did not bind to the protein.",291,"10.1021/acs.jmedchem.9b01611",,"6TVE",61.54,"1.05","1.05","Unliganded human CD73 (5'-nucleotidase) in the open state","MAHHHHHHVGTGSNDDDDKSPDPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANISASGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTSCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6TVE"
"6TVG",,"X-RAY DIFFRACTION",2.42,49.11,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris pH 7.8, 10 % PEG6000, 30 mM AMPCP, 10 % DMSO, 10 % glycerol",291,"10.1021/acs.jmedchem.9b01611","AP2","6TVG",61.08,"1.48","1.48","Human CD73 (ecto 5'-nucleotidase) in complex with AMPCP in the open state","MAHHHHHHVGTGSNDDDDKSPDPWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANISASGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTSCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFS","Homo sapiens","NT5E, hCG_401111, NT5, NTE","5'-nucleotidase, ecto (CD73), isoform CRA_a","1","6TVG"
"6TVM",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2020.08.012",,"6TVM",29.29,,,"LEDGF/p75 dimer (residues 345-467)","SNAASETSMDSRLQRIHAEIKNSLKIDNLDVNRCIEALDELASLQVTMQQAQKHTEMITTLKKIRRFKVSQVIMEKSTMLYNKFKNMFLVGEGDSVITQVLNKSLAEQRQHEEANKTKDQGKKGPNKK","Homo sapiens","PSIP1, DFS70, LEDGF, PSIP2","PC4 and SFRS1-interacting protein","1","6TVM"
"6TVN",,"X-RAY DIFFRACTION",2.17,43.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2",298,,,"6TVN",80.96,"2.31","2.31","Crystal Structure of 5-bromoindoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase","AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPAFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6TVN"
"6TVX",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, HANGING DROP",5.5,"Drop: 3 mg/ml CD73, 100 microM ZnCl2 and 1 mM of compound. Reservoir: 5-8 percent (w/v) polyethylene glycol 6000, 0.1 M NaMES pH 5.5. Cryo buffer: 25 percent PEG200, 0.1 M NaMES pH 5.5",291,"10.1021/acs.jmedchem.9b01611",,"6TVX",59.83,"2.6","2.6","Human CD73 (ecto 5'-nucleotidase) in complex with PSB12676 (an AOPCP derivative, compound 9 in paper) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6TVX"
"6TW0",,"X-RAY DIFFRACTION",2.64,53.39,"VAPOR DIFFUSION, HANGING DROP",,"Reservoir: 5 % (w/v) polyethylene glycol 6000, 0.1 M NaMES pH 5.5. Drop:
1 microL crystallization buffer + 1 microL of 3 mg/mL protein in 10 mM Tris pH 8.0, 100 microM ZnCl2 and 1 mM of compound. Cryo buffer: 25% PEG200, 0.1 M NaMES pH 5.5",291,"10.1021/acs.jmedchem.9b01611","NYZ","6TW0",59.83,"2.5","2.5","Human CD73 (ecto 5'-nucleotidase) in complex with PSB12690 (an AOPCP derivative, compound 10 in publication) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6TW0"
"6TW2",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, HANGING DROP",7,"2.1 M SODIUM MALATE",277,"10.1016/j.molcel.2020.01.028",,"6TW2",40.08,"1.8","1.8","Re-refined crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6TW2"
"6TWA",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",5.5,"Reservoir: 5-8 % (w/v) polyethylene glycol 6000, 0.1 M NaMES pH 5.5-6.0
Drop: 1 microL reservoir + 1 microL of 3 mg/mL protein in 10 mM Tris pH 8.0, 100 microM ZnCl2 and 1 mM of compound. Cryo: 25% PEG200, 0.1 M Na-MES pH 5.5",291,"10.1021/acs.jmedchem.9b01611","O02","6TWA",59.89,"2","2","Human CD73 (ecto 5'-nucleotidase) in complex with PSB12646 (an AOPCP derivative, compound 20 in publication) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6TWA"
"6TWF",,"X-RAY DIFFRACTION",2.62,52.98,"VAPOR DIFFUSION, HANGING DROP",5.5,"Reservoir: 5-8 % (w/v) polyethylene glycol 6000, 0.1 M NaMES pH 5.5-6.0.
Drop: 1 microL crystallization buffer + 1 microL of 3 mg/mL protein in 10 mM Tris pH 8.0, 100 microM ZnCl2 and 1 mM of compound. Cryo: 25% PEG200, 0.1 M Na-MES pH 5.5",291,"10.1021/acs.jmedchem.9b01611","O05","6TWF",59.94,"2.5","2.5","Human CD73 (ecto 5'-nucleotidase) in complex with PSB12604 (an AOPCP derivative, compound 21 in publication) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6TWF"
"6TX0",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 16% (w/v) PEG 3350",293,"10.1038/s41467-020-16983-2",,"6TX0",123.68,"2.01","2.01","Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dAMPNPP and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIINTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6TX0"
"6TX2",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"33% glycerol ethoxylate, 0.23 M lithium citrate tribasic tetrahydrate",293,"10.1038/s41586-020-2013-6",,"6TX2",36.78,"2.09","2.09","Human HPF1","MGHHHHHHLRKEVENHYKLSLPEDFYHFWKFCEELDPEKPSDSLSASLGLQLVGPYDILAGKHKTKKKSTGLNFNLHWRFYYDPPEFQTIIIGDNKTQYHMGYFRDSPDEFPVYVGINEAKKNCIIVPNGDNVFAAVKLFLTKKLKEITDKKKINLLKNIDEKLTEAARELGYSLEQRTVKMKQRDKKVVTKTFHGAGLVVPVDKNDVGYRELPETDADLKRICKTIVEAASDEERLKAFAPIQEMMTFVQFANDECDYGMGLELGMDLFCYGSHYFHKVAGQLLPLAYNLLKRNLFAEIIEEHLANRSQENIDQLAA","Homo sapiens","HPF1, C4orf27","Histone PARylation factor 1","1","6TX2"
"6TX4",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2 M NH4OAc, 0.1 M HEPES",293.15,"10.1021/acs.jmedchem.0c00120","HRZ","6TX4",14.3,"1.06","1.06","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PYRIDONE","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX4"
"6TX5",,"X-RAY DIFFRACTION",2.32,46.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2M NH4OAc, 0.1M HEPES",293.15,"10.1021/acs.jmedchem.0c00120","4MZ","6TX5",14.15,"1.08","1.08","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 4-METHYLIMIDAZOLE","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX5"
"6TX6",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2M NH4OAc, 0.1M HEPES",293.15,"10.1021/acs.jmedchem.0c00120",,"6TX6",14.35,"0.98","0.98","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDE","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX6"
"6TX7",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2 M NH4OAc, 0.1 M HEPES",293.15,"10.1021/acs.jmedchem.0c00120","V1L","6TX7",14.31,"1.13","1.13","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PIPERIDONE","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX7"
"6TX8",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2 M NH4OAc, 0.1 M HEPES",293.15,"10.1021/acs.jmedchem.0c00120",,"6TX8",14.18,"1.2","1.2","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLE","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX8"
"6TX9",,"X-RAY DIFFRACTION",2.32,47.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"28-41% PEG3350, 0.2 M NH4OAc, 0.1 M HEPES",293.15,"10.1021/acs.jmedchem.0c00120",,"6TX9",14.17,"1.42","1.42","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH HYDANTOIN","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TX9"
"6TXA",,"X-RAY DIFFRACTION",2.41,49.09,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 15% (w/v) PEG 3350, 0.15 M Li2SO4.",293,"10.1038/s41467-020-16983-2",,"6TXA",991.41,"2.853","2.853","Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dGMPNPP and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIINTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6TXA"
"6TXC",,"X-RAY DIFFRACTION",2.49,50.72,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCL pH 6, 17% (w/v) PEG 3350, 0.15 M Li2SO4.",293,"10.1038/s41467-020-16983-2",,"6TXC",989.81,"2.84","2.84","Crystal structure of tetrameric human wt-SAMHD1 (residues 109-626) with GTP, dATP, dCMPNPP and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6TXC"
"6TXE",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 19% (w/v) PEG 3350, 0.15 M Li2SO4",293,"10.1038/s41467-020-16983-2",,"6TXE",990,"3.19","3.19","Crystal structure of tetrameric human wt-SAMHD1 (residues 109-626) with GTP, dATP, dTMPNPP and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6TXE"
"6TXF",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 14% (w/v) PEG 3350",293,"10.1038/s41467-020-16983-2",,"6TXF",123.87,"2.25","2.25","Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dAMPNPP and Mn","GSQIHVDTMKVINDPIHGHIELHPLLVRIINTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6TXF"
"6TXP",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0: 15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 20% (w/v) PEG 6000
Soaking-buffer: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 25% (w/v) PEG 6000",291,,,"6TXP",37.49,"0.95","0.95","Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAALSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6TXP"
"6TXQ",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M ammonium acetate, 0.1M tris pH 8.5, 32% propan-2-ol",277,,,"6TXQ",41.2,"1.73","1.73","The high resolution structure of the FERM domain and helical linker of human moesin","SMPKTISVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWFFGLQYQDTKGFSTWLKLNKKVTAQDVRKESPLLFKFRAKFYPEDVSEELIQDITQRLFFLQVKEGILNDDIYCPPETAVLLASYAVQSKYGDFNKEVHKSGYLAGDKLLPQRVLEQHKLNKDQWEERIQVWHEEHRGMLREDAVLEYLKIAQDLEMYGVNYFSIKNKKGSELWLGVDALGLNIYEQNDRLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILALCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQMERAMLENEKKKREMAEKEKEKIEREKEE","Homo sapiens","MSN","Moesin","1","6TXQ"
,,,,,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M ammonium acetate, 0.1M tris pH 8.5, 34% propan-2-ol",277
"6TXV",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M CaCl2, 25% PEG400, 0.1M HEPES pH 7.5",291,"10.1111/febs.15339","TCW","6TXV",26.01,"1.6","1.6","A25T Transthyretin structure in complex with Tolcalpone","CPLMVKVLDAVRGSPTINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","TTR, PALB","Transthyretin","1","6TXV"
"6TXW",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M CaCl2, 30% PEG400, 0.1M HEPES pH 7.0",291,"10.1111/febs.15339","TCW","6TXW",25.87,"1.153","1.153","V30G Transthyretin structure in complex with Tolcalpone","CPLMVKVLDAVRGSPAINVAGHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","TTR, PALB","Transthyretin","1","6TXW"
"6TXX",,"X-RAY DIFFRACTION",2.24,45.16,"VAPOR DIFFUSION, HANGING DROP",,"28-43% PEG3350, 0.2M NH4OAc, 0.1M HEPES",293.15,"10.1021/acs.jmedchem.0c00120",,"6TXX",28.85,"2.1","2.1","CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6TXX"
"6TY5",,"X-RAY DIFFRACTION",2.59,52.51,"VAPOR DIFFUSION, SITTING DROP",,"20%(w/v) PEG3350, 0.2M Magnesium chloride hexahydrate",294,"10.1021/acs.jmedchem.0c00130",,"6TY5",192.81,"2.793","2.793","Crystal structure of human TLR8 in complex with Compound 11","EENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","6TY5"
"6TYH",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, SITTING DROP",,"Sodium Citrate, Phenol, Acetone, Zinc acetate",293,"10.1039/c9sc04555d",,"6TYH",36.36,"1.60001899481","1.60001899481","Four-Disulfide Insulin Analog A22/B22","GIVEQCCTSICSLYQLENYCNC","Homo sapiens","INS","Insulin A chain","1","6TYH"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGECGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","6TYH"
"6TYM",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, SITTING DROP",,"0.9M ammonium citrate and 100mM HEPES pH 7.0",289,"10.1016/j.bmcl.2019.126852","08A","6TYM",33.2,"1.422","1.422","KEAP1 Kelch domain in complex with Compound 9","GSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6TYM"
"6TYP",,"X-RAY DIFFRACTION",3.46,64.41,"VAPOR DIFFUSION, SITTING DROP",7,"3.0M sodium formate pH 7.0",289,"10.1016/j.bmcl.2019.126852","PKG","6TYP",32.58,"2.5","2.5","KEAP1 Kelch domain in complex with Compound 2","GSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6TYP"
"6TZ3",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, HANGING DROP",6,"0.2M Ammonium Sulfate, 30% PEG3350",298,"10.1016/j.neuron.2020.04.003",,"6TZ3",18.17,"1.17","1.17","Crystal Structure of Human Synaptotagmin 1 C2B without Ca2+","GDITHMEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","6TZ3"
"6TZ9","6.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0404-x",,"6TZ9",575.65,"6.2",,"CryoEM reconstruction of membrane-bound ESCRT-III filament composed of CHMP1B only","MSNMEKHLFNLKFAAKELSRSAKKCDKEEKAEKAKIEKAIQKGNMEVARIHAENAIRQKNQAVNFLRMSARVDAVAARVQTAVTMGKVTKSMAGVVKSMDATLKTMNLEKISALMDKFEHQFETLDVQTQQMEDTMSSTTTLTTPQNQVDMLLQEMADEAGLDLNMELPQGQTGSVGTSVASAEQDELSQRLARLRDQV","Homo sapiens","CHMP1B, C18orf2","Charged multivesicular body protein 1b","1","6TZ9"
"6TZA","7.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0404-x",,"6TZA",301.65,"7.2",,"CryoEM reconstruction of ESCRT-III filament composed of IST1 NTD R16E K27E double mutant","MLGSGFKAERLRVNLELVINRLKLLEEKKTELAQKARKEIADYLAAGKDERARIRVEHIIREDYLVEAMEILELYCDLLLARFGLIQSMKELDSGLAESVSTLIWAAPRLQSEVAELKIVADQLCAKYSKEYGKLCRTNQIGTVNDRLMHKLSVEAPPKILVERYLIEIAKNYNVPYEPDSVVMAEAPP","Homo sapiens","IST1, KIAA0174","IST1 homolog","1","6TZA"
"6TZE",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa689",,"6TZE",12.05,,,"Human CstF-64 RRM mutant - D50A","GGSMAGLTVRDPAVDRSLRSVFVGNIPYEATEEQLKDIFSEVGPVVSFRLVYARETGKPKGYGFCEYQDQETALSAMRNLNGREFSGRALRVDNAASEKNKEELKSLGTG","Homo sapiens","CSTF2","Cleavage stimulation factor subunit 2","1","6TZE"
"6U0A",,"X-RAY DIFFRACTION",3.64,66.21,"VAPOR DIFFUSION",,"0.1 M HEPES 7.5, 0.1 M sodium chloride, and 1.6 M ammonium sulfate

This solution with 20% glycerol was used as a cryoprotectant",295,,,"6U0A",24.55,"2.11","2.11","Human Angiopoietin-Like 4 C-Terminal Domain (cANGPTL4) with Glycerol","PRDCQELFQVGERQSGLFEIQPQGSPPFLVNCKMTSDGGWTVIQRRHDGSVDFNRPWEAYKAGFGDPHGEFWLGLEKVHSITGDRNSRLAVQLRDWDGNAELLQFSVHLGGEDTAYSLQLTAPVAGQLGATTVPPSGLSVPFSTWDQDHDLRRDKNCAKSLSGGWWFGTCSHSNLNGQYFRSIPQQRQKLKKGIFWKTWRGRYYPLQATTMLIQPM","Homo sapiens","ANGPTL4, ARP4, HFARP, PGAR, PP1158, PSEC0166, UNQ171/PRO197","Angiopoietin-related protein 4","1","6U0A"
"6U0D",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 15% PEG 3350 at pH 7.5",293,,,"6U0D",15.69,"1.43","1.43","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZL0590","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6U0D"
"6U0K",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, SITTING DROP",,"2M Sodium Potassium Phosphate and 10% Glycerol",277,,,"6U0K",70.45,"1.744","1.744","TTBK2 kinase domain in complex with Compound 1","GMSGGGEQLDILSVGILVKERWKVLRKIGGGGFGEIYDALDMLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNDRFNYVVMQLQGRNLADLRRSQSRGTFTISTTLRLGRQILESIESIHSVGFLHRDIKPSNFAMGRFPSTCRKCYMLDFGLARQFTNSCGDVRPPRAVAGFRGTVRYASINAHRNREMGRHDDLWSLFYMLVEFVVGQLPWRKIKDKEQVGSIKERYDHRLMLKHLPPEFSIFLDHISSLDYFTKPDYQLLTSVFDNSIKTFGVIESDPFDWEK","Homo sapiens","TTBK2, KIAA0847","Tau-tubulin kinase 2","1","6U0K"
"6U0Q",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M sodium citrate, 2% v/v glycerol",298,"10.1073/pnas.2013691118",,"6U0Q",28.52,"1.75","1.75","Transthyretin in complex with (E)-5,5'-(ethene-1,2-diyl)bis(1,1-dihydroxy-3-oxo-1,3-dihydrobenzo[c][1,2]oxaborol-1-uide)","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6U0Q"
"6U1U",,"X-RAY DIFFRACTION",3.62,66.04,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES 7.5
0.1 M Sodium chloride
1.6 M Ammonium sulfate
Palmitic Acid",295,,,"6U1U",24.71,"1.75","1.75","Human Angiopoietin-Like 4 C-Terminal Domain (cANGPTL4) with Palmitic Acid","PRDCQELFQVGERQSGLFEIQPQGSPPFLVNCKMTSDGGWTVIQRRHDGSVDFNRPWEAYKAGFGDPHGEFWLGLEKVHSITGDRNSRLAVQLRDWDGNAELLQFSVHLGGEDTAYSLQLTAPVAGQLGATTVPPSGLSVPFSTWDQDHDLRRDKNCAKSLSGGWWFGTCSHSNLNGQYFRSIPQQRQKLKKGIFWKTWRGRYYPLQATTMLIQPM","Homo sapiens","ANGPTL4, ARP4, HFARP, PGAR, PP1158, PSEC0166, UNQ171/PRO197","Angiopoietin-related protein 4","1","6U1U"
"6U23","3.49","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12279-2",,"6U23",1151.34,"3.49",,"EM structure of MPEG-1(w.t.) soluble pre-pore","KSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLLVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSHHHHHH","Homo sapiens","MPEG1","Macrophage-expressed gene 1 protein","1","6U23"
"6U26",,"X-RAY DIFFRACTION",1.1,54.68,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris (pH 7.8) 200 mM NaCl, 15% PEG 3350,",295,"10.1016/j.chembiol.2019.10.002",,"6U26",153.24,"1.53","1.53","PCSK9 in complex with compound 16","QEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQKGNSADIQHSGGRSSLEGPRFEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","6U26"
"6U2J","2.37","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12279-2",,"6U2J",1148.35,"2.37",,"EM structure of MPEG-1 (L425K, alpha conformation) soluble pre-pore complex","KSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLKVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSHHHHHH","Homo sapiens","MPEG1","Macrophage-expressed gene 1 protein","1","6U2J"
"6U2K","2.93","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12279-2",,"6U2K",71.97,"2.93",,"EM structure of MPEG-1 (L425K, alpha conformation) soluble pre-pore complex","KSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLKVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSHHHHHH","Homo sapiens","MPEG1","Macrophage-expressed gene 1 protein","1","6U2K"
"6U2L","2.83","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12279-2",,"6U2L",2296.7,"2.83",,"EM structure of MPEG-1 (L425K, beta conformation) soluble pre-pore complex","KSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLKVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSHHHHHH","Homo sapiens","MPEG1","Macrophage-expressed gene 1 protein","1","6U2L"
"6U2N",,"X-RAY DIFFRACTION",2.69,54.25,"VAPOR DIFFUSION",,"(10-22)% PEG 10000, 0.1M Tris, pH 8.5, 10% Ethylene Glycol, 1% BAM",303,"10.1016/j.chembiol.2019.10.002",,"6U2N",152.62,"2.15","2.15","PCSK9 in complex with compound 4","QEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQKGNSADIQHSGGRSSLEGPRFEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","6U2N"
"6U2P",,"X-RAY DIFFRACTION",2.69,54.21,"VAPOR DIFFUSION",,"(10-22)% PEG 10000, 0.1M Tris, pH 8.5, 10% Ethylene Glycol, 1% BAM",303,"10.1016/j.chembiol.2019.10.002",,"6U2P",152.95,"2.04","2.04","PCSK9 in complex with compound 5","QEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQKGNSADIQHSGGRSSLEGPRFEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","6U2P"
"6U2W","3.63","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-12279-2",,"6U2W",1151.6,"3.63",,"EM structure of MPEG-1(L425K) pre-pore complex bound to liposome","KSGKPSGEMDEVGVQKCKNALKLPVLEVLPGGGWDNLRNVDMGRVMELTYSNCRTTEDGQYIIPDEIFTIPQKQSNLEMNSEILESWANYQSSTSYSINTELSLFSKVNGKFSTEFQRMKTLQVKDQAITTRVQVRNLVYTVKINPTLELSSGFRKELLDISDRLENNQTRMATYLAELLVLNYGTHVTTSVDAGAALIQEDHLRASFLQDSQSSRSAVTASAGLAFQNTVNFKFEENYTSQNVLTKSYLSNRTNSRVQSIGGVPFYPGITLQAWQQGITNHLVAIDRSGLPLHFFINPNMLPDLPGPLVKKVSKTVETAVKRYYTFNTYPGCTDLNSPNFNFQANTDDGSCEGKMTNFSFGGVYQECTQLSGNRDVLLCQKLEQKNPLTGDFSCPSGYSPVHLLSQIHEEGYNHLECHRKCTLKVFCKTVCEDVFQVAKAEFRAFWCVASSQVPENSGLLFGGLFSSKSINPMTNAQSCPAGYFPLRLFENLKVCVSQDYELGSRFAVPFGGFFSCTVGNPLVDPAISRDLGAPSLKKCPGGFSQHPALISDGCQVSYCVKSGLFTGGSLPPARLPPFTRPPLMSQAATNTVIVTNSENARSWIKDSQTHQWRLGEPIELRRAMNVIHGDGGGLSHHHHHH","Homo sapiens","MPEG1","Macrophage-expressed gene 1 protein","1","6U2W"
"6U2X",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M sodium chloride, 0.1 M Bis-Tris pH 6.5",293.15,"10.1002/jimd.12184",,"6U2X",449.69,"2.15","2.15","Structure of ALDH7A1 mutant E399G complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTGTFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6U2X"
"6U34",,"X-RAY DIFFRACTION",4.94,75.11,"VAPOR DIFFUSION, SITTING DROP",7,"10-20 mM sodium citrate, 100 mM HEPES, pH 7, 8-8.5 % PEG6000 and 100 mM potassium nitrate",283,"10.1074/jbc.RA119.012400","PQV","6U34",121.59,"2.4","2.4","Binary complex of native hAChE with oxime reactivator RS194B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6U34"
"6U37",,"X-RAY DIFFRACTION",4.87,74.73,"VAPOR DIFFUSION, SITTING DROP",7,"10-20 mM sodium citrate, 100 mM HEPES, pH 7, 8-8.5 % PEG6000 and 100 mM potassium nitrate",283,"10.1074/jbc.RA119.012400",,"6U37",121.81,"2.25","2.25","Structure of VX-phosphonylated hAChE in complex with oxime reactivator RS194B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6U37"
"6U3E","53","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.09.007","4IP","6U3E",94,"53",,"Best fitting antiparallel model for Volume 1 of truncated dimeric Cytohesin-3 (Grp1; amino acids 14-399)","MGHHHHHHGSPEDLSLEEREELLDIRRRKKELIDDIERLKYEIAEVMTEIDNLTSVEESKYTQRNAQIAMGRKKFNMDPKKGIQFLIENDLLQSSPEDVAQFLYKGEGLNKTVIGDYLGERDDFNIKVLQAFVELHEFADLNLVQALRQFLWSFRLPGEAQKIDRMMEAFASRYCLCNPGVFQSTDTCYVLSFAIIMLNTSLHNHNVRDKPTAERFITMNRGINEGGDLPEELLRNLYESIKNEPFKIPEDDGNDLTYTFFNPDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVEDPRKPNCFELYNPSHKGQVIKACKTEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASISRDPFYDMLATRKRRIANKK","Homo sapiens","CYTH3, ARNO3, GRP1, PSCD3","Cytohesin-3","1","6U3E"
"6U3G","53","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.09.007","4IP","6U3G",94,"53",,"Best fitting antiparallel model for Volume 2 of truncated dimeric Cytohesin-3 (Grp1; amino acids 14-399)","MGHHHHHHGSPEDLSLEEREELLDIRRRKKELIDDIERLKYEIAEVMTEIDNLTSVEESKYTQRNAQIAMGRKKFNMDPKKGIQFLIENDLLQSSPEDVAQFLYKGEGLNKTVIGDYLGERDDFNIKVLQAFVELHEFADLNLVQALRQFLWSFRLPGEAQKIDRMMEAFASRYCLCNPGVFQSTDTCYVLSFAIIMLNTSLHNHNVRDKPTAERFITMNRGINEGGDLPEELLRNLYESIKNEPFKIPEDDGNDLTYTFFNPDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVEDPRKPNCFELYNPSHKGQVIKACKTEADGRVVEGNHVVYRISAPSPEEKEEWMKSIKASISRDPFYDMLATRKRRIANKK","Homo sapiens","CYTH3, ARNO3, GRP1, PSCD3","Cytohesin-3","1","6U3G"
"6U3J",,"X-RAY DIFFRACTION",2.44,49.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Magnesium Acetate, 0.1 M MOPS, 12% PEG 8000, 10% glycerol",298,"10.1021/acschembio.0c00114",,"6U3J",204.6,"2.25","2.25","Structure of the 2-oxoadipate dehydrogenase DHTKD1","MGQTERGVYGYRPRKPESREPQGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFAHHHHHHH","Homo sapiens","DHTKD1, KIAA1630","2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","6U3J"
"6U3P",,"X-RAY DIFFRACTION",4.98,75.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM potassium nitrate, 100 mM HEPES pH 7.5, 10.5 % PEG 3350",283,"10.1074/jbc.RA119.012400",,"6U3P",120.98,"3","3","Binary complex of native hAChE with oxime reactivator LG-703","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6U3P"
"6U3R",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1914999116",,"6U3R",21.83,,,"Solution NMR structure of the DNAJB6b deltaST variant (Aligned on the J domain)","GMVDYYEVLGVQRHASPEDIKKAYRKLALKWHPDKNPENKEEAERKFKQVAEAYEVLSDAKKRDIYDKYGKEGLNGGGGGGSHFDSPFEFGFTFRNPDDVFREFFGGRDPFSFDFFEDPFEDFFGNRRGPRGGMGNFKSISTSTKMVNGRKITTKRIVENGQERVEVEEDGQLKSLTINGKEQLLRLDNK","Homo sapiens","DNAJB6, HSJ2, MRJ, MSJ1","DnaJ homolog subfamily B member 6,DnaJ homolog subfamily B member 6","1","6U3R"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNAJB6, HSJ2, MRJ, MSJ1"
"6U3S",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1914999116",,"6U3S",21.83,,,"Solution NMR structure of the DNAJB6b deltaST variant (Aligned on the CTD domain)","GMVDYYEVLGVQRHASPEDIKKAYRKLALKWHPDKNPENKEEAERKFKQVAEAYEVLSDAKKRDIYDKYGKEGLNGGGGGGSHFDSPFEFGFTFRNPDDVFREFFGGRDPFSFDFFEDPFEDFFGNRRGPRGGMGNFKSISTSTKMVNGRKITTKRIVENGQERVEVEEDGQLKSLTINGKEQLLRLDNK","Homo sapiens","DNAJB6, HSJ2, MRJ, MSJ1","DnaJ homolog subfamily B member 6","1","6U3S"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNAJB6, HSJ2, MRJ, MSJ1"
"6U3X",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, SITTING DROP",,"10-22% PEG 10K, 0.1M Tris, pH 8.5, 10% ethylene glycol, 1% BAM",303,"10.1016/j.chembiol.2019.10.002",,"6U3X",152.51,"2.64","2.64","PCSK9 in complex with compound 2","QEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQKGNSADIQHSGGRSSLEGPRFEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","6U3X"
"6U41",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",4.6,"2.0 M Ammonium Sulfate, 0.1 M Sodium Acetate",298,"10.1016/j.neuron.2020.04.003",,"6U41",18.3,"1.7","1.7","1.7 angstrom structure of a pathogenic human Syt 1 C2B (D304G)","GDITHMEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMGVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","6U41"
"6U46",,"SOLUTION NMR",,,,,,,,,"6U46",6.79,,,"Solution Structure of a Heat-Resistant Long-Acting Insulin Analog","FVNQHLCGSHLVEALYLVCGERGFFYTPRTEEGSRRSRGIVEQCCRSICSLYQLENYCG","Homo sapiens","INS","Insulin","1","6U46"
"6U4J",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3000, 0.1 M Sodium citrate",293,"10.1021/acs.jmedchem.9b01423","PWV","6U4J",98.73,"2.11","2.11","Crystal structure of IDH1 R132H mutant in complex with FT-2102","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6U4J"
"6U4K",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG8000, Hepes pH 7.0",297,"10.1074/jbc.RA119.010789",,"6U4K",46.98,"2.555","2.555","Human talin2 residues 1-403","GPMVALSLKICVRHCNVVKTMQFEPSTAVYDACRVIRERVPEAQTGQASDYGLFLSDEDPRKGIWLEAGRTLDYYMLRNGDILEYKKKQRPQKIRMLDGSVKTVMVDDSKTVGELLVTICSRIGITNYEEYSLIQETIEEKKEEGTGTLKKDRTLLRDERKMEKLKAKLHTDDDLNWLDHSRTFREQGVDENETLLLRRKFFYSDQNVDSRDPVQLNLLYVQARDDILNGSHPVSFEKACEFGGFQAQIQFGPHVEHKHKPGFLDLKEFLPKEYIKQRGAEKRIFQEHKNCGEMSEIEAKVKYVKLARSLRTYGVSFFLVKEKMKGKNKLVPRLLGITKDSVMRVDEKTKEVLQEWPLTTVKRWAASPKSFTLDFGEYQESYYSVQTTEGEQISQLIAGYIDIIL","Homo sapiens","TLN2, KIAA0320","Talin-2","1","6U4K"
"6U4M",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2019.09.006",,"6U4M",8.44,,,"Solution structure of paxillin LIM4","GAMDPEFYHERRGSLCSGCQKPITGRCITAMAKKFHPEHFVCAFCLKQLNKGTFKEQNDKPYCQNCFLKLFC","Homo sapiens","PXN","Paxillin","1","6U4M"
"6U4Q",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",298,"10.1021/acs.jmedchem.9b01669","PX7","6U4Q",29.21,"1.306","1.306","Carbonic anhydrase 2 in complex with SB4197","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6U4Q"
"6U4T",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M NaCitrate, 50 mM Tris",298,"10.1021/acs.jmedchem.9b01669","PX7","6U4T",29.33,"1.356","1.356","Carbonic anhydrase 9 in complex with SB4197","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6U4T"
"6U4U",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M Ammonium Sulfate, 0.1 M Sodium Acetate",298,"10.1016/j.neuron.2020.04.003",,"6U4U",18.73,"1.3","1.3","1.3 A structure of a pathogenic human Syt 1 C2B (I368T)","GDITHMEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKTGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","6U4U"
"6U4W",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, HANGING DROP",4,"1.6 M Ammonium Sulfate, 0.1 M Citrate",298,"10.1016/j.neuron.2020.04.003",,"6U4W",18.28,"1.4","1.4","1.4 A structure of a pathogenic human Syt 1 C2B (D366E)","GDITHMEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYEKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","6U4W"
"6U5C",,"X-RAY DIFFRACTION",2.8,56.09,"BATCH MODE",7.5,"100 mM HEPES, pH 7.5, 5 mM TCEP, 20% PEG3350",291,,,"6U5C",18.04,"1.62","1.62","RT XFEL structure of CypA solved using MESH injection system","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6U5C"
"6U5D",,"X-RAY DIFFRACTION",2.8,56.09,"BATCH MODE",7.5,"100 mM HEPES, pH 7.5, 5 mM TCEP, 20% PEG3350",291,,,"6U5D",18.04,"1.65","1.65","RT XFEL structure of CypA solved using LCP injection system","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6U5D"
"6U5E",,"X-RAY DIFFRACTION",2.8,56.02,"BATCH MODE",7.5,"100 mM HEPES, pH 7.5, 5 mM TCEP, 20% PEG3350",291,,,"6U5E",18.04,"1.56","1.56","RT XFEL structure of CypA solved using celloluse carrier media","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6U5E"
"6U5G","2.5","ELECTRON CRYSTALLOGRAPHY",2.75,55.34,,,,,,,"6U5G",18.04,"2.5, 2.5","2.5","MicroED structure of a FIB-milled CypA Crystal","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6U5G"
"6U5L",,"X-RAY DIFFRACTION",3.45,64.34,"VAPOR DIFFUSION, HANGING DROP",7.25,"PEG 6000, Imidazole",298,"10.1021/jacs.9b10458",,"6U5L",33.19,"1.75","1.75","Structure of human ULK4 in complex with an inhibitor","SGMENFILYEEIGRGSKTVVYKGRRKGTINFVAILCTDKCKRPEITNWVRLTREIKHKNIVTFHEWYETSNHLWLVVELCTGGSLKTVIAQDENLPEDVVREFGIDLISGLHHLHKLGILFCDISPRKILLEGPGTLKFSNFCLAKVEGENLEEFFALVAAEEGGGDNGENVLAASMKSRVKGSPVYTAPEVVRGADFSISSDLWSLGCLLYEMFSGKPPFFSESISELTEKILCEDPLPPIPKDSSRPKASSDFINLLDGLLQRDPQKRLTWTRLLQHSFWKKAFA","Homo sapiens","ULK4","Serine/threonine-protein kinase ULK4","1","6U5L"
"6U5M",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01411","Q0S","6U5M",68.05,"1.8","1.8","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U5M"
"6U5Y",,"X-RAY DIFFRACTION",2.33,47.1,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris pH 6.5, 0.2 M ammonium acetate, 28% PEG 3350",291,"10.1021/acs.jmedchem.9b01411","Q0M","6U5Y",68.01,"1.532","1.532","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U5Y"
"6U63",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, SITTING DROP",8,"23 % PEG 3350, 0.1 M Tris pH 8.0",293,"10.1021/acs.jmedchem.9b01442",,"6U63",74.13,"2.75","2.75","Mcl-1 bound to compound 17","SNAEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6U63"
"6U64",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 3350, 0.2 mM MgCl2 and 0.1 M ADA pH 6.5",293,"10.1021/acs.jmedchem.9b01442",,"6U64",18.72,"2.55","2.55","Mcl-1 bound to compound 17","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFH","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6U64"
"6U65",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG 3350, 200 mM NH4 Acetate, 100 mM Bis-Tris pH 6.5",293,"10.1021/acs.jmedchem.9b01442","Q0A","6U65",74.31,"2.09","2.09","Mcl-1 bound to compound 19","SNAEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6U65"
"6U66",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.2 mM Li2SO4, 0.1 M sodium acetate pH 4.5, 50% PEG 400",298,"10.1074/jbc.RA119.010970",,"6U66",48.97,"0.99","0.99","Structure of the trimeric globular domain of Adiponectin","GPGSGAYVYRSAFSVGLETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITVYMKDVKVSLFKKDKAMLFTYDQYQENNVDQASGSVLLHLEVGDQVWLQVYGEGERNGLYADNDNDSTFTGFLLYHDTN","Homo sapiens","ADIPOQ, ACDC, ACRP30, APM1, GBP28","Adiponectin","1","6U66"
"6U67",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION, SITTING DROP",7,"20% (w/v) PEG-1000, 0.1 M Tris pH 7.0",293,"10.1021/acs.jmedchem.9b01442","Q01","6U67",39.57,"1.84","1.84","Mcl-1 bound to compound 24","SNAEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6U67"
"6U6F",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350 20-22.5%, 0.1 M Bis-Tris 6.5, 0.28 M Ammonium acetate",293,"10.1021/acs.jmedchem.9b01442",,"6U6F",55.79,"2.9","2.9","The crystal structure of anti-apoptotic Mcl-1 protein in complex with 2, 5-substituted benzoic acid inhibitor 21","SNAEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6U6F"
"6U6N",,"X-RAY DIFFRACTION",1.86,33.98,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M sodium nitrate, 0.1 M MES pH 5.5, 20% PEG 3350",298,"10.1074/jbc.RA119.010970",,"6U6N",16.3,"2.15","2.15","Structure of the trimeric globular domain of Adiponectin mutant - D187A Q188A","GPGGSSAYVYRSAFSVGLETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITVYMKDVKVSLFKKDKAMLFTYAAYQENNVDQASGSVLLHLEVGDQVWLQVYGEGERNGLYADNDNDSTFTGFLLYHDTN","Homo sapiens","ADIPOQ, ACDC, ACRP30, APM1, GBP28","Adiponectin","1","6U6N"
"6U6T",,"X-RAY DIFFRACTION",3.53,65.11,"VAPOR DIFFUSION, HANGING DROP",9,"Protein: 2.5 mg/ml NEGR1 in 10 mM HEPES, pH 8.0, 150 mM NaCl. Reservoir Solution: 20% (w/v) PEG 3350, 0.1 M Tris pH 9.0, 0.2 M MgCl2, 0.6 M NaI. Crystallization Drop: 1 micro-Liter NEGR1 + 1 micro-Liter Reservoir Solution Single crystals were obtained via microseeding, and their size improved to ~600 x 200 micro-meters by macroseeding. Crystals harvested from the crystallization drops were cryo-protected in reservoir solution containing 20% (v/v) MPD and then flash cooled by plunging into liquid nitrogen",293.15,"10.1016/j.jmb.2020.07.014",,"6U6T",65.87,"3.01","3.01","Neuronal growth regulator 1 (NEGR1)","ELGTGVDFPWAAVDNMMVRKGDTAVLRCYLEDGASKGAWLNRSSIIFAGGDKWSVDPRVSISTLNKRDYSLQIQNVDVTDDGPYTCSVQTQHTPRTMQVHLTVQVPPKIYDISNDMTVNEGTNVTLTCLATGKPEPSISWRHISPSAKPFENGQYLDIYGITRDQAGEYECSAENDVSFPDVRKVKVVVNFAPTIQEIKSGTVTPGRSGLIRCEGAGVPPPAFEWYKGEKKLFNGQQGIIIQNFSTRSILTVTNVTQEHFGNYTCVAANKLGTTNASLPLNASTSHHHHHH","Homo sapiens","NEGR1, IGLON4, UNQ2433/PRO4993","Neuronal growth regulator 1","1","6U6T"
"6U6V",,"X-RAY DIFFRACTION",1.71,28.18,"MICROBATCH",6,"0.3 ul protein in HBS with 0.3 ul of crystallization buffer consisting of 100 mM Bis-Tris:HCl pH 6.0 and 28% (v/v) polyethylene glycol monomethyl ether (MW 2000) (Sigma-Aldrich) under a drop of paraffin oil and silicon oil in a 2:1 ratio",298,"10.1073/pnas.1908711117",,"6U6V",19.9,"1.9","1.9","Crystal structure of human PD-1H / VISTA","FKVATPYSLYVCPEGQNVTLTCRLLGPVDKGHDVTFYKTWYRSSRGEVQTCSERRPIRNLTFQDLHLHHGGHQAANTSHDLAQRHGLESASDHHGNFSITMRNLTLLDSGLYCCLVVEIRHHHSEHRVHGAMELQVQTGKDAPSNCVVYPSSSQESENITAVKLQAGFHHHHHH","Homo sapiens","VSIR, C10orf54, SISP1, VISTA, PP2135, UNQ730/PRO1412","V-type immunoglobulin domain-containing suppressor of T-cell activation","1","6U6V"
"6U6W",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris pH 6.5, 0.2M ammonium acetate, PEG3350",291,"10.1021/acs.jmedchem.9b01411","Q0Y","6U6W",69.25,"1.2","1.2","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","TQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U6W"
"6U73",,"X-RAY DIFFRACTION",3.64,66.18,"VAPOR DIFFUSION, SITTING DROP",,"0.1M HEPES 7.5, 0.1M Sodium chloride, 1.6M Ammonium sulfate, Myristic acid",295,,,"6U73",24.69,"2.38","2.38","Human Angiopoietin-Like 4 C-Terminal Domain (cANGPTL4) with Myristic Acid","PRDCQELFQVGERQSGLFEIQPQGSPPFLVNCKMTSDGGWTVIQRRHDGSVDFNRPWEAYKAGFGDPHGEFWLGLEKVHSITGDRNSRLAVQLRDWDGNAELLQFSVHLGGEDTAYSLQLTAPVAGQLGATTVPPSGLSVPFSTWDQDHDLRRDKNCAKSLSGGWWFGTCSHSNLNGQYFRSIPQQRQKLKKGIFWKTWRGRYYPLQATTMLIQPM","Homo sapiens","ANGPTL4, ARP4, HFARP, PGAR, PP1158, PSEC0166, UNQ171/PRO197","Angiopoietin-related protein 4","1","6U73"
"6U7N",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"Protein: 5.4 mg/ml NTM in 10 mM HEPES, pH 8.0, 150 mM sodium chloride
Reservoir Solution: 2.5 M NaCl, 100 mM sodium acetate pH 4.5, 200 mM lithium sulfate
Crystallization Drop: 2 micro-Liters NTM + 2 micro-Liters Reservoir Solution
Single crystals grew to a size of ~250 x 150 micro-meters within 7-10 days.
Crystals harvested from the crystallization drops were cryo-protected in reservoir solution containing 20% (v/v) ethylene glycol and then flash cooled by plunging into liquid nitrogen",293.15,"10.1016/j.jmb.2020.07.014",,"6U7N",36.24,"3.321","3.321","Crystal structure of neurotrimin (NTM)","MGTALLQRGGCFLLCLSLLLLGCWAELGTGATFPKAMDNVTVRQGESATLRCTIDNRVTRVAWLNRSTILYAGNDKWCLDPRVVLLSNTQTQYSIEIQNVDVYDEGPYTCSVQTDNHPKTSRVHLIVQVSPKIVEISSDISINEGNNISLTCIATGRPEPTVTWRHISPKAVGFVSEDEYLEIQGITREQSGDYECSASNDVAAPVVRRVKVTVNYPPYISEAKGTGVPVGQKGTLQCEASAVPSAEFQWYKDDKRLIEGKKGVKVENRPFLSKLIFFNVSEHDYGNYTCVASNKLGHTNASIMLFTSHHHHHH","Homo sapiens","NTM, IGLON2, NT, UNQ297/PRO337","Neurotrimin","1","6U7N"
"6U80",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, Ammonium Acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01411","Q1J","6U80",69.33,"1.55","1.55","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","TQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U80"
"6U8B",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01411","Q1M","6U8B",69.34,"1.261","1.261","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","TQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U8B"
"6U8E","3.03","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6U8E",459.94,"3.03",,"Human IMPDH2 treated with ATP, IMP, and NAD+. Filament assembly interface reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6U8E"
"6U8L",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, Ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01411",,"6U8L",68.6,"1.57","1.57","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U8L"
"6U8N","3.29","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6U8N",919.9,"3.29",,"Human IMPDH2 treated with ATP, IMP, and NAD+. Fully extended filament segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6U8N"
"6U8O",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01411","Q1G","6U8O",33.92,"1.6","1.6","Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6U8O"
"6U8R","3.91","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6U8R",919.9,"3.91",,"Human IMPDH2 treated with ATP, IMP, and NAD+. Bent (1/4 compressed, 3/4 extended) segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6U8R"
"6U8S","3.14","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6U8S",455.09,"3.14",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Filament assembly interface reconstruction.","MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6U8S"
"6U8Z",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.2 M ammonium citrate, 15% PEG3350, pH 5.3",298,"10.1038/s41589-020-0499-8",,"6U8Z",69.75,"1.799","1.799","Crystal Structure of Catalytic Domain of Human Phospholipase D1","HGTNFLKDHRFGSYAAIQENALAKWYVNAKGYFEDVANAMEEANEEIFITDWWLSPEIFLKRPVVEGNRWRLDCILKRKAQQGVRIFIMLYKEVELALGINSEYTKRTLMRLHPNIKVMRHPDHVSSTVYLWAHHEKLVIIDQSVAFVGGIDLAYGRWDDNEHRLTDVGSVFWHGKDYCNFVFKDWVQLDKPFADFIDRYSTPRMPWHDIASAVHGKAARDVARHFIQRWNFTKIMKSKYRSLSYPFLLPKSQTTAHELRYQVPGSVHANVQLLRSAADWSAGIKYHEESIHAAYVHVIENSRHYIYIENQFFISCADDKVVFNKIGDAIAQRILKAHRENQKYRVYVVIPLLPGFEGDISTGGGNALQAIMHFNYRTMCRGENSILGQLKAELGNQWINYISFCGLRTHAELEGNLVTELIYVHSKLLIADDNTVIIGSANINDRSMLGKRDSEMAVIVQDTETVPSVMDGKEYQAGRFARGLRLQCFRVVLGYLDDPSEDIQDPVSDKFFKEVWVSTAARNATIYDKVFRCLPNDEVHNLIQLRDFINKPVLAKEDPIRAEEELKKIRGFLVQFPFYFLSEESLLPSVGTKEAIVPMEVWT","Homo sapiens","PLD1","Phospholipase D1,Phospholipase D1","1","6U8Z"
,,,,,,,,,,,,,,,,,"Homo sapiens","PLD1"
"6U98",,"X-RAY DIFFRACTION",3.22,61.8,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG-3350, 0.2 M MgCl2, 0.1 M HEPES pH 7.5",293,"10.1021/jacs.9b09684","Q2D","6U98",29.45,"1.5","1.5","Hsp90a NTD K58R bound reversibly to sulfonyl fluoride 6","MGSSHHHHHHSSGLEVLFQGPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDRIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6U98"
"6U99",,"X-RAY DIFFRACTION",3.24,62.07,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG-3350, 0.2 M MgCl2, 0.1 M sodium acetate, pH 5.6",293,"10.1021/jacs.9b09684",,"6U99",29.3,"1.6","1.6","Hsp90a NTD covalently bound to sulfonyl fluoride probe 1 at K58","MGSSHHHHHHSSGLEVLFQGPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6U99"
"6U9A",,"X-RAY DIFFRACTION",3.32,62.97,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG-3350, 0.2 M MgCl2, 0.1 M sodium acetate, pH 5.8",293,"10.1021/jacs.9b09684","Q2A","6U9A",29.39,"1.65","1.65","Hsp90a NTD K58R bound reversibly to sulfonyl fluoride 5","MGSSHHHHHHSSGLEVLFQGPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDRIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6U9A"
"6U9B",,"X-RAY DIFFRACTION",3.28,62.49,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG-3350, 0.2 M MgCl2, 0.1 M sodium acetate, pH 5.6",293,"10.1021/jacs.9b09684",,"6U9B",29.36,"1.75","1.75","Hsp90a NTD covalently bound to sulfonyl fluoride 5 at K58","MGSSHHHHHHSSGLEVLFQGPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6U9B"
"6U9K",,"X-RAY DIFFRACTION",2.63,53.29,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M Sodium Malonate pH 7.0",277,"10.1021/acsmedchemlett.0c00229","Q2V","6U9K",37.97,"2","2","MLL1 SET N3861I/Q3867L bound to inhibitor 18 (TC-5153)","SDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGIVIRSILTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","Histone-lysine N-methyltransferase","1","6U9K"
"6U9M",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M Sodium Malonate pH 7.0",277,"10.1021/acsmedchemlett.0c00229","Q2M","6U9M",37.77,"2.05","2.05","MLL1 SET N3861I/Q3867L bound to inhibitor 16 (TC-5109)","SDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGIVIRSILTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","Histone-lysine N-methyltransferase","1","6U9M"
"6U9N",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M Sodium Malonate pH 7.0",277,"10.1021/acsmedchemlett.0c00229","Q34","6U9N",37.74,"1.95","1.95","MLL1 SET N3861I/Q3867L bound to inhibitor 14 (TC-5139)","SDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGIVIRSILTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","Histone-lysine N-methyltransferase","1","6U9N"
"6U9O","3.36","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6U9O",924.21,"3.36",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Fully compressed filament segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6U9O"
"6U9R",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION, SITTING DROP",,"2.1 M Sodium Malonate pH 7.0",277,"10.1021/acsmedchemlett.0c00229","Q2P","6U9R",37.74,"2.1","2.1","MLL1 SET N3861I/Q3867L bound to inhibitor 12 (TC-5140)","SDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGIVIRSILTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGAKKCRKFLN","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","Histone-lysine N-methyltransferase","1","6U9R"
"6U9U",,"X-RAY DIFFRACTION",3.65,66.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"4M Sodium Formate",293,"10.1084/jem.20191155",,"6U9U",47.63,"2.26","2.26","Structure of GM9_TH8seq732127 FAB","QVQLQESGPGLVKASETLSLTCAVSGASINTDYWNWIRQTPGKGLEWIGRFYVPTERTEYNPSFMNRVTISGDTSKNHFSLRLTSATAADTAVYFCARGLWRGYFFWVDVWGPGVLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"GM9_TH8seq732127 FAB heavy chain","1","6U9U"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDTVTVTCRASQGIDKELSWYQQKPGQAPTLLIYAASTLQTGVSSRFSGSGSGTDYTLTLTGLQPEDVATYFCLQDYSTPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"GM9_TH8seq732127 FAB light chain","2","6U9U"
"6UA2","4.2","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UA2",922.05,"4.2",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Bent (2/4 compressed, 2/4 extended) segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UA2"
"6UA4","3.65","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UA4",923.13,"3.65",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Bent (3/4 compressed, 1/4 extended) segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UA4"
"6UA5","3.79","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UA5",459.94,"3.79",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Free interfacial octamer reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UA5"
"6UAJ","3.84","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UAJ",472.37,"3.84",,"Human IMPDH2 treated with ATP, IMP, NAD+, and 2 mM GTP. Free canonical octamer reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UAJ"
"6UBP",,"X-RAY DIFFRACTION",2.9,57.63,"MICROBATCH",10,"100 mM sodium thiosulfate, 100 mM CAPS, pH 10.0, 20% w/v PEG8000",277,"10.1021/jacs.0c09970",,"6UBP",97.28,"2.95","2.95","Crystal structure of a photochemical intermediate of human indoleamine 2,3-dioxygenase 1 in complex with carbon monoxide and tryptophan","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6UBP"
"6UBW",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"12% isopropanol, 10% PEG5000 MME, 0.06 M HEPES sodium, 0.04 M HEPES",293,"10.1158/1535-7163.MCT-16-0771","84S","6UBW",39.06,"2","2","MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody","GAMGSQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","6UBW"
"6UC2","4.48","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UC2",464.27,"4.48",,"Human IMPDH2 treated with ATP and 2 mM GTP. Free canonical octamer reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UC2"
"6UCA",,"X-RAY DIFFRACTION",2.94,58.22,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.03 M citric acid, 0.07 M Bis-Tris propane, pH 7.6, 11-12% PEG3350, 10% glycerol, 5 mM TCEP, pH 7.0",285,"10.1038/s41467-019-12923-x",,"6UCA",309.55,"3.103","3.103","Crystal structure of human ZCCHC4 in complex with SAH","SGMEVVLPLDPAVPAPLCPHGPTLLFVKVTQGAAATRRFYACSACRDRKDCNFFQWEDEKLSGARLAAREAHNRRCQPPLSRTQCVERYLKFIELPLTQRKFCQTCQQLLLPDDWGQHSEHQVLGNVSITQLRRPSQLLYPLENAATNAQYLFADRSCQFLVDLLSALGFRRVLCVGTPRLHELIKLTASGDKKSNIKSLLLDIDFRYSQFYMEDSFCHYNMFNHHFFDGKTALEVCRAFLQEDKGEGIIMVTDPPFGGLVEPLAITFKKLIAMWKEGQSQDDSHKELPIFWIFPYFFESRICQFFPSFQMLDYQVDYDNHALYKHGKTGRKQSPVRIFTNIPPNKIILPTEEGYRFCSPCQRYVSLENQHCELCNSCTSKDGRKWNHCFLCKKCVKPSWIHCSICNHCAVPDHSCEGPKHGCFICGELDHKRSTCPNIATS","Homo sapiens","ZCCHC4","rRNA N6-adenosine-methyltransferase ZCCHC4","1","6UCA"
"6UCG",,"X-RAY DIFFRACTION",3.14,60.84,"VAPOR DIFFUSION, HANGING DROP",,"1.2 to 1.8 M ammonium sulfate and 0.1 M Tris-HCl, pH 8.0 to 9.0",293,"10.1021/acsmedchemlett.9b00431","Q3Y","6UCG",28.64,"2.87","2.87","Retinoic acid receptor-related orphan receptor (ROR) gamma in complex with allosteric compound 28","LTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6UCG"
"6UCH",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2019.10.044",,"6UCH",4.75,,,"SMARCB1 nucleosome-interacting C-terminal alpha helix","GPLGSMPLLETLTDAEMEKKIRDQDRNTRRMRRLANTAPAW","Homo sapiens","SMARCB1, BAF47, INI1, SNF5L1","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1","1","6UCH"
"6UCI",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, HANGING DROP",5,"2.5 M sodium chloride, 0.1 M sodium acetate, pH 5.0",293,"10.1016/j.crstbi.2019.12.001",,"6UCI",33.36,"2.09","2.09","Transcription factor DeltaFosB bZIP domain self-assembly, oxidized form","SEEEEKRRVRRERNKLAAAKCRNRRRELTDRLQAETDQLEEEKAELESEIAELQKEKERLEFVLVAHK","Homo sapiens","FOSB, G0S3","Protein fosB","1","6UCI"
"6UCJ",,"SOLUTION NMR",,,,,,,"10.1111/febs.15253",,"6UCJ",8.05,,,"proIAPP in DPC Micelles - Two-Conformer Ensemble Refinement, Open Conformer","TPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLKREPLNYLPLKKKKD","Homo sapiens","IAPP","Islet amyloid polypeptide","1","6UCJ"
"6UCK",,"SOLUTION NMR",,,,,,,"10.1111/febs.15253",,"6UCK",8.05,,,"proIAPP in DPC Micelles - Two-Conformer Ensemble Refinement, Bent Conformer","TPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLKREPLNYLPLKKKKD","Homo sapiens","IAPP","Islet amyloid polypeptide","1","6UCK"
"6UCL",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION",7,"17% (w/v) PEG 4000, 0.2 M ammonium sulfate",293,"10.1016/j.crstbi.2019.12.001",,"6UCL",8.37,"2.207","2.207","Transcription factor deltaFosB bZIP domain self-assembly, type-I crystal","SEEEEKRRVRRERNKLAAAKCRNRRRELTDRLQAETDQLEEEKAELESEIAELQKEKERLEFVLVAHK","Homo sapiens","FOSB, G0S3","Protein fosB","1","6UCL"
"6UCM",,"X-RAY DIFFRACTION",3.1,60.38,"VAPOR DIFFUSION, HANGING DROP",7,"2 M ammonium sulfate, 5% (v/v) isopropanol",293,"10.1016/j.crstbi.2019.12.001",,"6UCM",25.21,"2.424","2.424","Transcription factor DeltaFosB bZIP domain self-assembly, type-II crystal","SEEEEKRRVRRERNKLAAAKCRNRRRELTDRLQAETDQLEEEKAELESEIAELQKEKERLEFVLVAHK","Homo sapiens","FOSB, G0S3","Protein fosB","1","6UCM"
"6UCO",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6UCO",3.85,,,"Backbone-modified variant of zinc finger 2 from the transcription factor Sp1 DNA binding domain: BTD in the metal-binding turn","RPFLCTWVCCGKRFTRSDELQRHKRTHTGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6UCO"
"6UCP",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6UCP",3.9,,,"Zinc finger 2 from the transcription factor Sp1 DNA binding domain","RPFLCTWSYCGKRFTRSDELQRHKRTHTGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6UCP"
"6UCS",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, Ammonium Acetate, PEG 3350",291,"10.1021/acs.jmedchem.9b01608","Q41","6UCS",69.81,"1.85","1.85","Discovery and Structure-Based optimization of potent and selective WDR5 inhibitors containing a dihydroisoquinolinone bicyclic core","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6UCS"
"6UD2",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% ethanol,
35% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q4D","6UD2",18.74,"1.7","1.7","co-crystal structure of compound 1 bound to human Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UD2"
"6UD5",,"X-RAY DIFFRACTION",2.97,58.56,"MICROBATCH",5,"50 mM sodium citrate, pH 5.6, 2% Tacsimate, pH 5.0, 5% PEG3350",298,"10.1021/jacs.0c09970",,"6UD5",184.94,"2.05","2.05","Crystal structure of human tryptophan 2,3-dioxygenase in complex with carbon monoxide and tryptophan","MLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFLEHHHHHH","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","6UD5"
"6UDI",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% Methanol,
35% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q4S","6UDI",18.64,"1.94","1.94","X-ray co-crystal structure of compound 20 with Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDI"
"6UDL",,"X-RAY DIFFRACTION",3.52,65.09,"VAPOR DIFFUSION, SITTING DROP",,"0.18 M sodium phosphate dibasic, 18% PEG3350, 5 mM (S)-O-methyl-serine dodecylamide hydrochloride",277.15,,,"6UDL",227,"2.85","2.85","Structure of Human Cytochrome P450 1A1 with Duocarmycin Prodrug (S) ICT-2700","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","6UDL"
"6UDM",,"X-RAY DIFFRACTION",4.66,73.58,"VAPOR DIFFUSION, SITTING DROP",,"0.16 M sodium phosphate dibasic, 16% w/v PEG3350, 1.8 mM n-decyl-B-D-maltoside",277.15,,,"6UDM",228.33,"3.075","3.075","Structure of Human Cytochrome P450 1A1 with Duocarmycin Prodrug (S) ICT-2726","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","6UDM"
"6UDO","3.21","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UDO",918.9,"3.21",,"Human IMPDH2 treated with ATP, IMP, and 20 mM GTP. Fully compressed filament segment reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UDO"
"6UDP","2.95","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UDP",454.63,"2.95",,"Human IMPDH2 treated with ATP, IMP, and 20 mM GTP. Filament assembly interface reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UDP"
"6UDQ","3.27","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53243",,"6UDQ",692.98,"3.27",,"Human IMPDH2 treated with ATP, IMP, and 20 mM GTP. Fully compressed filament end reconstruction.","SEFELMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6UDQ"
"6UDT",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% Ethanol,
36% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q4V","6UDT",18.52,"1.5","1.5","X-ray co-crystal structure of compound 10 bound to human Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDT"
"6UDU",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% Ethanol,
36% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q4Y","6UDU",18.46,"1.75","1.75","X-ray co-crystal structure of compound 8 bound to human Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDU"
"6UDV",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% eEthanol,
36% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q51","6UDV",18.52,"1.35","1.35","X-ray co-crystal structure of compound 3 bound to human Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDV"
"6UDX",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% Ethanol,
36% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q57","6UDX",36.73,"1.7","1.7","X-ray co-crystal structure of compound 7 with Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDX"
"6UDY",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0,
3% Ethanol,
36% PEG6000",277,"10.1021/acs.jmedchem.9b01310","Q54","6UDY",36.67,"1.7","1.7","X-ray co-crystal structure of compound 5 with Mcl-1","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6UDY"
"6UE6",,"X-RAY DIFFRACTION",2.17,43.22,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M potassium thiocyanate",291,"10.1021/acs.jmedchem.0c01768",,"6UE6",130.79,"2.4","2.4","PWWP1 domain of NSD2 in complex with MR837","GGRDKDHLLKYNVGDLVWSKVSGYPWWPCMVSADPLLHSYTKLKGQKKSARQYHVQFFGDAPERAWIFEKSLVAFEGEGQFEKLCQESAKQAPTKAEKIKLLKPISGKLRAQWEMGIVQAEEAASMSVEERKAKFTFLYVG","Homo sapiens","NSD2, KIAA1090, MMSET, TRX5, WHSC1","Histone-lysine N-methyltransferase NSD2","1","6UE6"
"6UEI",,"X-RAY DIFFRACTION",3.37,63.5,"VAPOR DIFFUSION, SITTING DROP",7,"20% Peg 3350 and 0.2M Sodium Malonate",293.15,"10.1073/pnas.1913232116",,"6UEI",26.25,"2.51","2.51","Crystal structure of human zinc finger antiviral protein","SNAADPEVCCFITKILCAHGGRMALDALLQEIALSEPQLCEVLQVAGPDRFVVLETGGEAGITRSVVATTRARVCRRKYCQRPCDNLHLCKLNLLGRCNYSQSERNLCKYSHEVLSEENFKVLKNHELSGLNKEELAVLLLQSDPFFMPEICKSYKGEGRQQICNQQPPCSRLHICDHFTRGNCRFPNCLRSHNLMDRKVLAIMREHGLNPDVVQNIQDICNSKHMQKN","Homo sapiens","ZC3HAV1, ZC3HDC2, PRO1677","Zinc finger CCCH-type antiviral protein 1","1","6UEI"
"6UEL",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, HANGING DROP",,"CPS1 protein was buffer exchanged into 50 mM glycyl-glycine pH 7.4, 50 mM KCl, 5% glycerol. CPS1 was concentrated to 10 mg/ml and H3B-4193 was added to a 5x excess molar ratio along with 1mM AMPPNP and 1mM NAG.  Ligand bound complex crystals grew by hanging drop vapor diffusion in 20% PEG 3350 and 0.2M trisodium citrate",293,"10.1016/j.chembiol.2020.01.009",,"6UEL",331.17,"1.9","1.9","CPS1 bound to allosteric inhibitor H3B-193","MTRILTAFKVVRTLKTGFGFTNVTAHQKWKFSRPGIRLLSVKAQTAHIVLEDGTKMKGYSFGHPSSVAGEVVFNTGLGGYPEAITDPAYKGQILTMANPIIGNGGAPDTTALDELGLSKYLESNGIKVSGLLVLDYSKDYNHWLATKSLGQWLQEEKVPAIYGVDTRMLTKIIRDKGTMLGKIEFEGQPVDFVDPNKQNLIAEVSTKDVKVYGKGNPTKVVAVDCGIKNNVIRLLVKRGAEVHLVPWNHDFTKMEYDGILIAGGPGNPALAEPLIQNVRKILESDRKEPLFGISTGNLITGLAAGAKTYKMSMANRGQNQPVLNITNKQAFITAQNHGYALDNTLPAGWKPLFVNVNDQTNEGIMHESKPFFAVQFHPEVTPGPIDTEYLFDSFFSLIKKGKATTITSVLPKPALVASRVEVSKVLILGSGGLSIGQAGEFDYSGSQAVKAMKEENVKTVLMNPNIASVQTNEVGLKQADTVYFLPITPQFVTEVIKAEQPDGLILGMGGQTALNCGVELFKRGVLKEYGVKVLGTSVESIMATEDRQLFSDKLNEINEKIAPSFAVESIEDALKAADTIGYPVMIRSAYALGGLGSGICPNRETLMDLSTKAFAMTNQILVEKSVTGWKEIEYEVVRDADDNCVTVCNMENVDAMGVHTGDSVVVAPAQTLSNAEFQMLRRTSINVVRHLGIVGECNIQFALHPTSMEYCIIEVNARLSRSSALASKATGYPLAFIAAKIALGIPLPEIKNVVSGKTSACFEPSLDYMVTKIPRWDLDRFHGTSSRIGSSMKSVGEVMAIGRTFEESFQKALRMCHPSIEGFTPRLPMNKEWPSNLDLRKELSEPSSTRIYAIAKAIDDNMSLDEIEKLTYIDKWFLYKMRDILNMEKTLKGLNSESMTEETLKRAKEIGFSDKQISKCLGLTEAQTRELRLKKNIHPWVKQIDTLAAEYPSVTNYLYVTYNGQEHDVNFDDHGMMVLGCGPYHIGSSVEFDWCAVSSIRTLRQLGKKTVVVNCNPETVSTDFDECDKLYFEELSLERILDIYHQEACGGCIISVGGQIPNNLAVPLYKNGVKIMGTSPLQIDRAEDRSIFSAVLDELKVAQAPWKAVNTLNEALEFAKSVDYPCLLRPSYVLSGSAMNVVFSEDEMKKFLEEATRVSQEHPVVLTKFVEGAREVEMDAVGKDGRVISHAISEHVEDAGVHSGDATLMLPTQTISQGAIEKVKDATRKIAKAFAISGPFNVQFLVKGNDVLVIECNLRASRSFPFVSKTLGVDFIDVATKVMIGENVDEKHLPTLDHPIIPADYVAIKAPMFSWPRLRDADPILRCEMASTGEVACFGEGIHTAFLKAMLSTGFKIPQKGILIGIQQSFRPRFLGVAEQLHNEGFKLFATEATSDWLNANNVPATPVAWPSQEGQNPSLSSIRKLIRDGSIDLVINLPNNNTKFVHDNYVIRRTAVDSGIPLLTNFQVTKLFAEAVQKSRKVDSKSLFHYRQYSAGKAA","Homo sapiens","CPS1","Carbamoyl-phosphate synthase [ammonia], mitochondrial","1","6UEL"
"6UEZ",,"X-RAY DIFFRACTION",2.85,56.81,"VAPOR DIFFUSION",7.4,"PEG3350, HEGA-11, potassium phosphate, lanosterol",293,"10.1074/jbc.RA120.014064",,"6UEZ",105.7,"1.98","1.98","Human sterol 14a-demethylase (CYP51) in complex with the substrate lanosterol","MAKKTSSKGKLPPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLAGGFSHAAWLLPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDEVAGMLIGLLLAGQATSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDLNLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLDFNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFPTVNYTTMIHTPENPVIRYKRRSK","Homo sapiens","CYP51A1, CYP51","Lanosterol 14-alpha demethylase","1","6UEZ"
"6UF0",,"X-RAY DIFFRACTION",2.98,58.73,"VAPOR DIFFUSION, HANGING DROP",7,"3.1-3.8 M sodium formate, pH 7",289,"10.1021/acs.jmedchem.9b01074","Q5V, Q5Y","6UF0",64.94,"1.96","1.96","Crystal structure of N-(4-((4-methoxy-N-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-N-((4-methoxyphenyl)sulfonyl)glycine bound to human Keap1 Kelch domain","SAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6UF0"
"6UFB",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir solution (2.5-2.8 M ammonium sulfate, 100 mM Tris, pH 8.5-9.0)",281,"10.1021/acs.jmedchem.9b02090","Q64","6UFB",30.01,"1.67","1.67","Carbonic anhydrase 2 with inhibitor (2Z)-2-benzylidene-3-oxo-N-(4-sulfamoylphenyl)butanamide (11a/D1)","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UFB"
"6UFC",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir solution (2.5-2.8 M ammonium sulfate, 100 mM Tris, pH 8.5-9.0)",281,"10.1021/acs.jmedchem.9b02090","Q6A","6UFC",29.84,"1.325","1.325","Carbonic anhydrase 2 with inhibitor (2Z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-N-(4-sulfamoylphenyl)butanamide (11d/D4)","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UFC"
"6UFD",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir solution (2.5-2.8 M ammonium sulfate, 100 mM Tris, pH 8.5-9.0)",281,"10.1021/acs.jmedchem.9b02090","Q6D","6UFD",30.02,"1.48","1.48","Carbonic anhydrase 2 with inhibitor (2Z)-3-oxo-N-(4-sulfamoylphenyl)-2-[(thiophen-2-yl)methylidene]butanamide (11g/D7)","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UFD"
"6UFR","2.5","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1917914117",,"6UFR",144.76,"2.5",,"Structure of recombinantly assembled E46K alpha-synuclein fibrils","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKKGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6UFR"
"6UFX",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris or HEPES or Tris-HCl, pH 6.0-8.0, 0.2 M ammonium acetate, 20-30% PEG3350",291,"10.1021/acs.jmedchem.9b01608","Q6S","6UFX",33.84,"2.015","2.015","WD repeat-containing protein 5 complexed with N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide (compound 13)","KPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSSGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6UFX"
"6UGK",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, SITTING DROP",5.5,"human taspase-1 VCID 11900 at 9.23 mg/mL in 20 mM HEPES pH 8, 0.5 M NaCl, 5% glycerol against PACT B11 optimization screen containing 16% PEG 6000, 0.1 M MES pH 5.8, 0.2 M calcium chloride supplemented with 20% ethylene glycol as a cryo-protectant, crystal tracking ID 271056c2, unique puck ID izc9-6",289,"10.1016/j.str.2021.03.008",,"6UGK",70.88,"2.15","2.15","CRYSTAL STRUCTURE OF CIRCULARLY PERMUTED HUMAN TASPASE-1","MTVGAVVVDHEGNVAAAVSSGGLALKHPGRVGQAALYGCGCWAENTGAHNPYSTAVSTSGCGEHLVRTILARECSHALQAEDAHQALLETMQNKFISSPFLASEDGVLGGVIVLRSCRCSAEPDSSQNKQTLLVEFLWSHTTESMCVGYMSAQDGKAKTHISRLPPGAVAGQSVAIEGGVCRLEGSGSGGFVLVHAGAGYHSESKAKEYKHVCKRACQKAIEKLQAGALATDAVTAALVELEDSPFTNAGMGSNLNLLGEIECDASIMDGKSLNFGAVGALSGIKNPVSVANRLLCEGQKGKLSAGRIPPCFLVGEGAYRWAVDHGIPSCPLEHHHHHH","Homo sapiens","TASP1, C20orf13","Threonine aspartase 1,Threonine aspartase 1","1","6UGK"
,,,,,,,,,,,,,,,,,"Homo sapiens","TASP1, C20orf13"
"6UGN",,"X-RAY DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",298,"10.1021/acs.jmedchem.9b01669","Q77","6UGN",29.45,"1.406","1.406","Human Carbonic Anhydrase 2 complexed with SB4-205","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UGN"
"6UGO",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",298,"10.1021/acs.jmedchem.9b01669",,"6UGO",29.78,"1.457","1.457","Human Carbonic Anhydrase IX-mimic complexed with SB4-205","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase IX-mimic","1","6UGO"
"6UGP",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",298,"10.1021/acs.jmedchem.9b01669","Q7A","6UGP",29.59,"1.306","1.306","Human Carbonic Anhydrase 2 complexed with SB4-206","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UGP"
"6UGQ",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",300,"10.1021/acs.jmedchem.9b01669",,"6UGQ",29.38,"1.305","1.305","Human Carbonic Anhydrase IX-mimic complexed with SB4-206","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase IX-mimic","1","6UGQ"
"6UGR",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",300,"10.1021/acs.jmedchem.9b01669","Q71","6UGR",29.21,"1.307","1.307","Human Carbonic Anhydrase 2 complexed with SB4-208","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UGR"
"6UGW",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, SITTING DROP",,"10 mg/mL protein with JCSG+ E7 (266849e7): 10% 2-propanol, 200 mM zinc acetate, 100 mM sodium cacodylate, pH 6.5, cryoprotectant: 20% ethylene glycol, puckID kux1-2",289,"10.1007/s40259-019-00390-1",,"6UGW",30.04,"2","2","Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A","MKKTAIAIAVALAGFATVAQADVESKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"PF-06438179/GP1111 Fc","1","6UGW"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6UGX",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, SITTING DROP",,"10 mg/mL protein with 200 mM potassium nitrate, 20% PEG3350, cryoprotectant: 20% ethylene glycol, puckID sxt1-6",289,"10.1007/s40259-019-00390-1",,"6UGX",59.52,"2.1","2.1","Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A","MKKTAIAIAVALAGFATVAQADVESKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"PF-06438179/GP1111 Fc","1","6UGX"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6UGY",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, SITTING DROP",,"10 mg/mL protein with JCSG+ E7 Opt screen H2 (267146h2): 4% 2-propanol, 200 mM zinc acetate, 100 mM sodium cacodylate, pH 6.8, cryoprotectant: 20% ethylene glycol, puckID kux1-9",289,"10.1007/s40259-019-00390-1",,"6UGY",30.04,"2.1","2.1","Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C","MKKTAIAIAVALAGFATVAQADVESKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Remicade Fc","1","6UGY"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6UGZ",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",300,"10.1021/acs.jmedchem.9b01669",,"6UGZ",29.13,"1.306","1.306","Human Carbonic Anhydrase IX-mimic complexed with SB4-208","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase IX-mimic","1","6UGZ"
"6UH0",,"X-RAY DIFFRACTION",2.1,41.52,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M sodium citrate, 50 mM Tris",300,"10.1021/acs.jmedchem.9b01669","PX7","6UH0",29.21,"1.306","1.306","Human Carbonic Anhydrase 2 in complex with SB4-202","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UH0"
"6UHA",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG3350 15%, protein in co-crystallization with 30mM Caffeine and 10mM ATP",297,,,"6UHA",48.49,"2.855","2.855","Open-form Crystal Structure of Human RYR Receptor 3 ( 848-1055)","SFIPCPVDTSQVILPPHLEKIRDRLAENIHELWGMNKIELGWTFGKIRDDNKRQHPCLVEFSKLPETEKNYNLQMSTETLKTLLALGCHIAHVNPAAEEDLKKVKLPKNYMMSNGYKPAPLDLSDVKLLPPQEILVDKLAENAHNVWAKDRIKQGWTYGIQQDLKNKRNPRLVPYALLDERTKKSNRDSLREAVRTFVGYGYNIEPSD","Homo sapiens","RYR3, HBRR","Ryanodine receptor 3","1","6UHA"
"6UHB",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M Na2HPO4:Citric Acid pH 4.2, 1.6 M NaH2PO4/0.4 M K2HPO4",297,,,"6UHB",50.14,"2.504","2.504","Crystal Structure of Human RYR Receptor 3 (848-1055)","SNASFIPCPVDTSQVILPPHLEKIRDRLAENIHELWGMNKIELGWTFGKIRDDNKRQHPCLVEFSKLPETEKNYNLQMSTETLKTLLALGCHIAHVNPAAEEDLKKVKLPKNYMMSNGYKPAPLDLSDVKLLPPQEILVDKLAENAHNVWAKDRIKQGWTYGIQQDLKNKRNPRLVPYALLDERTKKSNRDSLREAVRTFVGYGYNIEPSD","Homo sapiens","RYR3, HBRR","Ryanodine receptor 3","1","6UHB"
"6UHE",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, SITTING DROP",8.4,"0.1 M Tris:HCl pH 8.5, 1.2 M Sodium Citrate Tribasic",297,,,"6UHE",97.12,"2.892","2.892","Closed-form Crystal Structure of Human RYR Receptor 3 ( 848-1055)","SNASFIPCPVDTSQVILPPHLEKIRDRLAENIHELWGMNKIELGWTFGKIRDDNKRQHPCLVEFSKLPETEKNYNLQMSTETLKTLLALGCHIAHVNPAAEEDLKKVKLPKNYMMSNGYKPAPLDLSDVKLLPPQEILVDKLAENAHNVWAKDRIKQGWTYGIQQDLKNKRNPRLVPYALLDERTKKSNRDSLREAVRTFVGYGYNIEPSD","Homo sapiens","RYR3, HBRR","Ryanodine receptor 3","1","6UHE"
"6UHH",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris:HCl pH 8.5, 20% (w/v) PEG 1000, protein in co-crystallization with 10mM ATP",297,,,"6UHH",100.31,"3.138","3.138","Crystal Structure of Human RYR Receptor 3 ( 848-1055) in Complex with ATP","SNASFIPCPVDTSQVILPPHLEKIRDRLAENIHELWGMNKIELGWTFGKIRDDNKRQHPCLVEFSKLPETEKNYNLQMSTETLKTLLALGCHIAHVNPAAEEDLKKVKLPKNYMMSNGYKPAPLDLSDVKLLPPQEILVDKLAENAHNVWAKDRIKQGWTYGIQQDLKNKRNPRLVPYALLDERTKKSNRDSLREAVRTFVGYGYNIEPSD","Homo sapiens","RYR3, HBRR","Ryanodine receptor 3","1","6UHH"
"6UHY",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium
acetate, 28% to 32% PEG3350.",291,"10.1021/acs.jmedchem.0c00224",,"6UHY",67.47,"1.26","1.26","WDR5 in complex with Myc site fragment inhibitor","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WDR5","1","6UHY"
"6UHZ",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% PEG3350",291,"10.1021/acs.jmedchem.0c00224",,"6UHZ",67.47,"1.258","1.258","WDR5 in complex with Myc site fragment inhibitor","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WDR5","1","6UHZ"
"6UI9","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6UI9",488.22,"3.1",,"Structure of human ATP citrate lyase in complex with acetyl-CoA and oxaloacetate","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ACLY","1","6UI9"
"6UIA","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6UIA",485.47,"4.3",,"Structure of ATP citrate lyase with CoA in a partially open conformation","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6UIA"
"6UIF",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, Ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.0c00224","Q8P","6UIF",67.94,"1.603","1.603","Discovery of fragment-inspired heterocyclic benzenesulfonmides as inhibitors of the WDR5-MYC interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat domain 5","1","6UIF"
"6UIK",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris 6.5, 0.2 M Ammonium Acetate, 28% PEG 3350",291,"10.1021/acs.jmedchem.0c00224","Q8M","6UIK",67.83,"1.6","1.6","Discovery of fragment-inspired heterocyclic benzenesulfonmides as inhibitors of the WDR5-MYC interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat domanin 5","1","6UIK"
"6UIP",,"X-RAY DIFFRACTION",4.45,72,"VAPOR DIFFUSION, SITTING DROP",8.5,"15% PEG 20000, 3% Eextran Sulfate, 100 mM Bicine pH 8.5",277,"10.1021/acs.jmedchem.9b01624",,"6UIP",127.55,"3.7","3.7","DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6UIP"
"6UIQ",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.2 M Sodium tartrate dibasic dihydrate, 20% w/v Polyethylene glycol 3,350",293,"10.1016/j.str.2018.07.005",,"6UIQ",128.95,"2.3","2.3","Crystal structure of wild-type human phosphoglucomutase 1 in complex with Glucose-6-Phosphate","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","phosphoglucomutase-1","1","6UIQ"
"6UIV","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1781-3",,"6UIV",409.19,"3.3",,"Cryo-EM structure of human CALHM2 in an active/open state","MAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPSFESRLVPR","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6UIV"
"6UIW","2.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1781-3",,"6UIW",415.34,"2.7",,"Cryo-EM structure of human CALHM2 in a ruthenium red-bound inhibited state","MAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPSFESRLVPR","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6UIW"
"6UIX","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1781-3",,"6UIX",818.37,"3.5",,"Cryo-EM structure of human CALHM2 gap junction","MAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPSFESRLVPR","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6UIX"
"6UJ1",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES (pH6)
1.4 M (NH4)2SO4
6% isopropanol 
4% tertbutanol",298,"10.1021/acschemneuro.0c00629",,"6UJ1",100.14,"3.03","3.03","BACE2 mutant in complex with a macrocyclic compound","MGALARALLLPLLAQWLLRAAPELAPAPFTLPLRVAAATNRVVAPTPGPGTPAERHADGLALALEPALASPAGAANFLAMVDNLQGDSGRGYYLEMLIGTPPQKLQILVDTGSSNFAVAGTPHSYIDTYFDTERSSTYRSKGFDVTVKYTQGSWTGFVGEDLVTIPKGFNTSFLVNIATIFESENFFLPGIKWNGILGLAYATLAKPSSSLETFFDSLVTQANIPNVFSMQMCGAGLPVAGSGTNGGSLVLGGIEPSLYKGDIWYTPIKEEWYYQIEILKLEIGGQSLNLDCREYNADKAIVDSGTTLLRLPQKVFDAVVEAVARASLIPAFSDGFWTGSQLACWTNSETPWSYFPKISIYLRDENSSRSFRITILPQLYIQPMMGAGLNYECYRFGISPSTNALVIGATVMEGFYVIFDRAQKRVGFAASPCAEIAGAAVSEISGPFSTEDVASNCVPA","Homo sapiens","BACE2, AEPLC, ALP56, ASP21, CDA13, UNQ418/PRO852","Beta-secretase 2","1","6UJ1"
"6UJ4",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris 6.5, 0.2 M Ammonium acetate, 28% PEG 3350",291,"10.1021/acs.jmedchem.0c00224","Q8S","6UJ4",67.85,"1.53","1.53","Discovery of fragment-inspired heterocyclic benzenesulfonmides as inhibitors of the WDR5-MYC interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat domain 5","1","6UJ4"
"6UJ6",,"X-RAY DIFFRACTION",3.76,67.32,"VAPOR DIFFUSION, HANGING DROP",7,"HEPES, disodium malonate, PEG 3350, glycerol",298,"10.1016/j.jinorgbio.2020.111101",,"6UJ6",77.46,"2.68","2.68","X-ray Crystal Structure of Chromium-transferrin with Synergistic Anion Malonate","MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSIGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPGAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Transferrin","1","6UJ6"
"6UJG",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH8.0",293,,,"6UJG",465.67,"3","3","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UJG"
"6UJH",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes, 0.2 M ammonium acetate, 32% PEG3350",293,"10.1021/acs.jmedchem.0c00224",,"6UJH",69.69,"1.493","1.493","Discovery of fragment-inspired heterocyclic benzenesulfonamides as inhibitors of the WDR5-MYC interaction","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6UJH"
"6UJJ",,"X-RAY DIFFRACTION",2.04,39.62,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, 0.2 M ammonium acetate, 32% PEG3350",293,"10.1021/acs.jmedchem.0c00224",,"6UJJ",34.61,"1.731","1.731","Discovery of fragment-inspired heterocyclic benzenesulfonamides as inhibitors of the WDR5-MYC interaction","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6UJJ"
"6UJL",,"X-RAY DIFFRACTION",2.07,40.56,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, 0.2 M ammonium acetate, 32% PEG3350",293,"10.1021/acs.jmedchem.0c00224",,"6UJL",34.76,"1.599","1.599","Discovery of fragment-inspired heterocyclic benzenesulfonamides as inhibitors of the WDR5-MYC interaction","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6UJL"
"6UJM",,"X-RAY DIFFRACTION",3.32,62.98,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH 8.0",293,,,"6UJM",232.83,"2.5","2.5","Crystal structure of human GAC in complex with inhibitor UPGL00013","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UJM"
"6UK1",,"X-RAY DIFFRACTION",2.9,57.58,"MICROBATCH",,"24% PEG 8000, 100 mM Li2SO4, 10mM NaBr, 100 mM Bis-Tris Propane pH 6.0",277,,,"6UK1",104.34,"2.693","2.693","Crystal structure of nucleotide-binding domain 2 (NBD2) of the human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)","DIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLLAFLRLLNTEGEIQIDGVSWDSITLEQWRKAFGVIPQDVFIFSGTFRKNLDPNEQWSDQEIWKVADEVGLRSVIEQFPGGLDFVLVDGGCVLSHGHKQLMCLARAVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEARIEAMLECDQFLVIEENKVRQYDSIQKL","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","6UK1"
"6UK6",,"X-RAY DIFFRACTION",3.79,67.56,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.M LiCl, pH8.5",293,,,"6UK6",232.69,"2.9","2.9","Crystal structure of human GAC in complex with inhibitor UPGL00018","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UK6"
"6UKB",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH8.0",293,,,"6UKB",232.86,"3","3","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UKB"
"6UL7",,"X-RAY DIFFRACTION",3.37,63.5,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, pH 5.5, 2 M ammonium sulfate, 1.3 M potassium nitrate, 100 mM magnesium chloride, 220 mM fructose, 3.8 mM osthole",290.15,,,"6UL7",35.22,"2.3","2.3","Structure of human ketohexokinase-C in complex with fructose, NO3, and osthole","MGSSHHHHHHSSGLVPRGSHMEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6UL7"
"6UL8",,"X-RAY DIFFRACTION",3.71,66.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"85 mM Tris, pH 7.5, 200 mM calcium chloride, 10% PEG400, 5% glycerol, in 24 well Linbro trays at 22 degrees C. Crystals were frozen directly from the tray using paraffin oil as a cryoprotectant.",295,"10.1021/acsmedchemlett.9b00141",,"6UL8",71.14,"2.68","2.68","RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide","AISSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLCKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6UL8"
"6UL9",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH8.0",293,,,"6UL9",233.22,"2.5","2.5","Crystal structure of human GAC in complex with inhibitor UPGL00023","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UL9"
"6ULA",,"X-RAY DIFFRACTION",2.62,52.99,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH 8.0",293,,,"6ULA",466.05,"2.95","2.95","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6ULA"
"6ULB",,"X-RAY DIFFRACTION",2.23,44.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2M potassium thiocyanate",295,,,"6ULB",22.99,"1.75","1.75","Sex Hormone-binding globulin mutant E176K in complex with Danazol","LRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAKISASAPTSLRSCDVESNPGIFLPPGTQAE","Homo sapiens","SHBG","Sex hormone-binding globulin","1","6ULB"
"6ULJ",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0M LiCl, pH 8.0",293,,,"6ULJ",233.14,"2.69","2.69","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6ULJ"
"6ULM",,"X-RAY DIFFRACTION",2.56,52,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES pH 7, 0.1 M KCl, 15% PEG 5000 MME",277,"10.1107/S2053230X21002247",,"6ULM",51.62,"2.15","2.15","Crystal structure of human cadherin 17 EC1-2","MQEGKFSGPLKPMTFSIYEGQEPSQIIFQFKANPPAVTFELTGETDNIFVIEREGLLYYNRALDRETRSTHNLQVAALDANGIIVEGPVPITIEVKDINDNRPTFLQSKYEGSVRQNSRPGKPFLYVNATDLDDPATPNGQLYYQIVIQLPMINNVMYFQINNKTGAISLTREGSQELNPAKNPSYNLVISVKDMGGQSENSFSDTTSVDIIVTENIWKALEHHHHHH","Homo sapiens","CDH17","Cadherin-17","1","6ULM"
"6UMA",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, HANGING DROP",6,"Sodium malonate pH 6.0, glycerol",283,"10.1016/j.jbc.2021.100772",,"6UMA",41.14,"1.6","1.6","Crystal structure of the TRIM7 B30.2 domain at 1.6 angstrom resolution","SHMKEEKVELTLDPDTANPRLILSLDLKGVRLGERAQDLPNHPCRFDTNTRVLASCGFSSGRHHWEVEVGSKDGWAFGVARESVRRKGLTPFTPEEGVWALQLNGGQYWAVTSPERSPLSCGHLSRVRVALDLEVGAVSFYAVEDMRHLYTFRVNFQERVFPLFSVCSTGTYLRIWP","Homo sapiens","TRIM7, GNIP, RNF90","E3 ubiquitin-protein ligase TRIM7","1","6UMA"
"6UMB",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, SITTING DROP",6,"Sodium malonate pH 6.0",283,"10.1016/j.jbc.2021.100772",,"6UMB",40.83,"1.8","1.8","Crystal structure of TRIM7 B30.2 domain at 1.8 angstrom resolution","SHMKEEKVELTLDPDTANPRLILSLDLKGVRLGERAQDLPNHPCRFDTNTRVLASCGFSSGRHHWEVEVGSKDGWAFGVARESVRRKGLTPFTPEEGVWALQLNGGQYWAVTSPERSPLSCGHLSRVRVALDLEVGAVSFYAVEDMRHLYTFRVNFQERVFPLFSVCSTGTYLRIWP","Homo sapiens","TRIM7, GNIP, RNF90","E3 ubiquitin-protein ligase TRIM7","1","6UMB"
,,,,,,,,,,,,,,,,"SHMKEEKVELTLDPDTANPRLILSLDLKGVRLGERAQDLPNHPCRFDTNTRVLASCGFSSGRHHWEVEVGSKDGWAFGVARESVRRKGLTPFTPEEGVWALQLNGGQYWAVTSPERSPLSCGHLSRVRVALDLEVGAVSFYAVEDMRHLYTFRVNFQERVFPLFSVCSTGTYLRIWP","Homo sapiens","TRIM7, GNIP, RNF90","E3 ubiquitin-protein ligase TRIM7","2","6UMB"
"6UMC",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0 M LiCl, pH 8.0",293,,,"6UMC",233.14,"2.75","2.75","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UMC"
"6UMD",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0 M LiCl pH 8.0",293,,,"6UMD",233.28,"2.7","2.7","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UMD"
"6UME",,"X-RAY DIFFRACTION",2.69,54.34,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0 M LiCl pH8.0",293,,,"6UME",233.17,"2.9","2.9","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UME"
"6UMF",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG6000, 1.0 M LiCl, pH 8.0",293,,,"6UMF",232.93,"2.68","2.68","Crystal structure of human GAC in complex with inhibitor UPGL00012","LSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6UMF"
"6UMH",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M ammonium dihydrogen phosphate, 0.1 M Tris, pH 8.5, 50% MPD, 4% 1,3-propanediol",277,"10.1016/j.celrep.2020.01.029",,"6UMH",98.26,"2.15","2.15","Crystal structure of erenumab Fab-a","QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDEVD","Homo sapiens",,"erenumab Fab heavy chain, IgG1","1","6UMH"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"erenumab Fab light chain, IgG1","2","6UMH"
"6UMI",,"X-RAY DIFFRACTION",2.56,51.95,"VAPOR DIFFUSION, SITTING DROP",4,"0.1 M sodium acetate, pH 4.0, 22% PEG6000, 10% isopropanol",277,"10.1016/j.celrep.2020.01.029",,"6UMI",48.31,"2.4","2.4","Crystal structure of erenumab Fab-b","QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDEVD","Homo sapiens",,"erenumab Fab heavy chain, IgG1","1","6UMI"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"erenumab Fab light chain, IgG1","2","6UMI"
"6UMJ",,"X-RAY DIFFRACTION",2.86,56.96,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium acetate, pH 5.0, 30% MPD, 5% 1,3-butanediol",277,"10.1016/j.celrep.2020.01.029",,"6UMJ",48.64,"2.7","2.7","Crystal structure of erenumab Fab-c","QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDEVD","Homo sapiens",,"erenumab Fab heavy chain, IgG1","1","6UMJ"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"erenumab Fab light chain, IgG1","2","6UMJ"
"6UMQ",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"18% PEG 4000, 200mM MgCl2, 100mM Tris-HCl pH 8.5",277.15,"10.1016/j.jsb.2020.107576",,"6UMQ",102.56,"1.85","1.85","Structure of DUF89","MAVVPASLSGQDVGSFAYLTIKDRIPQILTKVIDTLHRHKSEFFEKHGEEGVEAEKKAISLLSKLRNELQTDKPFIPLVEKFVDTDIWNQYLEYQQSLLNESDGKSRWFYSPWLLVECYMYRRIHEAIIQSPPIDYFDVFKESKEQNFYGSQESIIALCTHLQQLIRTIEDLDENQLKDEFFKLLQISLWGNKCDLSLSGGESSSQNTNVLNSLEDLKPFILLNDMEHLWSLLSNCKKTREKASATRVYIVLDNSGFELVTDLILADFLLSSELATEVHFYGKTIPWFVSDTTIHDFNWLIEQVKHSNHKWMSKCGADWEEYIKMGKWVYHNHIFWTLPHEYCAMPQVAPDLYAELQKAHLILFKGDLNYRKLTGDRKWEFSVPFHQALNGFHPAPLCTIRTLKAEIQVGLQPGQGEQLLASEPSWWTTGKYGIFQYDGPL","Homo sapiens","ARMT1, C6orf211","Damage-control phosphatase DUF89","1","6UMQ"
"6UMR",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"18% PEG 4000, 200mM MgCl2, 100mM Tris-HCl pH 8.5",277.15,"10.1016/j.jsb.2020.107576",,"6UMR",102.42,"2.21","2.21","Structure of DUF89 - D291A mutant","MAVVPASLSGQDVGSFAYLTIKDRIPQILTKVIDTLHRHKSEFFEKHGEEGVEAEKKAISLLSKLRNELQTDKPFIPLVEKFVDTDIWNQYLEYQQSLLNESDGKSRWFYSPWLLVECYMYRRIHEAIIQSPPIDYFDVFKESKEQNFYGSQESIIALCTHLQQLIRTIEDLDENQLKDEFFKLLQISLWGNKCDLSLSGGESSSQNTNVLNSLEDLKPFILLNDMEHLWSLLSNCKKTREKASATRVYIVLDNSGFELVTDLILADFLLSSELATEVHFYGKTIPWFVSATTIHDFNWLIEQVKHSNHKWMSKCGADWEEYIKMGKWVYHNHIFWTLPHEYCAMPQVAPDLYAELQKAHLILFKGDLNYRKLTGDRKWEFSVPFHQALNGFHPAPLCTIRTLKAEIQVGLQPGQGEQLLASEPSWWTTGKYGIFQYDGPL","Homo sapiens","ARMT1, C6orf211","Damage-control phosphatase DUF89","1","6UMR"
"6UMU",,"X-RAY DIFFRACTION",1.89,35.01,"VAPOR DIFFUSION, HANGING DROP",,"100 mM sodium chloride, 100 mM Tris-HCl, pH 8.0, 27% w/v PEG5000 MME",293,"10.1073/pnas.1916916116",,"6UMU",14.58,"1.183","1.183","Human apo PD-1 triple mutant","MNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSGQPDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKVQIKESLRAELRVTERRAEGSWSHPQFEK","Homo sapiens","PDCD1, PD1","Programmed cell death protein 1","1","6UMU"
"6UMV",,"X-RAY DIFFRACTION",1.89,34.93,"VAPOR DIFFUSION, HANGING DROP",,"100 mM sodium chloride, 100 mM Tris-HCl, pH 8.0, 36% w/v PEG3350",293,"10.1073/pnas.1916916116",,"6UMV",14.64,"1.424","1.424","Human apo PD-1 double mutant","MNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQPDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKVQIKESLRAELRVTERRAEGSWSHPQFEK","Homo sapiens","PDCD1, PD1","Programmed cell death protein 1","1","6UMV"
"6UMW",,"X-RAY DIFFRACTION",2.12,41.88,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium malonate, pH 4.6, 14% PEG3350",291,"10.1073/pnas.2016265118",,"6UMW",34.85,"1.982","1.982","Crystal structure of hEphB1 bound with chlortetracycline","HHHHHHDPNEAVREFAKEIDVSFVKIEEVIGAGEFGEVYKGRLKLPGKREIYVAIKTLKAGYSEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAEMNYVHRDLAARNILVNSNLVCKVSDFGLSRYLQDDTSDPTYTSSLGGKIPVRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPMDCPAALHQLMLDCWQKDRNSRPRFAEIVNTLDKMIRNPASLKTVATITA","Homo sapiens","EPHB1, ELK, EPHT2, HEK6, NET","Ephrin type-B receptor 1","1","6UMW"
"6UNA",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION",7.7,"2.4M Ammonium sulfate, 50mM TRIS pH 7.7.",298,"10.1021/acs.biochem.9b00932",,"6UNA",83.24,"2.554","2.554","Crystal structure of inactive p38gamma","ARSGFYRQEVTKTAWEVRAVYRDLRPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL","Homo sapiens","MAPK12, ERK6, SAPK3","Mitogen-activated protein kinase 12","1","6UNA"
"6UNE",,"X-RAY DIFFRACTION",2.15,42.82,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNE",56.93,"2.55","2.55","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNE"
"6UNG",,"X-RAY DIFFRACTION",2.17,43.21,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349","QEP","6UNG",56.95,"2.3","2.3","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNG"
"6UNH",,"X-RAY DIFFRACTION",2.22,44.61,"MICROBATCH",7,"PEG 3350, succinate",298,"10.1016/j.bmc.2020.115349",,"6UNH",56.93,"2.72","2.72","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNH"
"6UNI",,"X-RAY DIFFRACTION",2.09,41.11,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNI",56.93,"2.602","2.602","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNI"
"6UNJ",,"X-RAY DIFFRACTION",2.53,51.37,"MICROBATCH",,"PEG3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNJ",113.89,"2.6","2.6","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNJ"
"6UNK",,"X-RAY DIFFRACTION",2.24,45.15,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNK",56.94,"2.75","2.75","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNK"
"6UNL",,"X-RAY DIFFRACTION",2.22,44.64,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNL",56.98,"2.55","2.55","CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNL"
"6UNM",,"X-RAY DIFFRACTION",2.52,51.27,"MICROBATCH",,"PEG 3350, sodium malonate",298,"10.1016/j.bmc.2020.115349",,"6UNM",113.37,"2.83","2.83","CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6UNM"
"6UNP",,"X-RAY DIFFRACTION",3.68,66.55,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Na Cacodylate, pH 6.0, 0.3 M Ammonium sulfate, 22% w/v PEG 8000",277,"10.1038/s41467-021-25248-5",,"6UNP",85.83,"2.3","2.3","Crystal structure of the kinase domain of BMPR2-D485G","MGSSHHHHHHSSGENLYFQGHMMEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLCKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDCESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWGQDAEARLTAQCAEERMAELMMIWERNKSVSPTVNPMSTAMQNER","Homo sapiens","BMPR2, PPH1","Bone morphogenetic protein receptor type-2","1","6UNP"
"6UNQ",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES 6.5 pH, 20 %v/v Ethylene glycol, 7 %w/v PEG 8000",298,"10.1038/s41467-021-25248-5",,"6UNQ",38.72,"2.4","2.4","Kinase domain of ALK2-K493A with AMPPNP","MSYYHHHHHHHHHHDYDIPTTENLYFQGAMGQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKATLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6UNQ"
"6UNR",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION, SITTING DROP",7,"0.05 M PIPES 7 pH, 0.01 M DTT, 10 %w/v PEG 4000",298,"10.1038/s41467-021-25248-5",,"6UNR",38.76,"2.2","2.2","Kinase domain of ALK2-K492A/K493A with AMPPNP","MSYYHHHHHHHHHHDYDIPTTENLYFQGAMGQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIAATLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6UNR"
"6UNS",,"X-RAY DIFFRACTION",2.27,45.91,"VAPOR DIFFUSION, SITTING DROP",7,"0.05 M PIPES pH 7, 0.01 M DTT, 10 %w/v PEG 4000",298,"10.1038/s41467-021-25248-5",,"6UNS",76.93,"2.3","2.3","Kinase domain of ALK2-K492A/K493A with LDN-193189","MSYYHHHHHHHHHHDYDIPTTENLYFQGAMGQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIAATLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6UNS"
"6UNT",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6UNT",20.24,"1.75","1.75","Barrier-to-autointegration factor soaked in DMSO: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6UNT"
"6UO6",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, HANGING DROP",8,"1.7-1.95 ammonium sulfate, 0.1 M Tris HCl, pH 8.0",293,"10.1002/jimd.12222",,"6UO6",129.14,"2.15","2.15","Crystal Structure of the R422Q missense variant of human PGM1","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGQNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","6UO6"
"6UOX","4.02","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13917-5",,"6UOX",146.88,"4.13, 4.02",,"Structure of itraconazole-bound NPC1","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNFWSHPQFEK","Homo sapiens","NPC1","NPC intracellular cholesterol transporter 1","1","6UOX"
"6UOZ",,"X-RAY DIFFRACTION",2.2,44.15,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris, ammonium acetate, PEG 3350",291,"10.1021/acs.jmedchem.0c00224",,"6UOZ",67.98,"1.532","1.532","Discovery of fragment-inspired heterocyclic benzenesulfonmides as inhibitors of the WDR5-MYC interaction","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat domain 5","1","6UOZ"
"6UP1",,"X-RAY DIFFRACTION",2.17,43.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 20% PEG 4000, and 10% 2-propanol",283.15,"10.1016/j.abb.2020.108473",,"6UP1",54.09,"1.83","1.83","Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure","GSHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6UP1"
"6UP5",,"X-RAY DIFFRACTION",2.14,42.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 20% PEG 4000, and 10% 2-propanol",283,"10.1016/j.abb.2020.108473",,"6UP5",54.58,"1.92","1.92","Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure","GSHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6UP5"
"6UP6","9","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.09.012",,"6UP6",1797.1,"9",,"Endophilin B1 helical scaffold","MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN","Homo sapiens","SH3GLB1, KIAA0491, CGI-61","Endophilin-B1","1","6UP6"
"6UP8",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 20% PEG 4000, and 10% 2-propanol",283,"10.1016/j.abb.2020.108473",,"6UP8",54.2,"2","2","Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure","GSHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPELVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6UP8"
"6UPF",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.05 M Tris-HCl pH 7.5, 0.05 M NaCl, 1 mM EDTA, 15% PEG 4000 and 2 mM 2-PG",283,"10.1016/j.abb.2020.108473",,"6UPF",54.3,"1.65","1.65","Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure","GSHMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPELVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6UPF"
"6UPN","10","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.09.012",,"6UPN",1960.48,"10",,"Endophilin B1 helical scaffold","MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN","Homo sapiens","SH3GLB1, KIAA0491, CGI-61","Endophilin-B1","1","6UPN"
"6UPT",,"X-RAY DIFFRACTION",2.9,57.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 0.1 M HEPES pH 7.5, 2% PEG 400",291,,,"6UPT",28.36,"1.96","1.96","Tudor Domain of Tumor suppressor p53BP1 with MFP-2706","GNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLGPYE","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6UPT"
"6UQF","3.04","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2019.11.006",,"6UQF",300.58,"3.04",,"Human HCN1 channel in a hyperpolarized conformation","MEGGGKPNSSSNSRDDGNSVFPAKASATGAGPAAAEKRLGTPPGGGGAGAKEHGNSVCFKVDGGGGGGGGGGGGEEPAGGFEDAEGPRRQYGFMQRQFTSMLQPGVNKFSLRMFGSQKAVEKEQERVKTAGFWIIHPYSDFRFYWDLIMLIMMVGNLVIIPVGITFFTEQTTTPWIIFNVASDTVCLLDLIMNFRTGTVNEDSSEIILDPKVIKMNYLKSWFVVDFISSIPVDYIFLIVEKGMDSEVYKTARALRIVRFTKILCLLRLLRLSRLIRYIHQWEEIFHMTYDLASAVVRIFNLIGMMLLLCHWDGCLQFLVPLLQDFPPDCWVSLNEMVNDSWGKQYSYALFKAMSHMLCIGYGAQAPVSMSDLWITMLSMIVGATCYAMFVGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPADMRQKIHDYYEHRYQGKIFDEENILNELNDPLREEIVNFNCRKLVATMPLFANADPNFVTAMLSKLRFEVFQPGDYIIREGAVGKKMYFIQHGVAGVITKSSKEMKLTDGSYFGEICLLTKGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLQKFQKDLNTGVFNNQENEILKQIVKHDREMVQAALPRESSSVLNTDPDAEKPRFASNL","Homo sapiens","HCN1, BCNG1","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1","1","6UQF"
,,,,,,,,,,,,,,,,,"Homo sapiens","HCN1, BCNG1"
"6UQG","3.54","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2019.11.006",,"6UQG",299.7,"3.54",,"Human HCN1 channel Y289D mutant","MEGGGKPNSSSNSRDDGNSVFPAKASATGAGPAAAEKRLGTPPGGGGAGAKEHGNSVCFKVDGGGGGGGGGGGGEEPAGGFEDAEGPRRQYGFMQRQFTSMLQPGVNKFSLRMFGSQKAVEKEQERVKTAGFWIIHPYSDFRFYWDLIMLIMMVGNLVIIPVGITFFTEQTTTPWIIFNVASDTVFLLDLIMNFRTGTVNEDSSEIILDPKVIKMNYLKSWFVVDFISSIPVDYIFLIVEKGMDSEVYKTARALRIVRFTKILSLLRLLRLSRLIRYIHQWEEIFHMTDDLASAVVRIFNLIGMMLLLCHWDGCLQFLVPLLQDFPPDCWVSLNEMVNDSWGKQYSYALFKAMSHMLCIGYGAQAPVSMSDLWITMLSMIVGATCYAMFVGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPADMRQKIHDYYEHRYQGKIFDEENILNELNDPLREEIVNFNCRKLVATMPLFANADPNFVTAMLSKLRFEVFQPGDYIIREGAVGKKMYFIQHGVAGVITKSSKEMKLTDGSYFGEICLLTKGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLQKFQKDLNTGVFNNQENEILKQIVKHDREMVQAALPRESSSVLNTDPDAEKPRFASNL","Homo sapiens","HCN1, BCNG1","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1","1","6UQG"
,,,,,,,,,,,,,,,,,"Homo sapiens","HCN1, BCNG1"
"6UQK","3.77","ELECTRON MICROSCOPY",,,,,,,"10.1074/jbc.RA119.011570",,"6UQK",1114.6,"3.77",,"Cryo-EM structure of type 3 IP3 receptor revealing presence of a self-binding peptide","MSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCXXXXXXXXXXXXXXXXDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEXXXXXXXXXPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVXXXXXXXXXXXXXXXXXXXXX","Homo sapiens","ITPR3","inositol 1,4,5-triphosphate receptor, type 3","1","6UQK"
"6URC",,"X-RAY DIFFRACTION",2.52,51.1,"VAPOR DIFFUSION, HANGING DROP",,"0.1M trisodium citrate pH 5.6, 10% isopropanol, 10% PEG4000, and cesium chloride",277,"10.1073/pnas.1906999116","QFV","6URC",100.42,"2.2","2.2","Crystal structure of IRE1a in complex with compound 18","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6URC"
"6URE",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URE",20.24,"1.653","1.653","Barrier-to-autointegration factor Aqueous: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URE"
"6URJ",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URJ",20.24,"1.653","1.653","Barrier-to-autointegration factor soaked in Acetone: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URJ"
"6URK",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URK",20.24,"1.86","1.86","Barrier-to-autointegration factor soaked in Glycerol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URK"
"6URL",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URL",20.24,"1.72","1.72","Barrier-to-autointegration factor soaked in isopropanol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URL"
"6URN",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URN",20.24,"1.68","1.68","Barrier-to-autointegration factor t-butanol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URN"
"6URR",,"X-RAY DIFFRACTION",2.33,47.1,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URR",20.24,"1.8","1.8","Barrier-to-autointegration factor soaked in Dioxane: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URR"
"6URZ",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6URZ",20.27,"1.653","1.653","Barrier-to-autointegration factor soaked in methanol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6URZ"
"6US0",,"X-RAY DIFFRACTION",2.31,46.84,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6US0",20.24,"1.653","1.653","Barrier-to-autointegration factor soaked in R,S,R-bisfuranol (RSR): 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6US0"
"6US1",,"X-RAY DIFFRACTION",2.32,46.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6US1",20.24,"1.653","1.653","Barrier-to-autointegration factor soaked in isobutanol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6US1"
"6US2",,"X-RAY DIFFRACTION",1.99,38.13,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 6000, 0.1M sodium acetate pH 4.0, 0.2M lithium sulfate",293,"10.1021/acsmedchemlett.9b00420","S3O","6US2",18.55,"1.80012657096","1.80012657096","MTH1 in complex with compound 5","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6US2"
"6US3",,"X-RAY DIFFRACTION",1.98,37.93,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 6000, 0.1M sodium acetate pH 4.0, 0.2M lithium sulfate",293,"10.1021/acsmedchemlett.9b00420","8JF","6US3",18.55,"1.47028917623","1.47028917623","MTH1 in complex with compound 4","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6US3"
"6US4",,"X-RAY DIFFRACTION",1.99,38.06,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 6000, 0.1M sodium acetate pH 4.0, 0.2M lithium sulfate",293,"10.1021/acsmedchemlett.9b00420","GN6","6US4",18.53,"1.95032907402","1.95032907402","MTH1 in complex with compound 32","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6US4"
"6US7",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6US7",20.24,"1.653","1.653","Barrier-to-autointegration factor soaked in TMAO: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6US7"
"6USB",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6USB",20.24,"1.68","1.68","Barrier-to-autointegration factor soaked in urea: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6USB"
"6USC",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM bis-Tris, 25% PEG 3350",298,"10.1021/jacs.9b11699","KO2","6USC",62.99,"1.59","1.59","Structure of Human Intelectin-1 in complex with KO","PSLPRSCKEIKDECPSAFDGLYFLRTENGVIYQTFCDMTSGGGGWTLVASVHENDMRGKCTVGDRWSSQQGSKAVYPEGDGNWANYNTFGSAEAATSDDYKNPGYYDIQAKDLGIWHVPNKSPMQHWRNSSLLRYRTDTGFLQTLGHNLFGIYQKYPVKYGEGKCWTDNGPVIPVVYDFGDAQKTASYYSPYGQREFTAGFVQFRVFNNERAANALCAGMRVTGCNTEHHCIGGGGYFPEASPQQCGDFSGFDWSGYGTHVGYSSSREITEAAVLLFYR","Homo sapiens","ITLN1, INTL, ITLN, LFR, UNQ640/PRO1270","Intelectin-1","1","6USC"
"6USD",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6USD",20.29,"1.653","1.653","Barrier-to-autointegration factor soaked in ethanol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6USD"
"6USI",,"X-RAY DIFFRACTION",2.3,46.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"80 mM Tris pH 8.5, 16% Ethanol, 10% PEG-1450",277.15,"10.1107/S2059798320011341",,"6USI",20.24,"1.653","1.653","Barrier-to-autointegration factor soaked in 1,6-hexanediol: 1 of 14 in MSCS set","MTTSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTCGANAKQSRDCFGCLREWCDAFL","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","6USI"
"6USN",,"X-RAY DIFFRACTION",4.91,74.96,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES pH 6.5,
2.3 M Ammonium Sulfate,
2% PEG1000",298,"10.1016/j.bmcl.2019.126793",,"6USN",119.7,"2.773","2.773","Co-crystal structure of SPR with compound 5","GSMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6USN"
"6USX",,"X-RAY DIFFRACTION",2.82,56.37,"VAPOR DIFFUSION, HANGING DROP",5.4,"29% PEG8K 0.1M 
NaCitrate pH 5.4
0.2M Amm Acetate",293,"10.1021/acs.jmedchem.9b02052",,"6USX",40.67,"2.27","2.27","Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6USX"
"6USY",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bit-Tris pH 7.0, 0.6 M NaCl, 25 % (w/v) PEG3,350",277,"10.1021/acs.jmedchem.0c00279","QGS","6USY",27.31,"1.26","1.26","COAGULATION FACTOR XI CATALYTIC DOMAIN (C123S) IN COMPLEX WITH NVP-XIV936","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XIa light chain","1","6USY"
"6USZ",,"X-RAY DIFFRACTION",2.34,47.53,"VAPOR DIFFUSION, HANGING DROP",4.6,"23% PEG8K
0.1M NaCitrate pH 4.6
0.2M Amm Acetate",293,"10.1021/acs.jmedchem.9b02052",,"6USZ",20.37,"2.03","2.03","Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6USZ"
"6UT0",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION, HANGING DROP",,"32% PEG 4K
0.1M NaOAc (unbuffered)
8% 2-Propanol",293,"10.1021/acs.jmedchem.9b02052",,"6UT0",81.71,"1.94","1.94","Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6UT0"
"6UUL",,"X-RAY DIFFRACTION",2.93,57.97,"VAPOR DIFFUSION, SITTING DROP",,"0.095M sodium citrate-citric acid (pH=6.2), 16%(v/v) 2-propanol, 5% (v/v) glycerol, 17%(w/v) PEG4000",293.15,"10.1126/sciadv.abb1328",,"6UUL",98.23,"2.06","2.06","Crystal structure of broad and potent HIV-1 neutralizing antibody 438-D5","QVQLVQSGAEVKKPGSSVTISCKPVGGTFTNFAIHWVRQAPGQGLEWVGGRVPVVGIYKYGKKFHDRLRLYEDDPMKTVFLELRSLTSDDTGVYYCTRWRGCGMCPYDTSSYYNDASDVWGPGTKVIVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"D5 Fab Heavy Chain","1","6UUL"
,,,,,,,,,,,,,,,,"EIVLTQSPVTLSLSSGETGTLSCRASQNISSSWIAWYQQRRGQVPRLLISAASARAAGIPDRFTGRGSGTDFTLTITRLEPEDLGVYSCQYYGGSFFTFGPGTQVDVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"D5 Fab Light Chain","2","6UUL"
"6UUM",,"X-RAY DIFFRACTION",3.4,63.88,"VAPOR DIFFUSION, SITTING DROP",,"0.1M sodium acetate (pH=4.16), 0.2M lithium sulfate, 40% %(v/v) PEG400",277.15,"10.1126/sciadv.abb1328",,"6UUM",101.78,"2.1","2.1","Crystal structure of antibody 438-B11 DSS mutant (Cys98A-Cys100aA)","EIVLTQSPVTLSLSSGETGTLSCRASQNISSSWIAWYQQRRGQVPRLLISAASARAAGIPDRFTGRGSGTDFTLTITRLEPEDFGVYSCQYYGGSFFTFGPGTQVDVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"B11 Fab Light Chain","1","6UUM"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVRKPGSSVTISCKPVGGTFTNFAIHWVRQAPGQGLEWVGGRVPVVGIYKYGKKFHDRLRLYEDDPMKTVFLELRSLTSDDTGVYYCTRWRGAGMAPYDTSSYYNDASDVWGPGTKVIVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"B11 DSS Fab Heavy Chain","2","6UUM"
"6UUO",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 6000, 0.1 M HEPES pH 7.0, 0.2 M Calcium Chloride",293.15,"10.1038/s41589-020-0609-7",,"6UUO",65.67,"3.288","3.288","Crystal structure of BRAF kinase domain bound to the PROTAC P4B","GAMDRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6UUO"
"6UUR","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0403-y",,"6UUR",96.86,"3.5",,"Human prion protein fibril, M129 variant","GTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHD","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","6UUR"
"6UUW","2.85","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6UUW",489.8,"2.85",,"Structure of human ATP citrate lyase E599Q mutant in complex with Mg2+, citrate, ATP and CoA","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAQGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6UUW"
"6UUZ","3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6UUZ",486.48,"3",,"Structure of ACLY in the presence of citrate and CoA","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMS","Homo sapiens","ACLY","ATP-citrate synthase","1","6UUZ"
"6UV0",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG, 0.26M NaSCN",298,"10.1016/j.celrep.2019.11.059",,"6UV0",102.62,"2.601","2.601","Crystal structure of apo core domain of RNA helicase DDX17","SGGNPGERLRKKKWDLSELPKFEKNFYVEHPEVARLTPYEVDELRRKKEITVRGGDVCPKPVFAFHHANFPQYVMDVLMDQHFTEPTPIQCQGFPLALSGRDMVGIAQTGSGKTLAYLLPAIVHINHQPYLERGDGPICLVLAPTRELAQQVQQVADDYGKCSRLKSTCIYGGAPKGPQIRDLERGVEICIATPGRLIDFLESGKTNLRRCTYLVLDEADRMLDMGFEPQIRKIVDQIRPDRQTLMWSATWPKEVRQLAEDFLRDYTQINVGNLELSANHNILQIVDVCMESEKDHKLIQLMEEIMAEKENKTIIFVETKRRCDDLTRRMRRDGWPAMCIHGDKSQPERDWVLNEFRSGKAPILIATDVASRGLDVEDVKFVINYDYPNSSEDYVHRIGRTARSTNKGTAYTFFTPGNLKQARELIKVLEEANQAINPKLMQLVDHRG","Homo sapiens","DDX17","Probable ATP-dependent RNA helicase DDX17","1","6UV0"
"6UV5","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6UV5",487.7,"3.4",,"Structure of human ATP citrate lyase in complex with acetyl-CoA and oxaloacetate","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMS","Homo sapiens","ACLY","ATP citrate lyase","1","6UV5"
"6UVC",,"X-RAY DIFFRACTION",3.47,64.52,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M ammonium sulphate, 0.1 M HEPES pH 6.5",293,"10.1021/acs.jmedchem.0c01771",,"6UVC",38.12,"1.9","1.9","Crystal structure of BCL-XL bound to compound 8: (R)-3-(Benzylthio)-2-(3-(2-((4'-chloro-[1,1'-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVC"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVD",,"X-RAY DIFFRACTION",2.82,56.41,"VAPOR DIFFUSION",,"1.4 M ammonium sulphate, 0.1 M HEPES pH 6.5",293,"10.1021/acs.jmedchem.0c01771",,"6UVD",37.88,"2.15","2.15","Crystal structure of BCL-XL bound to compound 2: (2R)-3-(Benzylsulfanyl)-2-({[(4-methylphenyl)methyl] [(4 phenylphenyl)carbonyl] carbamoyl}amino) propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVD"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVE",,"X-RAY DIFFRACTION",2.95,58.29,"VAPOR DIFFUSION, HANGING DROP",,"0.9 M trisodium citrate, 0.1 M MES pH 6.0, 5% (v/v) PEG400",293,"10.1021/acs.jmedchem.0c01771",,"6UVE",55.99,"2.87","2.87","Crystal structure of BCL-XL bound to compound 7: (R)-3-(Benzylthio)-2-(3-(4-chloro-[1,1':2',1'':3'',1'''-quaterphenyl]-4'''-carbonyl)-3-(4-methylbenzyl)ureido)propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVE"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVF",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, HANGING DROP",,"1.4 M ammonium sulfate, 0.1 M MES pH 6.0",293,"10.1021/acs.jmedchem.0c01771",,"6UVF",224.48,"2.24","2.24","Crystal structure of BCL-XL bound to compound 12: (R)-2-(3-([1,1'-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-((cyclohexylmethyl)sulfonyl)propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVF"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVG",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, HANGING DROP",,"1.7 M ammonium sulfate, 0.1 M MES pH 6.0",293,"10.1021/acs.jmedchem.0c01771",,"6UVG",223.64,"2.1","2.1","Crystal structure of BCL-XL bound to compound 13: (R)-2-(3-([1,1'-Biphenyl]-4-carbonyl)-3-(4-methylbenzyl)ureido)-3-(((3R,5R,7R)-adamantan-1-ylmethyl)sulfonyl)propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVG"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVH",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M ammonium sulfate, 0.1 M Tris pH 7.0",293,"10.1021/acs.jmedchem.0c01771",,"6UVH",74.95,"2.19","2.19","Crystal structure of BCL-XL bound to compound 15: (R)-2-(3-(2-((4'-Chloro-[1,1'-biphenyl]-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(4-methylbenzyl)ureido)-3-((cyclohexylmethyl)sulfonyl)propanoic acid","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6UVH"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6UVJ",,"X-RAY DIFFRACTION",2.27,46,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M bis-tris propane, 20 % PEG 3350",295,"10.1021/acsmedchemlett.9b00414","QJ1","6UVJ",15.62,"1.38","1.38","Cocrystal of BRD4(D1) with a methyl carbamate thiazepane inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6UVJ"
"6UVM",,"X-RAY DIFFRACTION",2.27,45.7,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.1 M bis-tris propane, 20% ethylene glycol, and 20% PEG3350",295,"10.1021/acsmedchemlett.9b00414","QJA","6UVM",15.4,"1.51","1.51","Cocrystal of BRD4(D1) with a methyl carbamate thiazepane inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6UVM"
"6UVP",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION",,"100mM Sodium Cacodylate pH 7.4, 12% PEG 8K, 200mM Ammonium Sulfate",277,"10.1016/j.bmc.2019.115194",,"6UVP",100.62,"1.56","1.56","BACE-1 in complex with compound #3","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6UVP"
"6UVR","4","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2020.03.046",,"6UVR",314.58,"4",,"Human Connexin-26 (Neutral pH open conformation)","MDWGTLQTILGGVNKHSTSIGKIWLTVLFIFRIMILVVAAKEVWGDEQADFVCNTLQPGCKNVCYDHYFPISHIRLWALQLIFVSTPALLVAMHVAYRRHEKKRKFIKGEIKSEFKDIEEIKTQKVRIEGSLWWTYTSSIFFRVIFEAAFMYVFYVMYDGFSMQRLVKCNAWPCPNTVDCFVSRPTEKTVFTVFMIAVSGICILLNVTELSYLLIRYSSGKSKKPV","Homo sapiens","GJB2","Gap junction beta-2 protein","1","6UVR"
"6UVS","4.2","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2020.03.046",,"6UVS",314.58,"4.2",,"Human Connexin-26 (Low pH open conformation)","MDWGTLQTILGGVNKHSTSIGKIWLTVLFIFRIMILVVAAKEVWGDEQADFVCNTLQPGCKNVCYDHYFPISHIRLWALQLIFVSTPALLVAMHVAYRRHEKKRKFIKGEIKSEFKDIEEIKTQKVRIEGSLWWTYTSSIFFRVIFEAAFMYVFYVMYDGFSMQRLVKCNAWPCPNTVDCFVSRPTEKTVFTVFMIAVSGICILLNVTELSYLLIRYSSGKSKKPV","Homo sapiens","GJB2","Gap junction beta-2 protein","1","6UVS"
"6UVT","7.5","ELECTRON MICROSCOPY",,,,,,,,,"6UVT",314.58,"7.5",,"Human Connexin-26 (Low pH closed conformation)","MDWGTLQTILGGVNKHSTSIGKIWLTVLFIFRIMILVVAAKEVWGDEQADFVCNTLQPGCKNVCYDHYFPISHIRLWALQLIFVSTPALLVAMHVAYRRHEKKRKFIKGEIKSEFKDIEEIKTQKVRIEGSLWWTYTSSIFFRVIFEAAFMYVFYVMYDGFSMQRLVKCNAWPCPNTVDCFVSRPTEKTVFTVFMIAVSGICILLNVTELSYLLIRYSSGKSKKPV","Homo sapiens","GJB2","Gap junction beta-2 protein","1","6UVT"
"6UVV",,"X-RAY DIFFRACTION",2.6,52.64,"VAPOR DIFFUSION",7.4,"100mM Sodium Cacodylate pH 7.4, 12% PEG 8K, 200mM Ammonium Sulfate",277,"10.1016/j.bmc.2019.115194","QJV","6UVV",99.38,"1.63","1.63","BACE-1 in complex with compound #17","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6UVV"
"6UVY",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION",,"100mM Sodium Cacodylate pH 7.4, 12% PEG 8K, 200mM Ammonium Sulfate",277,"10.1016/j.bmc.2019.115194","QJP","6UVY",99.4,"1.71","1.71","BACE-1 in complex with compound #18","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6UVY"
"6UW4","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0428-2",,"6UW4",377.3,"3.1",,"Cryo-EM structure of human TRPV3 determined in lipid nanodisc","MKAHPKEMVPLMGKRVAAPSGNPAVLPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSV","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6UW4"
"6UW6","3.66","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0428-2",,"6UW6",377.04,"3.66",,"Cryo-EM structure of the human TRPV3 K169A mutant determined in lipid nanodisc","MKAHPKEMVPLMGKRVAAPSGNPAVLPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGATCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSV","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6UW6"
"6UW8","4.02","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0428-2",,"6UW8",362.68,"4.02",,"Cryo-EM structure of the human TRPV3 K169A mutant briefly exposed to 2-APB for 3 minutes, determined in lipid nanodisc","MKAHPKEMVPLMGKRVAAPSGNPAVLPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGATCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSV","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6UW8"
"6UW9","4.33","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0428-2",,"6UW9",362.68,"4.33",,"Cryo-EM structure of the human TRPV3 K169A mutant in the presence of 2-APB, determined in lipid nanodisc","MKAHPKEMVPLMGKRVAAPSGNPAVLPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGATCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSV","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6UW9"
"6UWP",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION",,"100mM Sodium Cacodylate pH 7.4, 12% PEG 8K, 200mM Ammonium Sulfate",277,"10.1016/j.bmc.2019.115194","QKA","6UWP",99.65,"1.29","1.29","BACE-1 in complex with compound #32","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6UWP"
"6UWU",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM sodium sulfate, 10% (v/v) ethylene glycol and 18% (w/v) PEG 3350",293,"10.1021/acs.jmedchem.0c00035","QKP","6UWU",15.89,"2","2","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZL0516","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6UWU"
"6UWV",,"X-RAY DIFFRACTION",2.6,52.72,"VAPOR DIFFUSION",,"100mM Sodium Cacodylate pH 7.4, 14% PEG 8K, 200mM Ammonium Sulfate",281,"10.1016/j.bmc.2019.115194","QK7","6UWV",99.39,"1.47","1.47","BACE-1 in complex with compound #34","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6UWV"
"6UWX",,"X-RAY DIFFRACTION",2.26,45.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M bis-tris propane, 20 % PEG 3350",295,"10.1021/acsmedchemlett.9b00414","QKD","6UWX",15.43,"1.307","1.307","Cocrystal of BRD4(D1) with a ethyl carbamate thiazepane inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6UWX"
"6UWY",,"X-RAY DIFFRACTION",3.22,61.8,"VAPOR DIFFUSION, HANGING DROP",8.8,"35-45% PEG400, 0.2 M lithium sulfate, 0.1 M Tris, pH 8.8",277,"10.1021/acs.jmedchem.9b01379",,"6UWY",171.65,"2.95","2.95","DYRK1A bound to a harmine derivative","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6UWY"
"6UX1",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris
pH 7.8",298,"10.3390/biom10040527","SAL","6UX1",30.12,"1.36","1.36","Carbonic Anhydrase II Complexed with Salicylic Acid","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UX1"
"6UX9",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",,"0.1M sodium citrate, pH 6.5
12% PEG 5000 MME",293,"10.1021/acs.jmedchem.0c00227",,"6UX9",86.49,"1.71","1.71","Crystal Structure Analysis of PIP4K2A","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PIP5K2, PIP5K2A, PI5P4KA","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha","1","6UX9"
"6UXM",,"X-RAY DIFFRACTION",2.04,39.72,"VAPOR DIFFUSION, SITTING DROP",5.5,"ammonium sulphate, PEG 10000, sodium acetate, bis-tris chloride",293,"10.1038/s41594-020-0494-5",,"6UXM",61.5,"2.49","2.49","Crystal structure of BAK core domain BH3-groove-dimer in complex with E. coli lipid","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXM"
"6UXN",,"X-RAY DIFFRACTION",2.9,57.64,"VAPOR DIFFUSION, SITTING DROP",,"ammonium sulphate",293,"10.1038/s41594-020-0494-5",,"6UXN",125.13,"2.49","2.49","Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylserine","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXN"
"6UXO",,"X-RAY DIFFRACTION",2.92,57.9,"VAPOR DIFFUSION, SITTING DROP",4.6,"ammonium sulfate, n-Dodecyl-b-D-maltoside, sodium acetate",293,"10.1038/s41594-020-0494-5",,"6UXO",131.53,"1.799","1.799","Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXO"
"6UXP",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, SITTING DROP",8.5,"magnesium chloride, PEG 4000, tris-chloride",293,"10.1038/s41594-020-0494-5",,"6UXP",80.35,"2.492","2.492","Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylglycerol","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXP"
"6UXQ",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, SITTING DROP",5.5,"ammonium sulphate, trisodium citrate, tetraethylene glycol monooctyl ether, 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine",293,"10.1038/s41594-020-0494-5",,"6UXQ",41.78,"1.696","1.696","Crystal structure of BAK core domain BH3-groove-dimer in complex with POPC and C8E4","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXQ"
"6UXR",,"X-RAY DIFFRACTION",2.57,52.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"calcium chloride, PEG 3350, sodium acetate, sodium HEPES",293,"10.1038/s41594-020-0494-5",,"6UXR",20.79,"1.8","1.8","Crystal structure of BAK core domain BH3-groove-dimer in complex with LysoPC","GPLGSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLT","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6UXR"
"6UY7",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"6% PEG8000, 100mM MES, 8% ethylene glycol",277.15,"10.1016/j.str.2020.05.005",,"6UY7",14.04,"2.105","2.105","Crystal structure of the STAC3 tandem SH3 domains - P269R","GFQQSHYFVALYRFKALEKDDLDFRPGEKITVIDDSNEEWWRGKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI","Homo sapiens","STAC3","SH3 and cysteine-rich domain-containing protein 3","1","6UY7"
"6UY8",,"X-RAY DIFFRACTION",2.38,48.43,"VAPOR DIFFUSION, HANGING DROP",6.5,"6% PEG8000, 0.1M MES, 8% ethylene glycol",277.15,"10.1016/j.str.2020.05.005",,"6UY8",28.7,"1.649","1.649","Crystal structure of the STAC3 tandem SH3 domains - P269R, K329N","SNAGFQQSHYFVALYRFKALEKDDLDFRPGEKITVIDDSNEEWWRGKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLNKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI","Homo sapiens","STAC3","SH3 and cysteine-rich domain-containing protein 3","1","6UY8"
"6UY9",,"X-RAY DIFFRACTION",1.92,36.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M NaOAc, 0.2M LiSO4, 24% PEG3350",277.15,"10.1016/j.str.2020.05.005",,"6UY9",14.24,"1.6","1.6","Crystal structure of the STAC3 tandem SH3 domains - P269R, W284S","SNAGFQQSHYFVALYRFKALEKDDLDFRPGEKITVIDDSNEESWRGKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI","Homo sapiens","STAC3","SH3 and cysteine-rich domain-containing protein 3","1","6UY9"
"6UYA",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION",,"2.3M-2.7M ammonium sulfate, 0.1M HEPES Na pH 7.0-7.3",292,"10.1021/acsmedchemlett.9b00380",,"6UYA",146.71,"1.74","1.74","Crystal structure of Compound 19 bound to IRAK4","MHHHHHHGENLYFQGSVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTASGNS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6UYA"
"6UYB",,"X-RAY DIFFRACTION",2.59,52.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM potassium/sodium tartrate pH 6.5
20% PEG 3350",292,"10.1016/j.celrep.2020.107809","QSJ","6UYB",54.37,"1.543","1.543","Crystal structure of TEAD2 bound to Compound 1","GSAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDGNS","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6UYB"
"6UYC",,"X-RAY DIFFRACTION",2.56,51.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM potassium/sodium tartrate pH 6.5
20% PEG 3350",292,"10.1016/j.celrep.2020.107809","QLV","6UYC",54.22,"1.658","1.658","Crystal structure of TEAD2 bound to Compound 2","GSAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDGNS","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6UYC"
"6UZ8","2.84","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53311",,"6UZ8",396.58,"2.84",,"Cryo-EM structure of human TRPC6 in complex with agonist AM-0883","AYMFSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEECHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVGDALLLAISKGYVRIVEAILSHPAFAEGKRLATSPSQSELQQDDFYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRINAYKGLASPAYLSLSSEDPVMTALELSNELAVLANIEKEFKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGDHGRPNLSRLKLAIKYEVKKFVAHPNCQQQLLSIWYENLSGLRQQTMAVKFLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNAKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFELWNMLDFGMLAIFAASFIARFMAFWHASKAQSIIDANDTLKDLTKVTLGDNVKYYNLARIKWDPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVINYNHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYFEEGRTLPVPFNLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKRLIKRYTTQAQIDKESDEVNEGELKEIKQDISSLRYELLEEKSQNTEDLAELIRELGEKLSMEPNQEETNR","Homo sapiens","TRPC6, TRP6","Short transient receptor potential channel 6","1","6UZ8"
"6UZA","3.08","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53311",,"6UZA",398.06,"3.08",,"Cryo-EM structure of human TRPC6 in complex with antagonist AM-1473","AYMFSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEECHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVGDALLLAISKGYVRIVEAILSHPAFAEGKRLATSPSQSELQQDDFYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRINAYKGLASPAYLSLSSEDPVMTALELSNELAVLANIEKEFKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGDHGRPNLSRLKLAIKYEVKKFVAHPNCQQQLLSIWYENLSGLRQQTMAVKFLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNAKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFELWNMLDFGMLAIFAASFIARFMAFWHASKAQSIIDANDTLKDLTKVTLGDNVKYYNLARIKWDPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVINYNHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYFEEGRTLPVPFNLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKRLIKRYVLQAQIDKESDEVNEGELKEIKQDISSLRYELLEEKSQNTEDLAELIRELGEKLSMEPNQEETNR","Homo sapiens","TRPC6, TRP6","Short transient receptor potential channel 6","1","6UZA"
"6UZF",,"X-RAY DIFFRACTION",2.38,48.36,"EVAPORATION",,"0.05 M (NH4)2SO4, 0.05 M Bis-Tris (pH 6.5), 30% Pentaerythritol ethoxylate (15/4 EO/OH)",291,"10.1021/acs.jmedchem.9b01980",,"6UZF",14.55,"1.75","1.75","Crystal structure of the unliganded bromodomain of human BRD9","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6UZF"
"6UZJ",,"SOLUTION NMR",,,,,,,"10.1038/s42003-020-01397-z",,"6UZJ",9.66,,,"NMR structure of the HACS1 SH3 domain","GSDITSLYKKAGSSFRLDDDGPYSGPFCGRARVHTDFTPSPYDTDSLKIKKGDIIDIICKTPMGMWTGMLNNKVGNFKFIYVDVISE","Homo sapiens","SAMSN1, HACS1","SAM domain-containing protein SAMSN-1","1","6UZJ"
"6UZT",,"X-RAY DIFFRACTION",2.88,57,"VAPOR DIFFUSION, HANGING DROP",6,"MES, PEG 20000, DTT",298,"10.1074/jbc.RA119.011808",,"6UZT",139.22,"1.8","1.8","Crystal Structure of RPTP alpha","MSPSTNRKYPPLPVDKLEEEINRRMADDNKLFREEFNALPACPIQATCEAASKEENKEKNRYVNILPYDHSRVHLTPVEGVPDSDYINASFINGYQEKNKFIAAQGPKEETVNDFWRMIWEQNTATIVMVTNLKERKECKCAQYWPDQGCWTYGNIRVSVEDVTVLVDYTVRKFCIQQVGDMTNRKPQRLITQFHFTSWPDFGVPFTPIGMLKFLKKVKACNPQYAGAIVVHCSAGVGRTGTFVVIDAMLDMMHTERKVDVYGFVSRIRAQRCQMVQTDMQYVFIYQALLEHYLYGDTELEVTSLETHLQKIYNKIPGTSNNGLEEEFKKLTSIKIQNDKMRTGNLPANMKKNRVLQIIPYEFNRVIIPVKRGEENTDYVNASFIDGYRQKDSYIASQGPLLHTIEDFWRMIWEWKSCSIVMLTELEERGQEKCAQYWPSDGLVSYGDITVELKKEEECESYTVRDLLVTNTRENKSRQIRQFHFHGWPEVGIPSDGKGMISIIAAVQKQQQQSGNHPITVHCSAGAGRTGTFCALSTVLERVKAEGILDVFQTVKSLRLQRPHMVQTLEQYEFCYKVVQEYIDAFSDYANFKLEHHHHHH","Homo sapiens","PTPRA, PTPA, PTPRL2","Receptor-type tyrosine-protein phosphatase alpha","1","6UZT"
"6UZU",,"X-RAY DIFFRACTION",2.11,41.75,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M Na-Citrate, 50 mM Tris, pH 7.8",293,,"6LU","6UZU",29.39,"1.5","1.5","Carbonic Anhydrase IX-mimic In Complex WITH U-CH3","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6UZU"
"6V02",,"X-RAY DIFFRACTION",2.54,51.48,"VAPOR DIFFUSION, HANGING DROP",,"100 mM HEPES pH 7.0, 30% Jeffamine ED-2003",292.15,"10.1038/s42003-020-01211-w",,"6V02",81.42,"2.46","2.46","N-terminal 5 domains of CI-MPR","GSTQAAPFPELCSYTWEAVDTKNNVLYKINICGSVDIVQCGPSSAVCMHDLKTRTYHSVGDSVLRSATRSLLEFNTTVSCDQQGTNHRVQSSIAFLCGKTLGTPEFVTATECVHYFEWRTTAACKKDIFKANKEVPCYVFDEELRKHDLNPLIKLSGAYLVDDSDPDTSLFINVCRDIDTLRDPGSQLRACPPGTAACLVRGHQAFDVGQPRDGLKLVRKDRLVLSYVREEAGKLDFCDGHSPAVTITFVCPSERREGTIPKLTAKSNCRYEIEWITEYACHRDYLESKTCSLSGEQQDVSIDLTPLAQSGGSSYISDGKEYLFYLNVCGETEIQFCNKKQAAVCQVKKSDTSQVKAAGRYHNQTLRYSDGDLTLIYFGGDECSSGFQRMSVINFECNKTAGNDGKGTPVFTGEVDCTYFFTWDTEYACVKEKEDLLCGATDGKKRYDLSALVRHAEPEQNWEAVDGSQTETEKKHFFINICHRVLQEGKARGCPEDAAVCAVDKNGSKNLGKFISSPMKEKGNIQLSYSDGDDCGHGKKIKTNITLVCKPGDLESAPVLRTSGEGGCFYEFEWHTAAACVLSKTEGENCTVFDSQAGFSFDLSPLTKKNGAYKVETKKYDFYINVCGPVSVSPCQPDSGACQVAKSDEKTWNLGLSNAKLSYYDGMIQLNYRGGTPYNNERHTPRATLITFLCDRDAGVGFPEYQEEDNSTYNFRWYTSYACPEEALVPR","Homo sapiens","IGF2R, MPRI","Cation-independent mannose-6-phosphate receptor","1","6V02"
"6V06",,"X-RAY DIFFRACTION",10.61,88.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 1.5 M AmSO4, 20 mM CaCl2 and 2% glycerol",277,"10.1074/jbc.RA120.013939",,"6V06",42.61,"2.4","2.4","Crystal structure of Beta-2 glycoprotein I purified from plasma (pB2GPI)","GRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","6V06"
"6V08",,"X-RAY DIFFRACTION",10.95,88.76,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES and 1.6 M AMSO4",277,"10.1074/jbc.RA120.013939",,"6V08",41.75,"2.58","2.58","Crystal structure of human recombinant Beta-2 glycoprotein I (hrB2GPI)","GRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","6V08"
"6V09",,"X-RAY DIFFRACTION",10.87,88.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 1.5 M AmSO4, 20 mM CaCl2 and 2% glycerol",277,"10.1074/jbc.RA120.013939",,"6V09",41.78,"2.99","2.99","Crystal structure of human recombinant Beta-2 glycoprotein I short tag (ST-B2GPI)","EDQVDPRLIDGKGRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","6V09"
"6V0L",,"SOLUTION NMR",,,,,,,"10.1021/jacs.9b12770",,"6V0L",6.28,,,"PDGFR-b Promoter Forms a G-Vacancy Quadruplex that Can be Complemented by dGMP: Molecular Structure and Recognition of Guanine Derivatives and Metabolites","XAGGGAGGGCGGCGGGACA","Homo sapiens",,"DNA (5'-D(*(3D1)P*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*GP*CP*GP*GP*GP*AP*CP*A)-3')","1","6V0L"
"6V0M",,"X-RAY DIFFRACTION",2.39,48.54,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M sodium citrate tribasic dihydrate pH 5, 25 % (w/v) PEG3350",290,"10.1126/scisignal.aay6318",,"6V0M",24.49,"1.8","1.8","Sterile alpha-motif from apoptosis signal-regulating kinase 3","GPGDKELIDWLRLQGADAKTIEKIVEEGYTLSDILNEITKEDLRYLRLRGGLLCRLWSAVSQYRRAQEASE","Homo sapiens","MAP3K15, ASK3","Mitogen-activated protein kinase kinase kinase 15","1","6V0M"
"6V0Q",,"X-RAY DIFFRACTION",2.33,47.22,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M (NH4)2SO4, 0.05 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","EAE","6V0Q",59.05,"1.69","1.69","Crystal structure of the bromodomain of human BRD7 bound to TG003","ESEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V0Q"
"6V0S",,"X-RAY DIFFRACTION",2.7,54.44,"EVAPORATION",,"0.2 M Li2SO4, 0.1 M HEPES (pH 7.5), 25% w/v PEG 3,350",291,"10.1021/acs.jmedchem.9b01980","EAE","6V0S",29,"2.4","2.4","Crystal structure of the bromodomain of human BRD9 bound to TG003","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6V0S"
"6V0U",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M (NH4)2SO4, 0.1 M Tris (pH 8.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980","BMF","6V0U",15.57,"1.4","1.4","Crystal structure of the first bromodomain (BD1) of human BRD4 bound to bromosporine","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6V0U"
"6V0X",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaCl, 0.1 M Bis-Tris (pH 5.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980","B49","6V0X",14.65,"1.5","1.5","Crystal structure of the bromodomain of human BRD9 bound to sunitinib","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6V0X"
"6V0Z",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, SITTING DROP",,"21% PEG 3350, 0.2 M magnesium chloride, Bis-Tris pH 6.2",293,,,"6V0Z",449.9,"2.02","2.02","Structure of ALDH7A1 mutant R441C complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFCWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6V0Z"
"6V14",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaCl, 0.1 M Bis-Tris (pH 5.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980","QMG","6V14",14.65,"1.7","1.7","Crystal structure of the bromodomain of human BRD9 bound to TP472","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6V14"
"6V16",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M (NH4)2SO4, 0.05 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","QMG","6V16",29.73,"1.9","1.9","Crystal structure of the bromodomain of human BRD7 bound to TP472","ESEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V16"
"6V17",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M (NH4)2SO4, 0.05 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","H1B","6V17",29.82,"2.05","2.05","Crystal structure of the bromodomain of human BRD7 bound to I-BRD9","ESEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V17"
"6V1B",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M KSCN, 30% w/v PEG MME 2,000",291,"10.1021/acs.jmedchem.9b01980","H1B","6V1B",29.56,"1.35","1.35","Crystal structure of the bromodomain of human BRD9 bound to I-BRD9","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6V1B"
"6V1C",,"X-RAY DIFFRACTION",2.24,45.04,"VAPOR DIFFUSION, SITTING DROP",5.6,"2 M NH4SO4, 0.2 M potassium sodium tartrate, and 0.1 M trisodium citrate-citric acid, pH 5.6",298,"10.1038/s41467-020-16223-7",,"6V1C",7.29,"1.55","1.55","Crystal structure of human trefoil factor 3 in complex with its cognate ligand","EEYVGLSANQCAVPAKDRVDCGYPHVTPKECNNRGCCFDSRIPGVPWCFKPLQEAESTLEK","Homo sapiens","TFF3, ITF, TFI","Trefoil factor 3","1","6V1C"
"6V1D",,"X-RAY DIFFRACTION",2.29,46.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"1 M ammonium sulfate, 0.1 M Tris-HCl, pH 8.5",298,"10.1038/s41467-020-16223-7",,"6V1D",16.97,"2.4","2.4","Crystal structure of human trefoil factor 1","QTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTILEK","Homo sapiens","TFF1, BCEI, PS2","Trefoil factor 1","1","6V1D"
"6V1E",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M (NH4)2SO4, 0.05 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","5SW","6V1E",15.01,"2.3","2.3","Crystal structure of the bromodomain of human BRD7 bound to BI7273","GAASEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V1E"
"6V1F",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, HANGING DROP",,"0.05 M (NH4)2SO4, 0.1 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","5U6","6V1F",14.95,"2","2","Crystal structure of the bromodomain of human BRD7 bound to BI9564","GAASEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V1F"
"6V1H",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M (NH4)2SO4, 0.05 M Bis-tris (pH 6.5), and 30 % Pentaerythritol ethoxylate",291,"10.1021/acs.jmedchem.9b01980","BMF","6V1H",15.06,"1.93","1.93","Crystal structure of the bromodomain of human BRD7 bound to bromosporine","GAASEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6V1H"
"6V1K",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M (NH4)2SO4, 0.1 M Tris (pH 8.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980","5SW","6V1K",15.76,"1.75","1.75","Crystal structure of the first bromodomain (BD1) of human BRD4 bound to BI7273","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6V1K"
"6V1L",,"X-RAY DIFFRACTION",1.87,34.23,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M (NH4)2SO4, 0.1 M Tris (pH 8.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980","5U6","6V1L",15.45,"2.1","2.1","Crystal structure of the first bromodomain (BD1) of human BRD4 bound to BI9564","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6V1L"
"6V1U",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M (NH4)2SO4, 0.1 M Tris (pH 8.5), and 25% PEG 3350",291,"10.1021/acs.jmedchem.9b01980",,"6V1U",15.49,"1.73","1.73","Crystal structure of the first bromodomain (BD1) of human BRD4 bound to TP-472","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6V1U"
"6V2U",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris pH 7, 2.5 M Sodium Chloride, 100 mM Magnesium Chloride",293,,,"6V2U",65.27,"3.78","3.78","Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib","GGGRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6V2U"
"6V34",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Sodium Acetate, 0.1 M Tris: HCl, pH 8.5, 30 % (w/v) PEG 4000",293,,,"6V34",65.1,"3.15","3.15","Crystal structure of BRAF V600E oncogenic mutant in complex with TAK-580","GGGRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6V34"
"6V38","3.8","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.51409",,"6V38",509.33,"3.8",,"Cryo-EM structure of Ca2+-bound hsSlo1 channel","MDALIIPVTMEVPCDSRGQRMWWAFLASSMVTFFGGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNGSSQADGTLKPVDEKEEAVAAEVGWMTSVKDWAGVMISAQTLTGRVLVVLVFALSIGALVIYFIDSSNPIESCQNFYKDFTLQIDMAFNVFFLLYFGLRFIAANDKLWFWLEVNSVVDFFTVPPVFVSVYLNRSWLGLRFLRALRLIQFSEILQFLNILKTSNSIKLVNLLSIFISTWLTAAGFIHLVENSGDPWENFQNNQALTYWECVYLLMVTMSTVGYGDVYAKTTLGRLFMVFFILGGLAMFASYVPEIIELIGNRKKYGGSYSAVSGRKHIVVCGHITLESVSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEALFKRHFTQVEFYQGSVLNPHDLARVKIESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSWNWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNEMYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLGFFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRLEDEQPSTLSPKKKQRNGGMRNSPNTSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSGHVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVSILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIGVLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDDDPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEENALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRLRDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCLMQFDSNSLEVLFQ","Homo sapiens","KCNMA1, KCNMA, SLO","Calcium-activated potassium channel subunit alpha-1","1","6V38"
"6V3G","4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.51409",,"6V3G",479.95,"4",,"Cryo-EM structure of Ca2+-free hsSlo1 channel","MDALIIPVTMEVPCDSRGQRMWWAFLASSMVTFFGGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNGSSQADGTLKPVDEKEEAVAAEVGWMTSVKDWAGVMISAQTLTGRVLVVLVFALSIGALVIYFIDSSNPIESCQNFYKDFTLQIDMAFNVFFLLYFGLRFIAANDKLWFWLEVNSVVDFFTVPPVFVSVYLNRSWLGLRFLRALRLIQFSEILQFLNILKTSNSIKLVNLLSIFISTWLTAAGFIHLVENSGDPWENFQNNQALTYWECVYLLMVTMSTVGYGDVYAKTTLGRLFMVFFILGGLAMFASYVPEIIELIGNRKKYGGSYSAVSGRKHIVVCGHITLESVSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEALFKRHFTQVEFYQGSVLNPHDLARVKIESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSWNWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNEMYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLGFFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRLEDEQPSTLSPKKKQRNGGMRNSPNTSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSGHVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVSILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIGVLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDDDPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEENALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRLRDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCLMQFDSNSLEVLFQ","Homo sapiens","KCNMA1, KCNMA, SLO","Calcium-activated potassium channel subunit alpha-1","1","6V3G"
"6V3W",,"X-RAY DIFFRACTION",2.95,58.27,"VAPOR DIFFUSION, HANGING DROP",4,"0.2 M Ammonium acetate, 0.1 M Sodium acetate pH 4, 15% w/v PEG 4000",291.15,"10.1016/j.ccell.2021.06.018",,"6V3W",23.17,"2.04","2.04","Human Poly(ADP-Ribose) Polymerase 12, Catalytic fragment with four point mutations in complex with RBN-2397","SMDSSALPDPGFQKITLSSSSEEYQKVWNLFNRTLPFYFVQKIERVQNLALWEVYQWQKGQMQKQNGGKAVDERQLFHGTSAIVVDGICQHNFDWRVCGVHGTSYGKGSYFARDAAYSHHFSKSDTQTHTMFLARVLVGEFVRGNASFVRPPAKEGWSNAFYDSCVNSVSDPSIFVIFEKHQVYPEYVIQYTTSSKPS","Homo sapiens","PARP12, ZC3HDC1","Protein mono-ADP-ribosyltransferase PARP12","1","6V3W"
"6V4I",,"SOLUTION NMR",,,,,,,,,"6V4I",0.85,,,"DanD","GVFPIPX","Homo sapiens",,"DanD peptide","1","6V4I"
"6V4Q",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"1% w/v PEG 8000, 20% v/v 2-Propanol, 0.1 M Tris, pH 7.5",291,"10.1073/pnas.1922654117",,"6V4Q",48.2,"1.39","1.39","Crystal structure of a MR78-like antibody naive-1 Fab","EVQLVESGGVVVQPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSLISWDGGSTYYADSVKGRFTISRDNSKNSLYLQMSSLRAEDTALYYCASIAAAGSFYYYYYMDVWGKGTTVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Naive-1 Fab heavy chain","1","6V4Q"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCQASQVISNYLNWYQQKPGKAPKLLIYDTSNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYENLQFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Naive-1 Fab light chain","2","6V4Q"
"6V4R",,"X-RAY DIFFRACTION",5,75.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"4.5 M NaCl, 0.1 M HEPES, pH 7.5",287,"10.1073/pnas.1922654117",,"6V4R",47.49,"3.48","3.48","Crystal structure of a chimeric MR78-like antibody chimera-1 Fab","QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSVYYSGGASYNPSLKSRATISVDTSKNQFSLNLDSVSAADTAIYYCASIAAAGSFYYYYYMDVWGKGSTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Chimera-1 Fab heavy chain","1","6V4R"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCQASQVISNYLNWYQQKPGKAPKLLIYDTSNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYENLQFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Chimera-1 Fab light chain","2","6V4R"
"6V52",,"X-RAY DIFFRACTION",2.83,56.52,"VAPOR DIFFUSION",,"from commercial screen",293,"10.1021/acsmedchemlett.0c00010",,"6V52",89.45,"1.78","1.78","IDO1 IN COMPLEX WITH COMPOUND 1","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6V52"
"6V5A",,"X-RAY DIFFRACTION",3.03,59.42,"VAPOR DIFFUSION, HANGING DROP",4.9,"50 mM sodium acetate, 4% (w/v) PEG 4000, 100 mM sodium sulfate, and 100 mM lithium sulfate (pH 4.9)",295,"10.1073/pnas.1908183117",,"6V5A",81.76,"2","2","Crystal structure of the human BK channel gating ring L390P mutant","MGRKHIVVCGHITLESVSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEAPFKRHFTQVEFYQGSVLNPHDLARVKIESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSWNWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNEMYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLGFFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRLEDEQPSTLSPKKKQRNGGMRNSPNTSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSGHVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVSILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIGVLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDDDPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEENALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRLRDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCLMQFDSNSLEVLFQ","Homo sapiens","KCNMA1, KCNMA, SLO","Calcium-activated potassium channel subunit alpha-1","1","6V5A"
"6V5D",,"SOLUTION NMR",,,,,,,"10.1007/s10858-019-00288-8",,"6V5D",8.58,,,"EROS3 RDC and NOE Derived Ubiquitin Ensemble","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","6V5D"
"6V5L",,"SOLUTION NMR",,,,,,,"10.1111/cbdd.13519",,"6V5L",20.05,,,"The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6V5L"
"6V5N",,"X-RAY DIFFRACTION",2.07,40.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 25% PEG3350",298,"10.1021/acs.jmedchem.0c00200",,"6V5N",151.71,"2.4","2.4","EGFR(T790M/V948R) in complex with LN2084","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6V5N"
"6V5P",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 25% PEG3350",298,"10.1021/acs.jmedchem.0c00200",,"6V5P",151.73,"2.3","2.3","EGFR(T790M/V948R) in complex with LN2725","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6V5P"
"6V5T",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5,
25% PEG 8000",298,"10.1074/jbc.RA120.013419",,"6V5T",33.76,"2.1","2.1","Crystal structure of human prethrombin-2 with tryptophans replaced by 5-F-tryptophan","EADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","6V5T"
"6V5V","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2019.12.007",,"6V5V",51.7,"3.8",,"Structure of gamma-tubulin in the native human gamma-tubulin ring complex","MPREIITLQLGQCGNQIGFEFWKQLCAEHGISPEAIVEEFATEGTDRKDVFFYQADDEHYIPRAVLLDLEPRVIHSILNSPYAKLYNPENIYLSEHGGGAGNNWASGFSQGEKIHEDIFDIIDREADGSDSLEGFVLCHSIAGGTGSGLGSYLLERLNDRYPKKLVQTYSVFPNQDEMSDVVVQPYNSLLTLKRLTQNADCLVVLDNTALNRIATDRLHIQNPSFSQINQLVSTIMSASTTTLRYPGYMNNDLIGLIASLIPTPRLHFLMTGYTPLTTDQSVASVRKTTVLDVMRRLLQPKNVMVSTGRDRQTNHCYIAILNIIQGEVDPTQVHKSLQRIRERKLANFIPWGPASIQVALSRKSPYLPSAHRVSGLMMANHTSISSLFERTCRQYDKLRKREAFLEQFRKEDMFKDNFDEMDTSREIVQQLIDEYHAATRPDYISWGTQEQ","Homo sapiens","TUBG1, TUBG","Tubulin gamma-1 chain","1","6V5V"
"6V64",,"X-RAY DIFFRACTION",2.02,39.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M Na/K tartrate pH 7.5
14% PEG 3350",298,"10.1074/jbc.RA120.013419",,"6V64",33.96,"2.29","2.29","Crystal structure of human thrombin bound to ppack with tryptophans replaced by 5-F-tryptophan","ADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","6V64"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","6V64"
"6V66",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 25% PEG3350",298,"10.1021/acs.jmedchem.0c00200",,"6V66",151.92,"1.79","1.79","EGFR(T790M/V948R) in complex with LN2899","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6V66"
"6V6C","4.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2019.12.007",,"6V6C",200.73,"4.5",,"Structure of GCP6 in the native human gamma-tubulin ring complex","MASITQLFDDLCEALLPAAKTHLGQRSVNRKRAKRSLKKVAYNALFTNLFQDETQQLQPDMSKLPARNKILMLSFDLRVGGLGPKADRLEELVEELEAAPCCPLLEVGSVLDLLVQLAGSGPPQVLPRKRDYFLNNKHVGRNVPYSGYDCDDLSVFEMDVQSLISREECLCHSMIQETLQVMEAAPGTGLPTVGLFSFGDPCGDRFERDTRVSLFGALVHSRTYDMDVRLGLPPVPDNADLSGLAIKVPPSVDQWEDEGFQSASNLTPDSQSEPSVTPDVDLWEAALTYEASKRRCWERVGCPPGHREEPYLTEAGRDAFDKFCRLHQGELQLLAGGVLQAPQPVLVKECELVKDVLNVLIGVVSATFSLCQPAQAFVVKRGVHVSGASPESISSLLSEVAEYGTCYTRLSHFSLQPVLDSLYSKGLVFQAFTSGLRRYLQYYRACVLSTPPTLSLLTIGFLFKKLGRQLRYLAELCGVGAVLPGTCGGGPRAAFPTGVKLLSYLYQEALHNCSNEHYPVLLSLLKTSCEPYTRFIHDWVYSGVFRDAYGEFMIQVNHEYLSFRDKLYWTHGYVLISKEVEDCVPVFLKHIAHDIYVCGKTINLLKLCCPRHYLCWSDVPVPRISVIFSLEELKEIEKDCAVYVGRMERVARHSSVSKEEKELRMEIAKQELIAHAREAASRVLSALSDRQMSERMALDARKREQFQRLKEQFVKDQERRQAARQEELDDDFSYARELRDRERRLKSLEEELERKARQALVDHYSKLSAEAARREQKALWRIQRHRLESARLRFLLEDEKHIQEMLKAVSEAHQPQEPPDVLLSVHPQVTSPGPEHPEGGQGCDSGSAEQHSPAWDGWNRPGLLTPQPLKPLAVGAGGRGLQQAEGARPFSDSLSIGDFLPVGPGAEPSVQTGMVPLLEVALQTINLDLPPSAPGEAPAAASTQPSRPQEYDFSTVLRPAVATSPAPGPLQAAECSLGSSGLQLWEDSCGKMDACGSASRETLLPSHPPRRAALEEGSSQPTERLFGQVSGGGLPTGDYASEIAPTRPRWNTHGHVSDASIRVGENVSDVAPTQPRWNTHGHVSNASISLGESVSDVAPTRPRWNIHGHVSNASIRVGENVSDVAPTRPRWNTHGHVSNASIRVGENVSDVAPTRPRWNTHGHVSDASISLGESVSDMAPARPRWNTHGHVSDASISLGESVSDMAPTRPRWNTHGHVSDTSIRVGENVSDVAPIRSRCNTHGHVSDASISLGEPVSDVVSTRPRWNTHVPIPPPHMVLGALSPEAEPNTPRPQQSPPGHTSQSALSLGAQSTVLDCGPRLPVEVGPSLSSPSSGCGEGSISVGENVSDVAPTQPWWPNTPGDSVSEELGPGRSGDTEDLSPNWPLNSQEDTAAQSSPGRGEEAEASAAEAQGGEQAYLAGLAGQYHLERYPDSYESMSEPPIAHLLRPVLPRAFAFPVDPQVQSAADETAVQLSELLTLPVLMKRSITAPLAAHISLVNKAAVDYFFVELHLEAHYEALRHFLLMEDGEFAQSLSDLLFEKLGAGQTPGELLNPLVLNSVLSKALQCSLHGDTPHASNLSLALKYLPEVFAPNAPDVLSCLELRYKVDWPLNIVITEGCVSKYSGVFSFLLQLKLMMWALKDVCFHLKRTALLSHMAGSVQFRQLQLFKHEMQHFVKVIQGYIANQILHVTWCEFRARLATVGDLEEIQRAHAEYLHKAVFRGLLTEKAAPVMNVIHSIFSLVLKFRSQLISQAWGPPGGPRGAEHPNFALMQQSYNTFKYYSHFLFKVVTKLVNRGYQPHLEDFLLRINFNNYYQDA","Homo sapiens","TUBGCP6, GCP6, KIAA1669","Gamma-tubulin complex component 6","1","6V6C"
"6V6D","3.77","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0401-0",,"6V6D",343.78,"3.77",,"Cryo-EM structure of human pannexin 1","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCSNSLEVLFQ","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6V6D"
"6V6K",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 25% PEG3350",298,"10.1021/acs.jmedchem.0c00200",,"6V6K",303.24,"2.2","2.2","EGFR(T790M/V948R) in complex with LN2057","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6V6K"
"6V6L",,"X-RAY DIFFRACTION",2.12,42.06,"VAPOR DIFFUSION, HANGING DROP",,"7-12% (w:v) PEG 6000 and 5-8% MPD (v:v)",290,"10.1016/j.bmcl.2019.126930","QQA","6V6L",47.51,"2.19","2.19","Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one","MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6V6L"
"6V6M",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, HANGING DROP",8.3,"20-24% PEG8K, 15% Dioxane, 0.1M Tris pH8.0",277,"10.1016/j.str.2020.12.015",,"6V6M",21.3,"1.39","1.39","Crystal structure of an inactive state of GMPPNP-bound RhoA","GSMAAIRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA","Homo sapiens","RHOA, ARH12, ARHA, RHO12","Transforming protein RhoA","1","6V6M"
"6V6O",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 25% PEG3350",298,"10.1021/acs.jmedchem.0c00200",,"6V6O",303.34,"2.1","2.1","EGFR(T790M/V948R) in complex with LN2380","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6V6O"
"6V6Q",,"X-RAY DIFFRACTION",1.89,35.01,"VAPOR DIFFUSION, HANGING DROP",8.6,"160mM TMAO, 20% PEG 2000, 100mM Tris pH 8.6",293,,,"6V6Q",187.98,"2.46","2.46","Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657","GSPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEFELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLFVIVEFASKGNLREFLRARRPPGMEFSFDINRVPEEQMTFKDLVSCTFQLARGMEFLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYFKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELFMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","6V6Q"
"6V6U",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, HANGING DROP",8.3,"20-24% PEG8K, 15% Dioxane, 0.1M Tris pH8.0",277,"10.1016/j.str.2020.12.015",,"6V6U",21.22,"1.16","1.16","Crystal structure of RhoA-GDP with novel Switch I conformation","GSMAAIRKKLVIVGDGACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA","Homo sapiens","RHOA, ARH12, ARHA, RHO12","Transforming protein RhoA","1","6V6U"
"6V6V",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, HANGING DROP",8.3,"20-24% PEG8K, 15% Dioxane, 0.1M Tris pH8.0",277,"10.1016/j.str.2020.12.015",,"6V6V",21.26,"1.4","1.4","Crystal structure of oncogenic RhoA mutant G14V complexed with GDP","GSMAAIRKKLVIVGDVACGKTCLLIVNSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQA","Homo sapiens","RHOA, ARH12, ARHA, RHO12","Transforming protein RhoA","1","6V6V"
"6V6Z",,"X-RAY DIFFRACTION",3.07,59.92,"VAPOR DIFFUSION, HANGING DROP",7,"3.5-3.8 M sodium formate, pH 7",289,"10.1021/acsmedchemlett.9b00631","Q5Y","6V6Z",132.03,"1.6","1.6","Crystal structure of N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthalen-1-yl)glycine bound to human Keap1 Kelch domain","SAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6V6Z"
"6V74",,"X-RAY DIFFRACTION",2.34,47.53,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M NaBr, 0.1 M Bis-Tris propane, 20% PEG 3350",293,"10.1074/jbc.RA120.013030","ASN","6V74",244.06,"2.32","2.32","Crystal Structure of Human PKM2 in Complex with L-asparagine","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6V74"
"6V75",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M NaBr, 0.1 M Bis-Tris propane, 18% PEG 3350",293,"10.1074/jbc.RA120.013030",,"6V75",243.71,"2.85","2.85","Crystal Structure of Human PKM2 in Complex with L-aspartate","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6V75"
"6V76",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M NaBr, 0.1 M Bis-Tris propane, 24% PEG 3350",293,"10.1074/jbc.RA120.013030",,"6V76",243.23,"2.75","2.75","Crystal Structure of Human PKM2 in Complex with L-valine","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6V76"
"6V7C",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION",7,"10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000",293,"10.1021/acsmedchemlett.0c00058","QR1","6V7C",210.99,"1.8","1.8","Human Arginase1 Complexed with Bicyclic Inhibitor Compound 3","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6V7C"
"6V7D",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION",7,"10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000",293,"10.1021/acsmedchemlett.0c00058","QR4","6V7D",210.99,"1.82","1.82","Human Arginase1 Complexed with Bicyclic Inhibitor Compound 10","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6V7D"
"6V7E",,"X-RAY DIFFRACTION",2.48,50.3,"VAPOR DIFFUSION",7,"10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000",293,"10.1021/acsmedchemlett.0c00058","QRA","6V7E",211.06,"1.99","1.99","Human Arginase1 Complexed with Bicyclic Inhibitor Compound 12","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6V7E"
"6V7F",,"X-RAY DIFFRACTION",2.46,49.98,"VAPOR DIFFUSION",7,"10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000",293,"10.1021/acsmedchemlett.0c00058","QRJ","6V7F",211.07,"2.02","2.02","Human Arginase1 Complexed with Bicyclic Inhibitor Compound 13","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6V7F"
"6V7M",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, SITTING DROP",5.8,"Crystallization was by sitting drop vapor diffusion in Cryschem plates at room temperature. Reservoirs were 16% to 18 % 2-methyl-2,4-pentanediol (MPD) buffered with 0.1 M sodium acetate at pH 5.8 and including 0.25% octyl-beta-D-1-thioglucopyranoside. The droplets were initial composed of equal amounts of the reservoir and an 8 mg/ml solution of the protein in 0.02 M ammonium carbonate.",298,"10.1016/j.bbrc.2020.01.117",,"6V7M",21.33,"2","2","Crystal structure of a proteolytically cleaved, amino terminal domain of apolipoprotein E3","MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQL","Homo sapiens","APOE","Apolipoprotein E","1","6V7M"
,,,,,,,,,,,,,,,,"TPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAG","Homo sapiens","APOE","Apolipoprotein E","2","6V7M"
"6V7N",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",,"1.8 M Ammonium sulfate, 0.1 M CH3COONa, pH 5.5",298,"10.1194/jlr.RA120000748",,"6V7N",89.24,"2.62","2.62","Crystal Structure of a human Lysosome Resident Glycoprotein, Lysosomal Acid Lipase, and its Implications in Cholesteryl Ester Storage Disease (CESD)","SGGKLTAVDPETNMNVSEIISYWGFPSEEYLVETEDGYILCLNRIPHGRKQHSDKGPKPVVFLQHGLLADSSNWVTNLAQSSLGFILADAGFDVWMGNSRGNTWSRKHKTLSVSQDEFWAFSYDEMAKYDLPASINFILNKTGQEQVYYVGHSQGTTIGFIAFSQIPELAKRIKMFFALGPVASVAFCTSPMAKLGRLPDHLIKDLFGDKEFLPQSAFLKWLGTHVCTHVILKELCGNLCFLLCGFNERNLNMSRVDVYTTHSPAGTSVQNMLHWSQAVKFQKFQAFDWGSSAKNYFHYQQSYPPTYNVKDMLVPTAVWSGGHDWLADVYDVNILLTQITNLVFHESIPEWEHLDFIWGLDAPWRLYNKIINLMRKYQASENNL","Homo sapiens","LIPA","Lysosomal acid lipase/cholesteryl ester hydrolase","1","6V7N"
"6V87",,"X-RAY DIFFRACTION",2.14,42.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3,350, MgCl2, Tris",298,,"OHT","6V87",60.84,"2.4","2.4","Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen","HHHHHHENLYFQSMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6V87"
"6V89",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, pH 7.5, 80-200 mM calcium chloride, 2-6% PEG400",298,"10.1016/j.jbc.2021.100351",,"6V89",41,"2.45","2.45","Human CtBP1 (28-375) in complex with AMP","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNKDHLTAATHWASMDPAVVHPELN","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","6V89"
"6V8A",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, pH 7.5, 80-200 mM calcium chloride, 2-6% PEG400",298,"10.1016/j.jbc.2021.100351",,"6V8A",41.03,"2.35","2.35","Human CtBP1 (28-375) in complex with AMP","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRTGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNKDHLTAATHWASMDPAVVHPELN","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","6V8A"
"6V8B",,"X-RAY DIFFRACTION",2.52,51.09,"VAPOR DIFFUSION, SITTING DROP",5.5,"INDEX F6. 25% PEG3350, 0.2 M Ammonium sulfate, 0.1 M BisTris pH 5.5",277,"10.1002/cmdc.202000007",,"6V8B",40.96,"3.13","3.13","Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 1","MKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTGCMLVELHTQSQDRF","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6V8B"
"6V8C",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, HANGING DROP",,"16.5% PEG 1000
240 mM NaCl
25% glycerol.",293,,,"6V8C",135.74,"1.9","1.9","Design, Synthesis, and Mechanism of Fluorine-substituted Cyclohexene Analogues of GAMA-Aminobutyric Acid (GABA) as Selective Ornithine Aminotransferase Inactivators","GPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","Ornithine aminotransferase, mitochondrial","1","6V8C"
"6V8D",,"X-RAY DIFFRACTION",2.37,48.17,"VAPOR DIFFUSION, HANGING DROP",7.8,"16.5% PEG 1000
240 mM NaCl
25% glycerol
50 mM Tricine pH 7.8",298,,,"6V8D",135.74,"2.25","2.25","Design, Synthesis, and Mechanism of Fluorine-substituted Cyclohexene Analogues of GAMA-Aminobutyric Acid (GABA) as Selective Ornithine Aminotransferase Inactivators","GPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","Ornithine aminotransferase, mitochondrial","1","6V8D"
"6V8F",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES,
0.2 M Lithium sulfate,
25% (m/v) PEG 3350",294,,,"6V8F",100.78,"2.3","2.3","Crystal structure of recombinat mutant Q185R of human fumarase","ASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSRSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK","Homo sapiens","FH","Fumarate hydratase, mitochondrial","1","6V8F"
"6V8K",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",8,"0.24 mM HAT, 0.12 mM CoA, 0.75 mM ligand. 200+150 (+20) nL sitting drops.
Internal focus screen with microseeding. 17.5% MPD, 0.1 M Tris pH 8, 2.5 % PEG3350. Cryo 30% MPD, 5% PEG 3350, 1 mM ligand",277,"10.1002/cmdc.202000007",,"6V8K",38.3,"1.84","1.84","Crystal structure of the p300 acetyltransferase domain with peptide-competitive inhibitor 2","GSKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKESGGSGSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQ","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6V8K"
,,,,,,,,,,,,,,,,,"Homo sapiens","EP300, P300"
"6V8N",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M Ammonium Sulfate, 0.1 M BisTris pH 5.5, 20% PEG 3350, streak-seed with loop",277,"10.1002/cmdc.202000007",,"6V8N",41.08,"2.3","2.3","Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 17","MKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTGCMLVELHTQSQDRF","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6V8N"
"6V8T",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 8000, TRIS pH 7.0, MgCl2",298,"10.7554/eLife.72512","C6V","6V8T",61.01,"2.1","2.1","Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with LSZ102","HHHHHHENLYFQSMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6V8T"
"6V90",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, SITTING DROP",,"INDEX F6. 0.1 M Bis-Tris pH 5.5, 0.2 M ammonium sulfate 25% w/v PEG 3350. The crystal was cryoprotected with MiTeGen Low Viscosity Cryo Oil",277,"10.1002/cmdc.202000007","QSD","6V90",41.03,"2.04","2.04","Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 12","MKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTGCMLVELHTQSQDRF","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6V90"
"6V97",,"X-RAY DIFFRACTION",2.82,56.35,"VAPOR DIFFUSION, HANGING DROP",,"11% PEG 3350 and 0.2 M sodium thiocyanate",277,"10.1182/bloodadvances.2020001575",,"6V97",107.77,"2.381","2.381","Kindlin-3 double deletion mutant short form","MAGMKTASGDYIDSSWELRVFVGEEDPEAESVTLRVTGESHIGGVLLKIVEQINRKQDWSDHAIWWEQKRQWLLQTHWTLDKYGILADARLFFGPQHRPVILRLPNRRALRLRASFSQPLFQAVAAICRLLSIRHPEELSLLRAPEKKEKKKKEKEPEEELYDLSYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSSRCLMQQGIKAGDALWLRFKYYSFFDLDPKTDPVRLTQLYEQARWDLLLEEIDCTEEEMMVFAALQYHINKLSQSGEVGEPAEGLNPYGLVAPRFQRKFKAKQLTPRILEAHQNVAQLSLAEAQLRFIQAWQSLPDFGISYVMVRFKGSRKDEILGIANNRLIRIDLAVGDVVKTWRFSNMRQWNVNWDIRQVAIEFDEHINVAFSCVSASCRIVHEYIGGYIFLSTRERARGEELDEDLFLQLTGGHEAFLEHHHHHH","Homo sapiens","FERMT3, KIND3, MIG2B, URP2","Fermitin family homolog 3","1","6V97"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
"6V9C",,"X-RAY DIFFRACTION",2.3,46.45,"BATCH MODE",,"100 mM Bis-Tris pH 5.5, 14% (w/v) polyethylene glycol 3,350, 200 mM lithium sulfate and 2% (w/v) glycerol",277,"10.1021/acsmedchemlett.9b00601","QS7","6V9C",34.58,"1.9","1.9","Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6V9C"
"6V9G",,"X-RAY DIFFRACTION",3.06,59.83,"VAPOR DIFFUSION, HANGING DROP",,"0.2M potassium nitrate, 12% PEG3350, 30% glycerol",277,"10.1182/bloodadvances.2020001575",,"6V9G",113.79,"2.35","2.35","Kindlin-3 double deletion mutant long form","MAGMKTASGDYIDSSWELRVFVGEEDPEAESVTLRVTGESHIGGVLLKIVEQINRKQDWSDHAIWWEQKRQWLLQTHWTLDKYGILADARLFFGPQHRPVILRLPNRRALRLRASFSQPLFQAVAAICRLLSIRHPEELSLLRAPEKKEKKKKEKEPEEELYDLSYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSSRCLMQQGIKAGDALWLRFKYYSFFDLDPKTDPVRLTQLYEQARWDLLLEEIDCTEEEMMVFAALQYHINKLSQSGEVGEPAGTDPGLDDLDVALSNLEVKLEGSAPTDVLAEGLNPYGLVAPRFQRKFKAKQLTPRILEAHQNVAQLSLAEAQLRFIQAWQSLPDFGISYVMVRFKGSRKDEILGIANNRLIRIDLAVGDVVKTWRFSNMRQWNVNWDIRQVAIEFDEHINVAFSCVSASCRIVHEYIGGYIFLSTRERARGEELDEDLFLQLTGGHEAFLEHHHHHH","Homo sapiens","FERMT3, KIND3, MIG2B, URP2","Fermitin family homolog 3","1","6V9G"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
"6V9T",,"X-RAY DIFFRACTION",2.14,42.53,"VAPOR DIFFUSION, SITTING DROP",,"1.2 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",291,"10.1038/s41467-022-33229-5",,"6V9T",18.59,"2.154","2.154","Tudor domain of TDRD3 in complex with a small molecule","MHHHHHHSSGRENLYFQGKMWKPGDECFALYWEDNKFYRAEVEALHSSGMTAVVKFIDYGNYEEVLLSNIKPIQTE","Homo sapiens","TDRD3","Tudor domain-containing protein 3","1","6V9T"
"6V9U",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M magnesium formate, 20% (w/v) PEG 3,350, 10 mM praseodymium(III) acetate hydrate",293,"10.1021/acsmedchemlett.0c00264",,"6V9U",194.84,"2.65","2.65","Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 14c","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","6V9U"
"6V9V","2.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2480-9",,"6V9V",511.91,"2.6",,"Structure of TRPA1 modified by Bodipy-iodoacetamide with bound calcium, LMNG","MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6V9V"
"6V9W","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2480-9",,"6V9W",510.75,"3.1",,"Structure of TRPA1 (ligand-free) with bound calcium, LMNG","MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6V9W"
"6V9X","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2480-9",,"6V9X",510.81,"3.3",,"Structure of TRPA1 modified by iodoacetamide, PMAL-C8","MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6V9X"
"6V9Y","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2480-9",,"6V9Y",510.59,"3.6",,"Structure of TRPA1 bound with A-967079, PMAL-C8","MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6V9Y"
"6VA0",,"X-RAY DIFFRACTION",5.91,79.18,"VAPOR DIFFUSION, SITTING DROP",6.5,"MES, PEG4000, Magnesium chloride, AG1",293,"10.1073/pnas.2022790118",,"6VA0",59.96,"3.1","3.1","Crystal structure of glucose-6-phosphate dehydrogenase W509A mutant in complex with catalytic NADP+","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKAVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6VA0"
"6VA1",,"SOLUTION NMR",,,,,,,"10.1021/jacs.0c00768",,"6VA1",6.71,,,"Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element","CCGGCAGUGUG","Homo sapiens",,"RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3')","1","6VA1"
,,,,,,,,,,,,,,,,"CACACGUCGG","Homo sapiens",,"RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3')","2","6VA1"
"6VA2",,"SOLUTION NMR",,,,,,,"10.1021/jacs.0c00768",,"6VA2",7.12,,,"Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MH5","CCGGCAGUGUG","Homo sapiens",,"RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3')","1","6VA2"
,,,,,,,,,,,,,,,,"CACACGUCGG","Homo sapiens",,"RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3')","2","6VA2"
"6VA3",,"SOLUTION NMR",,,,,,,"10.1021/jacs.0c00768",,"6VA3",7.02,,,"Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MQC","CCGGCAGUGUG","Homo sapiens",,"RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3')","1","6VA3"
,,,,,,,,,,,,,,,,"CACACGUCGG","Homo sapiens",,"RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3')","2","6VA3"
"6VA4",,"SOLUTION NMR",,,,,,,"10.1021/jacs.0c00768",,"6VA4",7.08,,,"Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MIP","CCGGCAGUGUG","Homo sapiens",,"RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3')","1","6VA4"
,,,,,,,,,,,,,,,,"CACACGUCGG","Homo sapiens",,"RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3')","2","6VA4"
"6VA5",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 0.1 M HEPES pH 7.5, 2% PEG 400",291,,,"6VA5",14.79,"1.28","1.28","Tudor Domain of Tumor suppressor p53BP1 with MFP-4184","GGNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLGPYE","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6VA5"
"6VA7",,"X-RAY DIFFRACTION",5.9,79.14,"VAPOR DIFFUSION, SITTING DROP",,"MES, magnesium chloride, PEG3350, NADP",293,"10.1073/pnas.2022790118",,"6VA7",60.09,"3.07","3.07","Crystal structure of glucose-6-phosphate dehydrogenase P396L mutant in complex with catalytic NADP+","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQLNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6VA7"
"6VA8",,"X-RAY DIFFRACTION",6.01,79.54,"VAPOR DIFFUSION, SITTING DROP",,"MES, magnesium chloride, PEG3350, NADP",293,"10.1073/pnas.2022790118",,"6VA8",60.04,"3.95","3.95","Crystal structure of glucose-6-phosphate dehydrogenase F381L mutant in complex with catalytic NADP+","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDILHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6VA8"
"6VA9",,"X-RAY DIFFRACTION",5.88,79.07,"VAPOR DIFFUSION, SITTING DROP",,"MES, magnesium chloride, PEG3350, NADP",293,"10.1073/pnas.2022790118",,"6VA9",60.06,"3.95","3.95","Crystal structure of glucose-6-phosphate dehydrogenase R393H mutant in complex with catalytic NADP+","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIHVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6VA9"
"6VAH",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",7,"3.5M Na Formate, and 0.1M Bis-Tris Propane pH7.0",293,,,"6VAH",55.61,"2.11","2.11","Crystal structure of human TEAD2 transcription factor in complex with Flufenamic acid derivative","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6VAH"
"6VAI","3.68","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0369-9",,"6VAI",869.33,"3.68",,"Cryo-EM structure of a dimer of undecameric human CALHM2","MSAWSHPQFEKGGGSGGGSGGSAWSHPQFEKGGTGAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPS","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6VAI"
"6VAJ",,"X-RAY DIFFRACTION",2.03,39.42,"VAPOR DIFFUSION, SITTING DROP",,"100mM HEPES-7.5, 3.0M ammonium sulfate",293,"10.1038/s41589-021-00786-7",,"6VAJ",20.51,"1.42","1.42","Crystal Structure Analysis of human PIN1","GSHMARGCRNSARGKMADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEQITRTQEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","6VAJ"
"6VAK","3.48","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0369-9",,"6VAK",412.16,"3.48",,"Cryo-EM structure of human CALHM2","MAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPSGSAWSHPQFEK","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6VAK"
"6VAQ",,"X-RAY DIFFRACTION",6,79.49,"VAPOR DIFFUSION, SITTING DROP",,"MES, magnesium chloride, PEG3350, NADP",293,"10.1073/pnas.2022790118",,"6VAQ",60.09,"2.95","2.95","Crystal structure of glucose-6-phosphate dehydrogenase V394L mutant in complex with catalytic NADP+","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRLQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6VAQ"
"6VBA",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"2mM TRIS pH 8.5, 20 mM Mgcl2, 21% PEG8000, ATA inhibitor was co-crystallized with the UDG protein with a concentration of circa 4mM in solution",291,"10.1016/j.pbiomolbio.2021.02.004",,"6VBA",25.97,"1.8","1.8","Structure of human Uracil DNA Glycosylase (UDG) bound to Aurintricarboxylic acid (ATA)","MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG1, UNG15","Uracil-DNA glycosylase","1","6VBA"
"6VBE",,"X-RAY DIFFRACTION",2.86,57.1,"LIQUID DIFFUSION",,"0.2 M Amonium tartrate dibasic,
14% (m/v) PEG 3350",294,,,"6VBE",100.74,"1.899","1.899","Crystal structure of recombinant mutant H180R of human fumarase","ASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDRVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK","Homo sapiens","FH","Fumarate hydratase, mitochondrial","1","6VBE"
"6VBI",,"X-RAY DIFFRACTION",2.51,51.07,"EVAPORATION",,"8% PEG3350, 0.2 M ammonium acetate, 0.1 M Na Acetate, pH 4.6",298,,,"6VBI",76.05,"2.30000752706","2.30000752706","crystal structure of PDE5 in complex with a non-competitive inhibitor","EETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","6VBI"
"6VBN",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES pH 6.0, 16-19% PEG 6000, 0.2 M calcium chloride, 3% ethylene glycol",277,"10.1021/acsmedchemlett.0c00004",,"6VBN",185.53,"3.18","3.18","Crystal Structure of hTDO2 bound to inhibitor GNE1","MGSLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFGNSDYKDDDDK","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","6VBN"
"6VC8",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",,"32% PEG 4000, 800 mM LiCl, 100 mM Magnesium Chloride and 100 mM Tris pH 8.5",293,"10.1073/pnas.2113297119",,"6VC8",59.63,"2.5","2.5","Crystal structure of wild-type KRAS4b(1-169) in complex with GMPPNP and Mg ion","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6VC8"
"6VCJ",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, SITTING DROP",7.4,"Protein solution: 9mg/ml in 50mM NaCl, 10mM Tris, 5mM NADP+, 10mM 2,4-diaminopyrimidine, 20mM R-Naproxen
Mother Liquor: 20% PEG 20,000",293,"10.1021/acs.jmedchem.0c00546","NPX","6VCJ",92.25,"2.34","2.34","Crystal structure of hsDHFR in complex with NADP+, DAP, and R-naproxen","GMVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","6VCJ"
"6VCU",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, HANGING DROP",4.6,"2.5M Ammonium sulfate, 0.1M Sodium acetate trihydrate",293,,,"6VCU",52.74,"1.69","1.69","Homo sapiens FKBP12 protein bound with APX879 in P32 space group","GSHMGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","6VCU"
"6VED",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa520",,"6VED",19.48,,,"Solution structure of the TTD and linker region of UHRF1","GLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGEGSPMVDNPMRRKSGP","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","6VED"
"6VEI",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, SITTING DROP",4,"20% PEG 3350, 8% Tacsimate pH 4.0",293,"10.1021/acsmedchemlett.9b00509","9UO","6VEI",99.59,"2.1","2.1","Crystal Structure of Human Cytosolic Isocitrate Dehydrogenase (IDH1) R132H Mutant in Complex with NADPH and AG-881 (Vorasidenib) Inhibitor","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6VEI"
"6VEO",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG3350, 0.25 M ammonium sulfate, 0.1 M Bis-Tris, pH 5.5",277,"10.1021/acs.jmedchem.0c01178",,"6VEO",16.53,"2.4","2.4","ATAD2B bromodomain in complex with 4-({[(3R,4R)-4-{[3-methyl-5-(5-methylpyridin-3-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl]amino}piperidin-3-yl]oxy}methyl)-1lambda~6~-thiane-1,1-dione (compound 38)","GPLEDQEENTLRELRLFLRDVTKRLATDKRFNIFSKPVDIEEVSDYLEVIKEPMDLSTVITKIDKHNYLTAKDFLKDIDLICSNALEYNPDKDPGDKIIRHRACTLKDTAHAIIAAELDPEFNKLCEEIKEARIKR","Homo sapiens","ATAD2B, KIAA1240","ATPase family AAA domain-containing protein 2B","1","6VEO"
"6VER",,"X-RAY DIFFRACTION",1.82,32.43,"VAPOR DIFFUSION, SITTING DROP",,"Well condition: 100 mM Tri-HCl (pH 8.5) + 0.28 M magnesium formate. Protein: The insulin analog was prepared in a mixture that also contained receptor fragments: 5 mg/ml (IR310.T).Fv83-7 in 10mM HEPES-NaOH (pH7.5) + 0.02% NaN3 plus three mol equivalents of the IR-A alphaCT peptide 704-719 plus 1.8 mol equivalents of the analog. The analog crystallized in isolation from the receptor fragments and it is not known whether the receptor fragments aided crystallization",300,,,"6VER",4.97,"1.047","1.047","Human insulin analog: [GluB10,TyrB20]-DOI","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6VER"
,,,,,,,,,,,,,,,,"FVNQHLCGSELVEALYLVCYER","Homo sapiens","INS","Insulin B chain","2","6VER"
"6VES",,"X-RAY DIFFRACTION",1.85,33.57,"VAPOR DIFFUSION, SITTING DROP",,"WELL CONDITION: 0.2 M calcium acetate, 0.1 M imidazole (pH 8) + 10% w/v PEG 8000
Protein was provided as a sample comprising 5 mg/ml (IR310.T).Fv83-7 in 10mM HEPES-NaOH (pH7.5) + 0.02% NaN3 plus three mol equivalents of the IR-A alphaCT peptide 704-719 plus 1.8 mol of the analog",300,,,"6VES",4.97,"1.85","1.85","Human insulin analog: [GluB10,HisA8,ArgA9]-DOI","GIVEQCCHRICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6VES"
,,,,,,,,,,,,,,,,"FVNQHLCGSELVEALYLVCGER","Homo sapiens","INS","Insulin B chain","2","6VES"
"6VET",,"X-RAY DIFFRACTION",1.95,37.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"Well condition: 0.3 M magnesium formate plus  0.1 M TrisHCl. Protein: The insulin analog was prepared in a mixture that also contained receptor fragments: 5 mg/ml (IR310.T).Fv83-7 in 10mM HEPES-NaOH (pH7.5) + 0.02% NaN3 plus three mol equivalents of the IR-A alphaCT peptide 704-719 plus 1.8 mol equivalents of the analog. The analog crystallized in isolation from the receptor fragments and it is not known whether the receptor fragments aided crystallization",300,"10.1038/s41594-020-0430-8",,"6VET",15.24,"1.46","1.46","Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI","GIVEQCCHRICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6VET"
,,,,,,,,,,,,,,,,"FVNQHLCGSELVEALYLVCYER","Homo sapiens","INS","Insulin B chain","2","6VET"
"6VFE","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-021-03478-3",,"6VFE",886.06,"3.9",,"Gasdermin D pore","MGSAFERVVRRVVQELDHGGEFIPVTSLQSSTGFQPYCLVVRKPSSSWFWKPRYKCVNLSIKDILEPDAAEPDVQRGRSFHFYDAMDGQIQGSVELAAPGQAKIAGGAAVSDSSSTSMNVYSLSVDPNTWQTLLHERHLRQPEHKVLQQLRSRGDNVYVVTEVLQTQKEVEVTRTHKREGSGRFSLPGATCEQGEGQGHLSQKKTVTIPSGSTLAFRVAQLVIDSDLDVLLFPDKKQRTFQ","Homo sapiens","GSDMD, DFNA5L, GSDMDC1, FKSG10","Gasdermin-D, N-terminal","1","6VFE"
"6VFP",,"X-RAY DIFFRACTION",4.99,75.34,"VAPOR DIFFUSION, HANGING DROP",8.5,"8.5% (w/v) PEG 4000, 20% (v/v) glycerol, 0.1M tris-bicine buffer pH8.5, 0.02 M D-glucose, 0.02 M D-mannose, 0.02 M D-galactose, 0.02 M L-fucose, 0.02 M D-xylose, 0.02 M N-acetyl-D-glucosamine",296,"10.1016/j.celrep.2020.02.003",,"6VFP",50.12,"3.2","3.2","Crystal structure of human protocadherin 1 EC1-EC4","TRVVYKVPEEQPPNTLIGSLAADYGFPDVGHLYKLEVGAPYLRVDGKTGDIFTTETSIDREGLRECQNQLPGDPCILEFEVSITDLVQNGSPRLLEGQIEVQDINDNTPNFASPVITLAIPENTNIGSLFPIPLASDRDAGPNGVASYELQAGPEAQELFGLQVAEDQEEKQPQLIVMGNLDRERWDSYDLTIKVQDGGSPPRASSALLRVTVLDTNDNAPKFERPSYEAELSENSPIGHSVIQVKANDSDQGANAEIEYTFHQAPEVVRRLLRLDRNTGLITVQGPVDREDLSTLRFSVLAKDRGTNPKSARAQVVVTVKDMNDNAPTIEIRGIGLVTHQDGMANISEDVAEETAVALVQVSDRDEGENAAVTCVVAGDVPFQLRQASETGSDSKKKYFLQTTTPLDYEKVKDYTIEIVAVDSGNPPLSSTNSLKVQVVDHHHHHH","Homo sapiens","PCDH1","Protocadherin-1","1","6VFP"
"6VFQ",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, HANGING DROP",4.6,"14% PEG 400 (v/v), 0.1M sodium acetate pH 4.6, 0.1M CaCl2, with 30% ethylene glycol (v/v) added as cryoprotectant",296,"10.1016/j.celrep.2020.02.003",,"6VFQ",49.91,"2.3","2.3","Crystal structure of monomeric human protocadherin 10 EC1-EC4","SQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYLDLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDREQQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEESPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKSIQVQVSDHHHHHH","Homo sapiens","PCDH10, KIAA1400","Protocadherin-10","1","6VFQ"
"6VFR",,"X-RAY DIFFRACTION",4.13,70.21,"VAPOR DIFFUSION, HANGING DROP",6.5,"13% (w/v) PEG 20 000, 0.1M MES pH 6.5, with 30% (v/v) ethylene glycol added as cryoprotectant",296,"10.1016/j.celrep.2020.02.003",,"6VFR",102.37,"2.79","2.79","Crystal structure of human protocadherin 18 EC1-EC4","KNLKYRIYEEQRVGSVIARLSEDVADVLLKLPNPSTVRFRAMQRGNSPLLVVNEDNGEISIGATIDREQLCQKNLNCSIEFDVITLPTEHLQLFHIEVEVLDINDNSPQFSRSLIPIEISESAAVGTRIPLDSAFDPDVGENSLHTYSLSANDFFNIEVRTRTDGAKYAELIVVRELDRELKSSYELQLTASDMGVPQRSGSSILKISISDSNDNSPAFEQQSYIIQLLENSPVGTLLLDLNATDPDEGANGKIVYSFSSHVSPKIMETFKIDSERGHLTLFKQVDYEITKSYEIDVQAQDLGPNSIPAHCKIIIKVVDVNDNKPEININLMSPGKEEISYIFEGDPIDTFVALVRVQDKDSGLNGEIVCKLHGHGHFKLQKTYENNYLILTNATLDREKRSEYSLTVIAEDRGTPSLSTVKHFTVQINDHHHHHH","Homo sapiens","PCDH18, KIAA1562","Protocadherin-18","1","6VFR"
"6VFT",,"X-RAY DIFFRACTION",3.09,60.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"13%(w/v) PEG 4000
0.3M NaCl
0.1M MES pH 6.5
30% PEG 400 (v/v) added as cryoprotectant",296,"10.1016/j.celrep.2020.02.003",,"6VFT",204.44,"3.71","3.71","Crystal structure of human delta protocadherin 17 EC1-EC4","LKNLNYSVPEEQGAGTVIGNIGRDARLQPGLPPAERGGGGRSKSGSYRVLENSAPHLLDVDADSGLLYTKQRIDRESLCRHNAKCQLSLEVFANDKEICMIKVEIQDINDNAPSFSSDQIEMDISENAAPGTRFPLTSAHDPDAGENGLRTYLLTRDDHGLFGLDVKSRGDGTKFPELVIQKALDREQQNHHTLVLTALDGGEPPRSATVQINVKVIDSNDNSPVFEAPSYLVELPENAPLGTVVIDLNATDADEGPNGEVLYSFSSYVPDRVRELFSIDPKTGLIRVKGNLDYEENGMLEIDVQARDLGPNPIPAHCKVTVKLIDRNDNAPSIGFVSVRQGALSEAAPPGTVIALVRVTDRDSGKNGQLQCRVLGGGGTGGGGGLGGPGGSVPFKLEENYDNFYTVVTDRPLDRETQDEYNVTIVARDGGSPPLNSTKSFAIKILDHHHHHH","Homo sapiens","PCDH17, PCDH68, PCH68","Protocadherin-17","1","6VFT"
"6VFU",,"X-RAY DIFFRACTION",3.81,67.75,"VAPOR DIFFUSION, HANGING DROP",6.5,"7%(w/v) PEG 4000
0.2M NaCl
0.05M MES pH6.5
15% (v/v) 2R,3R-butanediol added as cryoprotectant",296,"10.1016/j.celrep.2020.02.003",,"6VFU",144.83,"3.5","3.5","Crystal structure of human protocadherin 19 EC1-EC4","LINLKYSVEEEQRAGTVIANVAKDAREAGFALDPRQASAFRVVSNSAPHLVDINPSSGLLVTKQKIDRDLLCRQSPKCIISLEVMSSSMEICVIKVEIKDLNDNAPSFPAAQIELEISEAASPGTRIPLDSAYDPDSGSFGVQTYELTPNELFGLEIKTRGDGSRFAELVVEKSLDRETQSHYSFRITALDGGDPPRLGTVGLSIKVTDSNDNNPVFSESTYAVSVPENSPPNTPVIRLNASDPDEGTNGQVVYSFYGYVNDRTRELFQIDPHSGLVTVTGALDYEEGHVYELDVQAKDLGPNSIPAHCKVTVSVLDTNDNPPVINLLSVNSELVEVSESAPPGYVIALVRVSDRDSGLNGRVQCRLLGNVPFRLQEYESFSTILVDGRLDREQHDQYNLTIQARDGGVPMLQSAKSFTVLITDHHHHHH","Homo sapiens","PCDH19, KIAA1313","Protocadherin-19","1","6VFU"
"6VFV",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 20 000 (w/v), 20% (v/v) PEG 550 monomethylether, 0.03M diethyleneglycol, 0.03M triethyleneglycol, 0.03M tetraethyleneglycol, 0.03M pentaethyleneglycol, 0.1M MES/imidazole buffer pH 6.5",296,"10.1016/j.celrep.2020.02.003",,"6VFV",25.93,"2.9","2.9","Crystal structure of human protocadherin 8 EC5-EC6","ENDNAPLFTRPVYEVSVRENNPPGAYLATVAARDRDLGRNGQVTYRLLEAEVGRAGGAVSTYVSVDPATGAIYALRSFDYETLRQLDVRIQASDGGSPQLSSSALVQVRVLDQNDHAPVLVHPAPANGSLEVAVPGRTAKDTVVARVQARDADEGANGELAFELQQQEPREAFAIGRRTGEILLTGDLSQEPPGRVFRALLVISDGGRPPLTTTATVSFVVTAHHHHHH","Homo sapiens","PCDH8","Protocadherin-8","1","6VFV"
"6VFW",,"X-RAY DIFFRACTION",4.87,74.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.1M Tris-bicine buffer pH8.5, 10% 0.02 M D-glucose, 0.02 M D-mannose, 0.02 M D-galactose, 0.02 M L-fucose, 0.02 M D-xylose, 0.02 M N-acetyl-D-glucosamine with no further cryoprotection",296,"10.1016/j.celrep.2020.02.003",,"6VFW",250.44,"3.6","3.6","Crystal structure of human delta protocadherin 10 EC1-EC4","SQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYLDLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDREQQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEESPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKSIQVQVSDHHHHHH","Homo sapiens","PCDH10, KIAA1400","Protocadherin-10","1","6VFW"
"6VFZ",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"200 mM CaCl2, 0.1M Tris-HCL pH8.5, 20% (w/v)  PEG 4000",291,"10.1021/acsmedchemlett.9b00509","9UO","6VFZ",105.6,"1.99","1.99","Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with NADPH and AG-881 (Vorasidenib) Inhibitor.","MAGYLRVVRSLCRASGSRPAWAPAALTAPTSQEQPRRHYADKRIKVAKPVVEMDGDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIQNILGGTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQHHHHHH","Homo sapiens","IDH2","Isocitrate dehydrogenase [NADP], mitochondrial","1","6VFZ"
"6VG0",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.25 M ammonium sulfate, 0.1M sodium citrate pH 5.6, 23% PEG 4000",291,"10.1021/acsmedchemlett.9b00509","QWM","6VG0",147.43,"2.66","2.66","CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC ISOCITRATE DEHYDROGENASE (IDH1) R132H MUTANT IN COMPLEX WITH NADPH and AGI-15056","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6VG0"
"6VG3",,"X-RAY DIFFRACTION",2.36,48,"VAPOR DIFFUSION, HANGING DROP",6.5,"11 mg/ml protein, 100 mM ADA (pH 6.5), 100 mM (NH4)2SO4, 30% (w/v) PEG monoethyl ether 5000",293.15,,,"6VG3",99.85,"1.95","1.95","Structure of unliganded, inactive PTK7 kinase domain","SGPAATNKRHSTSDKMHFPRSSLQPITTLGKSEFGEVFLAKAQGLEEGVAETLVLVKSLQSKDEQQQLDFRRELEMFGKLNHANVVRLLGLCREAEPHYMVLEYVDLGDLKQFLRISKSKDEKLKSQPLSTKQKVALCTQVALGMEHLSNNRFVHKDLAARNCLVSAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAILEGDFSTKSDVWAFGVLMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWALSPKDRPSFSEIASALGDSTVDSK","Homo sapiens","PTK7, CCK4","Inactive tyrosine-protein kinase 7","1","6VG3"
"6VG4",,"X-RAY DIFFRACTION",6.72,81.7,"VAPOR DIFFUSION, HANGING DROP",5,"0.22M CaCl2, 0.1M Na Acetate pH 5.0 with 30% (v/v) glycerol as cryoprotectant and glutaraldehyde (0.5% v/v) added to the reservoir after crystal formation to aid crystal stability by cross-linking",296,"10.1016/j.celrep.2020.02.003",,"6VG4",75.53,"3.298","3.298","Human protocadherin 10 ectodomain","SQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYLDLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDREQQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEESPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKSIQVQVSDVNDNAPRFSQPVYDVYVTENNVPGAYIYAVSATDRDEGANAQLAYSILECQIQGMSVFTYVSINSENGYLYALRSFDYEQLKDFSFQVEARDAGSPQALAGNATVNILIVDQNDNAPAIVAPLPGRNGTPAREVLPRSAEPGYLLTRVAAVDADDGENARLTYSIVRGNEMNLFRMDWRTGELRTARRVPAKRDPQRPYELVIEVRDHGQPPLSSTATLVVQLVDHHHHHH","Homo sapiens","PCDH10, KIAA1400","Protocadherin-10","1","6VG4"
"6VGC",,"X-RAY DIFFRACTION",3.18,61.31,"VAPOR DIFFUSION",6.5,"100 mM MES pH 6.5, 26% PEG 350 MME, 200 mM Calcium Chloride, 1 mM DG-031",298,"10.1016/j.bbagen.2020.129800",,"6VGC",118.5,"2.37","2.37","Crystal Structures of FLAP bound to DG-031","MSLDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQVPAAFAGLMYLFVRQKYFVGYLGERTQSTPGYIFGKRIILFLFLMSVAGIFNYYLIFFFGSDFENYIATISTTISPLLLIPEGHHHHHH","Homo sapiens","ALOX5AP, FLAP","5-lipoxygenase-activating protein","1","6VGC"
"6VGH",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3,350, Tris pH 7.5, MgCl2",298.15,,"C3D","6VGH",60.9,"2.1","2.1","Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene","HHHHHHENLYFQSMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6VGH"
"6VGI",,"X-RAY DIFFRACTION",3.29,62.57,"VAPOR DIFFUSION",4.6,"28% PEG 550 MME, 200 mM Ammonium Sulfate, 100mM Sodium Acetate pH 4.6, 1 mM MK-886",298,"10.1016/j.bbagen.2020.129800",,"6VGI",119.28,"2.61","2.61","Crystal Structures of FLAP bound to MK-866","MSLDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQVPAAFAGLMYLFVRQKYFVGYLGERTQSTPGYIFGKRIILFLFLMSVAGIFNYYLIFFFGSDFENYIATISTTISPLLLIPEGHHHHHH","Homo sapiens","ALOX5AP, FLAP","5-lipoxygenase-activating protein","1","6VGI"
"6VGJ",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, HANGING DROP",3.5,"0.1 M Citric acid pH 3.5, 14% w/v PEG 1000",298,"10.1107/S2059798320011687",,"6VGJ",71.78,"2.52","2.52","N-terminal variant of CXCL13","MEVYYTSLRCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKNKSIVCVDPQAEWIQRMMEVLRKRSSSTLPVPVFKRKIP","Homo sapiens","CXCL13, BCA1, BLC, SCYB13","C-X-C motif chemokine 13","1","6VGJ"
"6VGL",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, pH 5.5, 0.2 M sodium chloride, 25% PEG3350",291,"10.1021/acs.jmedchem.0c01952",,"6VGL",147.05,"1.9","1.9","JAK2 JH1 in complex with ruxolitinib","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VGL"
"6VGO",,"X-RAY DIFFRACTION",1.96,37.29,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M calcium acetate, 0.1 M sodium acetate pH 4.5, 10% w/v PEG4000",297,"10.1016/j.jsb.2020.107512",,"6VGO",53.75,"1.82","1.82","Crystal Structure of Human Dipeptidase 3","MQPTGREGSRALSRRYLRRLLLLLLLLLLRQPVTRAETTPGAPRALSTLGSPSLFTTPGVPSALTTPGLTTPGTPKTLDLRGRAQALMRSFPLVDGHNDLPQVLRQRYKNVLQDVNLRNFSHGQTSLDRLRDGLVGAQFWSASVSCQSQDQTAVRLALEQIDLIHRMCASYSELELVTSAEGLNSSQKLACLIGVEGGHSLDSSLSVLRSFYVLGVRYLTLTFTCSTPWAESSTKFRHHMYTNVSGLTSFGEKVVEELNRLGMMIDLSYASDTLIRRVLEVSQAPVIFSHSAARAVCDNLLNVPDDILQLLKKNGGIVMVTLSMGVLQCNLLANVSTVADHFDHIRAVIGSEFIGIGGNYDGTGRFPQGLEDVSTYPVLIEELLSRSWSEEELQGVLRGNLLRVFRQVEKVREESRAQSPVEAEFPYGQLSTSCHSHLVPQNGHQATHLEVTKQPTNRVPWRSSNASPYLVPGLVAAATIPTFTQWLC","Homo sapiens","DPEP3, UNQ834/PRO1772","Dipeptidase 3","1","6VGO"
"6VH4",,"X-RAY DIFFRACTION",3.51,65,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.4 M Sodium Citrate, 0.1 M MES",298,"10.1021/acs.jmedchem.0c00200",,"6VH4",37.79,"2.8","2.8","Wild type EGFR in complex with LN2380","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6VH4"
"6VH7","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.01.027",,"6VH7",69.65,"3.8",,"Doublet Tau Fibril from Corticobasal Degeneration Human Brain Tissue","KVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRE","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6VH7"
"6VHA","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.01.027",,"6VHA",34.83,"4.3",,"Singlet Tau Fibril from Corticobasal Degeneration Human Brain Tissue","KVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRE","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6VHA"
"6VHG",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.8M ammonium sulfate, 0.1M sodium acetate pH 4.6",293.15,"10.1021/acsmedchemlett.0c00015","QX1","6VHG",36.5,"2.303","2.303","Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrazolo[1,5-a]pyrimidine inhibitor","GASVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6VHG"
"6VHI",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, SITTING DROP",5.5,"1 M ammonium sulfate and 0.15 M trisodium citrate-citric acid, pH 5.5",293,"10.1016/j.heliyon.2020.e04115",,"6VHI",13.38,"2.46","2.46","Crystal structure of the human ILRUN Fw domain","DFESPNISVPSMSFVEDVTIGEGESIPPDTQFVKTWRIQNSGAEAWPPGVCLKYVGGDQFGHVNMVMVRSLEPQEIADVSVQMCSPSRAGMYQGQWRMCTATGLYYGDVIWVILSVEVGGLL","Homo sapiens","ILRUN, C6orf106","Protein ILRUN","1","6VHI"
"6VHL","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.01.027",,"6VHL",17.04,"3.3",,"Paired Helical Filament from Alzheimer's Disease Human Brain Tissue","GSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRE","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6VHL"
"6VHN",,"X-RAY DIFFRACTION",3.54,65.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.4M Sodium Citrate, 0.1 M MES",298,"10.1021/acs.jmedchem.0c00200",,"6VHN",37.78,"2.4","2.4","Wild type EGFR in complex with LN2057","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6VHN"
"6VHP",,"X-RAY DIFFRACTION",3.46,64.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.4M Sodium Citrate, 0.1 M MES",298,"10.1021/acs.jmedchem.0c00200",,"6VHP",37.83,"3.6","3.6","Wild type EGFR in complex with LN2899","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6VHP"
"6VI2",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris pH 8.5, 25% (w/v) Polyethylene glycol 3350",292,"10.1107/S2059798320009912",,"6VI2",98.62,"1.15","1.15","Structure of the unaligned Fab4","SDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQSVSYMGPLTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"FAB4 light chain","1","6VI2"
,,,,,,,,,,,,,,,,"ECEISEVQLVESGGGLVQPGGSLRLSCAASGFNFYSSYIHWVRQAPGKGLEWVASISPYSGSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYSWPWVSYKPYYGLHFSAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"FAB4 heavy chain","2","6VI2"
"6VI3","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.01.027",,"6VI3",16.89,"3.3",,"Straight Filament from Alzheimer's Disease Human Brain Tissue","GSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRE","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6VI3"
"6VID",,"X-RAY DIFFRACTION",2.16,43.07,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, Sodium acetate, Ammonium acetate",298,,,"6VID",93.99,"2.89","2.89","The Crystal Structure of Aps Domain-Swapped Trimer Q108K:K40D:T53A:R58L:Q38F:Q4F Variant of HCRBPII","TRDFNGTWEMESNENFEGYMKALDIDFATRKIAVRLTFTDVIDQDGDNFKTKATSTFLNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6VID"
"6VIN",,"X-RAY DIFFRACTION",4.3,70,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M sodium citrate pH 4.0, 1.0 M ammonium sulfate, 10% 2-methyl-2,4-pentanediol (MPD), and 0.4 M NaCl",293,"10.1016/j.str.2021.03.008",,"6VIN",82.48,"3.04","3.04","Crystallographic structure of the circularly permuted human Taspase1 protein","MTVGAVVVDHEGNVAAAVSSGGLALKHPGRVGQAALYGCGCWAENTGAHNPYSTAVSTSGCGEHLVRTILARECSHALQAEDAHQALLETMQNKFISSPFLASEDGVLGGVIVLRSCRCSAEPDSSQNKQTLLVEFLWSHTTESMCVGYMSAQDGKAKTHISRLPPGAVAGQSVAIEGGVCRLEGSGSGGFVLVHAGAGYHSESKAKEYKHVCKRACQKAIEKLQAGALATDAVTAALVELEDSPFTNAGMGSNLNLLGEIECDASIMDGKSLNFGAVGALSGIKNPVSVANRLLCEGQKGKLSAGRIPPCFLVGEGAYRWAVDHGIPSCPPNIMTTRFSLAAFKRNKRKLELAERVDTDFMQLKKRRQSSEKENDSGTLDLEHHHHHH","Homo sapiens","TASP1, C20orf13","Threonine aspartase 1","1","6VIN"
,,,,,,,,,,,,,,,,,"Homo sapiens","TASP1, C20orf13"
"6VIP",,"X-RAY DIFFRACTION",2.15,42.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 0.1 M HEPES pH 7.5, 2% PEG 400",291,,,"6VIP",28.9,"1.36","1.36","TUDOR DOMAIN OF TUMOR SUPPRESSOR P53BP1 WITH MFP-6008","GGNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLGPYE","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6VIP"
"6VIS",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION",,"PEG 4000, Sodium acetate, ammonium acetate",293,"10.1002/cbic.202000405",,"6VIS",47.01,"2.79","2.79","The Crystal Structure of Domain-Swapped Trimer Q108K:K40D:T53A:R58L:Q38F:Q4F:V62E Variant of HCRBPII","TRDFNGTWEMESNENFEGYMKALDIDFATRKIAVRLTFTDVIDQDGDNFKTKATSTFLNYDEDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6VIS"
"6VIT",,"X-RAY DIFFRACTION",4.2,70.74,"VAPOR DIFFUSION, HANGING DROP",6.4,"citric acid, PEG 3350",298,"10.1002/cbic.202000405",,"6VIT",31.2,"3.2","3.2","The Crystal Structure of Apo Domain-Swapped dimer Q108K:T51D:I32C Variant of HCRBPII with an Engineered Disulfide Bond","TRDQNGTWEMESNENFEGYMKALDIDFATRKCAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6VIT"
"6VIW",,"X-RAY DIFFRACTION",4.66,73.62,"VAPOR DIFFUSION, SITTING DROP",,"2.0 M Na Formate, 0.1M Tris pH 8.5",290,"10.1021/acs.jmedchem.0c00628","QYV","6VIW",43.27,"2.429","2.429","BRD4_Bromodomain1 complex with pyrrolopyridone compound 18","GSHMKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VIW"
"6VIX",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350, 0.2M AmSO4, 0.1M Na Cacodylate, pH 5.5",290,"10.1021/acs.jmedchem.0c00628","QYV","6VIX",53.46,"2.116","2.116","BRD4_Bromodomain2 complex with pyrrolopyridone compound 18","GSHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VIX"
"6VIY",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG1500, 0.2M AmSO4, 0.1M Na Cacodylate, pH 5.5",290,"10.1021/acs.jmedchem.0c00628","QYY","6VIY",26.88,"1.904","1.904","BRD2_Bromodomain2 complex with pyrrolopyridone compound 27","GSHMEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6VIY"
"6VIZ",,"X-RAY DIFFRACTION",4.63,73.45,"VAPOR DIFFUSION, SITTING DROP",,"2.0M Na Formate, 0.1M Bis-Tris Propane, pH 7.0",290,"10.1021/acs.jmedchem.0c00628","QYY","6VIZ",43.29,"2.391","2.391","BRD4_Bromodomain1 complex with pyrrolopyridone compound 27","GSHMKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VIZ"
"6VJ3",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M NaCitrate, 50 mM Tris",298,"10.1016/j.ejmech.2020.112112","QYA","6VJ3",29.55,"1.35","1.35","Carbonic Anhydrase II in complex with pyrimidine-based inhibitor","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6VJ3"
"6VJD",,"X-RAY DIFFRACTION",2.39,48.49,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Tris pH 7.5, MgCl2",298,,"C3D","6VJD",115.15,"1.8","1.8","Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene","MALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6VJD"
"6VK2",,"SOLUTION NMR",,,,,,,"10.1038/s41598-020-70034-w",,"6VK2",11.2,,,"NMR solution structure of Grb2-SH2 domain at pH 7","MKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRD","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","6VK2"
"6VKG",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 5.9 mg/mL protein + 200 nL reservoir (2.7 M ammonium sulfate, 50 mM Tris buffer, pH 8.2)",293,"10.1016/j.bioorg.2020.103669","SO4","6VKG",29.92,"1.37","1.37","Human carbonic anhydrase IX mimic with Epacadostat bound","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVDKALQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAEGVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","human carbonic anhydrase IX mimic","1","6VKG"
"6VKJ",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION, HANGING DROP",,"0.04M KH2PO4, 12% PEG 8000, 18% glycerol",289.15,,,"6VKJ",34.45,"2.105","2.105","Crystal structure of the G domain of human guanylate-binding protein 2 (hGBP2) in complex with GDP","INLPGPMSLIDNTKGQLVVNPEALKILSAITQPVVVVAIVGLYRTGKSYLMNKLAGKKNGFSLGSTVKSHTKGIWMWCVPHPKKPEHTLVLLDTEGLGDIEKGDNENDSWIFALAILLSSTFVYNSMGTINQQAMDQLHYVTELTDRIKANSSPGNNSVDDSADFVSFFPAFVWTLRDFTLELEVDGEPITADDYLELSLKLRKGTDKKSKSFNDPRLCIRKFFPKRKCFVFDWPAPKKYLAHLEQLKEEELNPDFIEQVAEFCSYILSHSNVKTLSGGIPVNGPRLESLVLTYVNAISSGDLPC","Homo sapiens","GBP2","Guanylate-binding protein 2","1","6VKJ"
"6VKK",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, SITTING DROP",8,"2M Ammonium Sulfate, 5% PEG 400, 100 mM Tris",298,"10.1126/science.aax6367",,"6VKK",168.72,"2.1","2.1","Crystal Structure of human PARP-1 CAT domain bound to inhibitor rucaparib","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6VKK"
"6VKO",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"2M Ammonium Sulfate, Bis-Tris pH6.5",298,"10.1126/science.aax6367",,"6VKO",169.38,"2.8","2.8","Crystal Structure of human PARP-1 CAT domain bound to inhibitor UKTT15","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6VKO"
"6VKQ",,"X-RAY DIFFRACTION",2.61,52.84,"VAPOR DIFFUSION, SITTING DROP",8,"2M Ammonium Sulfate, 5% PEG 400, 100 mM Tris pH 8",298,"10.1126/science.aax6367",,"6VKQ",169.59,"2.9","2.9","Crystal Structure of human PARP-1 CAT domain bound to inhibitor EB-47","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6VKQ"
"6VL4",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",8.2,"100mM Tris HCl pH 8.2, 29% PEG 1K, 1mM DG-031",298,"10.1016/j.bbagen.2020.129800",,"6VL4",18.37,"1.4","1.4","Crystal Structure of mPGES-1 bound to DG-031","MALPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","Prostaglandin E synthase","1","6VL4"
"6VLA",,"SOLUTION NMR",,,,,,,,,"6VLA",2.07,,,"Hs05 - Intragenic antimicrobial peptide","LMGLFNRIIRKVVKLFN","Homo sapiens","NAT10, ALP, KIAA1709","Intragenic antimicrobial peptide","1","6VLA"
"6VLD",,"X-RAY DIFFRACTION",3.73,66.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"2 M NH4SO4, 0.2 M NaCl, 0.1 M sodium cacodylate, pH 6.5",281,"10.1074/jbc.RA120.013291",,"6VLD",230.83,"2.28","2.28","Crystal structure of human alpha 1,6-fucosyltransferase, FUT8 bound to GDP and A2SGP","RNGLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEKHHHHHHHHHH","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6VLD"
"6VLE",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, SITTING DROP",7.5,"12% PEG 20000, 0.1 M HEPES, pH 7.5",298,"10.1074/jbc.RA120.013291",,"6VLE",111.59,"2.28","2.28","Crystal structure of human alpha 1,6-fucosyltransferase, FUT8 in its Apo-form","RNGLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEKHHHHHHHHHH","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6VLE"
"6VLT",,"X-RAY DIFFRACTION",4.26,71.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Lithium sulfate monohydrate, 0.1M Sodium citrate tribasic dehydrate pH 5.5, 20% w/v Polyethylene glycol 1000",291,"10.1124/molpharm.120.000042",,"6VLT",446.01,"3.12","3.12","Crystal Structure of Human P450 2C9*2 Genetic Variant in Complex with Losartan","MAKKTSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDCVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPIHHHH","Homo sapiens","CYP2C9, CYP2C10","Cytochrome P450 2C9","1","6VLT"
"6VLU",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION",,"0.1 M citrate pH 5, 23% PEG4000, seeded.",293,"10.1021/acs.jcim.0c00113","R2Y","6VLU",27.55,"1.6","1.6","Factor XIa in complex with compound 7","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XIa light chain","1","6VLU"
"6VLV",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION",5,"0.1 M CITRATE pH 5.0
32.0 w/v polyethylene glycol 4000",293,"10.1021/acs.jcim.0c00113","R3A","6VLV",27.7,"1.72","1.72","Factor XIa in complex with compound 11","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XIa light chain","1","6VLV"
"6VN2",,"X-RAY DIFFRACTION",2.5,50,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00245",,"6VN2",82.03,"2.93","2.93","USP7 IN COMPLEX WITH LIGAND COMPOUND 18","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6VN2"
"6VN3",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00245",,"6VN3",81.9,"2.73","2.73","USP7 IN COMPLEX WITH LIGAND COMPOUND 23","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6VN3"
"6VN4",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00245",,"6VN4",81.76,"2.69","2.69","USP7 IN COMPLEX WITH LIGAND COMPOUND 1","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6VN4"
"6VN5",,"X-RAY DIFFRACTION",2.5,50.75,"VAPOR DIFFUSION",,,277,"10.1021/acs.jmedchem.0c00245",,"6VN5",81.67,"2.9","2.9","USP7 IN COMPLEX WITH LIGAND COMPOUND 7","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6VN5"
"6VN6",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION",,"NULL",277,"10.1021/acs.jmedchem.0c00245",,"6VN6",82.1,"2.99","2.99","USP7 IN COMPLEX WITH LIGAND COMPOUND 14","GSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6VN6"
"6VN8",,"X-RAY DIFFRACTION",3.07,59.91,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VN8",73.65,"1.9","1.9","JAK2 JH1 in complex with baricitinib","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VN8"
"6VNB",,"X-RAY DIFFRACTION",3.1,60.32,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNB",73.87,"2.19","2.19","JAK2 JH1 in complex with BL2-084","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNB"
"6VNC",,"X-RAY DIFFRACTION",3.06,59.79,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNC",73.87,"2.3","2.3","JAK2 JH1 in complex with BL2-096","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNC"
"6VND",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION, SITTING DROP",4.8,"2.5 M ammonium sulfate, 30% glycerol, 0.1 M sodium acetate, pH 4.8",293,"10.1158/1535-7163.MCT-20-0550","R4P","6VND",42.54,"1.97","1.97","Quaternary Complex of human dihydroorotate dehydrogenase (DHODH) with flavin mononucleotide (FMN), orotic acid and AG-636","GMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6VND"
"6VNE",,"X-RAY DIFFRACTION",3.17,61.23,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNE",73.96,"2.32","2.32","JAK2 JH1 in complex with Fedratinib","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNE"
"6VNF",,"X-RAY DIFFRACTION",3.03,59.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNF",74.02,"2.06","2.06","JAK2 JH1 in complex with MA9-086","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNF"
"6VNG",,"X-RAY DIFFRACTION",3.06,59.76,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNG",74,"2.5","2.5","JAK2 JH1 in complex with PN2-118","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNG"
"6VNH",,"X-RAY DIFFRACTION",3.02,59.22,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNH",74.04,"2.4","2.4","JAK2 JH1 in complex with PN2-123","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNH"
"6VNI",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNI",74,"2.1","2.1","JAK2 JH1 in complex with PN3-115","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNI"
"6VNJ",,"X-RAY DIFFRACTION",3.04,59.58,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNJ",73.74,"1.9","1.9","JAK2 JH1 in complex with PN4-014","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNJ"
"6VNK",,"X-RAY DIFFRACTION",3.04,59.56,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNK",147.05,"2","2","JAK2 JH1 in complex with PN4-073","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNK"
"6VNL",,"X-RAY DIFFRACTION",3.06,59.8,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNL",148.24,"2.4","2.4","JAK2 JH1 in complex with SG3-179","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNL"
"6VNM",,"X-RAY DIFFRACTION",3.08,60.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VNM",73.74,"2.2","2.2","JAK2 JH1 in complex with SY5-103","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VNM"
"6VNO","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2673-2",,"6VNO",137.41,"3.5",,"Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Repeat Kinase 2 (LRRK2)","KKAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVGQLIPDCYVELEKIILSERKNVPIEFPVIDRKRLLQLVRENQLQLDENELPHAVHFLNESGVLLHFQDPALQLSDLYFVEPKWLCKIMAQILTVKVEGCPKHPKGIISRRDVEKFLSKKRKFPKNYMSQYFKLLEKFQIALPIGEEYLLVPSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELASKGSLDRLLQQDKASLTRTLQHRIALHVADGLRYLHSAMIIYRDLKPHNVLLFTLYPNAAIIAKIADYGIAQYCCRMGIKTSEGTPGFRAPEVARGNVIYNQQADVYSFGLLLYDILTTGGRIVEGLKFPNEFDELEIQGKLPDPVKEYGCAPWPMVEKLIKQCLKENPQERPTSAQVFDILNSAELVCLTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6VNO"
"6VNS",,"X-RAY DIFFRACTION",1.87,34.26,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1016/j.bmc.2020.115481","R5D","6VNS",36.96,"2.09","2.09","Crystal structure of TYK2 kinase with compound 13","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6VNS"
"6VNV",,"X-RAY DIFFRACTION",1.76,29.98,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1016/j.bmc.2020.115481","R4Y","6VNV",36.96,"2.15","2.15","Crystal structure of TYK2 kinase with compound 14","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6VNV"
"6VNX",,"X-RAY DIFFRACTION",1.9,35.32,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1016/j.bmc.2020.115481","R4V","6VNX",36.96,"2.18","2.18","Crystal structure of TYK2 kinase with compound 19","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6VNX"
"6VNY",,"X-RAY DIFFRACTION",1.85,33.64,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1016/j.bmc.2020.115481","R4S","6VNY",36.94,"2.3","2.3","Crystal structure of TYK2 kinase with compound 10","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6VNY"
"6VO4",,"X-RAY DIFFRACTION",1.93,36.35,"VAPOR DIFFUSION, HANGING DROP",7,"3.5M Sodium formate, pH 7.0",293,"10.1016/j.chembiol.2020.04.004",,"6VO4",18.6,"1.74","1.74","Crystal Structure Analysis of BFL1","MGHHHHHHSHMTDSEFGYIYRLAQDYLQSVLQIPQPGSGPSKTSRVLQNVAFSVQKEVEKNLKSCLDNVNVVSVDTARTLFNQVMEKEFEDGIINWGRIVTIFAFEGILIKKLLRQQIAPDVDTYKEISYFVAEFIMNNTGEWIRQNGGWENGFVKKFEPK","Homo sapiens","BCL2A1, BCL2L5, BFL1, GRS, HBPA1","Bcl-2-related protein A1","1","6VO4"
"6VO7",,"X-RAY DIFFRACTION",2.93,58.03,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCL, 0.7 M Na Citrate, pH 8.5",293,"10.1016/j.jmb.2021.166838",,"6VO7",16.8,"2.31","2.31","Crystal structure of PI3K-alpha Ras Binding Domain (RBD)","NSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMD","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6VO7"
"6VOV",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 100mM Tris pH 8.5",293,"10.1021/acsmedchemlett.9b00621","R6D","6VOV",66.26,"1.95","1.95","Crystal structure of Syk in complex with GS-9876","VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6VOV"
"6VP0","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2280-2",,"6VP0",120.96,"3.1",,"Human Diacylglycerol Acyltransferase 1 in complex with oleoyl-CoA","MGDRGSSRRRRTGSRPSSHGGGGPAAAEEEVRDAAAGPDVGAAGDAPAPAPNKDGDAGVGSGHWELRCHRLQDSLFSSDSGFSNYRGILNWCVVMLILSNARLFLENLIKYGILVDPIQVVSLFLKDPYSWPAPCLVIAANVFAVAAFQVEKRLAVGALTEQAGLLLHVANLATILCFPAAVVLLVESITPVGSLLALMAHTILFLKLFSYRDVNSWCRRARAKAASAGKKASSAAAPHTVSYPDNLTYRDLYYFLFAPTLCYELNFPRSPRIRKRFLLRRILEMLFFTQLQVGLIQQWMVPTIQNSMKPFKDMDYSRIIERLLKLAVPNHLIWLIFFYWLFHSCLNAVAELMQFGDREFYRDWWNSESVTYFWQNWNIPVHKWCIRHFYKPMLRRGSSKWMARTGVFLASAFFHEYLVSVPLRMFRLWAFTGMMAQIPLAWFVGRFFQGNYGNAAVWLSLIIGQPIAVLMYVHDYYVLNYEAPAAEA","Homo sapiens","DGAT1, AGRP1, DGAT","Diacylglycerol O-acyltransferase 1","1","6VP0"
"6VP6","3.47","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2673-2",,"6VP6",411.3,"3.47",,"Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Repeat Kinase 2 (LRRK2)","KKAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVGQLIPDCYVELEKIILSERKNVPIEFPVIDRKRLLQLVRENQLQLDENELPHAVHFLNESGVLLHFQDPALQLSDLYFVEPKWLCKIMAQILTVKVEGCPKHPKGIISRRDVEKFLSKKRKFPKNYMSQYFKLLEKFQIALPIGEEYLLVPSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELASKGSLDRLLQQDKASLTRTLQHRIALHVADGLRYLHSAMIIYRDLKPHNVLLFTLYPNAAIIAKIADYGIAQYCCRMGIKTSEGTPGFRAPEVARGNVIYNQQADVYSFGLLLYDILTTGGRIVEGLKFPNEFDELEIQGKLPDPVKEYGCAPWPMVEKLIKQCLKENPQERPTSAQVFDILNSAELVCLTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6VP6"
"6VP7","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2673-2",,"6VP7",136.94,"3.5",,"Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Repeat Kinase 2 (LRRK2)","KKAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVGQLIPDCYVELEKIILSERKNVPIEFPVIDRKRLLQLVRENQLQLDENELPHAVHFLNESGVLLHFQDPALQLSDLYFVEPKWLCKIMAQILTVKVEGCPKHPKGIISRRDVEKFLSKKRKFPKNYMSQYFKLLEKFQIALPIGEEYLLVPSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELASKGSLDRLLQQDKASLTRTLQHRIALHVADGLRYLHSAMIIYRDLKPHNVLLFTLYPNAAIIAKIADYGIAQYCCRMGIKTSEGTPGFRAPEVARGNVIYNQQADVYSFGLLLYDILTTGGRIVEGLKFPNEFDELEIQGKLPDPVKEYGCAPWPMVEKLIKQCLKENPQERPTSAQVFDILNSAELVCLTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6VP7"
"6VP8","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2673-2",,"6VP8",209.05,"3.5",,"Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein Leucine Rich Repeat Kinase 2 (LRRK2)","VPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVGQLIPDCYVELEKIILSERKNVPIEFPVIDRKRLLQLVRENQLQLDENELPHAVHFLNESGVLLHFQDPALQLSDLYFVEPKWLCKIMAQILTVKVEGCPKHPKGIISRRDVEKFLSKKRKFPKNYMSQYFKLLEKFQIALPIGEEYLLVPSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELASKGSLDRLLQQDKASLTRTLQHRIALHVADGLRYLHSAMIIYRDLKPHNVLLFTLYPNAAIIAKIADYGIAQYCCRMGIKTSEGTPGFRAPEVARGNVIYNQQADVYSFGLLLYDILTTGGRIVEGLKFPNEFDELEIQGKLPDPVKEYGCAPWPMVEKLIKQCLKENPQERPTSAQVFDILNSAELVCLTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6VP8"
,,,,,,,,,,,,,,,,"PSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELA","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","2","6VP8"
,,,,,,,,,,,,,,,,"LTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDI","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","3","6VP8"
"6VPF",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3,350, Tris pH 7.5, MgCl2",298,"10.7554/eLife.72512",,"6VPF",122.41,"1.6","1.6","Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene","HHHHHHENLYFQSMLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6VPF"
"6VPQ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M CaCl2, 15% PEG 400, 0.1 M Sodium acetate, pH 5.0",285,"10.1016/j.csbj.2020.03.009",,"6VPQ",135.35,"1.74","1.74","Crystal structure of the C-terminal domain of DENR","MAADISESSGADCKGDPRNSAKLDADYPLRVLYCGVCSLPTEYCEYMPDVAKCRQWLEKNFPNEFAKLTVENSPKQEAGISEGQGTAGEEEEKKKQKRGGRGQIKQKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFEIDLKEAQRFFAQKFSCGASVTGEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIEDLGEVKK","Homo sapiens","DENR, DRP1, H14","Density-regulated protein","1","6VPQ"
"6VPR",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M K/Na tartrate, 2.5 M Ammonium Sulfate, 0.1 M tri-Sodium citrate, pH 5.6",293,"10.1016/j.csbj.2020.03.009",,"6VPR",46.21,"2.2","2.2","Crystal structure of the C-terminal domain of DENR","MAADISESSGADCKGDPRNSAKLDADYPLRVLYCGVCSLPTEYCEYMPDVAKCRQWLEKNFPNEFAKLTVENSPKQEAGISEGQGTAGEEEEKKKQKRGGRGQIKQKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFEIDLKEAQRFFAQKFSCGASVTGEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIEDLGEVKK","Homo sapiens","DENR, DRP1, H14","Density-regulated protein","1","6VPR"
"6VQF",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, HANGING DROP",,"20-26% PEG3350, 0.2 M MAGNESIUM          CHLORIDE, 0.1 M BIS-TRIS PH 5.5-6.5,",298,"10.1021/acsmedchemlett.0c00063",,"6VQF",33.65,"2","2","CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C (NHIS-RORGT(244- 487)-L6-SRC1(678-692)) IN COMPLEX WITH AN INVERSE AGONIST","MGSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTSGGSGGLTERHKILHRLLQE","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6VQF"
"6VQL",,"X-RAY DIFFRACTION",2.41,49.05,"VAPOR DIFFUSION, HANGING DROP",,"NULL",293,"10.1021/acsmedchemlett.0c00082","R7S","6VQL",139.77,"2.069","2.069","CRYSTAL STRUCTURE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4-WT) COMPLEX WITH A NICOTINAMIDE INHIBITOR","GAMGVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6VQL"
"6VQM",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION",,"PEG4000",293,,,"6VQM",66.58,"2.87","2.87","Crystal Structure Analysis of human ACK1","GSAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA","Homo sapiens","TNK2, ACK1","Activated CDC42 kinase 1","1","6VQM"
"6VQN",,"X-RAY DIFFRACTION",3.86,68.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM NaCitrate, pH 6.5 and 22% (w/v) PEG 3000",293,"10.1038/s41467-021-21410-1",,"6VQN",45.57,"2.49","2.49","Co-crystal structure of human PD-L1 complexed with Compound A","MAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6VQN"
"6VR6",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M NaCl, 0.05 M Bis-Tris pH 6.5, 0.1 M ammonium acetate, 0.05 M HEPES pH 9.5, 25% (w/v) PEG 3350",281,"10.1016/j.abb.2020.108477",,"6VR6",435.11,"2.5","2.5","Structure of ALDH9A1 complexed with NAD+ in space group P1","STGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF","Homo sapiens","ALDH9A1, ALDH4, ALDH7, ALDH9","4-trimethylaminobutyraldehyde dehydrogenase","1","6VR6"
"6VRE",,"X-RAY DIFFRACTION",2.74,55.14,"VAPOR DIFFUSION",5.5,"0.1M BisTRIS pH 5.5, 0.2M ammonium acetate, 3% sorbitol and 12% PEG3350",300,"10.1021/acsmedchemlett.9b00611","RFG","6VRE",66.42,"2.29","2.29","Structure of ASK1 bound to BIO-1772961","TEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6VRE"
"6VRF",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION",8.5,"0.1M TRIS pH 8.5, 10% glycerol and 2.0M Na/K phosphate",300,"10.1007/s10571-020-00875-6",,"6VRF",70.61,"1.5","1.5","ADP bound TTBK2 kinase domain","MSGGGEQPDILSVGILVKERWKVLRKIGGGGFGEIYDALDMLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNDRFNYVVMQLQGRNLADLRRSQSRGTFTISTTLRLGRQILESIESIHSVGFLHRDIKPSNFAMGRFPSTCRKCYMLDFGLARQFTNSCGDVRPPRAVAGFRGTVRYASINAHRNREMGRHDDLWSLFYMLVEFVVGQLPWRKIKDKEQVGSIKERYDHRLMLKHLPPEFSIFLDHISSLDYFTKPDYQLLTSVFDNSIKTFGVIESDPFDWEK","Homo sapiens","TTBK2, KIAA0847","Tau-tubulin kinase 2","1","6VRF"
"6VRP",,"X-RAY DIFFRACTION",2.29,46.3,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M Ammonium Sulfate, 20% PEG 3350",293,"10.1016/j.str.2021.02.001",,"6VRP",54.47,"1.6","1.6","Reverse Transcriptase Diabody with R83T Mutation","MEVQLVESGGGLVQPGGSLRLSCAASGFSLSTSGIGVTWVRQAPGKGLEWLATIWWDDDNRYADSVKGRFTISADTSKNTAYLQMNSLTAEDTAVYYCAQSAITSVTDSAMDHWGQGTLVTVSSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSSLHSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSKFPWTFGQGTKVEIKGSHHHHHH","Homo sapiens",,"Single-chain Fv","1","6VRP"
"6VRR",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES
(pH 7.0), 14% PEG 6000",277,"10.1089/bioe.2020.0030",,"6VRR",14.95,"1.45","1.45","Crystal structure of a disease mutant of the Voltage-gated Sodium Channel Beta 2 subunit extracellular domain","SNAMEVTVPATLNVLNGSDARLPCTFNSAYTVNHKQFSLNWTYQECNNCSEEMFLQFRMKIINLKLERFQDRVEFSGNPSKYDVSVMLRNVQPEDEGIYNCYIMNPPDRHHGHGKIHLQVLMEEPPE","Homo sapiens","SCN2B, UNQ326/PRO386","Sodium channel subunit beta-2","1","6VRR"
"6VRU",,"X-RAY DIFFRACTION",3.59,65.77,"VAPOR DIFFUSION",6.5,"0.1 M imidazole, 0.7 M Na Acetate, pH6.5",277,"10.1016/j.bmcl.2020.127625",,"6VRU",32.1,"2.07","2.07","PIM-inhibitor complex 1","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6VRU"
"6VRV",,"X-RAY DIFFRACTION",3.62,66.02,"VAPOR DIFFUSION",,"100 mM imidazole, 1.4M sodium acetate pH 6.4",292,"10.1016/j.bmcl.2020.127625",,"6VRV",32.02,"1.74","1.74","Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6VRV"
"6VS3",,"X-RAY DIFFRACTION",3.02,59.32,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VS3",73.87,"2","2","JAK2 JH1 in complex with BL2-057","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VS3"
"6VSK",,"X-RAY DIFFRACTION",4.76,74.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M HEPES, pH 6.5, 45% w/v poly(acrylic acid sodium salt)2100",293.15,"10.1074/jbc.RA120.014534",,"6VSK",10.97,"3.12","3.12","Crystal structure of the P-Rex1 DEP1 domain","SNAIAEKGEKLYHMMMNKKVNLIKDRRRKLSTVPKCFLGNEFVAWLLEIGEISKTEEGVNLGQALLENGIIHHVSDKHQFKNEQVMYRFRYDDG","Homo sapiens","PREX1, KIAA1415","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein","1","6VSK"
"6VSL",,"X-RAY DIFFRACTION",2.89,57.37,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG4000, 0.1 M HEPES, pH 7.0",294,"10.1128/JVI.00796-21",,"6VSL",51.32,"2.1","2.1","Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)","LLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6VSL"
"6VSN",,"X-RAY DIFFRACTION",3.03,59.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.2 M NaCl, 25% PEG 3350",291,"10.1021/acs.jmedchem.0c01952",,"6VSN",147.05,"2.5","2.5","JAK2 JH1 in complex with BL2-110","HHHHHHHHENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6VSN"
"6VSV",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 (M) MES, pH 6.5, 15-17% PEG200-MME",277,"10.1089/bioe.2020.0030",,"6VSV",14.56,"1.62","1.62","Crystal structure of a disease mutant of the Voltage-gated Sodium Channel Beta 4 subunit extracellular domain","SNAEVSVGKATDIYAVNGTEILLPCTFSSAFGFEDLHFRWTYNSSDAFKILTEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTCHVKNPKENNLQHHATIFLQVVDRLEE","Homo sapiens","SCN4B","Sodium channel subunit beta-4","1","6VSV"
"6VSW",,"X-RAY DIFFRACTION",3.34,63.15,"VAPOR DIFFUSION",,"1.35M NaFormate, 0.1M Hepes pH7, 3%MPD",293,"10.1016/j.bmcl.2020.127205",,"6VSW",55.45,"3.202","3.202","Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORgt","EAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPI","Homo sapiens","RORC, NR1F3, RORG, RZRG","RAR-related orphan receptor C","1","6VSW"
"6VSZ",,"X-RAY DIFFRACTION",2.86,56.96,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG4000, 0.1 M HEPES, pH 7.0",294,"10.1128/JVI.00796-21",,"6VSZ",50.79,"2.6","2.6","Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)","LLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6VSZ"
"6VTC",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION",6,"20% (w/v) PEG 4000, 0.2 M LiSO4, 0.1 M MES",295,"10.1038/s41467-020-16755-y",,"6VTC",51.17,"1.83","1.83","p53-specific T cell receptor","MKEVEQDPGPLSVPEGAIVSLNCTYSNSAFQYFMWYRQYSRKGPELLMYTYSSGNKEDGRFTAQVDKSSKYISLFIRDSQPSDSATYLCAMSGLKEDSSYKLIFGSGTRLLVRPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"T-cell Receptor 1a2","1","6VTC"
,,,,,,,,,,,,,,,,"MEAQVTQNPRYLITVTGKKLTVTCSQNMNHEYMSWYRQDPGLGLRQIYYSMNVEVTDKGDVPEGYKVSRKEKRNFPLILESPSPNQTSLYFCASSIQQGADTQYFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"p53-specific T cell receptor, B-chain","2","6VTC"
"6VTH",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION",6,"18% (w/v) PEG 2000, 0.2 M AmSO4, 0.1 M MES",295,"10.1038/s41467-020-16755-y",,"6VTH",101.44,"2.36","2.36","p53-specific T cell receptor","MRKEVEQDPGPFNVPEGATVAFNCTYSNSASQSFFWYRQDCRKEPKLLMSVYSSGNEDGRFTAQLNRASQYISLLIRDSKLSDSATYLCVVQPGGYQKVTFGTGTKLQVIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"T-cell Receptor 12-6, Alfa chain","1","6VTH"
,,,,,,,,,,,,,,,,"MNAGVTQTPKFQVLKTGQSMTLQCAQDMNHNSMYWYRQDPGMGLRLIYYSASEGTTDKGEVPNGYNVSRLNKREFSLRLESAAPSQTSVYFCASSEGLWQVGDEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"TCR 12-6, beta chain","2","6VTH"
"6VTO",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Sodium Chloride, 0.1 M Tris pH 8, 20 % PEG3350, 5 % Glycerol",295,"10.1016/j.jbc.2021.101308",,"6VTO",30.62,"1.69","1.69","Crystal structure of human Galectin-7 in complex with 4-O-beta-D-Galactopyranosyl-D-glucose","SNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","6VTO"
"6VTP",,"X-RAY DIFFRACTION",2.16,42.93,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Sodium chloride, 0.1M Tris pH 8, 20 % PEG 3350, 15 % Glycerol",295.15,"10.1016/j.jbc.2021.101308",,"6VTP",30.21,"2.3","2.3","Crystal structure of G16C human Galectin-7 mutant","SNVPHKSSLPEGIRPCTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","6VTP"
"6VTQ",,"X-RAY DIFFRACTION",1.87,34.15,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8, 0.1 M Sodium Chloride, 25 % PEG3350, 7.5 mM alpha-lactose",295.15,"10.1016/j.jbc.2021.101308",,"6VTQ",30.92,"1.95","1.95","Crystal structure of G16C human Galectin-7 mutant in complex with lactose","SNVPHKSSLPEGIRPCTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","6VTQ"
"6VTR",,"X-RAY DIFFRACTION",2.14,42.66,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M NaCl, 0.1 M Tris pH 8.0, 20 % PEG 3350, 17.5 % Glycerol",295.15,"10.1016/j.jbc.2021.101308",,"6VTR",30.21,"2.3","2.3","Crystal structure of G16S human Galectin-7 mutant","SNVPHKSSLPEGIRPSTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","6VTR"
"6VTS",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8, 0.1 M NaCl, 16 % PEG 3350, 150 mM alpha-Lactose",295.15,"10.1016/j.jbc.2021.101308",,"6VTS",30.95,"1.9","1.9","Crystal structure of G16S human Galectin-7 mutant in complex with lactose","SNVPHKSSLPEGIRPSTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","Galectin-7","1","6VTS"
"6VU4",,"X-RAY DIFFRACTION",2.45,49.81,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1 M HEPES buffer at pH 7.2, 0.2 M sodium citrate, and 25% isopropanol",293,"10.1021/jacs.0c05186",,"6VU4",4.15,"2.077","2.077","Structure of a beta-hairpin peptide mimic derived from Abeta 14-36","HAKLVFFAEAAIIGLMV","Homo sapiens",,"Beta-hairpin Amyloid-beta precursor peptide mimic","1","6VU4"
"6VUA",,"X-RAY DIFFRACTION",2.73,55,"VAPOR DIFFUSION, HANGING DROP",7,"1) 100mM HEPES pH 7.0, 2) 38-42%  Morpheus Precipitant mix 1 (MD2-250-84) containing PEG 1K, 3350 and MPD, 3) 100mM Potassium phosphate dibasic",295,"10.1126/sciadv.aba6752",,"6VUA",61.95,"1.5","1.5","X-ray structure of human CD38 catalytic domain with 2'-Cl-araNAD+","SRWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1","1","6VUA"
"6VUB",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.ejmech.2020.112120","RLG","6VUB",15.14,"1.5","1.5","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 5 (1-methyl-4-phenylpyrrolidin-2-one)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VUB"
"6VUC",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.ejmech.2020.112120","RLS","6VUC",15.29,"1.55","1.55","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 7b (1-methyl-4-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-one)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VUC"
"6VUF",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.ejmech.2020.112120","RLV","6VUF",30.53,"1.59","1.59","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 7h (4-(1-methyl-5-oxopyrrolidin-3-yl)-N-propylbenzenesulfonamide)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VUF"
"6VUJ",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.ejmech.2020.112120","RLY","6VUJ",15.48,"1.48","1.48","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 15c (N,N-diethyl-3',4'-dimethoxy-6-(1-methyl-5-oxopyrrolidin-3-yl)-[1,1'-biphenyl]-3-sulfonamide)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6VUJ"
"6VUM","3.67","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2295-8",,"6VUM",273.49,"3.67, 3.67",,"Structure of nevanimibe-bound human tetrameric ACAT1","MVGEEKMSLRNRLSKSRENPEEDEDQRNPAKESLETPSNGRIDIKQLIAKKIKLTAEAEELKPFFMKEVGSHFDDFVTNLIEKSASLDNGGCALTTFSVLEGEKNNHRAKDLRAPPEQGKIFIARRSLLDELLEVDHIRTIYHMFIALLILFILSTLVVDYIDEGRLVLEFSLLSYAFGKFPTVVWTWWIMFLSTFSVPYFLFQHWATGYSKSSHPLIRSLFHGFLFMIFQIGVLGFGPTYVVLAYTLPPASRFIIIFEQIRFVMKAHSFVRENVPRVLNSAKEKSSTVPIPTVNQYLYFLFAPTLIYRDSYPRNPTVRWGYVAMKFAQVFGCFFYVYYIFERLCAPLFRNIKQEPFSARVLVLCVFNSILPGVLILFLTFFAFLHCWLNAFAEMLRFGDRMFYKDWWNSTSYSNYYRTWNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFFYPVLFVLFMFFGMAFNFIVNDSRKKPIWNVLMWTSLFLGNGVLLCFYSQEWYARQHCPLKNPTFLDYVRPRSWTCRYVFDYKDDDDK","Homo sapiens","SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT","Sterol O-acyltransferase 1","1","6VUM"
"6VUN",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION, HANGING DROP",,"14% v/v Propanol, 0.1 M Sodium citrate dibasic dehydrate pH 5.0, 10% w/v PEG 10,000",293,"10.1016/j.str.2021.02.001",,"6VUN",51.61,"1.4","1.4","Reverse Transcriptase Diabody with R83C Mutation","MEVQLVESGGGLVQPGGSLRLSCAASGFSLSTSGIGVTWVRQAPGKGLEWLATIWWDDDNRYADSVKGRFTISADTSKNTAYLQMNSLCAEDTAVYYCAQSAITSVTDSAMDHWGQGTLVTVSSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSSLHSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSKFPWTFGQGTKVEIK","Homo sapiens",,"Single-chain Fv","1","6VUN"
"6VUO",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, HANGING DROP",5.7,"14% PEG 1000, 0.1 M Sodium Citrate pH 5.7",293,"10.1016/j.str.2021.02.001",,"6VUO",51.76,"1.449","1.449","Reverse Transcriptase Diabody with S82bC/R83T Mutation","MEVQLVESGGGLVQPGGSLRLSCAASGFSLSTSGIGVTWVRQAPGKGLEWLATIWWDDDNRYADSVKGRFTISADTSKNTAYLQMNCLTAEDTAVYYCAQSAITSVTDSAMDHWGQGTLVTVSSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSSLHSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSKFPWTFGQGTKVEIK","Homo sapiens","scFv","Single-chain Fv","1","6VUO"
"6VUP",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION",5.4,"6 % v/v 2-Propanol, 0.1 M Sodium Acetate trihydrate pH 4.5, 26% PEG 550 MME",293,"10.1016/j.str.2021.02.001",,"6VUP",26.93,"1.4","1.4","Reverse Transcriptase Diabody with R83T/E85C Mutations","MEVQLVESGGGLVQPGGSLRLSCAASGFSLSTSGIGVTWVRQAPGKGLEWLATIWWDDDNRYADSVKGRFTISADTSKNTAYLQMNSLTACDTAVYYCAQSAITSVTDSAMDHWGQGTLVTVSSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSSLHSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSKFPWTFGQGTKVEIKGSHHHHHH","Homo sapiens","scFv","Single-chain Fv","1","6VUP"
"6VVQ",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, HANGING DROP",9.4,"0.1 M Tris HCl pH 9.4 and 27 % PEG 8000",277.15,"10.1073/pnas.2003877117",,"6VVQ",118.9,"3.09","3.09","Human START domain of Acyl-coenzyme A thioesterase 11 (ACOT11) bound to Myristic Acid","SMRPQPGDGERRYREASARKKIRLDRKYIVSCKQTEVPLSVPWDPSNQVYLSYNNVSSLKMLVAKDNWVLSSEISQVRLYTLEDDKFLSFHMEMVVHVDAAQAFLLLSDLRQRPEWDKHYRSVELVQQVDEDDAIYHVTSPALGGHTKPQDFVILASRRKPCDNGDPYVIALRSVTLPTHRETPEYRRGETLCSGFCLWREGDQLTKVSYYNQATPGVLNYVTTNVAGLSSEFYTTFKACEQFLLDNRNDLAPSLQTL","Homo sapiens","ACOT11, BFIT, KIAA0707, THEA","Acyl-coenzyme A thioesterase 11","1","6VVQ"
"6VWB",,"SOLUTION NMR",,,,,,,,,"6VWB",10.62,,,"Solution structure of the N-terminal helix-hairpin-helix domain of human MUS81","AAAPVRLGRKRPLPACPNPLFVRWLTEWRDEATRSRRRTRFVFQKALRSLRRYPLPLRSGKEAKILQHFGDGLCRMLDERLQRHRTSGGD","Homo sapiens","MUS81","Crossover junction endonuclease MUS81","1","6VWB"
"6VWC",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION",8.5,"30%(w/v) PEG 10,000, 0.1M Tris Hcl pH 8.5",290,"10.1021/acsmedchemlett.9b00568","RQ7","6VWC",38.55,"1.604","1.604","Crystal structure of Bcl-xL in complex with tetrahydroisoquinoline-pyridine based inhibitors","MSQSNRELVVDFLSYKLSQKGYSASGGGGGGGMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKKMQVLVSRIAAWMATYLNDHLEPWIQENGGWATFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6VWC"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"6VWF",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M succinic acid pH 7.0, 15% (w/v) PEG 3350",281,"10.1016/j.abb.2020.108477",,"6VWF",109.04,"2.64","2.64","Structure of ALDH9A1 complexed with NAD+ in space group C222","MSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF","Homo sapiens","ALDH9A1, ALDH4, ALDH7, ALDH9","4-trimethylaminobutyraldehyde dehydrogenase","1","6VWF"
"6VXF","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16155-2",,"6VXF",144.77,"3.5",,"Structure of apo-closed ABCG2","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","Broad substrate specificity ATP-binding cassette transporter ABCG2","1","6VXF"
"6VXG",,"SOLUTION NMR",,,,,,,"10.1126/scitranslmed.abf7084",,"6VXG",5.42,,,"Structure of the C-terminal Domain of RAGE and Its Inhibitor","MWQRRQRRGEERKAPENQEEEEERAELNQSEEPEAGESSTGGP","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6VXG"
"6VXH","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16155-2",,"6VXH",146.04,"4",,"Structure of ABCG2 bound to imatinib","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","Broad substrate specificity ATP-binding cassette transporter ABCG2","1","6VXH"
"6VXI","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16155-2",,"6VXI",145.99,"3.7",,"Structure of ABCG2 bound to mitoxantrone","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","Broad substrate specificity ATP-binding cassette transporter ABCG2","1","6VXI"
"6VXJ","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16155-2",,"6VXJ",145.94,"4.1",,"Structure of ABCG2 bound to SN38","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","Broad substrate specificity ATP-binding cassette transporter ABCG2","1","6VXJ"
"6VXQ",,"X-RAY DIFFRACTION",2.12,42.05,"VAPOR DIFFUSION",,"bis-tris, ammonium salt, PEG",277,"10.1021/acs.jmedchem.0c00702","RQS","6VXQ",34.38,"1.4","1.4","Bruton's tyrosine kinase in complex with compound 5","GPLGSRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6VXQ"
"6VXR",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 1,500",293,,,"6VXR",39.74,"2.1","2.1","Structure of Maternal embryonic leucine zipper kinase bound to LDSM276","SMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFS","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","6VXR"
"6VXU",,"X-RAY DIFFRACTION",2.58,52.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"27.5% PEG3350; 300 mM LiSO4; 0.1 M SBG (each Sodium-tartrate + Bis-Tris + Glycylglycine) pH 6.5",293,,,"6VXU",167.59,"2","2","Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6VXU"
"6VYC",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"12% PEG20000, 0.1 M MES",293,,,"6VYC",82.13,"2.1","2.1","Crystal structure of WD-repeat domain of human WDR91","MHHHHHHSSGRENLYFQGPEQPFIVLGQEEYGEHHSSIMHCRVDCSGRRVASLDVDGVIKVWSFNPIMQTKASSISKSPLLSLEWATKRDRLLLLGSGVGTVRLYDTEAKKNLCEININDNMPRILSLACSPNGASFVCSAAAPSLTSQVDFSAPDIGSKGMNQVPGRLLLWDTKTMKQQLQFSLDPEPIAINCTAFNHNGNLLVTGAADGVIRLFDMQQHECAMSWRAHYGEVYSVEFSYDENTVYSIGEDGKFIQWNIHKSGLKVSEYSLPSDATGPFVLSGYSGYKQVQVPRGRLFAFDSEGNYMLTCSATGGVIYKLGGDEKVLESCLSLGGHRAPVVTVDWSTAMDCGTCLTASMDGKIKLTTLLAHKA","Homo sapiens","WDR91, HSPC049","WD repeat-containing protein 91","1","6VYC"
"6VYI","3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2289-6",,"6VYI",113.55,"3",,"Cryo-EM structure of human diacylglycerol O-acyltransferase 1","MGDRGSSRRRRTGSRPSSHGGGGPAAAEEEVRDAAAGPDVGAAGDAPAPAPNKDGDAGVGSGHWELRCHRLQDSLFSSDSGFSNYRGILNWCVVMLILSNARLFLENLIKYGILVDPIQVVSLFLKDPYSWPAPCLVIAANVFAVAAFQVEKRLAVGALTEQAGLLLHVANLATILCFPAAVVLLVESITPVGSLLALMAHTILFLKLFSYRDVNSWCRRARAKAASAGKKASSAAAPHTVSYPDNLTYRDLYYFLFAPTLCYELNFPRSPRIRKRFLLRRILEMLFFTQLQVGLIQQWMVPTIQNSMKPFKDMDYSRIIERLLKLAVPNHLIWLIFFYWLFHSCLNAVAELMQFGDREFYRDWWNSESVTYFWQNWNIPVHKWCIRHFYKPMLRRGSSKWMARTGVFLASAFFHEYLVSVPLRMFRLWAFTGMMAQIPLAWFVGRFFQGNYGNAAVWLSLIIGQPIAVLMYVHDYYVLNYEAPAAEA","Homo sapiens","DGAT1, AGRP1, DGAT","Diacylglycerol O-acyltransferase 1","1","6VYI"
"6VYJ",,"X-RAY DIFFRACTION",1.92,36.01,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Bis-Tris, pH 5.75, 35 % w/v PEG 3350. The crystals were cryo-preserved by 25% glucose",277,"10.1038/s41598-020-80588-4",,"6VYJ",19.61,"1.39","1.39","Human UHRF1 TTD domain in complex with a fragment","SNADEDMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERP","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","6VYJ"
"6VZ1","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2289-6",,"6VZ1",115.61,"3.2",,"Cryo-EM structure of human diacylglycerol O-acyltransferase 1 complexed with acyl-CoA substrate","MGDRGSSRRRRTGSRPSSHGGGGPAAAEEEVRDAAAGPDVGAAGDAPAPAPNKDGDAGVGSGHWELRCHRLQDSLFSSDSGFSNYRGILNWCVVMLILSNARLFLENLIKYGILVDPIQVVSLFLKDPYSWPAPCLVIAANVFAVAAFQVEKRLAVGALTEQAGLLLHVANLATILCFPAAVVLLVESITPVGSLLALMAHTILFLKLFSYRDVNSWCRRARAKAASAGKKASSAAAPHTVSYPDNLTYRDLYYFLFAPTLCYELNFPRSPRIRKRFLLRRILEMLFFTQLQVGLIQQWMVPTIQNSMKPFKDMDYSRIIERLLKLAVPNHLIWLIFFYWLFHSCLNAVAELMQFGDREFYRDWWNSESVTYFWQNWNIPVHKWCIRHFYKPMLRRGSSKWMARTGVFLASAFFHEYLVSVPLRMFRLWAFTGMMAQIPLAWFVGRFFQGNYGNAAVWLSLIIGQPIAVLMYVHDYYVLNYEAPAAEA","Homo sapiens","DGAT1, AGRP1, DGAT","Diacylglycerol O-acyltransferase 1","1","6VZ1"
"6VZH",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, SITTING DROP",6.5,"27.5% PEG3350, 300 mM lithium sulfate, 0.1 M sodium tartrate, 0.1 M Bis-Tris, 0.1 M glycylglycine, cryoprotectant: 30% glycerol",293,,,"6VZH",166.2,"2.55","2.55","Structure of Human Vaccinia-related Kinase 1 (VRK1) Bound to LDSM311","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6VZH"
"6VZK",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 6000, 50 mM HEPES, 3-Aminobenzene-sulfonic acid, 5-Sulfosalicylic acid dihydrate,  p-Coumaric acid, PIPES, Terephthalic acid, Vanillic acid",277,"10.1002/pro.3869",,"6VZK",30.71,"2.55","2.55","Crystal structure of human CaMKII-alpha (CAMK2A)kinase domain","TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYKQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","1","6VZK"
"6VZL",,"X-RAY DIFFRACTION",2.67,53.93,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4, 0.8M SODIUM CITRATE",293,"10.1016/j.str.2021.02.006",,"6VZL",63.89,"2.07","2.07","Crystal structure of human PPARgamma ligand binding domain in complex with GW1929","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6VZL"
"6VZM",,"X-RAY DIFFRACTION",2.69,54.23,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4, 0.8M SODIUM CITRATE",293,"10.1016/j.str.2021.02.006",,"6VZM",63.67,"2.4","2.4","Crystal structure of human PPARgamma ligand binding domain Y473E mutant in complex with Darglitazone","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIEKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6VZM"
"6VZN",,"X-RAY DIFFRACTION",2.65,53.5,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4, 0.8M SODIUM CITRATE",293,"10.1016/j.str.2021.02.006",,"6VZN",62.83,"2.3","2.3","Crystal structure of human PPARgamma ligand binding domain Y473E mutant","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIEKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6VZN"
"6VZO",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M Tris, pH 7.4
0.8M SODIUM CITRATE",293,"10.1016/j.str.2021.02.006",,"6VZO",62.9,"2.27","2.27","Crystal structure of human PPARgamma ligand binding domain (Protein delipidated by denature and refold)","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6VZO"
"6W06",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION",,"bis-tris, ammonium salt, PEG",277,"10.1021/acs.jmedchem.0c00702","S5M","6W06",34.51,"1.55","1.55","Bruton's tyrosine kinase in complex with compound 6","GPLGSRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6W06"
"6W07",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION",,"bis-tris, ammonium salt, PEG",277,"10.1021/acs.jmedchem.0c00702","S9A","6W07",34.41,"1.51","1.51","Bruton's tyrosine kinase in complex with compound 1","GPLGSRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6W07"
"6W0N",,"X-RAY DIFFRACTION",3.59,65.73,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8000, 100 mM Na citrate, pH 4.5, and 0.2 M ammonium sulfate",295,"10.1021/acs.jmedchem.0c00944","RYS","6W0N",69.57,"2.41","2.41","Structure of KHK in complex with compound 2","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6W0N"
"6W0O","2.77","ELECTRON MICROSCOPY, SOLID-STATE NMR",,,,,,,"10.1073/pnas.2023089118",,"6W0O",26.02,"2.77",,"Amyloid-beta(1-40) fibril derived from Alzheimer's disease cortical tissue","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6W0O"
"6W0W",,"X-RAY DIFFRACTION",3.63,66.1,"VAPOR DIFFUSION, SITTING DROP",,"17-20% PEG 8000, 100 mM sodium citrate, pH 4.4-4.7, and 0.2 M ammonium sulfate",295,"10.1021/acs.jmedchem.0c00944",,"6W0W",69.25,"2.8","2.8","Structure of KHK in complex with compound 3","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6W0W"
"6W0X",,"X-RAY DIFFRACTION",3.59,65.74,"VAPOR DIFFUSION, SITTING DROP",,"17-20% PEG8000, 100 mM sodium citrate, pH 4.4-4.7, 0.2 M ammonium sulfate",295,"10.1021/acs.jmedchem.0c00944","S6J","6W0X",69.08,"2.38","2.38","Structure of KHK in complex with compound 4 (6-[(1~{S},5~{R})-6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexan-3-yl]-2-[(2~{S},3~{R})-2-methyl-3-oxidanyl-azetidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile)","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6W0X"
"6W0Y",,"X-RAY DIFFRACTION",3.46,64.42,"VAPOR DIFFUSION, SITTING DROP",,"17-20% PEG8000, 100 mM sodium citrate, pH 4.4-4.7, 0.2 M ammonium sulfate",295,"10.1021/acs.jmedchem.0c00944",,"6W0Y",69.23,"2.54","2.54","Structure of KHK in complex with compound 6 (2-[(1~{R},5~{S})-3-[5-cyano-6-[(2~{S},3~{R})-2-methyl-3-oxidanyl-azetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-yl]ethanoic acid)","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6W0Y"
"6W0Z",,"X-RAY DIFFRACTION",3.44,64.22,"VAPOR DIFFUSION, SITTING DROP",,"17-20% PEG8000, 100 mM sodium citrate, pH 4.4-4.7, 0.2 M ammonium sulfate",295,"10.1021/acs.jmedchem.0c00944","S6D","6W0Z",69.15,"2.3","2.3","Structure of KHK in complex with compound 8 (2-[(1~{S},5~{R})-3-[2-[(2~{S})-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hexan-6-yl]ethanoic acid)","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","6W0Z"
"6W12",,"X-RAY DIFFRACTION",2.98,58.73,"VAPOR DIFFUSION, SITTING DROP",,"200mM Magnesium chloride, 100mM Tris, 2-3M NaCl",291,"10.1021/acs.biochem.1c00009",,"6W12",15.65,"2","2","Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to the Tumor-Associated Tn Antigen","SCPVNWVEHQDSCYWFSHSGMSWAEAEKYCQLKNAHLVVINSREEQNFVQKYLGSAYTWMGLSDPEGAWKWVDGTDYATGFQNWKPGQPDDWQGHGLGGGEDCAHFHPDGRWNDDVCQRPYHWVCEAGL","Homo sapiens","CLEC10A, CLECSF13, CLECSF14, HML","C-type lectin domain family 10 member A","1","6W12"
"6W2G",,"X-RAY DIFFRACTION",1.76,29.94,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium sulfate, 0.1M Phosphate-citrate pH 4.2, 40%(v/v) Ethylene glycol",293,,,"6W2G",11.25,"1.1","1.1","Crystal Structure of Y188G Variant of the Internal UBA Domain of HHR23A in Monoclinic Unit Cell","GSTLVTGSEYETMLTEIMSMGYERERVVAALRASGNNPHRAVEYLLTGIPG","Homo sapiens","RAD23A","UV excision repair protein RAD23 homolog A","1","6W2G"
"6W2H",,"X-RAY DIFFRACTION",1.74,29.22,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Tris pH 8.5, 1.5 M Ammonium sulfate, 12%(v/v) Glycerol",293,"10.1021/acs.biochem.2c00011",,"6W2H",5.74,"1.6","1.6","Crystal Structure of the Internal UBA Domain of HHR23A","GSTLVTGSEYETMLTEIMSMGYERERVVAALRASYNNPHRAVEYLLTGIPG","Homo sapiens","RAD23A","UV excision repair protein RAD23 homolog A","1","6W2H"
"6W2I",,"X-RAY DIFFRACTION",1.78,30.83,"VAPOR DIFFUSION, SITTING DROP",,"2.0M Ammonium sulfate",293,,,"6W2I",5.63,"1.45","1.45","Crystal Structure of Y188G Variant of the Internal UBA Domain of HHR23A","GSTLVTGSEYETMLTEIMSMGYERERVVAALRASGNNPHRAVEYLLTGIPG","Homo sapiens","RAD23A","UV excision repair protein RAD23 homolog A","1","6W2I"
,,,,,"VAPOR DIFFUSION, SITTING DROP",,"2.0M Ammonium sulfate",293
"6W2J",,"X-RAY DIFFRACTION",2.8,56.05,"VAPOR DIFFUSION, HANGING DROP",,"CPS1 protein was buffer exchanged into 50 mM glycyl-glycine pH 7.4, 50 mM KCl, 5% glycerol. CPS1 was concentrated to 10 mg/ml and H3B-4193 was added to a 5x excess molar ratio along with 1mM AMPPNP and 1mM NAG.  Ligand bound complex crystals grew by hanging drop vapor diffusion in 20% PEG 3350 and 0.2M trisodium citrate",293,"10.1021/acsmedchemlett.0c00145",,"6W2J",331.29,"2.62","2.62","CPS1 bound to allosteric inhibitor H3B-374","MTRILTAFKVVRTLKTGFGFTNVTAHQKWKFSRPGIRLLSVKAQTAHIVLEDGTKMKGYSFGHPSSVAGEVVFNTGLGGYPEAITDPAYKGQILTMANPIIGNGGAPDTTALDELGLSKYLESNGIKVSGLLVLDYSKDYNHWLATKSLGQWLQEEKVPAIYGVDTRMLTKIIRDKGTMLGKIEFEGQPVDFVDPNKQNLIAEVSTKDVKVYGKGNPTKVVAVDCGIKNNVIRLLVKRGAEVHLVPWNHDFTKMEYDGILIAGGPGNPALAEPLIQNVRKILESDRKEPLFGISTGNLITGLAAGAKTYKMSMANRGQNQPVLNITNKQAFITAQNHGYALDNTLPAGWKPLFVNVNDQTNEGIMHESKPFFAVQFHPEVTPGPIDTEYLFDSFFSLIKKGKATTITSVLPKPALVASRVEVSKVLILGSGGLSIGQAGEFDYSGSQAVKAMKEENVKTVLMNPNIASVQTNEVGLKQADTVYFLPITPQFVTEVIKAEQPDGLILGMGGQTALNCGVELFKRGVLKEYGVKVLGTSVESIMATEDRQLFSDKLNEINEKIAPSFAVESIEDALKAADTIGYPVMIRSAYALGGLGSGICPNRETLMDLSTKAFAMTNQILVEKSVTGWKEIEYEVVRDADDNCVTVCNMENVDAMGVHTGDSVVVAPAQTLSNAEFQMLRRTSINVVRHLGIVGECNIQFALHPTSMEYCIIEVNARLSRSSALASKATGYPLAFIAAKIALGIPLPEIKNVVSGKTSACFEPSLDYMVTKIPRWDLDRFHGTSSRIGSSMKSVGEVMAIGRTFEESFQKALRMCHPSIEGFTPRLPMNKEWPSNLDLRKELSEPSSTRIYAIAKAIDDNMSLDEIEKLTYIDKWFLYKMRDILNMEKTLKGLNSESMTEETLKRAKEIGFSDKQISKCLGLTEAQTRELRLKKNIHPWVKQIDTLAAEYPSVTNYLYVTYNGQEHDVNFDDHGMMVLGCGPYHIGSSVEFDWCAVSSIRTLRQLGKKTVVVNCNPETVSTDFDECDKLYFEELSLERILDIYHQEACGGCIISVGGQIPNNLAVPLYKNGVKIMGTSPLQIDRAEDRSIFSAVLDELKVAQAPWKAVNTLNEALEFAKSVDYPCLLRPSYVLSGSAMNVVFSEDEMKKFLEEATRVSQEHPVVLTKFVEGAREVEMDAVGKDGRVISHAISEHVEDAGVHSGDATLMLPTQTISQGAIEKVKDATRKIAKAFAISGPFNVQFLVKGNDVLVIECNLRASRSFPFVSKTLGVDFIDVATKVMIGENVDEKHLPTLDHPIIPADYVAIKAPMFSWPRLRDADPILRCEMASTGEVACFGEGIHTAFLKAMLSTGFKIPQKGILIGIQQSFRPRFLGVAEQLHNEGFKLFATEATSDWLNANNVPATPVAWPSQEGQNPSLSSIRKLIRDGSIDLVINLPNNNTKFVHDNYVIRRTAVDSGIPLLTNFQVTKLFAEAVQKSRKVDSKSLFHYRQYSAGKAA","Homo sapiens","CPS1","Carbamoyl-phosphate synthase [ammonia], mitochondrial","1","6W2J"
"6W2Y","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2469-4",,"6W2Y",192.43,"3.2",,"CryoEM Structure of GABAB1b Homodimer","DYKDDDDKSHSPHLPRPHSRVPPHPSSERRAVYIGALFPMSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKCDPGQATKYLYELLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNLKRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDEMTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFYGYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGSRVHLLYKHHHHHH","Homo sapiens","GABBR1, GPRC3A","Gamma-aminobutyric acid type B receptor subunit 1","1","6W2Y"
"6W30",,"X-RAY DIFFRACTION",3.14,66.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"140 g/L PEG8000, 100 mM HEPES, 200 mM magnesium acetate, pH 7.5",277.15,"10.1021/acssynbio.1c00074",,"6W30",38.76,"2.1","2.1","Protein Tyrosine Phosphatase 1B Bound to Amorphadiene","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHNLEHHHHHH","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6W30"
"6W36",,"X-RAY DIFFRACTION",3.31,62.89,"LIQUID DIFFUSION",5.5,"1 M ammonium sulfate, 0.1 M Bis-Tris, pH 5.5, 1% PEG3350",293,"10.1016/j.str.2020.04.023",,"6W36",40.32,"2.854","2.854","Crystal structure of FAM46C","MAFSVLNWDQVSRLHEVLTEVVPIHGRGNFPTLEITLKDIVQTVRSRLEEAGIKVHDVRLNGSAAGHVLVKDNGLGCKDLDLIFHVALPTEAEFQLVRDVVLCSLLNFLPEGVNKLKISPVTLKEAYVQKLVKVCTDTDRWSLISLSNKNGKNVELKFVDSIRRQFEFSVDSFQIILDSLLFFYDCSNNPISEHFHPTVIGESMYGDFEEAFDHLQNRLIATKNPEEIRGGGLLKYSNLLVRDFRPTDQEEIKTLERYMCSRFFIDFPDILEQQRKLETYLQNHFAEEERSKYDYLMILRRVVNESTVCLMGHERRQTLNLISLLALRVLAEQNIIPSATNVTCYYQ","Homo sapiens","TENT5C, FAM46C","Terminal nucleotidyltransferase 5C","1","6W36"
"6W39",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES pH 6.5, 0.2 M magnesium acetate, 18% w/v PEG 8K",277,"10.1038/s41467-020-19974-5",,"6W39",99.6,"1.736","1.736","Structure of unphosphorylated IRE1 in complex with G-1749","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W39"
"6W3A",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M magnesium formate, 20 %w/v PEG 3350, and 1% CYMAL-1",277,"10.1038/s41467-020-19974-5",,"6W3A",100.11,"2.606","2.606","Structure of unphosphorylated IRE1 in complex with G-7658","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W3A"
"6W3B",,"X-RAY DIFFRACTION",2.98,58.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Hepes pH 7.5, 42% PEG200, 1 M lithium chloride, 3% w/v 6-aminohexanoic acid",277,"10.1038/s41467-020-19974-5",,"6W3B",49.56,"2.57","2.57","Structure of apo unphosphorylated IRE1","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W3B"
"6W3C",,"X-RAY DIFFRACTION",2.96,58.49,"VAPOR DIFFUSION, SITTING DROP",,"10% 2-propanol, 0.1 M sodium citrate tribasic dihydrate pH 5.0, and 26% PEG400, and 4% pentaerythritol ethoxylate, 4% 1,3-propanediol, 4% 1,3-butanediol",277,"10.1038/s41467-020-19974-5",,"6W3C",199.21,"2.3","2.3","Structure of phosphorylated apo IRE1","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W3C"
"6W3E",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.5, 0.1 M potassium dihydrogen phosphate, 16 %w/v PEG 8K, 5.2 mM FOS-MEA-10",277,"10.1038/s41467-020-19974-5",,"6W3E",100.06,"2.737","2.737","Structure of phosphorylated IRE1 in complex with G-0701","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W3E"
"6W3K",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, HANGING DROP",,"10% (v/v) isopropanol, 11% (w/v) PEG4000, 0.1 M Na-citrate, pH 5.6",277,"10.1038/s41467-020-19974-5",,"6W3K",49.99,"2.08","2.08","Structure of unphosphorylated human IRE1 bound to G-9807","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6W3K"
"6W44",,"X-RAY DIFFRACTION",2.32,46.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS.HCl pH 8.5, 25 %(v/v) PEG 550 MME",293,"10.1021/acs.jmedchem.0c02271",,"6W44",41.53,"1.64","1.64","Crystal structure of HAO1 in complex with indazole acid inhibitor - compound 4","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","6W44"
"6W45",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS.HCl pH 8.5, 25 %(v/v) PEG 550 MME",293,"10.1021/acs.jmedchem.0c02271",,"6W45",41.66,"1.7","1.7","Crystal structure of HAO1 in complex with biaryl acid inhibitor - compound 3","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","6W45"
"6W4C",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS HCl pH 8.5, 25 %(v/v) PEG 550 MME",293,"10.1021/acs.jmedchem.0c02271",,"6W4C",41.58,"1.75","1.75","Crystal structure of HAO1 in complex with indazole acid inhibitor - compound 5","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","6W4C"
"6W4O","4.8","ELECTRON MICROSCOPY",,,,,,,"10.1126/scisignal.aaz0240",,"6W4O",697.24,"4.8",,"CaMKII alpha-30 Cryo-EM reconstruction","STRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKSDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","1","6W4O"
,,,,,,,,,,,,,,,,"STRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKSDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","2","6W4O"
"6W4P","6.6","ELECTRON MICROSCOPY",,,,,,,"10.1126/scisignal.aaz0240",,"6W4P",697.24,"6.6",,"CaMKII alpha-30 Cryo-EM reconstruction - Class B","STRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKSDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","1","6W4P"
,,,,,,,,,,,,,,,,"STRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKSDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","2","6W4P"
"6W4R",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5 10% W/V PEG  8000 20% V/V ETHYLENE GLYCOL 0.03M SODIUM FLUORIDE 0.03M SODIUM BROMIDE 0.03M SODIUM IODIDE",292,,,"6W4R",105.55,"1.819","1.819","Structure of Tdp1 catalytic domain in complex with inhibitor XZ633p","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6W4R"
"6W4W",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, SITTING DROP",,"33% PEG 3350, 0.1 M Citric Acid/Sodium Citrate pH 4.0",273,"10.1021/acs.biochem.0c00474",,"6W4W",47.96,"1.77","1.77","Crystal Structure of the Fab fragment of humanized 5c8 antibody","DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"5c8 Fab light chain","1","6W4W"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"5c8 Fab heavy chain","2","6W4W"
"6W4Y",,"X-RAY DIFFRACTION",2.71,54.61,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350 and 0.25 M NH4H2PO4 at 23 degrees C",296,"10.1016/j.bmcl.2020.127356",,"6W4Y",47.06,"1.91","1.91","Structure of full-length human lambda-6A light chain JTO in complex with hydantoin stabilizer","NFMLNQPHSVSESPGKTVTISCTRSSGNIDSNYVQWYQQRPGSAPITVIYEDNQRPSGVPDRFAGSIDRSSNSASLTISGLKTEDEADYYCQSYDARNVVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"JTO light chain","1","6W4Y"
"6W4Z",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, HANGING DROP",,"0.1M sodium citrate dihydrate pH 5.6, 20% PEG 4000, 10% IPA",298.15,"10.1021/acs.jmedchem.0c00602","SZS","6W4Z",35.68,"1.59","1.59","Galectin-8N terminal domain in complex with Methyl 3-O-[3-O-benzyloxy]-malonyl-beta-D-galactopyranoside","MLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFS","Homo sapiens","LGALS8","Galectin-8","1","6W4Z"
"6W50",,"X-RAY DIFFRACTION",3.47,64.53,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.0c00464","SWP","6W50",29.13,"1.95","1.95","FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((10R,14S)- 14-(4-(3-CHLORO-2,6-DIFLUOROPHENYL)-6-OXO-3,6-DIHYDRO- 1(2H)-PYRIDINYL)-10-METHYL-9-OXO-8,16- DIAZATRICYCLO[13.3.1.0~2,7~]NONADECA-1(19),2,4,6,15,17- HEXAEN-5-YL)CARBAMATE","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","6W50"
"6W58",,"X-RAY DIFFRACTION",2.3,46.49,"VAPOR DIFFUSION",,"Protein [10 mg/mL in 50 mM tris(hydroxymethyl)aminomethane hydrochloride at pH 7.5, 50 mM sodium chloride, 1 mM dithiothreitol, 15 mM glutathione, and 1 mM magnesium chloride] was mixed with an equal volume of precipitant solution (21% poly(ethylene glycol) 6000, 1% 1,4-dioxane, 5.5% glycerol, 10 mM dithiothreitol, and 60 mM tris(hydroxymethyl)aminomethane hydrochloride at pH 8.5",295,"10.1016/j.bmc.2020.115791","SWS","6W58",47.79,"2.395","2.395","hPGDS complexed with an aza-quinoline","MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","6W58"
"6W5A",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 3350, 0.1 M Citric Acid/Sodium Citrate pH 3.8",273,"10.1021/acs.biochem.0c00474",,"6W5A",48.08,"1.75","1.75","Crystal Structure of the Fab fragment of humanized 5c8 antibody containing the fluorescent non-canonical amino acid L-(7-hydroxycoumarin-4-yl)ethylglycine at pH 9.7","QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"Antibody 5c8* Fab Heavy Chain","1","6W5A"
,,,,,,,,,,,,,,,,"DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEXPPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody 5c8* Fab Light Chain","2","6W5A"
"6W5B",,"X-RAY DIFFRACTION",1.97,37.53,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium chloride, 20% w/v PEG 3350",291,"10.1016/j.str.2020.11.006",,"6W5B",20.64,"1.15","1.15","N124D Deamidation Mutant of Human gammaD-Crystallin","GKITLYEDRGFQGRHYECSSDHPNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLDVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","6W5B"
"6W5D",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 0.1 M bis-tris pH 5.5, 25% PEG 3350",293.15,"10.1371/journal.ppat.1008943",,"6W5D",110.23,"2","2","Crystal Structure of Fab RSB1","MEFGLSWVFLVAILEGVHCQVQLVQSGAEVKKPGSSVKVSCKTSGGTYGTYSINWVRQAPGQGLEWMGAIIPIFGKTNYAQKFQGRVTITADASTSTAYMELGSLTSEDTAMYYCARVEDTALDHYFDYWGQGALVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGSENLYFQGGWSHPQFEKGGGSGGGSGGGSWSHPQFEK","Homo sapiens",,"RSB1 Fab Heavy Chain","1","6W5D"
,,,,,,,,,,,,,,,,"METPAELLFLLLLWLPDTTGQSALTQPRSVSGSPGQSVTISCTGTSGDVGTYNYVSWYQQLPGKAPKLMIYDVTRRPSGVPDRFSGSKSGNTASLTISGLQADDEADYYCCSYAGTLTWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"RSB1 Fab Light Chain","2","6W5D"
"6W5R","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.05.020",,"6W5R",150.48,"3.6",,"NPC1 structure in Nanodisc","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNFLEGSDEVDAGSHHHHHHHHHHGSVEDYKDDDDK","Homo sapiens","NPC1","NPC intracellular cholesterol transporter 1","1","6W5R"
"6W5S","3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.05.020",,"6W5S",151.24,"3",,"NPC1 structure in GDN micelles at pH 8.0","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNFLEGSDEVDAGSHHHHHHHHHHGSVEDYKDDDDK","Homo sapiens","NPC1","NPC intracellular cholesterol transporter 1","1","6W5S"
"6W5T","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.05.020",,"6W5T",150.87,"3.7",,"NPC1 structure in GDN micelles at pH 5.5, conformation a","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNFLEGSDEVDAGSHHHHHHHHHHGSVEDYKDDDDK","Homo sapiens","NPC1","NPC intracellular cholesterol transporter 1","1","6W5T"
"6W5U","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.05.020",,"6W5U",150.87,"3.9",,"NPC1 structure in GDN micelles at pH 5.5, conformation b","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNFLEGSDEVDAGSHHHHHHHHHHGSVEDYKDDDDK","Homo sapiens","NPC1","NPC intracellular cholesterol transporter 1","1","6W5U"
"6W65",,"X-RAY DIFFRACTION",2.88,57.33,"VAPOR DIFFUSION, SITTING DROP",,"100mM Sodium citrate pH5.5, 18%w/v PEG3350",291.15,"10.1016/j.chembiol.2020.06.009",,"6W65",96.23,"2.13","2.13","Human PARP16 in complex with RBN010860","SMGWAAAREAAGRDMLAADLRCSLFASALQSYKRDSVLRPFPASYARGDCKDFEALLADASKLPNLKELLQSSGDNHKRAWDLVSWILSSKVLTIHSAGKAEFEKIQKLTGAPHTPVPAPDFLFEIEYFDPANAKFYETKGERDLIYAFHGSRLENFHSIIHNGLHCHLNKTSLFGEGTYLTSDLSLALIYSPHGHGWQHSLLGPILSCVAVCEVIDHPDVKCQTKKKDSKEIDRRRARIKHSEGGDIPPKYFVVTNNQLLRVKYLLVYSQKPPKRA","Homo sapiens","PARP16, ARTD15, C15orf30","Protein mono-ADP-ribosyltransferase PARP16","1","6W65"
"6W67",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",,"160-400 mM lithium acetate and 14-18% PEG 3350 1:1 with protein at 11mg/ml in 150 mM NaCl, 25 mM Tris-HCl pH 8.0, 1 mM TCEP",293,"10.1038/s41586-020-2636-7",,"6W67",14.94,"2.2","2.2","The structure of S172A Keap1-BTB domain","GGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6W67"
"6W68",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, HANGING DROP",,"160-400 mM lithium acetate and 14-18% PEG 3350 1:1 with protein at 11mg/ml in 150 mM NaCl, 25 mM Tris-HCl pH 8.0, 1 mM TCEP",293,"10.1038/s41586-020-2636-7",,"6W68",14.91,"2.55","2.55","The structure of V98A S172A Keap1-BTB domain","GGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKAVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6W68"
"6W69",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, HANGING DROP",,"160-400 mM lithium acetate and 14-18% PEG 3350 1:1 with protein at 11mg/ml in 150 mM NaCl, 25 mM Tris-HCl pH 8.0, 1 mM TCEP",293,"10.1038/s41586-020-2636-7",,"6W69",14.86,"2.501","2.501","The structure of F64, S172A Keap1-BTB domain","GGNRTFSYTLEDHTKQAAGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6W69"
"6W6C",,"X-RAY DIFFRACTION",3.06,59.85,"EVAPORATION",,"0.2 M Ammonium sulfate, 0.1 M Tris pH 48.5, 20% PEG3350",285,"10.1074/jbc.RA120.014236",,"6W6C",70.58,"2.38","2.38","Structural and catalytic roles of human 18S rRNA methyltransferases DIMT1 in ribosome assembly and translation","MPKVKSGAIGRRRGRQEQRRELKSAGGLMFNTGIGQHILKNPLIINSIIDKAALRPTDVVLEVGPGTGNMTVKLLEKAKKVVACELDPRLVAELHKRVQGTPVASKLQVLVGDVLKTDLPFFDTCVANLPYQISSPFVFKLLLHRPFFRCAILMFQREFALRLVAKPGDKLYCRLSINTQLLARVDHLMKVGKNNFRPPPKVESSVVRIEPKNPPPPINFQEWDGLVRITFVRKNKTLSAAFKSSAVQQLLEKNYRIHCSVHNIIIPEDFSIADKIQQILTSTGFSDKRARSMDIDDFIRLLHGFNAEGIHFS","Homo sapiens","DIMT1, DIMT1L, HUSSY-05","Probable dimethyladenosine transferase","1","6W6C"
"6W6D",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, SITTING DROP",7,"12% (w/v) PEG3350, 4% (v/v) Tascimate TM pH 7.0",291,"10.1021/acs.jmedchem.0c02160",,"6W6D",42.93,"1.91","1.91","Crystal Structure of Human Protein arginine N-methyltransferase 6 (PRMT6) in complex with SGC6870 inhibitor","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","6W6D"
"6W6F",,"X-RAY DIFFRACTION",3.09,60.16,"EVAPORATION",,"0.2 M Ammonium sulfate, 0.1 M Tris pH 48.5, 20% PEG3350",285,"10.1074/jbc.RA120.014236",,"6W6F",70.58,"3.2","3.2","Structural and catalytic roles of human 18S rRNA methyltransferases DIMT1 in ribosome assembly and translation","MPKVKSGAIGRRRGRQEQRRELKSAGGLMFNTGIGQHILKNPLIINSIIDKAALRPTDVVLEVGPGTGNMTVKLLEKAKKVVACELDPRLVAELHKRVQGTPVASKLQVLVGDVLKTDLPFFDTCVANLPYQISSPFVFKLLLHRPFFRCAILMFQREFALRLVAKPGDKLYCRLSINTQLLARVDHLMKVGKNNFRPPPKVESSVVRIEPKNPPPPINFQEWDGLVRITFVRKNKTLSAAFKSSAVQQLLEKNYRIHCSVHNIIIPEDFSIADKIQQILTSTGFSDKRARSMDIDDFIRLLHGFNAEGIHFS","Homo sapiens","DIMT1, DIMT1L, HUSSY-05","Probable dimethyladenosine transferase","1","6W6F"
"6W73",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG1500, 8%MPD, 0.1M Tris pH8.5",296,,,"6W73",47.46,"2.8","2.8","Fab Structure of CD4 Binding Site (CD4bs) Huamn Monoclonal Antibody HmAb64","DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLISATSSLQSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSYSTPWTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"HmAb64 fab light chain","1","6W73"
,,,,,,,,,,,,,,,,"EVQLVESGAEVKKPGASVKVSCKASGYTFTSYDITWVRQAPGQGLEWMGWISAYNGDTNYAQRLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARAKHTVLVTAMRWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"HmAb64 fab heavy chain","2","6W73"
"6W74",,"X-RAY DIFFRACTION",2.02,39.15,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Magnesium Acetate Tetrahydrate, 20% w/v PEG3350",298,,,"6W74",12.56,"2.11","2.11","Structure of cIAP with compound 15","GSGPGSSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRY","Homo sapiens","BIRC2, API1, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","6W74"
"6W7F",,"X-RAY DIFFRACTION",2.75,55.2,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5, 4.3 M Sodium Formate, 18% Glycerol, 10 mM TCEP",293,"10.1021/acs.jmedchem.0c00479","Q3D","6W7F",43.46,"2.2","2.2","Structure of EED bound to inhibitor 5285","SNAKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSTDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6W7F"
"6W7G",,"X-RAY DIFFRACTION",2.73,54.9,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5, 4.2 M Sodium Formate, 18% glycerol, 10 mM TCEP",293,"10.1021/acs.jmedchem.0c00479","Q3A","6W7G",43.88,"1.85","1.85","Structure of EED bound to inhibitor 1056","SNAKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSTDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6W7G"
"6W7J",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",292,,,"6W7J",105.28,"1.489","1.489","Structure of Tdp1 catalytic domain in complex with inhibitor XZ635p","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6W7J"
"6W7K",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5 10% w/v PEG 8000 20% v/v ethylene glycol 0.03 M sodium fluoride 0.03 M sodium bromide 0.03 M sodium iodide",292,,,"6W7K",105.25,"1.7","1.7","Structure of Tdp1 catalytic domain in complex with inhibitor XZ634p","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6W7K"
"6W7L",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MOPS/HEPES-Na pH 7.5 10% w/v PEG 8000 20% v/v ethylene glycol 0.03M sodium fluoride 0.03M sodium bromide 0.03M sodium iodide",292,,,"6W7L",105.25,"1.856","1.856","Structure of Tdp1 catalytic domain in complex with inhibitor XZ632p","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6W7L"
"6W7Y",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M imidazole, pH 6.5, 40% 2-propanol, 15% PEG8000",293,,,"6W7Y",95.9,"3.3","3.3","Crystal structure of SARS-CoV and SARS-CoV-2 reactive human antibody CR3022","EVQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"CR3022 Heavy chain","1","6W7Y"
,,,,,,,,,,,,,,,,"DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CR3022 Light chain","2","6W7Y"
"6W8H",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION",,"50mM Tris(hydroxymethyl)aminomethane hydrochloride pH 7.5, 50 mM sodium chloride, 1mM DTT, 15 mM glutathione, 1 mM MgCl2",295,"10.1016/j.bmc.2020.115791","TJG","6W8H",51.75,"1.97","1.97","H-PGDS complexed with inhibitor 1Y","MHHHHHHENLYFQGMPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","6W8H"
"6W8L",,"X-RAY DIFFRACTION",2.05,40.14,"EVAPORATION",8,"0.1 M Tris pH 8.5, 6-9% MPD, 24-29% PEG-1500",298,"10.1016/j.bmc.2020.115481","R4S","6W8L",36.8,"2.11","2.11","Crystal structure of JAK1 kinase with compound 10","GSIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6W8L"
"6W8N","3.2","ELECTRON MICROSCOPY",,,,,,,,,"6W8N",111.33,"3.2",,"Structure of a trans-membrane protein","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6W8N"
"6W8O","3.4","ELECTRON MICROSCOPY",,,,,,,,,"6W8O",111.33,"3.4",,"Structure of an Apo membrane protein","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6W8O"
"6W8P","3.6","ELECTRON MICROSCOPY",,,,,,,,,"6W8P",111.45,"3.6",,"Structure of membrane protein with ions","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6W8P"
"6W92",,"X-RAY DIFFRACTION",1.93,36.35,"VAPOR DIFFUSION, HANGING DROP",5.75,"0.1 M Bis-Tris, pH = 5.5, 25 % w/v PEG 3350",295,"10.1038/s41598-020-80588-4",,"6W92",19.21,"1.3","1.3","Human UHRF1 TTD domain","SNADEDMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERP","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","6W92"
"6W9N",,"SOLUTION NMR",,,,,,,"10.1111/tra.12771",,"6W9N",9.07,,,"Solution structure of the FYVE domain of ALFY","SNAGRSAADHWVKDEGGDSCSGCSVRFSLTERRHHCRNCGQLFCQKCSRFQSEIKRLKISSPVRVCQNCYYNLQHERG","Homo sapiens","WDFY3, KIAA0993","WD repeat and FYVE domain-containing protein 3","1","6W9N"
"6WA2",,"X-RAY DIFFRACTION",2.07,40.69,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG-3350 0.1 M BisTris",298,"10.1021/acs.jmedchem.1c00848",,"6WA2",151.93,"2.4","2.4","Crystal structure of EGFR(T790M/V948R) in complex with LN3753","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6WA2"
"6WAB",,"X-RAY DIFFRACTION",2.15,42.71,"VAPOR DIFFUSION, HANGING DROP",7,"1.6 M ammonium sulfate, 4% (v/v) polyethylene glycol (PEG) 400, 0.1 M HEPES pH 7.0",293,,,"6WAB",62.88,"2.28","2.28","Crystal structure of human galectin-4 C-terminal carbohydrate recognition domain in complex with galactose derivative","GPPTFNPPVPYFGRLQGGLTARRTIIIKGYVPPTGKSFAINFKVGSSGDIALHINPRMGNGTVVRNSLLNGSWGSEEKKITHNPFGPGQFFDLSIRCGLDRFKVYANGQHLFDFAHRLSAFQRVDTLEIQGDVTLSYVQI","Homo sapiens","LGALS4","Galectin-4","1","6WAB"
"6WAD",,"X-RAY DIFFRACTION",2.87,57.17,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350 20%, 0.2 M di-Sodium Tartrate",291,,,"6WAD",42.85,"2.45","2.45","Crystal Structure of Human Protein arginine N-methyltransferase 6 (PRMT6) in complex with MT2739 inhibitor","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","6WAD"
"6WAJ",,"X-RAY DIFFRACTION",1.78,30.73,"VAPOR DIFFUSION, SITTING DROP",,"2.5 M ammonium sulfate, 0.1 M Tris",291,,,"6WAJ",10.58,"1.9","1.9","Crystal structure of the UBL domain of human NLE1","GMAAAVADEAVARDVQRLLVQFQDEGGQLLGSPFDVPVDITPDRLQLVCNALLAQEDPLPLAFFVHDAEIVSSLGKTLESQAVETEKVLDIIYQPQAI","Homo sapiens","NLE1, HUSSY-07","NLE1","1","6WAJ"
"6WAK",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG-3350, 0.1 M BisTris",298,"10.1021/acs.jmedchem.1c00848",,"6WAK",152.1,"2.4","2.4","A crystal structure of EGFR(T790M/V948R) in complex with LN3754","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6WAK"
"6WAX",,"X-RAY DIFFRACTION",2.47,50.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.3 M Ammonium Sulfate, 0.1 M Bis Tris pH 6.5",293,"10.1074/jbc.RA120.013976",,"6WAX",25.5,"1.5","1.5","C-terminal SH2 domain of p120RasGAP","GSGREEDPHEGKIWFHGKISKQEAYNLLMTVGQVSSFLVRPSDNTPGDYSLYFRTNENIQRFKISPTPNNQFMMGGRYYNSIGDIIDHYRKEQIVEGYYLKEPVPMQ","Homo sapiens","RASA1, GAP, RASA","Ras GTPase-activating protein 1","1","6WAX"
"6WB3",,"X-RAY DIFFRACTION",1.89,35.01,"VAPOR DIFFUSION",4.6,"0.1 M sodium acetate pH 4.6, 0.2 M NH4SO4, 16% w/v PEG 4000",291,"10.1016/j.jmb.2021.166889",,"6WB3",8.06,"1.35","1.35","Crystal structure of coiled coil region of human septin 4","XETEKLIREKDEELRRMQEMLHKIQKQMKENX","Homo sapiens","SEPTIN4, C17orf47, PNUTL2, SEP4, SEPT4, hucep-7","Septin-4","1","6WB3"
"6WB8","3.24","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1920777117",,"6WB8",348.72,"3.24",,"Cryo-EM structure of PKD2 C331S disease variant","GMGSAAPGGLCEQRGLEIEMQRIRQAAARDPPAGAAASPSPPLSSCSRQAWSRDNPGFEAEEEEEEVEGEEGGMVVEMDVEWRPGSRRSAASSAVSSVGARSRGLGGYHGAGHPSGRRRRREDQGPPCPSPVGGGDPLHRHLPLEGQPPRVAWAERLVRGLRGLWGTRLMEESSTNREKYLKSVLRELVTYLLFLIVLCILTYGMMSSNVYYYTRMMSQLFLDTPVSKTEKTNFKTLSSMEDFWKFTEGSLLDGLYWKMQPSNQTEADNRSFIFYENLLLGVPRIRQLRVRNGSSSIPQDLRDEIKECYDVYSVSSEDRAPFGPRNGTAWIYTSEKDLNGSSHWGIIATYSGAGYYLDLSRTREETAAQVASLKKNVWLDRGTRATFIDFSVYNANINLFCVVRLLVEFPATGGVIPSWQFQPLKLIRYVTTFDFFLAACEIIFCFFIFYYVVEEILEIRIHKLHYFRSFWNCLDVVIVVLSVVAIGINIYRTSNVEVLLQFLEDQNTFPNFEHLAYWQIQFNNIAAVTVFFVWIKLFKFINFNRTMSQLSTTMSRCAKDLFGFAIMFFIIFLAYAQLAYLVFGTQVDDFSTFQECIFTQFRIILGDINFAEIEEANRVLGPIYFTTFVFFMFFILLNMFLAIINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLD","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","6WB8"
"6WBE",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M zinc acetate, 12% w/v PEG 3350",291,"10.1016/j.jmb.2021.166889",,"6WBE",15.79,"2.1","2.1","Crystal structure of coiled coil region of human septin 1","DTEKLIREKDEELRRMQEMLEKMQAQMQQS","Homo sapiens","SEPTIN1, DIFF6, PNUTL3, SEPT1","Septin-1","1","6WBE"
"6WBF","2.83","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBF",322.58,"2.83",,"Cryo-EM structure of wild type human Pannexin 1 channel","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMI","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBF"
"6WBG","2.97","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBG",322.58,"2.97",,"Cryo-EM structure of human Pannexin 1 channel with its C-terminal tail cleaved by caspase-7","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMI","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBG"
"6WBI","4.39","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBI",294.59,"4.39",,"Cryo-EM structure of human Pannexin 1 channel with its C-terminal tail cleaved by caspase-7, in complex with CBX","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLG","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBI"
"6WBK","6.01","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBK",293.62,"6.01",,"Cryo-EM structure of human Pannexin 1 channel with deletion of N-terminal helix and C-terminal tail","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNL","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBK"
"6WBL","5.13","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBL",294.19,"5.13",,"Cryo-EM structure of human Pannexin 1 channel with deletion of N-terminal helix and C-terminal tail, in complex with CBX","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNL","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBL"
"6WBM","2.86","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBM",320.73,"2.86",,"Cryo-EM structure of human Pannexin 1 channel N255A mutant","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRADSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMI","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBM"
"6WBN","2.83","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2357-y",,"6WBN",641.46,"2.83",,"Cryo-EM structure of human Pannexin 1 channel N255A mutant, gap junction","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRADSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMI","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6WBN"
"6WBP",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, HANGING DROP",4.3,"0.1 M citric acid pH 4.3, 1.8 M ammonium sulfate",291,"10.1016/j.jmb.2021.166889",,"6WBP",15.47,"1.8","1.8","Crystal structure of coiled coil region of human septin 6","GSHMWVQRVKEKEAELKEAEKELHEKFDRLKKLHQDEKKKLEDKKKSLDDEVNAFKQR","Homo sapiens","SEPTIN6, KIAA0128, SEP2, SEPT6","Septin-6","1","6WBP"
"6WBS",,"X-RAY DIFFRACTION",2.59,52.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"CFTR NBD1 V510D in buffer A was crystallized by mixing equal amounts of protein at 6 mg/mL with 0.1 M Tris pH 7.6, 28% (w/v) polyethylene glycol 10,000. Crystallization was induced by streak-seeding using crystals grown in 0.1 M HEPES, pH 7.5, 25% (w/v) polyethylene glycol 550 monomethylether, and plates incubated at 4C. Crystals grew over several days and were frozen by quick dip in reservoir solution supplemented with 25% (w/v) ethylene glycol",277,,,"6WBS",51.39,"1.857","1.857","Human CFTR first nucleotide binding domain with dF508/V510D","TTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGDSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","6WBS"
"6WBW",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, 0.1 M Hepes pH 7.5",293,"10.1016/j.bmcl.2020.127197",,"6WBW",131.75,"1.46","1.46","Structure of Human HDAC2 in complex with an ethyl ketone inhibitor","MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6WBW"
"6WBZ",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, 0.1 M Hepes pH 7.5",293,"10.1016/j.bmcl.2020.127197",,"6WBZ",133.02,"1.32","1.32","Structure of Human HDAC2 in complex with an ethyl ketone inhibitor containing a spiro-bicyclic group","MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6WBZ"
"6WC9","2.64","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53430",,"6WC9",111.61,"2.64",,"Human open state TMEM175 in KCl","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6WC9"
"6WCA","3.03","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53430",,"6WCA",111.53,"3.03",,"Human closed state TMEM175 in KCl","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6WCA"
"6WCB","3.17","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53430",,"6WCB",112.26,"3.17",,"Human open state TMEM175 in CsCl","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6WCB"
"6WCC","3.24","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53430",,"6WCC",112,"3.24",,"Human closed state TMEM175 in CsCl","MSQPRTPEQALDTPGDCPPGRRDEDAGEGIQCSQRMLSFSDALLSIIATVMILPVTHTEISPEQQFDRSVQRLLATRIAVYLMTFLIVTVAWAAHTRLFQVVGKTDDTLALLNLACMMTITFLPYTFSLMVTFPDVPLGIFLFCVCVIAIGVVQALIVGYAFHFPHLLSPQIQRSAHRALYRRHVLGIVLQGPALCFAAAIFSLFFVPLSYLLMVTVILLPYVSKVTGWCRDRLLGHREPSAHPVEVFSFDLHEPLSKERVEAFSDGVYAIVATLLILDICEDNVPDPKDVKERFSGSLVAALSATGPRFLAYFGSFATVGLLWFAHHSLFLHVRKATRAMGLLNTLSLAFVGGLPLAYQQTSAFARQPRDELERVRVSCTIIFLASIFQLAMWTTALLHQAETLQPSVWFGGREHVLMFAKLALYPCASLLAFASTCLLSRFSVGIFHLMQIAVPCAFLLLRLLVGLALATLRVLRGLARPEHPPPAPTGQDDPQSQLLPAPC","Homo sapiens","TMEM175","Endosomal/lysosomal potassium channel TMEM175","1","6WCC"
"6WCK",,"X-RAY DIFFRACTION",1.85,33.45,"VAPOR DIFFUSION, SITTING DROP",7,"80 mM NaCl, 12 mM KCl, 20 mM MgCl.6H2O, 40 mM Na-cacodylate.3H2O pH 7.0, 35% v/v MPD, 12 mM spermine.4HCl",293,"10.1093/nar/gkaa262",,"6WCK",14.43,"1.801","1.801","KRAS G-quadruplex G16T mutant with Bromo Uracil replacing T8 and T16.","AGGGCGGUGTGGGAAUAGGGAA","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*CP*GP*GP*(BRU)P*GP*TP*GP*GP*GP*AP*AP*(BRU)P*AP*GP*GP*GP*AP*A)-3')","1","6WCK"
"6WCU",,"X-RAY DIFFRACTION",1.67,26.41,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M citric acid pH 5.0, 1.6 M ammonium sulfate",291,"10.1016/j.jmb.2021.166889",,"6WCU",7.78,"1.8","1.8","Crystal structure of coiled coil region of human septin 5","ETEKLIRMKDEELRRMQEMLQRMKQQMQDQ","Homo sapiens","SEPTIN5, PNUTL1, SEPT5","Septin-5","1","6WCU"
"6WCY",,"X-RAY DIFFRACTION",1.82,32.41,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M succinic acid (pH 7.0), 15% w/v PEG 3350",295,"10.1016/j.str.2020.11.006",,"6WCY",41.37,"1.204","1.204","N160D Deamidation Mutant of Human gammaD-Crystallin","GKITLYEDRGFQGRHYECSSDHPNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATDARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","6WCY"
"6WDP",,"X-RAY DIFFRACTION",3.01,59.11,"VAPOR DIFFUSION",5.9,"1.75 M ammonium sulfate, 0.2 M NaCl, and 0.1 M sodium cacodylate pH 5.9",293,"10.1016/j.cell.2021.01.018",,"6WDP",25.07,"2.01","2.01","Interleukin 12 receptor subunit beta-1","SECCFQDPPYPDADSGSASGPRDLRCYRISSDRYECSWQYEGPTAGVSHFLRCCLSSGRCCYFAAGSATRLQFSDQAGVSVLYTVTLWVESWARNQTEKSPEVTLQLYNSVKYEPPLGDIKVSKLAGQLRMEWETPDNQVGAEVQFRHRTPSSPWKLGDCGPQDDDTESCLCPLEMNVAQEFQLRRRQLGSQGSSWSKWSSPVCVPPENPPQPHHHHHH","Homo sapiens","IL12RB1, IL12R, IL12RB","Interleukin-12 receptor subunit beta-1","1","6WDP"

"6WE2",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulfate; 0.1 M tri-Sodium citrate pH 5.6; 25 % w/v PEG 4000",291.15,"10.1016/j.chembiol.2021.02.010",,"6WE2",44.13,"2.66","2.66","Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759","KQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Isoform 1 of Protein mono-ADP-ribosyltransferase PARP14","1","6WE2"
"6WE3",,"X-RAY DIFFRACTION",2.77,55.62,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M Ammonium sulfate, 0.1 M MES pH 6.5, 10% v/v Jeffamine M-600",291.15,"10.1016/j.chembiol.2021.02.010",,"6WE3",46.59,"1.95","1.95","Human PARP14 (ARTD8), catalytic fragment in complex with compound 3","SNADMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Protein mono-ADP-ribosyltransferase PARP14","1","6WE3"
"6WE4",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Lithium nitrate, 14% w/v PEG 3350",291.15,"10.1016/j.chembiol.2021.02.010",,"6WE4",45.64,"1.6","1.6","Human PARP14 (ARTD8), catalytic fragment in complex with compound 2","SNADMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Protein mono-ADP-ribosyltransferase PARP14","1","6WE4"
"6WE8",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1-0.15M ammonium sulfate
0.1 M Bis-Tris pH 5.5
25-29% PEG 3350",292,"10.1093/nar/gkaa604",,"6WE8",38.81,"1.18","1.18","YTH domain of human YTHDC1","GTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTH domain-containing protein 1","1","6WE8"
"6WET",,"X-RAY DIFFRACTION",3.3,62.69,"VAPOR DIFFUSION, SITTING DROP",,"7.5 mg/mL protein against 19-22% PEG4000, 240-270 mM trilithium/triammonium/tripotassium citrate",281,"10.1107/S2059798320010505",,"6WET",214.01,"2.6","2.6","Crystal structures of human E-NPP 1: apo","MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSLVLSVCVLTTILGCIFGLKPSCAKEVKSCKGRCFERTFGNCRCDAACVELGNCCLDYQETCIEPEHIWTCNKFRCGEKRLTRSLCACSDDCKDKGDCCINYSSVCQGEKSWVEEPCESINEPQCPAGFETPPTLLFSLDGFRAEYLHTWGGLLPVISKLKKCGTYTKNMRPVYPTKTFPNHYSIVTGLYPESHGIIDNKMYDPKMNASFSLKSKEKFNPEWYKGEPIWVTAKYQGLKSGTFFWPGSDVEINGIFPDIYKMYNGSVPFEERILAVLQWLQLPKDERPHFYTLYLEEPDSSGHSYGPVSSEVIKALQRVDGMVGMLMDGLKELNLHRCLNLILISDHGMEQGSCKKYIYLNKYLGDVKNIKVIYGPAARLRPSDVPDKYYSFNYEGIARNLSCREPNQHFKPYLKHFLPKRLHFAKSDRIEPLTFYLDPQWQLALNPSERKYCGSGFHGSDNVFSNMQALFVGYGPGFKHGIEADTFENIEVYNLMCDLLNLTPAPNNGTHGSLNHLLKNPVYTPKHPKEVHPLVQCPFTRNPRDNLGCSCNPSILPIEDFQTQFNLTVAEEKIIKHETLPYGRPRVLQKENTICLLSQHQFMSGYSQDILMPLWTSYTVDRNDSFSTEDFSNCLYQDFRIPLSPVHKCSFYKNNTKVSYGFLSPPQLNKNSSGIYSEALLTTNIVPMYQSFQVIWRYFHDTLLRKYAEERNGVNVVSGPVFDFDYDGRCDSLENLRQKRRVIRNQEILIPTHFFIVLTSCKDTSQTPLHCENLDTLAFILPHRTDNSESCVHGKHDSSWVEELLMLHRARITDVEHITGLSFYQQRKEPVSDILKLKTHLPTFSQED","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","6WET"
"6WEU",,"X-RAY DIFFRACTION",3.32,62.9,"VAPOR DIFFUSION, SITTING DROP",,"7.5 mg/mL protein against 19-22% PEG4000, 240-270 mM trilithium/triammonium/tripotassium citrate",281,"10.1107/S2059798320010505",,"6WEU",214.3,"2.65","2.65","Crystal structures of human E-NPP 1: bound to adenosine-5'-thio-monophosphate","MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSLVLSVCVLTTILGCIFGLKPSCAKEVKSCKGRCFERTFGNCRCDAACVELGNCCLDYQETCIEPEHIWTCNKFRCGEKRLTRSLCACSDDCKDKGDCCINYSSVCQGEKSWVEEPCESINEPQCPAGFETPPTLLFSLDGFRAEYLHTWGGLLPVISKLKKCGTYTKNMRPVYPTKTFPNHYSIVTGLYPESHGIIDNKMYDPKMNASFSLKSKEKFNPEWYKGEPIWVTAKYQGLKSGTFFWPGSDVEINGIFPDIYKMYNGSVPFEERILAVLQWLQLPKDERPHFYTLYLEEPDSSGHSYGPVSSEVIKALQRVDGMVGMLMDGLKELNLHRCLNLILISDHGMEQGSCKKYIYLNKYLGDVKNIKVIYGPAARLRPSDVPDKYYSFNYEGIARNLSCREPNQHFKPYLKHFLPKRLHFAKSDRIEPLTFYLDPQWQLALNPSERKYCGSGFHGSDNVFSNMQALFVGYGPGFKHGIEADTFENIEVYNLMCDLLNLTPAPNNGTHGSLNHLLKNPVYTPKHPKEVHPLVQCPFTRNPRDNLGCSCNPSILPIEDFQTQFNLTVAEEKIIKHETLPYGRPRVLQKENTICLLSQHQFMSGYSQDILMPLWTSYTVDRNDSFSTEDFSNCLYQDFRIPLSPVHKCSFYKNNTKVSYGFLSPPQLNKNSSGIYSEALLTTNIVPMYQSFQVIWRYFHDTLLRKYAEERNGVNVVSGPVFDFDYDGRCDSLENLRQKRRVIRNQEILIPTHFFIVLTSCKDTSQTPLHCENLDTLAFILPHRTDNSESCVHGKHDSSWVEELLMLHRARITDVEHITGLSFYQQRKEPVSDILKLKTHLPTFSQED","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","6WEU"
"6WEV",,"X-RAY DIFFRACTION",3.26,62.23,"VAPOR DIFFUSION, SITTING DROP",,"7.5 mg/mL protein against 19-22% PEG4000, 240-270 mM trilithium/triammonium/tripotassium citrate",281,"10.1107/S2059798320010505",,"6WEV",214.52,"2.9","2.9","Crystal structures of human E-NPP 1: bound to N-{[1-(6,7-dimethoxy-5,8-dihydroquinazolin-4-yl)piperidin-4-yl]methyl}sulfuric diamide","MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSLVLSVCVLTTILGCIFGLKPSCAKEVKSCKGRCFERTFGNCRCDAACVELGNCCLDYQETCIEPEHIWTCNKFRCGEKRLTRSLCACSDDCKDKGDCCINYSSVCQGEKSWVEEPCESINEPQCPAGFETPPTLLFSLDGFRAEYLHTWGGLLPVISKLKKCGTYTKNMRPVYPTKTFPNHYSIVTGLYPESHGIIDNKMYDPKMNASFSLKSKEKFNPEWYKGEPIWVTAKYQGLKSGTFFWPGSDVEINGIFPDIYKMYNGSVPFEERILAVLQWLQLPKDERPHFYTLYLEEPDSSGHSYGPVSSEVIKALQRVDGMVGMLMDGLKELNLHRCLNLILISDHGMEQGSCKKYIYLNKYLGDVKNIKVIYGPAARLRPSDVPDKYYSFNYEGIARNLSCREPNQHFKPYLKHFLPKRLHFAKSDRIEPLTFYLDPQWQLALNPSERKYCGSGFHGSDNVFSNMQALFVGYGPGFKHGIEADTFENIEVYNLMCDLLNLTPAPNNGTHGSLNHLLKNPVYTPKHPKEVHPLVQCPFTRNPRDNLGCSCNPSILPIEDFQTQFNLTVAEEKIIKHETLPYGRPRVLQKENTICLLSQHQFMSGYSQDILMPLWTSYTVDRNDSFSTEDFSNCLYQDFRIPLSPVHKCSFYKNNTKVSYGFLSPPQLNKNSSGIYSEALLTTNIVPMYQSFQVIWRYFHDTLLRKYAEERNGVNVVSGPVFDFDYDGRCDSLENLRQKRRVIRNQEILIPTHFFIVLTSCKDTSQTPLHCENLDTLAFILPHRTDNSESCVHGKHDSSWVEELLMLHRARITDVEHITGLSFYQQRKEPVSDILKLKTHLPTFSQED","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","6WEV"
"6WEW",,"X-RAY DIFFRACTION",3.36,63.35,"VAPOR DIFFUSION, SITTING DROP",,"7.5 mg/mL protein against 19-22% PEG4000, 240-270 mM trilithium/triammonium/tripotassium citrate",281,"10.1107/S2059798320010505",,"6WEW",215.04,"2.73","2.73","Crystal structures of human E-NPP 1: bound to N-{4-[(7-methoxyquinolin-4-yl)oxy]phenyl}sulfuric diamide","MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSLVLSVCVLTTILGCIFGLKPSCAKEVKSCKGRCFERTFGNCRCDAACVELGNCCLDYQETCIEPEHIWTCNKFRCGEKRLTRSLCACSDDCKDKGDCCINYSSVCQGEKSWVEEPCESINEPQCPAGFETPPTLLFSLDGFRAEYLHTWGGLLPVISKLKKCGTYTKNMRPVYPTKTFPNHYSIVTGLYPESHGIIDNKMYDPKMNASFSLKSKEKFNPEWYKGEPIWVTAKYQGLKSGTFFWPGSDVEINGIFPDIYKMYNGSVPFEERILAVLQWLQLPKDERPHFYTLYLEEPDSSGHSYGPVSSEVIKALQRVDGMVGMLMDGLKELNLHRCLNLILISDHGMEQGSCKKYIYLNKYLGDVKNIKVIYGPAARLRPSDVPDKYYSFNYEGIARNLSCREPNQHFKPYLKHFLPKRLHFAKSDRIEPLTFYLDPQWQLALNPSERKYCGSGFHGSDNVFSNMQALFVGYGPGFKHGIEADTFENIEVYNLMCDLLNLTPAPNNGTHGSLNHLLKNPVYTPKHPKEVHPLVQCPFTRNPRDNLGCSCNPSILPIEDFQTQFNLTVAEEKIIKHETLPYGRPRVLQKENTICLLSQHQFMSGYSQDILMPLWTSYTVDRNDSFSTEDFSNCLYQDFRIPLSPVHKCSFYKNNTKVSYGFLSPPQLNKNSSGIYSEALLTTNIVPMYQSFQVIWRYFHDTLLRKYAEERNGVNVVSGPVFDFDYDGRCDSLENLRQKRRVIRNQEILIPTHFFIVLTSCKDTSQTPLHCENLDTLAFILPHRTDNSESCVHGKHDSSWVEELLMLHRARITDVEHITGLSFYQQRKEPVSDILKLKTHLPTFSQED","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","6WEW"
"6WFG",,"X-RAY DIFFRACTION",2.72,54.72,"VAPOR DIFFUSION, SITTING DROP",5,"Soak of compound into CoA bound crystals. Naa50 apo protein (14.3 mg/ml) was incubated with CoA in a 1:3 molar ratio on ice for 60 min. Crystallization solution: 0.1 M Na acetate, pH5.0, 25% (w/v) PEG 3350, 10 mM Dithiothreitol (DTT), and 0.1% Dioxane",294.15,"10.1021/acsmedchemlett.0c00029","U3V","6WFG",62.44,"2.16","2.16","Crystal structure of human Naa50 in complex with an inhibitor (compound 3) identified using DNA encoded library technology","GSMKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAA50, MAK3, NAT13, NAT5","N-alpha-acetyltransferase 50","1","6WFG"
"6WFJ",,"X-RAY DIFFRACTION",3.3,62.67,"VAPOR DIFFUSION, SITTING DROP",,"7.5 mg/mL protein against 19-22% PEG4000, 240-270 mM trilithium/triammonium/tripotassium citrate",281,"10.1107/S2059798320010505",,"6WFJ",215.26,"2.5","2.5","Crystal structures of human E-NPP 1: apo","MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSLVLSVCVLTTILGCIFGLKPSCAKEVKSCKGRCFERTFGNCRCDAACVELGNCCLDYQETCIEPEHIWTCNKFRCGEKRLTRSLCACSDDCKDKGDCCINYSSVCQGEKSWVEEPCESINEPQCPAGFETPPTLLFSLDGFRAEYLHTWGGLLPVISKLKKCGTYTKNMRPVYPTKTFPNHYSIVTGLYPESHGIIDNKMYDPKMNASFSLKSKEKFNPEWYKGEPIWVTAKYQGLKSGTFFWPGSDVEINGIFPDIYKMYNGSVPFEERILAVLQWLQLPKDERPHFYTLYLEEPDSSGHSYGPVSSEVIKALQRVDGMVGMLMDGLKELNLHRCLNLILISDHGMEQGSCKKYIYLNKYLGDVKNIKVIYGPAARLRPSDVPDKYYSFNYEGIARNLSCREPNQHFKPYLKHFLPKRLHFAKSDRIEPLTFYLDPQWQLALNPSERKYCGSGFHGSDNVFSNMQALFVGYGPGFKHGIEADTFENIEVYNLMCDLLNLTPAPNNGTHGSLNHLLKNPVYTPKHPKEVHPLVQCPFTRNPRDNLGCSCNPSILPIEDFQTQFNLTVAEEKIIKHETLPYGRPRVLQKENTICLLSQHQFMSGYSQDILMPLWTSYTVDRNDSFSTEDFSNCLYQDFRIPLSPVHKCSFYKNNTKVSYGFLSPPQLNKNSSGIYSEALLTTNIVPMYQSFQVIWRYFHDTLLRKYAEERNGVNVVSGPVFDFDYDGRCDSLENLRQKRRVIRNQEILIPTHFFIVLTSCKDTSQTPLHCENLDTLAFILPHRTDNSESCVHGKHDSSWVEELLMLHRARITDVEHITGLSFYQQRKEPVSDILKLKTHLPTFSQED","Homo sapiens","ENPP1, M6S1, NPPS, PC1, PDNP1","Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","1","6WFJ"
"6WFK",,"X-RAY DIFFRACTION",2.72,54.85,"VAPOR DIFFUSION, SITTING DROP",5,"Compound 4a soaked into crystals of Naa50+CoA. CoA co-crystals: Naa50 apo protein (14.3 mg/ml) was incubated with CoA in a 1:3 molar ratio on ice for 60 min. Crystallization solution: 0.1 M Na acetate, pH5.0, 25% (w/v) PEG 3350, 10 mM Dithiothreitol (DTT), and 0.1% Dioxane",294,"10.1021/acsmedchemlett.0c00029","U2J","6WFK",62.67,"1.87","1.87","Crystal structure of human Naa50 in complex with CoA and an inhibitor (compound 4a) identified using DNA encoded library technology","GSMKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAA50, MAK3, NAT13, NAT5","N-alpha-acetyltransferase 50","1","6WFK"
"6WFN",,"X-RAY DIFFRACTION",1.99,38.23,"VAPOR DIFFUSION, SITTING DROP",5.77,"Naa50 apo protein (13.0 mg/ml) was incubated with 4a and AcCoA in a 1:3:3 molar ratio on ice for 60 min.  Reservoir solution containing 0.1 M Bis_tris, pH 5.77 and 21% w/v PEG 3350 was mixed 0.2ul:0.2ul with Naa50:4b:AcCoA complex",294,"10.1021/acsmedchemlett.0c00029","U2J","6WFN",20.93,"1.07","1.07","Crystal structure of human Naa50 in complex with AcCoA and an inhibitor (compound 4a) identified using DNA encoded library technology","GSMKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAA50, MAK3, NAT13, NAT5","N-alpha-acetyltransferase 50","1","6WFN"
"6WFO",,"X-RAY DIFFRACTION",2.71,54.67,"VAPOR DIFFUSION, SITTING DROP",5.77,"Naa50 apo protein (13.0 mg/ml) was incubated with 4b and AcCoA in a 1:3:3 molar ratio on ice for 60 min.  Reservoir solution of 0.1 M Bis_tris, pH 5.77 and 24% w/v PEG 3350 was mixed 0.2ul:0.2ul with Naa50:4b:AcCoA complex",294,"10.1021/acsmedchemlett.0c00029","U3Y","6WFO",62.8,"1.85","1.85","Crystal structure of human Naa50 in complex with AcCoA and an inhibitor (compound 4b) identified using DNA encoded library technology","GSMKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAA50, MAK3, NAT13, NAT5","N-alpha-acetyltransferase 50","1","6WFO"
"6WFV",,"X-RAY DIFFRACTION",2.85,56.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M magnesium chloride, 30% PEG 400, 0.1 M HEPES, pH 7.5. Additive: 0.002 M manganese chloride, 0.01 M UDP-Galactose",277,,,"6WFV",28.96,"1.7","1.7","The crystal structure of a collagen galactosylhydroxylysyl glucosyltransferase from human","MGSSHHHHHHASDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLG","Homo sapiens","PLOD3","Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3","1","6WFV"
,,,,,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M magnesium chloride, 30% PEG 400, 0.1 M HEPES, pH 7.5. Additive: 0.002 M manganese chloride, 0.01 M UDP-Galactose, crystal soaked in higher Mn and UDP-Glc prior to flash cooling.",277
,,,,,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M magnesium chloride, 30% PEG 400, 0.1 M HEPES, pH 7.5. Additive: 0.002 M manganese chloride, 0.01 M UDP-Galactose. Crystal soaked in 1 M NaI prior to flash cooling",277
"6WG5",,"X-RAY DIFFRACTION",3.16,61.05,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Na/K tartrate, 20% PEG 3350, cryo-protected with 20% glycerol",293,"10.1002/pro.3926",,"6WG5",59.34,"2.6","2.6","Human ectonucleoside triphosphate diphosphohydrolase 4 (ENTPD4, NTPDase 4)","DRHHHHHHKLYGRLTRDKKFQRYLARVTDIEATDTNNPNVNYGIVVDCGSSGSRVFVYCWPRHNGNPHDLLDIRQMRDKNRKPVVMKIKPGISEFATSPEKVSDYISPLLNFAAEHVPRAKHKETPLYILCTAGMRILPESQQKAILEDLLTDIPVHFDFLFSDSHAEVISGKQEGVYAWIGINFVLGRFEHIEDDDEAVVEVNIPGSESSEAIVRKRTAGILDMGGVSTQIAYEVPKTVSFASSQQEEVAKNLLAEFNLGCDVHQTEHVYRVYVATFLGFGGNAARQRYEDRIFANTIQKNRLLGKQTGLTPDMPYLDPCLPLDIKDEIQQNGQTIYLRGTGDFDLCRETIQPFMNKTNETQTSLNGVYQPPIHFQNSEFYGFSEFYYCTEDVLRMGGDYNAAKFTKAAKDYCATKWSILRERFDRGLYASHADLHRLKYQCFKSAWMFEVFHRGFSFPVNYKSLKTALQVYDKEVQWTLGAILYRTRFLPLRDIQQEAFRASHTHWRGVS","Homo sapiens","ENTPD4, KIAA0392, LALP70, LYSAL1","Ectonucleoside triphosphate diphosphohydrolase 4","1","6WG5"
"6WG8",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",,"100mM Hepes pH 7, 10% PEG MME 5K , 80mM tri-Sodium Citrate dihydrate pH 7",294,"10.1371/journal.pone.0232311",,"6WG8",49.5,"1.36","1.36","Fab portion of dupilumab with Crystal Kappa design","EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGHHHHHH","Homo sapiens",,"Dupilumab Fab heavy chain","1","6WG8"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTQGTTSVTKSFNRGEC","Homo sapiens",,"Dupilumab Fab light chain","2","6WG8"
"6WGH",,"X-RAY DIFFRACTION",1.99,38.15,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M Na Citrate pH 5.0, 15% PEG 4000 and 0.1 M MgCl2",293,"10.1074/jbc.RA119.011080",,"6WGH",42.28,"1.65","1.65","Crystal structure of GDP-bound NRAS with ten residues long internal tandem duplication in the switch II region","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKK","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","6WGH"
"6WGJ",,"X-RAY DIFFRACTION",2.39,48.48,"VAPOR DIFFUSION, SITTING DROP",,"100mM Bis-Tris pH 6.5, 20% PEG MME 5K",294,"10.1371/journal.pone.0232311",,"6WGJ",196.02,"1.9","1.9","Fab portion of dupilumab with Crystal Kappa design and no interchain disulfide","EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSSASTKGPSVFPLAPASRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGHHHHHH","Homo sapiens",,"Dupilumab Fab heavy chain","1","6WGJ"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTQGTTSVTKSFNRGEP","Homo sapiens",,"Dupilumab Fab light chain","2","6WGJ"
"6WGK",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",,"100mM Tris HCl pH 8.5, 20% PEG MME 2K , 200mM Trimethylamine N-oxide dihydrate",294,"10.1371/journal.pone.0232311",,"6WGK",196.13,"1.62","1.62","Fab portion of dupilumab with Crystal Kappa design and intrachain disulfide","EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKCGGHHHHHH","Homo sapiens",,"Dupilumab Fab heavy chain","1","6WGK"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTQGTTSVTKSFNRGEP","Homo sapiens",,"Dupilumab Fab light chain","2","6WGK"
"6WGX",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, HANGING DROP",,"NaI, pH 8.5, Bis-Tris propane, 20% (v/v) PEG 3350, ethylene glycol",295,"10.1002/anie.202008625","U0D","6WGX",31.64,"1.53","1.53","Cocrystal of BRD4(D1) with a selective inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6WGX"
"6WH2",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, HANGING DROP",5.5,"10-14% PEG 3350, 0.1M Bis-Tris pH 5.5 and 0.2M MgCl2",295,"10.1093/nar/gkaa1188",,"6WH2",22.84,"2.414","2.414","Structure of the C-terminal BRCT domain of human XRCC1","ELPDFFQGKHFFLYGEFPGDERRKLIRYVTAFNGELEDYMSDRVQFVITAQEWDPSFEEALMDNPSLAFVRPRWIYSCNEKQKLLPHQLYGVVPQA","Homo sapiens","XRCC1","X-ray repair cross complementing protein 1 variant","1","6WH2"
"6WH6",,"X-RAY DIFFRACTION",3.2,61.51,"VAPOR DIFFUSION, HANGING DROP",,"0.2M AMMONIUM TARTRATE DIBASIC, 
20% PEG 3350",293.15,"10.1021/jacs.0c06066",,"6WH6",96.39,"2.25","2.25","Crystal structure of human sulfide quinone oxidoreductase in complex with coenzyme Q (cyanide soaked)","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHHHHHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6WH6"
"6WHB",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.1 M Bis-Tris Propane pH 6.9, 1.5 M sodium acetate",290.15,"10.1073/pnas.2006429117",,"6WHB",38.54,"1.90032055102","1.90032055102","MEKK1 TOG domain (548-867)","GPGTHYGTQQIPPAYKDLAEPWIQVFGMELVGCLFSRNWNVREMALRRLSHDVSGALLLANGESTGNSGGSSGSSPSGGATSGSSQTSISGDVVEACCSVLSMVCADPVYKVYVAALKTLRAMLVYTPCHSLAERIKLQRLLQPVVDTILVKCADANSRTSQLSISTLLELCKGQAGELAVGREILKAGSIGIGGVDYVLNCILGNQTESNNWQELLGRLCLIDRLLLEFPAEFYPHIVSTDVSQAEPVEIRYKKLLSLLTFALQSIDNSHSMVGKLSRRIYLSSARMVTTVPHVFSKLLEMLSVSSSTHFTRMRRRLMAIADEVEIAEAIQLGVEDTLDGQQDSFLQAS","Homo sapiens","MAP3K1, MAPKKK1, MEKK, MEKK1","Mitogen-activated protein kinase kinase kinase 1","1","6WHB"
"6WHE",,"X-RAY DIFFRACTION",1.96,37.35,"VAPOR DIFFUSION",7,"20% PEG3350,
0.1M Hepes pH 7",289,"10.1016/j.bpj.2021.03.030",,"6WHE",43.34,"1.73","1.73","Structure of phosphomimetic Rab8a GTPase (T72E) in the GTP-bound state","GSHMAKTYDYLFKLLLIGDSGVGKTCVLFRFSEDAFNSTFISTIGIDFKIRTIELDGKRIKLQIWDTAGLERFREITTAYYRGAMGIMLVYDITNEKSFDNIRNWIRNIEEHASADVEKMILGNKCDVNDKRQVSKERGEKLALDYGIKFMETSAKANINVENAFFTLARDIKAKMDKKLEGNS","Homo sapiens","RAB8A, MEL, RAB8","Ras-related protein Rab-8A","1","6WHE"
"6WHH",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"33% PEG5000 MME, 0.2 M ammonium sulfate, 0.1 M MES, pH 6.5",293,,,"6WHH",42.3,"2.71","2.71","Crystal structure of human WDR41","GQNPYTELLVLKAHHDIVRFLVQLDDYRFASAGDDGIVVVWNAQTGEKLLELNGHTQKITAIITFPSLESCEEKNQLILTASADRTVIVWDGDTTRQVQRISCFQSTVKCLTVLQRLDVWLSGGNDLCVWNRKLDLLCKTSHLSDTGISALVEIPKNCVVAAVGKELIIFRLVAPTEGSLEWDILEVKRLLDHQDNILSLINVNDLSFVTGSHVGELIIWDALDWTMQAYERNFWDPSPQLDTQQEIKLCQKSNDISIHHFTCDEENVFAAVGRGLYVYSLQMKRVIACQKTAHDSNVLHVARLPNRQLISCSEDGSVRIWELREKQQLELIGDLIGHSSSVEMFLYFEDHGLVTCSADHLIILWKNGERESGL","Homo sapiens","WDR41, MSTP048","WD repeat-containing protein 41","1","6WHH"
"6WIA",,"X-RAY DIFFRACTION",2.09,41.23,"VAPOR DIFFUSION, HANGING DROP",4.6,"Crystallized in Crystal Screen Cryo II condition #12  (0.095 M cadmium chloride hydrate, 0.095 M sodium acetate trihydrate pH 4.6, 28.5% v/v PEG 400, 5% glycerol).  Mounted in 30% glycerol and 70% CS Cryo II condition #12. Protein was inhibited with DFP in 25 mM Tris pH 8, 300 mM NaCl at R.T.",277,"10.1016/j.bcp.2020.113980",,"6WIA",54.32,"2.21","2.21","CRYSTAL STRUCTURE OF HUMAN PROTECTIVE PROTEIN/CATHEPSIN A, DFP-INHIBITED (AGED)","APDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVRMDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYHHHHHH","Homo sapiens","CTSA, PPGB","Lysosomal protective protein","1","6WIA"
"6WIB",,"X-RAY DIFFRACTION",3.73,67.02,"VAPOR DIFFUSION",6.5,"0.01 M zinc sulfate heptahydrate; 0.1 M morpholineethanesulfonic acid (MES) monohydrate, pH 6.5, and 25% (w/v) PEG 550 MME at a protein concentration of 5.5 mg/mL",298,"10.1038/s42003-021-02565-5",,"6WIB",25.51,"2.55","2.55","Next generation monomeric IgG4 Fc","LGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTFPPSQEEMTKNQVSLRCLVKGFYPSDIAVEWESNGQPENNYKTTKPVLDSDGSFRLESRLTVDKSRWQEGNVFSCSVMHEACSWHLCKSLSLSL","Homo sapiens","IGHG4","Immunoglobulin heavy constant gamma 4","1","6WIB"
"6WIY",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 8000, 0.2 M NaCl, and 0.1 M phosphate-citrate pH 4.2",293,"10.1016/j.chom.2020.06.003",,"6WIY",49.2,"1.65","1.65","Crystal structure of Fab 54-1G05","QVQLQQSGPRLVKPSQTLSLTCAISGDSVSSSSAVWTWIRQSPSRGLEWLGRTYYRSKWYDDYAVSVQGRITINPDTSKNQISLQLNSVTPDDTAVYYCARSSINIFGVFVMAMDVWGQGTAVTVSSPSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCKSC","Homo sapiens",,"Fab 54-1G05 heavy chain","1","6WIY"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERVTLSCRASQTVYNSYLAWYQQKPGQAPTLLIYGTSTRATGVPDRFSGSGSGTVFTLTISRLEPEDFAVYFCQQYSTSPRALTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECC","Homo sapiens",,"Fab 54-1G05 light chain","2","6WIY"
"6WJ0",,"X-RAY DIFFRACTION",2.68,54.08,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 8000, 0.2 M NaCl, and 0.1 M phosphate-citrate pH 4.2",293,"10.1016/j.chom.2020.06.003",,"6WJ0",48.66,"1.802","1.802","Crystal structure of Fab 54-4H03","QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSVAWNWIRQSPSRGLEWLGRTYFRSKWYTDYAESLKSRMTINPDTSKNEFSLHLKSVTSDDTAVYYCVRGIIFNWPLGGWSFDLWGRGTLVSVSSPSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"Fab 54-4H03 heavy chain","1","6WJ0"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGDSATLSCRASQSVASSYLAWYQQKPGQSPRLLIYATINRAADIPDRFSGSGSGTDFALTISRLEPEDFAVYYCQQFDSSSMYTFGQGTKLEITRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKLYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab 54-4H03 light chain","2","6WJ0"
"6WJ5","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1084/jem.20201637",,"6WJ5",292.93,"3.6",,"Structure of human TRPA1 in complex with inhibitor GDC-0334","SPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISET","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6WJ5"
"6WJY",,"X-RAY DIFFRACTION",2.84,56.68,"VAPOR DIFFUSION",7.5,"0.1 mM Tris, 16% (w/v) PEG4000, 0.2 M NH4OAc",293,"10.1021/acsmedchemlett.0c00195","U41","6WJY",89.48,"1.91","1.91","HUMAN IDO1 IN COMPLEX WITH COMPOUND 4-A","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6WJY"
"6WJZ",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium acetate, 20% PEG 3350",295.15,,,"6WJZ",68.98,"1.8","1.8","Crystal structure of human ribokinase in complex with AMPCP","EVAAVVVVGSCMTDLVSLTSRLPKTGETIHGHKFFIGFGGKGANQCVQAARLGAMTSMVCKVGKDSFGNDYIENLKQNDISTEFTYQTKDAATGTASIIVNNEGQNIIVIVAGANLLLNTEDLRAAANVISRAKVMVCQLEITPATSLEALTMARRSGVKTLFNPAPAIADLDPQFYTLSDVFCCNESEAEILTGLTVGSAADAGEAALVLLKRGCQVVIITLGAEGCVVLSQTEPEPKHIPTEKVKAVDTTGAGDSFVGALAFYLAYYPNLSLEDMLNRSNFIAAVSVQAAGTQSSYPYKKDLPLTLFLEHHHHHH","Homo sapiens","RBKS, RBSK","Ribokinase","1","6WJZ"
"6WK0",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, 8% PEG 8000",277.15,,,"6WK0",137.47,"2","2","Crystal structure of human ribokinase in complex with AMPPCP and ribose","EVAAVVVVGSCMTDLVSLTSRLPKTGETIHGHKFFIGFGGKGANQCVQAARLGAMTSMVCKVGKDSFGNDYIENLKQNDISTEFTYQTKDAATGTASIIVNNEGQNIIVIVAGANLLLNTEDLRAAANVISRAKVMVCQLEITPATSLEALTMARRSGVKTLFNPAPAIADLDPQFYTLSDVFCCNESEAEILTGLTVGSAADAGEAALVLLKRGCQVVIITLGAEGCVVLSQTEPEPKHIPTEKVKAVDTTGAGDSFVGALAFYLAYYPNLSLEDMLNRSNFIAAVSVQAAGTQSSYPYKKDLPLTLFLEHHHHHH","Homo sapiens","RBKS, RBSK","Ribokinase","1","6WK0"
"6WKA",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, SITTING DROP",,"7.5 MG/ML PROTEIN WITH 2.7 M AMMONIUM SULFATE, 100 MM TRIS PH 8.5 AT 8 C",281,"10.1021/acs.jmedchem.0c00636",,"6WKA",29.83,"1.34","1.34","human carbonic anhydrase II bound to an inhibitor modified with azidothymidine","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WKA"
"6WKB",,"X-RAY DIFFRACTION",3.35,63.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 3350, 0.1 M Bis-Tris pH 6.5, 10% ethylene glycol",292.15,,,"6WKB",88.26,"2.55","2.55","Human S-adenosylmethionine synthetase co-crystallized with UppNHp and Met","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6WKB"
"6WKW","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.11.008",,"6WKW",149.14,"3.6",,"EM structure of CtBP2 with a minimal dehydrogenase domain of CtBP2","RPLVALLDGRDCTVEMPILKDLATVAFCDAQSTQEIHEKVLNEAVGAMMYHTITLTREDLEKFKALRVIVRIGSGYDNVDIKAAGELGIAVCNIPSAAVEETADSTICHILNLYRRNTWLYQALREGTRVQSVEQIREVASGAARIRGETLGLIGFGRTGQAVAVRAKAFGFSVIFYDPYLQDGIERSLGVQRVYTLQDLLYQSDCVSLHCNLNEHNHHLINDFTIKQMRQGAFLVNAARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFAQGPLKDAPNLICTPHTAWYSEQASLEMREAAATEIRRAITGRIPESLRNCVNKEFF","Homo sapiens","CTBP2","C-terminal-binding protein 2","1","6WKW"
"6WKZ",,"X-RAY DIFFRACTION",3.11,60.47,"VAPOR DIFFUSION, HANGING DROP",,"100mM Hepes (pH 7.0) and 2M sodium/potassium phosphate (pH 5.0)",298,"10.1021/acsmedchemlett.0c00331",,"6WKZ",83.13,"2.23","2.23","Cocomplex structure of Deoxyhypusine synthase with inhibitor 6-[(1R)-2-AMINO-1-PHENYLETHYL]-3-(PYRIDIN-3-YL)-4H,5H,6H,7H-THIENO[2,3-C]PYRIDIN-7-ONE","GGSMEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6WKZ"
"6WL6",,"X-RAY DIFFRACTION",3.09,60.19,"VAPOR DIFFUSION, HANGING DROP",,"100mM Hepes, 2.0M Na/K Phosphate",298,"10.1021/acsmedchemlett.0c00331",,"6WL6",83.09,"2.12","2.12","Cocomplex structure of Deoxyhypusine synthase with inhibitor 6-[(2R)-1-AMINO-4-METHYLPENTAN-2-YL]-3-(PYRIDIN-3-YL)-4H,5H,6H,7H-THIENO[2,3-C]PYRIDIN-7-ONE","GGSMEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6WL6"
"6WLA",,"X-RAY DIFFRACTION",3.11,60.47,"VAPOR DIFFUSION, HANGING DROP",4,"1M Lithium chloride, 0.1 Citric acid pH 4.0, 20% (w/v) PEG 6000",298,"10.1038/s41467-021-27949-3",,"6WLA",141.14,"2.6","2.6","Antigen binding fragment of ch128.1","EVQLQQSGPELVKPGASMKISCKASGYSFTGYTMNWVKQSHGENLEWIGRINPHNGGTDYNQKFKDKAPLTVDKSSNTAYMELLSLTSGDSAVYYCARGYYYYSLDYWGQGTSVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Fab ch128.1 heavy chain","1","6WLA"
,,,,,,,,,,,,,,,,"QIVLTQSPAIMSVSPGEKVTMTCSASSSIRYIHWYQQRPGTSPKRWIYDTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRNSYPWTFGGGTRLEIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRE","Homo sapiens",,"Fab ch128.1 light chain","2","6WLA"
"6WLG",,"X-RAY DIFFRACTION",2.58,52.29,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Magnesium Acetate, 13% PEG 3350",289,"10.1074/jbc.RA120.016393",,"6WLG",97.93,"3.111","3.111","Ints3 C-terminal Domain","HPIKETVVEEPVDITPYLDQLDESLRDKVLQLQKGSDTEAQCEVMQEIVDQVLEEDFDSEQLSVLASCLQELFKAHFRGEVLPEEITEESLEESVGKPLYLIFRNLCQMQEDNSSFSLLLDLLSELYQKQPKIGYHLLYYLRASKAAAGKMNLYESFAQATQLGDLHTCLMMDMKACQEDDVRLLCHLTPSIYTEFPDETLRSGELLNMIVAVIDSAQLQELVCHVMMGNLVMFRKDSVLNILIQSLDWETFEQYCAWQLFLAHNIPLETIIPILQHLKYKEHPEALSCLLLQLRREKPSEEMVKMVLSRPCHPDDQFTTSILRHWCMKHDELLAEHIKSLLIKNNSLPRKRQSLRSSSSKLAQLTLEQILEHLDNLRLNLTNTKQNFFSQTPILQALQHVQASCDEAHKMKFSDLFSLAEEY","Homo sapiens","INTS3, C1orf193, C1orf60","Integrator complex subunit 3","1","6WLG"
"6WM8",,"X-RAY DIFFRACTION",4.45,72.36,"VAPOR DIFFUSION, SITTING DROP",5,"2.4M Ammonium Sulphate
100 sodium citrate pH 5.0",293,,,"6WM8",126.45,"2.6","2.6","Proliferation-Associated protein 2G4 (PA2G4)","MGHHHHHHSGEDEQQEQTIAEDLVVTKYKMGGDIANRVLRSLVEASSSGVSVLSLCEKGDAMIMEETGKIFKKEKEMKKGIAFPTSISVNNCVCHFSPLKSDQDYILKEGDLVKIDLGVHVDGFIANVAHTFVVDVAQGTQVTGRKADVIKAAHLCAEAALRLVKPGNQNTQVTEAWNKVAHSFNCTPIEGMLSHQLKQHVIDGEKTIIQNPTDQQKKDHEKAEFEVHEVYAVDVLVSSGEGKAKDAGQRTTIYKRDPSKQYGLKMKTSRAFFSEVERRFDAMPFTLRAFEDEKKARMGVVECAKHELLQPFNVLYEKEGEFVAQFKFTVLLMPNGPMRITSGPFEPDLYKSEMEVQDAELKALLQSSA","Homo sapiens","PA2G4, EBP1","Proliferation-associated protein 2G4","1","6WM8"
"6WMG",,"X-RAY DIFFRACTION",2.44,49.65,"VAPOR DIFFUSION, HANGING DROP",8,"14.5% PEG 3350, 0.2M sodium bromide, 0.1M potassium formate",291,"10.1016/j.jmb.2020.09.019",,"6WMG",24.68,"1.9","1.9","Human Sun2 (500-717)","GPGGSGQGKSAREAAASLSLTLQKEGVIGVTEEQVHHIVKQALQRYSEDRIGLADYALESGGASVISTRCSETYETKTALLSLFGIPLWYHSQSPRVILQPDVHPGNCWAFQGPQGFAVVRLSARIRPTAVTLEHVPKALSPNSTISSAPKDFAIFGFDEDLQQEGTLLGKFTYDQDGEPIQTFHFQAPTMATYQVVELRILTNWGHPEYTCIYRFRVHGEPAH","Homo sapiens","SUN2, FRIGG, KIAA0668, RAB5IP, UNC84B","SUN domain-containing protein 2","1","6WMG"
"6WMH",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION",7.5,"DL-Glutamic acid monohydrate,
DL-Alanine,
Glycine,
DL-Lysine monohydrochloride,
DL-Serine,
 
Sodium HEPES, MOPS (acid),
 
Ethylene glycol,
PEG 8000",295,"10.1038/s42003-021-02565-5",,"6WMH",47.58,"2.3","2.3","Next generation monomeric IgG4 Fc","PSVFLFPPKPKDTLYITREPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFDSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTFPPEQEEMTKNQVSLRCLVKGFYPSDIAVEWESNGQPENNYKTTKPVLDSDGSFRLESRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG4","Immunoglobulin heavy constant gamma 4","1","6WMH"
"6WML",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, SITTING DROP",5,"4% (w/v) PEG 3350
0.2 M potassium formate
0.1 M sodium citrate, pH 5.0",293,"10.1021/acs.jmedchem.0c00100",,"6WML",385.5,"2.5","2.5","Human TLR8 bound to the potent agonist, GS-9688 (Selgantolimod)","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","6WML"
"6WMM",,"X-RAY DIFFRACTION",2.36,48,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% PEG3350, 16% Ethylene glycol, 100 mM Hepes pH 7.5",293,"10.1074/jbc.RA120.015305",,"6WMM",88.26,"1.548","1.548","Human poly-N-acetyl-lactosamine synthase structure demonstrates a modular assembly of catalytic subsites for GT-A glycosyltransferases","GKNGKGEVIIPKEKFWKISTPPEAYWNREQEKLNRQYNPILSMLTNQTGEAGRLSNISHLNYCEPDLRVTSVVTGFNNLPDRFKDFLLYLRCRNYSLLIDQPDKCAKKPFLLLAIKSLTPHFARRQAIRESWGQESNAGNQTVVRVFLLGQTPPEDNHPDLSDMLKFESEKHQDILMWNYRDTFFNLSLKEVLFLRWVSTSCPDTEFVFKGDDDVFVNTHHILNYLNSLSKTKAKDLFIGDVIHNAGPHRDKKLKYYIPEVVYSGLYPPYAGGGGFLYSGHLALRLYHITDQVHLYPIDDVYTGMCLQKLGLVPEKHKGFRTFDIEEKNKNNICSYVDLMLVHSRKPQEMIDIWSQLQSAHLKC","Homo sapiens","B3GNT2, B3GALT7, B3GNT1","N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2","1","6WMM"
"6WMN",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"11% PEG3350, 12% Ethylene glycol, 100 mM Hepes pH 7.5",293,"10.1074/jbc.RA120.015305",,"6WMN",174.21,"2.04","2.04","Human poly-N-acetyl-lactosamine synthase structure demonstrates a modular assembly of catalytic subsites for GT-A glycosyltransferases","GKNGKGEVIIPKEKFWKISTPPEAYWNREQEKLNRQYNPILSMLTNQTGEAGRLSNISHLNYCEPDLRVTSVVTGFNNLPDRFKDFLLYLRCRNYSLLIDQPDKCAKKPFLLLAIKSLTPHFARRQAIRESWGQESNAGNQTVVRVFLLGQTPPEDNHPDLSDMLKFESEKHQDILMWNYRDTFFNLSLKEVLFLRWVSTSCPDTEFVFKGDDDVFVNTHHILNYLNSLSKTKAKDLFIGDVIHNAGPHRDKKLKYYIPEVVYSGLYPPYAGGGGFLYSGHLALRLYHITDQVHLYPIDDVYTGMCLQKLGLVPEKHKGFRTFDIEEKNKNNICSYVDLMLVHSRKPQEMIDIWSQLQSAHLKC","Homo sapiens","B3GNT2, B3GALT7, B3GNT1","N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2","1","6WMN"
"6WMO",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"24% PEG3350, 6% Ethylene glycol, 100 mM Hepes pH 8.5",293,"10.1074/jbc.RA120.015305",,"6WMO",88.95,"1.85","1.85","Human poly-N-acetyl-lactosamine synthase structure demonstrates a modular assembly of catalytic subsites for GT-A glycosyltransferases","GKNGKGEVIIPKEKFWKISTPPEAYWNREQEKLNRQYNPILSMLTNQTGEAGRLSNISHLNYCEPDLRVTSVVTGFNNLPDRFKDFLLYLRCRNYSLLIDQPDKCAKKPFLLLAIKSLTPHFARRQAIRESWGQESNAGNQTVVRVFLLGQTPPEDNHPDLSDMLKFESEKHQDILMWNYRDTFFNLSLKEVLFLRWVSTSCPDTEFVFKGDDDVFVNTHHILNYLNSLSKTKAKDLFIGDVIHNAGPHRDKKLKYYIPEVVYSGLYPPYAGGGGFLYSGHLALRLYHITDQVHLYPIDDVYTGMCLQKLGLVPEKHKGFRTFDIEEKNKNNICSYVDLMLVHSRKPQEMIDIWSQLQSAHLKC","Homo sapiens","B3GNT2, B3GALT7, B3GNT1","N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2","1","6WMO"
"6WN7",,"X-RAY DIFFRACTION",2.26,45.49,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 20% w/v PEG8000, cryoprotectant: 25% PEG1500",277,"10.1002/pro.3958",,"6WN7",66.72,"1.25","1.25","Homo sapiens S100A5","SNAMETPLEKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELSLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLSMAYNDFFLEDNK","Homo sapiens","S100A5, S100D","Protein S100-A5","1","6WN7"
"6WNF",,"X-RAY DIFFRACTION",2.25,45.27,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, Sodium acetate, ammonium acetate",298,"10.1002/cbic.202000405",,"6WNF",31.81,"1.67","1.67","The Crystal Structure of Apo Domain-Swapped Dimer Q108K:K40D:T53A:R58L:Q38F:Q4F:F57H Variant of HCRBPII","TRDFNGTWEMESNENFEGYMKALDIDFATRKIAVRLTFTDVIDQDGDNFKTKATSTHLNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6WNF"
"6WNH",,"X-RAY DIFFRACTION",3.92,68.65,"VAPOR DIFFUSION, SITTING DROP",6.8,"1.96 M NaCl, 89 mM Bis-Tris pH 6.8, 0.178 M MgCl2 and 10.7 mM Pr Acetate",277,"10.1021/acs.jmedchem.0c00547",,"6WNH",63.47,"2.1","2.1","Menin bound to inhibitor M-808","SGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSGTVAGTARGPEGGSTAQVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVSTPSDYTLSFLKRQRKGL","Homo sapiens","MEN1, SCG2","Menin","1","6WNH"
"6WNJ",,"X-RAY DIFFRACTION",3.25,62.12,"VAPOR DIFFUSION, HANGING DROP",4.6,"sodium acetate trihydrate, ammonium sulfate",298,"10.1002/cbic.202000405",,"6WNJ",48.11,"2.1","2.1","The Crystal Structure of Apo Domain-Swapped Trimer Q108K:T51D:A28C:I32C of HCRBPII","TRDQNGTWEMESNENFEGYMKALDIDFCTRKCAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6WNJ"
"6WNL",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"50 mM MES pH 6.5, 0.1 M LiCl, 0.01 M MgCl2, 12% PEG 4000 (w/v)",300,"10.1074/jbc.RA120.014136",,"6WNL",86.85,"2.37","2.37","human Artemis/SNM1C catalytic domain, crystal form 2","SSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRSSQSTEPKKGENLYFQ","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","6WNL"
"6WNY",,"X-RAY DIFFRACTION",2.79,55.95,"VAPOR DIFFUSION, HANGING DROP",6.6,"21% PEG 5000 MME, 190 mM ammonium iodide, 190 mM sodium citrate, 3% (v/v) DMSO",293,"10.1016/j.bmcl.2020.127240","U64","6WNY",46.7,"1.86","1.86","Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6WNY"
"6WO0",,"X-RAY DIFFRACTION",2.57,52.14,"VAPOR DIFFUSION, HANGING DROP",,"50 mM MES pH 6.5, 0.1 M LiCl, 0.01 M MgCl2, 12% PEG 4000 (w/v)",300,"10.1074/jbc.RA120.014136",,"6WO0",43.61,"1.97","1.97","human Artemis/SNM1C catalytic domain, crystal form 1","SSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRSSQSTEPKKGENLYFQ","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","6WO0"
"6WO7",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in condition of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 2mM 5-IP7",293,"10.1096/fj.202001489R",,"6WO7",20.45,"1.4","1.4","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 5-Diphosphoinositol pentakisphosphate (5-IP7), Mg, and Fluoride ion","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WO7"
"6WO8",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 2mM 5-PP-IP4",293,"10.1096/fj.202001489R",,"6WO8",20.43,"1.7","1.7","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 5-diphosphoinositol 1,3,4,6-tetrakisphosphate (5-PP-IP4), Mg, and Fluoride ion","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WO8"
"6WO9",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM Li2SO4, 25% (w/v) PEG 8000, 10% (v/v) isopropanol, 75mM NaAc, pH 5.5, 25 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 4mM 1-IP7",293,"10.1096/fj.202001489R",,"6WO9",20.49,"2","2","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 1-diphosphoinositol pentakisphosphate (1-IP7) and Mg","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WO9"
"6WOA",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM Li2SO4, 25% (w/v) PEG 8000, 10% (v/v) isopropanol, 75mM NaAc, pH 5.5, 25 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 4mM 2-IP7",293,"10.1096/fj.202001489R",,"6WOA",20.51,"1.5","1.5","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 2-Diphosphoinositol pentakisphosphate (2-IP7), Mg, and Fluoride ion","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOA"
"6WOB",,"X-RAY DIFFRACTION",2.12,42.05,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 2mM 4-IP7",293,"10.1096/fj.202001489R",,"6WOB",20.45,"1.45","1.45","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 4-diphosphoinositol pentakisphosphate (4-IP7), Mg, and Fluoride ion","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOB"
"6WOC",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, HANGING DROP",7,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 80 mM NaF, 20 mM MgCl2 in present of 2mM 5-IP7 for 2 days, and transferred into 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 for 1min.",293,"10.1096/fj.202001489R",,"6WOC",20.43,"1.35","1.35","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 5-diphosphoinositol pentakisphosphate and Mg, presoaked with 5-IP7, Mg and Fluoride, soaking 1min in the absence of Fluoride.","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOC"
"6WOD",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, HANGING DROP",7,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 80 mM NaF, 20 mM MgCl2 in present of 2mM 5-IP7 for 2 days, and transferred into 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 for 2min.",293,"10.1096/fj.202001489R",,"6WOD",20.3,"1.35","1.35","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with inositol hexakisphosphate and Mg, presoaked with 5-IP7, Mg and Fluoride, soaking 2min in the absence of Fluoride.","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOD"
"6WOE",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",7,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 80 mM NaF, 20 mM MgCl2 in present of 2mM 5-IP7 for 2 days, and transferred into 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 for 10min.",293,"10.1096/fj.202001489R",,"6WOE",20.3,"1.4","1.4","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with inositol hexakisphosphate and Mg, presoaked with 5-IP7, Mg and Fluoride, soaking 10min in the absence of Fluoride.","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOE"
"6WOF",,"X-RAY DIFFRACTION",2.21,44.38,"VAPOR DIFFUSION, HANGING DROP",7,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 80 mM NaF, 20 mM MgCl2 in present of 2mM 5-IP7 for 2 days, and transferred into 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 for 20 min.",293,"10.1096/fj.202001489R",,"6WOF",20.35,"1.6","1.6","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with inositol hexakisphosphate and Mg, presoaked with 5-IP7, Mg and Fluoride, soaking 20min in the absence of Fluoride.","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOF"
"6WOG",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, HANGING DROP",4.5,"200 mM Li2SO4, 18% (w/v) PEG 8000, 5% (v/v) isopropanol, 100mM NaAc, pH 4.5",293,"10.1096/fj.202001489R",,"6WOG",20.38,"1.5","1.5","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 5-methylenebisphosphonate inositol pentakisphosphate (5-PCP-IP5)","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOG"
"6WOH",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, HANGING DROP",6,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution of 200 mM LiCl, 20% (w/v) PEG 8000, 20% (v/v) isopropanol, 100 mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF in present of 2mM 1,5-PCP-IP4",293,"10.1096/fj.202001489R",,"6WOH",20.55,"1.7","1.7","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 1,5-di-methylenebisphosphonate inositol tetrakisphosphate (1,5-PCP-IP4)","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOH"
"6WOI",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, HANGING DROP",7,"10% (w/v) PEG 8000, 10% (v/v) isopropanol, 200 mM Li2SO4, 75 mM NaAc, pH 5.5 and 25 mM HEPES, pH 7.0 and soaking in solution 400 mM LiCl, 30% (w/v) PEG 8000, 20% (v/v) isopropanol, 100mM NaAc, pH 4.5, 20 mM MgCl2 and 80 mM NaF in present of 2mM 1,5-IP8, and transferred into 400 mM LiCl, 30% (w/v) PEG 8000, 20% (v/v) isopropanol, 100mM HEPES, pH 7.0, 20 mM MgCl2 and 80 mM NaF for 30 second.",293,"10.1096/fj.202001489R",,"6WOI",20.45,"1.5","1.5","Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP1/NUDT3) in complex with 1-Diphosphoinositol pentakisphosphate, Mg, and Fluoride ion, presoaked with 1,5-IP8, Mg and Fluoride for 30 seconds","HHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6WOI"
"6WOK",,"X-RAY DIFFRACTION",2.02,39.03,"VAPOR DIFFUSION",,"25-35% PEG 3,350 
0.1 M Bis-Tris (pH 6.1-6.5) 
150-300 mM MgCl2",298,"10.1021/acsmedchemlett.0c00224","U6D","6WOK",130.8,"2.309","2.309","Crystal structure of estrogen receptor alpha in complex with receptor degrader 6","MHHHHHHSSGVDLGTENLYFQSNAIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6WOK"
"6WOR",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",,"17% (w/v) PEG 4000, 15% (v/v) glycerol, 8.5% (v/v) isopropanol, 0.085M Na-HEPES pH 7.5",293,"10.1126/sciadv.abb5642",,"6WOR",47.78,"2.601","2.601","Structure of the broadly neutralizing antibody HC1AM","QLQLVQSGAEVRKPGSSVKVSCKASGGTYNGEVISWVRQAPGEGLEWLGVFIPMFGIADYAQKFHGRVTISADRTTSTTYMELSSLRSEDTAIYYCAKVLQVGRNLVVRPLDLWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCGS","Homo sapiens",,"Fab HC1AM heavy chain","1","6WOR"
,,,,,,,,,,,,,,,,"EIVLTQSPGILSLSPGERATLSCRASRTISRTHLAWYQQKPGQAPRLLIYGVSSRAIGIPDRFSGSGSGADFTLTISRLEPEDFAVYYCHQYGNSPQTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab HC1AM light chain","2","6WOR"
"6WOS",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, SITTING DROP",,"20% (w/v) PEG 3350, 0.2M Na thiocyanate, 10% ethylene glycol",293,"10.1126/sciadv.abb5642",,"6WOS",47.45,"1.645","1.645","Structure of broadly neutralizing antibody AR3B","LLEQSGPEVKKPGSSVKVSCKDSGDTFNEPVTWVRQAPGQGLEWIGGIIPAFGVTKYAQKFQGRVIISADASTATAYLELSSLRSEDTAVYYCAKVGLRGIVMVGGLAMNWLDPWGQGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCGS","Homo sapiens",,"Fab AR3B heavy chain","1","6WOS"
,,,,,,,,,,,,,,,,"EIELTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPQTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab AR3B light chain","2","6WOS"
"6WP0",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",,"sodium acetate, ammonium acetate, PEG 4000",298,"10.1002/cbic.202000405",,"6WP0",189.4,"2.78","2.78","The Crystal Structure of Domain-Swapped Trimer Q108K:T51D variant of HCRBPII","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6WP0"
"6WP1",,"X-RAY DIFFRACTION",2.62,52.99,"VAPOR DIFFUSION, HANGING DROP",,"PEG4000, sodium acetate, ammonium acetate",298,"10.1002/cbic.202000405",,"6WP1",94.7,"2.99","2.99","The Crystal Structure of Apo Domain-Swapped Trimer Q108K:K40L:T51K Variant of HCRBPII","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKKKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6WP1"
"6WP2",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, HANGING DROP",,"ammonium iodide, PEG 3350",298,"10.1002/cbic.202000405",,"6WP2",47.53,"2.48","2.48","The Crystal Structure of Apo Zinc-Bound Domain Swapped-Trimer Q108K:K40D:T53A:R58L:Q38F:Q4F:F57H Variant of HCRBPII","TRDFNGTWEMESNENFEGYMKALDIDFATRKIAVRLTFTDVIDQDGDNFKTKATSTHLNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6WP2"
"6WP3",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, SITTING DROP",,"0.25 M NaNO3, 15% PEG 4000",295,"10.1074/jbc.RA120.015800",,"6WP3",121.17,"1.84","1.84","Pyruvate Kinase M2 Mutant-K433Q","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTQSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6WP3"
"6WP4",,"X-RAY DIFFRACTION",2.64,53.39,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M K2HPO4, 0.1 M HEPES, 20-24% PEG 3350",295,"10.1074/jbc.RA120.015800",,"6WP4",243.61,"1.9","1.9","Pyruvate Kinase M2 mutant-S37E","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDEPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6WP4"
"6WP5",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M NaBr, 0.1 M Bis-Tris Propane, 16-20% PEG 3350",295,"10.1074/jbc.RA120.015800","FBP","6WP5",242.74,"2.17","2.17","Pyruvate Kinase M2 mutant-S37D","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDDPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6WP5"
"6WP6",,"X-RAY DIFFRACTION",2.38,48.41,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaNO3, 18% PEG 3350",295,"10.1074/jbc.RA120.015800",,"6WP6",120.66,"2.45","2.45","Pyruvate Kinase M2 mutant-S37E K433E","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDEPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTESGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6WP6"
"6WPE",,"X-RAY DIFFRACTION",3,59.06,"VAPOR DIFFUSION",,"0.1 mM Tris pH 8.0, 20% (w/v) PEG6000, 0.2 M NaCl",293,"10.1021/acsmedchemlett.0c00525",,"6WPE",89.59,"2.43","2.43","HUMAN IDO1 IN COMPLEX WITH COMPOUND 4","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6WPE"
"6WPK","3.3","ELECTRON MICROSCOPY",,,,,,,,,"6WPK",605.44,"3.3",,"SARM1 Autoinhibited Conformation","MGPREVSPGAGTEVQDALERALPELQQALSALKQAGGARAVGAGLAEVFQLVEEAWLLPAVGREVAQGLCDAIRLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQAVQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNRLEAQCIGAFYLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAPMGPTGGSENLYFQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","NAD(+) hydrolase SARM1","1","6WPK"
"6WPP",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG1500, pH 7",278,"10.1021/acs.jcim.0c00445",,"6WPP",76.41,"2.55","2.55","HUMAN NIK IN COMPLEX WITH LIGAND COMPOUND X","GPMGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDAEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVSLEVFRAEELMACAGLTSPRIVPLYGAVREGPAVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQANYHQTL","Homo sapiens","MAP3K14, NIK","Mitogen-activated protein kinase kinase kinase 14","1","6WPP"
"6WPQ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"salt: 0.15M Ammonium Acetate, precipitant: 35% MPD, buffer: 0.1M Bis-Tris",298,"10.1038/s41467-020-17905-y",,"6WPQ",0.71,"1.1","1.1","GNYNVF from hnRNPA2-low complexity domain segment, residues 286-291, D290V variant","GNYNVF","Homo sapiens","HNRNPA2B1, HNRPA2B1","Heterogeneous nuclear ribonucleoprotein A2","1","6WPQ"
"6WQ1",,"X-RAY DIFFRACTION",2.11,41.76,"VAPOR DIFFUSION, HANGING DROP",,"PEG400, PEG4000",273,"10.1016/j.cell.2021.04.001",,"6WQ1",203.95,"2.295","2.295","Eukaryotic LanCL2 protein","MGETMSKRLKLHLGGEAEMEERAFVNPFPDYEAAAGALLASGAAEETGCVRPPATTDEPGLPFHQDGKIIHNFIRRIQTKIKDLLQQMEEGLKTADPHDCSAYTGWTGIALLYLQLYRVTCDQTYLLRSLDYVKRTLRNLNGRRVTFLCGDAGPLAVGAVIYHKLRSDCESQECVTKLLQLQRSVVCQESDLPDELLYGRAGYLYALLYLNTEIGPGTVCESAIKEVVNAIIESGKTLSREERKTERCPLLYQWHRKQYVGAAHGMAGIYYMLMQPAAKVDQETLTEMVKPSIDYVRHKKFRSGNYPSSLSNETDRLVHWCHGAPGVIHMLMQAYKVFKEEKYLKEAMECSDVIWQRGLLRKGYGICHGTAGNGYSFLSLYRLTQDKKYLYRACKFAEWCLDYGAHGCRIPDRPYSLFEGMAGAIHFLSDVLGPETSRFPAFELDSSKRD","Homo sapiens","LANCL2, GPR69B, TASP","LanC-like protein 2","1","6WQ1"
"6WQ4",,"X-RAY DIFFRACTION",2.1,41.49,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate and 50mM Tris at pH 7.8",298,"10.1021/acs.jmedchem.0c00733","U7A","6WQ4",30.09,"1.35","1.35","Carbonic Anhydrase II Complexed with 2-((2-Cyanoethyl)(phenethyl)amino)-N-phenethyl-N-(4-sulfamoylphenethyl)acetamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WQ4"
"6WQ5",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate and 50mM Tris",298,"10.1021/acs.jmedchem.0c00733","U7G","6WQ5",29.98,"1.304","1.304","Carbonic Anhydrase II Complexed with 2-((3-Aminopropyl)(phenethyl)amino)-N-(furan-2-ylmethyl)-N-(4-sulfamoylphenethyl)acetamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WQ5"
"6WQ7",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate and 50mM Tris",298,"10.1021/acs.jmedchem.0c00733","U6V","6WQ7",30,"1.304","1.304","Carbonic Anhydrase II Complexed with 2-((3-Aminopropyl)(phenethyl)amino)-N-(4-fluorobenzyl)-N-(4-sulfamoylphenethyl)acetamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WQ7"
"6WQ8",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate and 50mM tris",298,"10.1021/acs.jmedchem.0c00733","U77","6WQ8",30.6,"1.405","1.405","Carbonic Anhydrase II Complexed with 3-((2-((Furan-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WQ8"
"6WQ9",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate and 50mM tris",298,"10.1021/acs.jmedchem.0c00733","U7J","6WQ9",30.14,"1.305","1.305","Carbonic Anhydrase II Complexed with 3-((2-((Naphthalen-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6WQ9"
"6WR0",,"X-RAY DIFFRACTION",2.75,55.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"175 mM Tris HCl, pH 8.5, 30% PEG-3350, 350 mM LiSO4, and 3% glycerol",293.15,,,"6WR0",226.92,"2.7","2.7","Human steroidogenic cytochrome P450 17A1 with 3-keto-delta4-abiraterone analog","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6WR0"
"6WR1",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris HCl, pH 8.5, 30% PEG 3350, 250 mM Li2SO4, 3% glycerol, covered with Al's oil",293.15,,,"6WR1",113.51,"1.85","1.85","Human steroidogenic cytochrome P450 17A1 mutant N52Y with inhibitor abiraterone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNYFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6WR1"
"6WR4","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2020.107837",,"6WR4",289.68,"2.9",,"Structure of human ATG9A, the only transmembrane protein of the core autophagy machinery","MAQFDTEYQRLEASYSDSPPGEEDLLVHVAEGSKSPWHHIENLDLFFSRVYNLHQKNGFTCMLIGEIFELMQFLFVVAFTTFLVSCVDYDILFANKMVNHSLHPTEPVKVTLPDAFLPAQVCSARIQENGSLITILVIAGVFWIHRLIKFIYNICCYWEIHSFYLHALRIPMSALPYCTWQEVQARIVQTQKEHQICIHKRELTELDIYHRILRFQNYMVALVNKSLLPLRFRLPGLGEAVFFTRGLKYNFELILFWGPGSLFLNEWSLKAEYKRGGQRLELAQRLSNRILWIGIANFLLCPLILIWQILYAFFSYAEVLKREPGALGARCWSLYGRCYLRHFNELEHELQSRLNRGYKPASKYMNCFLSPLLTLLAKNGAFFAGSILAVLIALTIYDEDVLAVEHVLTTVTLLGVTVTVCRSFIPDQHMVFCPEQLLRVILAHIHYMPDHWQGNAHRSQTRDEFAQLFQYKAVFILEELLSPIVTPLILIFCLRPRALEIIDFFRNFTVEVVGVGDTCSFAQMDVRQHGHPQWLSAGQTEASVYQQAEDGKTELSLMHFAITNPGWQPPRESTAFLGFLKEQVQRDGAAASLAQGGLLPENALFTSIQSLQSESEPLSLIANVVAGSSCRGPPLPRDLQGSRHRAEVASALRSFSPLQPGQAPTGRAHSTMTGSGVDARTASSGSSVWEGQLQSLVLSEYASTEMSLHALYMHQLHKQQAQAEPERHVWHRRESDESGESAPDEGGEGARAPQSIPRSASYPCAAPRPGAPETTALHGGFQRRYGGITDPGTVPRVPSHFSRLPLGGWAEDGQSASRHPEPVPEEGSEDELPPQVHKV","Homo sapiens","ATG9A, APG9L1","Autophagy-related protein 9A","1","6WR4"
"6WRP",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, HANGING DROP",,"2.2M Ammonium Sulfate, 2.2% PEG 400, 0.11M Hepes pH 7.5",295,"10.1080/19420862.2021.1912884",,"6WRP",49.51,"2.08","2.08","Crystal Structure of PI3-E12 Fab, An Antibody Against Human Parainfluenza Virus Type III","QVQLLESGGKLVKPGGSLRLSCAASGFTFSDHYMIWIRQAPGKGLEWISYISSSGSNTIYADSLMGRFTISRDNAKNSLYLQMNSLRTEDTAVYYCARAKWGTMGRGAPPTIYDHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKT","Homo sapiens",,"PI3-E12 Fab Heavy Chain","1","6WRP"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLQSNGNNYLEWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDAGVYYCMQALQTPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PI3-E12 Fab Light Chain","2","6WRP"
"6WS1",,"X-RAY DIFFRACTION",3.3,61.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"100 mM Sodium Cacodylate pH 5.5, 170 mM LiCl, 12 % PEG 6000",295,"10.1021/jacs.0c05446",,"6WS1",65.99,"2.76","2.76","Crystal structure of human phenylethanolamine N-methyltransferase (PNMT) in complex with (2S)-2-amino-4-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(7,8-dichloro-1,2,3,4-tetrahydroisoquinolin-4-yl)propyl)amino)butanoic acid and AdoHcy (SAH)","HHHHHHLVPRGSMSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGL","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","6WS1"
"6WS2",,"X-RAY DIFFRACTION",2.36,47.86,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5 and 2 M ammonium sulfate",293,,,"6WS2",79.89,"1.59","1.59","Crystal structure of KRAS-K104Q mutant, GDP-bound","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVQDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6WS2"
"6WS4",,"X-RAY DIFFRACTION",2.4,48.71,"VAPOR DIFFUSION, SITTING DROP",7.3,"3.0 % Xylitol, 0.2 M ammonium acetate and 2.2 M ammonium sulfate",293,,,"6WS4",79.66,"1.84","1.84","Crystal structure of KRAS-G12D/K104Q mutant, GDP-bound","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVQDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6WS4"
"6WS6",,"X-RAY DIFFRACTION",4.62,73.37,"VAPOR DIFFUSION",8,"1.1 M Sodium Malonate, 0.1 M HEPES, pH 7.0 and 0.5% (w/v) Jeffamine ED-2001",293,"10.1038/s41586-020-2349-y",,"6WS6",143.93,"3.3","3.3","Structural and functional analysis of a potent sarbecovirus neutralizing antibody","QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"S309 antigen-binding (Fab) fragment, heavy chain","1","6WS6"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"S309 antigen-binding (Fab) fragment, light chain","2","6WS6"
"6WSM",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",3.5,"100mM Citric acid, 1.25M Ammonium Sulphate",291,"10.1016/j.jmb.2021.166889",,"6WSM",15.58,"2.451","2.451","Crystal structure of coiled coil region of human septin 8","GSHMWGFQDSDGDSQPFSLQETYEAKRKEFLSELQRKEEEMRQMFVNKVKETELELKEKERELHEKFEHLKRVHQEEKRKVEEKRRELEEETNAFNRRKAAVEALQSQALHATSQQPLRKDKDKKN","Homo sapiens","SEPTIN8, KIAA0202, SEPT8","Septin-8","1","6WSM"
"6WTL",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.1,"1.7 M (NH4)2SO4, 0.2 M LI2SO4, AND 0.1 M HEPES PH 7.1",297,,,"6WTL",41.8,"2.85","2.85","Structure of Human pir-miRNA-19b-2 Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCAUAUGUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (124-MER)","1","6WTL"
"6WTN",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",5,"1.6-2.4 M sodium malonate, pH 5",291,"10.1182/blood.2020006846",,"6WTN",36.9,"1.83","1.83","Human JAK2 JH1 domain in complex with Ruxolitinib","MAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGGSGSENLYFQ","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6WTN"
"6WTO",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, HANGING DROP",5,"1.6-2.4 M sodium malonate, pH 5",291,"10.1182/blood.2020006846",,"6WTO",36.91,"1.74","1.74","Human JAK2 JH1 domain in complex with Baricitinib","MAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGGSGSENLYFQ","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6WTO"
"6WTP",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M SODIUM CITRATE PH 6.0, 27% PEG 8000 AND 0.2 M AMMONIUM ACETATE.
REMARK 280  6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1182/blood.2020006846",,"6WTP",37.07,"2.5","2.5","Human JAK2 JH1 domain in complex with PROTAC-intermediate linker handle 3","MAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGGSGSENLYFQ","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6WTP"
"6WTQ",,"X-RAY DIFFRACTION",2.11,41.79,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M SODIUM CITRATE PH 6.5, 27% PEG 8000 AND 0.2 M AMMONIUM ACETATE.
REMARK 280  6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1182/blood.2020006846",,"6WTQ",36.97,"1.79968475557","1.79968475557","Human JAK2 JH1 domain in complex with PROTAC-intermediate linker handle 4","MAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGGSGSENLYFQ","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6WTQ"
"6WTR",,"X-RAY DIFFRACTION",5.2,76.38,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.90 M (NH4)2SO4, 0.158 M Li2SO4, and 0.1 M NaHEPES pH 7.4",,,,"6WTR",41.94,"3.082","3.082","Structure of Human pir-miRNA-300 Apical Loop Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCUUUACUUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (125-MER)","1","6WTR"
"6WU5",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M Lithium Sulfate
0.2M Sodium Thiocyanate",293,"10.1016/j.neuron.2021.05.007",,"6WU5",45.18,"1.88","1.88","Human Calcium and Integrin Binding Protein 3","GSHMMGNKQTVFTHEQLEAYQDCTFFTRKEIMRLFYRYQDLAPQLVPLDYTTCPDVKVPYELIGSMPELKDNPFRQRIAQVFSEDGDGHMTLDNFLDMFSVMSEMAPRDLKAYYAFKIYDFNNDDYICAWDLEQTVTKLTRGELSAEEVSLVCEKVLDEADGDHDGRLSLEDFQNMILRAPDFLSTFHIRI","Homo sapiens","CIB3, KIP3","Calcium and integrin-binding family member 3","1","6WU5"
"6WU7",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 8000
0.2M Calcium Acetate",293,"10.1016/j.neuron.2021.05.007",,"6WU7",45.13,"1.84","1.84","Human Calcium and Integrin Binding Protein 3 E150Q K151H","GSHMMGNKQTVFTHEQLEAYQDCTFFTRKEIMRLFYRYQDLAPQLVPLDYTTCPDVKVPYELIGSMPELKDNPFRQRIAQVFSEDGDGHMTLDNFLDMFSVMSEMAPRDLKAYYAFKIYDFNNDDYICAWDLEQTVTKLTRGELSAEEVSLVCQHVLDEADGDHDGRLSLEDFQNMILRAPDFLSTFHIRI","Homo sapiens","CIB3, KIP3","Calcium and integrin-binding family member 3","1","6WU7"
"6WU8",,"X-RAY DIFFRACTION",2.03,39.45,"VAPOR DIFFUSION, HANGING DROP",8,"300 mM potassium formate, 14% w/v PEG3350",293,"10.1158/0008-5472.CAN-20-1634",,"6WU8",123.74,"2.4","2.4","Structure of human SHP2 in complex with inhibitor IACS-13909","GAMADIMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIE","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6WU8"
"6WUV",,"X-RAY DIFFRACTION",4.39,72,"VAPOR DIFFUSION, HANGING DROP",7,"15-21% Polyethylene glycol 3350 (PEG), 0.17 - 0.21M Potassium Nitrate",295,"10.1021/acs.chemrestox.0c00406",,"6WUV",121.58,"2.63","2.63","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by GA","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WUV"
"6WUW",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",,"Prior to crystallization, protein was incubated with myristic acid (5 mM final concentration of fatty acid) for several hours at 37 oC. Then, 0.2 ul of 100 mg/ml protein in 25 mM Tris (pH 7.4) and 50 mM NaCl were mixed with 0.2 ul of the well condition (25% PEG 3350, 50 mM K2HPO4 at pH 7.0), the crystallization plate was incubated at 37oC for several days and, after growth of the first HSA crystals, the plate was transferred to RT. JMS-053 powder (~50 ug) was added to the crystallization drop containing crystals, and then incubated for 48 h before harvesting.",311,"10.1124/molpharm.120.000131",,"6WUW",136.97,"2.2","2.2","Crystal structure of Human Serum Albumin complex with JMS-053","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6WUW"
"6WUY",,"X-RAY DIFFRACTION",4.38,71.89,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WUY",121.56,"2.46","2.46","Crystal Structure of Recombinant Human Acetylcholinesterase In Complex with GA and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WUY"
"6WUZ",,"X-RAY DIFFRACTION",4.32,71.55,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WUZ",121.41,"2.253","2.253","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by GB","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WUZ"
"6WV1",,"X-RAY DIFFRACTION",4.27,71.17,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WV1",121.64,"2.372","2.372","Crystal Structure of Recombinant Human Acetylcholinesterase In Complex with GB and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WV1"
"6WVC",,"X-RAY DIFFRACTION",4.34,71.69,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WVC",120.92,"2.599","2.599","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by GD","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WVC"
"6WVO",,"X-RAY DIFFRACTION",,71.46,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WVO",121.78,"2.19","2.19","Crystal Structure of Recombinant Human Acetylcholinesterase In Complex with GD and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WVO"
"6WVP",,"X-RAY DIFFRACTION",4.31,71.45,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WVP",120.95,"2.308","2.308","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by GF","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WVP"
"6WVQ",,"X-RAY DIFFRACTION",4.33,71.61,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, KNO3",295,"10.1021/acs.chemrestox.0c00406",,"6WVQ",121.67,"2.289","2.289","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by GP","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6WVQ"
"6WVX",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, SITTING DROP",,"0.18 M Triammonium Citrate, 20% (w/v) PEG 3350",277,"10.1021/acschembio.1c00376",,"6WVX",31.14,"1.55","1.55","Crystal structure of the first bromodomain of human BRD4 with benzodiazepine inhibitor","GSMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6WVX"
"6WW0",,"X-RAY DIFFRACTION",2.6,52.74,"VAPOR DIFFUSION, HANGING DROP",8.5,"175 mM Tris HCl (pH = 8.5), 30% PEG 3350, 300 mM LiSO4, 3% glycerol",293.15,,,"6WW0",226.9,"2.01","2.01","Human steroidogenic cytochrome P450 17A1 with 3-keto-5alpha-abiraterone analog","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6WW0"
"6WW8",,"X-RAY DIFFRACTION",2.26,45.47,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris pH 8.5, 25%(w/v) PEG 3350, and 200 mM NH4Cl",291,"10.1038/s41421-020-0181-z",,"6WW8",16.85,"2.302","2.302","BRD4 Bromodomain 1 in complex with triple CDK4/6-PI3K-BET inhibitor","TNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRG","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6WW8"
"6WWB",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES, PEG 400",293.15,"10.1002/anie.202108848",,"6WWB",14.58,"1.31","1.31","Crystal Structure of the second bromodomain of human BRD2 in complex with the compound 3b","GSHMQDPEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6WWB"
"6WX6","2","ELECTRON MICROSCOPY",,,,,,,"10.1107/S2059798320012474",,"6WX6",582.94,"2",,"Cryo-EM Structure of Human Apoferritin Light Chain Vitrified Using Back-it-up","TGWSHPQFEKLKGGSSRGGGGGSGGSGGSGGSMSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLRHDGGSGGSGGSGGSGGGASGGS","Homo sapiens","FTL","Ferritin light chain","1","6WX6"
"6WXJ",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION",,"0.1 M MES, pH 6.5, 21.3% polyethylene glycol 3350 and 0.25 M ammonium sulfate",294,"10.1038/s41419-020-03084-7",,"6WXJ",38.18,"2.62","2.62","CSF1R signaling is a regulator of pathogenesis in progressive MS","YKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","6WXJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FMS"
"6WXK",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, HANGING DROP",8.65,"0.1 M Tris pH 8.65 and 25% tert-butanol",291,"10.1038/s41467-020-17098-4",,"6WXK",35.62,"2.9","2.9","PHF23 PHD Domain Apo","GPLGSDLITCYCRKPFAGRPMIECSLCGTWIHLSCAKIKKTNVPDFFYCQKCKELRPEARR","Homo sapiens","PHF23","PHD finger protein 23","1","6WXK"
"6WXM",,"X-RAY DIFFRACTION",2.92,57.89,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M sodium acetate (pH 5.0), 0.1 M CoCl2, 1.1 M 1,6-hexanediol",296.15,"10.1021/acschemneuro.0c00290",,"6WXM",28.54,"2.3","2.3","X-ray crystallographic structure of a beta-hairpin peptide derived from amyloid beta 16-36","VAKLVFFCEDVGSNKGACIGLM","Homo sapiens","APP, A4, AD1","Amyloid-beta protein","1","6WXM"
"6WXN",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M BisTris, 25% PEG-3350",298,"10.1021/acs.jmedchem.1c00848",,"6WXN",151.76,"1.76","1.76","EGFR(T790M/V948R) in complex with LN3844","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6WXN"
"6WXZ",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1016/j.bmc.2020.115723","UEY","6WXZ",136.23,"2.226","2.226","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-29 A.K.A 7-(1,2-DIPHENYLETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase light chain","1","6WXZ"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","6WXZ"
"6WY0",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1016/j.bmc.2020.115723",,"6WY0",272.21,"2.799","2.799","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-40 A.K.A 7-[(1R)-1-phenyl-3-{[(1r,4r)-4-phenylcyclohexyl]amino}propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase light chain","1","6WY0"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","6WY0"
"6WY5",,"X-RAY DIFFRACTION",2.68,54.15,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1016/j.bmc.2020.115723",,"6WY5",136.12,"2.898","2.898","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-37 A.K.A 7-(1-phenyl-3-(((1S,3S)-3-phenyl-2,3-dihydro-1H-inden-1-yl)amino)propyl)-1H-[1,2,3]triazolo[4,5-b]pyridin-5-amine","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase light chain","1","6WY5"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","6WY5"
"6WY7",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1016/j.bmc.2020.115723","UFD","6WY7",135.7,"2.089","2.089","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-41 A.K.A 7-[1-phenyl-3-({4-phenylbicyclo[2.2.2]octan-1-yl}amino)propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase light chain","1","6WY7"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","6WY7"
"6WYD",,"X-RAY DIFFRACTION",2.39,48.64,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1016/j.bmc.2020.115723",,"6WYD",271.96,"2.55","2.55","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-12 (AKA; 7-benzyl-1H-[1,2,3]triazolo[4,5-b]pyrid","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase light chain","1","6WYD"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","Myeloperoxidase heavy chain","2","6WYD"
"6WYF",,"X-RAY DIFFRACTION",2.88,57.32,"VAPOR DIFFUSION, SITTING DROP",,"5 uL reservoir + 5 uL 25 uM 157C delta C-star Human H-chain Ferritin in 15 mM HEPES, pH 7.0 against reservoir of 500 uL 25 mM HEPES, pH 8.0, 10 mM calcium chloride, 140 mM sodium chloride",298,"10.1021/jacs.0c10065",,"6WYF",22.01,"1.25","1.25","Crystal structure of Human H-chain Ferritin variant 157C Delta C-star Modified with a RAFT Agent Soaked in an Acrylate Solution","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRCMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6WYF"
"6WYG",,"X-RAY DIFFRACTION",2.71,54.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"5 uL reservoir + 5 uL 25 uM 157C delta C-star Human H-chain Ferritin in 15 mM HEPES, pH 7.0 against reservoir of 500 uL 50 mM MES, pH 6.5, 6 mM calcium chloride",298,"10.1021/jacs.0c10065",,"6WYG",86.57,"2.27","2.27","Crystal structure of Human H-chain Ferritin variant 157C Delta C-star Modified with a RAFT agent","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRCMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6WYG"
"6WYH",,"X-RAY DIFFRACTION",2.77,55.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"5 uL reservoir + 5 uL of 25 uM 157C delta C-star Human H-chain Ferritin in 15 mM HEPES, pH 7.0 against reservoir of 500 uL 50 mM MES, pH 6.5, 6 mM calcium chloride; crystals soaked in 1 M sodium acrylate, 50 mM calcium chloride, 25 mM MES, pH 6.5",298,"10.1021/jacs.0c10065",,"6WYH",86.58,"2.22","2.22","Crystal structure of Human H-chain Ferritin variant 157C Delta C-star Modified with a RAFT Agent Soaked in an Acrylate Solution","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRCMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6WYH"
"6WYR",,"X-RAY DIFFRACTION",2.52,51.28,"VAPOR DIFFUSION",8.5,"20% PEG6000, 0.1 M bicine, pH 8.5",291,"10.1084/jem.20200513",,"6WYR",98.21,"1.8","1.8","Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1A","SYELTQPPSVSLSPGQTATITCSGDKLDDNYVCWYQQKPGQSPVLVIYQDTMRPSGIPERFSGSNSGNIATLTISGTQAVDEADYYCQAWDGSTVVFGGGTRLTVLGQPKAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"MuSK1A light chain","1","6WYR"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKTSGYTFNNYDINWVRQAAGQGLEWMGWMNPYSGNTGYAQKFQGRVTMTRNISITTVYMELSSLRSEDTAVYYCAREVRGDTGYGGGSDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"MuSK1A heavy chain","2","6WYR"
"6WYS",,"X-RAY DIFFRACTION",3.77,67.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M sodium chloride, 1.6M ammonium sulfate, 0.1M HEPES pH 7.5",277,"10.1021/acs.jmedchem.0c02152",,"6WYS",71.84,"2.229","2.229","Lon protease proteolytic domain","MGSDKIHHHHHHERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER","Homo sapiens","LONP1, PRSS15","Lon protease homolog, mitochondrial","1","6WYS"
"6WYT",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.085 M HEPES, pH 7.5, 17% PEG4000, 8.5% isopropanol, 15% glycerol",291,"10.1084/jem.20200513",,"6WYT",46.65,"1.75","1.75","Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1B","EVQLVEWGAGLLKPSETLSLTCAVYGGSFSGDYWWTWIRQPPGKGLEWIGEIDHTGNTNYNPSLKSRLTLSVDMSKNHFSLKLTSVTAADTALYFCARQEGLGYYDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"MuSK1B heavy chain","1","6WYT"
,,,,,,,,,,,,,,,,"SYELTQSPSVSVSPGQTANITCSGDKLGDRYASWYQQKPAQSPVLVIYQDDRRPSGIPERFSGSNSGNTATLTISGTQGMDEADYYCQAWDGTTVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"MuSK1B light chain","2","6WYT"
"6WZV",,"X-RAY DIFFRACTION",3.74,67.08,"VAPOR DIFFUSION, SITTING DROP",9,"1.6M ammonium sulfate, 0.1M Bicine",293,"10.1021/acs.jmedchem.0c02152",,"6WZV",72.52,"2.51","2.51","Lon protease proteolytic domain","MGSDKIHHHHHHERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER","Homo sapiens","LONP1, PRSS15","Lon protease homolog, mitochondrial","1","6WZV"
"6WZW",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 30% PEG3350",290,"10.1038/s41467-021-23152-6",,"6WZW",27.43,"1.69","1.69","Ash1L SET domain in complex with AS-85","GAMAGSYKKIRSNVYVDVKPLSGYEATTCNCKKPDDDTRKGCVDDCLNRMIFAECSPNTCPCGEQCCNQRIQRHEWVQCLERFRAEEKGWGIRTKEPLKAGQFIIEYLGEVVSEQEFRNRMIEQYHNHSDHYCLNLDSGMVIDSYRMGNEARFINHSCDPNCEMQKWSVNGVYRIGLYALKDMPAGTELTYDYNFHSFNVEKQQLCKCGFEKCRGIIGGKSQRVNG","Homo sapiens","ASH1L, KIAA1420, KMT2H","Histone-lysine N-methyltransferase ASH1L","1","6WZW"
"6X0P",,"X-RAY DIFFRACTION",2.39,48.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5, 0.2 M MgCl2, 30% PEG4000",290,"10.1038/s41467-021-23152-6",,"6X0P",107.52,"1.69","1.69","Ash1L SET domain Q2265A mutant in complex with AS-5","GAMAGSYKKIRSNVYVDVKPLSGYEATTCNCKKPDDDTRKGCVDDCLNRMIFAECSPNTCPCGEQCCNQRIQRHEWVQCLERFRAEEKGWGIRTKEPLKAGQFIIEYLGEVVSEQEFRNRMIEQYHNHSDHYCLNLDSGMVIDSYRMGNEARFINHSCDPNCEMQKWSVNGVYRIGLYALKDMPAGTELTYDYNFHSFNVEKAQLCKCGFEKCRGIIGGKSQRVNG","Homo sapiens","ASH1L, KIAA1420, KMT2H","Histone-lysine N-methyltransferase ASH1L","1","6X0P"
"6X0S",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, HANGING DROP",,"18% PEG3350, 200 mM lithium sulfate, 0.7 mM cadmium chloride, 100 mM Bis-Tris, pH 6.3",291,,,"6X0S",85.74,"1.898","1.898","Structure of human plasma factor XIIa in complex with (2S)-4-(5-chloro-1,3-benzoxazol-2-yl)-1-(N,3-dicyclohexyl-D-alanyl)-N-[(thiophen-2-yl)methyl]piperazine-2-carboxamide (compound 7)","LSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS","Homo sapiens","F12","Coagulation factor XII","1","6X0S"
"6X0T",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, HANGING DROP",6.3,"18% PEG3350, 200 mM lithium sulfate, 0.7 mM cadmium chloride, 100 mM Bis-Tris, pH 6.3",291,,,"6X0T",85.77,"1.388","1.388","Structure of human plasma factor XIIa in complex with (2S)-1-(N,3-dicyclohexyl-D-alanyl)-4-[(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-N-[(thiophen-2-yl)methyl]piperazine-2-carboxamide (compound 8h)","LSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS","Homo sapiens","F12","Coagulation factor XII","1","6X0T"
"6X1M",,"X-RAY DIFFRACTION",3.72,66.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"2% PEG 400; 2.0M (NH4)2SO4 0.1M HEPES pH 7.5",293,"10.1021/acs.jmedchem.0c02152",,"6X1M",72.16,"3.51","3.51","Lon protease proteolytic domain complexed with covalent boronic acid inhibitor","MGSDKIHHHHHHERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER","Homo sapiens","LONP1, PRSS15","Lon protease homolog, mitochondrial","1","6X1M"
"6X27",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, SITTING DROP",4,"5.0% polyethylene glycol 6000, 0.1M citric acid",293,"10.1021/acs.jmedchem.0c02152",,"6X27",291.68,"2.12","2.12","Lon protease proteolytic domain complexed with bortezomib","MGSDKIHHHHHHERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER","Homo sapiens","LONP1, PRSS15","Lon protease homolog, mitochondrial","1","6X27"
"6X2J","3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.neuron.2020.10.014",,"6X2J",292.29,"3",,"Structure of human TRPA1 in complex with agonist GNE551","SPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISET","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6X2J"
"6X2L","2.85","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abf5814",,"6X2L",171.83,"2.85",,"hEAAT3-IFS-Na","GPMGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHSNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSNVSGKIGLRAVVYYFCTTLIAVILGIVLVVSIKPGVTQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMTMTEESFTAVMTTAISKTKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFFNALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVILPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLPVGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMVIVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF","Homo sapiens","SLC1A1, EAAC1, EAAT3, HEAAC1","Excitatory amino acid transporter 3","1","6X2L"
"6X2Z","3.03","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abf5814",,"6X2Z",57.48,"3.03",,"hEAAT3-OFS-Asp","GPMGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHSNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSNVSGKIGLRAVVYYFCTTLIAVILGIVLVVSIKPGVTQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMTMTEESFTAVMTTAISKTKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFFNALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVILPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLPVGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMVIVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF","Homo sapiens","SLC1A1, EAAC1, EAAT3, HEAAC1","Excitatory amino acid transporter 3","1","6X2Z"
"6X3A",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, HANGING DROP",,"200 mM Magnesium formate, 20% (w/v) PEG 3350",293,"10.1371/journal.pone.0269037",,"6X3A",34.96,"1.77","1.77","Crystal structure of the FN4-FN6 domains of human PTPRD","PSTGSKPSAPPQDISCTSPSSTSILVSWQPPPVEKQNGIITEYSIKYTAVDGEDDKPHEILGIPSDTTKYLLEQLEKWTEYRITVTAHTDVGPGPESLSVLIRTNEDVPSGPPRKVEVEAVNSTSVKVSWRSPVPNKQHGQIRGYQVHYVRMENGEPKGQPMLKDVMLADAQWEFDDTTEHDMIISGLQPETSYSLTVTAYTTKGDGARSKPKLVSTTGAVPGKPRLVINHTQMNTALIQWHPPVDTFGPLQGYRLKFGRKDMEPLTTLEFSEKEDHFTATDIHKGASYVFRLSARNKVGFGEEMVKEISIPEE","Homo sapiens","PTPRD","Receptor-type tyrosine-protein phosphatase delta","1","6X3A"
"6X3E","3.42","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abf5814",,"6X3E",172.11,"3.42",,"hEAAT3-Asymmetric-1o2i","GPMGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHSNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSNVSGKIGLRAVVYYFCTTLIAVILGIVLVVSIKPGVTQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMNMTEESFTAVMTTAISKNKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFFNALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVILPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLPVGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMVIVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF","Homo sapiens","SLC1A1, EAAC1, EAAT3, HEAAC1","Excitatory amino acid transporter 3","1","6X3E"
"6X3F","3.03","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abf5814",,"6X3F",172.22,"3.03",,"hEAAT3-IFS-Apo","GPMGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHSNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSNVSGKIGLRAVVYYFCTTLIAVILGIVLVVSIKPGVTQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMNMTEESFTAVMTTAISKNKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFFNALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVILPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLPVGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMVIVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF","Homo sapiens","SLC1A1, EAAC1, EAAT3, HEAAC1","Excitatory amino acid transporter 3","1","6X3F"
"6X3I",,"X-RAY DIFFRACTION",2.79,55.92,"VAPOR DIFFUSION, SITTING DROP",,"30% polyethylene glycol 1500",294,"10.1080/19420862.2020.1814583",,"6X3I",25.62,"2.268","2.268","NNAS Fc mutant","TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNNASRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6X3I"
"6X3L",,"X-RAY DIFFRACTION",3.19,61.39,"VAPOR DIFFUSION, HANGING DROP",,"20-25% PEG3350, 0.4M Na Malonate, pH8, 0.1M Tris, 5% Glycerol",293,"10.1016/j.bmcl.2020.127403",,"6X3L",86.19,"2.7","2.7","Sortilin-Progranulin Interaction With Compound 2","MERPWGAADGLSRWPHGLGLLLLLQLLPPSTLSQDRLDAPPPPAAPLPRWSGPIGVSWGLRAAAAGGAFPRGGRWRRSAPGEDEECGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPEKQNSKSNSHHHHHH","Homo sapiens","SORT1","Sortilin","1","6X3L"
"6X3N",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-TRIS pH 6.5, 0.1M NaCl, 15% w/v PEG 20K 5mM TCEP Cl, 4mM (S)-4-(8-amino-3-(1-(4-(dimethylamino)butanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(thiazol-2-yl)benzamide",277,"10.1016/j.bmcl.2020.127390","ULV","6X3N",32.65,"1.95","1.95","Co-structure of BTK kinase domain with L-005085737 inhibitor","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6X3N"
"6X3O",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M BIS-TRIS CL pH 7.5, 18%w/vPEG 20,000, 5mM 4-(8-amino-3-((6R,8aS)-3-oxooctahydroindolizin-6-yl)imidazo[1,5-a]pyrazin-1-yl)-3-methoxy-N-(4-(trifluoromethyl)pyridin-2-yl)benzamide, 5mM (S)-4-(8-amino-3-(1-(4-(dimethylamino)butanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(thiazol-2-yl)benzamide, 10% v/v deuterated-DMSO",277,"10.1016/j.bmcl.2020.127390","ULY","6X3O",65.36,"1.9","1.9","Co-structure of BTK kinase domain with L-005191930 inhibitor","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6X3O"
"6X3P",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris.Cl at pH 6.5, 2 mM TCEP Cl, 6% w/v PEG 20K, 10mM (S)-4-(8-amino-3-(1-(4-(dimethylamino)butanoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(thiazol-2-yl)benzamide, 5%v/v deuterated-DMSO,protein:precipitant volume ratio=1:2",277,"10.1016/j.bmcl.2020.127390","UM4","6X3P",33.05,"1.34","1.34","Co-structure of BTK kinase domain with L-005298385 inhibitor","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6X3P"
"6X3R",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","ZXX","6X3R",18.68,"1.8","1.8","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X3R"
"6X3Y",,"X-RAY DIFFRACTION",2.74,55.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UMM","6X3Y",18.78,"1.4","1.4","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X3Y"
"6X48",,"X-RAY DIFFRACTION",3.85,68.09,"VAPOR DIFFUSION, HANGING DROP",,"20-25% PEG3350, 0.4M Na Malonate, pH8, 0.1M Tris, 5% Glycerol",293,"10.1016/j.bmcl.2020.127403",,"6X48",76.01,"2.9","2.9","Sortilin-Progranulin Interaction With Compound 17","CGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPE","Homo sapiens","SORT1","Sortilin","1","6X48"
"6X4H",,"X-RAY DIFFRACTION",3.9,68.49,"VAPOR DIFFUSION, HANGING DROP",,"20-25% PEG3350, 0.4M Na Malonate, pH8, 0.1M Tris, 5% Glycerol",293,"10.1016/j.bmcl.2020.127403",,"6X4H",75.54,"2.9","2.9","Sortilin-Progranulin Interaction With Compound 24","CGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPE","Homo sapiens","SORT1","Sortilin","1","6X4H"
"6X4J",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION, SITTING DROP",5.6,"PEG 4000, ammonium acetate, citrate",291.15,"10.1016/j.bmc.2021.116504",,"6X4J",43.07,"2.3","2.3","PANK3 complex structure with compound PZ-2863","MGSSHHHHHHSSGLVPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","6X4J"
"6X4K",,"X-RAY DIFFRACTION",2.29,46.37,"VAPOR DIFFUSION, SITTING DROP",5.6,"PEG 4000, ammonium acetate, citrate",291.15,"10.1016/j.bmc.2021.116504",,"6X4K",43.16,"2.1","2.1","PANK3 complex structure with compound PZ-2890","MGSSHHHHHHSSGLVPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","6X4K"
"6X4L",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, SITTING DROP",5.6,"PEG 4000, ammonium acetate, citrate",291.15,"10.1016/j.bmc.2021.116504",,"6X4L",43.17,"2","2","PANK3 complex structure with compound PZ-3565","MGSSHHHHHHSSGLVPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","6X4L"
"6X4M",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UMM","6X4M",18.78,"1.5","1.5","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: tert-butyl [(2S)-1-{[(3S,17S)-2,16-dioxo-10,15-dioxa-1,21-diazatricyclo[15.3.1.1~5,9~]docosa-5(22),6,8-trien-3-yl]amino}-3-methyl-1-oxobutan-2-yl]carbamate (compound 3)","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X4M"
"6X4N",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UOD","6X4N",18.78,"1.51","1.51","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,11,17,17-tetramethyl-14-(propan-2-yl)-3-oxa-9,12,15,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 24)","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X4N"
"6X4O",,"X-RAY DIFFRACTION",2.74,55.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UO7","6X4O",18.75,"1.5","1.5","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,11-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,21,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(26),18,20,22,24,27-hexaene-4,10,13,16-tetrone (compound 21)","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X4O"
"6X4P",,"X-RAY DIFFRACTION",2.79,55.92,"VAPOR DIFFUSION, HANGING DROP",,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UOG","6X4P",18.78,"1.5","1.5","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,11,17,17-tetramethyl-14-(propan-2-yl)-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 28)","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X4P"
"6X4Q",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"20 mM Tris-HCl, pH 8.5, 2 mM DTT, 2 mM EDTA, 20-35% PEG 3350, 5% ethanol",277,"10.1021/acs.jcim.0c00132","UOJ","6X4Q",18.79,"1.8","1.8","Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-14-cyclobutyl-2,11,17,17-tetramethyl-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 33)","GHMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6X4Q"
"6X4X",,"SOLUTION NMR",,,,,,,"10.1073/pnas.2010908117",,"6X4X",5.81,,,"B24Y DKP insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin chain A","1","6X4X"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGYFYTKPT","Homo sapiens","INS","Insulin","2","6X4X"
"6X5H",,"X-RAY DIFFRACTION",3.75,67,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6 M Ammonium sulfate, 0.6 M L-proline, 100 mM Hepes pH 7.5",293,"10.1074/jbc.RA120.014625","GDP","6X5H",249.7,"2.25","2.25","Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP","RELSKILAKLERLKQQNEDLRRMAESLRIPEGPIDQGPAIGRVRVLEEQLVKAKEQIENYKKQTRNGLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEK","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6X5H"
"6X5I","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.xcrp.2020.100085",,"6X5I",61.67,"4.3",,"Cryo-EM of peptide-like filament of 1-KMe3","XFFYK","Homo sapiens",,"1-KMe3 peptide-like fibril","1","6X5I"
"6X5J",,"X-RAY DIFFRACTION",3.77,67.36,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M CITRIC ACID, 20% PEG 6000",277,"10.1016/j.bmcl.2020.127279",,"6X5J",34.33,"2.513","2.513","Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT","Homo sapiens","F9","Coagulation factor IX","1","6X5J"
,,,,,,,,,,,,,,,,"MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTR","Homo sapiens","F9","Coagulation factor IX","2","6X5J"
"6X5L",,"X-RAY DIFFRACTION",3.94,68.78,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M CITRIC ACID, 20% PEG 6000",277,"10.1016/j.bmcl.2020.127279","UQG","6X5L",34.23,"2.246","2.246","Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKL","Homo sapiens","F9","Coagulation factor IX","1","6X5L"
,,,,,,,,,,,,,,,,"MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTR","Homo sapiens","F9","Coagulation factor IX","2","6X5L"
"6X5P",,"X-RAY DIFFRACTION",3.75,67.21,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M CITRIC ACID, 20% PEG 6000",277,"10.1016/j.bmcl.2020.127279","UQD","6X5P",34.25,"1.997","1.997","Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGASALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT","Homo sapiens","F9","Coagulation factor IX","1","6X5P"
,,,,,,,,,,,,,,,,"MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTR","Homo sapiens","F9","Coagulation factor IX","2","6X5P"
"6X5T",,"X-RAY DIFFRACTION",3.3,62,"VAPOR DIFFUSION, HANGING DROP",7.2,"10% PEG 3350, 0.2 M L-proline, 100 mM Hepes pH 7.2",293,"10.1074/jbc.RA120.014625",,"6X5T",502.3,"2.47","2.47","Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and A3-Asn","RELSKILAKLERLKQQNEDLRRMAESLRIPEGPIDQGPAIGRVRVLEEQLVKAKEQIENYKKQTRNGLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEK","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6X5T"
"6X5U",,"X-RAY DIFFRACTION",3.3,63,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 3350, 0.2 M Ammonium chloride",293,"10.1074/jbc.RA120.014625",,"6X5U",506.35,"3.2","3.2","Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and NM5M2-Asn","RELSKILAKLERLKQQNEDLRRMAESLRIPEGPIDQGPAIGRVRVLEEQLVKAKEQIENYKKQTRNGLGKDHEILRRRIENGAKELWFFLQSELKKLKNLEGNELQRHADEFLLDLGHHERSIMTDLYYLSQTDGAGDWREKEAKDLTELVQRRITYLQNPKDCSKAKKLVCNINKGCGYGCQLHHVVYCFMIAYGTQRTLILESQNWRYATGGWETVFRPVSETCTDRSGISTGHWSGEVKDKNVQVVELPIVDSLHPRPPYLPLAVPEDLADRLVRVHGDPAVWWVSQFVKYLIRPQPWLEKEIEEATKKLGFKHPVIGVHVRRTDKVGTEAAFHPIEEYMVHVEEHFQLLARRMQVDKKRVYLATDDPSLLKEAKTKYPNYEFISDNSISWSAGLHNRYTENSLRGVILDIHFLSQADFLVCTFSSQVCRVAYEIMQTLHPDASANFHSLDDIYYFGGQNAHNQIAIYAHQPRTADEIPMEPGDIIGVAGNHWDGYSKGVNRKLGRTGLYPSYKVREKIETVKYPTYPEAEK","Homo sapiens","FUT8","Alpha-(1,6)-fucosyltransferase","1","6X5U"
"6X5Y",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION",,"0.1 mM Tris pH 8.0, 20% (w/v) PEG 6000",293,,,"6X5Y",89.52,"2.65","2.65","IDO1 in complex with compound 4","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6X5Y"
"6X7B",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350, 0.2 M NH4Cl, 0.1 M Tris pH 8.5",291,"10.1038/s41598-020-68964-6","ZVP","6X7B",32.72,"1.951","1.951","BRD4 Bromodomain 1 in complex with multi-action inhibitor SRX3212P","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQA","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6X7B"
"6X7C",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, SITTING DROP",,"40% PEG 3350, 0.2 M Pottassium thiocyanate pH 7.5, and 4% 1,1,1,3,3,3-Hexafluoro-2-propanol",277,"10.1038/s41598-020-68964-6",,"6X7C",16.36,"2.7","2.7","BRD4 Bromodomain 1 in complex with multi-action inhibitor SRX3212","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQA","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6X7C"
"6X7D",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, SITTING DROP",,"2.5 M Ammonium Sulfate and 0.1 M Tris pH 8.5",291,"10.1038/s41598-020-68964-6","UT4","6X7D",32.28,"2.5","2.5","BRD4 Bromodomain 1 in complex with multi-action inhibitor SF2523P","NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQA","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6X7D"
"6X7I",,"SOLUTION NMR, SOLID-STATE NMR",,,,,,,"10.1016/j.bpj.2020.08.014",,"6X7I",3.17,,,"Structure of the C-terminal domain of BCL-XL in membrane","GQERFNRWFLTGMTVAGVVLLGSLFSRK","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6X7I"
"6X7U",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium chloride and 20% (w/v) PEG 3350",293,"10.1093/nar/gkaa402",,"6X7U",41.67,"2.7","2.7","Crystal Structure of the Human Nudix Hydrolase Nudt16 in complex with FAD","MAGARRLELGEALALGSGWRHACHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSG","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","6X7U"
"6X7V",,"X-RAY DIFFRACTION",2.01,38.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M ammonium chloride, 20% (w/v) PEG 3350, 0.1 M MES pH 5.5",293,"10.1093/nar/gkaa402",,"6X7V",85.3,"2.3","2.3","Crystal Structure of the Human Nudix Hydrolase Nudt16","MAGARRLELGEALALGSGWRHACHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","6X7V"
"6X81",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION",6.5,"15% PEG8000, 0.2M Magnesium acetate, 0.05 M sodium cacodylate, pH 6.5",293,"10.1021/acs.jmedchem.0c01280",,"6X81",105.99,"2.81","2.81","Crystal Structure of TNFalpha with isoquinoline compound 2","MVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6X81"
"6X82",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION",6.5,"15% PEG8000, 0.2M Magnesium acetate, 0.05M sodium cacodylate, pH 6.5",293,"10.1021/acs.jmedchem.0c01280",,"6X82",106.12,"2.75","2.75","Crystal Structure of TNFalpha with isoquinoline compound 4","MVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6X82"
"6X83",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION",6.5,"15% PEG8000, 0.2M magnesium acetate, 0.05M sodium cacodylate, pH 6.5",293,"10.1021/acs.jmedchem.0c01280",,"6X83",105.84,"2.83","2.83","Crystal Structure of TNFalpha with fragment compound 6","MVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6X83"
"6X85",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION",6.5,"15% PEG 8000, 0.2M magnesium acetate, 0.05M sodium cacodylate, pH 6.5",293,"10.1021/acs.jmedchem.0c01280",,"6X85",105.33,"2.85","2.85","Crystal Structure of TNFalpha with indolinone compound 9","MVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6X85"
"6X86",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION",6.5,"15% PEG8000, 0.2M magnesium acetate, 0.05M sodium cacadylate, pH 6.5",293,"10.1021/acs.jmedchem.0c01280",,"6X86",106.03,"2.93","2.93","Crystal Structure of TNFalpha with indolinone compound 11","MVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6X86"
"6X8E",,"X-RAY DIFFRACTION",2.01,38.7,"EVAPORATION",7.5,"0.1 M HEPES pH 7.5, 0.1 M sodium acetate trihydrate, and 30-35% PEG-3350",298,"10.1021/acs.jmedchem.0c00948","UWP","6X8E",70.95,"1.75","1.75","Crystal structure of JAK2 with Compound 11","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6X8E"
"6X8F",,"X-RAY DIFFRACTION",1.84,33.09,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1021/acs.jmedchem.0c00948","UWP","6X8F",73.98,"2.15","2.15","Crystal structure of TYK2 with Compound 11","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6X8F"
"6X8G",,"X-RAY DIFFRACTION",1.81,32.06,"EVAPORATION",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1021/acs.jmedchem.0c00948","UWM","6X8G",36.93,"2.21","2.21","Crystal structure of TYK2 with Compound 22","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6X8G"
"6X8O",,"X-RAY DIFFRACTION",2,38.45,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG600, 0.05 M Tris-HCl, 0.15 M potassium thiocyanate, 0.5% CHAPS",277,"10.1016/j.str.2020.09.002",,"6X8O",13.15,"1.31","1.31","BimBH3 peptide tetramer","DMRPEIWIAQELRRIGDEFNAYYARRX","Homo sapiens","BCL2L11, BIM","Bcl-2-like protein 11","1","6X8O"
"6X8Z",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG8000, 100 mM Tris-HCl, pH 8.5, 200 mM magnesium chloride",293,"10.1021/jacs.0c06590",,"6X8Z",46.31,"2.5","2.5","Crystal structure of N-truncated human B12 chaperone CblD(C262S)-thiolato-cob(III)alamin complex (108-296)","GHMSSERHEFVMAQYVNEFQGNDAPVEQEINSAETYFESARVECAIQTCPELLRKDFESLFPEVANGKLMILTVTQKTKNDMTVWSEEVEIEREVLLEKFINGAKEICYALRAEGYWADFIDPSSGLAFFGPYTNNTLFETDERYRHLGFSVDDLGCSKVIRHSLWGTHVVVGSIFTNATPDSHIMKKLSGN","Homo sapiens","MMADHC, C2orf25, CL25022, HSPC161, My011","Methylmalonic aciduria and homocystinuria type D protein, mitochondrial","1","6X8Z"
"6X9X",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, HANGING DROP",8,"0.4 M Ammonium Acetate,
20% PEG 2000 MME,
Cryoprotectant-Ethylene glycol",295,"10.1016/j.jmb.2020.11.013",,"6X9X",48.16,"1.8","1.8","Crystal structure of Fab fragment of Anti-HCV E2 antibody (HC84.26)","QVQPVQSGAEVKKPGSSVKVSCEASGGTHSNYVITWVRQAPGQGLEWMGGFIPDFRTAMYAQGFQGRVTITADESTSLAYMELTNLRSEDTAVYYCARGPLSRGYYDYWGPGTLVTVSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTAGWSHPQFEK","Homo sapiens",,"HC84.26 Fab Heavy Chain","1","6X9X"
,,,,,,,,,,,,,,,,"SYVLTQPPSVSVAPGQTASITCSGDKLGDKYVSWYQQRPGQSPVLVLYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSALVFGGGTKLTVLRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"HC84.26 Fab Light Chain","2","6X9X"
"6XAE",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",5.5,"PROTEIN AT 8-10MG/ML, WITH 0.2M MGCL2,
 22% PEG3350, 0.1M BIS-TRIS PH 5.5, PH 0, VAPOR DIFFUSION,
 HANGING DROP, TEMPERATURE 295K",295,"10.1016/j.bmcl.2020.127204",,"6XAE",33.53,"2.257","2.257","SUBSTITUTED BENZYLOXYTRICYCLIC COMPOUNDS AS RETINOIC ACID-RELATED ORPHAN RECEPTOR GAMMA T AGONISTS","MGSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTSGGSGGLTERHKILHRLLQE","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6XAE"
"6XAF",,"X-RAY DIFFRACTION",2.11,41.83,"MICROBATCH",6.5,"100 mM potassium thiocyanate, 25% PEG2000 MME, 0.1 M Bis-Tris, pH 6.5",298,,,"6XAF",47.69,"1.968","1.968","1.9A crystal structure of the GTPase domain of Parkinson's disease-associated protein LRRK2 carrying R1398H","MGSSHHHHHHSQDPAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGHEEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEAQRAACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVG","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6XAF"
"6XAH",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.0c00596",,"6XAH",10.92,,,"Structure of a Stable Interstrand DNA Crosslink Involving an dA Amino Group and an Abasic Site","TATGTCTAAGTTCATCTA","Homo sapiens",,"DNA (5'-D(*TP*AP*TP*GP*TP*CP*TP*AP*AP*GP*TP*TP*CP*AP*TP*CP*TP*A)-3')","1","6XAH"
,,,,,,,,,,,,,,,,"TAGATGAACXTAGACATA","Homo sapiens",,"DNA (5'-D(*TP*AP*GP*AP*TP*GP*AP*AP*CP*(AAB)P*TP*AP*GP*AP*CP*AP*TP*A)-3')","2","6XAH"
"6XAT",,"X-RAY DIFFRACTION",1.72,28.32,"VAPOR DIFFUSION, SITTING DROP",,"Sodium Formate 4 M",292,,,"6XAT",13.24,"2.2","2.2","Crystal structure of the human FoxP4 DNA binding Domain","GMKETAAAKFERQHMDSDDDKHMADVRPPFTYASLIRQAILETPDRQLTLNEIYNWFTRMFAYFRRNTATWKNAVRHNLSLHKCFVRVENVKGAVWTVDEREYQKRRPPK","Homo sapiens","FOXP4, FKHLA","FOXP4 protein","1","6XAT"
"6XAX",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ca(CH3COO)2, 0.1M imidazole pH 8.0, 10%(w/v) PEG 8000",277,,,"6XAX",59.7,"2.4","2.4","Structure of a fragment of human fibronectin containing the 11th type III domain, extra domain A, and the 12th type III domain","GSGRTEIDKPSQMQVTDVQDNSISVKWLPSSSPVTGYRVTTTPKNGPGPTKTKTAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQVSRYRVTYSSPEDGIHELFPAPDGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLIGTQSTAIPAPTDLKFTQVTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVVTTLE","Homo sapiens","FN1, FN","Fibronectin","1","6XAX"
"6XAY",,"X-RAY DIFFRACTION",3.49,64.76,"VAPOR DIFFUSION, SITTING DROP",,"0.5M (NH4)2SO4, 0.1M Citric acid pH 4.0, 30%(v/v)PEG 600, 10%(v/v) glycerol",277,,,"6XAY",119.85,"2.48","2.48","Structure of a fragment of human fibronectin containing the 10th, 11th and 12th type III domains","GSHMVSDVPRDLEVVAATPTSLLISWDAPAVTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYRTEIDKPSQMQVTDVQDNSISVKWLPSSSPVTGYRVTTTPKNGPGPTKTKTAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTTIPAPTDLKFTQGTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVVTTLE","Homo sapiens","FN1, FN","Fibronectin","1","6XAY"
"6XAZ",,"X-RAY DIFFRACTION",2.35,47.67,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium cacodylate pH 6.5, 2.0 M ammonium sulfate, 0.2 M NaCl",277,,,"6XAZ",30.17,"1.7","1.7","Structure of the PR domain from human PRDM5","GSGMLGMYVPDRFSLKSSRVQDGMGLYTARRVRKGEKFGPFAGEKRMPEDLDENMDYRLMWEVRGSKGEVLYILDATNPRHSNWLRFVHEAPSQEQKNLAAIQEGENIFYLAVEDIETDTELLIGYLDSD","Homo sapiens","PRDM5, PFM2","PR domain zinc finger protein 5","1","6XAZ"
"6XCA",,"X-RAY DIFFRACTION",2.55,52,"VAPOR DIFFUSION, SITTING DROP",3.5,"150 mM lithium sulfate, 100 mM citric acid, pH 3.5, 18% v/v PEG6000",293,"10.1016/j.cell.2020.06.025",,"6XCA",47.71,"1.8","1.8","Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105","QSALTQPPSGSGSPGQSVTISCTGTSSDVGGYKYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSNNFVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"C105 Light Chain","2","6XCA"
,,,,,,,,,,,,,,,,"QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGEGWELPYDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"C105 Heavy Chain","1","6XCA"
"6XCG",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6 M ammonium sulfate, 0.01 M magnesium chloride, 0.1 M HEPES, pH 7.5",291,,,"6XCG",49.77,"1.64","1.64","Histone-lysine N-methyltransferase NSD2-PWWP1 with compound UNC6934","GGRDKDHLLKYNVGDLVWSKVSGYPWWPCMVSADPLLHSYTKLKGQKKSARQYHVQFFGDAPERAWIFEKSLVAFEGEGQFEKLCQESAKQAPTKAEKIKLLKPISGKLRAQWEMGIVQAEEAASMSVEERKAKFTFLYVG","Homo sapiens","NSD2, KIAA1090, MMSET, TRX5, WHSC1","Histone-lysine N-methyltransferase NSD2","1","6XCG"
"6XCL",,"X-RAY DIFFRACTION",3.58,65.63,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM KCl, 10 mM MgCl2, 50 mM MES (pH 6.0), 10% PEG 400",285,"10.1002/anie.202012520",,"6XCL",16.05,"2.7","2.7","Crystal Structure of human telomeric DNA G-quadruplex in complex with a novel platinum(II) complex.","AGGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","6XCL"
"6XDB",,"X-RAY DIFFRACTION",2.97,58.52,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Hepes pH 7.5, 42% PEG200, 1 M Lithium chloride, 3% w/v 6-Aminohexanoic acid",277,"10.1021/acsmedchemlett.0c00344",,"6XDB",50.38,"2.45","2.45","Crystal structure of IRE1a in complex with G-6904","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRNLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6XDB"
"6XDD",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",,"10% 2-propanol, 0.1 M sodium citrate tribasic dihydrate pH 5.0, and 26% PEG400, 4% pentaerythritol ethoxylate (3/4 EO/OH), 4% 1,3-Propanediol",277,"10.1021/acsmedchemlett.0c00344",,"6XDD",100.82,"2.4","2.4","Crystal structure of IRE1 in complex with G-3053","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDALGNS","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6XDD"
"6XDF",,"X-RAY DIFFRACTION",3.06,59.85,"VAPOR DIFFUSION, SITTING DROP",,"10% (v/v) isopropanol, 11% (w/v) PEG4000, 0.1 M Na-citrate, pH 5.6",277,"10.1021/acsmedchemlett.0c00344",,"6XDF",99.12,"2.54","2.54","Crystal structure of IRE1a in complex with G-4100","GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6XDF"
"6XDM",,"X-RAY DIFFRACTION",2.48,50.49,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, 0.1 M Hepes pH 7.5",293,"10.1021/acsmedchemlett.0c00302","V1D","6XDM",132.74,"1.56","1.56","STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN ARYL KETONE INHIBITOR","MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6XDM"
"6XE4",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION",7,"PEG 10000, Li2SO4, pH 7.0",291,"10.1021/acsmedchemlett.0c00249","V1G","6XE4",34.56,"1.6","1.6","BTK Fluorocyclopropyl amide inhibitor, Compound 25","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6XE4"
"6XE6","4.53","ELECTRON MICROSCOPY",,,,,,,"10.26508/lsa.202000776",,"6XE6",127.15,"4.54, 4.53",,"Structure of Human Dispatched-1 (DISP1)","MAWSHPQFEKSRPFKLPKSYAALIADWPVVVLGMCTMFIVVCALVGVLVPELPDFSDPLLGFEPRGTAIGQRLVTWNNMVKNTGYKATLANYPFKYADEQAKSHRDDRWSDDHYEREKREVDWNFHKDSFFCDVPSDRYSRVVFTSSGGETLWNLPAIKSMCNVDNSRIRSHPQFGDLCQRTTAASCCPSWTLGNYIAILNNRSSCQKIVERDVSHTLKLLRTCAKHYQNGTLGPDCWDMAARRKDQLKCTNVPRKCTKYNAVYQILHYLVDKDFMTPKTADYATPALKYSMLFSPTEKGESMMNIYLDNFENWNSSDGVTTITGIEFGIKHSLFQDYLLMDTVYPAIAIVIVLLVMCVYTKSMFITLMTMFAIISSLIVSYFLYRVVFHFEFFPFMNLTALIILVGIGADDAFVLCDVWNYTKFDKPHAETSETVSITLQHAALSMFVTSFTTAAAFYANYVSNITAIRCFGVYAGTAILVNYVLMVTWLPAVVVLHERYLLNIFTCFKKPQQQIYDNKSCWTVACQKCHKVLFAISEASRIFFEKVLPCIVIKFRYLWLFWFLALTVGGAYIVCINPKMKLPSLELSEFQVFRSSHPFERYDAEYKKLFMFERVHHGEELHMPITVIWGVSPEDNGNPLNPKSKGKLTLDSSFNIASPASQAWILHFCQKLRNQTFFYQTDEQDFTSCFIETFKQWMENQDCDEPALYPCCSHWSFPYKQEIFELCIKRAIMELERSTGYHLDSKTPGPRFDINDTIRAVVLEFQSTYLFTLAYEKMHQFYKEVDSWISSELSSAPEGLSNGWFVSNLEFYDLQDSLSDGTLIAMGLSVAVAFSVMLLTTWNIIISLYAIISIAGTIFVTVGSLVLLGWELNVLESVTISVAVGLSVDFAVHYGVAYRLAPDPDREGKVIFSLSRVGSAMAMAALTTFVAGAMMMPSTVLAYTQLGTFMMLIMCISWAFATFFFQCMCRCLGPQGTCGQIPLPKKLQCSAFSHALSTSPSDKGQSKTHTINAYHLDPRGPKSELEHEFYELEPLASHSCTAPEKTTYEETHICSEFFNSQAKNLGMPVHAAYNSELSKSTESDAGSDYKDDDDK","Homo sapiens","DISP1, DISPA","Protein dispatched homolog 1","1","6XE6"
"6XE8",,"X-RAY DIFFRACTION",3.17,59.92,"VAPOR DIFFUSION, HANGING DROP",8.5,"tris hydrochloride pH 8.5, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",277.15,"10.1039/d2sc04135a",,"6XE8",37.62,"1.952","1.952","Crystal Structure of the PTP1B YopH WPD loop Chimera 3 apo form","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYGNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XE8"
"6XEA",,"X-RAY DIFFRACTION",3.28,61.27,"VAPOR DIFFUSION, HANGING DROP",8.2,"tris hydrochloride pH 8.2, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",277.15,"10.1039/d2sc04135a",,"6XEA",37.71,"1.549","1.549","Crystal Structure of the PTP1B YopH WPD loop Chimera 3 bound to vanadate","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYGNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XEA"
"6XEB",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, 0.1 M Hepes pH 7.5",293,"10.1016/j.bmcl.2020.127367",,"6XEB",132.7,"1.5","1.5","STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND E)","MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6XEB"
"6XEC",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, 0.1 M Hepes pH 7.5",293,"10.1016/j.bmcl.2020.127367",,"6XEC",132.86,"1.701","1.701","STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND O)","MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6XEC"
"6XED",,"X-RAY DIFFRACTION",3.29,61.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"tris hydrochloride pH 7.8, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",295,"10.1039/d2sc04135a",,"6XED",38.04,"1.795","1.795","Crystal Structure of the PTP1B YopH WPD loop Chimera 3 bound to tungstate","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYGNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XED"
"6XEE",,"X-RAY DIFFRACTION",3.25,60.79,"VAPOR DIFFUSION, HANGING DROP",7.8,"tris hydrochloride pH 7.8, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",295,"10.1039/d2sc04135a",,"6XEE",37.84,"2.501","2.501","Crystal Structure of the PTP1B YopH WPD loop Chimera 4 apo form","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XEE"
"6XEF",,"X-RAY DIFFRACTION",3.27,61.12,"VAPOR DIFFUSION, HANGING DROP",7.8,"tris hydrochloride pH 7.8, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",277.15,"10.1039/d2sc04135a",,"6XEF",37.78,"2.048","2.048","Crystal structure of the PTP1B YopH WPD loop Chimera 4 bound to vanadate","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XEF"
"6XEG",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",7.8,"tris hydrochloride pH 7.8, magnesium acetate tetrahydrate, PEG 8000 and benzamidine",295,"10.1039/d2sc04135a",,"6XEG",37.89,"2.549","2.549","Crystal structure of the PTP1B YopH WPD loop Chimera 4 bound to tungstate","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTNWPDQTAPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6XEG"
"6XF3",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5,
0.2M CaCl2,
15% (w/v) PEG 8000",291,"10.1002/cmdc.202100068",,"6XF3",43.95,"2.38","2.38","Crystal structure of STING in complex with E7766","GSVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","STING1, ERIS, MITA, TMEM173, STING","Stimulator of interferon genes protein","1","6XF3"
"6XF4",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5,
0.2M CaCl2,
15% (w/v) PEG 8000",291,"10.1002/cmdc.202100068",,"6XF4",44.28,"2.77","2.77","Crystal structure of STING REF variant in complex with E7766","GSVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","STING1, ERIS, MITA, TMEM173, STING","Stimulator of interferon genes protein","1","6XF4"
"6XFI",,"X-RAY DIFFRACTION",2.81,56.3,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M potassium/sodium tartrate, 0.1 M Bis-Tris, pH 7.5, 10% PEG10000",296,"10.1107/S2059798321001261",,"6XFI",61.88,"2","2","Crystal Structures of beta-1,4-N-Acetylglucosaminyltransferase 2 (POMGNT2): Structural Basis for Inherited Muscular Dystrophies","DYPKALQILMEGGTHMVCTGRTHTDRICRFKWLCYSNEAEEFIFFHGNTSVMLPNLGSRRFQPALLDLSTVEDHNTQYFNFVELPAAALRFMPKPVFVPDVALIANRFNPDNLMHVFHDDLLPLFYTLRQFPGLAHEARLFFMEGWGEGAHFDLYKLLSPKQPLLRAQLKTLGRLLCFSHAFVGLSKITTWYQYGFVQPQGPKANILVSGNEIRQFARFMTEKLNVSHTGVPLGEEYILVFSRTQNRLILNEAELLLALAQEFQMKTVTVSLEDHTFADVVRLVSNASMLVSMHGAQLVTTLFLPRGATVVELFPYAVNPDHYTPYKTLAMLPGMDLQYVAWRNMMPENTVTHPERPWDQGGITHLDRAEQARILQSREVPRHLCCRNPEWLFRIYQDTKVDIPSLIQTIRRVVKGRPGPRKQKWTVGLYPGKVREARCQASVHGASEARLTVSWQIPWNLKYLKVREVKYEVWLQEQGENTYVPYILALQNHTFTENIKPFTTYLVWVRCIFNKILLGPFADVLVCNT","Homo sapiens","POMGNT2, AGO61, C3orf39, EOGTL, GTDC2","Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2","1","6XFI"
"6XFM","2.62","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-19512-3",,"6XFM",80.2,"2.62",,"Molecular structure of the core of amyloid-like fibrils formed by residues 111-214 of FUS","GSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQGDRG","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6XFM"
"6XFP",,"X-RAY DIFFRACTION",2.31,46.72,"VAPOR DIFFUSION",,"(18% PEG
3350, and 0.2M Na Iodine, and 0.1 M bis-Tris propane pH6.5)",298,"10.1038/s41586-021-03515-1",,"6XFP",33.52,"2","2","Crystal Structure of BRAF kinase domain bound to Belvarafenib","MHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYKHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6XFP"
"6XFV",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",,"1.0M NaAcetate, 0.3 M NaSCN, 0.1M Tris pH 8.0",295,"10.1016/j.bmcl.2020.127392",,"6XFV",62.54,"2.15","2.15","CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C IN COMPLEX WITH A NOVEL INVERSE AGONIST","MGSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFST","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6XFV"
"6XI4",,"X-RAY DIFFRACTION",2.51,51.03,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Hepes pH 7, 10% (w/v) PEG 5K MME, 5% tacsimate, 2.5 mM MgCl2 and 0.2 mM CoCl2.  10 mM of TFBQ was added to the crystallization drop and let to soak for 2.5 hours",298,,,"6XI4",52.01,"2.22","2.22","Crystal structure of Maf domain of human N-acetylserotonin O-methyltransferase-like protein soaked with TFBQ","LLHKRVVLASASPRRQEILSNAGLRFEVVPSKFKEKLDKASFATPYGYAMETAKQKALEVANRLYQKDLRAPDVVIGADTIVTVGGLILEKPVDKQDAYRMLSRLSGREHSVFTGVAIVHCSSKDHQLDTRVSEFYEETKVKFSELSEELLWEYVHSGEPMDKAGGYGIQALGGMLVESVHGDFLNVVGFPLNHFCKQLVKLYYPPRPEDLRRSVKHDSIPAADTFEDLS","Homo sapiens","ASMTL","Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein","1","6XI4"
"6XI5",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Hepes pH 7, 10% (w/v) PEG 5K MME, 5% tacsimate, 2.5 mM MgCl2 and 0.2 mM CoCl2.  10 mM of PDHPTAO was added to the crystallization drop and let to soak for 2.5 hours",298,,,"6XI5",51.83,"2.61","2.61","Crystal structure of human N-acetylserotonin O-methyltransferase-like protein soaked with PDHPTAO","LLHKRVVLASASPRRQEILSNAGLRFEVVPSKFKEKLDKASFATPYGYAMETAKQKALEVANRLYQKDLRAPDVVIGADTIVTVGGLILEKPVDKQDAYRMLSRLSGREHSVFTGVAIVHCSSKDHQLDTRVSEFYEETKVKFSELSEELLWEYVHSGEPMDKAGGYGIQALGGMLVESVHGDFLNVVGFPLNHFCKQLVKLYYPPRPEDLRRSVKHDSIPAADTFEDLS","Homo sapiens","ASMTL","Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein","1","6XI5"
"6XIH",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, SITTING DROP",6,"6% polyethylene glycol 2000 MME , 20% glycerol, 0.1M MES, pH 6.0",277,"10.1016/j.bmcl.2020.127405",,"6XIH",67.24,"2.65","2.65","Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile","MESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSASHHHHHH","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6XIH"
"6XIY",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, SITTING DROP",,"200mM Magnesium chloride, 2.0 - 2.8M sodium chloride",291,"10.1021/acs.biochem.1c00009",,"6XIY",15.46,"2.307","2.307","Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to methyl 2-(acetylamino)-2-deoxy-1-thio-alpha-D-galactopyranose","SCPVNWVEHQDSCYWFSHSGMSWAEAEKYCQLKNAHLVVINSREEQNFVQKYLGSAYTWMGLSDPEGAWKWVDGTDYATGFQNWKPGQPDDWQGHGLGGGEDCAHFHPDGRWNDDVCQRPYHWVCEAGL","Homo sapiens","CLEC10A, CLECSF13, CLECSF14, HML","C-type lectin domain family 10 member A","1","6XIY"
"6XJK",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION",,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jctc.0c00847",,"6XJK",33.52,"2.02350796538","2.02350796538","JAK2 JH2 in complex with JAK067","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6XJK"
"6XJN",,"X-RAY DIFFRACTION",3.77,67.39,"VAPOR DIFFUSION, HANGING DROP",7,"3.5 M sodium formate pH 7, crystals transferred to cryo solution supplemented with 25% glycerol",293.15,"10.1083/jcb.202104128",,"6XJN",50.87,"2.2","2.2","Human atlastin-1 (residues 1-439) bound to GDP-Mg2+ exhibits an ordered amino terminus","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSK","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","6XJN"
"6XJO",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"187.5 mM Ammonium acetate, 21.5% PEG3350, 100 mM Bis-Tris pH 6.5",293.15,"10.1083/jcb.202104128",,"6XJO",76.21,"2.1","2.1","Human atlastin-3 (residues 1-334) bound to GDP-Mg2+ exhibits an ordered amino terminus","MLSPQRVAAAASRGADDAMESSKPGPVQVVLVQKDQHSFELDEKALASILLQDHIRDLDVVVVSVAGAFRKGKSFILDFMLRYLYSQKESGHSNWLGDPEEPLTGFSWRGGSDPETTGIQIWSEVFTVEKPGGKKVAVVLMDTQGAFDSQSTVKDCATIFALSTMTSSVQIYNLSQNIQEDDLQQLQLFTEYGRLAMDEIFQKPFQTLMFLVRDWSFPYEYSYGLQGGMAFLDKRLQVKEHQHEEIQNVRNHIHSCFSDVTCFLLPHPGLQVATSPDFDGKLKDIAGEFKEQLQALIPYVLNPSKLMEKEINGSKVTCRGLLEYFKAYIKIYQG","Homo sapiens","ATL3","Atlastin-3","1","6XJO"
"6XKC",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, SITTING DROP",7,"16% Jeffamine M-600 pH 7.0 and 0.1 M HEPES 7.0",291,"10.1038/s41589-020-00703-4",,"6XKC",159.75,"2.03","2.03","Crystal structure of E3 ligase","GSMDLKTAVFNAARDGKLRLLTKLLASKSKEEVSSLISEKTNGATPLLMAARYGHLDMVEFLLEQCSASIEVGGSVNFDGETIEGAPPLWAASAAGHLKVVQSLLNHGASVNNTTLTNSTPLRAACFDGHLEIVKYLVEHKADLEVSNRHGHTCLMISCYKGHKEIAQYLLEKGADVNRKSVKGNTALHDCAESGSLDIMKMLLMYCAKMEKDGYGMTPLLSASVTGHTNIVDFLTHHAQTSKTER","Homo sapiens","FEM1C, KIAA1785","Protein fem-1 homolog C","1","6XKC"
"6XKG",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"Protein: 15.5mg/ml 3ost3a, 4mM PAP, 5mM 8mer Nac/NS2S6S, 25mM Tris pH 7.5, 125mM NaCl,

Reservoir: 0.1M Bicine and 10% MPD",293,"10.1039/d1cb00079a",,"6XKG",67.85,"1.55","1.55","Crystal structure of 3-O-Sulfotransferase isoform 3 in complex with 8mer oligosaccharide with 6S sulfation","GSPNSGTLALLLDEGSKQLPQAIIIGVKKGGTRALLEFLRVHPDVRAVGAEPHFFDRSYDKGLAWYRDLMPRTLDGQITMEKTPSYFVTREAPARISAMSKDTKLIVVVRDPVTRAISDYTQTLSKRPDIPTFESLTFKNRTAGLIDTSWSAIQIGIYAKHLEHWLRHFPIRQMLFVSGERLISDPAGELGRVQDFLGLKRIITDKHFYFNKTKGFPCLKKAEGSSRPHCLGKTKGRTHPEIDREVVRRLREFYRPFNLKFYQMTGHDFGWDG","Homo sapiens","HS3ST3A1, 3OST3A1, HS3ST3A, UNQ2551/PRO6180","Heparan sulfate glucosamine 3-O-sulfotransferase 3A1","1","6XKG"
"6XKJ","3.54","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20320-y",,"6XKJ",161.65,"3.54",,"Cryo-EM structure of CARD8-CARD filament","AAFVKENHRQLQARMGDLKGVLDDLQDNEVLTENEKELVEQEKTRQSKNEALLSMVEKKGDLALDVLFRSISERDPYLVSYLRQQNL","Homo sapiens","CARD8, KIAA0955, NDPP1, DACAR","Caspase recruitment domain-containing protein 8","1","6XKJ"
"6XKK","3.72","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20320-y",,"6XKK",490.11,"3.6, 3.72",,"Cryo-EM structure of the NLRP1-CARD filament","LHFVDQYREQLIARVTSVEVVLDKLHGQVLSQEQYERVLAENTRPSQMRKLFSLSQSWDRKCKDGLYQALKETHPHLIMELWEKGSKKGLLPLSS","Homo sapiens","NLRP1, CARD7, DEFCAP, KIAA0926, NAC, NALP1","NACHT, LRR and PYD domains-containing protein 1","1","6XKK"
"6XL4",,"X-RAY DIFFRACTION",2.06,40.26,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG 3350, 0.1 M Bis-Tris",298,"10.1038/s41467-022-30258-y",,"6XL4",152.41,"2.06","2.06","EGFR(T790M/V948R) in complex with AZD9291 and DDC4002","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6XL4"
"6XL8",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"Protein: 14mg/ml 3ost3a in 25mM Tris pH 7.5, 125mM NaCl, 4mM PAP and 5mM 8mer oligosaccharide

Reservoir: 0.2M KI and 20%PEG3350",293,"10.1039/d1cb00079a",,"6XL8",67.65,"2.34","2.34","Crystal structure of 3-O-Sulfotransferase isoform 3 in complex with 8mer oligosaccharide with no 6S sulfation","GSPNSGTLALLLDEGSKQLPQAIIIGVKKGGTRALLEFLRVHPDVRAVGAEPHFFDRSYDKGLAWYRDLMPRTLDGQITMEKTPSYFVTREAPARISAMSKDTKLIVVVRDPVTRAISDYTQTLSKRPDIPTFESLTFKNRTAGLIDTSWSAIQIGIYAKHLEHWLRHFPIRQMLFVSGERLISDPAGELGRVQDFLGLKRIITDKHFYFNKTKGFPCLKKAEGSSRPHCLGKTKGRTHPEIDREVVRRLREFYRPFNLKFYQMTGHDFGWDG","Homo sapiens","HS3ST3A1, 3OST3A1, HS3ST3A, UNQ2551/PRO6180","Heparan sulfate glucosamine 3-O-sulfotransferase 3A1","1","6XL8"
"6XLO",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, HANGING DROP",,"18% PEG 3350, and 0.2M Na Nitrate, and 0.1 M bis-Tris propane pH 6.5",292,"10.1021/acs.jmedchem.0c02085",,"6XLO",66.7,"2.493","2.493","Crystal structure of bRaf in complex with inhibitor","MHHHHHGSRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYKHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6XLO"
"6XMH",,"X-RAY DIFFRACTION",4.03,,"VAPOR DIFFUSION, SITTING DROP",5.75,"10% (w/v) PEG 8,000, 18% (v/v) glycerol, 0.04 M potassium phosphate, pH 5.75",277,"10.1002/pro.4222",,"6XMH",79.96,"1.95","1.95","Human aldolase A wild type","MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY","Homo sapiens","ALDOA, ALDA","Fructose-bisphosphate aldolase A","1","6XMH"
"6XML",,"X-RAY DIFFRACTION",4.1,69.98,"VAPOR DIFFUSION, SITTING DROP",6,"10% (w/v) PEG 8000, 21% (v/v) glycerol in 0.04 M potassium phosphate, pH 6.0",277,"10.1002/pro.4222",,"6XML",79.85,"1.88","1.88","Human aldolase A I98C","MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVCKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY","Homo sapiens","ALDOA, ALDA","Fructose-bisphosphate aldolase A","1","6XML"
"6XMM",,"X-RAY DIFFRACTION",4.04,69.56,"VAPOR DIFFUSION, SITTING DROP",6,"10% (w/v) PEG 8000, 15% (v/v) glycerol, 0.04 M potassium phosphate, pH 6.0",277,"10.1002/pro.4222",,"6XMM",79.82,"2.11","2.11","Human aldolase A I98S","MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVSKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY","Homo sapiens","ALDOA, ALDA","Fructose-bisphosphate aldolase A","1","6XMM"
"6XMO",,"X-RAY DIFFRACTION",3.85,68.05,"VAPOR DIFFUSION, SITTING DROP",5.75,"12% (w/v) PEG 8000, 15% (v/v) glycerol, 0.04 M potassium phosphate, pH 5.75",277,"10.1002/pro.4222",,"6XMO",79.94,"2.6","2.6","Human aldolase A I98F","MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVFKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY","Homo sapiens","ALDOA, ALDA","Fructose-bisphosphate aldolase A","1","6XMO"
"6XMX","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2925-1",,"6XMX",359.92,"3.7",,"Cryo-EM structure of BCL6 bound to BI-3802","MDWSHPQFEKSAVGLNDIFEAQKIEWHEGGGGSGENLYFQGGGRADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASEAEMVSAIKPPREEFLNSRMLMPQDIMAYRGCEVVENNLPLRSAPGCESRAFAPSLYSGLSTPPASYSMYSHLPVSSLLFSDEEFRDVRMPVANPFPKERALPCDSARPVPGEYSRPTLEVSPNVCHSNIYSPKETIPEEARSDMHYSVAEGLKPAAPSARNAPYFPCDKASKEEERPSSEDEIALHFEPPNAPLNRKGLVSPQSPQKSDCQPNSPTESCSSKNACILQASG","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6XMX"
"6XNK",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, SITTING DROP",9.9,"30% MPD, 0.1 M CHES pH 9.9",293,"10.1021/jacs.2c08325",,"6XNK",48.8,"2.08","2.08","Crystal structure of dimeric K72A human cytochrome c alkaline conformer","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPAKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","6XNK"
"6XNO",,"X-RAY DIFFRACTION",3.75,67.18,"VAPOR DIFFUSION, SITTING DROP",8,"41% Tascimate with 0.5 % n-Octyl-D-glucoside pH 8.0",298,"10.1038/s42003-021-01871-2",,"6XNO",24.48,"1.9","1.9","Crystal structure of E99A mutant of human CEACAM1","QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEAATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","6XNO"
"6XNP",,"X-RAY DIFFRACTION",2.04,39.6,"BATCH MODE",,"PEG8000, calcium acetate, HEPES",296,"10.1126/science.abb4255","V67","6XNP",44.14,"1.77","1.77","Crystal Structure of Human STING CTD complex with SR-717","GSVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6XNP"
"6XNT",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION, SITTING DROP",8,"54% Tascimate with 0.5 % n-Octyl-D-glucoside pH 8.0",298,"10.1038/s42003-021-01871-2",,"6XNT",24.3,"3.1","3.1","Crystal structure of I91A mutant of human CEACAM1","QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVAKSDLVNEEATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","6XNT"
"6XNW",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.005 M Cobalt(II) chloride hexahydrate, 0.005 M Nickel(II) chloride hexahydrate, 0.005 M Cadmium chloride hydrate, 0.005 M Magnesium chloride hexahydrate with 12% w/v Polyethylene glycol 3,350 in 0.1 M HEPES pH 7.5 buffer",298,"10.1038/s42003-021-01871-2",,"6XNW",47.6,"1.9","1.9","Crystal structure of V39A mutant of human CEACAM1","QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERADGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","6XNW"
"6XO1",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",6,"6% Tascimate with 25% polyethylene glycol 400 in 0.1 M MES monohydrate pH 6.0",298,"10.1038/s42003-021-01871-2",,"6XO1",23.92,"1.758","1.758","Crystal structure of N97A mutant of human CEACAM1","QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAIGTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVAEEATGQFHVY","Homo sapiens","CEACAM1, BGP, BGP1","Carcinoembryonic antigen-related cell adhesion molecule 1","1","6XO1"
"6XOC",,"X-RAY DIFFRACTION",3.37,63.55,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 7.5, 8%w/v PEG 20K, 8%w/v PEG MME 550 and 0.2 M KSCN",293,"10.1016/j.celrep.2021.109084",,"6XOC",95.63,"2.45","2.45","Crystal structure of glVRC01 Fab in complex with anti-idiotypic iv4 Fab","QVQLQQPGAELVKPGASVKLSCKASAYTFTSYWINWVKQRPGQGLEWIGNIYPGSSSTNYNEKFKTKATLTVDRSSRTAYMQLSSLTSDDSAVYYCARLDSGDWYYYGLDYWGQGTSVTVFNQIKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"Iv4 Fab Heavy Chain","1","6XOC"
,,,,,,,,,,,,,,,,"DVLMTQTPLSLPVSLGDQASISCRSSQNIVHYNGNTYLEWYLQKPGQSPKLLIYQVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPFTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"IV4 Fab Light Chain","2","6XOC"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGKNCDYNWDFQHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"iGL-VRC01 Fab Heavy Chain","3","6XOC"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR","Homo sapiens",,"iGL-VRC01 Fab Light Chain","4","6XOC"
"6XOS","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-022-29322-4",,"6XOS",114.9,"3.7",,"CryoEM structure of human presequence protease in partial open state 1","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILEHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","1","6XOS"
"6XOT","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-022-29322-4",,"6XOT",114.9,"3.9",,"CryoEM structure of human presequence protease in partial open state 2","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILEHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","1","6XOT"
"6XOU","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-022-29322-4",,"6XOU",114.9,"4",,"CryoEM structure of human presequence protease in open state","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILEHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","1","6XOU"
"6XOW","4.6","ELECTRON MICROSCOPY",,,,,,,,,"6XOW",114.9,"4.6",,"CryoEM structure of human presequence protease in partial close state 2, induced by presequence of citrate synthase","MHHHHHHAAACERALQYKLGDKIHGFTVNQVTSVPELFLTAVKLTHDDTGARYLHLAREDTNNLFSVQFRTTPMDSTGVPHILEHTVLCGSQKYPCRDPFFKMLNRSLSTFMNAFTASDYTLYPFSTQNPKDFQNLLSVYLDATFFPCLRELDFWQEGWRLEHENPSDPQTPLVFKGVVFNEMKGAFTDNERIFSQHLQNRLLPDHTYSVVSGGDPLCIPELTWEQLKQFHATHYHPSNARFFTYGNFPLEQHLKQIHEEALSKFQKIEPSTVVPAQTPWDKPREFQITCGPDSFATDPSKQTTVSVSFLLPDITDTFEAFTLSLLSSLLTSGPNSPFYKALIESGLGTDFSPDVGYNGYTREAYFSVGLQGIVEKDIETVRSLIDRTIDEVVEKGFEDDRIEALLHKIEIQMKHQSTSFGLMLTSYIASCWNHDGDPVELLKLGNQLAKFRQCLQENPKFLQEKVKQYFKNNQHKLTLSMRPDDKYHEKQAQVEATKLKQKVEALSPGDRQQIYEKGLELRSQQSKPQDASCLPALKVSDIEPTIPVTELDVVLTAGDIPVQYCAQPTNGMVYFRAFSSLNTLPEELRPYVPLFCSVLTKLGCGLLDYREQAQQIELKTGGMSASPHVLPDDSHMDTYEQGVLFSSLCLDRNLPDMMQLWSEIFNNPCFEEEEHFKVLVKMTAQELANGIPDSGHLYASIRAGRTLTPAGDLQETFSGMDQVRLMKRIAEMTDIKPILRKLPRIKKHLLNGDNMRCSVNATPQQMPQTEKAVEDFLRSIGRSKKERRPVRPHTVEKPVPSSSGGDAHVPHGSQVIRKLVMEPTFKPWQMKTHFLMPFPVNYVGECIRTVPYTDPDHASLKILARLMTAKFLHTEIREKGGAYGGGAKLSHNGIFTLYSYRDPNTIETLQSFGKAVDWAKSGKFTQQDIDEAKLSVFSTVDAPVAPSDKGMDHFLYGLSDEMKQAHREQLFAVSHDKLLAVSDRYLGTGKSTHGLAILGPENPKIAKDPSWIIR","Homo sapiens","PITRM1, KIAA1104, MP1, PREP","Presequence protease, mitochondrial","1","6XOW"
"6XOZ",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization reservoir contained 3 M NaCl and 0.1 M HEPES at pH 7.5-8.0. Crystal was soaked in cryobuffer containing 50 mM L-tetrahydro-2-furoic acid and 30% glycerol.",295,"10.1074/jbc.RA120.016106",,"6XOZ",170.83,"2.35","2.35","Structure of human PYCR1 complexed with L-tetrahydro-2-furoic acid","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","6XOZ"
"6XP0",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization reservoir contained 250 mM
Li2SO4, 19% (w/v) PEG 3350, and 0.1 M HEPES at pH 7.5. Crystal was soaked in cryobuffer containing 100 mM N-formyl L-proline and 20% PEG 200.",295,"10.1074/jbc.RA120.016106",,"6XP0",170.93,"1.95","1.95","Structure of human PYCR1 complexed with N-formyl L-proline","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","6XP0"
"6XP1",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization reservoir contained 250 mM
Li2SO4, 19% (w/v) PEG 3350, and 0.1 M HEPES at pH 7.5. Crystal was soaked in cryobuffer containing 50 mM D,L-thiazolidine-2-carboxylate and 20% PEG 200.",295,"10.1074/jbc.RA120.016106",,"6XP1",170.73,"1.75","1.75","Structure of human PYCR1 complexed with L-thiazolidine-2-carboxylate","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","6XP1"
"6XP2",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization reservoir contained 250 mM
Li2SO4, 19% (w/v) PEG 3350, and 0.1 M HEPES at pH 7.5. Crystal was soaked in cryobuffer containing 50 mM L-thiazolidine-4-carboxylate and 20% PEG 200.",295,"10.1074/jbc.RA120.016106",,"6XP2",170.77,"2.3","2.3","Structure of human PYCR1 complexed with L-thiazolidine-4-carboxylate","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","6XP2"
"6XP3",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir contained 200 mM Li2SO4, 18% (w/v) PEG 3350, and 0.1 M HEPES at pH 7.5. Enzyme solution contained 10 mM cyclopentanecarboxylic acid. Crystal was soaked in cryobuffer containing 20% PEG 200, and 100 mM cyclopentanecarboxylic acid.",293,"10.1074/jbc.RA120.016106",,"6XP3",170.83,"1.93","1.93","Structure of human PYCR1 complexed with cyclopentanecarboxylic acid","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","6XP3"
"6XPB",,"X-RAY DIFFRACTION",2.93,58.06,"VAPOR DIFFUSION, HANGING DROP",6,"20-25% PEG3350, 0.1M ammonium chloride, 0.1M sodium cacodilate pH6.0",295,"10.1074/jbc.RA120.016265",,"6XPB",60.37,"1.74","1.74","Structure of human GGT1 in complex with 2-amino-4-(((1-((carboxymethyl)amino)-1-oxobutan-2-yl)oxy)(phenoxy)phosphoryl)butanoic acid (ACPB) molecule","SASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDAVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFYTPDDGG","Homo sapiens","GGT1, GGT","Glutathione hydrolase 1 heavy chain","1","6XPB"
,,,,,,,,,,,,,,,,"TAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY","Homo sapiens","GGT1, GGT","Glutathione hydrolase 1 light chain","2","6XPB"
"6XPC",,"X-RAY DIFFRACTION",2.93,58.06,"VAPOR DIFFUSION, HANGING DROP",6,"20-25%PEG3350, 0.1M ammonium cloride, 0.1M sodium cacodilate pH 6.0",295,"10.1074/jbc.RA120.016265",,"6XPC",60.28,"2.26","2.26","Structure of human GGT1 in complex with full GSH molecule","SASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDAVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFYTPDDGG","Homo sapiens","GGT1, GGT","Glutathione hydrolase 1 heavy chain","1","6XPC"
,,,,,,,,,,,,,,,,"TAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY","Homo sapiens","GGT1, GGT","Glutathione hydrolase 1 light chain","2","6XPC"
"6XPD","3.8","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.58823",,"6XPD",70.43,"3.8",,"Cryo-EM structure of human ZnT8 double mutant - D110N and D224N, determined in outward-facing conformation","MYHCHSGSKPTEKGANEYAYAKWKLCSASAICFIFMIAEVVGGHIAGSLAVVTDAAHLLINLTSFLLSLFSLWLSSKPPSKRLTFGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQIQATVMIIVSSCAVAANIVLTVVLHQRCLGHNHKEVQANASVRAAFVHALGNLFQSISVLISALIIYFKPEYKIADPICTFIFSILVLASTITILKDFSILLMEGVPKSLNYSGVKELILAVDGVLSVHSLHIWSLTMNQVILSAHVATAASRDSQVVRREIAKALSKSFTMHSLTIQMESPVDQDPDCLFCEDPCD","Homo sapiens","SLC30A8, ZNT8","Zinc transporter 8","1","6XPD"
"6XPE","4.1","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.58823",,"6XPE",70.7,"4.1",,"Cryo-EM structure of human ZnT8 WT, in the presence of zinc, determined in outward-facing conformation","MYHCHSGSKPTEKGANEYAYAKWKLCSASAICFIFMIAEVVGGHIAGSLAVVTDAAHLLIDLTSFLLSLFSLWLSSKPPSKRLTFGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQIQATVMIIVSSCAVAANIVLTVVLHQRCLGHNHKEVQANASVRAAFVHALGDLFQSISVLISALIIYFKPEYKIADPICTFIFSILVLASTITILKDFSILLMEGVPKSLNYSGVKELILAVDGVLSVHSLHIWSLTMNQVILSAHVATAASRDSQVVRREIAKALSKSFTMHSLTIQMESPVDQDPDCLFCEDPCD","Homo sapiens","SLC30A8, ZNT8","Zinc transporter 8","1","6XPE"
"6XPF","5.9","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.58823",,"6XPF",70.44,"5.9",,"Cryo-EM structure of human ZnT8 WT, in the absence of zinc, determined in heterogeneous conformations- one subunit in an inward-facing and the other in an outward-facing conformation","MYHCHSGSKPTEKGANEYAYAKWKLCSASAICFIFMIAEVVGGHIAGSLAVVTDAAHLLIDLTSFLLSLFSLWLSSKPPSKRLTFGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQIQATVMIIVSSCAVAANIVLTVVLHQRCLGHNHKEVQANASVRAAFVHALGDLFQSISVLISALIIYFKPEYKIADPICTFIFSILVLASTITILKDFSILLMEGVPKSLNYSGVKELILAVDGVLSVHSLHIWSLTMNQVILSAHVATAASRDSQVVRREIAKALSKSFTMHSLTIQMESPVDQDPDCLFCEDPCD","Homo sapiens","SLC30A8, ZNT8","Zinc transporter 8","1","6XPF"
"6XQ1",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ1",47.73,"1.51","1.51","Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-((4-(4-carboxyphenoxy)benzyl)oxy)phenyl)-1H-indole-2-carboxylic acid","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ1"
"6XQ3",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ3",48.49,"1.71","1.71","Receptor for Advanced Glycation End Products VC1 domain in complex with 3-(3-(((3-(4-Carboxyphenoxy)benzyl)oxy)methyl)phenyl)-1H-indole-2-carboxylic acid","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ3"
"6XQ5",,"X-RAY DIFFRACTION",3.29,62.59,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ5",47.25,"1.8","1.8","Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 1","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ5"
"6XQ6",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ6",47.31,"1.9","1.9","Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 11","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ6"
"6XQ7",,"X-RAY DIFFRACTION",3.36,63.42,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ7",48.64,"1.8","1.8","Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 5","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ7"
"6XQ8",,"X-RAY DIFFRACTION",3.34,63.14,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ8",47.75,"1.82","1.82","Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ8"
"6XQ9",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION, HANGING DROP",,"2.5 M NaOAc (pH 7.5)",277,"10.1002/prot.26162",,"6XQ9",47.92,"2.3","2.3","Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13","GAMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","6XQ9"
"6XQC",,"SOLUTION NMR",,,,,,,,,"6XQC",8.55,,,"UbKEKS","MKIFVKTLTGKTITLEVEPSDTIENVKAKIQDEEGIPPDQQRLIFAGKKLEDGRTLSDYSIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","6XQC"
"6XQQ",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION",,"16-24% PEG3350,
100 mM Bis Tris Propane,
200 mM Sodium Fluoride",293,"10.1074/jbc.RA120.015292",,"6XQQ",100.96,"2.68","2.68","Structure of human D462-E4 TCR","MQKEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMFIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVRDAGNMLTFGGGTRLMVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"TRAV12-2 alpha chain","1","6XQQ"
,,,,,,,,,,,,,,,,"MSAVISQKPSRDICQRGTSLTIQCQVDSQVTMMFWYRQQPGQSLTLIATANQGSEATYESGFVIDKFPISRPNLTFSTLTVSNMSPEDSSIYLCSVGGDSLIGNQPQHFGDGTRLSILEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"TRBV29-1","2","6XQQ"
"6XR4","14","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.08.004",,"6XR4",572.9,"14",,"Integrative in situ structure of Parkinsons disease-linked human LRRK2","MASGSCQGCEEDEETLKKLIVRLNNVQEGKQIETLVQILEDLLVFTYSERASKLFQGKNIHVPLLIVLDSYMRVASVQQVGWSLLCKLIEVCPGTMQSLMGPQDVGNDWEVLGVHQLILKMLTVHNASVNLSVIGLKTLDLLLTSGKITLLILDEESDIFMLIFDAMHSFPANDEVQKLGCKALHVLFERVSEEQLTEFVENKDYMILLSALTNFKDEEEIVLHVLHCLHSLAIPCNNVEVLMSGNVRCYNIVVEAMKAFPMSERIQEVSCCLLHRLTLGNFFNILVLNEVHEFVVKAVQQYPENAALQISALSCLALLTETIFLNQDLEEKNENQENDDEGEEDKLFWLEACYKALTWHRKNKHVQEAACWALNNLLMYQNSLHEKIGDEDGHFPAHREVMLSMLMHSSSKEVFQASANALSTLLEQNVNFRKILLSKGIHLNVLELMQKHIHSPEVAESGCKMLNHLFEGSNTSLDIMAAVVPKILTVMKRHETSLPVQLEALRAILHFIVPGMPEESREDTEFHHKLNMVKKQCFKNDIHKLVLAALNRFIGNPGIQKCGLKVISSIVHFPDALEMLSLEGAMDSVLHTLQMYPDDQEIQCLGLSLIGYLITKKNVFIGTGHLLAKILVSSLYRFKDVAEIQTKGFQTILAILKLSASFSKLLVHHSFDLVIFHQMSSNIMEQKDQQFLNLCCKCFAKVAMDDYLKNVMLERACDQNNSIMVECLLLLGADANQAKEGSSLICQVCEKESSPKLVELLLNSGSREQDVRKALTISIGKGDSQIISLLLRRLALDVANNSICLGGFCIGKVEPSWLGPLFPDKTSNLRKQTNIASTLARMVIRYQMKSAVEEGTASGSDGNFSEDVLSKFDEWTFIPDSSMDSVFAQSDDLDSEGSEGSFLVKKKSNSISVGEFYRDAVLQRCSPNLQRHSNSLGPIFDHEDLLKRKRKILSSDDSLRSSKLQSHMRHSDSISSLASEREYITSLDLSANELRDIDALSQKCCISVHLEHLEKLELHQNALTSFPQQLCETLKSLTHLDLHSNKFTSFPSYLLKMSCIANLDVSRNDIGPSVVLDPTVKCPTLKQFNLSYNQLSFVPENLTDVVEKLEQLILEGNKISGICSPLRLKELKILNLSKNHISSLSENFLEACPKVESFSARMNFLAAMPFLPPSMTILKLSQNKFSCIPEAILNLPHLRSLDMSSNDIQYLPGPAHWKSLNLRELLFSHNQISILDLSEKAYLWSRVEKLHLSHNKLKEIPPEIGCLENLTSLDVSYNLELRSFPNEMGKLSKIWDLPLDELHLNFDFKHIGCKAKDIIRFLQQRLKKAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVGQLIPDCYVELEKIILSERKNVPIEFPVIDRKRLLQLVRENQLQLDENELPHAVHFLNESGVLLHFQDPALQLSDLYFVEPKWLCKIMAQILTVKVEGCPKHPKGIISRRDVEKFLSKKRKFPKNYMSQYFKLLEKFQIALPIGEEYLLVPSSLSDHRPVIELPHCENSEIIIRLYEMPYFPMGFWSRLINRLLEISPYMLSGRERALRPNRMYWRQGIYLNWSPEAYCLVGSEVLDNHPESFLKITVPSCRKGCILLGQVVDHIDSLMEEWFPGLLEIDICGEGETLLKKWALYSFNDGEEHQKILLDDLMKKAEEGDLLVNPDQPRLTIPISQIAPDLILADLPRNIMLNNDELEFEQAPEFLLGDGSFGSVYRAAYEGEEVAVKIFNKHTSLRLLRQELVVLCHLHHPSLISLLAAGIRPRMLVMELASKGSLDRLLQQDKASLTRTLQHRIALHVADGLRYLHSAMIIYRDLKPHNVLLFTLYPNAAIIAKIADYGTAQYCCRMGIKTSEGTPGFRAPEVARGNVIYNQQADVYSFGLLLYDILTTGGRIVEGLKFPNEFDELEIQGKLPDPVKEYGCAPWPMVEKLIKQCLKENPQERPTSAQVFDILNSAELVCLTRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6XR4"
"6XR6",,"SOLUTION NMR",,,,,,,"10.1126/science.abc2754",,"6XR6",33.18,,,"Abl 1b isoform active state","SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6XR6"
"6XR7",,"SOLUTION NMR",,,,,,,"10.1126/science.abc2754",,"6XR7",33.18,,,"Abl isoform 1b inactive1 state","SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6XR7"
"6XRG",,"SOLUTION NMR",,,,,,,"10.1126/science.abc2754",,"6XRG",33.3,,,"Abl 1b isoform inactive2 state","SPNYDKWEMERTDITMKHKLGEGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVLKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMYGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6XRG"
"6XRJ",,"X-RAY DIFFRACTION",4.23,70.93,"VAPOR DIFFUSION, SITTING DROP",3.5,"0.1M Citric acid pH3.5, 14% PEG 1000",295.15,"10.1016/j.cell.2021.04.042",,"6XRJ",185.3,"3.15","3.15","Crystal structure of the disulfide linked DH717.1 Fab dimer, derived from a macaque HIV-1 vaccine-induced Env glycan-reactive neutralizing antibody B cell lineage","QVQLQESGPGLVKPSETLSLTCAVSGVSINDGYDWTWIRQTPGKGLEWIGYVFGRSGNFNLNPSLRNRGIISKDTCKNQFSLNLNSATAADTAVYFCARGMEGLFAAYNSLDVWGRGLLVTVSSASTKGPSVFPLAPSSRSTSESTAALGCLVKDYFPEPVTVSWNSGSLTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYVCNVNHKPSNTKVDKRVEIKT","Homo sapiens",,"DH717.1 heavy chain Fab fragment","1","6XRJ"
,,,,,,,,,,,,,,,,"ALTQPPSVSGSPGQSVIISCTGTSSDIGQYNSVSWYQQHPDKAPKLVIYGVTSRPSGVSDRFSGSKYGDTASLTISGLQAEDEADYYCSSHADENMALFGGGTRLTVLGQPKASPTVTLFPPSSEELQANKATLVCLISDFYPGVVKVAWKADGSAVNAGVETTTPSKQSNNKYAASSYLSLTSDQWKSHKSYSCQVTHEGSTVEKTVAPA","Homo sapiens",,"DH717.1 light chain Fab fragment","2","6XRJ"
"6XRL",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION",,"PEG 4000,  (NH4)2SO4, Na Form, Tris",277,"10.1021/acs.jmedchem.0c01203",,"6XRL",109.47,"2.99","2.99","Crystal structure of human PI3K-gamma in complex with inhibitor IPI-549","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLV","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6XRL"
"6XRM",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION",,"PEG 4000,  (NH4)2SO4, Na Form, Tris",277,"10.1021/acs.jmedchem.0c01203",,"6XRM",109.42,"2.88","2.88","Crystal structure of human PI3K-gamma in complex with Compound 4","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLV","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6XRM"
"6XRN",,"X-RAY DIFFRACTION",2.45,49.8,"SMALL TUBES",,"PEG 4000,  (NH4)2SO4, Na Form, Tris",277,"10.1021/acs.jmedchem.1c01153",,"6XRN",109.21,"2.96","2.96","Crystal structure of human PI3K-gamma in complex with Compound 17","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLV","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6XRN"
"6XSD",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"100mM Hepes, pH 7.5, 1.8M Ammonium Sulfate",277,,,"6XSD",37.59,"2.54","2.54","Patient-derived B2GPI","GRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","6XSD"
"6XST",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"100mM Hepes, pH 7.5, 1.8M Ammonium Sulfate",,,,"6XST",38.05,"2.92","2.92","Recombinant Beta-2-Glycoprotein I with putative membrane insertion loop","GRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC","Homo sapiens","APOH, B2G1","Beta-2-glycoprotein 1","1","6XST"
"6XTA",,"X-RAY DIFFRACTION",3.18,61.3,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate",293,"10.1016/j.ejmech.2020.112766","O0Z","6XTA",62.59,"2.5","2.5","Recombinant human butyrylcholinesterase in complex with (2S)-N-[2-(1-benzylazepan-4-yl)ethyl]-2-(butylamino)-3-(1H-indol-3-yl)propanamide","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6XTA"
"6XTB","4.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.53910",,"6XTB",38.8,"4.3",,"Subunit BBS 5 of the human core BBSome complex","MSVLDALWEDRDVRFDLSAQQMKTRPGEVLIDCLDSIEDTKGNNGDRGRLLVTNLRILWHSLALSRVNVSVGYNCILNITTRTANSKLRGQTEALYILTKCNSTRFEFIFTNLVPGSPRLFTSVMAVHRAYETSKMYRDFKLRSALIQNKQLRLLPQEHVYDKINGVWNLSSDQGNLGTFFITNVRIVWHANMNDSFNVSIPYLQIRSIKIRDSKFGLALVIESSQQSGGYVLGFKIDPVEKLQESVKEINSLHKVYSASPIFGVDYEMEEKPQPLEALTVEQIQDDVEIDSDGHTDAFVAYFADGNKQQDREPVFSEELGLAIEKLKDGFTLQGLWEVMS","Homo sapiens","BBS5","Bardet-Biedl syndrome 5 protein","1","6XTB"
"6XTJ",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH 7.0, 1.4M sodium citrate tribasic",277,,,"6XTJ",56.16,"1.6","1.6","The high resolution structure of the FERM domain of human FERMT2","SMPDGCYADGTWELSVHVTDLNRDVTLRVTGEVHIGGVMLKLVEKLDVKKDWSDHALWWEKKRTWLLKTHWTLDKYGIQADAKLQFTPQHKLLRLQLPNMKYVKVKVNFSDRVFKAVSDICKTFNIRHPEELSLLKKPRDPTKKKKKKLDDQSEDEALELEPGILAVSQPITSPEILAKMFKPQALLDKAKINQGWLDSSRSLMEQDVKENEALLLRFKYYSFFDLNPKYDAIRINQLYEQAKWAILLEEIECTEEEMMMFAALQYHINKLSIMTSENHLNNSDKEVDEVDAALSDLEITLEGGKTSTILTTDITPECLVSPRYLKKYKNKQITARILEAHQNVAQMSLIEAKMRFIQAWQSLPEFGITHFIARFQGGKKEELIGIAYNRLIRMDASTGDAIKTWRFSNMKQWNVNWEIKMVTVEFADEVRLSFICTEVDCKVVHEFIGGYIFLSTRAKDQNESLDEEMFYKLTSGWV","Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1","Fermitin family homolog 2,Fermitin family homolog 2,Fermitin family homolog 2","1","6XTJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1"
"6XTK",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M CaCl2, 30% PEG400, 0.1M HEPES, pH 7.0",291,"10.1111/febs.15339","TCW","6XTK",25.83,"1.7","1.7","Y114C Transthyretin structure in complex with Tolcalpone","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPCSYSTTAVVTNP","Homo sapiens","TTR, PALB","Transthyretin","1","6XTK"
"6XU1",,"X-RAY DIFFRACTION",2.2,44.22,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 15% (w/v) PEG 3350, 0.1 M MgCl2",293,"10.1038/s41467-020-16983-2","DZ4","6XU1",494.22,"2.2","2.2","Crystal structure of tetrameric human H215A-SAMHD1 (residues 109-626) with GTP, dAMPNPP and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSAMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6XU1"
"6XU5",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, SITTING DROP",5.5,"36% PEG 6000, 0.1 M citrate pH 5.5",277,"10.1074/jbc.RA120.013087",,"6XU5",15.63,"1.65","1.65","Human myelin protein P2 mutant N2D","GMSDKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XU5"
"6XU9",,"X-RAY DIFFRACTION",3.52,65.02,"VAPOR DIFFUSION, SITTING DROP",5,"35% PEG 6000, 0.1 M citrate pH 5.0",277,"10.1074/jbc.RA120.013087",,"6XU9",15.46,"2.7","2.7","Human myelin protein P2 mutant K3N","GMSNNFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XU9"
"6XUA",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, SITTING DROP",5,"38% PEG 6000, 0.1 M citrate pH 5.0",277,"10.1074/jbc.RA120.013087",,"6XUA",15.63,"2.3","2.3","Human myelin protein P2 mutant K21Q","GMSNKFLGTWKLVSSENFDDYMQALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XUA"
"6XUE",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, HANGING DROP",,"Reservoir: 13 % PEG 6000, 0.1 M MES pH 6.0. Drop: 1 micro-L crystallization buffer + 1 micro-L of 3 mg/mL CD73 in 10 mM Tris pH 8.0, 10 micro-M ZnCl2, 3 % DMSO, compound: saturated solution.
Cryo: 20% PEG200 in crystallization drop.",291,"10.1021/acs.jmedchem.9b01713","O1H","6XUE",120.32,"1.94","1.94","Human Ecto-5'-nucleotidase (CD73) in complex with A2396 (compound 74 in publication) in the closed form in crystal form IV","WELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSGGGGAGGGGHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6XUE"
"6XUG",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, HANGING DROP",,"Reservoir: 9 % PEG 6000, 0.1 M MES pH 5.8.
Drop: 1 micro-L crystallization buffer +1 micro-L of 3 mg/mL CD73 in 10 mM Tris pH 8.0, 10 micro-M ZnCl2; 200 micro-M NaH2PO4, 3 % DMSO, compound: saturated solution. Cryo: 20% PEG200 in crystallization drop",291,"10.1021/acs.jmedchem.9b01713","O1Q","6XUG",120.27,"2.09","2.09","Human Ecto-5'-nucleotidase (CD73) in complex with A2410 (compound 53 in publication) in the closed form in crystal form IV","WELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSGGGGAGGGGHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6XUG"
"6XUH",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 4000,  magnesium chloride, TRIS-HCl",294,"10.1016/j.bioorg.2020.104048","O1B","6XUH",252.95,"2.38","2.38","Crystal structure of human phosphoglucose isomerase in complex with inhibitor","AALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARV","Homo sapiens","GPI","Glucose-6-phosphate isomerase","1","6XUH"
"6XUI",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 4000, magnesium chloride, TRIS-HCl",294,"10.1016/j.bioorg.2020.104048",,"6XUI",254.12,"1.95","1.95","Crystal structure of human phosphoglucose isomerase in complex with inhibitor","AALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARV","Homo sapiens","GPI","Glucose-6-phosphate isomerase","1","6XUI"
"6XUL",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, SITTING DROP",,"NaCl, Bis tris propane pH9, PEG 1500",293.15,"10.1016/j.jmb.2021.167099",,"6XUL",290.08,"2.41","2.41","Apo Ab 5b1","QVQLVESGGGSVQPGRSLRLSCEASGFTFEAYAMHWVRQPPGKGLEWVSSINWNSGRIAYADSVKGRFTISRDNARNSLYLQMNSLRLEDTAFYYCAKDIRRFSTGGAEFEYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Heavy chain","1","6XUL"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNFVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSRSGTSASLAISGLRSEDEADYYCAAWDDSLGGHYVFGTGTKVTVLRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain","2","6XUL"
"6XUM",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5.0:
15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate  pH 5.0, 20% (w/v) PEG 6000
Soaking-buffer: 120 mM Di-Ammoniumhydrogen citrate pH 5.0, 25% (w/v) PEG 6000",291,,,"6XUM",37.1,"0.97","0.97","Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAAASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6XUM"
"6XUN",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, SITTING DROP",,"NaCl, Bis tris propane pH9, PEG 1500",293.15,"10.1016/j.jmb.2021.167099",,"6XUN",147.87,"2.41","2.41","Ab 5b1 bound to CA19-9","QVQLVESGGGSVQPGRSLRLSCEASGFTFEAYAMHWVRQPPGKGLEWVSSINWNSGRIAYADSVKGRFTISRDNARNSLYLQMNSLRLEDTAFYYCAKDIRRFSTGGAEFEYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Heavy chain","1","6XUN"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNFVYWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSRSGTSASLAISGLRSEDEADYYCAAWDDSLGGHYVFGTGTKVTVLRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain","2","6XUN"
"6XUQ",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",8,"Reservoir: 7.5 % PEG 6.000, 0.1 M MES pH 6.2. Drop: 1 micro-L crystallization buffer + 1 micro-L of 3 mg/mL CD73 in 10 mM Tris pH 8.0, 10 micro-M ZnCl2 and 1 mM of compound. Cryo: 20% PEG200 in crystallization drop",291,"10.1021/acs.jmedchem.9b01713","O1T","6XUQ",62.45,"1.97","1.97","Human Ecto-5'-nucleotidase (CD73) in complex with A1618 (compound 1b in publication) in the closed state in crystal form III","MEWSWVFLFFLSVTTGVHSWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSGGGGAGGGGHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6XUQ"
"6XUW",,"X-RAY DIFFRACTION",3.54,65.27,"VAPOR DIFFUSION, SITTING DROP",5,"38% PEG 6000, 0.1 M citrate, pH 5.0",291,"10.1074/jbc.RA120.013087",,"6XUW",15.29,"2.31","2.31","Human myelin protein P2 mutant L27D","GMSNKFLGTWKLVSSENFDDYMKALGVGDATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XUW"
"6XUY",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, HANGING DROP",5.7,"100 mM Bis-Tris pH 5.7, 1.6 M (NH4)2SO4, and 10% PEG 400",293,"10.1038/s41589-021-00749-y",,"6XUY",69.53,"2.13","2.13","Human Sirt6 13-308 in complex with ADP-ribose","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6XUY"
"6XUZ",,"X-RAY DIFFRACTION",1.94,36.5,"VAPOR DIFFUSION, HANGING DROP",7.2,"29% PEG 3350, 0.2 M disodium malonate, 0.1 M HEPES",293,"10.1002/anie.202003732",,"6XUZ",15.58,"1.07","1.07","CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 4","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6XUZ"
"6XV0",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM potassium phosphate (pH 7.0), 150 mM KCl, 22-26% PEG3350, 125 mg/ml protein",293,"10.1021/acs.inorgchem.9b03407",,"6XV0",70.42,"3","3","lauric acid functionalized hexamolybdoaluminate bound to human serum albumin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6XV0"
"6XV1",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, HANGING DROP",5.7,"100 mM Bis-Tris pH 5.7, 1.6 M (NH4)2SO4, and 10% PEG 400",293,"10.1038/s41589-021-00749-y",,"6XV1",69.89,"1.95","1.95","Human Sirt6 13-308 in complex with ADP-ribose and the activator MDL-801","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6XV1"
"6XV3",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",7.2,"29 % PEG 3350, 0.2 M disodium malonate, 0.1 M HEPES",293,"10.1002/anie.202003732",,"6XV3",62.44,"1.47","1.47","CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 3","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6XV3"
"6XV6",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"85 mM HEPES pH 7.5, 85 mM sodium chloride, 1.36 M (NH4)2SO4, 15% glycerol",293,"10.1038/s41589-021-00749-y",,"6XV6",217.35,"1.75","1.75","Human Sirt6 3-318 in complex with ADP-ribose","VNYAAGLSPYADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRINGSIPAGPKQE","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6XV6"
"6XV7",,"X-RAY DIFFRACTION",1.99,38.18,"VAPOR DIFFUSION, HANGING DROP",7.2,"29 % PEG 3350, 0.2 M disodium malonate, 0.1 M HEPES",293,"10.1002/anie.202003732",,"6XV7",15.57,"1.668","1.668","CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 2","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6XV7"
"6XV9",,"X-RAY DIFFRACTION",2.37,48.04,"VAPOR DIFFUSION",6.5,"10 % PEG4000, 20 % glycerol, 10 % MORPHEUS halogens, 0.1 M Imidazole-MES buffer pH 6.5",293,"10.1021/jacs.9b13391",,"6XV9",75.64,"3.38","3.38","Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit,Mast/stem cell growth factor receptor Kit","1","6XV9"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6XVA",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION",7.5,"10 % PEG4000, 20 % glycerol, 10 % MORPHEUS carboxylic acids, 0.1 M HEPES-MOPS buffer pH 7.5",293,"10.1021/jacs.9b13391","O2K","6XVA",75.69,"2.3","2.3","Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing an acrylamide","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit,Mast/stem cell growth factor receptor Kit","1","6XVA"
"6XVB",,"X-RAY DIFFRACTION",2.42,49.11,"VAPOR DIFFUSION",6.2,"9 % PEG8000, 18 % ethylene glycol, 10 % MORPHEUS halogens, 0.1 M Imidazole-MES buffer pH 6.2",293,"10.1021/jacs.9b13391",,"6XVB",75.75,"2.15","2.15","Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit,Mast/stem cell growth factor receptor Kit","1","6XVB"
"6XVC",,"X-RAY DIFFRACTION",1.88,34.73,"VAPOR DIFFUSION, HANGING DROP",7.2,"29 % PEG 3350, 0.2 M disodium malonate, 0.1 M HEPES",293,"10.1002/anie.202003732",,"6XVC",15.61,"1.098","1.098","CRYSTAL STRUCTURE OF BRD4-BD1 WITH COMPOUND 1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6XVC"
"6XVG",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"85 mM HEPES pH 7.5, 85 mM sodium chloride, 1.36 M (NH4)2SO4, 15% glycerol",293,"10.1038/s41589-021-00749-y",,"6XVG",219.43,"2.1","2.1","Human Sirt6 3-318 in complex with ADP-ribose and the activator MDL-801","VNYAAGLSPYADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRINGSIPAGPKQE","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6XVG"
"6XVH",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION",,"Tris, Ammonium sulfate",298,,,"6XVH",29.2,"1.8","1.8","carbonic anhydrase with bound arylsulfonamide- boronic acid","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6XVH"
"6XVJ",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION",8.5,"25 % PEG550MME, 0.1 M NaCl, 0.1 M TRIS buffer pH 8.5",293,"10.1021/jacs.9b13391",,"6XVJ",37.48,"1.78","1.78","Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDENLYFQ","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","6XVJ"
"6XVK",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION",6.5,"11 % PEG8000, 0.1 M PCTP buffer pH 6.5",293,"10.1021/jacs.9b13391","O3E","6XVK",37.53,"1.99","1.99","Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor bearing an acrylamide","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDENLYFQ","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","6XVK"
"6XVP",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M NH4Cl, 22% PEG3350",291,"10.1021/acs.jmedchem.0c00441",,"6XVP",81.64,"2.65","2.65","Crystal structure of Neprilysin in complex with Sampatrilat.","YDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6XVP"
"6XVQ",,"X-RAY DIFFRACTION",2.89,57.44,"VAPOR DIFFUSION, SITTING DROP",5,"32% PEG 6000, 0.1 M citrate pH 5.0",277,"10.1074/jbc.RA120.013087",,"6XVQ",15.44,"1.8","1.8","Human myelin protein P2 mutant K31Q","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRQLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XVQ"
"6XVR",,"X-RAY DIFFRACTION",3.67,66.46,"VAPOR DIFFUSION, SITTING DROP",7,"3.6 M ammonium sulphate, 0.1 M HEPES pH 7.0",291,"10.1074/jbc.RA120.013087",,"6XVR",15.51,"2","2","Human myelin protein P2 mutant L35S","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNSAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XVR"
"6XVS",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",5,"40% PEG 1000, 0.1 M citrate pH 5.0",277,"10.1074/jbc.RA120.013087",,"6XVS",30.03,"1.8","1.8","Human myelin protein P2 mutant P38G, unliganded","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKGTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XVS"
"6XVW",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS pH 8.5, 20% (w/w) PEG 2.000 MME, 0.01 M NiCl2",293,"10.1021/acsmedchemlett.9b00654",,"6XVW",81.03,"2","2","Catalytic domain of human PARP-1 in complex with the inhibitor MC2050","HMSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLW","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6XVW"
"6XVY",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION, SITTING DROP",5,"40% PEG 1000, 0.1 M citrate pH 5.0",291,"10.1074/jbc.RA120.013087",,"6XVY",61.4,"1.8","1.8","Human myelin protein P2 mutant R88Q","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQQGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XVY"
"6XW9",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, SITTING DROP",5,"30% PEG 6000, 0.1 M citrate pH 5.0",277,"10.1074/jbc.RA120.013087",,"6XW9",15.24,"2.9","2.9","Human myelin protein P2 mutant K120S","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMSGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6XW9"
"6XWF",,"X-RAY DIFFRACTION",3.7,66.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.2M NaCl, 10% MPD, 0.1M imidazole pH 6.5, 0.1M CaCl2",298,"10.1107/S2052252520015754",,"6XWF",15.64,"1.6","1.6","Crystal structure of an NCoR1BBD2-BCL6BTB chimera","GPSSDLYLRPGDSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6XWF"
"6XWJ",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa465",,"6XWJ",6.69,,,"Constitutive decay element CDE2 from human 3'UTR","GGUGCCUAAUAUUUAGGCACC","Homo sapiens",,"RNA (5'-R(*GP*GP*UP*GP*CP*CP*UP*AP*AP*UP*AP*UP*UP*UP*AP*GP*GP*CP*AP*CP*C)-3')","1","6XWJ"
"6XWZ",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, HANGING DROP",8,"solution of 1.5-1.7 M sodium citrate, 0.1 M Tris pH 8.0",296,,,"6XWZ",29.6,"1.38","1.38","Carbonic Anhydrase II-mediated hydrolysis of selenolester","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6XWZ"
"6XXH",,"X-RAY DIFFRACTION",3.12,60.57,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 1000, PEG 3350), 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522",,"6XXH",82.43,"1.52","1.52","Crystal Structure of Human Deoxyhypusine Synthase in apo form","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXH"
"6XXI",,"X-RAY DIFFRACTION",3.1,60.33,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 1000, PEG 3350), 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522",,"6XXI",85.84,"1.679","1.679","Crystal Structure of Human Deoxyhypusine Synthase in complex with NAD","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXI"
"6XXJ",,"X-RAY DIFFRACTION",3.29,62.59,"VAPOR DIFFUSION, HANGING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 1000, PEG 3350), 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522",,"6XXJ",85.4,"1.41","1.41","Crystal Structure of Human Deoxyhypusine Synthase in complex with spermidine and NAD","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXJ"
"6XXK",,"X-RAY DIFFRACTION",3.12,60.55,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix, 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522","SPD","6XXK",84.72,"1.65","1.65","Crystal Structure of Human Deoxyhypusine Synthase in complex with spermidine","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXK"
"6XXL",,"X-RAY DIFFRACTION",3.1,60.37,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 3350, PEG 1000), 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522",,"6XXL",83.69,"1.69","1.69","Crystal Structure of Human Deoxyhypusine Synthase in complex with spermine","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXL"
"6XXM",,"X-RAY DIFFRACTION",3.1,60.29,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 3350, PEG 1000), 100 mM Tris-Bicine pH = 8.5",293,"10.3390/biom10040522",,"6XXM",82.42,"1.67","1.67","Crystal Structure of Human Deoxyhypusine Synthase in complex with putrescine","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6XXM"
,,,,,,,,,,,,,,,,"MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","2","6XXM"
"6XXT",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.2 M sodium citrate
0.1 M Tris-HCl",293,"10.1021/acsmedchemlett.0c00062","O42","6XXT",30.01,"1.05","1.05","The crystal structure of hCA II in complex with a 4-(4-aroylpiperazine-1-carbonyl)benzenesulfonamide derivative.","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6XXT"
"6XXU",,"SOLUTION NMR",,,,,,,"10.1007/s12104-019-09923-9",,"6XXU",17.89,,,"Solution NMR structure of the native form of UbcH7 (UBE2L3)","MAASRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPFKPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRADLAEEYSKDRKKFCKNAEEFTKKYGEKRPVD","Homo sapiens","UBE2L3, UBCE7, UBCH7","Ubiquitin-conjugating enzyme E2 L3","1","6XXU"
"6XXV",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium tartrate dibasic, 20 % w/v PEG 3350",291,"10.1126/science.aay5051",,"6XXV",134.01,"2.20116418766","2.20116418766","Crystal Structure of a computationally designed Immunogen S2_1.2 in complex with its elicited antibody C57","MGCVAETGEFTREVQLVESGGGLAKPGGSLRLSCAASGFTFSPYWMYWVRQAPGKGLEWVSVINSGGGITYYTDSVKGRFTISRENAKNTLYLQMDSLRPEDTAVYYCVRDRTYYSGVYYTEDGLDSWGQGVLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDGTKHHHHHH","Homo sapiens",,"Antibody C57, Heavy Chain","1","6XXV"
,,,,,,,,,,,,,,,,"MGCVAETGTRDIQMTQSPSSLSASVGDRVTVTCRAGQGVSNYLSWYQQKPGKVPKLLIYKASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNIHPYSFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECGTKHHHHHH","Homo sapiens",,"Antibody C57, Light Chain","2","6XXV"
,,,,,,,,,,,,,,,,"MASREDMREEADEDFKSFVEAAKDNFNKFKARLRKGKITREHREMMKKLAKQNANKAKEAVRKRLSELLSKINDMPITNDQKKLMSNQVLQFADDAEAEIDQLAAKATKEFTGGSWLEHHHHHH","Homo sapiens",,"S2_1.2","3","6XXV"
"6XY7",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulphate, 100 mM MES/imidazole, pH 6.5, 20 % PEG 500 MME, 10% PEG 20,000",293,,,"6XY7",53.38,"1.086","1.086","Human SHIP1 with magnesium and phosphate bound to the active site","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","6XY7"
"6XYO","2.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2317-6",,"6XYO",144.76,"2.6",,"Multiple system atrophy Type I alpha-synuclein filament","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6XYO"
"6XYP","3.29","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2317-6",,"6XYP",144.76,"3.29",,"Multiple system atrophy Type II-1 alpha-synuclein filament","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6XYP"
"6XYQ","3.09","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2317-6",,"6XYQ",144.76,"3.09",,"Multiple system atrophy Type II-2 alpha-synuclein filament","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6XYQ"
"6XZ3",,"X-RAY DIFFRACTION",3.39,63.73,"VAPOR DIFFUSION, HANGING DROP",,"0.3 M ammonium citrate dibasic, 25% PEG 3350",294,"10.1083/jcb.202005214",,"6XZ3",14.52,"2.19","2.19","Crystal structure of TLNRD1 4-helix bundle","GGSAQPGLVDRYRVTRCRHEVEQGCAVLRATPLADMTPQLLLEVSQGLSRNLKFLTDACALASDKSRDRFSREQFKLGVKCMSTSASALLACVREVKVAPSELARSRCALFSGPLVQAVSALVGFATEPQFLGR","Homo sapiens","TLNRD1, MESDC1","Talin rod domain-containing protein 1","1","6XZ3"
"6XZ4",,"X-RAY DIFFRACTION",2.12,41.98,"VAPOR DIFFUSION, HANGING DROP",,"250 mM sodium thiocyanate, 20% PEG 3350",294,"10.1083/jcb.202005214",,"6XZ4",76.87,"2.3","2.3","Crystal structure of TLNRD1","GIDPFTMASGSAGKPTGEAASPAPASAIGGASSQPRKRLVSVCDHCKGKMQLVADLLLLSSEARPVLFEGPASSGAGAESFEQCRDTIIARTKGLSILTHDVQSQLNMGRFGEAGDSLVELGDLVVSLTECSAHAAYLAAVATPGAQPAQPGLVDRYRVTRCRHEVEQGCAVLRATPLADMTPQLLLEVSQGLSRNLKFLTDACALASDKSRDRFSREQFKLGVKCMSTSASALLACVREVKVAPSELARSRCALFSGPLVQAVSALVGFATEPQFLGRAAAVSAEGKAVQTAILGGAMSVVSACVLLTQCLRDLAQHPDGGAKMSDHRERLRNSACAVSEGCTLLSQALRERSSPRTLPPVNSNSVN","Homo sapiens","TLNRD1, MESDC1","Talin rod domain-containing protein 1","1","6XZ4"
"6XZ8",,"X-RAY DIFFRACTION",2.89,57.43,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG3350, 0.09M ammonium citrate",293,"10.1021/acs.jmedchem.0c00233",,"6XZ8",171.76,"3","3","Structure of aldosterone synthase (CYP11B2) in complex with N-[(1R)-1-[5-(6-chloro-1,1-dimethyl-3-oxo-isoindolin-2-yl)-3-pyridyl]ethyl]methanesulfonamide","MATKAARAPRTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFRYNLGGPRMVCVMLPEDVEKLQQVDSLHPCRMILEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPDVLSPKAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWISPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFNRPQHYTGIVAELLLKAELSLEAIKANSMELTAGSVDTTAFPLLMTLFELARNPDVQQILRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVVSSDLVLQNYHIPAGTLVQVFLYSLGRNAALFPRPERYNPQRWLDIRGSGRNFHHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHFLVETLTQEDIKMVYSFILRPGTSPLLTFRAINGGRHHHHHH","Homo sapiens","CYP11B2","Cytochrome P450 11B2, mitochondrial","1","6XZ8"
"6XZ9",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG3350, 0.09M ammonium citrate",293,"10.1021/acs.jmedchem.0c00233",,"6XZ9",171.94,"2.77","2.77","Structure of aldosterone synthase (CYP11B2) in complex with 5-chloro-3,3-dimethyl-2-[5-[1-(1-methylpyrazole-4-carbonyl)azetidin-3-yl]oxy-3-pyridyl]isoindolin-1-one","MATKAARAPRTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFRYNLGGPRMVCVMLPEDVEKLQQVDSLHPCRMILEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPDVLSPKAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWISPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFNRPQHYTGIVAELLLKAELSLEAIKANSMELTAGSVDTTAFPLLMTLFELARNPDVQQILRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVVSSDLVLQNYHIPAGTLVQVFLYSLGRNAALFPRPERYNPQRWLDIRGSGRNFHHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHFLVETLTQEDIKMVYSFILRPGTSPLLTFRAINGGRHHHHHH","Homo sapiens","CYP11B2","Cytochrome P450 11B2, mitochondrial","1","6XZ9"
"6XZE",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, SITTING DROP",9,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl
Inhibitor: 10 mM inhibitor solution (150 mM NaCl, 10% DMSO,  50 mM Tris pH 7)",293,"10.3390/ijms21072560","O4Z","6XZE",58.68,"1.54","1.54","crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6XZE"
"6XZO",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, SITTING DROP",,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl pH 9.
Inhibitor 150 mM NaCl, 10% DMSO,  50 mM Tris pH 7",293,"10.3390/ijms21072560","O55","6XZO",58.83,"1.44","1.44","Crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((4-bromo-2-hydroxybenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6XZO"
"6XZS",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, SITTING DROP",9,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl pH 9.
Inhibitor: 150 mM NaCl, 10% DMSO,  50 mM Tris pH 7",293,"10.3390/ijms21072560","O5K","6XZS",58.68,"1.53","1.53","Crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((4-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6XZS"
"6XZX",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, SITTING DROP",9,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl pH 9.
Inhibitor:150 mM NaCl, 10% DMSO,  50 mM Tris pH 7",293,"10.3390/ijms21072560","O5H","6XZX",58.64,"1.55","1.55","crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6XZX"
"6XZY",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, SITTING DROP",9,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl pH 9.
Inhibitor: 150 mM NaCl, 10% DMSO,  50 mM Tris pH 7",293,"10.3390/ijms21072560","O5N","6XZY",58.68,"1.66","1.66","crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6XZY"
"6Y00",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, SITTING DROP",9,"200 mM Na-acetate, 30% PEG 4000, 100 mM Tris-HCl pH 9.
Inhibitor: 150 mM NaCl, 10% DMSO,  50 mM Tris pH 7",293,"10.3390/ijms21072560","O5T","6Y00",58.83,"1.37","1.37","crystal structure of human carbonic anhydrase I in complex with 4-(3-(2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6Y00"
"6Y03",,"X-RAY DIFFRACTION",2.12,42.01,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5: 15 mg/mL hAR, 5,2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5, 20% (w/v) PEG 6000",291,,,"6Y03",36.75,"1.69","1.69","Structure of Human Aldose Reductase Mutant L300/301A with a Citrate Molecule Bound in the Anion Binding Pocket","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAAASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6Y03"
"6Y0F",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION",9,"35% (v/v) PEG2000MME, 0.40 M lithium salt",293,,,"6Y0F",341.54,"2.924","2.924","Structure of human FAPalpha in complex with linagliptin","ENTMRALTLKDILNGTFSYKTFFPNWISGQEYLHQSADNNIVLYNIETGQSYTILSNRTMKSVNASNYGLSPDRQFVYLESDYSKLWRYSYTATYYIYDLSNGEFVRGNELPRPIQYLCWSPVGSKLAYVYQNNIYLKQRPGDPPFQITFNGRENKIFNGIPDWVYEEEMLATKYALWWSPNGKFLAYAEFNDTDIPVIAYSYYGDEQYPRTINIPYPKAGAKNPVVRIFIIDTTYPAYVGPQEVPVPAMIASSDYYFSWLTWVTDERVCLQWLKRVQNVSVLSICDFREDWQTWDCPKTQEHIEESRTGWAGGFFVSTPVFSYDAISYYKIFSDKDGYKHIHYIKDTVENAIQITSGKWEAINIFRVTQDSLFYSSNEFEEYPGRRNIYRISIGSYPPSKKCVTCHLRKERCQYYTASFSDYAKYYALVCYGPGIPISTLHDGRTDQEIKILEENKELENALKNIQLPKEEIKKLEVDEITLWYKMILPPQFDRSKKYPLLIQVYGGPCSQSVRSVFAVNWISYLASKEGMVIALVDGRGTAFQGDKLLYAVYRKLGVYEVEDQITAVRKFIEMGFIDEKRIAIWGWSYGGYVSSLALASGTGLFKCGIAVAPVSSWEYYASVYTERFMGLPTKDDNLEHYKNSTVMARAEYFRNVDYLLIHGTADDNVHFQNSAQIAKALVNAQVDFQAMWYSDQNHGLSGLSTNHLYTHMTHFLKQCFS","Homo sapiens","FAP","Prolyl endopeptidase FAP","1","6Y0F"
"6Y0L",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION, SITTING DROP",,"2.0M ammonium sulphate, 0.2M sodium chloride, 0.1M sodium-cacodylate, 8mM CaCl2",291,"10.1002/2211-5463.13214",,"6Y0L",16.45,"1.65","1.65","Crystal structure of human CD23 lectin domain N225D, K229E, S252N, T251N, R253G, S254G mutant","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRDLDLEGEFIWVDGSHVDYSNWAPGEPNNGGQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor membrane-bound form","1","6Y0L"
"6Y0M",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M sodium-cacodylate pH 6.5, 1M tri-sodium-citrate 

Crystals were soaked with a solution of 0.1M sodium-cacodylate at pH 7.1, 1.4M tri-sodium-citrate and 10mM CaCl2 for four days before harvesting which also served as a cryoprotectant.",291,"10.1002/2211-5463.13214",,"6Y0M",16.21,"1.5","1.5","Crystal structure of human CD23 lectin domain N225D, K229E, S252N, T251N mutant","SGFVCNTCPEKWINFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGSWIGLRDLDLEGEFIWVDGSHVDYSNWAPGEPNNRSQGEDCVMMRGSGRWNDAFCDRKLGAWVCDRLATCTPPASEGSAE","Homo sapiens","FCER2, CD23A, CLEC4J, FCE2, IGEBF","Low affinity immunoglobulin epsilon Fc receptor membrane-bound form","1","6Y0M"
"6Y1A","4.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0442-4",,"6Y1A",62.81,"4.2",,"Amyloid fibril structure of islet amyloid polypeptide","KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY","Homo sapiens","IAPP","Islet amyloid polypeptide","1","6Y1A"
"6Y1E",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"10 mg/ml hGSTP1-1 (50 mM dipotassium phosphate, 1.5 mM EDTA, 10 mM DTT, 10 mM GSH and 0.02 % (w/v) sodium azide, pH 7.0) with 3.5 mM IAA-94 (5% DMSO (v/v)) was crystallized in 100 mM MES and 16 % (w/v) PEG-6000, pH 6.5. The crystals were harvested and then immersed two to three times in 100% (v/v) Parabar 10312 (Paratone)",293,,,"6Y1E",97.28,"1.402","1.402","Crystal structure of human glutathione transferase P1-1 (hGSTP1-1) that was co-crystallised in the presence of indanyloxyacetic acid-94 (IAA-94)","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","6Y1E"
"6Y1I",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG3350, 0.15M Na tartrate, 0.1M MES pH 5.6",277.15,,,"6Y1I",124.36,"3","3","Human Eg5 motor domain mutant R234C","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSCSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6Y1I"
"6Y1K",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, HANGING DROP",,"0.1M ADA, pH 7.5
0.16M MgCl2
16% PEG 6K",293,"10.1073/pnas.2010317117",,"6Y1K",54.05,"1.65","1.65","Crystal structure of the unmodified A.17 antibody FAB fragment - L47R mutant","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLAMDYKDHDGDYKDHDIDYKDDDDKVDHHHHHH","Homo sapiens",,"FAB A.17 L47R mutant Heavy Chain","1","6Y1K"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKRLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"FAB A.17 L47R mutant Light Chain","2","6Y1K"
"6Y1L",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M ADA, pH 7.5
0.3M MgCl2
12% PEG 6K",293,"10.1073/pnas.2010317117",,"6Y1L",54.21,"1.4","1.4","Crystal structure of the paraoxon-modified A.17 antibody FAB fragment - L47R mutant","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLAMDYKDHDGDYKDHDIDYKDDDDKVDHHHHHH","Homo sapiens",,"FAB A.17 L47R mutant HEAVY CHAIN","1","6Y1L"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKRLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"FAB A.17 L47R mutant Light CHAIN","2","6Y1L"
"6Y1M",,"X-RAY DIFFRACTION",2.07,40.52,"VAPOR DIFFUSION, HANGING DROP",,"0.1M ADA, pH 7.5
0.17M MgCl2 
20% PEG 6K",,"10.1073/pnas.2010317117",,"6Y1M",54.16,"2","2","Crystal structure of the paraoxon-modified A.17 antibody FAB fragment - L47K mutant","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLAMDYKDHDGDYKDHDIDYKDDDDKVDHHHHHH","Homo sapiens",,"FAB A.17 L47K mutant HEAVY CHAIN","1","6Y1M"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKKLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"FAB A.17 L47K mutant Light CHAIN","2","6Y1M"
"6Y1N",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",7,"Ammonium citrate, pH 7.0, 1.7M",292,"10.1073/pnas.2010317117",,"6Y1N",54.42,"2.2","2.2","Crystal structure of the phosphonate-modified A.5 antibody FAB fragment","QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARFGTRGNTHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLAMDYKDHDGDYKDHDIDYKDDDDKVDHHHHHH","Homo sapiens",,"FAB A.5 Heavy chain","1","6Y1N"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVDWYQQLPGTAPKLLIYRNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLGTVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"FAB A.5 Light Chain","2","6Y1N"
"6Y1P",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM Di-Ammoniumhydrogen citrate pH 5: 15 mg/mL hAR, 5.2 mg/mL DTT, 0.7 mg/mL NADP+, 5% (w/v) PEG 6000
Reservoir: 120 mM Di-Ammoniumhydrogen citrate pH 5, 20% (w/v) PEG 6000
Soaking: 120 mM Di-Ammoniumhydrogen citrate pH 5, 25% (w/v) PEG 6000",291,,,"6Y1P",37.44,"0.94","0.94","Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAAASCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldo-keto reductase family 1 member B1","1","6Y1P"
"6Y22",,"X-RAY DIFFRACTION",4.87,74.75,"VAPOR DIFFUSION, SITTING DROP",7.6,"Morpheus condition 60: 0.12 M ethylene glycols (0.3M Diethylene glycol; 0.3M Triethylene glycol; 0.3M Tetraethylene glycol; 0.3M Pentaethylene glycol), 0.1 M Buffer system 3 (1 M Tris-Bicine pH 8.5), 37.5% Precipitation mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)",292,"10.1126/sciadv.abc0629",,"6Y22",26.07,"2.069","2.069","RING-DTC domains of Deltex 2, Form 1","GSEPEPEQVIKNYTEELKVPPDEDCIICMEKLSTASGYSDVTDSKAIGSLAVGHLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGEKTGTQPQGKMEVLRFQMSLPGHEDCGTILIVYSIPHGIQGPEHPNPGKPFTARGFPRQCYLPDNAQGRKVLELLKVAWKRRLIFTVGTSSTTGETDTVVWNEIHHKTEMDRNITGHGYPDPNYLQNVLAELAAQGVTEDCLEQQ","Homo sapiens","DTX2, KIAA1528, RNF58","Probable E3 ubiquitin-protein ligase DTX2","1","6Y22"
"6Y23",,"X-RAY DIFFRACTION",2.78,55.76,"VAPOR DIFFUSION, SITTING DROP",,"9.5 mg/ml protein in 20 mM HEPES pH 7.5, 200 mM NaCl, 1 mM TCEP. Precipitant: 100 mM Tris pH 8.0, 1.5 M ammonium sulphate.",277,"10.1073/pnas.2007271117",,"6Y23",117.91,"2.58","2.58","DDR1 kinase autoinhibited by its juxtamembrane region","GPVPHFAEADIVTLQGVTGGNTFAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6Y23"
"6Y24",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, SITTING DROP",,"3.1 M sodium formate",293,"10.1038/s41598-020-69832-z",,"6Y24",10.33,"1.86","1.86","Crystal structure of fourth KH domain of FUBP1","SMQGNWNMGPPGGLQEFNFIVPTGKTGLIIGKGGETIKSISQQSGARIELQRNPPPNADPNMKLFTIRGTPQQIDYARQLIEEKIGGPVNPLG","Homo sapiens","FUBP1","Far upstream element-binding protein 1","1","6Y24"
"6Y2C",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 6000,  10% ethylene glycol,  0.015M Zinkchlorid, 0.1 M MES, pH 6.0",293,"10.1038/s41598-020-69832-z",,"6Y2C",21.06,"2","2","Crystal structure of the third KH domain of FUBP1","SMFREVRNEYGSRIGGNEGIDVPIPRFAVGIVIGRNGEMIKKIQNDAGVRIQFKPDDGTTPERIAQITGPPDRCQHAAEIITDLLRSVQAGNP","Homo sapiens","FUBP1","Far upstream element-binding protein 1","1","6Y2C"
"6Y2D",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"2M ammonium sulfate, 5% 2-propanol, 2.5% Glycerol",293,"10.1038/s41598-020-69832-z",,"6Y2D",33.8,"1.9","1.9","Crystal structure of the second KH domain of FUBP1","SMNAVQEIMIPASKAGLVIGKGGETIKQLQERAGVKMVMIQDGPQNTGADKPLRITGDPYKVQQAKEMVLELIRDQG","Homo sapiens","FUBP1","Far upstream element-binding protein 1","1","6Y2D"
"6Y2H",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION",,"0.1M NaSCN, 17%PEG 3350, 7% MEG",292,"10.1096/fj.202000399R",,"6Y2H",108.58,"2.154","2.154","The crystal structure of human chloride intracellular channel protein 5","GAMGIELFVKAGIDGESIGNCPFSQRLFMILWLKGVVFNVTTVDLKRKPADLHNLAPGTHPPFLTFNGDVKTDVNKIEEFLEETLTPEKYPKLAAKHRESNTAGIDIFSKFSAYIKNTKQQNNAALERGLTKALKKLDDYLNTPLPEEIDANTCGEDKGSRRKFLDGDELTLADCNLLPKLHVVKIVAKKYRNYDIPAEMTGLWRYLKNAYARDEFTNTCAADSEIELAYADVAKRLSRS","Homo sapiens","CLIC5","Chloride intracellular channel protein 5","1","6Y2H"
"6Y2V",,"X-RAY DIFFRACTION",1.84,33.16,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Bis-Tris, 25% PEG3350, pH 5.5",277,"10.1371/journal.pone.0235133",,"6Y2V",18.31,"2","2","Crystal structure of the double mutant L13R I16K of Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP)","MAEQATKSVLFVCRGNKCRSPIAEAVFRKLVTDQNISENWVIDSGAVSDWNVGRSPDPRAVSCLRNHGIHTAHKARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH","Homo sapiens","ACP1","Low molecular weight phosphotyrosine protein phosphatase","1","6Y2V"
"6Y2W",,"X-RAY DIFFRACTION",2.06,40.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Sodium acetate trihydrate, 0.1M Bis-Tris, 25% PEG3350, pH 6.5",277,"10.1371/journal.pone.0235133",,"6Y2W",17.95,"1.77","1.77","Crystal structure of the single mutant I16K of Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP)","AEQATKSVLFVCLGNKCRSPIAEAVFRKLVTDQNISENWVIDSGAVSDWNVGRSPDPRAVSCLRNHGIHTAHKARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH","Homo sapiens","ACP1","Low molecular weight phosphotyrosine protein phosphatase","1","6Y2W"
"6Y2X",,"X-RAY DIFFRACTION",2.44,49.69,"VAPOR DIFFUSION, SITTING DROP",7.6,"Morpheus condition 60",292,"10.1126/sciadv.abc0629",,"6Y2X",52.13,"1.77","1.77","RING-DTC domains of Deltex 2, Form 2","GSEPEPEQVIKNYTEELKVPPDEDCIICMEKLSTASGYSDVTDSKAIGSLAVGHLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGEKTGTQPQGKMEVLRFQMSLPGHEDCGTILIVYSIPHGIQGPEHPNPGKPFTARGFPRQCYLPDNAQGRKVLELLKVAWKRRLIFTVGTSSTTGETDTVVWNEIHHKTEMDRNITGHGYPDPNYLQNVLAELAAQGVTEDCLEQQ","Homo sapiens","DTX2, KIAA1528, RNF58","Probable E3 ubiquitin-protein ligase DTX2","1","6Y2X"
"6Y2Z",,"X-RAY DIFFRACTION",2.82,56.45,"VAPOR DIFFUSION, SITTING DROP",,"na2hpo4 0.8 M 
K2HPO4 0.8 M 
HEPES 0.1 M (pH 7.5)",291.15,"10.1016/j.str.2020.09.008",,"6Y2Z",66.99,"2.15","2.15","NG domain of human SRP54","MGHHHHHMVLADLGRKITSALRSLSNATIINEEVLNAMLKEVCTALLEADVNIKLVKQLRENVKSAIDLEEMASGLNKRKMIQHAVFKELVKLVDPGVKAWTPTKGKQNVIMFVGLQGSGKTTTCSKLAYYYQRKGWKTCLICADTFRAGAFDQLKQNATKARIPFYGSYTEMDPVIIASEGVEKFKNENFEIIIVDTSGRHKQEDSLFEEMLQVANAIQPDNIVYVMDASIGQACEAQAKAFKDKVDVASVIVTKLDGHAKGGGALSAVAATKSPIIFIGTGEHIDDFEPFKTQPFISKLLG","Homo sapiens","SRP54","Signal recognition particle 54 kDa protein","1","6Y2Z"
"6Y30",,"X-RAY DIFFRACTION",3.05,59.62,"VAPOR DIFFUSION, SITTING DROP",,"1M Potassium Citrate",291.15,"10.1016/j.str.2020.09.008",,"6Y30",66.69,"2.65","2.65","NG domain of human SRP54 T115A mutant","MGHHHHHMVLADLGRKITSALRSLSNATIINEEVLNAMLKEVCTALLEADVNIKLVKQLRENVKSAIDLEEMASGLNKRKMIQHAVFKELVKLVDPGVKAWTPTKGKQNVIMFVGLQGSGKATTCSKLAYYYQRKGWKTCLICADTFRAGAFDQLKQNATKARIPFYGSYTEMDPVIIASEGVEKFKNENFEIIIVDTSGRHKQEDSLFEEMLQVANAIQPDNIVYVMDASIGQACEAQAKAFKDKVDVASVIVTKLDGHAKGGGALSAVAATKSPIIFIGTGEHIDDFEPFKTQPFISKLLG","Homo sapiens","SRP54","Signal recognition particle 54 kDa protein","1","6Y30"
"6Y31",,"X-RAY DIFFRACTION",2.96,58.5,"VAPOR DIFFUSION, SITTING DROP",,"0.8 M Na2HPO4 , 0.8 M K2HPO4 
HEPES 0.1 M (pH 7.5)",291.15,"10.1016/j.str.2020.09.008",,"6Y31",133.64,"4.001","4.001","NG domain of human SRP54 T117 deletion mutant","MGHHHHHHMVLADLGRKITSALRSLSNATIINEEVLNAMLKEVCTALLEADVNIKLVKQLRENVKSAIDLEEMASGLNKRKMIQHAVFKELVKLVDPGVKAWTPTKGKQNVIMFVGLQGSGKTTCSKLAYYYQRKGWKTCLICADTFRAGAFDQLKQNATKARIPFYGSYTEMDPVIIASEGVEKFKNENFEIIIVDTSGRHKQEDSLFEEMLQVANAIQPDNIVYVMDASIGQACEAQAKAFKDKVDVASVIVTKLDGHAKGGGALSAVAATKSPIIFIGTGEHIDDFEPFKTQPFISKLLG","Homo sapiens","SRP54","Signal recognition particle 54 kDa protein","1","6Y31"
"6Y3C",,"X-RAY DIFFRACTION",3.74,67.11,"VAPOR DIFFUSION, SITTING DROP",7.3,"Sodium citrate 0.7M, LiCl 0.72M",293,"10.1038/s41598-021-83438-z",,"6Y3C",68.4,"3.361","3.361","Human COX-1 Crystal Structure","ADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRSNLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRFLLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQYQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLYATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKFDPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEALVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQELVGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICSPEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL","Homo sapiens","PTGS1, COX1","Prostaglandin G/H synthase 1","1","6Y3C"
"6Y3E",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.17 M Sodium acetate trihydrate,0.085 M Sodium cacodylate trihydrate pH 6.5,25.5% w/v Polyethylene glycol 8,000.",298,,,"6Y3E",19.35,"1.45","1.45","Scaffold-ligand complex with ligand unmodelled","MGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6Y3E"
"6Y3J",,"X-RAY DIFFRACTION",2.32,73.11,"VAPOR DIFFUSION, SITTING DROP",7.6,"Morpheus condition 39 (Molecular Dimensions)",292,"10.1126/sciadv.abc0629",,"6Y3J",26.62,"2.6","2.6","RING-DTC domains of Deltex 2, bound to ADP-ribose","GSEPEPEQVIKNYTEELKVPPDEDCIICMEKLSTASGYSDVTDSKAIGSLAVGHLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGEKTGTQPQGKMEVLRFQMSLPGHEDCGTILIVYSIPHGIQGPEHPNPGKPFTARGFPRQCYLPDNAQGRKVLELLKVAWKRRLIFTVGTSSTTGETDTVVWNEIHHKTEMDRNITGHGYPDPNYLQNVLAELAAQGVTEDCLEQQ","Homo sapiens","DTX2, KIAA1528, RNF58","Probable E3 ubiquitin-protein ligase DTX2","1","6Y3J"
"6Y3U",,"X-RAY DIFFRACTION",2.54,51.56,"VAPOR DIFFUSION, SITTING DROP",,"33% PEG 3350, 0.1 M sodium citrate",293.15,"10.1021/acs.jmedchem.9b01786",,"6Y3U",32.2,"2.62","2.62","Crystal structure of PPARgamma in complex with compound (R)-16","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6Y3U"
"6Y41",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus A12 (0.06M Divalents, 0.1M Buffer System 3 pH 8.5, 50% v/v Precipitant Mix 4) + 25 mM CaCl2.",298,,,"6Y41",429.95,"1.79","1.79","Fibrinogen-like globe domain of human ANGPTL2","SMDKPSGPWRDCLQALEDGHDTSSIYLVKPENTNRLMQVWCDQRHDPGGWTVIQRRLDGSVNFFRNWETYKQGFGNIDGEYWLGLENIYWLTNQGNYKLLVTMEDWSGRKVFAEYASFRLEPESEYYKLRLGRYHGNAGDSFTWHNGKQFTTLDRDHDVYTGNCAHYQKGGWWYNACAHSNLNGVWYRGGHYRSRYQDGVYWAEFRGGSYSLKKVVMMIRPNPNTFH","Homo sapiens","ANGPTL2, ARP2, UNQ170/PRO196","Angiopoietin-related protein 2","1","6Y41"
"6Y43",,"X-RAY DIFFRACTION",1.92,35.85,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus B5 (0.09M Halogens, 0.1M Buffer System 2 pH 7.5, 50% v/v Precipitant Mix 1) + 25 mM CaCl2",298,,,"6Y43",25.98,"1.6","1.6","Fibrinogen-like globe domain of human ANGPTL6","SMTKPVGPWQDCAEARQAGHEQSGVYELRVGRHVVSVWCEQQLEGGGWTVIQRRQDGSVNFFTTWQHYKAGFGRPDGEYWLGLEPVYQLTSRGDHELLVLLEDWGGRGARAHYDGFSLEPESDHYRLRLGQYHGDAGDSLSWHNDKPFSTVDRDRDSYSGNCALYQRGGWWYHACAHSNLNGVWHHGGHYRSRYQDGVYWAEFRGGAYSLRKAAMLIRPLKL","Homo sapiens","ANGPTL6, AGF, ARP5, UNQ152/PRO178","Angiopoietin-related protein 6","1","6Y43"
"6Y49",,"X-RAY DIFFRACTION",2.05,39.99,"VAPOR DIFFUSION, HANGING DROP",,"0.15M K/Na tartrate
23% PEG 3350",293,"10.1073/pnas.2010317117",,"6Y49",54.14,"1.65","1.65","Crystal structure of the paraoxon-modified A.17kappa antibody FAB fragment","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLAMDYKDHDGDYKDHDIDYKDDDDKVDHHHHHH","Homo sapiens",,"A.17kappa antibody FAB fragment - Heavy Chain","1","6Y49"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"A.17kappa antibody FAB fragment - Light Chain","2","6Y49"
"6Y4C",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystals were grown on an XtalTool support (Jena Bioscience) over a 24 well VDX-plate with 1 ml reservoir. The drop consisted of 1 microlitre 20 mg/ml protein in 10 mM sodium phosphate pH 7.4, 100 mM NaCl, 10 mM beta-mercaptoethanol, 2 mM lactose), 0.25 microlitre of seed crystals in a stabilization solution containing 0.1 M Tris pH 7.5, 33% (w/v) PEG 4000, 0.1 M MgCl2, 0.2 M NaSCN) and 0.75 microlitre reservoir solution containing 0.1 M Tris pH 7.5, 30% PEG 4000, 0.05 M MgCl2, 0.2 M NaSCN and 8 mM beta-mercaptoethanol.",277,"10.1107/S1600577520008735",,"6Y4C",16.08,"1.7","1.7","Structure of galectin-3C in complex with lactose determined by serial crystallography using an XtalTool support","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6Y4C"
"6Y4S",,"X-RAY DIFFRACTION",2.74,55.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.9 M ammonium sulphate, 0.1 M HEPES, pH 8.5 and 0.5-2 %
PEG 3350",292,"10.1021/acs.jmedchem.9b01806",,"6Y4S",74.94,"2.23","2.23","Human kallikrein-related peptidase 7 (KLK7) in the unliganded state","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","6Y4S"
"6Y5N",,"X-RAY DIFFRACTION",3.7,66.76,"VAPOR DIFFUSION, SITTING DROP",7.6,"BCS condition 44 (Molecular dimensions)",292,"10.1126/sciadv.abc0418",,"6Y5N",52.6,"1.88","1.88","RING-DTC domain of Deltex1","GSKSKNPEDVVRRYMQKVKNPPDEDCTICMERLVTASGYEGVLRHKGVRPELVGRLGRCGHMYHLLCLVAMYSNGNKDGSLQCPTCKAIYGEKTGTQPPGKMEFHLIPHSLPGFPDTQTIRIVYDIPTGIQGPEHPNPGKKFTARGFPRHCYLPNNEKGRKVLRLLITAWERRLIFTIGTSNTTGESDTVVWNEIHHKTEFGSNLTGHGYPDASYLDNVLAELTAQGVSEAAAKA","Homo sapiens","DTX1","E3 ubiquitin-protein ligase DTX1","1","6Y5N"
"6Y5P",,"X-RAY DIFFRACTION",3.64,66.23,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.16M Calcium acetate hydrate, 0.08MSodium cacodylate pH 6.5, 14.4% w/v PEG 8000, 20% v/v Glycerol",292,"10.1126/sciadv.abc0418",,"6Y5P",54.22,"1.74","1.74","RING-DTC domain of Deltex1 bound to NAD","GSKSKNPEDVVRRYMQKVKNPPDEDCTICMERLVTASGYEGVLRHKGVRPELVGRLGRCGHMYHLLCLVAMYSNGNKDGSLQCPTCKAIYGEKTGTQPPGKMEFHLIPHSLPGFPDTQTIRIVYDIPTGIQGPEHPNPGKKFTARGFPRHCYLPNNEKGRKVLRLLITAWERRLIFTIGTSNTTGESDTVVWNEIHHKTEFGSNLTGHGYPDASYLDNVLAELTAQGVSEAAAKA","Homo sapiens","DTX1","E3 ubiquitin-protein ligase DTX1","1","6Y5P"
"6Y5R","3.76","ELECTRON MICROSCOPY",,,,,,,,,"6Y5R",246.16,"3.76",,"Structure of Human Potassium Chloride Transporter KCC3 S45D/T940D/T997D in NaCl","MPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNDITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERDLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMDWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYS","Homo sapiens","SLC12A6, KCC3","Solute carrier family 12 member 6","1","6Y5R"
"6Y5V","4.08","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"6Y5V",246.3,"4.08",,"Structure of Human Potassium Chloride Transporter KCC3b (S45D/T940D/T997D) in KCl","MPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNDITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERDLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMDWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYSA","Homo sapiens","SLC12A6, KCC3","Solute carrier family 12 member 6","1","6Y5V"
"6Y6F",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, SITTING DROP",5.5,"16% PEG 3350, 0.1M NaCl, 0.1M bis-tris 5.5",277.15,"10.1021/acs.jmedchem.0c01174",,"6Y6F",37.92,"1.98","1.98","Crystal structure of STK17B (DRAK2) in complex with PKIS43","MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS","Homo sapiens","STK17B, DRAK2","Serine/threonine-protein kinase 17B","1","6Y6F"
"6Y6H",,"X-RAY DIFFRACTION",2.68,54.14,"VAPOR DIFFUSION, SITTING DROP",6,"13% PEG 3350, 0.1M NaCl, 0.1M bis-tris 6.0",277.15,"10.1021/acs.jmedchem.0c01174",,"6Y6H",38,"1.95","1.95","Crystal structure of STK17b (DRAK2) in complex with UNC-AP-194 probe","MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS","Homo sapiens","STK17B, DRAK2","Serine/threonine-protein kinase 17B","1","6Y6H"
"6Y6N",,"X-RAY DIFFRACTION",3.6,65.87,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.65 M (NH4)2SO4, 4 % PEG 300, 100 mM Hepes pH 7.4, 2 % DMSO",291,,,"6Y6N",26.61,"2.03","2.03","Structure of mature activin A with small molecule 2","GLECDGKVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAGTSGSSLSFHSTVINHYRMRGHSPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS","Homo sapiens","INHBA","Inhibin beta A chain","1","6Y6N"
"6Y6O",,"X-RAY DIFFRACTION",3.57,65.52,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.65 M (NH4)2SO4, 4 % PEG 300, 100 mM Hepes pH 7.4, 2 % DMSO",291,,,"6Y6O",26.72,"2.04","2.04","Structure of mature activin A with small molecule 42","GLECDGKVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAGTSGSSLSFHSTVINHYRMRGHSPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS","Homo sapiens","INHBA","Inhibin beta A chain","1","6Y6O"
"6Y6R",,"X-RAY DIFFRACTION",6.38,80.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES sodium pH 7.5, 0.8 M Potassium sodium tartrate tetrahydrate",293.15,"10.1016/j.molcel.2021.08.024",,"6Y6R",32.05,"3.32","3.32","Crystal structure of MINDY1 T335D mutant","GPLGSPEFPGRLEMEPDFYCVKWIPWKGEQTPIITQSTNGPCPLLAIMNILFLQWKVKLPPQKEVITSDELMAHLGNCLLSIKPQEKSEGLQLNFQQNVDDAMTVLPKLATGLDVNVRFTGVSDFEYTPECSVFDLLGIPLYHGWLVDPQSPEAVRAVGKLSYNQLVERIITCKHSSDTNLVTEGLIAEQFLETTAAQLTYHGLCELTAAAKEGELSVFFRNNHFSTMTKHKSHLYLLVDDQGFLQEEQVVWESLHNVDGDSCFCDSDFHLSHSLGKGPGAEGGSGSPE","Homo sapiens","MINDY1, FAM63A, KIAA1390","Ubiquitin carboxyl-terminal hydrolase MINDY-1","1","6Y6R"
"6Y73",,"X-RAY DIFFRACTION",1.87,34.16,"VAPOR DIFFUSION, HANGING DROP",6.7,"0.2 M Ammonium tartarate dibasic pH 6.7, 20% PEG 3350",293,"10.1107/S2053230X20011309",,"6Y73",328.62,"1.7","1.7","The crystal structure of human MACROD2 in space group P43","MHHHHHHSSGMSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAKLNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGTENLYFQSMKKKVWREEKERLLKMTLEERRKEYLRDYIPLNSILSWKEEMKGKGQNDEENTQETSQVKKSLTEKVSLYRGDITLLEVDAIVNAANASLLGGGGVDGCIHRAAGPCLLAECRNLNGCDTGHAKITCGYDLPAKYVIHTVGPIARGHINGSHKEDLANCYKSSLKLVKENNIRSVAFPCISTGIYGFPNEPAAVIALNTIKEWLAKNHHEVDRIIFCVFLEVDFKIYKKKMNEFFSVD","Homo sapiens","MACROD2, C20orf133","ADP-ribose glycohydrolase MACROD2","1","6Y73"
"6Y74",,"X-RAY DIFFRACTION",2.3,46.64,"VAPOR DIFFUSION, SITTING DROP",4.3,"17% PEG 6000, 1.4 M Sodium citrate pH 4.3, 1 M LiCl",293,,,"6Y74",57.89,"1.53","1.53","X-ray crystal structure of human carbonic anhydrase IX catalytic domain.","DQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFCPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGV","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6Y74"
"6Y76",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium fluoride and 20% v/v PEG 3350",293,"10.1002/prot.25974",,"6Y76",36.17,"1.98","1.98","AP01 - a redesigned transferrin receptor apical domain","MQNSVIIVDKNGRLVYLVENPGGSVANSKAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFTGKGKSGIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSGSGSLEHHHHHH","Homo sapiens","TFRC","Transferrin receptor protein 1","1","6Y76"
"6Y78",,"X-RAY DIFFRACTION",1.96,37.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystals were grown on XtalTool supports (Jena Bioscience) over a 24 well VDX-plate with 1 ml reservoir. The drop was made up of 1 microlitre 20 mg/ml protein in 10 mM sodium phosphate pH 7.4, 100 mM NaCl, 10 mM beta-mercaptoethanol, 2 mM lactose, 0.25 microlitres of galectin-3C seed crystals in a stabilization solution containing 0.1 M Tris pH 7.5, 33% (w/v) PEG 4000, 0.1 M MgCl2, 0.2 M NaSCN and 0.75 microlitres reservoir solution containing 0.1 M Tris pH 7.5, 34% (w/v) PEG 4000, 0.2 M NaSCN and 8 mM beta-mercapthoethanol. Crystals grew to a size of approximately 10-15 micrometer.",277,"10.1107/S1600577520008735",,"6Y78",16.04,"1.7","1.7","Structure of galectin-3C in complex with lactose determined by serial crystallography using a silicon nitride membrane support","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6Y78"
"6Y7F",,"X-RAY DIFFRACTION",3.73,67.04,"VAPOR DIFFUSION, HANGING DROP",4.5,"30-36% PEG400 -- 0.1M acetate pH 4.5 -- 0.23M sodium chloride",279,,,"6Y7F",73.01,"2.052","2.052","Crystal structure of human ELOVL fatty acid elongase 7 (ELOVL7)","MAFSDLTSRTVHLYDNWIKDADPRVEDWLLMSSPLPQTILLGFYVYFVTSLGPKLMENRKPFELKKAMITYNFFIVLFSVYMCYEFVMSGWGIGYSFRCDIVDYSRSPTALRMARTCWLYYFSKFIELLDTIFFVLRKKNSQVTFLHVFHHTIMPWTWWFGVKFAAGGLGTFHALLNTAVHVVMYSYYGLSALGPAYQKYLWWKKYLTSLQLVQFVIVAIHISQFFFMEDCKYQFPVFACIIMSYSFMFLLLFLHFWYRAYTKGQRLPKTVKNGTCKNKDNAENLYFQ","Homo sapiens","ELOVL7","Elongation of very long chain fatty acids protein 7","1","6Y7F"
"6Y7G",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1M BIS-TRIS pH 6.5",277,,,"6Y7G",53.31,"2.3","2.3","Structure of the human RAB3C in complex with GDP","MRHEAPMQMASAQDARYGQKDSSDQNFDYMFKLLIIGNSSVGKTSFLFRYADDSFTSAFVSTVGIDFKVKTVFKNEKRIKLQIWDTAGQERYRTITTAYYRGAMGFILMYDITNEESFNAVQDWSTQIKTYSWDNAQVILVGNKCDMEDERVISTERGQHLGEQLGFEFFETSAKDNINVKQTFERLVDIICDKMSESLETDPAITAAKQNTRLKETPPPPQPNCAC","Homo sapiens","RAB3C","Ras-related protein Rab-3C","1","6Y7G"
"6Y7H",,"X-RAY DIFFRACTION",2.33,47.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M ammonium sulfate, 30% pentaerythritol ethoxylate 15/4, 0.1M bis-tris pH 6.5",277,,,"6Y7H",28.78,"1.8","1.8","Structure of the BRD9 bromodomain and compound 11","LKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6Y7H"
"6Y7I",,"X-RAY DIFFRACTION",2.31,46.79,"EVAPORATION",6.5,"20% PEG3350, 10% ethylene glycol, 0.1M bis-tris-propane pH 6.5, 0.02M sodium/potassium phosphate",277,,,"6Y7I",28.6,"1.6","1.6","Structure of the BRD9 bromodomain and compound 2","LKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6Y7I"
"6Y7J",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M ammonium acetate, 25% PEG3350, 0.1M HEPES pH 7.5",277,,,"6Y7J",28.75,"1.6","1.6","Structure of the BRD9 bromodomain and compound 15","LKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6Y7J"
"6Y7K",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350,10% ethylene glycol, 0.1M bis-tris-propane pH 7.5, 0.2M potassium thiocyanate",277,,,"6Y7K",14.57,"1.2","1.2","Structure of the BRD9 bromodomain and compound 27","LKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6Y7K"
"6Y7L",,"X-RAY DIFFRACTION",2.3,46.46,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M sodium chloride, 25% PEG3350, 0.1M tris pH 8.5",277,,,"6Y7L",14.36,"1.8","1.8","Structure of the BRD9 bromodomain and TP-472","LKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6Y7L"
"6Y7Q",,"X-RAY DIFFRACTION",1.75,29.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"hERG3 PAS domain (15 mg/ml, in 50 mM NaCl, 1 mM TCEP in a 1:1 ratio with reservoir solution (0.1 M NaCl, 0.1 M HEPES pH=7.5, 1.6 M (NH4)2SO4",295,"10.1074/jbc.RA120.014150",,"6Y7Q",15.61,"1.39","1.39","Crystal Structure of the N-terminal PAS domain from the hERG3 Potassium Channel","MPVRRGHVAPQNTFLGTIIRKFEGQNKKFIIANARVQNCAIIYCNDGFCEMTGFSRPDVMQKPCTCDFLHGPETKRHDIAQIAQALLGSEERKVEVTYYHKNGSTFICNTHIIPVKNQEGVAMMFIINFEYVTDN","Homo sapiens","KCNH7, ERG3","Potassium voltage-gated channel subfamily H member 7","1","6Y7Q"
"6Y8I",,"X-RAY DIFFRACTION",3.26,62.27,"VAPOR DIFFUSION, SITTING DROP",,"2.8M ammonium sulphate and 0.1M Tris pH7.9",291,,,"6Y8I",17.75,"1.46","1.46","Fragment KCL_I013 in complex with IL-1-beta","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","6Y8I"
"6Y8M",,"X-RAY DIFFRACTION",3.25,62.1,"VAPOR DIFFUSION, SITTING DROP",,"2.8M ammonium sulphate and 0.1M Tris pH7.9",291,,,"6Y8M",18.04,"1.9","1.9","Fragment bikinin bound to Interleukin 1 beta","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","6Y8M"
"6Y8P",,"X-RAY DIFFRACTION",3.48,61.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM Na HEPES pH 7.5
25% PEG 8000
10 mg/mL protein 100 nl:100 nL",291,"10.1021/acs.biochem.1c00258",,"6Y8P",19.61,"2.3","2.3","Crystal structure of SNAP-tag labeled with a benzyl-tetramethylrhodamine fluorophore","GDCEMKRTTLDSPLGKLELSGCEQGLHEIIFLGKGTSAADAVEVPAPAAVLGGPEPLMQATAWLNAYFHQPEAIEEFPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISYSHLAALAGNPAATAAVKTALSGNPVPILIPCHRVVQGDLDVGGYEGGLAVKEWLLAHEGHRLGKR","Homo sapiens",,"O6-alkylguanine-DNA alkyltransferase mutant","1","6Y8P"
"6Y94",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA120.013430",,"6Y94",16.88,,,"Ca2+-bound Calmodulin mutant N53I","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIIEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","6Y94"
"6Y95",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA120.013430",,"6Y95",16.72,,,"Ca2+-free Calmodulin mutant N53I","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIIEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","6Y95"
"6Y99",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M tri-Sodium Citrate dihydrate
20% (w/v) PEG 3350",291,"10.1002/anie.202016805",,"6Y99",23.84,"2.984","2.984","hSTING mutant R232K in complex with 2',3'-cGAMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDKAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING1, ERIS, MITA, TMEM173, STING","Stimulator of interferon genes protein","1","6Y99"
"6Y9R",,"X-RAY DIFFRACTION",3.01,59.14,"VAPOR DIFFUSION",,"18 % PEG8000
0.13 M NaCl
0.10 M Tris_Acetat_7.5
5 mM TCEP",277,"10.3390/molecules25092163","OH8","6Y9R",40.58,"2.08","2.08","Crystal structure of GSK-3b in complex with the 1H-indazole-3-carboxamide inhibitor 2","SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6Y9R"
"6Y9S",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION",,"0.10 M TrisAc pH8.25
26 % PEG 8K
0.13 M NaCl",277,"10.3390/molecules25092163","OHK","6Y9S",80.73,"2.03","2.03","Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16","SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6Y9S"
"6YAT",,"X-RAY DIFFRACTION",3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",11,"0.6 M ammonium sulfate, 0.1 M lithium sulfate and 0.1 M CAPS, pH 11.0",293.15,"10.1021/acs.jmedchem.1c00804",,"6YAT",73.14,"2.58","2.58","Crystal structure of STK4 (MST1) in complex with compound 6","SMETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREEG","Homo sapiens","STK4, KRS2, MST1","Serine/threonine-protein kinase 4","1","6YAT"
"6YAU",,"X-RAY DIFFRACTION",2.05,40.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein Buffer: 20 mM Tris-HCl (pH 7.4), 25 mM CaCl2.
Reservoir: 100 mM Tris-Hcl (pH 7.5), 28% PEG4000",293,"10.1002/advs.202002997",,"6YAU",18.54,"1.397","1.397","CRYSTAL STRUCTURE OF ASGPR 1 IN COMPLEX WITH GN-A.","MGSERTCCPVNWVEHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGPVNTWMGLHDQNGPWKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHFTDDGRWNDDVCQRPYRWVCETELDKASQEPPLLGSHHHHHH","Homo sapiens","ASGR1, CLEC4H1","Asialoglycoprotein receptor 1","1","6YAU"
"6YAW",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"Tris-HCl 0.1M pH 7.5, PEG4000 18%",293,"10.1093/chemse/bjaa055",,"6YAW",52.4,"2.19","2.19","Crystal structure of human GSTA1-1 bound to the glutathione adduct of cinnamaldehyde","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","6YAW"
"6YB4",,"X-RAY DIFFRACTION",4.06,69.73,"VAPOR DIFFUSION, SITTING DROP",,"0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate",277,"10.1021/acs.jmedchem.0c00021",,"6YB4",16.35,"1.85","1.85","Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-(3-methylpyrrolidin-1-yl)sulfonyl)phenyl)-2-(-4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetamide","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6YB4"
"6YB8",,"X-RAY DIFFRACTION",2.78,55.72,"VAPOR DIFFUSION, SITTING DROP",,"16 mg/ml PAICS with 5 mM SAICAR; 0.1 M MES/imidazole pH 6.5, 10% w/v PEG 8000, 20% v/v ethylene glycol, 0.02 M sodium L-glutamate, 0.02 M DL-alanine, 0.02 M glycine, 0.02 M DL-lysine HCl, and 0.02 M DL-serine",294,"10.1074/jbc.RA120.013695",,"6YB8",96.5,"2.36","2.36","Human octameric PAICS in complex with CAIR and SAICAR","MATAEVLNIGKKLYEGKTKEVYELLDSPGKVLLQSKDQITAGNAARKNHLEGKAAISNKITSCIFQLLQEAGIKTAFTRKCGETAFIAPQCEMIPIEWVCRRIATGSFLKRNPGVKEGYKFYPPKVELFFKDDANNDPQWSEEQLIAAKFCFAGLLIGQTEVDIMSHATQAIFEILEKSWLPQNCTLVDMKIEFGVDVTTKEIVLADVIDNDSWRLWPSGDRSQQKDKQSYRDLKEVTPEGLQMVKKNFEWVAERVELLLKSESQCRVVVLMGSTSDLGHCEKIKKACGNFGIPCELRVTSAHKGPDETLRIKAEYEGDGIPTVFVAVAGRSNGLGPVMSGNTAYPVISCPPLTPDWGVQDVWSSLRLPSGLGCSTVLSPEGSAQFAAQIFGLSNHLVWSKLRASILNTWISLKQADKKIRECNL","Homo sapiens","PAICS, ADE2, AIRC, PAIS","Multifunctional protein ADE2","1","6YB8"
"6YB9",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, SITTING DROP",,"6 mg/ml PAICS with 5 mM SAICAR, 5 mM AMP-PNP, and 10 mM MgCl2; 0.1 M MES/imidazole pH 6.5, 10% w/v PEG 8000, 20% v/v ethylene glycol, 0.02 M sodium formate, 0.02 M ammonium acetate, 0.02 M trisodium citrate, 0.02 M sodium potassium L-tartrate, and 0.02 M sodium oxamate",294,"10.1074/jbc.RA120.013695",,"6YB9",96.66,"2.406","2.406","Human octameric PAICS in complex with SAICAR, AMP-PNP, and magnesium","MATAEVLNIGKKLYEGKTKEVYELLDSPGKVLLQSKDQITAGNAARKNHLEGKAAISNKITSCIFQLLQEAGIKTAFTRKCGETAFIAPQCEMIPIEWVCRRIATGSFLKRNPGVKEGYKFYPPKVELFFKDDANNDPQWSEEQLIAAKFCFAGLLIGQTEVDIMSHATQAIFEILEKSWLPQNCTLVDMKIEFGVDVTTKEIVLADVIDNDSWRLWPSGDRSQQKDKQSYRDLKEVTPEGLQMVKKNFEWVAERVELLLKSESQCRVVVLMGSTSDLGHCEKIKKACGNFGIPCELRVTSAHKGPDETLRIKAEYEGDGIPTVFVAVAGRSNGLGPVMSGNTAYPVISCPPLTPDWGVQDVWSSLRLPSGLGCSTVLSPEGSAQFAAQIFGLSNHLVWSKLRASILNTWISLKQADKKIRECNL","Homo sapiens","PAICS, ADE2, AIRC, PAIS","Multifunctional protein ADE2","1","6YB9"
"6YBG",,"X-RAY DIFFRACTION",3.1,59,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Hepes buffer pH 7.5, 0.2 M Ammonium Acetate, 30% PegMME550",284,"10.1021/acs.jmedchem.0c01234","OJT","6YBG",40.44,"2.1","2.1","Structure of Mcl-1 in complex with compound 2g","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6YBG"
"6YBM",,"X-RAY DIFFRACTION",2.92,57.93,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% v/v (+/-)-2-Methyl-2,4-pentanediol",298,,,"6YBM",53.73,"1.41","1.41","Scaffold-ligand complex with ligand unmodelled.","MGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6YBM"
"6YDB",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium chloride, 0.1 M Na/K phosphate pH 6.2, 40% (v/v) PEG 400",291,"10.1002/anie.202016805",,"6YDB",23.88,"2.801","2.801","Human wtSTING in complex with 2',2'-difluoro-3',3'-c-di-GMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6YDB"
"6YDV",,"X-RAY DIFFRACTION",2.77,55.58,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5, 24% PEG3350, 0.4M magnesium chloride",277,,,"6YDV",86.65,"2.07","2.07","Crystal Structure of the Jmjc Domain of Human JMJD1B in complex with FM001511a from the DSPL fragment library","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","JMJD1B","JMJD1B protein","1","6YDV"
"6YDX",,"X-RAY DIFFRACTION",2.88,57.31,"VAPOR DIFFUSION",5,"PEG 1500, SPG (succinic acid, phosphate, glycine) buffer",289,"10.1021/acsmedchemlett.0c00172",,"6YDX",216.17,"3.2","3.2","Insulin-regulated aminopeptidase complexed with a macrocyclic peptidic inhibitor","MGILPSPGNPALLSLVSLLSVLLMGCVAETGATNGKLFPWAQIRLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEYFSLEKIFKELSSYEDFLDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLDVKRMMKTWTLQKGFPLVTVQKKGKELFIQQERFFLNMKPEIQPSDTSYLWHIPLSYVTEGRNYSKYQSVSLLDKKSGVINLTEEVLWVKVNINMNGYYIVHYADDDWEALIHQLKINPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEALFQTDLIYNLLEKLGYMDLASRLVTRVFKLLQNQIQQQTWTDEGTPSMRELRSALLEFACTHNLGNCSTTAMKLFDDWMASNGTQSLPTDVMTTVFKVGAKTDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKLSFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSYTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRLRCVQEALEVIQLNIQWMEKNLKSLTWWLRTETSQVAPA","Homo sapiens","LNPEP, OTASE","Leucyl-cystinyl aminopeptidase","1","6YDX"
"6YDZ",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION, SITTING DROP",,"12.5% w/v PEG 1000, 12.5% w/v PEG3350, 12.5% v/v MPD, carboxylic acid 0.02 M, 0.1 M bicine/Trizma base pH 8.5",291,"10.1002/anie.202016805",,"6YDZ",23.86,"2.9","2.9","Human wtSTING in complex with 3',3'-cGAMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6YDZ"
"6YE1",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",,"1mM of compound, 0.1 mM ZnCl2, 11-14% PEG6000, 100 mM sodium citrate pH 5.4-5.6, 15% glycerol for cryo",291,"10.1021/acs.jmedchem.0c01835",,"6YE1",119.71,"2.66","2.66","Human Ecto-5'-nucleotidase (CD73) in complex with the AMPCP derivative A894 (compound 2n in publication) in the closed form (crystal form IV)","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6YE1"
"6YE2",,"X-RAY DIFFRACTION",2.45,49.89,"VAPOR DIFFUSION, HANGING DROP",,"1 mM ZnCl2, 11-14% PEG6000, 15 % Glycerol, 100 mM sodium citrate pH 5.4-5.6",291,"10.1021/acs.jmedchem.0c01835",,"6YE2",119.79,"2.44","2.44","Human Ecto-5'-nucleotidase (CD73) in complex with the AMPCP derivative A1202 (compound 4a in publication) in the closed form (crystal form IV)","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6YE2"
"6YE9",,"X-RAY DIFFRACTION",2.76,55.43,"VAPOR DIFFUSION, SITTING DROP",,"0.095 M HEPES Na (pH 7.1), 27% (v/v) PEG 400, 0.19 M CaCL2, 5% (v/v) Glycerol",277,,,"6YE9",26.94,"1.8","1.8","Small-molecule inhibitor of 14-3-3 protein-protein interactions","GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","6YE9"
"6YEA",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",,"12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD, 0.2M d-glucose, 0.2M d-mannose, 0.2M d-galactose, 0.2M l-fucose, 0.2M d-xylose, 0.2M N-acetyl-d-glucosamine, 0.1M bicine/Trizma base pH 8.5",291,"10.1002/anie.202016805",,"6YEA",23.87,"2.805","2.805","Human wtSTING in complex with 2',2'-difluoro-3',3'-cGAMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6YEA"
"6YEJ","18.2","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.06.008",,"6YEJ",355.28,"18.2",,"Cryo-EM structure of the Full-length disease type human Huntingtin","MATLEKLMKAFESLKSFQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQPPPPPPPPPPPQLPQPPPQAQPLLPQPQPPPPPPPPPPGPAVAEEPLHRPKKELSATKKDRVNHCLTICENIVAQSVRNSPEFQKLLGIAMELFLLCSDDAESDVRMVADECLNKVIKALMDSNLPRLQLELYKEIKKNGAPRSLRAALWRFAELAHLVRPQKCRPYLVNLLPCLTRTSKRPEESVQETLAAAVPKIMASFGNFANDNEIKVLLKAFIANLKSSSPTIRRTAAGSAVSICQHSRRTQYFYSWLLNVLLGLLVPVEDEHSTLLILGVLLTLRYLVPLLQQQVKDTSLKGSFGVTRKEMEVSPSAEQLVQVYELTLHHTQHQDHNVVTGALELLQQLFRTPPPELLQTLTAVGGIGQLTAAKEESGGRSRSGSIVELIAGGGSSCSPVLSRKQKGKVLLGEEEALEDDSESRSDVSSSALTASVKDEISGELAASSGVSTPGSAGHDIITEQPRSQHTLQADSVDLASCDLTSSATDGDEEDILSHSSSQVSAVPSDPAMDLNDGTQASSPISDSSQTTTEGPDSAVTPSDSSEIVLDGTDNQYLGLQIGQPQDEDEEATGILPDEASEAFRNSSMALQQAHLLKNMSHCRQPSDSSVDKFVLRDEATEPGDQENKPCRIKGDIGQSTDDDSAPLVHCVRLLSASFLLTGGKNVLVPDRDVRVSVKALALSCVGAAVALHPESFFSKLYKVPLDTTEYPEEQYVSDILNYIDHGDPQVRGATAILCGTLICSILSRSRFHVGDWMGTIRTLTGNTFSLADCIPLLRKTLKDESSVTCKLACTAVRNCVMSLCSSSYSELGLQLIIDVLTLRNSSYWLVRTELLETLAEIDFRLVSFLEAKAENLHRGAHHYTGLLKLQERVLNNVVIHLLGDEDPRVRHVAAASLIRLVPKLFYKCDQGQADPVVAVARDQSSVYLKLLMHETQPPSHFSVSTITRIYRGYNLLPSITDVTMENNLSRVIAAVSHELITSTTRALTFGCCEALCLLSTAFPVCIWSLGWHCGVPPLSASDESRKSCTVGMATMILTLLSSAWFPLDLSAHQDALILAGNLLAASAPKSLRSSWASEEEANPAATKQEEVWPALGDRALVPMVEQLFSHLLKVINICAHVLDDVAPGPAIKAALPSLTNPPSLSPIRRKGKEKEPGEQASVPLSPKKGSEASAASRQSDTSGPVTTSKSSSLGSFYHLPSYLRLHDVLKATHANYKVTLDLQNSTEKFGGFLRSALDVLSQILELATLQDIGKCVEEILGYLKSCFSREPMMATVCVQQLLKTLFGTNLASQFDGLSSNPSKSQGRAQRLGSSSVRPGLYHYCFMAPYTHFTQALADASLRNMVQAEQENDTSGWFDVLQKVSTQLKTNLTSVTKNRADKNAIHNHIRLFEPLVIKALKQYTTTTCVQLQKQVLDLLAQLVQLRVNYCLLDSDQVFIGFVLKQFEYIEVGQFRESEAIIPNIFFFLVLLSYERYHSKQIIGIPKIIQLCDGIMASGRKAVTHAIPALQPIVHDLFVLRGTNKADAGKELETQKEVVVSMLLRLIQYHQVLEMFILVLQQCHKENEDKWKRLSRQIADIILPMLAKQQMHIDSHEALGVLNTLFEILAPSSLRPVDMLLRSMFVTPNTMASVSTVQLWISGILAILRVLISQSTEDIVLSRIQELSFSPYLISCTVINRLRDGDSTSTLEEHSEGKQIKNLPEETFSRFLLQLVGILLEDIVTKQLKVEMSEQQHTFYCQELGTLLMCLIHIFKSGMFRRITAAATRLFRSDGCGGSFYTLDSLNLRARSMITTHPALVLLWCQILLLVNHTDYRWWAEVQQTPKRHSLSSTKLLSPQMSGEEEDSDLAAKLGMCNREIVRRGALILFCDYVCQNLHDSEHLTWLIVNHIQDLISLSHEPPVQDFISAVHRNSAASGLFIQAIQSRCENLSTPTMLKKTLQCLEGIHLSQSGAVLTLYVDRLLCTPFRVLARMVDILACRRVEMLLAANLQSSMAQLPMEELNRIQEYLQSSGLAQRHQRLYSLLDRFRLSTMQDSLSPSPPVSSHPLDGDGHVSLETVSPDKDWYVHLVKSQCWTRSDSALLEGAELVNRIPAEDMNAFMMNSEFNLSLLAPCLSLGMSEISGGQKSALFEAAREVTLARVSGTVQQLPAVHHVFQPELPAEPAAYWSKLNDLFGDAALYQSLPTLARALAQYLVVVSKLPSHLHLPPEKEKDIVKFVVATLEALSWHLIHEQIPLSLDLQAGLDCCCLALQLPGLWSVVSSTEFVTHACSLIHCVHFILEAVAVQPGEQLLSPERRTNTPKAISEEEEEVDPNTQNPKYITAACEMVAEMVESLQSVLALGHKRNSGVPAFLTPLLRNIIISLARLPLVNSYTRVPPLVWKLGWSPKPGGDFGTAFPEIPVEFLQEKEVFKEFIYRINTLGWTSRTQFEETWATLLGVLVTQPLVMEQEESPPEEDTERTQINVLAVQAITSLVLSAMTVPVAGNPAVSCLEQQPRNKPLKALDTRFGRKLSIIRGIVEQEIQAMVSKRENIATHHLYQAWDPVPSLSPATTGALISHEKLLLQINPERELGSMSYKLGQVSIHSVWLGNSITPLREEEWDEEEEEEADAPAPSSPPTSPVNSRKHRAGVDIHSCSQFLLELYSRWILPSSSARRTPAILISEVVRSLLVVSDLFTERNQFELMYVTLTELRRVHPSEDEILAQYLVPATCKAAAVLGMDKAVAEPVSRLLESTLRSSHLPSRVGALHGVLYVLECDLLDDTAKQLIPVISDYLLSNLKGIAHCVNIHSQQHVLVMCATAFYLIENYPLDVGPEFSASIIQMCGVMLSGSEESTPSIIYHCALRGLERLLLSEQLSRLDAESLVKLSVDRVNVHSPHRAMAALGLMLTCMYTGKEKVSPGRTSDPNPAAPDSESVIVAMERVSVLFDRIRKGFPCEARVVARILPQFLDDFFPPQDIMNKVIGEFLSNQQPYPQFMATVVYKVFQTLHSTGQSSMVRDWVMLSLSNFTQRAPVAMATWSLSCFFVSASTSPWVAAILPHVISRMGKLEQVDVNLFCLVATDFYRHQIEEELDRRAFQSVLEVVAAPGSPYHRLLTCLRNVHKVTTC","Homo sapiens","HTT, HD, IT15","Huntingtin","1","6YEJ"
"6YEK",,"X-RAY DIFFRACTION",4.4,72.07,"VAPOR DIFFUSION, HANGING DROP",4,"45% (v/v) ethylene glycol
50mM acetate (pH 4.0)",293,"10.1016/j.chembiol.2020.07.010",,"6YEK",20.66,"3.2","3.2","Crystal structure of human NEMO apo form","GPMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAAQHAIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLK","Homo sapiens","IKBKG, hCG_2003089, FIP3, NEMO","Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, isoform CRA_b","1","6YEK"
"6YEL",,"SOLUTION NMR",,,,,,,"10.1038/s41589-020-00672-8",,"6YEL",13.92,,,"Stromal interaction molecule 1 coiled-coil 1 fragment","GSPEFNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWYA","Homo sapiens","STIM1, GOK","Stromal interaction molecule 1","1","6YEL"
"6YF0",,"X-RAY DIFFRACTION",3.17,61.16,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.2 M AmSO4, 0.2 M NaThiocyanate",298,"10.1016/j.chembiol.2021.04.001",,"6YF0",12.89,"1.55","1.55","FKBP12 in complex with the BMP potentiator compound 9 at 1.55 A resolution","GPGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","6YF0"
"6YF1",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, HANGING DROP",,"2.2 M AmSO4, 0.2 M CdCl2",298,"10.1016/j.chembiol.2021.04.001",,"6YF1",12.8,"1.12","1.12","FKBP12 in complex with the BMP potentiator compound 8 at 1.12A resolution","GPGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","6YF1"
"6YF2",,"X-RAY DIFFRACTION",1.88,34.44,"VAPOR DIFFUSION, HANGING DROP",,"1.9 M AmSO4, 0.15 M CdCl2",298,"10.1016/j.chembiol.2021.04.001",,"6YF2",13.02,"1.03","1.03","FKBP12 in complex with the BMP potentiator compound 6 at 1.03A resolution","GPGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","6YF2"
"6YF3",,"X-RAY DIFFRACTION",1.86,33.77,"VAPOR DIFFUSION, HANGING DROP",,"2.2 M AmSO4, 0.2 M CdCl2",298,"10.1016/j.chembiol.2021.04.001",,"6YF3",12.97,"1","1","FKBP12 in complex with the BMP potentiator compound 10 at 1.00A resolution","GPGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","6YF3"
"6YF8",,"X-RAY DIFFRACTION",2.61,52.83,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.05M LiCl; 10% PEG 3350, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"6YF8",171.81,"3.198","3.198","DYRK1A with PST001","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6YF8"
"6YFZ",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, SITTING DROP",7.8,"19% PEG3350, 
0.15 M ammonium acetate, 0.1 M tris, pH 7.8",277.15,"10.1016/j.chembiol.2020.07.014",,"6YFZ",34.94,"1.9","1.9","Crystal structure of MKK7 (MAP2K7), apo form","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YFZ"
"6YG0",,"X-RAY DIFFRACTION",2.55,51.73,"VAPOR DIFFUSION, SITTING DROP",8.2,"16% PEG3350,
0.25 M ammonium acetate, 0.1 M tris, pH 8.2",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG0",34.99,"2","2","Crystal structure of S287D,T291D MKK7 (MAP2K7), apo form","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG0"
"6YG1",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"27% PEG3350, 0.2 M potassium thiocyanate, 10% ethylene glycol, 0.1 M bis-tris propane, pH 7.5",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG1",120.41,"2.22","2.22","Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal helix","SMSSPQHPTPPARPRHMLGLPSTLFTPRSMESIEIDQKLQEIMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG1"
"6YG2",,"X-RAY DIFFRACTION",2.47,50.17,"VAPOR DIFFUSION, SITTING DROP",7.8,"19% PEG3350, 
0.1 M ammonium acetate,
0.1 M tris, pH 7.8",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG2",36.64,"2","2","Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric binding modes","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG2"
"6YG3",,"X-RAY DIFFRACTION",2.29,46.4,"VAPOR DIFFUSION, SITTING DROP",8.2,"19% PEG3350, 0.25 M ammonium acetate, 
0.1 M tris, pH 8.2",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG3",35.97,"2.05","2.05","Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG3"
"6YG4",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, SITTING DROP",8.2,"19% PEG3350,  0.1 M ammonium acetate, 
0.1 M tris, pH 8.2",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG4",35.61,"2.3","2.3","Crystal structure of MKK7 (MAP2K7) in complex with K00007","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG4"
"6YG5",,"X-RAY DIFFRACTION",2.46,49.94,"VAPOR DIFFUSION, SITTING DROP",7.8,"16% PEG3350, 0.2 M ammonium acetate, 
0.1 M tris, pH 7.8",277.15,"10.1016/j.chembiol.2020.07.014",,"6YG5",35.36,"2.4","2.4","Crystal structure of MKK7 (MAP2K7) in complex with ASC69","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG5"
"6YG6",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, SITTING DROP",8.2,"19% PEG3350,  0.15 M ammonium acetate,
0.1 M tris, pH 8.2",293.15,"10.1016/j.chembiol.2020.07.014",,"6YG6",71.5,"2.15","2.15","Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG6"
"6YG7",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG3350, 0.1 M ammonium acetate,
0.1 M tris, pH 8.5",293.15,"10.1016/j.chembiol.2020.07.014",,"6YG7",71.44,"2.2","2.2","Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YG7"
"6YG9",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, HANGING DROP",7,"Essentially defatted human serum albumin from Sigma was purified by size exclusion chromatography to obtain pure monomeric protein. The purified HSA was dissolved in 20 mM potassium phosphate (pH 7.0) and concentrated to 120 mg/mL. To the HSA solution we added 10 mM cpdX and 3 mM myristate, dissolved DMSO. The final concentration of DMSO was 5% (v/v). The crystal was grown by the hanging drop vapor diffusion method using a reservoir solution containing 50 mM sodium-potassium-phosphate (pH 7.0), and 30% polyethylene glycol 3350. For crystallization 1 uL of HSA/cpdX solution was equilibrated against 1 uL of reservoir solution. After about one-week, colorless crystals appeared.",293,"10.1002/advs.202002997",,"6YG9",68.76,"1.89","1.89","CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN (HSA) IN COMPLEX WITH GN-07.","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6YG9"
"6YGN",,"X-RAY DIFFRACTION",2.74,55.17,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 8K, 0.1 MES pH6.5",293.15,"10.15252/embr.201948018",,"6YGN",126.23,"2.4","2.4","Titin kinase and its flanking domains","ADVPDPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKEDKTRAMNYDEEVDETREVSMTKASHSSTKELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASIEIGPVSGQIMHAVGEEGGHVKYVCKIENYDQSTQVTWYFGVRQLENSEKYEITYEDGVAILYVKDITKLDDGTYRCKVVNDYGEDSSYAELFVKGVREVYDY","Homo sapiens","TTN","Titin","1","6YGN"
"6YH4",,"X-RAY DIFFRACTION",2.04,39.68,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH4",29.7,"1.3","1.3","Crystal structure of chimeric carbonic anhydrase XII with 2,3,5,6-Tetrafluoro-4-(propylthio)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH4"
"6YH5",,"X-RAY DIFFRACTION",2.05,39.99,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH5",29.83,"1.2","1.2","Crystal structure of chimeric carbonic anhydrase XII with 2-Chloro-4-[(pyrimidin-2-ylsulfanyl)acetyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH5"
"6YH6",,"X-RAY DIFFRACTION",1.96,37.2,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE a
nd 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH6",29.7,"1.4","1.4","Crystal structure of chimeric carbonic anhydrase XII with 2-(Cyclooctylamino)-3,5,6-trifluorobenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH6"
"6YH7",,"X-RAY DIFFRACTION",2.03,39.39,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH7",30.27,"1.12","1.12","Crystal structure of chimeric carbonic anhydrase XII with 3-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH7"
"6YH8",,"X-RAY DIFFRACTION",2.05,39.9,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH8",29.88,"1.2","1.2","Crystal structure of chimeric carbonic anhydrase XII with 2-[(1S)-1,2,3,4-Tetrahydronapthalen-1-ylamino)-3,5,6-trifluorobenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH8"
"6YH9",,"X-RAY DIFFRACTION",2.01,38.93,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YH9",29.82,"1.55","1.55","Crystal structure of chimeric carbonic anhydrase XII with 2,3,6-trifluoro-5-{[(1R,2S)-2-hydroxy-1,2-diphenylethyl]amino}-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YH9"
"6YHA",,"X-RAY DIFFRACTION",2,38.43,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YHA",30.33,"1.25","1.25","Crystal structure of chimeric carbonic anhydrase XII with 2,3,5,6-Tetrafluoro-4-(propylthio)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YHA"
"6YHB",,"X-RAY DIFFRACTION",2.01,38.74,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YHB",29.65,"1.65","1.65","Crystal structure of chimeric carbonic anhydrase XII with 4-[(4,6-dimethylpyrimidin-2-yl)thio]-2,3,5,6-tetrafluorobenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YHB"
"6YHC",,"X-RAY DIFFRACTION",2.04,39.59,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,"10.1002/open.202100042",,"6YHC",30.21,"1.28","1.28","Crystal structure of chimeric carbonic anhydrase XII with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFKVEFDDSQDKAVLKGGPLDGTYRLTQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDAGKASQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLNECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YHC"
"6YHF",,"SOLUTION NMR",,,,,,,"10.1021/acschemneuro.0c00640",,"6YHF",3.07,,,"Solution NMR Structure of APP TMD","SNKGAIIGLMVGGVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6YHF"
"6YHI",,"SOLUTION NMR",,,,,,,"10.1021/acschemneuro.0c00640",,"6YHI",3.13,,,"Solution NMR Structure of APP G38L mutant TMD","SNKGAIIGLMVGLVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein G38L mutant","1","6YHI"
"6YHO",,"SOLUTION NMR",,,,,,,"10.1021/acschemneuro.0c00640",,"6YHO",3.11,,,"Solution NMR Structure of APP G38P mutant TM","SNKGAIIGLMVGPVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein G38P mutant","1","6YHO"
"6YHP",,"SOLUTION NMR",,,,,,,"10.1021/acschemneuro.0c00640",,"6YHP",3.1,,,"Solution NMR Structure of APP V44M mutant TMD","SNKGAIIGLMVGGVVIATMIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein V44M mutant","1","6YHP"
"6YHR",,"X-RAY DIFFRACTION",2.56,51.91,"VAPOR DIFFUSION, SITTING DROP",6.5,"1M Na Acetate, 0.1 M Cacodylate pH 6.5",277,"10.26508/lsa.202000795",,"6YHR",67.41,"2.2","2.2","Crystal structure of Werner syndrome helicase","MNEGEEDDDKDFLWPAPNEEQVTCLKMYFGHSSFKPVQWKVIHSVLEERRDNVAVMATGYGKSLCFQYPPVYVGKIGLVISPLISLMEDQVLQLKMSNIPACFLGSAQSENVLTDIKLGKYRIVYVTPEYCSGNMGLLQQLEADIGITLIAVDEAHCISEWGHDFRDSFRKLGSLKTALPMVPIVALTATASSSIREDIVRCLNLRNPQITCTGFDRPNLYLEVRRKTGNILQDLQPFLVKTSSHWEFEGPTIIYCPSRKMTQQVTGELRKLNLSCGTYHAGMSFSTRKDIHHRFVRDEIQCVIATIAFGMGINKADIRQVIHYGAPKDMESYYQEIGRAGRDGLQSSCHVLWAPADINLNRHLLTEIRNEKFRLYKLKMMAKMEKYLHSSRCRRQIILSHFEDKQVQKASLGIMGTEKCCDNCRSRLDHCYSMDDSEDTSWDFGPQAFKLLSAVDILGEKFGIGLPILFLRGSNSQRLADQYRRHSLFGTGKDQTESWWKAFSRQLITEGFLVEVSRYNKFMKICALTKKGRNWLHKANTESQSLILQANEELCPKKFLLPSSKTVSSGTKEHCYNQAENLYFQ","Homo sapiens","WRN, RECQ3, RECQL2","Werner syndrome ATP-dependent helicase","1","6YHR"
"6YHX",,"SOLUTION NMR",,,,,,,"10.1021/acschemneuro.0c00640",,"6YHX",3.06,,,"Solution NMR Structure of APP I45T mutant TMD","SNKGAIIGLMVGGVVIATVTVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein I45T mutant","1","6YHX"
"6YI0",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, HANGING DROP",,"20% (v/v) ethylene glycol, 5% (w/v) PEG 3350, 20 mM MgCl2",298,"10.1016/j.bbagen.2021.129968",,"6YI0",68.76,"1.65","1.65","Human histidine triad nucleotide-binding protein 2 (hHINT2) refined to 1.65 A in P41212 space group","MAAAVVLAAGLRAARRAVAATGVRGGQVRGAAGVTDGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","6YI0"
"6YI1",,"X-RAY DIFFRACTION",3.08,60.08,"VAPOR DIFFUSION, HANGING DROP",,"1.6M ammonium sulfate, 0.1M MES pH 6.5, 4% (v/v) 1,4-Dioxane",298,"10.1021/acs.biochem.0c00337",,"6YI1",80.37,"1.92","1.92","Crystal structure of human glutaminyl cyclase in complex with Glu(gamma-hydrazide)-Phe-Ala","GPAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","6YI1"
"6YI8",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, HANGING DROP",,"mixing 0.5 ul of protein solution (13 mg/ml in 50 mM HEPES pH 8.0, 100 mM NaCl, 3% glycerol, 1 mM TCEP and 2 mM roblitinib incubated for 1h on ice) with 0.5 ul of reservoir solution (13.5 % PEG 3350, 0.1 M (NH4)2SO4, 0.1 M NaAc pH 4.25)",277,"10.1021/acs.jmedchem.0c01019",,"6YI8",70.18,"2.13","2.13","HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB","AGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6YI8"
"6YID",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, SITTING DROP",5.75,"32.5% PEG 3350, 0.1M sodium citrate, pH 5.9, 0.2M MgCl2, 0.1M bis-tris, pH 5.75",293.15,"10.1021/acs.jmedchem.0c00873",,"6YID",129.03,"2.7","2.7","Crystal structure of ULK2 in complex with SBI-0206965","GGGSMEVVGDFEYSKRDLVGHGAFAVVFRGRHRQKTDWEVAIKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAADLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPSIPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQGPV","Homo sapiens","ULK2, KIAA0623","Serine/threonine-protein kinase ULK2","1","6YID"
"6YIJ",,"X-RAY DIFFRACTION",2.95,58.37,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% ethylene glycol
21% PEG6K
0.1M tris pH 8.3
0.125M lithium chloride",277,,,"6YIJ",102.4,"2.2","2.2","Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREBBP","1","6YIJ"
"6YIK",,"X-RAY DIFFRACTION",3.42,64.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"21% PEG3350
15% ethylene glycol
0.25M sodium formate",277,,,"6YIK",44.74,"1.7","1.7","Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREBBP","1","6YIK"
"6YIL",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium acetate",277,,,"6YIL",14.64,"1.22","1.22","Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREBBP","1","6YIL"
"6YIM",,"X-RAY DIFFRACTION",2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.2M sodium fluoride",277,,,"6YIM",14.65,"1.23","1.23","Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREBBP","1","6YIM"
"6YIN",,"X-RAY DIFFRACTION",1.96,37.36,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG1000
0.1M MIB pH 7.0",277,,,"6YIN",15.52,"1.53","1.53","Crystal structure of the first bromodomain of BRD4 in complex with a benzo-diazepine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6YIN"
"6YIP",,"X-RAY DIFFRACTION",2.46,50.05,"VAPOR DIFFUSION",5.6,"20% (w/v) PEG 4,000, 20 % (v/v) 2-propanol, 100 mM sodium citrate, pH 5.6.",291,"10.1083/jcb.201910059",,"6YIP",18.21,"1.43","1.43","Structure of MKLP2 coiled coil","GPMVEQMQQREQWCSEHLDTQKELLEEMYEEKLNILKESLTSFYQEEIQERDEKIEELEALLQEARQQSVAHQQS","Homo sapiens","KIF20A, MKLP2, RAB6KIFL","Kinesin-like protein KIF20A","1","6YIP"
"6YJ3",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 MM TRIS-HCL, 1.6 M SODIUM CITRATE",290,"10.1002/cplu.202000574",,"6YJ3",30.42,"1.55","1.55","Metala-Carborane di-propyl-sulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YJ3"
"6YJG",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl pH 8.5, 1.5 M Ammonium phosphate dibasic",293.15,"10.1016/j.molcel.2021.08.024",,"6YJG",32.02,"3.28","3.28","Crystal structure of MINDY1 mutant-Y114F","GPLGSPEFPGRLEMEPDFFCVKWIPWKGEQTPIITQSTNGPCPLLAIMNILFLQWKVKLPPQKEVITSDELMAHLGNCLLSIKPQEKSEGLQLNFQQNVDDAMTVLPKLATGLDVNVRFTGVSDFEYTPECSVFDLLGIPLYHGWLVDPQSPEAVRAVGKLSYNQLVERIITCKHSSDTNLVTEGLIAEQFLETTAAQLTYHGLCELTAAAKEGELSVFFRNNHFSTMTKHKSHLYLLVTDQGFLQEEQVVWESLHNVDGDSCFCDSDFHLSHSLGKGPGAEGGSGSPE","Homo sapiens","MINDY1, FAM63A, KIAA1390","Ubiquitin carboxyl-terminal hydrolase MINDY1","1","6YJG"
"6YJM",,"X-RAY DIFFRACTION",1.89,34.85,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH 7.0, 300% v/v Jeffamine ED-2001 pH 7.0",293,"10.1021/acs.jmedchem.0c02008",,"6YJM",50.59,"2.25","2.25","Crystal Structure of the Catalytic Domain of ADAMTS-5 in Complex with the Inhibitor GLPG1972","SISRARQVELLLVADASMARKYGRGLQHYLLTLASIANRLYSHASIENHIRLAVVKVVVLGDKDKSLEVSKNAATTLKNFCKWQHQHNQLGDDHEEHYDAAILFTREDLCGHHSCDTLGMADVGTICSPERSCAVIEDDGLHAAFTVAHEIGHLLGLSHDDSKFCEETFGSTEDKRLMSSILTSIDASKPWSKCTSATITEFLDDGHGNCLLDLPRKQILVPR","Homo sapiens","ADAMTS5, ADAMTS11, ADMP2","A disintegrin and metalloproteinase with thrombospondin motifs 5","1","6YJM"
"6YJQ",,"X-RAY DIFFRACTION",1.55,20.52,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 8.0, 
0.3 M Li2SO4, 
30 % (w/v) PEG 3350, 
10 % (v/v) ethylene glycol",293,,,"6YJQ",119.67,"1.9","1.9","Crystal structure of unliganded MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain with a Lys329-Ile345 loop truncation","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMGGGGVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A,Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","MGAT5, GGNT5"
"6YJR",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Citrate pH 5.0
16% w/v PEG6000",293,,,"6YJR",122.29,"2.198","2.198","Crystal structure of unliganded MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain.","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMKKVVGNRSGCPTVGDRIVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJR"
"6YJS",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 8.0, 
0.3 M Li2SO4, 
30 % (w/v) PEG 3350, 
10 % (v/v) ethylene glycol
wXHPcQHrME",293,,,"6YJS",121.9,"1.6","1.6","Crystal structure of MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain with a Lys329-Ile345 loop truncation, in complex with biantennary pentasaccharide M592","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMGGGGVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJS"
"6YJT",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 8.0, 
0.3 M Li2SO4, 
30 % (w/v) PEG 3350, 
10 % (v/v) ethylene glycol",293,,,"6YJT",120.32,"1.7","1.7","Crystal structure of MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain with a Lys329-Ile345 loop truncation, in complex with UDP","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMGGGGVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJT"
"6YJU",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 8.0, 
0.3 M Li2SO4, 
30 % (w/v) PEG 3350, 
10 % (v/v) ethylene glycol",293,,,"6YJU",120.5,"1.96","1.96","Crystal structure of MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain with a Lys329-Ile345 loop truncation, in complex with UDP and biantennary pentasaccharide M592","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMGGGGVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJU"
"6YJV",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 8.0, 
0.3 M Li2SO4, 
30 % (w/v) PEG 3350, 
10 % (v/v) ethylene glycol",293,,,"6YJV",120.92,"1.7","1.7","Crystal structure of unliganded MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase V) luminal domain with a Lys329-Ile345 loop truncation, in complex with UDP-2-deoxy-2-fluoroglucose and biantennary pentasaccharide M592","SLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMGGGGVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","6YJV"
"6YJY",,"X-RAY DIFFRACTION",3.05,59.65,"VAPOR DIFFUSION, HANGING DROP",,"1.6M ammonium sulfate, 0.1M MES pH 6.5, 4% (v/v) 1,4-Dioxane",298,"10.1021/acs.biochem.0c00337",,"6YJY",78.41,"1.67","1.67","Crystal structure of human glutaminyl cyclase in complex with neurotensin 1-5","GPAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","6YJY"
"6YKC",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/cplu.202000574",,"6YKC",30.3,"1.2","1.2","Metala-Carborane di-ethyl-sulfonamide (trans isomer) in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YKC"
"6YKD",,"X-RAY DIFFRACTION",3.02,59.25,"COUNTER-DIFFUSION",6.3,"0.1 M imidazole pH 6.3
1 M sodium acetate",277,"10.1002/minf.202000109",,"6YKD",38.27,"1.86","1.86","Human Pim-1 kinase in complex with an inhibitor identified by virtual screening","MGSSHHHHHHSQDPNSMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6YKD"
"6YKE",,"X-RAY DIFFRACTION",1.95,36.92,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YKE",43.1,"1.52","1.52","Crystal structure of YTHDC1 with compound DHU_DC1_038","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YKE"
"6YKG",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, HANGING DROP",7,"1.4 M sodium malonate pH 7.0, 0.1 M BIS-TRIS",293,"10.1021/acs.jmedchem.1c00114",,"6YKG",72.93,"3.12","3.12","Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease","MHHHHHHSSGVDLGTENLYFQSMSKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLAKSANMPAQLFFKTEDGGKYPVLFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFLQWIQGSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","Phosphatidylinositol 3-kinase catalytic subunit type 3","1","6YKG"
"6YKH",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/cplu.202000574",,"6YKH",29.79,"1.1","1.1","Metala-Carborane di-ethyl-sulfonamide (cis isomer) in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YKH"
"6YKI",,"X-RAY DIFFRACTION",1.97,37.46,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YKI",43.3,"1.3","1.3","Crystal structure of YTHDC1 with compound DHU_DC1_092","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YKI"
"6YKJ",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YKJ",42.75,"1.6","1.6","Crystal structure of YTHDC1 with compound DHU_DC1_125","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YKJ"
"6YKY",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, SITTING DROP",6,"100 mM Bis-Tris (pH 6), 100 mM Lithium acetate, 18%v/v Sokalan CP42, 3%vv Glycerol",277,"10.1016/j.bmcl.2020.127551",,"6YKY",146.33,"2.52","2.52","Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors","MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI","Homo sapiens","MAPK6, ERK3, PRKM6","Mitogen-activated protein kinase 6","1","6YKY"
"6YKZ",,"X-RAY DIFFRACTION",2,38.43,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YKZ",43.03,"1.2","1.2","Crystal structure of YTHDC1 with compound DHU_DC1_234","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YKZ"
"6YL0",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YL0",43.11,"1.2","1.2","Crystal structure of YTHDC1 with compound T_96","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YL0"
"6YL1",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, HANGING DROP",,"Protein: 8 mg/mL in pH 6.2 phosphate buffer
Resovoir: 8-12% PEG3350, HEPES 0.1 M (pH 7.5-8.5)
1:1",293,"10.1002/cbic.202000457",,"6YL1",34.61,"1.66","1.66","Cdk2(F80C) with Covalent Adduct TK37 at F80C","GPLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVCEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGAKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6YL1"
"6YL4",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein solution (5-10 mg/mL, 50 mM NaCl, 50 mM sodium phosphate, 10% (v/v) glycerol (98%), 2 mM DTT at pH 7.4) was mixed at differnt ratios (2/1, 1/1, 1/2) with precipitant solution (23%-28% (w/v) polyethenglycol (PEG) 6000, 70 mM ammonium acetat, 200 mM magnesium acetat, 100 mM sodium cacodylate at pH 6.1-6.5)",277,"10.1021/acs.jmedchem.0c00561","OWW","6YL4",40.17,"2.001","2.001","Soluble epoxide hydrolase in complex with 3-((R)-3-(1-hydroxyureido)but-1-yn-1-yl)-N-((S)-3-phenyl-3-(4-trifluoromethoxy)phenyl)propyl)benzamide","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6YL4"
"6YL6",,"X-RAY DIFFRACTION",1.96,37.21,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution: 8 mg/mL, 100 mM phosphate buffer (pH6.2)
Reservoir solution: 8-12% PEG3350, HEPES (0.1 M pH 7.5 - 8.5)",298,"10.1002/cbic.202000457",,"6YL6",34.31,"1.7","1.7","Cdk2(F80C)","GPLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVCEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGAKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6YL6"
"6YL8",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YL8",43.34,"1.5","1.5","Crystal structure of YTHDC1 with compound DHU_DC1_011","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YL8"
"6YL9",,"X-RAY DIFFRACTION",2.01,38.65,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YL9",42.93,"1.5","1.5","Crystal structure of YTHDC1 with compound DHU_DC1_085","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YL9"
"6YLC",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, SITTING DROP",6,"100 mM Bis-Tris (pH 6), 100 mM Lithium acetate, 18%v/v Sokalan CP42, 3%v/v Glycerol",277,"10.1016/j.bmcl.2020.127551",,"6YLC",146.45,"2.43","2.43","Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors","MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI","Homo sapiens","MAPK6, ERK3, PRKM6","Mitogen-activated protein kinase 6","1","6YLC"
"6YLK",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution: 8 mg/mL in 100 mM pH 6.2 phosphate buffer
Reservoir solution: 8-12% PEG3350, 100 mM HEPES pH 7.5-8.15",298,"10.1002/cbic.202000457",,"6YLK",34.59,"1.65","1.65","Cdk2(F80C) with Covalent Adduct TK22 at F80C","GPLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVCEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGAKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6YLK"
"6YLL",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.3 M CaCl2, 6% v/v PEG1500, 0.1 M Mes pH 6.5",294,"10.1016/j.bmcl.2020.127551",,"6YLL",72.73,"2.89","2.89","Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors","MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI","Homo sapiens","MAPK6, ERK3, PRKM6","Mitogen-activated protein kinase 6","1","6YLL"
"6YM2",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YM2",43.32,"1.7","1.7","Crystal structure of YTHDC1 with compound ADO_AC_25","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YM2"
"6YM3",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, magnesium formate, glycerol",277,"10.1021/acs.jmedchem.1c01245",,"6YM3",91.7,"2.05","2.05","Crystal structure of Compound 1 with PIP4K2A","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDGEEEGESDGTHPVGTPPDSPGNTLNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PIP5K2, PIP5K2A, PI5P4KA","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha","1","6YM3"
"6YM4",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, SITTING DROP",,"16% PEG 3350, 200mM Magnesium formate, 25% glycerol",277,"10.1021/acs.jmedchem.1c01245",,"6YM4",91.82,"1.95","1.95","Crystal structure of BAY-297 with PIP4K2A","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDGEEEGESDGTHPVGTPPDSPGNTLNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PIP5K2, PIP5K2A, PI5P4KA","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha","1","6YM4"
"6YM5",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3350, 200mM Magnesium formate, 25% gylcerol",277,"10.1021/acs.jmedchem.1c01245",,"6YM5",91.7,"2.5","2.5","Crystal structure of BAY-091 with PIP4K2A","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDGEEEGESDGTHPVGTPPDSPGNTLNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PIP5K2, PIP5K2A, PI5P4KA","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha","1","6YM5"
"6YM6",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YM6",43.27,"1.2","1.2","Crystal structure of YTHDC1 with compound ADO_AC_89","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YM6"
"6YM8",,"X-RAY DIFFRACTION",1.99,38.2,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YM8",42.78,"1.5","1.5","Crystal structure of YTHDC1 with compound YLI_DC1_002","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YM8"
"6YMA","2.5","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1038/s42003-020-01155-1",,"6YMA",29.65,"2.5, 2.5","2.5","MicroED structure of acetazolamide-bound human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6YMA"
"6YMB","2.5","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1038/s42003-020-01155-1",,"6YMB",29.35,"2.5, 2.5","2.5","MicroED structure of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","6YMB"
"6YN8",,"X-RAY DIFFRACTION",3.26,62.26,"VAPOR DIFFUSION, SITTING DROP",6.9,"1.8 M Sodium/Potassium phosphate pH 6.9
10mg/ml protein  in 25mM HEPES pH7.5, 50mM NaCl, 1mM TCEP.  Mixed with compound (final concentration at 1mM)",294,,,"6YN8",44.5,"3.052","3.052","Human MALT1(334-719) in complex with a tetrazole containing compound","GPGTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHR","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","6YN8"
"6YN9",,"X-RAY DIFFRACTION",2.03,39.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG MME 2000, 0.1M MES pH6.5
Protein at 12 mg/ml in 25mM HEPES pH 7.5, 50mM NaCl, 1mM TCEP, 100 mM Mg formate added prior to crystallization",298,,,"6YN9",46.09,"2.558","2.558","MALT1(329-728) in complex with a sulfonamide containing compound","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","6YN9"
"6YND",,"X-RAY DIFFRACTION",2.48,50.34,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M MORPHEUS Amino acids solution (DL-Glutamic acid; DL-Alanine; Glycine; DL-Lysine; DL-Serine), 0.1M MORPHEUS Buffer System 3 (Tris (base); BICINE), 30% v/v MORPHEUS Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000)",291,"10.12688/wellcomeopenres.15893.2",,"6YND",295.39,"1.525","1.525","GAPDH purified from the supernatant of HEK293F cells: crystal form 1 of 4.","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6YND"
"6YNE",,"X-RAY DIFFRACTION",2.51,50.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS condition F9: 0.12M MORPHEUS monosaccharides solution , 0.1M MORPHEUS Buffer System 3, 30% v/v MORPHEUS Precipitant Mix 1",291,"10.12688/wellcomeopenres.15893.2",,"6YNE",150.36,"1.853","1.853","GAPDH purified from the supernatant of HEK293F cells: crystal form 2 of 4.","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6YNE"
"6YNF",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"Condition F4 of MORPHEUS screen. 0.12M  monosaccharides solution, 0.1M MORPHEUS Buffer System 3, 30% v/v MORPHEUS Precipitant Mix 1",291,"10.12688/wellcomeopenres.15893.2",,"6YNF",291.59,"2.394","2.394","GAPDH purified from the supernatant of HEK293F cells: crystal form 3 of 4.","GKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6YNF"
"6YNH",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"Condition F9 of the MORPHEUS crystallisation screen, 0.12M  MORPHEUS monosaccharides solution, 0.1M MORPHEUS Buffer System 3, 30% v/v MORPHEUS Precipitant Mix 1",291,"10.12688/wellcomeopenres.15893.2",,"6YNH",146.55,"2.621","2.621","GAPDH purified from the supernatant of HEK293F cells: crystal form 4 of 4","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6YNH"
"6YNI",,"X-RAY DIFFRACTION",1.94,36.71,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNI",43.37,"1.36","1.36","Crystal structure of YTHDC1 with compound DHU_DC1_036","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNI"
"6YNJ",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNJ",43.38,"1.5","1.5","Crystal structure of YTHDC1 with compound DHU_DC1_046","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNJ"
"6YNK",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNK",43.28,"1.3","1.3","Crystal structure of YTHDC1 with compound DHU_DC1_068","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNK"
"6YNL",,"X-RAY DIFFRACTION",1.97,37.48,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNL",43.21,"1.5","1.5","Crystal structure of YTHDC1 with compound DHU_DC1_078","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNL"
"6YNM",,"X-RAY DIFFRACTION",1.96,37.21,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNM",43.49,"1.5","1.5","Crystal structure of YTHDC1 with compound DHU_DC1_096","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNM"
"6YNN",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6YNN",43.2,"1.2","1.2","Crystal structure of YTHDC1 with compound DHU_DC1_135","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNN"
"6YNO",,"X-RAY DIFFRACTION",2,38.36,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6YNO",42.92,"1.4","1.4","Crystal structure of YTHDC1 with compound DHU_DC1_139","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNO"
"6YNP",,"X-RAY DIFFRACTION",1.99,38.16,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YNP",42.91,"1.1","1.1","Crystal structure of YTHDC1 with compound T96C1","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YNP"
"6YO2",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YO2",29.52,"1.2","1.2","Meta-Carborane propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YO2"
"6YO4",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YO4",29.52,"1.7","1.7","Para-Carborane propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YO4"
"6YO7",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YO7",29.64,"1.17","1.17","Ortho-Carborane di-propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YO7"
"6YOI",,"X-RAY DIFFRACTION",2.06,40.34,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YOI",29.64,"1.2","1.2","Meta-Carborane di-propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YOI"
"6YOJ",,"X-RAY DIFFRACTION",2.06,40.28,"VAPOR DIFFUSION, HANGING DROP",,"16% PEG 3350, 0.1 M TRIS, pH 8.6",293,"10.1016/j.chembiol.2021.01.003",,"6YOJ",32.8,"1.361","1.361","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 6-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YOJ"
"6YOK",,"X-RAY DIFFRACTION",2.07,40.56,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YOK",29.64,"1.25","1.25","Para-Carborane di-propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YOK"
"6YOL",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1002/chem.202002809",,"6YOL",29.51,"1.15","1.15","Meta-Nidocarborane propyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YOL"
"6YOM",,"X-RAY DIFFRACTION",2.25,45.49,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 15% (w/v) PEG 3350, 0.05 M MgCl2",293,"10.1038/s41467-020-16983-2",,"6YOM",123.7,"3.25","3.25","Crystal structure of tetrameric human D137N-SAMHD1 (residues 109-626) with XTP, dATP, dCMPNPP, Mn and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIINTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6YOM"
"6YOQ",,"X-RAY DIFFRACTION",1.96,37.13,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,,,"6YOQ",43.15,"1.3","1.3","Crystal structure of YTHDC1 with compound VVR_DC1_002","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6YOQ"
"6YPE",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, SITTING DROP",6.5,"15% (v/v) glycerol, 25.5% (w/v) polyethylene glycol (PEG) 8000, 0.17M ammonium sulphate, 0.085 M sodium cacodylate.",293,"10.1126/science.abb4853",,"6YPE",45.83,"1.45","1.45","Crystal structure of the human neuronal pentraxin 1 (NP1) pentraxin (PTX) domain.","GDKFQLTFPLRTNYMYAKVKKSLPEMYAFTVCMWLKSSATPGVGTPFSYAVPGQANELVLIEWGNNPMEILINDKVAKLPFVINDGKWHHICVTWTTRDGVWEAYQDGTQGGSGENLAPYHPIKPQGVLVLGQEQDTLGGGFDATQAFVGELAHFNIWDRKLTPGEVYNLATCSTKALSGNVIAWAESHIEIYGGATKWTFEACR","Homo sapiens","NPTX1","Neuronal pentraxin-1","1","6YPE"
"6YPG",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"112.5mM Mes, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1021/acs.jmedchem.0c01173",,"6YPG",39.45,"1.51","1.51","Crystal Structure of CK2alpha with Compound 2 bound to second crystal form","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YPG"
"6YPH",,"X-RAY DIFFRACTION",2.28,46.02,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M HEPES 7.5 pH, 10 %w/v PEG 8K, 8 %v/v Ethelyene glycol",298,"10.1021/acs.jmedchem.0c01173",,"6YPH",81.61,"1.67","1.67","Crystal Structure of CK2alpha with Compound 2 bound","GSMDISGSGSGSGSSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YPH"
"6YPJ",,"X-RAY DIFFRACTION",2.04,39.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"112.5mM Mes, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1021/acs.jmedchem.0c01173",,"6YPJ",39.39,"1.64","1.64","Crystal Structure of CK2alpha with Compound 1 bound","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YPJ"
"6YPK",,"X-RAY DIFFRACTION",1.99,38.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"112.5mM Mes, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1021/acs.jmedchem.0c01173",,"6YPK",39.47,"1.79","1.79","Crystal Structure of CK2alpha with GTP bound","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YPK"
"6YPN",,"X-RAY DIFFRACTION",1.94,36.58,"VAPOR DIFFUSION, SITTING DROP",6.2,"20 %v/v PEGSM, 10 %v/v Glycerol, 0.2 M Na Form, 0.1 M Na-Phosphate",298,"10.1021/acs.jmedchem.0c01173",,"6YPN",40.46,"1.58","1.58","Crystal Structure of CK2alpha with 2 molecules of ADP bound","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YPN"
"6YPR",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8 M Na/K Tartrate, 0.1 M HEPES 7.5",281,"10.1016/j.bbagen.2021.129968",,"6YPR",17.46,"1.26","1.26","Human histidine triad nucleotide-binding protein 2 (hHINT2) refined to 1.26 A in H32 space group","MAAAVVLAAGLRAARRAVAATGVRGGQVRGAAGVTDGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","6YPR"
"6YPW",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, HANGING DROP",8,"1.2 M sodium citrate, 50 mM Tris pH 8.0",293,"10.1021/acs.jmedchem.1c00756",,"6YPW",29.83,"1.1","1.1","Crystal structure for the complex of human carbonic anhydrase II and 4-((1-(2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methoxy)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YPW"
"6YPX",,"X-RAY DIFFRACTION",3.99,69.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M sodium citrate, 0.1 M sodium cacodylate, 30 % 2-propanol",281,"10.1016/j.bbagen.2021.129968",,"6YPX",69.24,"2.11","2.11","Human histidine triad nucleotide-binding protein 2 (hHINT2) refined to 2.11 A in C2221 space group","MAAAVVLAAGLRAARRAVAATGVRGGQVRGAAGVTDGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","6YPX"
"6YQ1",,"X-RAY DIFFRACTION",2.79,55.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, 0.2 M Na acetate",293,"10.1016/j.chembiol.2021.01.003",,"6YQ1",131.42,"1.784","1.784","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-(3-{[2-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-pyridin-2-yl)-methanesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YQ1"
"6YQD",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, HANGING DROP",8.5,"8 % w/v PEG8000, 0.1 M Tris-HCl",281,"10.1016/j.bbagen.2021.129968",,"6YQD",34.41,"1.407","1.407","Human histidine triad nucleotide-binding protein 2 (hHINT2) refined to 1.41 A in P212121 space group","MAAAVVLAAGLRAARRAVAATGVRGGQVRGAAGVTDGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","6YQD"
"6YQM",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, HANGING DROP",5.7,"16 % (w/v) PEG 4000, 0.1 M sodium cacodylate",281,"10.1016/j.bbagen.2021.129968",,"6YQM",28.1,"1.02","1.02","Human histidine triad nucleotide-binding protein 1 (hHINT1) complexed with dGMP and refined to 1.02 A","MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6YQM"
"6YQN",,"X-RAY DIFFRACTION",2.14,42.53,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.5 mM TCEP, and 5% glycerol. 50 mM stock solution of TW12 in DMSO added to give a final inhibitor concentration 1.5 mM.
Reservoir buffer: 24% PEG 3350, 0.1 M sodium formate, 15% ethylene glycol and 0.1 M bis-Tris-propane pH 7.3.
Ratio protein/reservoir solution = 2:1",277,"10.1002/ijc.33137","P8T","6YQN",15.83,"1.05","1.05","Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW9","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6YQN"
"6YQO",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.5 mM TCEP, and 5% glycerol. 50 mM stock solution of TW12 in DMSO added to give a final inhibitor concentration 1.5 mM.
Reservoir buffer: 24% PEG 3350, 0.1 M sodium formate, 15% ethylene glycol and 0.1 M bis-Tris-propane pH 7.3.
Ratio protein/reservoir solution = 2:1",277,"10.1002/ijc.33137","P8Q","6YQO",15.95,"1.07","1.07","Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW12","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6YQO"
"6YQP",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.5 mM TCEP, and 5% glycerol. 50 mM stock solution of TW22 in DMSO added to give a final inhibitor concentration 1.5 mM.
Reservoir buffer: 24% PEG 3350, 0.2 M sodium formate, 15 % ethylene glycol and 0.1 M bis-Tris-propane pH 7.9",277,"10.1002/ijc.33137","P8N","6YQP",15.86,"1.25","1.25","Crystal structure of the first bromodomain of human BRD4 in complex with the dual inhibitor TW22","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6YQP"
"6YQR",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, SITTING DROP",,"0.10M  morpheus buffer 1 (1M pH 6.5), 30.00%   morpheus EDO_P8K (60%)   0.10M   Morpheus Amino Acids (1M)",277,"10.1021/acs.jmedchem.0c00075",,"6YQR",12.53,"1.684","1.684","BRD9 with Biphenyl-methylamino-dimethylpyridazinone","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6YQR"
"6YQS",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",,"0.03M NaF, 0.03M NaI, 0.03M NaBr, 0.10M  morpheus buffer 3 (1M pH 8.5), 37.5%  morpheus MPD_P1K_3350",277,"10.1021/acs.jmedchem.0c00075",,"6YQS",12.56,"1.683","1.683","BRD9 with methylpiperazinyl-benzyl-amino-dimethylpyridazinone","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6YQS"
"6YQT",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1039/d0cc02857f",,"6YQT",29.89,"1.5","1.5","CRYSTAL STRUCTURE OF HUMAN CA II IN COMPLEX WITH A SULFONAMIDE DERIVATIVE OF 2-MERCAPTOBENZOXAZOLE","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YQT"
"6YQU",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1039/d0cc02857f",,"6YQU",29.75,"1.478","1.478","CRYSTAL STRUCTURE OF HUMAN CA II IN COMPLEX WITH 2-MERCAPTOBENZOXAZOLE","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YQU"
"6YQW",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, SITTING DROP",,"0.1M morpheus buffer 3, pH 8.5, 30% morpheus_EDO_p8K, 0.1M morpheus alcohol",277,"10.1021/acs.jmedchem.0c00075",,"6YQW",12.4,"1.5","1.5","BRD9 with 4-chloro-2-methyl-methylamino-pyridazinone","GAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6YQW"
"6YQZ",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",,"20%w/v PEG 3350, 0.2M sodium sulphate,0.1M bis-tris-propane (pH 6.5)",298,"10.1021/acs.jmedchem.0c00075",,"6YQZ",15.47,"1.39","1.39","N-terminal domain of BRD4 with biphenyl-methyamino-dimethylpyridazinone","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6YQZ"
"6YR9",,"X-RAY DIFFRACTION",2.67,53.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, 0.2 M Na acetate",294,"10.1016/j.chembiol.2021.01.003",,"6YR9",131.23,"1.925","1.925","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-(2-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-phenyl)-methanesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YR9"
"6YRI",,"X-RAY DIFFRACTION",2.07,40.6,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",293,"10.1039/d0cc05172a",,"6YRI",29.91,"1.6","1.6","THE CRYSTAL STRUCTURE OF THE COMPLEX OF HCAII WITH CAFFEIC ACID","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YRI"
"6YS4",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM amino acids mixture,
0.1 M Gly-Gly / AMPD buffer,
50% v/v of precipitant mix (25% w/v PEG 4000 and 40% w/v 1,2,6-Hexanetriol)",277,"10.1016/j.str.2022.02.005",,"6YS4",74.36,"2.11","2.11","Structure of the Homo sapiens SAS-6 coiled-coil domain","GPSQELTNEKEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRMSELEAANKDLTERKYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHE","Homo sapiens","SASS6, SAS6","Spindle assembly abnormal protein 6 homolog","1","6YS4"
"6YSC",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, SITTING DROP",7,"15% (w/v) PEG4000, 0.1M HEPES",294,"10.1038/s41467-020-18477-7",,"6YSC",55.51,"2.05","2.05","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPCRDELTKNQVSLWCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6YSC"
,,,,,,,,,,,,,,,,"DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDKLTKNQVSLSCAVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGGGSHHHHHHHHC","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","2","6YSC"
"6YSK",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium sulphate
0.1 M Sodium citrate, pH4.2",300,"10.1021/acs.jmedchem.0c00660","PJK","6YSK",45.04,"1.21","1.21","1-phenylpyrroles and 1-enylpyrrolidines as inhibitors of Notum","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YSK"
"6YT2",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG4000, lithium sulphate, ADA buffer",277,"10.1002/cmdc.202000264","PJW","6YT2",120.4,"1.8","1.8","Crystal Structure of human monoamine oxidase B in complex with Diphenylene iodonium (DPI)","SNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6YT2"
"6YT6",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION, HANGING DROP",9,"16-20 % PEG 3350, 0.1 M TRIS, pH 9.0",294,"10.1016/j.chembiol.2021.01.003",,"6YT6",65.58,"1.537","1.537","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-pyrimidin-4-ylamino]-methyl}-pyridin-2-yl)-methanesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YT6"
"6YTA",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, SITTING DROP",8,"14% PEG 6k, 0.1M bicine",277,"10.1021/acs.jmedchem.0c00898","IYZ","6YTA",39.95,"2.3","2.3","CLK1 bound with imidazopyridazine (Cpd 1)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6YTA"
"6YTB",,"X-RAY DIFFRACTION",2.57,52.12,"VAPOR DIFFUSION, SITTING DROP",,"20% (w/v) PEG3350, 0.2M potassium formate",294,"10.1038/s41467-020-18477-7",,"6YTB",56.81,"1.65","1.65","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLWCLVEGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGGGSHHHHHHHH","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6YTB"
,,,,,,,,,,,,,,,,"DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDKLTKNQVSLSCAVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGGGSHHHHHHHH","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","2","6YTB"
"6YTD",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION, SITTING DROP",7,"17% PEG 3350, 0,2M Na malonate",277,"10.1021/acs.jmedchem.0c00898","EAE","6YTD",39.8,"2","2","CLK1 V324A mutant bound with benzothiazole Tg003 (Cpd 2)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVADFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6YTD"
"6YTE",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, SITTING DROP",9,"26% PEG 6k, 0.1M bicine",277,"10.1021/acs.jmedchem.0c00898","EAE","6YTE",39.83,"2.3","2.3","CLK1 bound with benzothiazole Tg003 (Cpd 2)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6YTE"
"6YTG",,"X-RAY DIFFRACTION",2.54,51.59,"VAPOR DIFFUSION, SITTING DROP",8,"17% PEG 6k, 0.1M bicine",277,"10.1021/acs.jmedchem.0c00898","KHC","6YTG",40.31,"1.95","1.95","CLK1 bound with beta-carboline KH-CARB13 (Cpd 3)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6YTG"
"6YTI",,"X-RAY DIFFRACTION",2.57,52.11,"VAPOR DIFFUSION, SITTING DROP",9.3,"29% PEG 6k, 0.1M bicine",277,"10.1021/acs.jmedchem.0c00898",,"6YTI",40.21,"2.4","2.4","CLK1 bound with ETH1610 (Cpd 17)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6YTI"
"6YTK","4.07","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTK",701.87,"4.07",,"Cryo-EM structure of a dimer of decameric human CALHM4 in the absence of Ca2+","MCPTLNNIVSSLQRNGIFINSLIAALTIGGQQLFSSSTFSCPCQVGKNFYYGSAFLVIPALILLVAGFALRSQMWTITGEYCCSCAPPYRRISPLECKLACLRFFSITGRAVIAPLTWLAVTLLTGTYYECAASEFASVDHYPMFDNVSASKREEILAGFPCCRSAPSDVILVRDEIALLHRYQSQMLGWILITLATIAALVSCCVAKCCSPLTSLQHCYWTSHLQNERELFEQAAEQHSRLLMMHRIKKLFGFIPGSEDVKHIRIPSCQDWKDISVPTLLCMGDDLQGHYSFLGNRVDEDNEEDRSRGIELKP","Homo sapiens","CALHM4, C6orf78, FAM26D, UNQ6481/PRO21277","Calcium homeostasis modulator protein 4","1","6YTK"
"6YTL","3.82","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTL",772.06,"3.82",,"Cryo-EM structure of a dimer of undecameric human CALHM4 in the absence of Ca2+","MCPTLNNIVSSLQRNGIFINSLIAALTIGGQQLFSSSTFSCPCQVGKNFYYGSAFLVIPALILLVAGFALRSQMWTITGEYCCSCAPPYRRISPLECKLACLRFFSITGRAVIAPLTWLAVTLLTGTYYECAASEFASVDHYPMFDNVSASKREEILAGFPCCRSAPSDVILVRDEIALLHRYQSQMLGWILITLATIAALVSCCVAKCCSPLTSLQHCYWTSHLQNERELFEQAAEQHSRLLMMHRIKKLFGFIPGSEDVKHIRIPSCQDWKDISVPTLLCMGDDLQGHYSFLGNRVDEDNEEDRSRGIELKP","Homo sapiens","CALHM4, C6orf78, FAM26D, UNQ6481/PRO21277","Calcium homeostasis modulator protein 4","1","6YTL"
"6YTM",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",8.75,"0.1 M Tris pH 8.75, 55% pentaerythiol propoxylate (5/4 PO/OH)",293,"10.1039/d0ob01165g","PMW","6YTM",28.35,"1.56","1.56","Human Brd2(BD2) L383V mutant in complex with ET-JQ1-OMe","SMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGVHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6YTM"
"6YTO","4.24","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTO",701.87,"4.24",,"Cryo-EM structure of a dimer of decameric human CALHM4 in the presence of Ca2+","MCPTLNNIVSSLQRNGIFINSLIAALTIGGQQLFSSSTFSCPCQVGKNFYYGSAFLVIPALILLVAGFALRSQMWTITGEYCCSCAPPYRRISPLECKLACLRFFSITGRAVIAPLTWLAVTLLTGTYYECAASEFASVDHYPMFDNVSASKREEILAGFPCCRSAPSDVILVRDEIALLHRYQSQMLGWILITLATIAALVSCCVAKCCSPLTSLQHCYWTSHLQNERELFEQAAEQHSRLLMMHRIKKLFGFIPGSEDVKHIRIPSCQDWKDISVPTLLCMGDDLQGHYSFLGNRVDEDNEEDRSRGIELKP","Homo sapiens","CALHM4, C6orf78, FAM26D, UNQ6481/PRO21277","Calcium homeostasis modulator protein 4","1","6YTO"
"6YTP",,"X-RAY DIFFRACTION",3.2,61.61,"VAPOR DIFFUSION, HANGING DROP",4.6,"1 M (NH3)2SO4, 0.17 M guanidine HCl, 0.02 M KCl, 0.1 M sodium acetate pH 4.6",291,"10.1002/chem.202102359",,"6YTP",115.81,"1.7","1.7","Structure of recombinant human beta-glucocerebrosidase in complex with azide tagged cyclophellitol epoxide inhibitor","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6YTP"
"6YTQ","4.02","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTQ",772.06,"4.02",,"Cryo-EM structure of a dimer of undecameric human CALHM4 in the presence of Ca2+","MCPTLNNIVSSLQRNGIFINSLIAALTIGGQQLFSSSTFSCPCQVGKNFYYGSAFLVIPALILLVAGFALRSQMWTITGEYCCSCAPPYRRISPLECKLACLRFFSITGRAVIAPLTWLAVTLLTGTYYECAASEFASVDHYPMFDNVSASKREEILAGFPCCRSAPSDVILVRDEIALLHRYQSQMLGWILITLATIAALVSCCVAKCCSPLTSLQHCYWTSHLQNERELFEQAAEQHSRLLMMHRIKKLFGFIPGSEDVKHIRIPSCQDWKDISVPTLLCMGDDLQGHYSFLGNRVDEDNEEDRSRGIELKP","Homo sapiens","CALHM4, C6orf78, FAM26D, UNQ6481/PRO21277","Calcium homeostasis modulator protein 4","1","6YTQ"
"6YTR",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Na2SO4, 14% (v/v) PEG3350, 0.25 M HEPES pH 7.0",291,"10.1002/chem.202102359",,"6YTR",117.01,"1.7","1.7","Structure of recombinant human beta-glucocerebrosidase in complex with cyclophellitol aziridine inhibitor","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","Lysosomal acid glucosylceramidase","1","6YTR"
"6YTU",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"45% MPD, 0.1 M Tris-HCl (pH 7.5)",281,"10.1111/febs.15618",,"6YTU",9.21,"0.95","0.95","Atomic-resolution structure of the coiled-coil dimerisation domain of human Arc","XQETIANLERWVKREMHVWREVFYRLERWADRLES","Homo sapiens","ARC, KIAA0278","Activity-regulated cytoskeleton-associated protein","1","6YTU"
"6YTV","4.39","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTV",344.94,"4.39",,"Cryo-EM structure of decameric human CALHM6 in the presence of Ca2+","MEKFRAVLDLHVKHHSALGYGLVTLLTAGGERIFSAVAFQCPCSAAWNLPYGLVFLLVPALALFLLGYVLSARTWRLLTGCCSSARASCGSALRGSLVCTQISAAAALAPLTWVAVALLGGAFYECAATGSAAFAQRLCLGRNRSCAAELPLVPCNQAKASDVQDLLKDLKAQSQVLGWILIAVVIIILLIFTSVTRCLSPVSFLQLKFWKIYLEQEQQILKSKATEHATELAKENIKCFFEGSHPKEYNTPSMKEWQQISSLYTFNPKGQYYSMLHKYVNRKEKTHSIRSTEGDTVIPVLGFVDSSGINSTPEL","Homo sapiens","CALHM6, C6orf187, FAM26F","Calcium homeostasis modulator protein 6","1","6YTV"
"6YTW",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, SITTING DROP",7,"21% PEG 3350, 0,2M Na/K PO4, 10% Ethylene Glycol",277,"10.1021/acs.jmedchem.0c00898","EAE","6YTW",86.57,"2","2","CLK3 bound with benzothiazole Tg003 (Cpd 2)","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6YTW"
"6YTX","6.23","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.55853",,"6YTX",379.44,"6.23",,"Cryo-EM structure of undecameric human CALHM6 in the presence of Ca2+","MEKFRAVLDLHVKHHSALGYGLVTLLTAGGERIFSAVAFQCPCSAAWNLPYGLVFLLVPALALFLLGYVLSARTWRLLTGCCSSARASCGSALRGSLVCTQISAAAALAPLTWVAVALLGGAFYECAATGSAAFAQRLCLGRNRSCAAELPLVPCNQAKASDVQDLLKDLKAQSQVLGWILIAVVIIILLIFTSVTRCLSPVSFLQLKFWKIYLEQEQQILKSKATEHATELAKENIKCFFEGSHPKEYNTPSMKEWQQISSLYTFNPKGQYYSMLHKYVNRKEKTHSIRSTEGDTVIPVLGFVDSSGINSTPEL","Homo sapiens","CALHM6, C6orf187, FAM26F","Calcium homeostasis modulator protein 6","1","6YTX"
"6YTY",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, SITTING DROP",7,"17% PEG 3350, 0,2M NaBr, 10% Ethylene Glycol, 0.1M bis-tris propane",277,"10.1021/acs.jmedchem.0c00898",,"6YTY",42.66,"1.76","1.76","CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVVDFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6YTY"
"6YU1",,"X-RAY DIFFRACTION",2.97,58.56,"VAPOR DIFFUSION, SITTING DROP",7,"18% PEG 3350, 0,2M Na/K PO4, 10% Ethylene Glycol",277,"10.1021/acs.jmedchem.0c00898",,"6YU1",87.4,"1.9","1.9","CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6YU1"
"6YUH",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, HANGING DROP",8.25,"Tris buffer 0.1 M, pH 8.25
Magnesium acetate 0.1 M
PEG3350 16%",293,"10.1002/cbic.202000736",,"6YUH",50.1,"1.93","1.93","Crystal structure of SMYD3 with diperodon R enantiomer bound to allosteric site","PLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRA","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6YUH"
"6YUL",,"X-RAY DIFFRACTION",2.87,57.15,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M ammonia sulphate, 0.1 MES pH 6.5,  31-35% (v/v) polyethylene glycol PEG 5000 MME 
10 mg / mL protein",293,,,"6YUL",92.06,"2.4","2.4","CK2 alpha bound to Macrocycle","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQ","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YUL"
"6YUM",,"X-RAY DIFFRACTION",2.71,54.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5
0.2 ammonia sulphate
30% PEG 5000 MME

10 mg/mL protein",293,,,"6YUM",91.91,"2.75","2.75","CK2 alpha bound to unclosed Macrocycle","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQ","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6YUM"
"6YUT",,"X-RAY DIFFRACTION",3.26,62.3,"VAPOR DIFFUSION, HANGING DROP",,"1 M (NH3)2SO4, 0.17 M guanidine HCl, 0.03 M KCl, 0.1 M sodium acetate pH 4.6",291,"10.1002/chem.202102359",,"6YUT",116.4,"1.76","1.76","Structure of recombinant human beta-glucocerebrosidase in complex with N-acyl functionalised cyclophellitol aziridine","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6YUT"
"6YUW",,"X-RAY DIFFRACTION",1.96,37.17,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 0.1 M CITRIC ACID, PH 4.0",295,"10.1021/acs.jmedchem.0c00660","PQZ","6YUW",44.17,"1.94","1.94","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 454","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YUW"
"6YUY",,"X-RAY DIFFRACTION",1.96,37.16,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 0.1 M CITRIC ACID, PH 4.0",295,"10.1021/acs.jmedchem.0c00660","PQH","6YUY",45.6,"2","2","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 471","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YUY"
"6YUZ","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2008111117",,"6YUZ",159.73,"2.8",,"Homodimeric structure of the rBAT complex","MAEDKSKRDSIEMSMKGCQTNNGFVHNEDILEQTPDPGSSTDNLKHSTRGILGSQEPDFKGVQPYAGMPKEVLFQFSGQARYRIPREILFWLTVASVLVLIAATIAIIALSPKCLDWWQEGPMYQIYPRSFKDSNKDGNGDLKGIQDKLDYITALNIKTVWITSFYKSSLKDFRYGVEDFREVDPIFGTMEDFENLVAAIHDKGLKLIIDFIPNHTSDKHIWFQLSRTRTGKYTDYYIWHDCTHENGKTIPPNNWLSVYGNSSWHFDEVRNQCYFHQFMKEQPDLNFRNPDVQEEIKEILRFWLTKGVDGFSLDAVKFLLEAKHLRDEIQVNKTQIPDTVTQYSELYHDFTTTQVGMHDIVRSFRQTMDQYSTEPGRYRFMGTEAYAESIDRTVMYYGLPFIQEADFPFNNYLSMLDTVSGNSVYEVITSWMENMPEGKWPNWMIGGPDSSRLTSRLGNQYVNVMNMLLFTLPGTPITYYGEEIGMGNIVAANLNESYDINTLRSKSPMQWDNSSNAGFSEASNTWLPTNSDYHTVNVDVQKTQPRSALKLYQDLSLLHANELLLNRGWFCHLRNDSHYVVYTRELDGIDRIFIVVLNFGESTLLNLHNMISGLPAKMRIRLSTNSADKGSKVDTSGIFLDKGEGLIFEHNTKNLLHRQTAFRDRCFVSNRACYSSVLNILYTSC","Homo sapiens","SLC3A1, RBAT","Neutral and basic amino acid transport protein rBAT","1","6YUZ"
"6YV0",,"X-RAY DIFFRACTION",1.96,37.4,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 0.1 M CITRIC ACID, PH 4.0",295,"10.1021/acs.jmedchem.0c00660","PQT","6YV0",44.36,"2","2","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 587","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YV0"
"6YV1","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2008111117",,"6YV1",53.52,"3.4",,"Structure of human b(0,+)AT1","MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE","Homo sapiens","SLC7A9, BAT1","b(0,+)-type amino acid transporter 1","1","6YV1"
"6YV2",,"X-RAY DIFFRACTION",1.97,37.7,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 0.1 M CITRIC ACID, PH 4.0",295,"10.1021/acs.jmedchem.0c00660","PUE","6YV2",44.45,"2.1","2.1","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 598","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YV2"
"6YV3",,"X-RAY DIFFRACTION",3.25,62.19,"VAPOR DIFFUSION, HANGING DROP",,"1 M (NH3)2SO4, 0.17 M guanidine HCl, 0.02 M KCl, 0.1 M sodium acetate pH 4.8",291,"10.1002/chem.202102359",,"6YV3",115.73,"1.8","1.8","Structure of recombinant human beta-glucocerebrosidase in complex with galacto-configured cyclophellitol aziridine inhibitor","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6YV3"
"6YV4",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 0.1 M CITRIC ACID, PH 4.0",295,"10.1021/acs.jmedchem.0c00660","PQK","6YV4",44.47,"2","2","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 686","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YV4"
"6YVI",,"X-RAY DIFFRACTION",2.13,42.37,"VAPOR DIFFUSION, SITTING DROP",,"0.15M CaCl2, 18% PEG 3350, 0.1M PCPT pH 8.3",293,"10.1016/j.bmcl.2021.127904",,"6YVI",85.46,"2.26","2.26","EED in complex with a cyano-benzofuran","KKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6YVI"
"6YVJ",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.1M PCTP pH7.7, 130mM MgCl2",293,"10.1016/j.bmcl.2021.127904",,"6YVJ",85.49,"1.84","1.84","EED in complex with a triazolopyrimidine","KKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6YVJ"
"6YVK",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6YVK",29.73,"1.25","1.25","Human OMPD-domain of UMPS in complex with the substrate OMP at 1.25 Angstroms resolution, 0.71 MGy exposure","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YVK"
"6YVL",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6YVL",29.73,"1.25","1.25","Human OMPD-domain of UMPS in complex with the substrate OMP at 1.25 Angstroms resolution, 1.42 MGy exposure","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YVL"
"6YVM",,"X-RAY DIFFRACTION",2.46,49.91,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6YVM",29.73,"1.25","1.25","Human OMPD-domain of UMPS in complex with the substrate OMP at 1.25 Angstroms resolution, 2.13 MGy exposure","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YVM"
"6YVN",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6YVN",29.73,"1.25","1.25","Human OMPD-domain of UMPS in complex with the substrate OMP at 1.25 Angstroms resolution, 2.84 MGy exposure","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YVN"
"6YVO",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6YVO",29.73,"1.25","1.25","Human OMPD-domain of UMPS in complex with the substrate OMP at 1.25 Angstroms resolution, 3.55 MGy exposure","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YVO"
"6YVP",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"15 % (w/v) PEG6000, 5 % (v/v) glycerol",281,"10.1016/j.bbagen.2021.129968",,"6YVP",35.06,"2.77","2.77","Human histidine triad nucleotide-binding protein 2 (hHINT2) complexed with dGMP and refined to 2.77 A","MAAAVVLAAGLRAARRAVAATGVRGGQVRGAAGVTDGNEVAKAQQATPGGAAPTIFSRILDKSLPADILYEDQQCLVFRDVAPQAPVHFLVIPKKPIPRISQAEEEDQQLLGHLLLVAKQTAKAEGLGDGYRLVINDGKLGAQSVYHLHIHVLGGRQLQWPPG","Homo sapiens","HINT2","Histidine triad nucleotide-binding protein 2, mitochondrial","1","6YVP"
"6YVS",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350",294,"10.1016/j.chembiol.2021.01.003",,"6YVS",130.91,"1.81","1.81","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YVS"
"6YVT",,"X-RAY DIFFRACTION",3.2,61.53,"VAPOR DIFFUSION, SITTING DROP",6.5,"Sample: 19.0 mg/ml PHD2 (50  mM  Tris.HCl  pH  7.5),  1.0  mM  MnCl2  and  1.2  mM  compound.  Reservoir: 1.88 M ammonium sulfate, 0.1 M MES pH 6.5 and 5-7% dioxoane (v/v). Cryo-protection: 30% v/v glycerol.",293,"10.1002/anie.201202000",,"6YVT",171.21,"2.847","2.847","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with MD-253","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6YVT"
"6YVW",,"X-RAY DIFFRACTION",2.79,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"Sample: (20 mg/ml PHD2 + 1 mM FeSO4 + 2 mM compound); Reservoir: 1.6-2.0 M (NH4)2SO4, 2-8% dioxane, 0.1 M MES-Na pH 6.5, and 1 mM FeSO4; Hanging drop (2 ul), protein-to-well ratio, 1:1, 293K",293,"10.1038/s41598-020-76307-8",,"6YVW",28.55,"1.97","1.97","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with monocyclic BB-328","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6YVW"
"6YVX",,"X-RAY DIFFRACTION",2.71,54.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"Sample: (20 mg/ml PHD2 + 1 mM FeSO4 + 2 mM compound); Reservoir: 1.6-2.0 M (NH4)2SO4, 2-8% dioxane, 0.1 M MES-Na pH 6.5, and 1 mM FeSO4; hanging drop vapour diffusion",293,"10.1038/s41598-020-76307-8",,"6YVX",28.46,"1.8","1.8","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic BB-287","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6YVX"
"6YVY",,"X-RAY DIFFRACTION",2.82,56.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350",294,"10.1016/j.chembiol.2021.01.003",,"6YVY",131.15,"1.918","1.918","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YVY"
"6YVZ",,"X-RAY DIFFRACTION",2.73,54.94,"VAPOR DIFFUSION, SITTING DROP",6.5,"Sample: (~20 mg/ml-1 PHD2 + 1 mM MnCl2 + 2 mM compound); Reservoir: 1.6-2.0 M (NH4)2SO4, 2-8% dioxane, 0.1 M MES-Na pH 6.5, and 1 mM MnCl2; Sitting drop (2 ul), protein-to-well ratio, 1:1, 293K",293,"10.1038/s41598-020-76307-8",,"6YVZ",28.54,"1.91","1.91","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic JLS-367","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6YVZ"
"6YW0",,"X-RAY DIFFRACTION",3.09,60.25,"VAPOR DIFFUSION, SITTING DROP",,"Sample: 18 mg/mL PHD2-Me + 1 mM FeSO4 + 2 mM compound; Reservoir: 1.7% polyethylene glycol 400, 15% glycerol, 1.7 M ammonium sulphate and 0.085 M HEPES-Na pH 7.5; Sitting drop (2 uL), protein-to-well ratio, 1:1",293,"10.1038/s41598-020-76307-8",,"6YW0",29.03,"2.2","2.2","Lysine-N,N-Dimethylated HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with BB-287","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6YW0"
"6YW8",,"SOLUTION NMR",,,,,,,"10.1016/j.csbj.2021.05.009",,"6YW8",26.57,,,"NMR solution structure of unbound recombinant human Nerve Growth Factor (rhNGF)","SSSHPIFHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVDSGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRKAVR","Homo sapiens","NGF, NGFB","Beta-nerve growth factor","1","6YW8"
"6YWA",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Citric acid pH 5.0,
20% PEG 6000",291,,,"6YWA",47.11,"2.311","2.311","Human REF STING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)]","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING1, ERIS, MITA, TMEM173, STING","Stimulator of interferon genes protein","1","6YWA"
"6YWB",,"X-RAY DIFFRACTION",2.37,47.99,"VAPOR DIFFUSION, SITTING DROP",,"1.0 M Sodium/Potassium tartrate, 0.2 M Lithium sulfate, 0.1 M Tris pH 7.0",291,,,"6YWB",23.87,"2.503","2.503","Human wtSTING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)]","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6YWB"
"6YWT",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 7.8, 1.6 - 1.8 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 5mg/mL OMPD, 12 mM BMP
Cryo-protection: 100 mM Tris/HCl pH 7.8, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12 mM BMP, 2 M L-proline",293,,,"6YWT",28.94,"1.05","1.05","Human OMPD-domain of UMPS (K314AcK) in complex with 6-hydroxy-UMP at 1.05 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YWT"
"6YWU",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 7.8, 1.8 - 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM UMP
Cryo-protection: 100 mM Tris/HCl pH 7.8, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM UMP, 2 M L-proline",293,,,"6YWU",28.89,"1.1","1.1","Human OMPD-domain of UMPS (K314AcK) in complex with UMP at 1.1 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6YWU"
"6YWZ",,"X-RAY DIFFRACTION",2.76,55.4,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES pH 7
PEG 400 35%",293,"10.1039/d0sc05694d",,"6YWZ",26.14,"2.12","2.12","Crystal structure of SHANK1 PDZ in complex with a peptide-small molecule hybrid","GPLGSDYIIKEKTVLLQKKDSEGFGFVLRGAKAQTPIEEFTPTPAFPALQYLESVDEGGVAWRAGLRMGDFLIEVNGQNVVKVGHRQVVNMIRQGGNTLMVKVVMVTRHPDM","Homo sapiens","SHANK1","SH3 and multiple ankyrin repeat domains protein 1","1","6YWZ"
"6YX1",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES 7.75
PEG 400 40%
30% w/v Trimethylamine N-oxide dihydrate",293,"10.1039/d0sc05694d",,"6YX1",26.06,"1.8","1.8","Crystal structure of SHANK1 PDZ in complex with a peptide-small molecule hybrid","GPLGSDYIIKEKTVLLQKKDSEGFGFVLRGAKAQTPIEEFTPTPAFPALQYLESVDEGGVAWRAGLRMGDFLIEVNGQNVVKVGHRQVVNMIRQGGNTLMVKVVMVTRHPDM","Homo sapiens","SHANK1","SH3 and multiple ankyrin repeat domains protein 1","1","6YX1"
"6YXE",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.26 M NH4SO4, 0.2 M LiSO4, and 0.1 M Tris pH 8.5",291,"10.1107/S2059798320010499",,"6YXE",29.74,"2.1","2.1","Structure of the Trim69 RING domain","HHHHHHSAALEVLFQGPGMEVSTNPSSNIDPGDYVEMNDSITHLPSKVVIQDITMELHCPLCNDWFRDPLMLSCGHNFCEACIQDFWRLQAKETFCPECKMLCQYNNCTFNPVLDKLVEKIKKLPLLK","Homo sapiens","TRIM69, RNF36, HSD-34, HSD34","E3 ubiquitin-protein ligase TRIM69","1","6YXE"
"6YXH",,"X-RAY DIFFRACTION",3.45,64.3,"LIPIDIC CUBIC PHASE",,"30 or 50 nl bolus overlaid with 600 nl precipitant solution in CrystalDirect plate-2.
41% PEG 400, 100 mM HEPES pH 7.5, 75 mM magnesium sulfate and 5% DMSO.
Crystallisation experiments were carried out at the HTX facility of EMBL Grenoble. LCP bolus were harvested automatically at cryogenic condition using CrystalDirect technology.",293,"10.1016/j.crmeth.2021.100102",,"6YXH",41.27,"2.6","2.6","Cryogenic human alkaline ceramidase 3 (ACER3) at 2.6 A resolution determined by Serial Crystallography (SSX) using CrystalDirect","FAPAADREGYWGPTTSTLDWCEENYSVTWYIAEFWNTVSNLIMIIPPMFGAVQSVRDGLEKRYIASYLALTVVGMGSWCFHMTLKYEMQLLDELPMIYSCCIFVYCMFECFKIKNSVNYHLLFTLVLFSLIVTTVYLKVKEPIFHQVMYGMLVFTLVLRSIYIVTWVYPWLRGLGYTSLGIFLLGFLFWNIDNIFCESLRNFRKKVPPIIGITTQFHAWWHILTGLGSYLHILFSLYTRTLYLRADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYL","Homo sapiens","ACER3, APHC, PHCA","Alkaline ceramidase 3","1","6YXH"
"6YXI",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M ammonium sulphate, 0.1 M citric acid, pH 4",300,"10.1021/acs.jmedchem.0c00660","PZ8","6YXI",44.91,"1.34","1.34","Structure of Notum in complex with a 1-(3-Chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid inhibitor","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6YXI"
"6YXL",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, SITTING DROP",,"20mM Tris pH 7.4, 50mM NaCl, 0.2M Potassium thiocyanate, 2.2M Ammonium sulfate)",293,"10.1126/sciadv.abm1759",,"6YXL",47.2,"2.1","2.1","Crystal structure of ACPA F3","QVQLVQSGAEVKKPGASVRVSCKASGFVTDYFIQWVRQAPGQGPEWMAWINPHNGETDYAPKLQDRVTVTCDTSTNTAFMELSRLTSDDTALYYCGRSGRTDARRAPVSYWGQGALVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"ACPA F3 Fab fragment - heavy chain","1","6YXL"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGARATLSCRASQTVRGNYLAWFQQKRGQPPRLLIYLASNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVNTPETFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"ACPA F3 Fab fragment - light chain","2","6YXL"
"6YXM",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, SITTING DROP",,"20mM Tris pH 7.4, 20mMNaCl, 20% (w/v) PEG 6000, 0.1M HEPES 7.0 pH 7.0, 0.01M zinc chloride.",293,"10.1126/sciadv.abm1759",,"6YXM",48.56,"2.85","2.85","Crystal structure of ACPA 1F2 in complex with CII-C-39-CIT","LPGQRGERG","Homo sapiens",,"CII-C-39-CIT","1","6YXM"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"QVHLEQSGSELKKPGASVTISCKTSGYNFSHFAINWVRQAPGQGLQWMGWINTKTANLTYAQTFTGRFVFSFDTSVSTAYLHIHGLKTEDTAMYYCVRGGSLGIFGGSVGYWGQGALVSVSSAKTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGLYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKIEPR","Homo sapiens",,"ACPA 1F2 Fab fragment - heavy chain","2","6YXM"
,,,,,,,,,,,,,,,,"NLTLIQSRSVSGSPGQTVSISCTANGAHIGDSYVQWFQQRPGSAPRSVIFEDDKRPSGVPDRLSGSTDFSSNSASLTISGLESEDEADYYCQSYYRGDWVLGGGTKLTVLGQPKSSPSVTLFPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYLTLTARAWERHSSYSCQVTHEGHTVEKSLSR","Homo sapiens",,"ACPA 1F2 Fab fragment - light chain","3","6YXM"
"6YXO",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.2 M Magnesium formate (pH 5.9), 20% PEG 3350.  Protein at 16 mg/ml.",290,"10.1038/s42003-021-02050-z",,"6YXO",65.41,"2","2","Structure of the N-terminal module of the human SWI/SNF-subunit BAF155/SMARCC1","SLAVYRRKDGGPATKFWESPETVSQLDSVRVWLGKHYKKYVHADAPTNKTLAGLVVQLLQFQEDAFGKHVTNPAFTKLPAKCFMDFKAGGALCHILGAAYKYKNEQGWRRFDLQNPSRMDRNVEMFMNIEKTLVQNNCLTRPNIYLIPDIDLKLANKLKDIIKRHQGTFTDEKSKASHHIYPYSSSQDDEEWLRPVMRKEKQVLVHWGFYPDSYDTWVHSNDVDAEIEDPPIPEKPWKVHVKWILDTDIFNEWMNEEDYEVDENRKPVSFRQRIST","Homo sapiens","SMARCC1, BAF155","SWI/SNF complex subunit SMARCC1","1","6YXO"
"6YXP",,"X-RAY DIFFRACTION",2.45,49.77,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.2 M Magnesium formate (pH 5.9), 20% PEG 3350.  Protein at 16 mg/ml.",290,"10.1038/s42003-021-02050-z",,"6YXP",65.71,"1.6","1.6","Higher resolution structure of the N-terminal module of the human SWI/SNF-subunit BAF155/SMARCC1","GSLAVYRRKDGGPATKFWESPETVSQLDSVRVWLGKHYKKYVHADAPTNKTLAGLVVQLLQFQEDAFGKHVTNPAFTKLPAKCFMDFKAGGALCHILGAAYKYKNEQGWRRFDLQNPSRMDRNVEMFMNIEKTLVQNNCLTRPNIYLIPDIDLKLANKLKDIIKRHQGTFTDEKSKASHHIYPYSSSQDDEEWLRPVMRKEKQVLVHWGFYPDSYDTWVHSNDVDAEIEDPPIPEKPWKVHVKWILDTDIFNEWMNEEDYEVDENRKPVSFRQRISTKNE","Homo sapiens","SMARCC1, BAF155","SWI/SNF complex subunit SMARCC1","1","6YXP"
"6YXV",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3350",294,"10.1016/j.chembiol.2021.01.003",,"6YXV",131.11,"2.298","2.298","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-{3-[(2-phenylamino-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl]-pyridin-2-yl}-methanesulfonamide","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6YXV"
"6YYF",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2 500 mM NaCl",298,,,"6YYF",40.37,"1.93","1.93","Crystal Structure of 5-chloroindoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6YYF"
"6YYG",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2 500 mM NaCl",298,,,"6YYG",80.89,"1.95","1.95","Crystal Structure of 5-(trifluoromethoxy)indoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6YYG"
"6YYK",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS 8.5 pH, 32.5% w/v PEG 3350, 200mM MgCl2 500 mM NaCl",298,,,"6YYK",40.2,"2.04","2.04","Crystal Structure of 1,5-dimethylindoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase mutant R28C","AAVILESIFLKRSQQKKKTSPLNFKKCLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6YYK"
"6YYN",,"X-RAY DIFFRACTION",2.76,55.39,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1 M sodium citrate pH 4.8, 0.2 M ammonium sulfate, 17% w/v PEG 4000",285,"10.1021/acs.jmedchem.0c00949",,"6YYN",51.87,"2.22","2.22","Structure of Cathepsin S in complex with Compound 14","RILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","6YYN"
"6YYO",,"X-RAY DIFFRACTION",2.74,55.17,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M sodium citrate pH 4.2, 0.2 M ammonium sulfate and 20 % w/v PEG 4000",285,"10.1021/acs.jmedchem.0c00949",,"6YYO",53.41,"1.5","1.5","Structure of Cathepsin S in complex with Compound 1","RILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","6YYO"
"6YYP",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION, HANGING DROP",6.8,"54% v/v tacsimate pH 6.8",285,"10.1021/acs.jmedchem.0c00949",,"6YYP",51.21,"2.05","2.05","Structure of Cathepsin S in complex with Compound 2","RILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","6YYP"
"6YYQ",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.2 M potassium formate pH 7.3, 20% w/v PEG 3350",285,"10.1021/acs.jmedchem.0c00949",,"6YYQ",101.1,"2.51","2.51","Structure of Cathepsin S in complex with Compound 3","RILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","6YYQ"
"6YYR",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.10 M sodium citrate pH 4.8, 0.2 M ammonium sulfate, 29% w/v PEG4000",277,"10.1021/acs.jmedchem.0c00949",,"6YYR",52.27,"1.3","1.3","Structure of Cathepsin S in complex with Compound 20b","RILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEIHHHHHH","Homo sapiens","CTSS","Cathepsin S","1","6YYR"
"6YYU",,"X-RAY DIFFRACTION",2.95,58.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES sodium, 10% v/v 2-Propanol, 20% w/v PEG 4000, 1 mM manganese chloride, 2 mM 2-oxoglutarate, 18 mg/ml protein",277,,,"6YYU",49.61,"2.11","2.11","Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese and 2-oxoglutarate","KPKLLNKFDKTIKAELDAAEKLRKRGKIEEAVNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEVASLPDVPADLLKLSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTSLKNDLGVGYLLIGDNDNAKKVYEEVLSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGDPGTDDGRFYFHLGDAMQRVGNKEAYKWYELGHKRGHFASVWQRSLYNVNGLKAQPWWTPKETGYTELVKSLERNWKLIRDEGLAVMDKAKGLFLPEDENLREKGDWSQFTLWQQGRRNENACKGAPKTCTLLEKFPETTGCRRGQIKYSIMHPGTHVWPHTGPTNCRLRMHLGLVIPKEGCKIRCANETKTWEEGKVLIFDDSFEHEVWQDASSFRLIFIVDVWHPELTPQQRRSLPAI","Homo sapiens","ASPH, BAH","Aspartyl/asparaginyl beta-hydroxylase","1","6YYU"
"6YYV",,"X-RAY DIFFRACTION",3.04,59.49,"VAPOR DIFFUSION, SITTING DROP",7.9,"200 mM magnesium acetate tetrahydrate, 20% w/v PEG 3350, 1 mM manganese chloride, 2 mM 3-methyl-2-oxoglutarate, 18 mg/ml protein",277,,,"6YYV",49.62,"1.77","1.77","Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese and 3-methyl-2-oxoglutarate","KPKLLNKFDKTIKAELDAAEKLRKRGKIEEAVNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEVASLPDVPADLLKLSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTSLKNDLGVGYLLIGDNDNAKKVYEEVLSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGDPGTDDGRFYFHLGDAMQRVGNKEAYKWYELGHKRGHFASVWQRSLYNVNGLKAQPWWTPKETGYTELVKSLERNWKLIRDEGLAVMDKAKGLFLPEDENLREKGDWSQFTLWQQGRRNENACKGAPKTCTLLEKFPETTGCRRGQIKYSIMHPGTHVWPHTGPTNCRLRMHLGLVIPKEGCKIRCANETKTWEEGKVLIFDDSFEHEVWQDASSFRLIFIVDVWHPELTPQQRRSLPAI","Homo sapiens","ASPH, BAH","Aspartyl/asparaginyl beta-hydroxylase","1","6YYV"
"6YZ4",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, SITTING DROP",7.8,"16% PEG3350, 0.1 M tris pH 7.8, 0.25 M ammonium acetate",277.15,"10.1016/j.chembiol.2020.07.014",,"6YZ4",36.26,"1.7","1.7","Crystal structure of MKK7 (MAP2K7) with ibrutinib bound at allosteric site","SMKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPR","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6YZ4"
"6YZJ",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, HANGING DROP",7.8,"10 mM Tris, 1.6 M natrium Citrate",291,"10.1080/14756366.2020.1816996",,"6YZJ",29.51,"1.2","1.2","Closo-carborane ethyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZJ"
"6YZK",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996",,"6YZK",29.55,"0.99","0.99","Carborane closo-pentyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZK"
"6YZL",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 7.8
1.6 Natrium Citrate",291,"10.1080/14756366.2020.1816996",,"6YZL",29.49,"1.2","1.2","Closo-carborane methyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZL"
"6YZM",,"X-RAY DIFFRACTION",2.02,39.24,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996",,"6YZM",29.54,"1.5","1.5","Carborane nido-pentyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZM"
"6YZN",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM Tris 
1.6 M Natrium Citrate",291,"10.1080/14756366.2020.1816996",,"6YZN",29.53,"0.95","0.95","Closo-carborane butyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZN"
"6YZO",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996",,"6YZO",29.56,"1.5","1.5","Carborane closo-hexyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZO"
"6YZP",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996",,"6YZP",29.55,"1.35","1.35","Carborane nido-hexyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZP"
"6YZQ",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q3Q","6YZQ",29.62,"1.04","1.04","Carborane closo-butyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZQ"
"6YZR",,"X-RAY DIFFRACTION",2.08,40.79,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q3W","6YZR",29.61,"1.2","1.2","Carborane nido-butyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZR"
"6YZS",,"X-RAY DIFFRACTION",2.07,40.55,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q3N","6YZS",29.66,"1.05","1.05","Carborane closo-pentyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZS"
"6YZT",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM Tris
1.6 M Natrium Citrate",291,"10.1080/14756366.2020.1816996","Q3E","6YZT",29.61,"1.05","1.05","Closo-carborane propyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZT"
"6YZU",,"X-RAY DIFFRACTION",2.08,40.81,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q4B, Q38","6YZU",29.9,"1","1","Carborane nido-pentyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZU"
"6YZV",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM Tris
1.6 M Natrium Citrate",291,"10.1080/14756366.2020.1816996","Q2Z","6YZV",29.59,"1.65","1.65","Closo-carborane ethyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZV"
"6YZW",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q3K","6YZW",29.65,"1.03","1.03","Carborane closo-hexyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZW"
"6YZX",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1080/14756366.2020.1816996","Q3H","6YZX",29.64,"1.1","1.1","Carborane nido-hexyl-sulfonamide in complex with CA II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6YZX"
"6Z04",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH=7.8
1.6 M Natrium Citrate",291,"10.1080/14756366.2020.1816996",,"6Z04",29.52,"1.05","1.05","Nido-carborane butyl-sulfonamide in complex with CA IX mimic","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6Z04"
"6Z0E",,"X-RAY DIFFRACTION",2.59,52.57,"VAPOR DIFFUSION, SITTING DROP",5,"1 M LiCl, 20% PEG6000, 0.1M Citrate pH 5.0",293,,,"6Z0E",51.31,"2.6","2.6","HtrA1 inactive protease domain S328A with CARASIL mutation R274Q","MGSSHHHHHHSSGLVPRGSHMDPNSLRHKYNFIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELQPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNAGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTESHDRQAKGK","Homo sapiens","HTRA1, HTRA, PRSS11","Serine protease HTRA1","1","6Z0E"
"6Z0G",,"SOLUTION NMR",,,,,,,"10.15252/embj.2019104247",,"6Z0G",5.17,,,"Structure of TREM2 transmembrane helix in DPC micelles","GSGRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTH","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","6Z0G"
"6Z0H",,"SOLUTION NMR",,,,,,,"10.15252/embj.2019104247",,"6Z0H",5.11,,,"Structure of TREM2 transmembrane helix K186A variant in DPC micelles","GSGRSLLEGEIPFPPTSILLLLACIFLIAILAASALWAAAWHGQKPGTH","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","6Z0H"
"6Z0I",,"SOLUTION NMR",,,,,,,"10.15252/embj.2019104247",,"6Z0I",5.17,,,"Structure of the TREM2 transmembrane helix in complex with DAP12 in DPC micelles","GSGRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTH","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","6Z0I"
"6Z0X",,"X-RAY DIFFRACTION",2.96,58.45,"VAPOR DIFFUSION, SITTING DROP",4,"1.6 M ammonium sulfate, 100 mM Citrate pH 4",293,,,"6Z0X",77.84,"3.1","3.1","HtrA1 inactive protease domain S328A with CARASIL mutations D174R R274Q","MGSSHHHHHHSSGLVPRGSHMDPNSLRHKYNFIARVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELQPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNAGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTESHDRQAKGK","Homo sapiens","HTRA1, HTRA, PRSS11","Serine protease HTRA1","1","6Z0X"
"6Z0Y",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",4,"1.6 M ammonium sulfate, 100 mM Citrate pH 4",293,,,"6Z0Y",77.36,"2.2","2.2","HtrA1 inactive protease domain S328A with CARASIL mutations D174R R274Q","MGSSHHHHHHSSGLVPRGSHMDPNSLRHKYNFIARVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELQPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNAGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTESHDRQAKGK","Homo sapiens","HTRA1, HTRA, PRSS11","Serine protease HTRA1","1","6Z0Y"
"6Z0Z",,"X-RAY DIFFRACTION",3.31,62.83,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Lithium acetate, 20% (w/v) PEG 3350",291,"10.1002/anie.202016805",,"6Z0Z",23.85,"2.499","2.499","Human wtSTING in complex with 3',3'-c-(2'FdAMP-2'FdAMP)","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6Z0Z"
"6Z15",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION, SITTING DROP",,"12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD, 0.1 M bicine/Trizma base pH 8.5, 0.03 M diethyleneglycol, 0.03 M triethyleneglycol, 0.03 M tetraethyleneglycol, 0.03 M pentaethyleneglycol",293,"10.1002/anie.202016805",,"6Z15",23.85,"2.5","2.5","Human wtSTING in complex with 3',3'-c-di-AMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6Z15"
"6Z1I","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-21126-2",,"6Z1I",51.99,"3.4",,"AL amyloid fibril from a lambda 3 light chain in conformation B","AVSVALGQTVRITCQGDSLRSYSASWYQQKPGQAPVLVIFRNTASLTITGAQAEDEADYYCNSRDSSANHQVFGGGTKLTV","Homo sapiens","IGLV3-19","lambda 3 light chain fragment, residues 2-116","1","6Z1I"
"6Z1O","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-21126-2",,"6Z1O",56.59,"3.2",,"AL amyloid fibril from a lambda 3 light chain in conformation A","AVSVALGQTVRITCQGDSLRSYSASWYQQKPGQAPVLVIFRRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSANHQVFGGGTKLTV","Homo sapiens","IGLV3-19","lambda 3 immunoglobulin light chain fragment, residues 2-116","1","6Z1O"
"6Z1Q",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION",7.6,"12-20% Ethanol, 0.1M Hepes pH 7.6",277,,,"6Z1Q",78.52,"2.42","2.42","MAP3K14 (NIK) in complex with DesF-3R/4076","KFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA","Homo sapiens","MAP3K14, NIK","Mitogen-activated protein kinase kinase kinase 14","1","6Z1Q"
"6Z1T",,"X-RAY DIFFRACTION",2.8,56.03,"VAPOR DIFFUSION",7.6,"12-20% Ethanol, 0.1M Hepes pH 7.6",277,,,"6Z1T",78.32,"2.31","2.31","MAP3K14 (NIK) in complex with 4S/3694","KFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA","Homo sapiens","MAP3K14, NIK","Mitogen-activated protein kinase kinase kinase 14","1","6Z1T"
"6Z1W",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.4,"2.2 M ammonium sulfate, 0.2 M NaCl and 0.1 M citric acid",277,,,"6Z1W",14.04,"2.48","2.48","Crystal structure of human steroid carrier protein SL (SCP-2L) mutant A100C","MEGGKLQSTFVFEEIGRRLKDIGPEVVKKVNAVFEWHITKGGNIGAKWTIDLKSGSGKVYQGPAKGAADTTIILSDEDFMEVVLGKLDPQKAFFSGRLKCRGNIMLSQKLQMILKDYAKL","Homo sapiens","HSD17B4, EDH17B4, SDR8C1","Peroxisomal multifunctional enzyme type 2","1","6Z1W"
"6Z1X",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",5.4,"2.2 M ammonium sulfate, 0.2 M NaCl and 0.1 M citric acid",277,,,"6Z1X",14.66,"2.09","2.09","Crystal structure of human steroid carrier protein SL (SCP-2L) mutant V83C","MEGGKLQSTFVFEEIGRRLKDIGPEVVKKVNAVFEWHITKGGNIGAKWTIDLKSGSGKVYQGPAKGAADTTIILSDEDFMEVCLGKLDPQKAFFSGRLKARGNIMLSQKLQMILKDYAKL","Homo sapiens","HSD17B4, EDH17B4, SDR8C1","Peroxisomal multifunctional enzyme type 2","1","6Z1X"
"6Z2C",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 3350, ammonium tartrate",293,,,"6Z2C",66.91,"1.8","1.8","Engineered lipocalin C3A5 in complex with a transition state analog","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGMAGNGDLREDKDPYKMRATIYELKEDKSYNVTWVWFLPKKCKYFINTFVPGSQPGEFTLGLIKSYPGQTSLLVRVVSTNYNQHAMVFFKTVIQNRERFYITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAWSHPQFEK","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6Z2C"
"6Z2F",,"X-RAY DIFFRACTION",1.97,37.45,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M MgCl2, 0.1 M Tris, pH 8.5, 30% PEG 4000",289.15,,,"6Z2F",116.37,"1.7","1.7","Crystal structure of human AGX1 mutant complexed with UDPGLCNAC","GPELMNINDLKLTLSKAGQEHLLRFWNELEEAQQVELYAELQAMNFEELNFFFQKAIEGFNQSSYQKNVDARMEPVPREVLGSATRDQDQLQAWESEGLFQISQNKVAVLLLAGGQGTRLGVAYPKGMYDVGLPSRKTLFQIQAERILKLQQVAEKYYGNKCIIPWYIMTSGRTMESTKEFFTKHKYFGLKKENVIFFQQGMLPAMSFDGKIILEEKNKVSMAPDGNGGLYRTLAAQNIVEDMEQRGIWSIHVYCVDNILVKVADPRFIGFCIQKGADCGAKVVEKTNPTEPVGVVCRVDGVYQVVEYSEISLATAQKRSSDGRLLFNAGNIANHFFTVPFLRDVVNVYEPQLQHHVAQKKIPYVDTQGQLIKPDKPNGIKMEKFVFDIFQFAKKFVVYEVLREDEFSPLKNADSQNGKDNPTTARHALMSLHHCWVLNAGGHFIDENGSRLPAIPRLKDANDVPIQCEISPLISYAGEGLESYVADKEFHAPLIIDENGVHELVKNGI","Homo sapiens","UAP1, SPAG2","UDP-N-acetylhexosamine pyrophosphorylase","1","6Z2F"
,,,,,,,,,,,,,,,,"GPELMNINDLKLTLSKAGQEHLLRFWNELEEAQQVELYAELQAMNFEELNFFFQKAIEGFNQSSYQKNVDARMEPVPREVLGSATRDQDQLQAWESEGLFQISQNKVAVLLLAGGQGTRLGVAYPKGMYDVGLPSRKTLFQIQAERILKLQQVAEKYYGNKCIIPWYIMTSGRTMESTKEFFTKHKYFGLKKENVIFFQQGMLPAMSFDGKIILEEKNKVSMAPDGNGGLYRTLAAQNIVEDMEQRGIWSIHVYCVDNILVKVADPRFIGFCIQKGADCGAKVVEKTNPTEPVGVVCRVDGVYQVVEYSEISLATAQKRSSDGRLLFNAGNIANHFFTVPFLRDVVNVYEPQLQHHVAQKKIPYVDTQGQLIKPDKPNGIKMEKFVFDIFQFAKKFVVYEVLREDEFSPLKNADSQNGKDNPTTARHALMSLHHCWVLNAGGHFIDENGSRLPAIPRLKDANDVPIQCEISPLISYAGEGLESYVADKEFHAPLIIDENGVHELVKNGI","Homo sapiens","UAP1, SPAG2","UDP-N-acetylhexosamine pyrophosphorylase","2","6Z2F"
"6Z2G",,"X-RAY DIFFRACTION",2.3,46,"VAPOR DIFFUSION, HANGING DROP",9,"0.1 M Bicine pH 9.0, 0.2 M sodium thiocyanate, 0.1 M sodium formate, and 25-27% v/w PEG3350",288,"10.1002/1873-3468.13865",,"6Z2G",11.98,"1.95","1.95","Crystal structure of human NLRP9 PYD","GAMAESFFSDFGLLWYLKELRKEEFWKFKELLKQPLEKFELKPIPWAELKKASKEDVAKLLDKHYPGKQAWEVTLNLFLQINRKDLWTKAQEEMRNKLN","Homo sapiens","NLRP9, NALP9, NOD6, PAN12","NACHT, LRR and PYD domains-containing protein 9","1","6Z2G"
"6Z2H",,"X-RAY DIFFRACTION",2.21,44.3,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M sodium actetate pH 7.0 
20 % PEG3350
65 mM oxaloacetate
7 mM acetyl-CoA",293,"10.1038/s41594-021-00624-3",,"6Z2H",124.74,"1.8","1.8","Citryl-CoA lyase module of human ATP citrate lyase in complex with (3S)-citryl-CoA.","GSHMKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6Z2H"
"6Z2U",,"X-RAY DIFFRACTION",3.01,59.22,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium malonate pH 6 and 20% w/v polyethylene glycol 3,350",281,"10.1002/cbic.202100449",,"6Z2U",15.99,"2.4","2.4","M2 mutant (R111K:Y134F:T54V:R132Q:P39Y:R59Y) of human cellular retinoic acid binding protein II","GSHMPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6Z2U"
"6Z2V",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 0,2M KSCN,  
10% Ethylene Glycol, 0.1M bis-tris propane",278,"10.1021/acs.jmedchem.0c00898",,"6Z2V",42.81,"2.6","2.6","CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVVDFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z2V"
"6Z2Z",,"X-RAY DIFFRACTION",3.18,61.36,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium malonate pH 7 and 20% w/v polyethylene glycol 3,350",281,"10.1002/cbic.202100449",,"6Z2Z",16.24,"2.55","2.55","M2 mutant (R111K:Y134F:T54V:R132Q:P39Y:R59Y) of human cellular retinoic acid binding protein II - 2a conjugate","GSHMPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6Z2Z"
"6Z30",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",9,"0.1 M SPG buffer (succinic acid, sodium dihydrogen phosphate monohydrate, glycine) pH 9, 25 % PEG 1500",298,"10.1016/j.str.2020.08.002",,"6Z30",34.72,"1.5","1.5","Human cation-independent mannose 6-phosphate/ IGF2 receptor domains 9-10","ETGASVEGDNCEVKDPRHGNLYDLKPLGLNDTIVSAGEYTYYFRVCGKLSSDVCPTSDKSKVVSSCQEKREPQGFHKVAGLLTQKLTYENGLLKMNFTGGDTCHKVYQRSTAIFFYCDRGTQRPVFLKETSDCSYLFEWRTQYACPPFDLTECSFKDGAGNSFDLSSLSRYSDNWEAITGTGDPEHYLINVCKSLAPQAGTEPCPPEAAACLLGGSKPVNLGRVRDGPQWRDGIIVLKYVDGDLCPDGIRKKSTTIRFTCSESQVNSRPMFISAVEDCEYTFAWPTATACPMKSTRHHHHHH","Homo sapiens","IGF2R, MPRI","Cation-independent mannose-6-phosphate receptor","1","6Z30"
"6Z31",,"X-RAY DIFFRACTION",3.12,60.61,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5 M Ammonium sulphate, 0.1 M Tris pH 8.5, 12 % glycerol",298,"10.1016/j.str.2020.08.002",,"6Z31",30.28,"2.56","2.56","Human cation-independent mannose 6-phosphate/ IGF2 receptor domain 8","SVDCQVTDLAGNEYDLTGLSTVRKPWTAVDTSVDGRKRTFYLSVCNPLPYIPGCQGSAVGSCLVSEGNSWNLGVVQMSPQAAANGSLSIMYVNGDKCGNQRFSTRITFECAQISGSPAFQLQDGCEYVFIWRTVEACPVV","Homo sapiens","IGF2R, MPRI","Cation-independent mannose-6-phosphate receptor","1","6Z31"
"6Z32",,"X-RAY DIFFRACTION",3.75,67.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 1.6 M MgSO4, 10 mM mannose 6-phosphate",298,"10.1016/j.str.2020.08.002",,"6Z32",164.57,"3.47","3.47","Human cation-independent mannose 6-phosphate/IGF2 receptor domains 7-11","ETGQLKHHHHHHEFTTDTDQACSIRDPNSGFVFNLNPLNSSQGYNVSGIGKIFMFNVCGTMPVCGTILGKPASGCEAETQTEELKNWKPARPVGIEKSLQLSTEGFITLTYKGPLSAKGTADAFIVRFVCNDDVYSGPLKFLHQDIDSGQGIRNTYFEFETALACVPSPVDCQVTDLAGNEYDLTGLSTVRKPWTAVDTSVDGRKRTFYLSVCNPLPYIPGCQGSAVGSCLVSEGNSWNLGVVQMSPQAAANGSLSIMYVNGDKCGNQRFSTRITFECAQISGSPAFQLQDGCEYVFIWRTVEACPVVRVEGDNCEVKDPRHGNLYDLKPLGLNDTIVSAGEYTYYFRVCGKLSSDVCPTSDKSKVVSSCQEKREPQGFHKVAGLLTQKLTYENGLLKMNFTGGDTCHKVYQRSTAIFFYCDRGTQRPVFLKETSDCSYLFEWRTQYACPPFDLTECSFKDGAGNSFDLSSLSRYSDNWEAITGTGDPEHYLINVCKSLAPQAGTEPCPPEAAACLLGGSKPVNLGRVRDGPQWRDGIIVLKYVDGDLCPDGIRKKSTTIRFTCSESQVNSRPMFISAVEDCEYTFAWPTATACPMKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYSEKGLVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACEQA","Homo sapiens","IGF2R, MPRI","Cation-independent mannose-6-phosphate receptor","1","6Z32"
"6Z36",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, SITTING DROP",5.2,"0.1M Citrate pH 5.2, 1.2M ammonium sulphate, 0.2M sodiuim/potassium tartarate.",277,,,"6Z36",71.71,"1.37","1.37","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6Z36"
"6Z39",,"X-RAY DIFFRACTION",3.27,62.34,"VAPOR DIFFUSION, HANGING DROP",,"0.95 M (NH3)2SO4, 0.17 M guanidine HCl, 0.02 M KCl, 0.1 M sodium acetate pH 4.6",291,"10.1002/chem.202102359",,"6Z39",116.57,"1.7","1.7","Structure of recombinant human beta-glucocerebrosidase in complex with BODIPY functionalised epoxide activity based probe","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Z39"
"6Z3E",,"X-RAY DIFFRACTION",2.02,39.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% 2-propanol
50 mM ammonium acetate",277,,,"6Z3E",31.61,"2.80038678769","2.80038678769","Crystal structure of GDP-bound human GIMAP5, amino acid residues 1-276","GPMGGFQRGKYGTMAEGRSEDNLSATPPALRIILVGKTGCGKSATGNSILGQPVFESKLRAQSVTRTCQVKTGTWNGRKVLVVDTPSIFESQADTQELYKNIGDCYLLSAPGPHVLLLVIQLGRFTAQDTVAIRKVKEVFGTGAMRHVVILFTHKEDLGGQALDDYVANTDNCSLKDLVRECERRYCAFNNWGSVEEQRQQQAELLAVIERLGREREGSFHSNDLFLDAQLLQRTGAGACQEDYRQYQAKVEWQVEKHKQELRENESNWAYKALLRVK","Homo sapiens","GIMAP5, IAN4L1, IAN5, IMAP3","GTPase IMAP family member 5","1","6Z3E"
"6Z3I",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Na2SO4, 0.25 M HEPES pH 7, PEG3350 14%, 1:1000 seed",291,"10.1002/chem.202102359",,"6Z3I",58.61,"1.8","1.8","Structure of recombinant beta-glucocerebrosidase in complex with bifunctional cyclophellitol aziridine activity based probe","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ","Homo sapiens","GBA, GC, GLUC","Lysosomal acid glucosylceramidase","1","6Z3I"
"6Z3K",,"X-RAY DIFFRACTION",2.56,51.9,"VAPOR DIFFUSION, SITTING DROP",4,"20% (v/v) PEG 6000, 0.1 M citrate, pH 4.0, 1 M lithium chloride",293,"10.1038/s41467-020-19013-3",,"6Z3K",440.94,"2.7","2.7","Structure of protective antibody 38-1-10A Fab","MGCVAQLQLQESGPGLVKPSETLSLTCTVSGGSISSSSYYWGWIRQPPGKGLEWIGSIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAREITMIAWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKHHHHHH","Homo sapiens",,"Heavy chain","1","6Z3K"
,,,,,,,,,,,,,,,,"MGCVADIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQDYNYLLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light Chain","2","6Z3K"
"6Z3V",,"X-RAY DIFFRACTION",2.04,39.75,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z3V",33.27,"1.25","1.25","A4V mutant of human SOD1 bound with N-aryl benzoisoselenazolone derivative 13 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z3V"
"6Z48",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM MOPS/sodium HEPES pH 7.5, 12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD",293,"10.1038/s41467-022-31428-8",,"6Z48",138.1,"2.27","2.27","Crystal structure of Thrombin in complex with macrocycle X1vE","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","6Z48"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","6Z48"
"6Z49",,"X-RAY DIFFRACTION",2.53,51.47,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M Magnesium chloride and 25% PEG 3350",293.15,"10.1016/j.molcel.2021.08.024",,"6Z49",125.56,"2","2","Crystal structure of deubiquitinase Mindy2","GPLGSPEFMSVYHIKWIQWKEENTPIITQNENGPCPLLAILNVLLLAWKVKLPPMMEIITAEQLMEYLGDYMLDAKPKEISEIQRLNYEQNMSDAMAILHKLQTGLDVNVRFTGVRVFEYTPECIVFDLLDIPLYHGWLVDPQIDDIVKAVGNCSYNQLVEKIISCKQSDNSELVSEGFVAEQFLNNTATQLTYHGLCELTSTVQEGELCVFFRNNHFSTMTKYKGQLYLLVTDQGFLTEEKVVWESLHNVDGDGNFCDSEFHLRPPSDPETV","Homo sapiens","MINDY2, FAM63B, KIAA1164","Ubiquitin carboxyl-terminal hydrolase MINDY-2","1","6Z49"
"6Z4A",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES
30% w/v PEG 6000
Cryoprotected by addition of 20% v/v glycerol",291,,,"6Z4A",17.84,"1.46","1.46","Structure of the human SAS-6 N-terminal domain, F131E mutant","GPMSQVLFHQLVPLQVKCKDCEERRVSIRMSIELQSVSNPVHRKDLVIRLTDDTDPFFLYNLVISEEDFQSLKFQQGLLVDFLAFPQKFIDLLQQCTQEHAKEIPRFLLQLVSPAAILDNSPAFLNVVETNPEKHLTHLSLKLLPGNDVEIKKF","Homo sapiens","SASS6, SAS6","Spindle assembly abnormal protein 6 homolog","1","6Z4A"
"6Z4B",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole, 4.7 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acsmedchemlett.0c00472",,"6Z4B",78.66,"2.5","2.5","Crystal Structure of EGFR-T790M/V948R in Complex with Osimertinib and EAI045","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6Z4B"
"6Z4D",,"X-RAY DIFFRACTION",,34.9,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 100 mM MgSO4, 2 % ethylen glycole, 5.0 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acsmedchemlett.0c00472",,"6Z4D",77.59,"2","2","Crystal Structure of EGFR-T790M/V948R in Complex with Mavelertinib and EAI001","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6Z4D"
"6Z4G",,"X-RAY DIFFRACTION",2.02,39.13,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4G",33.1,"1.45","1.45","A4V mutant of human SOD1 bound with ebselen in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4G"
"6Z4H",,"X-RAY DIFFRACTION",2.04,39.61,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.6M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4H",32.81,"1.95","1.95","A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 2 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4H"
"6Z4I",,"X-RAY DIFFRACTION",2.01,38.92,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4I",33.24,"1.6","1.6","A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 3 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4I"
"6Z4J",,"X-RAY DIFFRACTION",2.04,39.76,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.5M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4J",32.69,"1.55","1.55","A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 5 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4J"
"6Z4K",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4K",32.68,"1.45","1.45","A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 6 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4K"
"6Z4L",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4L",32.84,"1.6","1.6","A4V mutant of human SOD1 bound with 2-(pyridin-3-ylmethyl)benzoisoselenazolone derivative 9 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4L"
"6Z4M",,"X-RAY DIFFRACTION",2.01,38.89,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4M",32.78,"1.55","1.55","A4V mutant of human SOD1 bound with 2-(pyridin-3-ylmethyl)benzoisoselenazolone derivative 10 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4M"
"6Z4O",,"X-RAY DIFFRACTION",2,38.4,"VAPOR DIFFUSION, HANGING DROP",4.7,"100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate",292,"10.1016/j.ebiom.2020.102980",,"6Z4O",32.84,"1.4","1.4","A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 1 in P21 space group","ATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6Z4O"
"6Z4Y",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, SITTING DROP",,"15%(w/v) PEG 3350, 0.2M ammonium citrate",277.15,,,"6Z4Y",34.08,"2.25","2.25","Crystal structure of Aurora A (STK6) in complex with macrocycle ODS2003208","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6Z4Y"
"6Z4Z",,"X-RAY DIFFRACTION",2.5,50.72,"VAPOR DIFFUSION, SITTING DROP",,"17.5% isopropanol, 5% glycerol, 0.1M sodium/potassium phosphate",277.15,,,"6Z4Z",120.24,"2.07","2.07","Crystal structure of CLK1 in complex with macrocycle ODS2004070","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6Z4Z"
"6Z50",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 0.1M sodium malonate",277.15,,,"6Z50",41.32,"1.6","1.6","Crystal structure of CLK1 in complex with macrocycle ODS2003208","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6Z50"
"6Z51",,"X-RAY DIFFRACTION",2.45,49.89,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG 3350, 0.2M potassium/sodium phosphate, 10% ethylene glycol",277.15,,,"6Z51",43.99,"1.92","1.92","Crystal structure of CLK3 in complex with macrocycle ODS2002941","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z51"
"6Z52",,"X-RAY DIFFRACTION",3.05,59.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"20.0% PEG 3350, 0.20M NaI, 0.1M bis-tris propane pH 7.5, 10.0% ethylene glycol",277.15,,,"6Z52",88.13,"2.12","2.12","Crystal structure of CLK3 in complex with macrocycle ODS2003136","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z52"
"6Z53",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M Na/K phosphate, 10% ethylene glycol",277.15,,,"6Z53",43.8,"1.65","1.65","Crystal structure of CLK3 in complex with macrocycle ODS2003128","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z53"
"6Z54",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG 3350, 0.2M potassium/sodium phosphate, 10% ethylene glycol",277.15,,,"6Z54",43.7,"1.73","1.73","Crystal structure of CLK3 in complex with macrocycle ODS2003178","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z54"
"6Z55",,"X-RAY DIFFRACTION",2.99,58.93,"VAPOR DIFFUSION, SITTING DROP",7,"18% PEG 3350, 0.2M potassium/sodium phosphate, 0.1M bis-tris-propane pH 7.0, 10% ethylene glycol",277.15,,,"6Z55",87.41,"1.7","1.7","Crystal structure of CLK3 in complex with macrocycle ODS2004070","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6Z55"
"6Z56",,"X-RAY DIFFRACTION",3.09,60.17,"VAPOR DIFFUSION, SITTING DROP",6,"60.0% MPD, 0.1M MMT pH 6.0",277.15,,,"6Z56",41.23,"1.9","1.9","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2003208","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z56"
"6Z57",,"X-RAY DIFFRACTION",3.06,59.79,"VAPOR DIFFUSION, SITTING DROP",6,"57% MPD, 0.1M MIB pH 6.0",277.15,,,"6Z57",41.57,"1.5","1.5","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2004078","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z57"
"6Z58",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, SITTING DROP",6,"54% MPD, 0.1M SPG pH 6.0",277.15,,,"6Z58",41.17,"1.8","1.8","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2003791","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z58"
"6Z59",,"X-RAY DIFFRACTION",2.88,57.24,"VAPOR DIFFUSION, SITTING DROP",6,"63% MPD, 0.1M MMT pH 6.0",277.15,,,"6Z59",41.06,"2","2","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2003816","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z59"
"6Z5A",,"X-RAY DIFFRACTION",3.11,60.49,"VAPOR DIFFUSION, SITTING DROP",6,"60.0% MPD, 0.1M SPG pH 6.0",277.15,,,"6Z5A",41.68,"1.55","1.55","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2002941","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z5A"
"6Z5B",,"X-RAY DIFFRACTION",3.09,60.23,"VAPOR DIFFUSION, SITTING DROP",7,"60.0% MPD, 0.1M SPG pH 7.0",277.15,,,"6Z5B",41.32,"1.9","1.9","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2003128","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z5B"
"6Z5C",,"X-RAY DIFFRACTION",3.08,60.08,"VAPOR DIFFUSION, SITTING DROP",6,"60.0% MPD, 0.1M SPG pH 6.0",277.15,,,"6Z5C",41.37,"1.75","1.75","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2004070","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z5C"
"6Z5D",,"X-RAY DIFFRACTION",3.07,60,"VAPOR DIFFUSION, SITTING DROP",6,"60.0% MPD, 0.1M SPG pH 6.0",277.15,,,"6Z5D",41.5,"1.75","1.75","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2004082","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z5D"
"6Z5E",,"X-RAY DIFFRACTION",3.07,59.99,"VAPOR DIFFUSION, SITTING DROP",6,"60%(v/v) MPD, 0.1M SPG pH 6.0",277.15,,,"6Z5E",41.48,"1.5","1.5","Crystal structure of haspin (GSG2) in complex with macrocycle ODS2004093","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6Z5E"
"6Z5N",,"SOLUTION NMR",,,,,,,"10.1038/s41586-020-2906-4",,"6Z5N",12.22,,,"DnaJB1 JD-GF","MGKDYYQTLGLARGASDEEIKRAYRRQALRYHPDKNKEPGAEEKFKEIAEAYDVLSDPRKREIFDRYGEEGLKGSGPSGGSGGGANGTSFSYTFHGDPHAMFAEFFGGRN","Homo sapiens","DNAJB1, DNAJ1, HDJ1, HSPF1","DnaJ homolog subfamily B member 1","1","6Z5N"
"6Z6A",,"X-RAY DIFFRACTION",4.54,72.91,"VAPOR DIFFUSION, SITTING DROP",,"200 nL of protein (11-13 mg / mL) and 200 nL of well solution (3.7 to 4.1 M ammonium acetate, 0.09 M sodium acetate pH 4.6 and 10 mM cadmium chloride).",293,"10.1021/acs.jmedchem.0c01569","Q9E","6Z6A",64.68,"2.37","2.37","Keap1 macrocycle complex","PRGSAGAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6Z6A"
"6Z6U","1.25","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2833-4",,"6Z6U",511.09,"1.25",,"1.25 A structure of human apoferritin obtained from Titan Mono-BCOR microscope","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6Z6U"
"6Z6Y",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Na-HEPES, pH 7.6, 10% PEG 4000 and 20% Isopropanol",298,"10.1016/j.isci.2020.101919",,"6Z6Y",18.53,"1.34","1.34","Galectin-8 N-terminal domain in complex with a sulfatide mimicking a sphingolipid","LNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSDLQST","Homo sapiens","LGALS8","Galectin-8","1","6Z6Y"
"6Z6Z",,"X-RAY DIFFRACTION",1.97,37.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, calcium chloride",293,,,"6Z6Z",21.54,"1.78","1.78","Crystal structure of an Anticalin directed towards colchicine without ligand","MQDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGVAGNGFLREDKDPIKMAATIYELKEDKSYNVTFMKFPMKKCQYMTDTLVPGSQPGEFTLGNIKSEPGYTSWLVRVVSTNYNQHAMVFFKAVQQNREDFFITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAHHHHHH","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6Z6Z"
"6Z7F",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION",6.5,"30% PEG300, 0.1M MES",293,"10.1021/acs.jmedchem.0c00605",,"6Z7F",14.15,"1.605","1.605","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)benzamide","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6Z7F"
"6Z7G",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION",,"0.2M BTP pH 6.5, 20% PEG3350, 0.2M NaKtartrate",293,"10.1021/acs.jmedchem.0c00605",,"6Z7G",15.48,"1.59","1.59","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)benzamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6Z7G"
"6Z7L",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION",,"0.1M MES pH 6.5, 15% v/v PEG400",293,"10.1021/acs.jmedchem.0c00614",,"6Z7L",15.56,"1.624","1.624","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 with GSK789","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6Z7L"
"6Z7M",,"X-RAY DIFFRACTION",2.16,42.97,"VAPOR DIFFUSION",,"0.1M Hepes pH 7.0, 5% MgCl2, 20% PEG6K",293,"10.1021/acs.jmedchem.0c00614",,"6Z7M",15.48,"1.26","1.26","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 (3R,4R)-N-cyclohexyl-4-((3-methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl)amino)piperidine-3-carboxamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6Z7M"
"6Z83",,"X-RAY DIFFRACTION",2.93,58.06,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonia sulphate
0.1 M bis-tris pH 5.5
23-26%  PEG 3350",293,"10.1016/j.chembiol.2020.12.013",,"6Z83",88.25,"2.171","2.171","CK2 alpha bound to chemical probe SGC-CK2-1","MHHHHHHSSGVDLGTENLYFQSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6Z83"
"6Z84",,"X-RAY DIFFRACTION",3.08,60.07,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M bis-tris pH 5.5 
23-26% (v/v) PEG 3350
0.2 M ammonia sulphate",293,"10.1016/j.chembiol.2020.12.013",,"6Z84",82.55,"2.5","2.5","CK2 alpha bound to chemical probe SGC-CK2-1 derivative","SMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6Z84"
"6Z86",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Morpheus Buffer 1, 30 % EDO_P8K and Morpheus ethylene glycols (Morpheus HT-96; E10; Molecular Dimensions)",293.15,"10.1073/pnas.2013473117","QBQ","6Z86",518.25,"2.206","2.206","human GTP cyclohydrolase I in complex with 7-deaza-GTP","MHHHHHHGSDDDDKRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS","Homo sapiens","GCH1, DYT5, GCH","GTP cyclohydrolase 1","1","6Z86"
"6Z87",,"X-RAY DIFFRACTION",3.26,62.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.26 M Ammonium Sulfate, 0.1 M TRIS pH 8.5 and 0.2 M Lithium sulfate",293.15,"10.1073/pnas.2013473117",,"6Z87",126.95,"2.564","2.564","human GTP cyclohydrolase I","MHHHHHHGSDDDDKRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS","Homo sapiens","GCH1, DYT5, GCH","GTP cyclohydrolase 1","1","6Z87"
"6Z88",,"X-RAY DIFFRACTION",3.26,62.33,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M Magnesium chloride, 10 % PEG 8000; TRIS pH 7.0",293.15,"10.1073/pnas.2013473117",,"6Z88",255.2,"2.687","2.687","human GTP cyclohydrolase I in complex with allosteric inhibitor","MHHHHHHGSDDDDKRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS","Homo sapiens","GCH1, DYT5, GCH","GTP cyclohydrolase 1","1","6Z88"
"6Z89",,"X-RAY DIFFRACTION",3.02,59.26,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M Magnesium chloride, PEG8000; TRIS pH 7.0",293.15,"10.1073/pnas.2013473117",,"6Z89",127.32,"2.366","2.366","human GTP cyclohydrolase I in complex with allosteric inhibitor","MHHHHHHGSDDDDKRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS","Homo sapiens","GCH1, DYT5, GCH","GTP cyclohydrolase 1","1","6Z89"
"6Z8L",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, HANGING DROP",,"60 % MPD",291.15,"10.1039/d0sc04297h",,"6Z8L",57.59,"1.40000369636","1.40000369636","Alpha-Amylase in complex with probe fragments","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFMPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","6Z8L"
"6Z8P",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION",,"30% PEG 300, 0.1M MES buffer pH6.5",293,"10.1021/acsmedchemlett.0c00247",,"6Z8P",14.28,"1.55","1.55","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK973","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6Z8P"
"6Z90",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"0.7 M sodium citrate tribasic dihydrate, 0.1 M BIS-TRIS propane pH 7.0",293.15,"10.1016/j.molcel.2021.08.024",,"6Z90",32.01,"3.59","3.59","Crystal structure of MINDY1 mutant-P138A","GPLGSPEFPGRLEMEPDFYCVKWIPWKGEQTPIITQSTNGPCALLAIMNILFLQWKVKLPPQKEVITSDELMAHLGNCLLSIKPQEKSEGLQLNFQQNVDDAMTVLPKLATGLDVNVRFTGVSDFEYTPECSVFDLLGIPLYHGWLVDPQSPEAVRAVGKLSYNQLVERIITCKHSSDTNLVTEGLIAEQFLETTAAQLTYHGLCELTAAAKEGELSVFFRNNHFSTMTKHKSHLYLLVTDQGFLQEEQVVWESLHNVDGDSCFCDSDFHLSHSLGKGPGAEGGSGSPE","Homo sapiens","MINDY1, FAM63A, KIAA1390","Ubiquitin carboxyl-terminal hydrolase MINDY-1","1","6Z90"
"6Z9B",,"X-RAY DIFFRACTION",2.55,51.71,"VAPOR DIFFUSION, HANGING DROP",5.5,"CD73 at 7 mg/mL was incubated on ice for one hour with 1mM of the inhibitor and 0.1 mM ZnCl2. 1 uL of protein was mixed with 1 uL of 11-14% PEG6000 and 100 mM sodium citrate pH 5.4-5.6. For cryoprotection glycerol was added to a final concentration of 15 % to the reservoir buffer.",291,"10.1021/acs.jmedchem.0c00525","QCQ","6Z9B",59.98,"2.17","2.17","Human Ecto-5'-nucleotidase (CD73) in complex with AOPCP derivative A830 (compound 16 in publication) in the closed form (crystal form III)","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHADEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6Z9B"
"6Z9C",,"X-RAY DIFFRACTION",2.79,56.01,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Calcium acetate hydrate
0.1M Sodium cacodylate
pH 6.5
40% (v/v) PEG 300",293,"10.1002/pro.4085",,"6Z9C",37.04,"2.8","2.8","Structure of human POLDIP2, a multifaceted adaptor protein in metabolism and genome stability","SMLSSRNRPEGKVLETVGVFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQARLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRSQTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERFLLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYMGMREAQNSHVYWWRYCIRLENLDSDVVQLRERHWRIFSLSGTLETVRGRGVVGREPVLSKEQPAFQYSSHVSLQASSGHMWGTFRFERPDGSHFDVRIPPFSLESNKDEKTPPSGLHW","Homo sapiens","POLDIP2, PDIP38, POLD4, HSPC017","Polymerase delta-interacting protein 2","1","6Z9C"
"6Z9D",,"X-RAY DIFFRACTION",2.39,48.59,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization buffer: 5 % PEG 6000, 0.1 M MES pH 6.0. 1 uL crystallization buffer + 1 uL of 4 mg/mL CD73 in 50 mM Tris pH 8.0, 100 mM NaCl, 10 uM ZnCl2, 1 mM AB680.",293,"10.1021/acs.jmedchem.0c00525","QDH","6Z9D",62.45,"1.9","1.9","Human Ecto-5'-nucleotidase (CD73) in complex with AOPCP derivative AB680 (compound 55 in publication) in the closed form (crystal form III)","MEWSWVFLFFLSVTTGVHSWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSGGGGAGGGGHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6Z9D"
"6Z9E","1.55","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2833-4",,"6Z9E",511.23,"1.55",,"1.55 A structure of human apoferritin obtained from data subset of Titan Mono-BCOR microscope","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6Z9E"
"6Z9F","1.56","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2833-4",,"6Z9F",511.23,"1.56",,"1.56 A structure of human apoferritin obtained from data subset of Titan Mono-BCOR microscope","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6Z9F"
"6ZB0",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION",6.5,"30% PEG 300, 0.1M MES buffer pH6.5",293,"10.1021/acs.jmedchem.0c00796",,"6ZB0",13.93,"1.613","1.613","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-benzyl-N-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6ZB0"
"6ZB1",,"X-RAY DIFFRACTION",2.24,45.16,"VAPOR DIFFUSION",6.5,"30% PEG 300, 0.1M MES buffer pH6.5",293,"10.1021/acs.jmedchem.0c00796",,"6ZB1",13.88,"1.6","1.6","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK620","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6ZB1"
"6ZB2",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION",6.5,"30% PEG 300, 0.1M MES buffer pH6.5",293,"10.1021/acs.jmedchem.0c00796",,"6ZB2",14.09,"2.282","2.282","C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH GSK549","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6ZB2"
"6ZB3",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION",,"30%w/v PEG3350, 0.1M NaAc, 0.1M MES, pH 6.5",293,"10.1021/acs.jmedchem.0c00796",,"6ZB3",15.79,"1.419","1.419","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH GSK620","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6ZB3"
"6ZBA",,"X-RAY DIFFRACTION",2.7,54.42,"VAPOR DIFFUSION, SITTING DROP",,"Protein stored at 20.6 mg/mL in a storage buffer of 50 mM NaCl, 20 mM Tris HCl (pH 7.5), 1 mM TCEP, 1 mM EDTA. Reservoir was 0.1 M HEPES (pH 7.5), 19% PEG3350, 25% ethylene glycol, 5% 2-propanol, 5% glycerol. Drops were microseeded. Apo crystals were soaked with 0.8 mM LEO39652A for 3 days.",277,"10.1021/acs.jmedchem.0c00797",,"6ZBA",169.57,"1.6","1.6","Crystal structure of PDE4D2 in complex with inhibitor LEO39652","GMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFEL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6ZBA"
"6ZBN",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, SITTING DROP",7,"0.15M Potassium thiocyanate pH 7, 20.5% PEG 3350, Sitting Drop (300 nL), protein-to-well ratio, 2:1, 298K",298,"10.1002/cmdc.202100133",,"6ZBN",155.18,"2.01","2.01","HIF Prolyl Hydroxylase 2 (PHD2/EGLN1) in complex with tert-butyl 6-(5-hydroxy-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-1-yl)nicotinate (IOX4)","PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGE","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6ZBN"
"6ZBO",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M Potassium thiocyanate pH 7, 21% PEG 3350, Sitting drop (300 nL), protein-to-well ratio 2:1, 298K",298,"10.1002/cmdc.202100133",,"6ZBO",155.47,"1.79","1.79","HIF Prolyl Hydroxylase 2 (PHD2/EGLN1) in Complex with 1-(6-morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-ol (Molidustat)","PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGE","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6ZBO"
"6ZBQ",,"X-RAY DIFFRACTION",2.59,52.44,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 8000, 0.2 M ammonium sulphate, 0.1 M MES pH 6.5",293,,,"6ZBQ",21.1,"1.43","1.43","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DKFZp586M1622, DVL3, hCG_40299, KIAA0208","Dishevelled, dsh homolog 3 (Drosophila), isoform CRA_b","1","6ZBQ"
"6ZBZ",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 8000, 0.1 M MES pH 5.5",293,,,"6ZBZ",42.28,"1.6","1.6","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DKFZp586M1622, DVL3, hCG_40299, KIAA0208","Dishevelled, dsh homolog 3 (Drosophila), isoform CRA_b","1","6ZBZ"
"6ZC0",,"X-RAY DIFFRACTION",2.22,44.54,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",277,,,"6ZC0",35.25,"1.97","1.97","SYK Kinase domain in complex with azabenzimidazole inhibitor 2b","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZC0"
"6ZC3",,"X-RAY DIFFRACTION",3.12,60.55,"VAPOR DIFFUSION, SITTING DROP",,"1.2 M ammonium sulphate, 0.1 M citric acid pH 5.0",293,,,"6ZC3",20.93,"1.67","1.67","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DKFZp586M1622, DVL3, hCG_40299, KIAA0208","Dishevelled, dsh homolog 3 (Drosophila), isoform CRA_b","1","6ZC3"
"6ZC4",,"X-RAY DIFFRACTION",2.59,52.55,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 8000, 0.2 M ammonium sulphate, 0.1 M MES pH 6.5",293,,,"6ZC4",21.22,"1.85","1.85","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DKFZp586M1622, DVL3, hCG_40299, KIAA0208","Dishevelled, dsh homolog 3 (Drosophila), isoform CRA_b","1","6ZC4"
"6ZC6",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, SITTING DROP",,"1 M ammonium sulphate, 1% PEG 3350, 0.1 M Bis-Tris pH 5.5",293,,,"6ZC6",11.2,"1.58","1.58","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DVL3, KIAA0208","Segment polarity protein dishevelled homolog DVL-3","1","6ZC6"
"6ZC7",,"X-RAY DIFFRACTION",3.04,59.47,"VAPOR DIFFUSION, SITTING DROP",,"1.26 M sodium phosphate, 0.14 M potassium phosphate",293,,,"6ZC7",21.51,"1.48","1.48","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DKFZp586M1622, DVL3, hCG_40299, KIAA0208","Dishevelled, dsh homolog 3 (Drosophila), isoform CRA_b","1","6ZC7"
"6ZC8",,"X-RAY DIFFRACTION",3.72,66.92,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M ammonium sulphate, 12% glycerol, 0.1 M Tris-HCl pH 8.5",293,,,"6ZC8",21.4,"2.76","2.76","Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling","AMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKS","Homo sapiens","DVL3, KIAA0208","Segment polarity protein dishevelled homolog DVL-3","1","6ZC8"
"6ZCI",,"X-RAY DIFFRACTION",1.95,36.92,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 200 mM Sodium Malonate pH 5.0",293.15,"10.1038/s41589-020-00716-z",,"6ZCI",17.98,"1.976","1.976","Crystal structure of BRD4-BD1 in complex with NVS-BET-1","MHHHHHHSSGVDLGTENLYFQSMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6ZCI"
"6ZCM",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZCM",43.49,"1.24","1.24","Crystal structure of YTHDC1 with compound DHU_DC1_180","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6ZCM"
"6ZCN",,"X-RAY DIFFRACTION",1.97,37.66,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZCN",43.23,"1.6","1.6","Crystal structure of YTHDC1 with m6A","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6ZCN"
"6ZCP",,"X-RAY DIFFRACTION",2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCP",35.29,"2.2","2.2","SYK Kinase domain in complex with azabenzimidazole inhibitor 2b","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCP"
"6ZCQ",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCQ",35.34,"2.32","2.32","SYK Kinase domain in complex with diamine inhibitor 5","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCQ"
"6ZCR",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCR",35.3,"1.73","1.73","SYK Kinase domain in complex with azabenzimidazole inhibitor 7","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCR"
"6ZCS",,"X-RAY DIFFRACTION",2.27,45.72,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCS",35.31,"1.47","1.47","SYK Kinase domain in complex with azabenzimidazole inhibitor 3","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCS"
"6ZCU",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",277,,,"6ZCU",35.3,"1.73","1.73","syk in complex with 57262_SYKB-AZ13344324-2","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCU"
"6ZCX",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCX",35.34,"1.66","1.66","SYK Kinase domain in complex with azabenzimidazole inhibitor 18","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCX"
"6ZCY",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na3Cit pH 6.4, 16% PEG3350, 0.2M KH2PO4",278,,,"6ZCY",35.33,"1.81","1.81","SYK Kinase domain in complex with diamine inhibitor 16","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6ZCY"
"6ZD3",,"X-RAY DIFFRACTION",2,38.42,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD3",42.6,"1.25","1.25","Crystal structure of YTHDC1 M438A mutant","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKALGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1","YTH domain containing 1","1","6ZD3"
"6ZD4",,"X-RAY DIFFRACTION",1.97,37.68,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD4",42.57,"1.4","1.4","Crystal structure of YTHDC1 S378A mutant","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWATLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1","YTH domain containing 1","1","6ZD4"
"6ZD5",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD5",43.14,"2.3","2.3","Crystal structure of YTHDC1 S378A mutant complex with m6A","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWATLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1","YTH domain containing 1","1","6ZD5"
"6ZD7",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD7",43.17,"1.75","1.75","Crystal structure of YTHDC1 T379V mutant complex with m6A","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSVLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1","YTH domain containing 1","1","6ZD7"
"6ZD8",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD8",42.79,"1.5","1.5","Crystal structure of YTHDC1 T379V mutant","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSVLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens",,"YTHDC1","1","6ZD8"
"6ZD9",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZD9",93.97,"1.51","1.51","Crystal structure of YTHDC1 apo purified using GST tag","MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKSDLEVLFQGPLGSENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens","YTHDC1, KIAA1966, YT521","YTHDC1","1","6ZD9"
"6ZDA",,"X-RAY DIFFRACTION",2.27,45.91,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M Ammonium Sulphate, 0.1M bis-tris, pH 6.5",295,"10.1021/acs.jctc.0c01136",,"6ZDA",43.05,"1.3","1.3","Crystal structure of YTHDC1 M438A mutant complex with m6A","MHHHHHHSSGRENLYFQGTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKALGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRH","Homo sapiens",,"YTHDC1","1","6ZDA"
"6ZDC",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",6,"100 mM MIB buffer, pH 6.0.
Protein at 5.5 mg/ml in 50 mM potassium phosphate, 50 mM KCl.
150 nl protein solution and 150 nl reservoir solution.",292,"10.1073/pnas.2013620117",,"6ZDC",44.84,"2.251","2.251","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with nickel","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZDC"
"6ZDE",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, SITTING DROP",7.1,"PEG6000 20% w/v
HEPES 0.1 M
DMSO 2.5%
gamma-cyclodextrin 5 mM",291.15,,,"6ZDE",29.2,"1.87","1.87","17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with pentafluorophenol","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6ZDE"
"6ZDF",,"X-RAY DIFFRACTION",2.71,54.6,"VAPOR DIFFUSION, SITTING DROP",7,"1 M sodium succinate pH 7.0, 1% w/v PEG-MME2000
Protein at 10 mg/ml in buffer: 25 mM HEPES pH 7.0, 200 mM NaCl
100 nl protein solution and 200 nl reservoir solution.",292,"10.1073/pnas.2013620117",,"6ZDF",135.06,"3","3","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with HEPES","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZDF"
"6ZDI",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, HANGING DROP",7.1,"PEG6000 27% w/v
HEPES 1M
DMSO 2.5%
2-hydroxypropyl-betaczclodextrin 5mM",291.15,,,"6ZDI",29.17,"2.13","2.13","17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with 2-fluoro-5-nitrophenol","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6ZDI"
"6ZDK",,"X-RAY DIFFRACTION",2.61,53.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM  HEPES pH 7.5, 200 mM MgCl2, 30% v/v PEG 400 (Alfa Aesar), 1 mM Anderson-Evans polyoxotungstate TEW.
Protein at 10 mg/ml in 25 mM HEPES pH 7.0, 200 mM NaCl buffer.",292,"10.1073/pnas.2013620117",,"6ZDK",49.89,"2","2","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with HEPES and hexatungstotellurate(VI) TEW","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZDK"
"6ZDL",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM  HEPES pH 7.5, 200 mM MgCl2, 30% v/v PEG 400 (Alfa Aesar), 1 mM Anderson-Evans polyoxotungstate TEW.
Protein at 10 mg/ml in 25 mM HEPES pH 7.0, 200 mM NaCl buffer.",292,"10.1073/pnas.2013620117",,"6ZDL",50.22,"1.9","1.9","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with GlcIFG and hexatungstotellurate(VI) TEW","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZDL"
"6ZDM",,"X-RAY DIFFRACTION",2.37,48.16,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES pH 5.5, 0.1 M MgCl2, 17% PEG3350",293,"10.1039/d0cc05932c",,"6ZDM",53.71,"1.714","1.714","Crystal structure of human heparanase in complex with a N',6O'-bis-sulfated 4-methylumbelliferyl heparan sulfate disaccharide","DPGKKFKNSTYSRSSVDVLYTFANCSGLDLIFGLNALLRTADLQWNSSNAQLLLDYCSSKGYNISWELGNEPNSFLKKADIFINGSQLGEDFIQLHKLLRKSTFKNAKLYGPDVGQPRRKTAKMLKSFLKAGGEVIDSVTWHHYYLNGRTATREDFLNPDVLDIFISSVQKVFQVVESTRPGKKVWLGETSSAYGGGAPLLSDTFAAGFMWLDKLGLSARMGIEVVMRQVFFGAGNYHLVDENFDPLPDYWLSLLFKKLVGTKVLMASVQGSKRRKLRVYLHCTNTDNPRYKEGDLTLYAINLHNVTKYLRLPYPFSNKQVDKYLLRPLGPHGLLSKSVQLNGLTLKMVDDQTLPPLMEKPLRPGSSLGLPAFSYSFFVIRNAKVAACI","Homo sapiens","HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1","Heparanase","1","6ZDM"
,,,,,,,,,,,,,,,,"DPGQDVVDLDFFTQEPLHLVSPSFLSVTIDANLATDPRFLILLGSPKLRTLARGLSPAYLRFGGTKTDFLIFDPKKE","Homo sapiens","HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1","Heparanase","2","6ZDM"
"6ZE8",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",7.2,"31% (w/v) polyethylene glycol (PEG) 3350, 200 mM potassium sodium tartrate (PST)",291,"10.1021/acs.jmedchem.0c01179","QGB","6ZE8",247.28,"1.5","1.5","Crystal structure of human chitotriosidase-1 (hCHIT) catalytic domain in complex with compound OATD-01","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELS","Homo sapiens","CHIT1","Chitotriosidase-1","1","6ZE8"
"6ZE9",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES pH 7.5, 200 mM ammonium acetate, 45% (v/v) 2-methyl-2,4-pentanediol",293,"10.12688/wellcomeopenres.16078.2",,"6ZE9",15.42,"2.9","2.9","Non-native fold of the putative VPS39 zinc finger domain","MHHHHHHMVCMVCKKKIGNSAFARYPNGVVVHYFCSKEVNPADT","Homo sapiens","VPS39, KIAA0770, TLP, VAM6","Vam6/Vps39-like protein","1","6ZE9"
"6ZEC",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",,"25 %w/v Polyethylene Glycol 3350
0.200 M Magnesium Chloride
0.100 M bis-Tris pH 5.5",296,"10.1182/blood.2021012052",,"6ZEC",50.69,"1.65","1.65","Crystal Structure of the Fab Fragment of a Glycosylated Lymphoma Antibody","DIVMTQSPDSLSVSLGERATINCKSSQSVLYSSHNKNYLAWYQQKPGQPPRLLIYWASTRESGVPDRFSGSGSGTDFTLTINTLQAEDVAVYYCQQYYTTPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment light chain","1","6ZEC"
,,,,,,,,,,,,,,,,"ETGQVQLQQWGAGLLKTSETLSLTCAVYGGSFNNYNWTWIRQPPGKGLEWIGQINHSGTTNYNPSLKSRVTMSIDPSENQFSLKVRSVTAADTAIYYCVRGSPESSGNYWGHFQYWGQGTLATVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCGTKHHHHHH","Homo sapiens",,"Fab fragment heavy chain","2","6ZEC"
"6ZED",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M bis-tris-propane pH 6.5, 20% PEG3350, 0.2M sodium fluoride, 10% ethylene glycol",277,,,"6ZED",15.39,"1.08","1.08","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound F1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6ZED"
"6ZEL",,"X-RAY DIFFRACTION",2.15,42.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M bis-tris-propane pH 7.9, 20% PEG3350, 0.2M sodium fluoride, 10% ethylene glycol",277,,,"6ZEL",15.52,"1.12","1.12","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound F5","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6ZEL"
"6ZF9",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, SITTING DROP",6,"20% w/v MMW PgSm, 100mM MES pH 6, 150 mM Ammonium nitrate, 5% ethylene glycol",277,,,"6ZF9",15.51,"1.2","1.2","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX with compound SSR4","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6ZF9"
"6ZFA",,"X-RAY DIFFRACTION",2.55,51.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM  HEPES pH 7.5, 200 mM MgCl2, 30% v/v PEG 400 (Alfa Aesar), 1 mM Anderson-Evans polyoxotungstate TEW.
Protein at 10 mg/ml in 25 mM HEPES pH 7.0, 200 mM NaCl buffer.",292,"10.1073/pnas.2013620117",,"6ZFA",50.56,"1.8","1.8","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with GlcIFG, alpha-1,2-mannobiose and hexatungstotellurate(VI) TEW","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZFA"
"6ZFH",,"X-RAY DIFFRACTION",2.42,49.17,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus condition:

Buffer system 1:
0.1 M pH 6.5, Imidazole; MES monohydrate (acid)

Amino acids:
0.02M L-Na-Glutamate; 0.02M Alanine (racemic); 0.02M Glycine; 0.02M Lysine HCl (racemic); 0.02M Serine (racemic)

Precipitant Mix 1:
20% v/v PEG 500 MME; 10 % w/v PEG 20000",293,"10.1021/acschembio.0c00498",,"6ZFH",348.62,"2.439","2.439","Structure of human galactokinase in complex with galactose and 2'-(benzo[d]oxazol-2-ylamino)-7',8'-dihydro-1'H-spiro[cyclopentane-1,4'-quinazolin]-5'(6'H)-one","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZFH"
"6ZFL",,"X-RAY DIFFRACTION",3.51,64.93,"VAPOR DIFFUSION, HANGING DROP",8.5,"(VEGF)2:2 PEPTIDE_2C COMPLEX PURIFIED ON SEC AND CONCENTRATED AT 17MG/ML IN TRIS/HCL 10MM PH 8.5. (SEE ID 6Z3F) mix 1UL OF COMPLEX WITH 1 UL OF RESERVOIR : TRIS/HCL 100MM PH 8.5 / MPD 42% (V/V) / (NH4)2PO4 200MM",293,"10.1002/chem.202200465",,"6ZFL",23.28,"1.6","1.6","High resolution structure of VEGF-A 12:107 crystallized in tetragonal form","MEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPK","Homo sapiens","VEGFA, VEGF","Vascular endothelial growth factor A","1","6ZFL"
"6ZFN",,"X-RAY DIFFRACTION",2.07,40.5,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate pH 4.6, 200 mM ammonium sulfate, 12.8% PEG-MME 2000.
Protein at 10 mg/ml in 25 mM HEPES pH 7.0, 200 mM NaCl buffer with 2.3 mM GlcMan4OMe (10 x molar ratio). 500 nl protein solution and 500 nl reservoir solution.",279,"10.1073/pnas.2013620117",,"6ZFN",45.23,"1.1","1.1","Structure of an inactive E404Q variant of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with 1-methyl alpha-1,2-mannobiose","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNQWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZFN"
"6ZFQ",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"100 mM bis-tris pH 5.5, 25% w/v PEG 3350.
Protein at 10 mg/ml in 25 mM HEPES pH 7.0, 200 mM NaCl buffer with 2.23 mM GlcIFG and 2.23 mM alpha-1,2-mannobiose (10 x molar ratio). 300 nl droplet (150 nl protein solution, 150 nl reservoir solution). The ligand additives are probably not required for crystallization.",292,"10.1073/pnas.2013620117",,"6ZFQ",44.99,"1.2","1.2","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with bis-tris","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZFQ"
"6ZFV",,"SOLUTION NMR",,,,,,,,,"6ZFV",7.13,,,"Solution NMR structure of human GATA2 N-terminal zinc finger domain","MAHHHHHHSSGLEVLFQGPEGRECVNCGATATPLWRRDGTGHYLCNACGLYHKMNGQNRPLIK","Homo sapiens","GATA2","Endothelial transcription factor GATA-2","1","6ZFV"
"6ZFX","2.88","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.62021",,"6ZFX",642.46,"2.88, 2.88",,"hSARM1 GraFix-ed","MSYHHHHHHDYDIPTTENLYFQGAMGSERLAVPGPDGGGGTGPWWAAGGRGPREVSPGAGTEVQDALERALPELQQALSALKQAGGARAVGAGLAEVFQLVEEAWLLPAVGREVAQGLCDAIRLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQAVQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNRLEAQCIGAFYLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKQIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAPMGPT","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","NAD(+) hydrolase SARM1","1","6ZFX"
"6ZG0","7.7","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.62021",,"6ZG0",641.81,"7.7",,"SARM1 SAM1-2 domains","MSYHHHHHHDYDIPTTENLYFQGAMGSERLAVPGPDGGGGTGPWWAAGGRGPREVSPGAGTEVQDALERALPELQQALSALKQAGGARAVGAGLAEVFQLVEEAWLLPAVGREVAQGLCDAIRLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQAVQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNRLEAQCIGAFYLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKQIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAPMGPT","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","NAD(+) hydrolase SARM1","1","6ZG0"
"6ZG1","3.77","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.62021",,"6ZG1",152.63,"3.77",,"SARM1 SAM1-2 domains","GSSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHS","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6ZG1"
"6ZGC",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.26M sodium phosphate monobasic
0.14M potassium phosphate dibasic",277,"10.1172/jci.insight.95042",,"6ZGC",141.99,"2.67","2.67","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","6ZGC"
"6ZGV",,"X-RAY DIFFRACTION",2.97,58.54,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of:sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,"10.1021/acschembio.0c00498",,"6ZGV",174.25,"2.3","2.3","Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZGV"
"6ZGW",,"X-RAY DIFFRACTION",2.91,57.72,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of:sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,"10.1021/acschembio.0c00498",,"6ZGW",174.25,"2.3","2.3","Structure of human galactokinase 1 bound with (4-chlorophenyl)methyl pyridine-3-carboxylate","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZGW"
"6ZGX",,"X-RAY DIFFRACTION",2.97,58.62,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of - sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate)",293,"10.1021/acschembio.0c00498",,"6ZGX",174.25,"1.86","1.86","Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZGX"
"6ZGY",,"X-RAY DIFFRACTION",2.89,57.5,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of-sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,"10.1021/acschembio.0c00498",,"6ZGY",174.46,"2.3","2.3","Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZGY"
"6ZGZ",,"X-RAY DIFFRACTION",2.88,57.32,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of - sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,"10.1021/acschembio.0c00498",,"6ZGZ",174.23,"2.3","2.3","Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZGZ"
"6ZH0",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of - sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,"10.1021/acschembio.0c00498",,"6ZH0",174.9,"2.5","2.5","Structure of human galactokinase 1 bound with 2-(4-chlorophenyl)-N-(pyrimidin-2-yl)acetamide","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6ZH0"
"6ZH2","3.92","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-00517-x",,"6ZH2",472.06,"3.92",,"Cryo-EM structure of DNA-PKcs (State 1)","MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRAAKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGLLGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEEDPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKWCAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELSIAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASVLLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCISTVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQMMDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGVWMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRLPLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQYKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYIDRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNLSSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFREMKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQLYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDPVDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASLAFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEKKHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPGNRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLLLAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGNRTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPASIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPDAQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCLPSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFYSLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLATTILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLADTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYVDCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLESVYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNESTFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCYDAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFENLIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEMSQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTALVKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPYAKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLMKHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIVMANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEESLCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEVVLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVEFVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLIIRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHPLSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQQHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDFGKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSELKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEMDKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGCLASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLRGIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLDCYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQSLLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVLLHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWDDIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKMKMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTVLKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRILELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFCDQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETLSLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESYSFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTPVNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFNDITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIAGFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSACSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYKDWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLALRSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMPFRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKMLKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAVARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWMXXXXXXXXXXXXXXXXXXXXXXXXXXXX","Homo sapiens","PRKDC","DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-dependent protein kinase catalytic subunit,DNA-PKcs","1","6ZH2"
,,,,,,,,,,,,,,,,,"Homo sapiens","PRKDC"
"6ZH4","3.62","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-00517-x",,"6ZH4",472.06,"3.62",,"Cryo-EM structure of DNA-PKcs (State 3)","MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRAAKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGLLGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEEDPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKWCAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELSIAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASVLLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCISTVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQMMDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGVWMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRLPLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQYKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYIDRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNLSSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFREMKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQLYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDPVDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASLAFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEKKHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPGNRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLLLAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGNRTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPASIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPDAQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCLPSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFYSLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLATTILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLADTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYVDCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLESVYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNESTFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCYDAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFENLIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEMSQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTALVKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPYAKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLMKHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIVMANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEESLCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEVVLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVEFVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLIIRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHPLSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQQHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDFGKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSELKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEMDKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGCLASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLRGIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLDCYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQSLLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVLLHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWDDIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKMKMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTVLKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRILELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFCDQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETLSLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESYSFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTPVNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFNDITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIAGFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSACSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYKDWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLALRSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMPFRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKMLKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAVARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWMXXXXXXXXXXXXXXXXXXXXXXXXXXXX","Homo sapiens","PRKDC","DNA-dependent protein kinase catalytic subunit,DNA-PKcs","1","6ZH4"
,,,,,,,,,,,,,,,,,"Homo sapiens","PRKDC"
"6ZIO",,"X-RAY DIFFRACTION",2.03,39.41,"VAPOR DIFFUSION",,"25% PEG 2000, 100mM HEPES PH=7.5",278,"10.4155/fmc-2020-0221",,"6ZIO",40.18,"1.55","1.55","CRYSTAL STRUCTURE OF NRAS (C118S) IN COMPLEX WITH GDP","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKSDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLN","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","6ZIO"
"6ZIR",,"X-RAY DIFFRACTION",4.34,71.68,"VAPOR DIFFUSION",,"3.7M sodium formate, 2% PEG 3000, 100mM bicine PH=8",278,"10.4155/fmc-2020-0221","EZZ","6ZIR",20.75,"1.9","1.9","CRYSTAL STRUCTURE OF NRAS (C118S) IN COMPLEX WITH GDP AND COMPOUND 18","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKSDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLN","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","6ZIR"
"6ZIW",,"X-RAY DIFFRACTION",3.95,68.82,"VAPOR DIFFUSION, SITTING DROP",5.5,"1 M lithium sulphate
0.5 M ammonium sulphate
0.1 M citrate pH 5.5",277,,,"6ZIW",37.19,"2.18","2.18","The IRAK3 Pseudokinase Domain Bound To ATPgammaS","SEHNEKGVLLKSSISFQNIIEGTRNFHKDFLIGEGEIFEVYRVEIQNLTYAVKLFKQEKKMQCKKHWKRFLSELEVLLLFHHPNILELAAYFTETEKFCLIYPYMRNGTLFDRLQCVGDTAPLPWHIRIGILIGISKAIHYLHNVQPCSVICGSISSANILLDDQFQPKLTDFAMAHFRSHLEHQSCTINMTSSSSKHLWYMPEEYIRQGKLSIKTDVYSFGIVIMEVLTGCRVVLDDPKHIQLRDLLRELMEKRGLDSCLSFLDKKVPPCPRNFSAKLFCLAGRCAATRAKLRPSMDEVLNTLESTQASLYFAED","Homo sapiens","IRAK3","Interleukin-1 receptor-associated kinase 3","1","6ZIW"
"6ZIZ",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION",,"Morpheus buffer 1 100mM pH=6.6
Morpheus Monosacharides 14%
P550MME_P20K 32%",278,"10.4155/fmc-2020-0221",,"6ZIZ",41.02,"1.785","1.785","CRYSTAL STRUCTURE OF NRAS Q61R IN COMPLEX WITH GTP AND COMPOUND 18","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGREEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKSDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLN","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","6ZIZ"
"6ZJ0",,"X-RAY DIFFRACTION",3.64,66.19,"VAPOR DIFFUSION",,"30% PEG400, 200mM MgCl2, 100mM TRIS PH=8,5",278,"10.4155/fmc-2020-0221",,"6ZJ0",19.88,"1.763","1.763","CRYSTAL STRUCTURE OF HRAS-G12D IN COMPLEX WITH GCP AND COMPOUND 18","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6ZJ0"
"6ZJ1",,"X-RAY DIFFRACTION",2.71,54.7,"VAPOR DIFFUSION, SITTING DROP",,"100 mM HEPES pH 7.5 - 8.1, 200 mM MgCl2, 25-27.5% v/v PEG 400, 1 mM TEW
Protein in 25 mM HEPES pH 7.0, 200 mM NaCl buffer at 10 mg/ml.",292,"10.1073/pnas.2013620117",,"6ZJ1",48.72,"1.957","1.957","Structure of an inactive E404Q variant of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with tetrasaccharide N-glycan fragment and hexatungstotellurate(VI) TEW","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNQWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZJ1"
"6ZJ5",,"X-RAY DIFFRACTION",2.57,52.2,"VAPOR DIFFUSION, SITTING DROP",,"100 mM HEPES pH 7.5 - 8.1, 200 mM MgCl2, 25-27.5% v/v PEG 400, 1 mM TEW
Protein in 25 mM HEPES pH 7.0, 200 mM NaCl buffer at 10 mg/ml.",292,"10.1073/pnas.2013620117",,"6ZJ5",50.71,"2.269","2.269","Structure of the catalytic domain of human endo-alpha-mannosidase MANEA in complex with GlcDMJ and hexatungstotellurate(VI) TEW","MNHKVHHHHHHIEGRHMPLNNYLHVFYYSWYGNPQFDGKYIHWNHPVLEHWDPRIAKNYPQGRHNPPDDIGSSFYPELGSYSSRDPSVIETHMRQMRSASIGVLALSWYPPDVNDENGEPTDNLVPTILDKAHKYNLKVTFHIEPYSNRDDQNMYKNVKYIIDKYGNHPAFYRYKTKTGNALPMFYVYDSYITKPEKWANLLTTSGSRSIRNSPYDGLFIALLVEEKHKYDILQSGFDGIYTYFATNGFTYGSSHQNWASLKLFCDKYNLIFIPSVGPGYIDTSIRPWNTQNTRNRINGKYYEIGLSAALQTRPSLISITSFNEWHEGTQIEKAVPKRTSNTVYLDYRPHKPGLYLELTRKWSEKYSKERATYALDRQLPVS","Homo sapiens","MANEA","Glycoprotein endo-alpha-1,2-mannosidase","1","6ZJ5"
"6ZJB",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, HANGING DROP",5.6,"Purified hAK3 was dialyzed against 30 mM MOPS buffer with 50 mM NaCl pH 7.0 and concentrated to 15-20 mg per ml. The resevoir contained 20% isopropanol, 0.1 M NaCitrate pH 5.6 and 20% PEG 4000. Drop size 1 plus 1 microliter.",291,"10.1021/acs.biochem.0c00549",,"6ZJB",159.34,"1.822","1.822","Crystal structure of human adenylate kinase 3, AK3, in complex with inhibitor Gp5A","MGASARLLRAVIMGAPGSGKGTVSSRITTHFELKHLSSGDLLRDNMLRGTEIGVLAKAFIDQGKLIPDDVMTRLALHELKNLTQYSWLLDGFPRTLPQAEALDRAYQIDTVINLNVPFEVIKQRLTARWIHPASGRVYNIEFNPPKTVGIDDLTGEPLIQREDDKPETVIKRLKAYEDQTKPVLEYYQKKGVLETFSGTETNKIWPYVYAFLQTKVPQRSQKASVTP","Homo sapiens","AK3, AK3L1, AK6, AKL3L","GTP:AMP phosphotransferase AK3, mitochondrial","1","6ZJB"
"6ZJD",,"X-RAY DIFFRACTION",2.46,49.93,"VAPOR DIFFUSION, HANGING DROP",8,"Purified hAK3 was dialyzed against 30 mM MOPS buffer with 50 mM NaCl pH 7.0 and concentrated to 15-20 mg per ml. The resevoir contained 0.2 M MgCl2, 0.1 M Tris pH 8.0 and 20% PEG 6000. Drop size 1 plus 1 microliter. Cryo protection 30% PEG6000",291,"10.1021/acs.biochem.0c00549","ATP","6ZJD",26.31,"1.75","1.75","Crystal structure of human adenylate kinase 3, AK3, in complex with inhibitor ATP","MGASARLLRAVIMGAPGSGKGTVSSRITTHFELKHLSSGDLLRDNMLRGTEIGVLAKAFIDQGKLIPDDVMTRLALHELKNLTQYSWLLDGFPRTLPQAEALDRAYQIDTVINLNVPFEVIKQRLTARWIHPASGRVYNIEFNPPKTVGIDDLTGEPLIQREDDKPETVIKRLKAYEDQTKPVLEYYQKKGVLETFSGTETNKIWPYVYAFLQTKVPQRSQKASVTP","Homo sapiens","AK3, AK3L1, AK6, AKL3L","GTP:AMP phosphotransferase AK3, mitochondrial","1","6ZJD"
"6ZJE",,"X-RAY DIFFRACTION",2.49,50.66,"VAPOR DIFFUSION, HANGING DROP",8,"Purified hAK3 was dialyzed against 30 mM MOPS buffer with 50 mM NaCl pH 7.0 and concentrated to 15-20 mg per ml. The resevoir contained 0.2 M CaCl2, 0.1 M Tris pH 8.0 and 20% PEG 6000. Drop size 1 plus 1 microliter. Cryo protection 30% PEG 6000",291,"10.1021/acs.biochem.0c00549",,"6ZJE",26.63,"1.48","1.48","Crystal structure of human adenylate kinase 3, AK3, in complex with inhibitor Ap5A","MGASARLLRAVIMGAPGSGKGTVSSRITTHFELKHLSSGDLLRDNMLRGTEIGVLAKAFIDQGKLIPDDVMTRLALHELKNLTQYSWLLDGFPRTLPQAEALDRAYQIDTVINLNVPFEVIKQRLTARWIHPASGRVYNIEFNPPKTVGIDDLTGEPLIQREDDKPETVIKRLKAYEDQTKPVLEYYQKKGVLETFSGTETNKIWPYVYAFLQTKVPQRSQKASVTP","Homo sapiens","AK3, AK3L1, AK6, AKL3L","GTP:AMP phosphotransferase AK3, mitochondrial","1","6ZJE"
"6ZJF",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, SITTING DROP",6,"19% PEG 3350, 0.1M NaCl, 0.1M bis-tris 6.0",277.15,"10.1021/acs.jmedchem.0c01174",,"6ZJF",37.79,"1.75","1.75","Crystal structure of STK17B (DRAK2) in complex with AP-229","MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS","Homo sapiens","STK17B, DRAK2","Serine/threonine-protein kinase 17B","1","6ZJF"
"6ZJG",,"X-RAY DIFFRACTION",2.03,39.41,"VAPOR DIFFUSION, SITTING DROP",,"(20% (w/v) PEG 3350, 0.1M Bis-Tris propane, pH 6.5, 0.2M Potassium thiocyanate",293,,,"6ZJG",49,"2.45","2.45","Crystal structure of ACPA E4 in complex with CII-C-48-CIT","CEAGEPGERGLKGHRGCA","Homo sapiens",,"CII-C-48-CIT","1","6ZJG"
,,,,,,,,,,,,,,,,"QVQLEESGPGLVRPSETLSLSCTVSGFPMNESYFWGWIRQSPGKGLEWLGSVIHTGTTYYRPSLESRLTIAMDPSKNQVSLSLTSVTVADSAMYYCVRIRGGSSNWLDPWGPGIVVTASSAKTTPPSVYPLAPGCGDTTGSSVTLGCLVKGYFPESVTVTWNSGSLSSSVHTFPALLQSGLYTMSSSVTVPSSTWPSQTVTCSVAHPASSTTVDKKIEPRP","Homo sapiens",,"ACPA E4 Fab fragment - heavy chain","2","6ZJG"
,,,,,,,,,,,,,,,,"QSVWTQPPSVSAAPGQNVTISCSGDDSILRSAFVSWYQQVPGSAPKLVIFDDRQRPSGIPARFSGSNSGTTATLDIAGLQRGDEADYYCAAWNGRLSAFVFGSGTKLTVLGQPKSSPSVTLFPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYLTLTARAWERHSSYSCQVTHEGHTVEKSLSRADCS","Homo sapiens",,"ACPA E4 Fab fragment - light chain","3","6ZJG"
"6ZJZ",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, HANGING DROP",5,"12.5% PEG 3350, 0.2 M K formate, 0.1 M Na citrate, pH 5.0",294,"10.1124/jpet.120.000275","QLH","6ZJZ",190.95,"2.489","2.489","Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity","EENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVT","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","6ZJZ"
"6ZK0",,"X-RAY DIFFRACTION",2.52,51.18,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2M MnS04, 0.1M MES, 28% PEG4000 and pH 5.5",293,"10.1107/S2053230X20011310",,"6ZK0",63.03,"1.47","1.47","1.47A human IMPase with ebselen","GPMADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED","Homo sapiens","IMPA1, IMPA","Inositol monophosphatase 1","1","6ZK0"
"6ZK6",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, SITTING DROP",8,"PEG 3350, TRIS , lithium chloride",293,"10.1002/cbic.202000669",,"6ZK6",38.01,"1.9","1.9","Protein Phosphatase 1 (PP1) T320E mutant","GMSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPIEPPRNSAKAKK","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","6ZK6"
"6ZK7",,"X-RAY DIFFRACTION",3.77,67.38,"VAPOR DIFFUSION, SITTING DROP",6.7,"2 M (NH4)2SO4
0.5 g/ml PEG 400
100 mM MES-NaOH pH 6.7
100 mM CH3COOLi
5 mM TCEP",278,"10.1016/j.molcel.2021.04.007",,"6ZK7",57.76,"3.2","3.2","Crystal Structure of human PYROXD1/FAD complex","GPLGSMEAARPPPTAGKFVVVGGGIAGVTCAEQLATHFPSEDILLVTASPVIKAVTNFKQISKILEEFDVEEQSSTMLGKRFPNIKVIESGVKQLKSEEHCIVTEDGNQHVYKKLCLCAGAKPKLICEGNPYVLGIRDTDSAQEFQKQLTKAKRIMIIGNGGIALELVYEIEGCEVIWAIKDKAIGNTFFDAGAAEFLTSKLIAEKSEAKIAHKRTRYTTEGRKKEARSKSKADNVGSALGPDWHEGLNLKGTKEFSHKIHLETMCEVKKIYLQDEFRILKKKSFTFPRDHKSVTADTEMWPVYVELTNEKIYGCDFIVSATGVTPNVEPFLHGNSFDLGEDGGLKVDDHMHTSLPDIYAAGDICTTSWQLSPVWQQMRLWTQARQMGWYAAKCMAAASSGDSIDMDFSFELFAHVTKFFNYKVVLLGKYNAQGLGSDHELMLRCTKGREYIKVVMQNGRMMGAVLIGETDLEETFENLILNQMNLSSYGEDLLDPNIDIEDYFD","Homo sapiens","PYROXD1","Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1","1","6ZK7"
"6ZL3",,"X-RAY DIFFRACTION",3.66,66.4,"VAPOR DIFFUSION",,"160mM Calcium acetate
20% Glycerol
14.4% PEG8000
80mM Sodium cacodylate",278,"10.4155/fmc-2020-0221",,"6ZL3",19.72,"2.031","2.031","CRYSTAL STRUCTURE OF HRAS IN COMPLEX WITH COMPOUND 18 and GDP","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6ZL3"
"6ZL5",,"X-RAY DIFFRACTION",4.13,70.25,"VAPOR DIFFUSION",,"2M Ammonium sulfate
100mM Sodium cacodylate
200mM Sodium cloride",278,"10.4155/fmc-2020-0221","F0K","6ZL5",20.45,"1.645","1.645","CRYSTAL STRUCTURE OF KRAS-G12D(C118S) IN COMPLEX WITH BI-2852 AND GDP","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6ZL5"
"6ZLE",,"SOLUTION NMR",,,,,,,"10.1073/pnas.2017406117",,"6ZLE",18.18,,,"Solution structure of unliganded MLKL executioner domain","GSPGENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRD","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6ZLE"
"6ZLI",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION",,"51.8% MPD
50mM MES PH= 6.4",278,"10.4155/fmc-2020-0221",,"6ZLI",40.07,"1.73","1.73","CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH COMPOUND 13 AND GCP","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6ZLI"
"6ZLN",,"X-RAY DIFFRACTION",2.59,52.54,"VAPOR DIFFUSION, SITTING DROP",9,"14% PEG 6k, 0.1M bicine",277,"10.1021/acs.jmedchem.0c00898","PKB","6ZLN",40.14,"1.7","1.7","CLK1 bound with GW807982X (Cpd 8)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6ZLN"
"6ZLX",,"X-RAY DIFFRACTION",3.5,64.88,"BATCH MODE",,"20% PEG 8000",298,,,"6ZLX",34.46,"3.394","3.394","The structure of the ClpX-associated factor PDIP38","VFEVPKQNGKYETGQLFLHSIFGYRGVVLFPWQARLYDRDVASAAPEKAENPAGHGSKEVKGKTHTYYQVLIDARDCPHISQRSQTEAVTFLANHDDSRALYAIPGLDYVSHEDILPYTSTDQVPIQHELFERFLLYDQTKAPPFVARETLRAWQEKNHPWLELSDVHRETTENIRVTVIPFYMGMREAQNSHVYWWRYCIRLENLDSDVVQLRERHWRIFSLSGTLETVRGRGVVGREPVLSKEQPAFQYSSHVSLQASSGHMWGTFRFERPDGSHFDVRIPPFSLESNKDE","Homo sapiens","POLDIP2, PDIP38, POLD4, HSPC017","Polymerase delta-interacting protein 2","1","6ZLX"
"6ZLY",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M SODIUM CITRATE, 0.15 M TRIS, PH    
8.0",293,"10.1021/acs.jmedchem.0c01555","QMH","6ZLY",68.76,"1.79","1.79","Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a)","HHHHHHSSGLVPRGSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6ZLY"
"6ZMJ",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.75, 0.2 M Potassium sodium tartrae, 20 % PEG3350",293.15,"10.1038/s41467-021-22320-y",,"6ZMJ",156.02,"2.774","2.774","Crystal structure of human GFAT-1 R203H","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRHGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6ZMJ"
"6ZMK",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.5, 0.3 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-021-22320-y",,"6ZMK",156.23,"2.382","2.382","Crystal structure of human GFAT-1 L405R","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFRDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6ZMK"
,,,,,,,,,,,,,,,,"MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFRDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","2","6ZMK"
"6ZMM",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",,"1.4 M sodium malonate (pH 6.25), 10 mM TCEP",285.15,"10.1111/febs.15660",,"6ZMM",63.4,"2.96","2.96","Crystal structure of human NDRG1","DVQEQDIETLHGSVHVTLCGTPKGNRPVILTYHDIGMNHKTCYNPLFNYEDMQEITQHFAVCHVDAPGQQDGAASFPAGYMYPSMDQLAEMLPGVLQQFGLKSIIGMGTGAGAYILTRFALNNPEMVEGLVLINVNPCAEGWMDWAASKISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYRQHIVNDMNPGNLHLFINAYNSRRDLEIERPMPGTHTVTLQCPALLVVGDSSPAVDAVVECNSKLDPTKTTLLKMADCGGLPQISQPAKLAEAFKYFVQGMGYMPSAS","Homo sapiens","NDRG1, CAP43, DRG1, RTP","Protein NDRG1","1","6ZMM"
"6ZN2","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-27657-y",,"6ZN2",160.68,"4.3",,"Partial structure of tyrosine hydroxylase in complex with dopamine showing the catalytic domain and an alpha-helix from the regulatory domain involved in dopamine binding.","VPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG","Homo sapiens","TH, TYH","Tyrosine 3-monooxygenase","1","6ZN2"
,,,,,,,,,,,,,,,,"SLIEDARKEREAAVAAAA","Homo sapiens","TH, TYH","SER-LEU-ILE-GLU-ASP-ALA-ARG-LYS-GLU-ARG-GLU-ALA-ALA-VAL-ALA-ALA-ALA-ALA","2","6ZN2"
"6ZN6",,"X-RAY DIFFRACTION",2.56,51.97,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M NaCl
25% (w/v) PEG3350
0.1 M bis-tris pH 5.5",277,"10.1021/acs.jmedchem.0c01242",,"6ZN6",27.25,"2.02","2.02","Protein polybromo-1 (PB1 BD2) Bound To MW278","SMSPAYLKEILEQLLEAIVVATNPSGRLISELFQKLPSKVQYPDYYAIIKEPIDLKTIAQRIQNGSYKSIHAMAKDIDLLAKNAKTYNEPGSQVFKDANSIKKIFYMKKAEIEHHE","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","6ZN6"
"6ZND",,"X-RAY DIFFRACTION",1.98,37.76,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M MgCl2, 0.1 M Tris-HCl pH 8.0 and 20 % PEG 3350",293,"10.1021/acs.jmedchem.0c01272","QMZ","6ZND",83.84,"2.35","2.35","[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors","MGSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYERHHHHHH","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6ZND"
"6ZNV",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.005 M zinc acetate
20% (w/v) PEG 3350",277,"10.1021/acs.jmedchem.0c01242",,"6ZNV",13.81,"1.14","1.14","Protein polybromo-1 (PB1 BD2) Bound To DP28","SMSPAYLKEILEQLLEAIVVATNPSGRLISELFQKLPSKVQYPDYYAIIKEPIDLKTIAQRIQNGSYKSIHAMAKDIDLLAKNAKTYNEPGSQVFKDANSIKKIFYMKKAEIEHHE","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","6ZNV"
"6ZOQ",,"X-RAY DIFFRACTION",2.04,39.81,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, magnesium chloride",293,"10.1021/acs.jmedchem.0c01163",,"6ZOQ",58.3,"1.8","1.8","Oestrogen receptor ligand binding domain in complex with compound 16","GSHMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6ZOQ"
"6ZOR",,"X-RAY DIFFRACTION",2.1,41.32,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, magnesium chloride",293,"10.1021/acs.jmedchem.0c01163",,"6ZOR",58.23,"1.97","1.97","Oestrogen receptor ligand binding domain in complex with compound 28","GSHMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6ZOR"
"6ZOS",,"X-RAY DIFFRACTION",2.05,40.03,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, magnesium chloride",293,"10.1021/acs.jmedchem.0c01163",,"6ZOS",58.24,"2","2","Oestrogen receptor ligand binding domain in complex with compound 18","GSHMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6ZOS"
"6ZOV",,"X-RAY DIFFRACTION",2.73,55.05,"VAPOR DIFFUSION, SITTING DROP",7.25,"PEG20000",293,"10.1124/jpet.120.000219",,"6ZOV",106.85,"2.19","2.19","ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6","IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLHMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGIDSCQGDSGGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQSFLH","Homo sapiens","TMPRSS15, ENTK, PRSS7","Enteropeptidase","1","6ZOV"
"6ZPD",,"X-RAY DIFFRACTION",3.65,66.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000, ammonium sulfate, HEPES",291.15,"10.1016/j.redox.2020.101773","VIV","6ZPD",27.66,"2.24","2.24","gamma-tocopherol transfer protein","TDSFLLRFLRARDFDLDLAWRLLKNYYKWRAECPEISADLHPRSIIGLLKAGYHGVLRSRDPTGSKVLIYRIAHWDPKVFTAYDVFRVSLITSELIVQEVETQRNGIKLIFDLEGWQFSHAFQITPSVAKKIAAVLTDSFPLKVRGIHLINEPVIFHAVFSMIKPFLTEKIKERIHMHGNNYKQSLLQHFPDILPLEYGGEEFSMEDICQEWTNFIMKSEDYLSSISESIQ","Homo sapiens","TTPA, TPP1","Alpha-tocopherol transfer protein","1","6ZPD"
"6ZPG","4.6","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.61481",,"6ZPG",71.91,"4.6",,"Kinesin binding protein (KBP)","MANVPWAEVCEKFQAALALSRVELHKNPEKEPYKSKYSARALLEEVKALLGPAPEDEDERPEAEDGPGAGDHALGLPAEVVEPEGPVAQRAVRLAVIEFHLGVNHIDTEELSAGEEHLVKCLRLLRRYRLSHDCISLCIQAQNNLGILWSEREEIETAQAYLESSEALYNQYMKEVGSPPLDPTERFLPEEEKLTEQERSKRFEKVYTHNLYYLAQVYQHLEMFEKAAHYCHSTLKRQLEHNAYHPIEWAINAATLSQFYINKLCFMEARHCLSAANVIFGQTGKISATEDTPEAEGEVPELYHQRKGEIARCWIKYCLTLMQNAQLSMQDNIGELDLDKQSELRALRKKELDEEESIRKKAVQFGTGELCDAISAVEEKVSYLRPLDFEEARELFLLGQHYVFEAKEFFQIDGYVTDHIEVVQDHSALFKVLAFFETDMERRCKMHKRRIAMLEPLTVDLNPQYYLLVNRQIQFEIAHAYYDMMDLKVAIADRLRDPDSHIVKKINNLNKSALKYYQLFLDSLRDPNKVFPEHIGEDVLRPAMLAKFRVARLYGKIITADPKKELENLATSLEHYKFIVDYCEKHPEAAQEIEVELELSKEMVSLLPTKMERFRTKMALT","Homo sapiens","KIFBP, KBP, KIAA1279, KIF1BP","KIF-binding protein","1","6ZPG"
"6ZPQ",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1111/febs.15601",,"6ZPQ",298.37,"1.85","1.85","Crystal structure of the open conformation of Angiotensin-1 converting enzyme N-domain.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6ZPQ"
"6ZPR",,"SOLUTION NMR",,,,,,,"10.1073/pnas.2017406117",,"6ZPR",18.45,,,"Solution structure of MLKL executioner domain in complex with a covalent inhibitor","GSPGENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRD","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein,Mixed lineage kinase domain-like protein","1","6ZPR"
,,,,,,,,,,,,,,,,,"Homo sapiens","MLKL"
"6ZPT",,"X-RAY DIFFRACTION",2.97,58.57,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1111/febs.15601",,"6ZPT",294.44,"2.8","2.8","Crystal structure of the open conformation of S2_S'-mutant human Angiotensin-1 converting enzyme N-domain.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQTWSNIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMEQLVVVHHEMGHIQYFLQYKDLPVSLREGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALDKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6ZPT"
"6ZPU",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M MIB pH 4.0, 5% glycerol, 15% PEG 3350",289,"10.1111/febs.15601",,"6ZPU",71.29,"2","2","Crystal structure of Angiotensin-1 converting enzyme C-domain with inserted symmetry molecule C-terminus.","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSARSEGPLP","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6ZPU"
"6ZQR",,"X-RAY DIFFRACTION",2.77,55.56,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.5 M Ammonium Sulphate, 7% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZQR",52.96,"1.93","1.93","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with GlcNAc ligand bound","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZQR"
"6ZQX",,"X-RAY DIFFRACTION",3.03,59.42,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6 M Ammonium Sulphate, 8% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZQX",52.61,"1.84","1.84","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with N,N'-diacetyl chitobiose ligand bound","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZQX"
"6ZQY",,"X-RAY DIFFRACTION",3.06,59.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6 M Ammonium Sulphate, 9% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZQY",52.8,"1.85","1.85","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with Neu5Ac ligand bound","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZQY"
"6ZQZ",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M MgCl2, 0.1 M Tris-HCl pH 8.0 and 24 % PEG 3350",293,"10.1021/acs.jmedchem.0c01272","QOQ","6ZQZ",167.68,"1.88","1.88","[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors","MGSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYERHHHHHH","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6ZQZ"
"6ZR0",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.5 M Ammonium Sulphate, 8% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZR0",52.65,"1.94","1.94","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with N-acetylalanine ligand bound","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZR0"
"6ZR3",,"X-RAY DIFFRACTION",3.05,59.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.7 M Ammonium Sulphate, 8% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZR3",52.57,"1.97","1.97","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1 with N-acetyl-galactosamine-4-sulfate ligand bound","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZR3"
"6ZR4",,"X-RAY DIFFRACTION",3,59.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.7 M Ammonium Sulphate, 9% Dioxane, 0.1 M MES pH 6.5",293,,,"6ZR4",52.6,"2","2","Crystal structure of tetrameric fibrinogen-like recognition domain of FIBCD1","ATGSRPRDCLDVLLSGQQDDGVYSVFPTHYPAGFQVYCDMRTDGGGWTVFQRREDGSVNFFRGWDAYRDGFGRLTGEHWLGLKRIHALTTQAAYELHVDLEDFENGTAYARYGSFGVGLFSVDPEEDGYPLTVADYSGTAGDSLLKHSGMRFTTKDRDSDHSENNCAAFYRGAWWYRNCHTSNLNGQYLRGAHASYADGVEWSSWTGWQYSLKFSEMKIRPVREDR","Homo sapiens","FIBCD1, UNQ701/PRO1346","Fibrinogen C domain-containing protein 1","1","6ZR4"
"6ZR6",,"X-RAY DIFFRACTION",2.4,48.9,"VAPOR DIFFUSION, SITTING DROP",7.1,"PEG6000 23% w/v
HEPES 0.1 M
DMSO 2.5%
2-hydroxypropyl-gamma-cyclodextrin 5mM",291.15,,,"6ZR6",29.52,"1.5","1.5","17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal inhibitor","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6ZR6"
"6ZR7",,"X-RAY DIFFRACTION",3.48,64.72,"VAPOR DIFFUSION",7.5,"Glycerol, calcium acetate, PEG 8000, HEPES",292,"10.1107/S2059798320013753",,"6ZR7",36.05,"1.85","1.85","X-ray structure of human Dscam Ig7-Ig9","GTVPPFIQPFEFPRFSIGQRVFIPCVVVSGDLPITITWQKDGRPIPGSLGVTIDNIDFTSSLRISNLSLMHNGNYTCIARNEAAAVEHQSQLIVRVPPKFVVQPRDQDGIYGKAVILNCSAEGYPVPTIVWKFSKGAGVPQFQPIALNGRIQVLSNGSLLIKHVVEEDSGYYLCKVSNDVGADVSKSMYLTVKIPAMITSYPNTTLATQGQKKEMSCTAHGEKPIIVRWEKEDRIINPEMARYLVSTKEVGEEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQLTVQEELENLYFQGSHHHHHH","Homo sapiens","DSCAM","Down syndrome cell adhesion molecule","1","6ZR7"
"6ZR8",,"X-RAY DIFFRACTION",2.06,40.21,"VAPOR DIFFUSION, HANGING DROP",,"1.2 M Sodium Citrate, 0.1 M Tris-HCl pH 8.5",293,,,"6ZR8",30.01,"1.79","1.79","The crystal structure of 2-(4-Benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ZR8"
"6ZR9",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 3350, 0.2 M Ammonium acetate, 0.1 M Tris-HCl (pH 8.5)",293,,,"6ZR9",31.46,"2.05","2.05","The crystal structure of the complex of hCAVII with 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6ZR9"
"6ZRA",,"X-RAY DIFFRACTION",2.93,58,"VAPOR DIFFUSION, SITTING DROP",7.1,"PEG6000 25% w/v
HEPES 0.1M
DMSO 2.5%
2-hydroxypropyl-beta-cyclodextrin 5mM",291.15,,,"6ZRA",29.35,"1.73","1.73","17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with 2-fluoro-5-nitrophenol","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6ZRA"
"6ZRB",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, HANGING DROP",8.25,"Protein was pre-incubated with the covalent inhibitor, 7 mg/mL and 0.4 mM, respectively, for 8 h at RT. Crystallization was performed in 2 uL hanging drops, 1:1 protein to reservoir ratio, reservoir: 16% PEG3350, 100 mM Tris (pH 8.25), 100 mM Mg(OAc)2). Protein crystals were cryoprotected in 20% PEG3350, 100 mM Tris (pH 8.25), 100 mM Mg(OAc)2, 10% DMSO and 10% glycerol.",298,,,"6ZRB",50.43,"1.55","1.55","Crystal structure of SMYD3 conjugate with piperidine-based covalent inhibitor EM127","GSHMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6ZRB"
"6ZRM",,"SOLUTION NMR",,,,,,,"10.3390/molecules25204867",,"6ZRM",6.4,,,"G-quadruplex with a G-A bulge","TGGGAGGGAGCGGGAGTGGG","Homo sapiens",,"DNA (5'-D(*TP*GP*GP*GP*AP*GP*GP*GP*AP*GP*CP*GP*GP*GP*AP*GP*TP*GP*GP*G)-3')","1","6ZRM"
"6ZRQ","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0496-3",,"6ZRQ",46.54,"3.9",,"two-protofilament amyloid structure of S20G variant of human amylin (IAPP - islet amyloid polypeptide)","KCNTATCATQRLANFLVHSGNNFGAILSSTNVGSNTY","Homo sapiens","IAPP","Islet amyloid polypeptide","1","6ZRQ"
"6ZRR","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0496-3",,"6ZRR",69.81,"4",,"three-protofilament amyloid structure of S20G variant of human amylin (IAPP - Islet Amyloid Polypeptide)","KCNTATCATQRLANFLVHSGNNFGAILSSTNVGSNTY","Homo sapiens","IAPP","Islet amyloid polypeptide","1","6ZRR"
"6ZS2",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization buffer: 20% medium-molecular-weight PEG smear, 0.1 M Tris pH 8.5",293,"10.1021/acs.jmedchem.0c01242",,"6ZS2",29.13,"1.57","1.57","Crystal Structure of the bromodomain of human transcription activator BRG1 (SMARCA4) in complex with 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol","SMLSPNPPNLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDD","Homo sapiens","SMARCA4, BAF190A, BRG1, SNF2B, SNF2L4","Transcription activator BRG1","1","6ZS2"
"6ZS3",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, SITTING DROP",,"22% (w/v) PEG 3350, 0.2 M sodium malonate, 10% (v/v) ethylene glycol, 0.1 M bis-tris propane pH 7.1",293,"10.1021/acs.jmedchem.0c01242",,"6ZS3",29.96,"1.67","1.67","Crystal structure of the fifth bromodomain of human protein polybromo-1 in complex with 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol","SMSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAIFLRLPSRSELPDYYLTIKKPMDMEKIRSHMMANKYQDIDSMVEDFVMMFNNACTYNEPESLIYKDALVLHKVLLETRRDLEGD","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","6ZS3"
"6ZS4",,"X-RAY DIFFRACTION",2.59,52.54,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 5000 MME, 0.2 M (NH4)2SO4, 0.1 M MES pH 5.8",277,"10.1021/acs.jmedchem.0c01242",,"6ZS4",15.08,"2","2","Crystal structure of the fifth bromodomain of human protein polybromo-1 in complex with tert-butyl 4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate","SMSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAIFLRLPSRSELPDYYLTIKKPMDMEKIRSHMMANKYQDIDSMVEDFVMMFNNACTYNEPESLIYKDALVLHKVLLETRRDLEGD","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","6ZS4"
"6ZS5","3.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.60265",,"6ZS5",140.98,"3.5",,"3.5 A cryo-EM structure of human uromodulin filament core","MGQPSLTWMLMVVVASWFITTAATDTSEARWCSECHSNATCTEDEAVTTCTCQEGFTGDGLTCVDLDECAIPGAHNCSANSSCVNTPGSFSCVCPEGFRLSPGLGCTDVDECAEPGLSHCHALATCVNVVGSYLCVCPAGYRGDGWHCECSPGSCGPGLDCVPEGDALVCADPCQAHRTLDEYWRSTEYGEGYACDTDLRGWYRFVGQGGARMAETCVPVLRCNTAAPMWLNGTHPSSDEGIVSRKACAHWSGHCCLWDASVQVKACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCKSNNGRWHCQCKQDFNITDISLLEHRLECGANDMKVSLGKCQLKSLGFDKVFMYLSDSRCSGFNDRDNRDWVSVVTPARDGPCGTVLTRNETHATYSNTLYLADEIIIRDLNIKINFACSYPLDMKVSLKTALQPMVSALNIRVGGTGMFTVRMALFQTPSYTQPYQGSSVTLSTEAFLYVGTMLDGGDLSRFALLMTNCYATPSSNATDPLKYFIIQDRCPHTRDSTIQVVENGESSQGRFSVQMFRFAGNYDLVYLHCEVYLCDTMNEKCKPTCSGTRFRSGSVIDQSRVLNLGPITRKGVQATVSRAFSSLGLLKVWLPLLLSATLTLTFQ","Homo sapiens","UMOD","Uromodulin","1","6ZS5"
"6ZSH",,"X-RAY DIFFRACTION",2.86,56.98,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M di-Ammonium hydrogen citrate
20% (w/v) PEG 3350",293,"10.1038/s41467-020-17792-3",,"6ZSH",51.36,"2.2","2.2","The mechanism of activation of the actin binding protein EHBP1 by Rab8 family members","GHMDEVLNKGFKDTSQYVVGELAALENEQKQIDTRAALVEKRLRYLMDTGRNTEEEEAMMQEWFMLVNKKNALIRRMNQLSLLEKEHDLERRYELLNRELRAMLAI","Homo sapiens","EHBP1, KIAA0903, NACSIN","EH domain-binding protein 1","1","6ZSH"
,,,,,,,,,,,,,,,,"GHMGRKPNASQSLLVWCKEVTKNYRGVKITNFTTSWRNGLSFCAILHHFRPDLIDYKSLNPQDIKENNKKAYDGFASIGISRLLEPSDMVLLAIPDKLTVMTYLYQIRAHFSGQ","Homo sapiens","EHBP1, KIAA0903, NACSIN","EH domain-binding protein 1","2","6ZSH"
"6ZSO",,"SOLUTION NMR",,,,,,,"10.3390/ijms21197280",,"6ZSO",11.01,,,"Solution structure of the water-soluble LU-domain of human Lypd6b protein","MFKCFTCENAGDNYNCNRWAEDKWCPQNTQYCLTVHHFTSHGRSTSITKKCASRSECHFVGCHHSRDSEHTECRSCCEGMICNVELPTNHTNAVFA","Homo sapiens","LYPD6B","Ly6/PLAUR domain-containing protein 6B","1","6ZSO"
"6ZSP",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350
230 mM sodium malonate
15 mM magnesium chloride",293,"10.1038/s42003-022-03264-5",,"6ZSP",77.57,"1.6","1.6","Human serine racemase bound to ATP and malonate.","MDAQYDISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGALNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQAYGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGVKSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQTVSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSVHHHHHHQ","Homo sapiens","SRR","Serine racemase","1","6ZSP"
"6ZSS",,"SOLUTION NMR",,,,,,,"10.3390/ijms21197280",,"6ZSS",9.39,,,"NMR structure of water-soluble domain of human Lynx2 (Lypd1) protein","MIQCYQCEEFQLNNDCSSPEFIVNCTVNVQDMCQKEVMEQSAGIMYRKSCASSAACLIASAGYQSFCSPGKLNSVCISCCNTPLCN","Homo sapiens","LYPD1, LYPDC1, PSEC0181, UNQ3079/PRO9917","Ly6/PLAUR domain-containing protein 1","1","6ZSS"
"6ZSW",,"X-RAY DIFFRACTION",3.18,61.34,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M sodium malonate pH 7 and 20 % w/v PEG 3350",281,"10.1002/cbic.202100449",,"6ZSW",16.24,"2.08","2.08","M2 mutant (R111K:Y134F:T54V:R132Q:P39Y:R59Y) of human cellular retinoic acid binding protein II - 6 conjugate","GSHMPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6ZSW"
"6ZSX",,"X-RAY DIFFRACTION",3.14,60.89,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M sodium malonate pH 7 and 20 % w/v PEG 3350",281,"10.1002/cbic.202100449",,"6ZSX",16.17,"2.4","2.4","M2 mutant (R111K:Y134F:T54V:R132Q:P39Y:R59Y) of human cellular retinoic acid binding protein II - 4 conjugate","GSHMPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELILTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6ZSX"
"6ZT2",,"X-RAY DIFFRACTION",2.9,58.3,"VAPOR DIFFUSION, SITTING DROP",,"HEPES 0.1M pH 7
PEG6000 25% w/v
DMSO 2.5%
2-hydroxypropyl-beta-cyclodextrin 5mM",291,,,"6ZT2",29.36,"1.95","1.95","17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with 3-chloro-2,6-difluorophenol","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6ZT2"
"6ZTB",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7.5,"3.655M NaCl, 85mM HEPES, 15.0% GLYCEROL",293,"10.1158/1535-7163.MCT-20-0708",,"6ZTB",24.07,"1.4","1.4","Crystal Structure of human P-Cadherin EC1_EC2","GPDWVVAPISVPENGKGPFPQRLNQLKSNKDRDTKIFYSITGPGADSPPEGVFAVEKETGWLLLNKPLDREEIAKYELFGHAVSENGASVEDPMNISIIVTDQNDHKPKFTQDTFRGSVLEGVLPGTSVMQVTATDEDDAIYTYNGVVAYSIHSQEPKDPHDLMFTIHRSTGTISVISSGLDREKVPEYTLTIQATDMDGDGSTTTAVAVVEILDANDN","Homo sapiens","CDH3, CDHP","Cadherin-3","1","6ZTB"
"6ZTC",,"X-RAY DIFFRACTION",2.43,49.36,"VAPOR DIFFUSION, SITTING DROP",8.4,"PEG6000, dioxane, TRIS-HCl, glycerol.",293,,,"6ZTC",48.32,"1.84","1.84","CRYSTAL STRUCTURE OF PROSTAGLANDIN D2 SYNTHASE IN COMPLEX WITH FRAGMENT 1A AT 1.84A RESOLUTION.","GMPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","6ZTC"
"6ZTD",,"X-RAY DIFFRACTION",3.09,60.14,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Na Malate pH 7
26 % PEG 4000",293,"10.1182/blood.2020005216",,"6ZTD",46.77,"3.43","3.43","Crystal structure of the BCR Fab fragment from subset #169 case P6540","EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMNWVRQAPGKGLQWVSYISDSASTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAMYYCARDGVGAPLWGQGTTVTVSSGSASAPTLFPLVSCENSPSDTSSVLVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYAATSQVLLPSKDVMQGTDEHVVCKVQHPNGNKEKNVPLPV","Homo sapiens",,"Heavy chain of the Fab fragment from BCR derived from the P6540 CLL clone","1","6ZTD"
,,,,,,,,,,,,,,,,"SYVLTQPPSVSVAPGKTARISCGGNNIGSKSVHWYQQKPGQAPVLVIYYDTDRPSGIPERFSGSNSGNTATLTISRVEAGDEAGYYCQVWDSSSDHPWVFGGGTKLTVLRQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Light chain of the Fab fragment from BCR derived from the P6540 CLL clone","2","6ZTD"
"6ZTF",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.16M calcium acetate, 14.4% PEG 8,000, 20% glycerol",293,"10.1158/1535-7163.MCT-20-0708",,"6ZTF",99.4,"1.55","1.55","Crystal Structure of the anti-human P-Cadherin Fab CQY684","QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSQSAAWNWIRQSPSRGLEWLGRIYYRSKWYNDYALSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARGEGYGREGFAIWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSEFDYKDDDDKGAPHHHHHH","Homo sapiens",,"CQY684 Fab heavy-chain","1","6ZTF"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQTISNTLAWYQQKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLSWFTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEA","Homo sapiens",,"CQY684 Fab light-chain","2","6ZTF"
"6ZU4",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",5.7,"100 mM Bis-Tris pH 5.7, 1.6 M (NH4)2SO4, and 10% PEG 400",293,"10.1021/acsmedchemlett.0c00407",,"6ZU4",69.97,"2.46","2.46","Human Sirt6 13-308 in complex with ADP-ribose and the activator fluvastatin","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6ZU4"
"6ZU8",,"X-RAY DIFFRACTION",2.01,38.92,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Mes Ph 6.0, 0.2 M Ammonium Chloride, 20 % PEG 6000, 10 % Ethylene Glycol.",277,,,"6ZU8",22.63,"1.95","1.95","Crystal structure of human Brachyury G177D variant in complex with Afatinib","MGELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYNPFAKAFLDAKERSHHHHHH","Homo sapiens","TBXT, T","Brachyury protein","1","6ZU8"
"6ZUJ",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, SITTING DROP",6.2,"100 mM MES pH 6.2
100 mM calcium chloride
5% ethylene glycol
20% PEG Smear Broad",293,"10.1038/s42003-022-03264-5",,"6ZUJ",153.2,"1.8","1.8","Human serine racemase holoenzyme from 20% DMSO soak (XChem crystallographic fragment screen).","MDAQYDISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGALNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQAYGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGVKSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQTVSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSVHHHHHH","Homo sapiens","SRR","Serine racemase","1","6ZUJ"
"6ZUV",,"X-RAY DIFFRACTION",1.99,38.13,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",293,"10.1021/acs.jmedchem.0c01391","B1J","6ZUV",44.76,"1.54","1.54","Notum fragment 286","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6ZUV"
"6ZUY",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZUY",9.06,,,"Human TFIIS N-terminal domain (TND)","MEDEVVRFAKKMDKMVQKKNAAGALDLLKELKNIPMTLELLQSTRIGMSVNAIRKQSTDEEVTSLAKSLIKSWKKLLDGGS","Homo sapiens","TCEA1, GTF2S, TFIIS","Transcription elongation factor A protein 1","1","6ZUY"
"6ZUZ",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZUZ",9.71,,,"TFIIS N-terminal domain (TND) from human Elongin-A","SNAASAMAAESALQVVEKLQARLAANPDPKKLLKYLKKLSTLPITVDILAETGVGKTVNSLRKHEHVGSFARDLVAQWKKLVPVERNAGS","Homo sapiens","ELOA, TCEB3, MSTP059","Elongin-A","1","6ZUZ"
"6ZV0",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZV0",10.65,,,"TFIIS N-terminal domain (TND) from human LEDGF/p75","SNAASETSMDSRLQRIHAEIKNSLKIDNLDVNRCIEALDELASLQVTMQQAQKHTEMITTLKKIRRFKVSQVIMEKSTMLYNKFKNMFLVGE","Homo sapiens","PSIP1, DFS70, LEDGF, PSIP2","PC4 and SFRS1-interacting protein","1","6ZV0"
"6ZV1",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZV1",16.74,,,"TFIIS N-terminal domain (TND) from human IWS1","SNAASGTFISDADDVVSAMIVKMNEAAEEDRQLNNQKKPALKKLTLLPAVVMHLKKQDLKETFIDSGVMSAIKEWLSPLPDRSLPALKIREELLKILQELPSVSQETLKHSGIGRAVMYLYKHPKESRSNKDMAGKLINEWSRPIFGLGS","Homo sapiens","IWS1, IWS1L","Protein IWS1 homolog","1","6ZV1"
"6ZV2",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZV2",17.22,,,"TFIIS N-terminal domain (TND) from human PPP1R10","SNAASMGSGPIDPKELLKGLDSFLNRDGEVKSVDGISKIFSLMKEARKMVSRCTYLNILLQTRSPEILVKFIDVGGYKLLNNWLTYSKTTNNIPLLQQILLTLQHLPLTVDHLKQNNTAKLVKQLSKSSEDEELRKLASVLVSDWMAVIRSQGS","Homo sapiens","PPP1R10, CAT53, FB19, PNUTS","Serine/threonine-protein phosphatase 1 regulatory subunit 10","1","6ZV2"
"6ZV3",,"SOLUTION NMR",,,,,,,"10.1126/science.abe2913",,"6ZV3",10.18,,,"TFIIS N-terminal domain (TND) from human MED26","SMTAAPASPQQIRDRLLQAIDPQSNIRNMVAVLEVISSLEKYPITKEALEETRLGKLINDVRKKTKNEELAKRAKKLLRSWQKLIEPAGS","Homo sapiens","MED26, ARC70, CRSP7","Mediator of RNA polymerase II transcription subunit 26","1","6ZV3"
"6ZVA",,"X-RAY DIFFRACTION",2.25,45.45,"VAPOR DIFFUSION, HANGING DROP",,"1.9M ammonium sulfate
0.3M trisodium citrate",293,,,"6ZVA",23.48,"2.68","2.68","Crystal structure of My5","GPSEGIVPGPPTDLSVTEATRSYVVLSWKPPGQRGHEGIMYFVEKCEAGTENWQRVNTELPVKSPRFALFDLAEGKSYCFRVRCSNSAGVGEPSEATEVTVVGDK","Homo sapiens","MYOM1","Myomesin-1","1","6ZVA"
"6ZVL",,"X-RAY DIFFRACTION",1.92,36.02,"EVAPORATION",4.2,"1.5 M  Ammonium Sulphate
0.1 M Sodium Citrate, pH 4.2",293,"10.1021/acs.jmedchem.0c01391","QR2","6ZVL",44.66,"1.3","1.3","ARUK3000263 complex with Notum","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6ZVL"
"6ZVO",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",,"31 % Polyethylene glycol monomethyl ether 2,000, 0.15 M Potassium bromide, 0.1 M TRIS, pH 9",277,"10.1073/pnas.2017406117",,"6ZVO",53.11,"1.371","1.371","Crystal structure of unliganded MLKL executioner domain","GSPGENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQM","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6ZVO"
"6ZVP","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-27657-y",,"6ZVP",206.44,"4",,"Atomic model of the EM-based structure of the full-length tyrosine hydroxylase in complex with dopamine (residues 40-497) in which the regulatory domain (residues 40-165) has been included only with the backbone atoms","SLIEDARKEREAAVAAAAAAVPSEPGDPLEAVAFEEKEGKAMLNLLFSPRATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVRQVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG","Homo sapiens","TH, TYH","Tyrosine 3-monooxygenase","1","6ZVP"
"6ZWE",,"X-RAY DIFFRACTION",6.29,80.43,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M LiSO4, 100 mM HEPES pH7, 60 mM MgSO4",293,"10.3390/antiox10020329",,"6ZWE",123.95,"3","3","Crystal structure of human acetylcholinesterase in complex with ((6-((2E,4E)-5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienamido)hexyl)triphenylphosphonium bromide)","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6ZWE"
"6ZWI",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate, 2-(N-Morpholino)-ethanesulfonic acid, pH 6.5,",298,"10.3390/antiox10020329",,"6ZWI",64.47,"1.85","1.85","Human butyrylcholinesterase in complex with ((6-((2E,4E)-5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dienamido)hexyl)triphenylphosphonium bromide)","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6ZWI"
"6ZWP",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, SITTING DROP",5.8,"15% MMW PegSmear
0.1 M MES",278,"10.1016/j.ejmech.2020.112721","OE8","6ZWP",41.99,"1.9","1.9","p38a bound with SR348","GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6ZWP"
"6ZWY",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.6 - 1.8 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 1 M L-proline, 25 mM UMP",293,,,"6ZWY",28.96,"1","1","OMPD-domain of human UMPS in complex with UMP at 1.0 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZWY"
"6ZWZ",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Cryo-protection: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 2 M L-proline",293,,,"6ZWZ",28.44,"1.2","1.2","Resting state structure of the OMPD-domain of human UMPS variant (K314AcK) at 1.2 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZWZ"
"6ZX0",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, HANGING DROP",7.8,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"6ZX0",29.54,"1.25","1.25","OMPD-domain of human UMPS in complex with the substrate OMP at 1.25 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZX0"
"6ZX1",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.6 - 1.8 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 1 M L-proline, 25 mM 6-Aza-UMP",293,,,"6ZX1",28.98,"1","1","OMPD-domain of human UMPS in complex with 6-Aza-UMP at 1.0 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZX1"
"6ZX2",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.8 - 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM CA-UMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM CA-UMP, 1 M L-proline",293,,,"6ZX2",28.88,"1.2","1.2","OMPD-domain of human UMPS in complex with 6-carboxamido-UMP at 1.2 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZX2"
"6ZX3",,"X-RAY DIFFRACTION",2.47,50.17,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.8 - 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM TCA-UMP
Cryo-protection: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 12.5 mM TCA-UMP, 1 M L-proline",293,,,"6ZX3",28.99,"1.15","1.15","OMPD-domain of human UMPS in complex with 6-thiocarboxamido-UMP at 1.15 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","6ZX3"
"6ZX6",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkab057",,"6ZX6",7.98,,,"Antiparallel basket-type G-quadruplex DNA structure formed in human Bcl-2 promoter containing 8-oxoG","CGGGCGCGGGAGGAAGGGGGCGGGA","Homo sapiens",,"bcl2ex-oxoG19","1","6ZX6"
"6ZX7",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkab057",,"6ZX7",7.96,,,"Antiparallel basket-type G-quadruplex DNA structure formed in human Bcl-2 promoter","CGGGCGCGGGAGGAAGGGGGCGGGA","Homo sapiens",,"bcl2ex","1","6ZX7"
"6ZXO",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, HANGING DROP",9,"25% (w/v) PEG4000, 30 mM ammonium sulfate and 20 mM beta-mercaptoethanol, 0.1 M TRIS pH 9",297,"10.3390/cancers13092061",,"6ZXO",227.98,"2.6","2.6","Crystal structure of His-tagged human thymidylate synthase (HT-hTS) in complex with FdUMP and Raltitrexed (Tomudex)","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6ZXO"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","2","6ZXO"
"6ZYA","3.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.60265",,"6ZYA",71.48,"3.5",,"Extended human uromodulin filament core at 3.5 A resolution","MGQPSLTWMLMVVVASWFITTAATDTSEARWCSECHSNATCTEDEAVTTCTCQEGFTGDGLTCVDLDECAIPGAHNCSANSSCVNTPGSFSCVCPEGFRLSPGLGCTDVDECAEPGLSHCHALATCVNVVGSYLCVCPAGYRGDGWHCECSPGSCGPGLDCVPEGDALVCADPCQAHRTLDEYWRSTEYGEGYACDTDLRGWYRFVGQGGARMAETCVPVLRCNTAAPMWLNGTHPSSDEGIVSRKACAHWSGHCCLWDASVQVKACAGGYYVYNLTAPPECHLAYCTDPSSVEGTCEECSIDEDCKSNNGRWHCQCKQDFNITDISLLEHRLECGANDMKVSLGKCQLKSLGFDKVFMYLSDSRCSGFNDRDNRDWVSVVTPARDGPCGTVLTRNETHATYSNTLYLADEIIIRDLNIKINFACSYPLDMKVSLKTALQPMVSALNIRVGGTGMFTVRMALFQTPSYTQPYQGSSVTLSTEAFLYVGTMLDGGDLSRFALLMTNCYATPSSNATDPLKYFIIQDRCPHTRDSTIQVVENGESSQGRFSVQMFRFAGNYDLVYLHCEVYLCDTMNEKCKPTCSGTRFRSGSVIDQSRVLNLGPITRKGVQATVSRAFSSLGLLKVWLPLLLSATLTLTFQ","Homo sapiens","UMOD","Uromodulin","1","6ZYA"
"6ZYF",,"X-RAY DIFFRACTION",2.46,50.06,"EVAPORATION",7,"0.1 M Hepes pH 7.0
0.1 M KCl
15% PEG MME 5000",296,"10.1016/j.molmet.2021.101201",,"6ZYF",88.1,"2.19","2.19","Notum_Ghrelin complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSAAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6ZYF"
"6ZYI",,"X-RAY DIFFRACTION",2.47,50.24,"VAPOR DIFFUSION, SITTING DROP",8.4,"10% PEG8000,
0.1M Tris Ph8.4, 
0.2M CaCl2",293,"10.7554/eLife.62601",,"6ZYI",42.19,"1.52","1.52","Crystal structure of HSP70 ATPase domain in complex with ADP and calcium","AAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGDTKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILM","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70kDa protein 1A variant","1","6ZYI"
"6ZYJ",,"X-RAY DIFFRACTION",2.47,50.26,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG3350, 
0.2M Ca acetate",293,"10.7554/eLife.62601",,"6ZYJ",85.01,"1.85","1.85","Crystal structure of Hsc70 ATPase domain in complex with ADP and calcium","PAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDK","Homo sapiens","HSPA8, HSC70, HSP73, HSPA10","Heat shock cognate 71 kDa protein","1","6ZYJ"
"6ZZ1",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, HANGING DROP",,"32 % Polyethylene glycol monomethyl ether 2,000, 0.15 M Potassium bromide, 0.1 M TRIS, pH 9",277,"10.1073/pnas.2017406117",,"6ZZ1",35.82,"1.64","1.64","Crystal structure of MLKL executioner domain in complex with a covalent inhibitor","GSPGENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQM","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6ZZ1"
"6ZZ4",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION",,"0.1 M Tris HCl pH 8.5, 2 M ammonium phosphate",291,"10.1002/pro.4246",,"6ZZ4",73.79,"2.43","2.43","Crystal structure of the PTPN2 C216G mutant","MPTTIEREFEELDTQRRWQPLYLEIRNESHDYPHRVAKFPENRNRNRYRDVSPYDHSRVKLQNAENDYINASLVDIEEAQRSYILTQGPLPNTCCHFWLMVWQQKTKAVVMLNRIVEKESVKCAQYWPTDDQEMLFKETGFSVKLLSEDVKSYYTVHLLQLENINSGETRTISHFHYTTWPDFGVPESPASFLNFLFKVRESGSLNPDHGPAVIHGSAGIGRSGTFSLVDTCLVLMEKGDDINIKQVLLNMRKYRMGLIQTPDQLRFSYMAIIEGAKCIKGDSSIQKRWKELSKEDLSPAFDHSPNKIMTEKYN","Homo sapiens","PTPN2, PTPT","Tyrosine-protein phosphatase non-receptor type 2","1","6ZZ4"
"6ZZE",,"SOLUTION NMR",,,,,,,"10.3390/ijms21197280",,"6ZZE",8.99,,,"Structure of the trans-(Tyr39-Pro40) form of the Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1)","MLKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL","Homo sapiens","SLURP1, ARS","Secreted Ly-6/uPAR-related protein 1","1","6ZZE"
"6ZZF",,"SOLUTION NMR",,,,,,,"10.3390/ijms21197280",,"6ZZF",8.99,,,"Structure of the cis-(Tyr39-Pro40) form of the Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1)","MLKCYTCKEPMTSASCRTITRCKPEDTACMTTLVTVEAEYPFNQSPVVTRSCSSSCVATDPDSIGAAHLIFCCFRDLCNSEL","Homo sapiens","SLURP1, ARS","Secreted Ly-6/uPAR-related protein 1","1","6ZZF"
"6ZZR",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Na malonate, 0.1M Bis-Tris propane pH6.5, 20% PEG3,350",283,,,"6ZZR",310.63,"2.65","2.65","The Crystal Structure of human LDHA from Biortus","MGGSHHHHHHENLYFQGATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6ZZR"
"6ZZU","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-27657-y",,"6ZZU",152.57,"3.5",,"Partial structure of the substrate-free tyrosine hydroxylase (apo-TH).","VPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG","Homo sapiens","TH, TYH","Tyrosine 3-monooxygenase","1","6ZZU"
"721P",,"X-RAY DIFFRACTION",2,38.41,,,,,"10.1016/0092-8674(90)90018-a",,"721P",19.41,"2","2","THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGLEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","H-RAS P21 PROTEIN","1","721P"
"7A04",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, potassium chloride",291,"10.1016/j.ejmech.2020.112797",,"7A04",90.7,"2.15","2.15","Structure of human CKa1 in complex with compound b","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","Choline kinase alpha","1","7A04"
"7A06",,"X-RAY DIFFRACTION",2.32,46.88,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350 
magensium nitrate",291,"10.1016/j.ejmech.2020.112797",,"7A06",46.39,"1.8","1.8","Structure of human CKa1 in complex with compound o","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","Choline kinase alpha","1","7A06"
"7A12",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, HANGING DROP",7.4,"200mM potassium phosphate pH 7.4, 100mM MnCl2, 5mM dithiothreitol (DTT) and 25-50% 2-methyl-2,4-pentanediol (MPD)",293,"10.1016/j.bmcl.2020.127533","QVK","7A12",42.75,"2","2","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR GW557358X (COMPOUND 9)","GPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","7A12"
"7A13",,"X-RAY DIFFRACTION",2.69,54.28,"VAPOR DIFFUSION, HANGING DROP",7.4,"200mM potassium phosphate pH 7.4, 100mM MnCl2, 5mM dithiothreitol (DTT) and 25-50% 2-methyl-2,4-pentanediol (MPD).",293,"10.1016/j.bmcl.2020.127533",,"7A13",42.59,"2.04","2.04","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR GSK1978537A (COMPOUND 27)","GPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","7A13"
"7A14",,"X-RAY DIFFRACTION",2.65,53.61,"VAPOR DIFFUSION, HANGING DROP",7.4,"200mM potassium phosphate pH 7.4, 100mM MnCl2, 5mM dithiothreitol (DTT) and 25-50% 2-methyl-2,4-pentanediol (MPD)",293,"10.1016/j.bmcl.2020.127533","QVB","7A14",42.63,"2.14","2.14","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR GSK2218325A (COMPOUND 32)","GPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","7A14"
"7A15",,"X-RAY DIFFRACTION",2.69,54.35,"VAPOR DIFFUSION, HANGING DROP",7.4,"200mM potassium phosphate pH 7.4, 100mM MnCl2, 5mM dithiothreitol (DTT) and 25-50% 2-methyl-2,4-pentanediol (MPD)",293,"10.1016/j.bmcl.2020.127533","QV5","7A15",42.72,"2.15","2.15","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR GSK2224863A (COMPOUND 42)","GPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","7A15"
"7A16",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, HANGING DROP",7.4,"200mM potassium phosphate pH 7.4, 100mM MnCl2, 5mM dithiothreitol (DTT) and 25-50% 2-methyl-2,4-pentanediol (MPD)",293,"10.1016/j.bmcl.2020.127533","HZE","7A16",42.7,"1.9","1.9","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR GSK2229238A (COMPOUND 43)","GPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","7A16"
"7A1B",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser)/inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the inhibitor 5,6-dibromo-1H-triazolo[4,5-b]pyridine by extensive crystal soaking.",293,"10.1016/j.bioorg.2020.104502","QXW","7A1B",43.62,"1.287","1.287","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 5,6-dibromo-1H-triazolo[4,5-b]pyridine","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7A1B"
"7A1F",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2M Ammonium chloride",277,"10.1093/nar/gkab692",,"7A1F",78.87,"1.8","1.8","Crystal structure of human 5' exonuclease Appollo in complex with 5'dAMP","MNGVLIPHTPIAVDFWSLRRAGTARLFFLSHMHSDHTVGLSSTWARPLYCSPITAHLLHRHLQVSKQWIQALEVGESHVLPLDEIGQETMTVTLLDANHCPGSVMFLFEGYFGTILYTGDFRYTPSMLKEPALTLGKQIHTLYLDNTNCNPALVLPSRQEAAHQIVQLIRKHPQHNIKIGLYSLGKESLLEQLALEFQTWVVLSPRRLELVQLLGLADVFTVEEKAGRIHAVDHMEICHSNMLRWNQTHPTIAILPTSRKIHSSHPDIHVIPYSDHSSYSELRAFVAALKPCQVVPIVSRRPCGGFQDSLSPRISVPLIPDSVQQYMSSSSRKPSAENLYFQ","Homo sapiens","DCLRE1B, SNM1B","5' exonuclease Apollo","1","7A1F"
"7A1J",,"X-RAY DIFFRACTION",3.43,64.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES PH 7.5",277,"10.1038/s41467-021-26673-2",,"7A1J",41.14,"1.9","1.9","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-(3-phenylpropyl)-2-oxoglutarate","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1-alpha inhibitor","1","7A1J"
"7A1K",,"X-RAY DIFFRACTION",3.43,64.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES PH 7.5",277,"10.1038/s41467-021-26673-2",,"7A1K",41.13,"1.99","1.99","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-((9,9-dimethyl-9H-fluoren-2-yl)methyl)-2-oxoglutarate","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1-alpha inhibitor","1","7A1K"
"7A1L",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES PH 7.5",277,"10.1038/s41467-021-26673-2",,"7A1L",40.94,"2.29","2.29","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-methyl-2-oxoglutarate","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1-alpha inhibitor","1","7A1L"
"7A1M",,"X-RAY DIFFRACTION",3.41,63.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG 400, 0.1M HEPES PH 7.5",277,"10.1038/s41467-021-26673-2",,"7A1M",40.87,"2.18","2.18","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II) AND 3-propyl-2-oxoglutarate","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1-alpha inhibitor","1","7A1M"
"7A1V",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.1M Sodium Citrate Tribasic Dihydrate pH 5.2, 2 M ammonium sulfate.",277.15,,,"7A1V",39.65,"2.2","2.2","Crystal structure of YTHDF2 in complex with m1A","MGSSYHHHHHHSSGENLYFQHMKHGRVFIIKSYSEDDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYNTCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQVLKIIASYKHTTS","Homo sapiens","YTHDF2, HGRG8","YTH domain-containing family protein 2","1","7A1V"
"7A1W",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350 20% - Na2HPO4 200mM - pH7",293,"10.1080/21541248.2021.1979360",,"7A1W",20.53,"1.76","1.76","KRASG12C GDP form in complex with Cpd3","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","Isoform 2B of GTPase KRas","1","7A1W"
"7A1X",,"X-RAY DIFFRACTION",1.88,34.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"TRIS 100mM - PEG 4K 23% - Na Acet 100mM - pH8.5",277,"10.1080/21541248.2021.1979360",,"7A1X",20.04,"1.32","1.32","KRASG12C GDP form in complex with Cpd1","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7A1X"
"7A1Y",,"X-RAY DIFFRACTION",2.52,51.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES 100mM - (NH4)2SO4 2.25M - pH7.5",293,"10.1080/21541248.2021.1979360",,"7A1Y",20.2,"2.004","2.004","KRASG12C GDP form in complex with Cpd2","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7A1Y"
"7A1Z",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser)/inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine by extensive crystal soaking.",293,"10.1016/j.bioorg.2020.104502","QWN","7A1Z",43.52,"1.024","1.024","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7A1Z"
"7A21",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, SITTING DROP",7.4,"16% PEG8K, 15% glycerol, 0.08M potassium phosphate dibasic",293,,,"7A21",70.19,"2.14","2.14","Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2158","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type I","1","7A21"
"7A22",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser)/inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the inhibitor 5,6,7-tribromo-1H-triazolo[4,5-b]pyridine by extensive crystal soaking.",293,"10.1016/j.bioorg.2020.104502","QWW","7A22",44.04,"1.01","1.01","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 5,6,7-tribromo-1H-triazolo[4,5-b]pyridine","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7A22"
"7A2A",,"X-RAY DIFFRACTION",1.91,35.73,"VAPOR DIFFUSION, HANGING DROP",,"25 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole, 5.0 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acsmedchemlett.0c00472",,"7A2A",77.9,"1.9","1.9","Crystal Structure of EGFR-T790M/V948R in Complex with Spebrutinib and EAI001","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7A2A"
"7A2G","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-27657-y",,"7A2G",190.13,"4.1",,"Full-length structure of the substrate-free tyrosine hydroxylase (apo-TH).","GKAMLNLLFSPRATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVRQVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG","Homo sapiens","TH, TYH","Tyrosine 3-monooxygenase","1","7A2G"
"7A2H",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser)/inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the inhibitor 5,6,7-tribromo-1H-imidazo[4,5-b]pyridine by extensive crystal soaking.",293,"10.1016/j.bioorg.2020.104502",,"7A2H",43.42,"1.01","1.01","Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 5,6,7-tribromo-1H-imidazo[4,5-b]pyridine","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7A2H"
"7A2J",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"4.5M sodium formate, 0.1M Hepes",298,,,"7A2J",13.61,"1.5","1.5","Crystal structure of the Fyn SH3 domain in space group C21 at pH 7.5","GVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2J"
"7A2K",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"4.5M sodium formate, 0.1M Hepes",298,,,"7A2K",27.27,"1.5","1.5","Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5","GVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2K"
"7A2L",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, SITTING DROP",4,"3.5M sodium formate, 0.1M sodium acetate",298,,,"7A2L",13.7,"1.9","1.9","Crystal structure of the Fyn SH3 domain mutant E129Q in space group C21 at pH 4.0","GVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGQTGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2L"
"7A2M",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, SITTING DROP",4,"4.5 M sodium formate, 0.1 sodium acetate",298,,,"7A2M",13.81,"1.5","1.5","Crystal structure of the Fyn SH3 domain A95S-D99T mutant in C21 space group","GVTLFVALYDYESRTETDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2M"
"7A2N",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, SITTING DROP",4,"4.5 M sodium formate, 0.1 sodium acetate",298,,,"7A2N",27.88,"1.4","1.4","Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21","GVTLFVALYDYESRTETDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2N"
"7A2O",,"X-RAY DIFFRACTION",2.06,40.2,"VAPOR DIFFUSION, SITTING DROP",4.5,"5% PEG 300, 1.5 ammonium sulfate, 0.1M sodium acetate",298,,,"7A2O",6.94,"0.94","0.94","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.5","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2O"
"7A2P",,"X-RAY DIFFRACTION",2.05,39.86,"VAPOR DIFFUSION, SITTING DROP",5,"5% PEG 300, 2.0 ammonium sulfate, 0.1M sodium acetate",298,,,"7A2P",7.02,"0.9","0.9","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 with PEG","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2P"
"7A2Q",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, SITTING DROP",5,"5% PEG 300, 5 mM beta-cyclodextrin, 2.0 ammonium sulfate, 0.1M sodium citrate",298,,,"7A2Q",7.16,"0.94","0.94","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 3.0 with PEG","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2Q"
"7A2R",,"X-RAY DIFFRACTION",1.99,38.15,"VAPOR DIFFUSION, SITTING DROP",6,"1.5 ammonium sulfate, 0.1M MES",298,,,"7A2R",6.93,"1.05","1.05","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 6.0","GGVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2R"
"7A2S",,"X-RAY DIFFRACTION",1.98,37.78,"VAPOR DIFFUSION, SITTING DROP",5,"2.0 ammonium sulfate, 0.1M sodium acetate",298,,,"7A2S",6.93,"1.02","1.02","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0","GGVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2S"
"7A2T",,"X-RAY DIFFRACTION",2.01,38.87,"VAPOR DIFFUSION, SITTING DROP",4,"1 ammonium sulfate, 0.1M sodium acetate",298,,,"7A2T",6.93,"1.22","1.22","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.0","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWLAHSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2T"
"7A2U",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.5 M ammonium sulfate, 0.1 sodium acetate",298,,,"7A2U",6.88,"1.7","1.7","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T at pH 4.5","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWEARSLTTGETGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2U"
"7A2V",,"X-RAY DIFFRACTION",2.57,52.17,"VAPOR DIFFUSION, SITTING DROP",4,"1.5 M ammonium sulfate, 0.1 sodium acetate",298,,,"7A2V",6.82,"1.81","1.81","Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E129Q at pH 4.0","GVTLFVALYDYEARTEDDLSFHKGEKFQIVNNTEGDWWEARSLTTGQTGYIPSNYVAPVD","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","7A2V"
"7A3F",,"X-RAY DIFFRACTION",2.68,54.08,"VAPOR DIFFUSION, HANGING DROP",,"0.08 M Na-Cacodilate pH 5.25, 0.16 M Ca-Acetate, 30 % Glycerol, 10 % PEG 8K",293,,,"7A3F",411.07,"2.9","2.9","Crystal structure of apo DPP9","MRKVKKLRLDKENTGSWRSFSLNSEGAERMATTGTPTADRGDAAATDDPAARFQVQKHSWDGLRSIIHGSRKYSGLIVNKAPHDFQFVQKTDESGPHSHRLYYLGMPYGSRENSLLYSEIPKKVRKEALLLLSWKQMLDHFQATPHHGVYSREEELLRERKRLGVFGITSYDFHSESGLFLFQASNSLFHCRDGGKNGFMVSPMKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYLHHHHHH","Homo sapiens","DPP9, DPRP2","Dipeptidyl peptidase 9","1","7A3F"
"7A3G",,"X-RAY DIFFRACTION",4.45,72.33,"VAPOR DIFFUSION, HANGING DROP",,"0.46 M Na citrate",273,"10.1002/anie.202210498",,"7A3G",210.1,"2.8","2.8","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, 91","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7A3G"
"7A3I",,"X-RAY DIFFRACTION",4.32,71.54,"VAPOR DIFFUSION, HANGING DROP",,"0.46 M Na citrate",277,,,"7A3I",313.11,"2.8","2.8","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, LMC375","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7A3I"
"7A3J",,"X-RAY DIFFRACTION",4.37,71.84,"VAPOR DIFFUSION, HANGING DROP",,"0.46 M Na citrate",277,"10.1002/anie.202210498",,"7A3J",312.15,"3","3","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, A272","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7A3J"
"7A3K",,"X-RAY DIFFRACTION",4.3,71.39,"VAPOR DIFFUSION, HANGING DROP",,"0.46 M Na citrate",277,,,"7A3K",312.27,"2.65","2.65","Crystal structure of DPP8 in complex with a b-lactam based inhibitor, A296.1","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7A3K"
"7A3L",,"X-RAY DIFFRACTION",4.36,71.8,"VAPOR DIFFUSION, HANGING DROP",,"0.46 M Na citrate",277,"10.1002/anie.202210498",,"7A3L",312.4,"2.8","2.8","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, A241","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7A3L"
"7A41",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Magnesium formate dehydrate
15% w/v PEG3550",293,,,"7A41",92.58,"2.13","2.13","MALT1 in complex with a NVS-MALT1 chemical probe","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","7A41"
"7A47",,"X-RAY DIFFRACTION",3.54,65.21,"VAPOR DIFFUSION, HANGING DROP",6,"1.1 M Sodium Citrate pH 6.0",293,"10.1080/21541248.2021.1979360",,"7A47",61.3,"2.16","2.16","KRASG12C GDP form in complex with Cpd4","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","Isoform 2B of GTPase KRas","1","7A47"
"7A49",,"X-RAY DIFFRACTION",3.16,61.11,"VAPOR DIFFUSION, SITTING DROP",,"1 MIKROLITER OF THE CK2ALPHA/INHIBITOR MIXTURE (COMPOSITION: 7 MG/ML CK2ALPHA ENZYME, 1 MILLIMOLAR INHIBITOR, 10 % DIMETHYL SULFOXIDE, 450 MM NACL, 22.5 MM TRIS/HCL, PH 8.5) WAS MIXED WITH 1 MIKROLITER RESERVOIR SOLUTION (COMPOSITION: 25 % PEG3350, 0.2 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS BUFFER, PH 5.5) FOLLOWED BY VAPOUR DIFFUSION EQUILIBRATION AGAINST THE RESERVOIR SOLUTION.",293.15,"10.1016/j.bioorg.2020.104502","QWN","7A49",81.56,"2.03","2.03","Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7A49"
"7A4B",,"X-RAY DIFFRACTION",3.18,61.3,"VAPOR DIFFUSION, SITTING DROP",,"1 MIKROLITER OF THE CK2ALPHA/INHIBITOR MIXTURE (COMPOSITION: 7 MG/ML CK2ALPHA ENZYME, 1 MILLIMOLAR INHIBITOR, 10 % DIMETHYL SULFOXIDE, 450 MM NACL, 22.5 MM TRIS/HCL, PH 8.5) WAS MIXED WITH 1 MIKROLITER RESERVOIR SOLUTION (COMPOSITION: 25 % PEG3350, 0.2 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS BUFFER, PH 5.5) FOLLOWED BY VAPOUR DIFFUSION EQUILIBRATION AGAINST THE RESERVOIR SOLUTION.",293.15,"10.1016/j.bioorg.2020.104502","QXW","7A4B",81.74,"2.06","2.06","Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-competitive inhibitor 5,6-dibromo-1H-triazolo[4,5-b]pyridine","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7A4B"
"7A4C",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, SITTING DROP",,"1 MIKROLITER OF THE CK2ALPHA/INHIBITOR MIXTURE (COMPOSITION: 7 MG/ML CK2ALPHA ENZYME, 1 MILLIMOLAR INHIBITOR, 10 % DIMETHYL SULFOXIDE, 450 MM NACL, 22.5 MM TRIS/HCL, PH 8.5) WAS MIXED WITH 1 MIKROLITER RESERVOIR SOLUTION (COMPOSITION: 25 % PEG3350, 0.2 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS BUFFER, PH 5.5) FOLLOWED BY VAPOUR DIFFUSION EQUILIBRATION AGAINST THE RESERVOIR SOLUTION.",293.15,"10.1016/j.bioorg.2020.104502","QWW","7A4C",81.7,"2.502","2.502","Crystal structure of human protein kinase CK2alpha (CSNK2A1 gene product) in complex with the ATP-competitive inhibitor 5,6,7-tribromo-1H-triazolo[4,5-b]pyridine","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7A4C"
"7A4O",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A4O",90.12,"1.9","1.9","Structure of DYRK1A in complex with AMPNP","MHHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A4O"
"7A4Q",,"X-RAY DIFFRACTION",1.99,38.23,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,,,"7A4Q",39.23,"1.42","1.42","The Crystal structure of RO4613269 bound to CK2alpha","GPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7A4Q"
"7A4R",,"X-RAY DIFFRACTION",2.3,46.52,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A4R",82.69,"1.8","1.8","Structure of DYRK1A in complex with compound 1","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFAA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A4R"
"7A4S",,"X-RAY DIFFRACTION",2.8,56.1,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A4S",41.83,"3.1","3.1","Structure of DYRK1A in complex with compound 2","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A4S"
"7A4W",,"X-RAY DIFFRACTION",2.28,46.17,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A4W",89.54,"2.7","2.7","Structure of DYRK1A in complex with compound 3","MHHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A4W"
"7A4Z",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A4Z",41.84,"1.9","1.9","Structure of DYRK1A in complex with compound 4","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A4Z"
"7A51",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION",,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A51",41.9,"1.9","1.9","Structure of DYRK1A in complex with compound 5","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A51"
"7A52",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A52",82.92,"2.1","2.1","Structure of DYRK1A in complex with compound 6","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFAA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A52"
"7A53",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A53",83.74,"2.2","2.2","Structure of DYRK1A in complex with compound 7","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A53"
"7A55",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A55",89.49,"2.2","2.2","Structure of DYRK1A in complex with compound 8","MHHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A55"
"7A5B",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A5B",89.59,"2.6","2.6","Structure of DYRK1A in complex with complex 10","MHHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A5B"
"7A5D",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A5D",41.97,"1.8","1.8","Structure of DYRK1A in complex with compound 16","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A5D"
"7A5L",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION",6.5,"0.1M MES buffer at pH 6.5, 12% Peg3350, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A5L",42.02,"2.1","2.1","tructure of DYRK1A in complex with compound 24","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A5L"
"7A5N",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION",7.5,"0.1M Hepes buffer at pH 7.5, 20% Peg4k, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00024",,"7A5N",84.13,"2.3","2.3","Structure of DYRK1A in complex with compound 34","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7A5N"
"7A5O","2.95","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2020.09.021",,"7A5O",1535.15,"2.95",,"Human MUC2 AAs 21-1397","SELQTEGRTRYHGRNVCSTWGNFHYKTFDGDVFRFPGLCDYNFASDCRGSYKEFAVHLKRGPGQAEAPAGVESILLTIKDDTIYLTRHLAVLNGAVVSTPHYSPGLLIEKSDAYTKVYSRAGLTLMWNREDALMLELDTKFRNHTCGLCGDYNGLQSYSEFLSDGVLFSPLEFGNMQKINQPDVVCEDPEEEVAPASCSEHRAECERLLTAEAFADCQDLVPLEPYLRACQQDRCRCPGGDTCVCSTVAEFSRQCSHAGGRPGNWRTATLCPKTCPGNLVYLESGSPCMDTCSHLEVSSLCEEHRMDGCFCPEGTVYDDIGDSGCVPVSQCHCRLHGHLYTPGQEITNDCEQCVCNAGRWVCKDLPCPGTCALEGGSHITTFDGKTYTFHGDCYYVLAKGDHNDSYALLGELAPCGSTDKQTCLKTVVLLADKKKNAVVFKSDGSVLLNQLQVNLPHVTASFSVFRPSSYHIMVSMAIGVRLQVQLAPVMQLFVTLDQASQGQVQGLCGNFNGLEGDDFKTASGLVEATGAGFANTWKAQSTCHDKLDWLDDPCSLNIESANYAEHWCSLLKKTETPFGRCHSAVDPAEYYKRCKYDTCNCQNNEDCLCAALSSYARACTAKGVMLWGWREHVCNKDVGSCPNSQVFLYNLTTCQQTCRSLSEADSHCLEGFAPVDGCGCPDHTFLDEKGRCVPLAKCSCYHRGLYLEAGDVVVRQEERCVCRDGRLHCRQIRLIGQSCTAPKIHMDCSNLTALATSKPRALSCQTLAAGYYHTECVSGCVCPDGLMDDGRGGCVVEKECPCVHNNDLYSSGAKIKVDCNTCTCKRGRWVCTQAVCHGTCSIYGSGHYITFDGKYYDFDGHCSYVAVQDYCGQNSSLGSFSIITENVPCGTTGVTCSKAIKIFMGRTELKLEDKHRVVIQRDEGHHVAYTTREVGQYLVVESSTGIIVIWDKRTTVFIKLAPSYKGTVCGLCGNFDHRSNNDFTTRDHMVVSSELDFGNSWKEAPTCPDVSTNPEPCSLNPHRRSWAEKQCSILKSSVFSICHSKVDPKPFYEACVHDSCSCDTGGDCECFCSAVASYAQECTKEGACVFWRTPDLCPIFCDYYNPPHECEWHYEPCGNRSFETCRTINGIHSNISVSYLEGCYPRCPKDRPIYEEDLKKCVTADKCGCYVEDTHYPPGASVPTEETCKSCVCTNSSQVVCRPEEGKILNQTQDGAFCYWEICGPNGTVEKHFNICSITTRPSTLTTFTTITLPTTPTSFTTTTTTTTPTSSTVLSTTPKLCCLWSDWINEDHPSSGSDDGDRETFDGVCGAPEDIECRSVKDPHLSLEQHGQKVQCDVSVGFICKNEDQFGNGPFGLCYDYKIRVNCCWPMDKCITHHHHHH","Homo sapiens","MUC2, SMUC","Mucin-2","1","7A5O"
"7A5Y",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bistris methane-HCl pH 6, 15% (w/v) PEG 3350, 0.15 M Li2SO4",293,"10.1021/acs.biochem.0c00944",,"7A5Y",494.72,"2.29","2.29","Crystal structure of tetrameric human H215A-SAMHD1 (residues 109-626) with Rp-dGTP-alphaS (T8T) and Mg","GSQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSAMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","7A5Y"
"7A62",,"X-RAY DIFFRACTION",2.83,56.6,"VAPOR DIFFUSION, HANGING DROP",6.25,"14% IN PEG 3350, 0.1 M IN PHOSPHATE BUFFER AT A PH OF 6.25 
PROTEIN : IN HEPES 5 MM AND NACL 200MM 
CRYOPROTECTION IN 20% OF GLYCEROL AND 20 MM OF SODIUM DITHIONITE, PH 7.6",293,"10.1107/S2059798320013510",,"7A62",184.39,"2.43796448682","2.43796448682","Structure of human indoleamine-2,3-dioxygenase 1 (hIDO1) with a complete JK loop","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","7A62"
"7A6A","1.15","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2833-4",,"7A6A",511.23,"1.15",,"1.15 A structure of human apoferritin obtained from Titan Mono- BCOR microscope","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","7A6A"
"7A6B","1.33","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2833-4",,"7A6B",511.23,"1.33",,"1.33 A structure of human apoferritin obtained from Titan Mono- BCOR microscope","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","7A6B"
"7A6I",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",,"27.5 % PEG3350, 200 mM MgSO4, 4 % ethylen glycole, 7.5 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.1c02080",,"7A6I",38.84,"2.4","2.4","Crystal Structure of EGFR-T790M/V948R in Complex with LDC8201","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7A6I"
"7A6J",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"20.0 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole, 7.5 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.1c02080",,"7A6J",77.55,"2","2","Crystal Structure of EGFR-T790M/V948R in Complex with Poziotinib","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7A6J"
"7A6K",,"X-RAY DIFFRACTION",1.76,29.93,"VAPOR DIFFUSION, HANGING DROP",,"25.0 % PEG3350, 100 mM MgSO4, 4 % ethylen glycole, 6.8 mg/mL EGFR-T790M/V948R (in 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0) 1 ul reservoir + 1 ul protein solution)",293,"10.1021/acs.jmedchem.1c02080",,"7A6K",154.88,"2","2","Crystal Structure of EGFR-T790M/V948R in Complex with TAK-788","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7A6K"
"7A6Q",,"X-RAY DIFFRACTION",2.63,53.19,"VAPOR DIFFUSION, SITTING DROP",,"2.4 M sodium malonate, pH 7.0",293.15,"10.3390/cancers13020356",,"7A6Q",115.16,"2.95","2.95","Crystal structure of human aldehyde dehydrogenase 1A3 in complex with selective NR6 inhibitor compound","MATANGAVENGQPDRKPPALPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLGDKNP","Homo sapiens","ALDH1A3, ALDH6","Aldehyde dehydrogenase family 1 member A3","1","7A6Q"
"7A6S",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 3350, PEG 1000), 100 mM Tris-Bicine pH = 8.5",293,,,"7A6S",82.68,"1.75","1.75","Crystal Structure of Asn173Ser variant of Human Deoxyhypusine Synthase","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPSENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","7A6S"
"7A6T",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, SITTING DROP",,"0.025-0.125 mM carboxylic acid mix, 30-60% precipitant mix (MPD, PEG 3350, PEG 1000), 100 mM Tris-Bicine pH = 8.5",293,,,"7A6T",84.19,"1.66","1.66","Crystal Structure of Asn173Ser variant of Human Deoxyhypusine Synthase in complex with NAD and spermidine","MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPSENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","7A6T"
"7A6U","3.62","ELECTRON MICROSCOPY",,,,,,,,,"7A6U",439.4,"3.62",,"Cryo-EM structure of the cytoplasmic domain of human TRPC6","MSQSPAFGPRRGSSPRGAAGAAARRNESQDYLLMDSELGEDGCPQAPLPCYGYYPCFRGSDNRLAHRRQTVLREKGRRLANRGPAYMFSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEECHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVGDALLLAISKGYVRIVEAILSHPAFAEGKRLATSPSQSELQQDDFYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRINAYKGLASPAYLSLSSEDPVMTALELSNELAVLANIEKEFKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGDHGRPNLSRLKLAIKYEVKKFVAHPNCQQQLLSIWYENLSGLRQQTMAVKFLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNAKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFELWNMLDFGMLAIFAASFIARFMAFWHASKAQSIIDANDTLKDLTKVTLGDNVKYYNLARIKWDPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVINYNHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYFEEGRTLPVPFNLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKRLIKRYVLQAQIDKESDEVNEGELKEIKQDISSLRYELLEEKSQNTEDLAELIRELGEKLSMEPNQEETNRAENLYFQSHHHHHHHHHHDYKDDDDK","Homo sapiens","TRPC6, TRP6","Short transient receptor potential channel 6","1","7A6U"
"7A6V",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, SITTING DROP",8,"1,5-1,8 M sodium citrate",295,"10.1002/chem.202103527",,"7A6V",29.59,"2","2","Human Carbonic Anhydrase II in complex with 4-(3-(3-phenoxypropyl)thioureido)benzenesulfonamide","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7A6V"
"7A6W",,"X-RAY DIFFRACTION",1.96,37.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG-3350, 0.2 M NH4-acetate, 0.1 M HEPES-NaOH pH 7.5",293,"10.1021/acs.jmedchem.0c02195",,"7A6W",30.09,"1.85","1.85","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 33-(Z)","HMGAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7A6W"
"7A6X",,"X-RAY DIFFRACTION",1.78,30.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1021/acs.jmedchem.0c02195",,"7A6X",14.99,"1.67","1.67","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 56","HMGAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7A6X"
"7A7G",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION",6.13,"28% PEG6000, 70 mM Ammoniumacetat, 200 mM Magnesium acetat tetrahydrate",293,"10.1021/acs.jmedchem.0c02063",,"7A7G",80.12,"2.4","2.4","Soluble epoxide hydrolase in complex with TK90","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","7A7G"
"7A7H",,"X-RAY DIFFRACTION",2.57,52.14,"VAPOR DIFFUSION",,"27% PEG 3350, 0.2M Sodium citrate tribasic dehydrate",293,"10.1021/acs.jmedchem.0c02063",,"7A7H",32.14,"2.4","2.4","Crystal structure of PPARgamma in complex with compound TK90","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","7A7H"
"7A8P","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-03048-z",,"7A8P",130.28,"3.5",,"Structure of human mitochondrial RNA polymerase in complex with IMT inhibitor.","MGHHHHHHENLYFQSNARKVQMGAKDATPVPCGRWAKILEKDKRTQQMRMQRLKAKLQMPFQSGEFKALTRRLQVEPRLLSKQMAGCLEDCTRQAPESPWEEQLARLLQEAPGKLSLDVEQAPSGQHSQAQLSGQQQRLLAFFKCCLLTDQLPLAHHLLVVHHGQRQKRKLLTLDMYNAVMLGWARQGAFKELVYVLFMVKDAGLTPDLLSYAAALQCMGRQDQDAGTIERCLEQMSQEGLKLQALFTAVLLSEEDRATVLKAVHKVKPTFSLPPQLPPPVNTSKLLRDVYAKDGRVSYPKLHLPLKTLQCLFEKQLHMELASRVCVVSVEKPTLPSKEVKHARKTLKTLRDQWEKALCRALRETKNRLEREVYEGRFSLYPFLCLLDEREVVRMLLQVLQALPAQGESFTTLARELSARTFSRHVVQRQRVSGQVQALQNHYRKYLCLLASDAEVPEPCLPRQYWEALGAPEALREQPWPLPVQMELGKLLAEMLVQATQMPCSLDKPHRSSRLVPVLYHVYSFRNVQQIGILKPHPAYVQLLEKAAEPTLTFEAVDVPMLCPPLPWTSPHSGAFLLSPTKLMRTVEGATQHQELLETCPPTALHGALDALTQLGNCAWRVNGRVLDLVLQLFQAKGCPQLGVPAPPSEAPQPPEAHLPHSAAPARKAELRRELAHCQKVAREMHSLRAEALYRLSLAQHLRDRVFWLPHNMDFRGRTYPCPPHFNHLGSDVARALLEFAQGRPLGPHGLDWLKIHLVNLTGLKKREPLRKRLAFAEEVMDDILDSADQPLTGRKWWMGAEEPWQTLACCMEVANAVRASDPAAYVSHLPVHQDGSCNGLQHYAALGRDSVGAASVNLEPSDVPQDVYSGVAAQVEVFRRQDAQRGMRVAQVLEGFITRKVVKQTVMTVVYGVTRYGGRLQIEKRLRELSDFPQEFVWEASHYLVRQVFKSLQEMFSGTRAIQHWLTESARLISHMGSVVEWVTPLGVPVIQPYRLDSKVKQIGGGIQSITYTHNGDISRKPNTRKQKNGFPPNFIHSLDSSHMMLTALHCYRKGLTFVSVHDCYWTHAADVSVMNQVCREQFVRLHSEPILQDLSRFLVKRFCSEPQKILEASQLKETLQAVPKPGAFDLEQVKRSTYFFS","Homo sapiens","POLRMT","DNA-directed RNA polymerase, mitochondrial","1","7A8P"
"7A8Q",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7A8Q",172.36,"2.24","2.24","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-654","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7A8Q"
"7A90",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M tri-Potassium Citrate monohydrate, 
20% (w/v) PEG 3350, 0.1 M Natrium Citrate, 50 mM EDTA",291,,,"7A90",23.89,"3.185","3.185","WT STING in complex with 3',3'-c-di[2'FdAM(PS)]","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","7A90"
"7A9C",,"X-RAY DIFFRACTION",2.69,54.28,"BATCH MODE",,"2mM yttrium chloride",293,,,"7A9C",66.72,"2.75","2.75","Human serum albumin (HSA) crystallized in the presence of yttrium (III) chloride","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKEEQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Albumin","1","7A9C"
"7A9U",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION",,"20% PEG 3350 0.2M NaBr",293,"10.1002/anie.202008361",,"7A9U",15.58,"1.444","1.444","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)-N-(3-methyl-[1,2,4]triazolo[4,3-a]pyridin-8-yl)propanamide","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7A9U"
"7A9V",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,,,"7A9V",171.87,"2.17","2.17","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-635","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7A9V"
"7A9Y",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION, SITTING DROP",,"PEG mixture",298,"10.1107/S2059798320015247",,"7A9Y",31.69,"1.64","1.64","Structural comparison of cellular retinoic acid binding protein I and II in the presence and absence of natural and synthetic ligands","MPNFAGTWKMRSSENFDELLKALGVNAMCRKVAVAAASKPHVEIRQDGDQFYIKTSTTVRTTEINFKVGEGFEEETVDGRKCRSLATWENENKIHCTQTLLEGDGPKTYWTRELANDELILTFGADDVVCTRIYVRE","Homo sapiens","CRABP1, RBP5","Cellular retinoic acid-binding protein 1","1","7A9Y"
"7A9Z",,"X-RAY DIFFRACTION",3.93,68.72,"VAPOR DIFFUSION, SITTING DROP",,"PEG mixture",298,"10.1107/S2059798320015247",,"7A9Z",31.49,"2.41","2.41","Structural comparison of cellular retinoic acid binding protein I and II in the presence and absence of natural and synthetic ligands","MPNFAGTWKMRSSENFDELLKALGVNAMCRKVAVAAASKPHVEIRQDGDQFYIKTSTTVRTTEINFKVGEGFEEETVDGRKCRSLATWENENKIHCTQTLLEGDGPKTYWTRELANDELILTFGADDVVCTRIYVRE","Homo sapiens","CRABP1, RBP5","Cellular retinoic acid-binding protein 1","1","7A9Z"
"7AA0",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION, SITTING DROP",,"PEG based",298,"10.1107/S2059798320015247",,"7AA0",32.12,"1.82","1.82","Structural comparison of cellular retinoic acid binding protein I and II in the presence and absence of natural and synthetic ligands","MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTRVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","7AA0"
"7AA1",,"X-RAY DIFFRACTION",2.57,52.17,"VAPOR DIFFUSION, SITTING DROP",,"PEG based vapor diffusion",298,"10.1107/S2059798320015247",,"7AA1",16.05,"1.71","1.71","Structural comparison of cellular retinoic acid binding proteins I and II in the presence and absence of natural and synthetic ligands","MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTRVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","7AA1"
"7AAA",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION",8.5,"2.45 M ammonium sulfate, 0.1 M Tris pH 8.5",293,"10.1093/nar/gkab020",,"7AAA",79.13,"1.74","1.74","Crystal structure of the catalytic domain of human PARP1 (apo)","GSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","7AAA"
"7AAB",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",5.5,"0.4 M ammonium sulfate, 25 % PEG3350, 0.1 M PCTP pH 5.5",293,"10.1093/nar/gkab020",,"7AAB",80.09,"2.8","2.8","Crystal structure of the catalytic domain of human PARP1 in complex with inhibitor EB-47","GSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","7AAB"
"7AAC",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION",8.5,"2.5 M ammonium sulfate, 0.1 M Tris pH 8.5",293,"10.1093/nar/gkab020",,"7AAC",79.31,"1.593","1.593","Crystal structure of the catalytic domain of human PARP1 in complex with veliparib","GSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","7AAC"
"7AAD",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION",8.5,"2.5 M ammonium sulfate, 0.1 M Tris pH 8.5",293,"10.1093/nar/gkab020",,"7AAD",79.78,"2.21","2.21","Crystal structure of the catalytic domain of human PARP1 in complex with olaparib","GSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","7AAD"
"7AAE",,"X-RAY DIFFRACTION",2.47,50.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM HEPES, 50 mM MOPS, 30 mM sodium fluoride, 30 mM sodium bromide, 30 mM sodium iodide, 12.5% v/v MPD, 12.5% w/v PEG 1000, 12.5% w/v PEG 3350",293,"10.1002/pro.4036",,"7AAE",68.56,"2.27","2.27","Crystal structure of Human serum albumin in complex with myristic acid at 2.27 Angstrom Resolution","AHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Albumin","1","7AAE"
"7AAG",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7AAG",175.81,"1.79","1.79","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-617","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7AAG"
"7AAH",,"X-RAY DIFFRACTION",2,38.63,"VAPOR DIFFUSION, SITTING DROP",,"Lithium citrate tribasic tetrahydrate, Glycerol ethoxylate, n-decyl-beta-D-maltopyranoside",293.15,"10.1016/j.jmb.2021.166826",,"7AAH",36.71,"1.4","1.4","Structure of human pERp1","GHMDRAPLTATAPQLDDEEMYSAHMPAHLRCDACRAVAYQMWQNLAKAETKLHTSNSGGRRELSELVYTDVLDRSCSRNWQDYGVREVDQVKRLTGPGLSEGPEPSISVMVTGGPWPTRLSRTCLHYLGEFGEDQIYEAHQQGRGALEALLCGGPQGACSEKVSAT","Homo sapiens","MZB1, MEDA7, PACAP, HSPC190","Marginal zone B- and B1-cell-specific protein","1","7AAH"
"7AAI",,"X-RAY DIFFRACTION",2.47,50.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM HEPES, 50 mM MOPS, 30 mM diethylene glycol, 30 mM triethylene glycol (PGE), 30 mM tetraethylene glycol (PG4), 30 mM pentaethylene glycol, 12.5% v/v MPD, 12.5% w/v PEG 1000, 12.5% w/v PEG 3350",293,"10.1002/pro.4036",,"7AAI",70.35,"2.1","2.1","Crystal structure of Human serum albumin in complex with perfluorooctanoic acid (PFOA) at 2.10 Angstrom Resolution","AHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Albumin","1","7AAI"
"7AAJ",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",5.1,"25% polyethylene glycol 3350, 200 mM ammonium citrate",293,"10.1016/j.isci.2021.102152",,"7AAJ",80.17,"1.8","1.8","Human porphobilinogen deaminase in complex with cofactor","GSMSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH","Homo sapiens","HMBS, PBGD, UPS","Porphobilinogen deaminase","1","7AAJ"
"7AAK",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",5.1,"polyethylene glycol 3350, ammonium citrate",293,"10.1016/j.isci.2021.102152",,"7AAK",81.16,"1.7","1.7","Human porphobilinogen deaminase R173W mutant crystallized in the ES2 intermediate state","GSMSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTWLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH","Homo sapiens","HMBS, PBGD, UPS","Porphobilinogen deaminase","1","7AAK"
"7AAL",,"X-RAY DIFFRACTION",2.63,53,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis-Tris-propane (pH 6.5), 15% (w/v) PEG 3350, 0.25 M sodium citrate",298,"10.1007/s00018-022-04173-w",,"7AAL",68.55,"1.97","1.97","Crystal structure of the F-BAR domain of PSTIPIP1, G258A mutant","GSHMMPQLQFKDAFWCRDFTAHTGYEVLLQRLLDGRKMCKDMEELLRQRAQAEERYGKELVQIARKAGGQTEINSLRASFDSLKQQMENVGSSHIQLALTLREELRSLEEFRERQKEQRKKYEAVMDRVQKSKLSLYKKAMESKKTYEQKCRDADDAEQAFERISANGHQKQVEKSQNKARQCKDSATEAERVYRQSIAQLEKVRAEWEQEHRTTCEAFQLQEFDRLTILRNALWVHSNQLSMQCVKDDELYEEVRLTLEACSIDADIDSFIQAKSTGTEPPAPVPYQNYYD","Homo sapiens","PSTPIP1, CD2BP1","Proline-serine-threonine phosphatase-interacting protein 1","1","7AAL"
"7AAN",,"X-RAY DIFFRACTION",2.59,53,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Bis-Tris-propane (pH=6.0), 17% (w/v) PEG 3350, 150 mM sodium citrate",298,"10.1007/s00018-022-04173-w",,"7AAN",68.52,"2.14","2.14","Crystal structure of the F-BAR domain of PSTIPIP1","GSHMMPQLQFKDAFWCRDFTAHTGYEVLLQRLLDGRKMCKDMEELLRQRAQAEERYGKELVQIARKAGGQTEINSLRASFDSLKQQMENVGSSHIQLALTLREELRSLEEFRERQKEQRKKYEAVMDRVQKSKLSLYKKAMESKKTYEQKCRDADDAEQAFERISANGHQKQVEKSQNKARQCKDSATEAERVYRQSIAQLEKVRAEWEQEHRTTCEAFQLQEFDRLTILRNALWVHSNQLSMQCVKDDELYEEVRLTLEGCSIDADIDSFIQAKSTGTEPPAPVPYQNYYD","Homo sapiens","PSTPIP1, CD2BP1","Proline-serine-threonine phosphatase-interacting protein 1","1","7AAN"
"7AAX",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION",7.5,"0.05M Tris pH 7.5, 4.4M NaCl",293,"10.1042/BCJ20200735",,"7AAX",35.05,"1.762","1.762","Crystal structure of MerTK kinase domain in complex with LDC1267","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AAX"
"7AAY",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION",6.2,"0.1M MES pH 6.2, 0.75M LiCl, 23% PEG 6k",293,"10.1042/BCJ20200735",,"7AAY",34.5,"1.87","1.87","Crystal structure of MerTK kinase domain in complex with Merestinib","GSHMEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AAY"
"7AAZ",,"X-RAY DIFFRACTION",3.12,60.64,"VAPOR DIFFUSION",8.5,"0.1M HEPES pH 6.6, 3.1M NaCl",293,"10.1042/BCJ20200735",,"7AAZ",34.92,"1.855","1.855","Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor","GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AAZ"
"7AB0",,"X-RAY DIFFRACTION",2.19,43.72,"VAPOR DIFFUSION",8.5,"0.1M Tris pH 8.5, 4.3M NaCl",293,"10.1042/BCJ20200735",,"7AB0",34.56,"1.74","1.74","Apo crystal structure of the MerTK kinase domain","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AB0"
"7AB1",,"X-RAY DIFFRACTION",2.26,45.53,"VAPOR DIFFUSION",8.5,"0.1M Tris pH 8.5, 4.3M NaCl",293,"10.1042/BCJ20200735",,"7AB1",35.15,"1.93","1.93","Crystal structure of MerTK kinase domain in complex with Gilteritinib","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AB1"
"7AB2",,"X-RAY DIFFRACTION",2.2,44.12,"VAPOR DIFFUSION",8.5,"0.1M Tris pH 8.5, 4.3M NaCl",293,"10.1042/BCJ20200735",,"7AB2",35.16,"1.78","1.78","Crystal structure of MerTK kinase domain in complex with UNC2025","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AB2"
"7AB9",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7AB9",171.85,"2.19","2.19","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-656","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7AB9"
"7ABD",,"X-RAY DIFFRACTION",2.63,53.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7ABD",172.07,"2.41","2.41","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-768","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7ABD"
"7ABE",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7ABE",173.85,"1.83","1.83","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-769","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7ABE"
"7ABJ",,"X-RAY DIFFRACTION",2.64,53.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,,,"7ABJ",173.21,"2.11","2.11","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1361","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7ABJ"
"7ABM",,"X-RAY DIFFRACTION",2.95,58,"VAPOR DIFFUSION, SITTING DROP",8,"pBAF was crystallized by the hanging drop method against 0.2 M sodium fluoride, 20% w/v PEG 3350",293,"10.1093/nar/gkab184",,"7ABM",9.95,"3.004","3.004","X-ray structure of phosphorylated Barrier-to-autointegration factor (BAF)","TSQKHRDFVAEPMGEKPVGSLAGIGEVLGKKLEERGFDKAYVVLGQFLVLKKDEDLFREWLKDTAGANAKQSRDAFGALREWADAF","Homo sapiens","BANF1, BAF, BCRG1","Barrier-to-autointegration factor","1","7ABM"
"7ACA",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION",,"Morpheus Screen D12

Morpheus Alcohol 10%
Morpheus Buffer 3
MPD_P1K_P3350 37.5% w/v",294,,,"7ACA",81.13,"1.57","1.57","CRYSTAL STRUCTURE OF AN ACTIVE KRAS G12D (GPPCP) DIMER IN COMPLEX WITH BI-5747","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7ACA"
"7ACC",,"X-RAY DIFFRACTION",2.07,40.58,"VAPOR DIFFUSION, SITTING DROP",7,"2.4 M di-Sodium malonate; pH 7.0 (JCSG F9)",293.15,"10.1073/pnas.2013473117",,"7ACC",99.75,"2.04","2.04","human GTP cyclohydrolase I feedback regulatory protein (GFRP)","SHMPYLLISTQIRMEVGPTMVGDEQSDPELMQHLGASKRRALGNNFYEYYVDDPPRIVLDKLERRGFRVLSMTGVGQTLVWCLHKE","Homo sapiens","GCHFR, GFRP","GTP cyclohydrolase 1 feedback regulatory protein","1","7ACC"
"7ACF",,"X-RAY DIFFRACTION",2.66,53.76,"VAPOR DIFFUSION",,"Morpheus Screen E9",278,,,"7ACF",81.07,"1.91","1.91","CRYSTAL STRUCTURE OF CRYSTAL FORM 2 OF AN ACTIVE KRAS G12D (GPPCP) DIMER IN COMPLEX WITH BI-5747","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7ACF"
"7ACH",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION",,"MPD 51% v/v
50mM MES pH 6.4",278,,,"7ACH",40.53,"1.9","1.9","CRYSTAL STRUCTURE OF ACTIVE KRAS G12D (GPPCP) IN COMPLEX WITH THE SOAKED DIMERIC INHIBITOR BI-5747","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7ACH"
"7ACQ",,"X-RAY DIFFRACTION",2.38,48.38,"VAPOR DIFFUSION",,"200 mM CaCl2
100 mM MES pH6
PEG6000 20% W/v",278,,,"7ACQ",60.9,"1.86","1.86","CRYSTAL STRUCTURE OF INACTIVE KRAS G12D (GDP) IN COMPLEX WITH THE SOAKED DIMERIC INHIBITOR BI-5747","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","7ACQ"
"7ACU",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.2 M acetate buffer pH 4.8, 2.2 M ammonium sulfate, 7% glycerol",293,"10.3390/ijms21197166","R75","7ACU",26.06,"1.541","1.541","Crystal structure of human transthyretin in complex with Benzbromarone","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","7ACU"
"7AEI",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION",7.5,"Trisodium citrate 0.68M",293,,,"7AEI",38.06,"2.65","2.65","Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7AEI"
"7AEL",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION",,"22% PEG1500, 0.2M MES pH 6.0",293,"10.15252/emmm.202013167",,"7AEL",46.06,"1.76","1.76","alpha 1-antitrypsin (C232S) complexed with GSK716","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHSKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","7AEL"
"7AEM",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION",7.5,"Tris sodium citrate 0.68M",293,,,"7AEM",39.91,"2.65","2.65","Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series","GSTSLYKKAGSENLYFQGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7AEM"
"7AEN",,"X-RAY DIFFRACTION",2.01,38.85,"LIQUID DIFFUSION",8,"buffer (10mM Tris/HCl pH 8.0, 150 mM NaCl, 10 mm lactose and 1 mM TCEP) mixed with reservoir 25% (w/v) PEG 2000 monomethylethyer (MME), a cryo solution (10 mM Tris/HCl pH 8.0, 50 mM NaCl, 10 mM lactose, 25% (w/v) PEG 2000 MME, 20% ethylene glycol (EG) and 1 mM TCEP) and flash-frozen in liquid nitrogen. 
A co-crystal with lactose, grown from a seeded drop with 24% (w/v) PEG 2000 MME in the reservoir, was used to soak in compound 1 by transferring crystals in three steps to different soaking drops.  First to a 2 ul drop with glycerol ( 20% (v/v) glycerol, 25% (w/v PEG 2000 MME, 10 mM Tris/HCl pH 8.0, 50 mM NaCl and 1 mM TCEP)  and secondly to a 2 ul drop with 10 mM compound 1 (10 mM Tris/HCl pH 8.0, 50 mM NaCl, 5 mM compound 1, 25% (w/v) PEG 2000 MME and 1 mM TCEP) and thirdly to a second drop with 5 mM compound 1 (same composition as before).",293.5,,,"7AEN",34.82,"1.6","1.6","Galectin-8 N-terminal carbohydrate recognition domain in complex with methyl 3-O-((7-carboxy)quinolin-2-yl)-methoxy)-beta-D-galactopyranoside","NLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSD","Homo sapiens","LGALS8","Isoform 2 of Galectin-8","1","7AEN"
"7AEP",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkab135",,"7AEP",13.78,,,"Solution structure of U1-A RRM2 (190-282)","MPGQPPYMPPPGMIPPPGLAPGQIPPGAMPPQQLMPGQMPPAQPLSENPPNHILFLTNLPEETNELMLSMLFNQFPGFKEVRLVPGRHDIAFVEFDNEVQAGAARDALQGFKITQNNAMKISFAKK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","7AEP"
"7AEQ",,"X-RAY DIFFRACTION",2.05,40.01,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1007/s00249-021-01561-1",,"7AEQ",29.94,"1.5","1.5","Human carbonic anhydrase II in complex with 2,3,5,6-tetrafluoro-4-(2-hydroxyethylsulfanyl)-N-methyl-benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","7AEQ"
"7AES",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1007/s00249-021-01561-1",,"7AES",30.08,"1.4","1.4","Human carbonic anhydrase II in complex with 2,3,5,6-tetrafluoro-N-methyl-4-propylsulfanyl-benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","7AES"
"7AF1",,"X-RAY DIFFRACTION",1.19,35.52,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350 0.3 M Ammonium Chloride",277.15,"10.1093/nar/gkab693",,"7AF1",42.47,"1.7","1.7","The structure of Artemis/SNM1C/DCLRE1C with 2 Zinc ions","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","7AF1"
"7AFS",,"X-RAY DIFFRACTION",1.92,36.09,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M Ammonium Acetate, 0.1 M Bis-TRIS pH 5.5, 25% PEG 3350",277.15,"10.1093/nar/gkab693",,"7AFS",42.04,"1.7","1.7","The structure of Artemis variant D37A","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKAHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","7AFS"
"7AFU",,"X-RAY DIFFRACTION",1.91,35.58,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Sodium Citrate pH 5.5, 20% PEG 3350",277.15,"10.1093/nar/gkab693",,"7AFU",42.45,"1.56","1.56","The structure of Artemis variant H33A","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSACHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","7AFU"
"7AFV",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION, SITTING DROP",8.5,"Drop protein volume 0.2 uL
Drop well volume 0.1 uL
 
0.04 M Porpheus Alcohol Mix (Complex ingredient) 
0.1 M Morpheus Buffer System 3 pH 8.5 (Buffer) 
31 %w/v Morpheus Precipitant Mix 4 (Precipitant) 
 
Stock Solutions:
Porpheus Alcohol Mix 
0.2 M 1,6-hexanediol, 0.2 M 1-butanol, 0.2 M (RS)-1,2-propanediol, 0.2 M 2-propanol, 0.2 M 1,4-butanediol, 0.2 M 1,3-propanediol 
(for a final concentration of 6.7 mM of 1,6-hexanediol, 1-butanol, (RS)-1,2-propanediol, 2-propanol, 1,4-butanediol, 1,3-propanediol)
 
Morpheus Buffer System 3 pH 8.5 
1M Tris and 1M BICINE 
(for a final concentration of 39.1 mM Bicine pH = 5.03 and 60.9 M Tris pH = 10.83)
 
Morpheus Precipitant Mix 
25% w/v PEG 3350, 25% w/v PEG 1000, 25% v/v MPD 
(for a final concentration of 7.75% w/v PEG 1000, 7.75% w/v PEG 3350 and 7.75% v/v MPD)",293,"10.1021/jacs.0c10629",,"7AFV",22.17,"2.4","2.4","Crystal structure of tetrameric beta-2-microglobulin deltaN6 S52C stabilized by a covalent ligand","MIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHCDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWD","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","7AFV"
"7AFW",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION",,"25% PEG 3350, 100 mM BIS-TRIS buffer pH 5.5 and 0.2 M Magnesium chloride",278,"10.1002/cmdc.202000839","R9Q","7AFW",18.45,"1.814","1.814","Beta-Catenin in complex with compound 6","GSNYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILA","Homo sapiens","CTNNB1, CTNNB, OK/SW-cl.35, PRO2286","Catenin beta-1","1","7AFW"
"7AGI",,"X-RAY DIFFRACTION",1.93,36.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Sodium Citrate pH 5.5, 20% PEG 3350",277.15,"10.1093/nar/gkab693",,"7AGI",42.31,"1.7","1.7","The structure of Artemis variant H35D","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCDKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","7AGI"
"7AGN",,"X-RAY DIFFRACTION",2.06,40.31,"VAPOR DIFFUSION, SITTING DROP",,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1007/s00249-021-01561-1",,"7AGN",119.44,"1.15","1.15","Human carbonic anhydrase II in complex with 4-(2-aminoethylsulfanyl)-2,3,5,6-tetrafluoro-N-methyl-benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","7AGN"
"7AH1",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION",7,"10 mg/ml in 100 mM HEPES/NaOH, 10% PEG 6000, pH 7.0",293,"10.1016/j.jsb.2021.107696",,"7AH1",26.14,"2","2","L19 diabody fragment from immunocytokine L19-IL2","EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSSGDGSSGGSGGASEIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIKKEFSSSSGSS","Homo sapiens",,"Anti-(ED-B) scFV","1","7AH1"
"7AH4",,"X-RAY DIFFRACTION",2.92,57.93,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG 4000, 0.1 M Tris pH 7.5, 0.2 M Magnesium chloride hexahydrate",291,"10.1021/acs.jmedchem.0c01968",,"7AH4",97.02,"2.401","2.401","Crystal structure of indoleamine 2,3-dioxygenase 1 (IDO1) in complex with ferric heme and MMG-0363","MGSSHHHHHHSSGLVPRGSHMASAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","7AH4"
"7AH5",,"X-RAY DIFFRACTION",2.71,54.68,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 10% PEG 1000, 0.2 M Potassium thiocyanate, 0.1 M Tris pH 7.5",291,"10.1021/acs.jmedchem.0c01968",,"7AH5",97.02,"2.9","2.9","Crystal structure of indoleamine 2,3-dioxygenase 1 (IDO1) in complex with ferric heme and MMG-0706","MGSSHHHHHHSSGLVPRGSHMASAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","7AH5"
"7AH6",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",,"4.0 M Sodium formate, 0.1 M Tris, pH 7.5",291,"10.1021/acs.jmedchem.0c01968",,"7AH6",97.29,"2.998","2.998","Crystal structure of indoleamine 2,3-dioxygenase 1 (IDO1) in complex with ferric heme and MMG-0752","MGSSHHHHHHSSGLVPRGSHMASAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","7AH6"
"7AHF",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, SITTING DROP",,"1.33 M magnesium formate dihydrate, 15% PEG 3350",293,,,"7AHF",35.15,"2.15","2.15","Dimeric structure of the catalytic domain of the human ubiquitin-conjugating enzyme UBE2S L114E varaiant","MNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLETIKCLLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHG","Homo sapiens","UBE2S, E2EPF, OK/SW-cl.73","Ubiquitin-conjugating enzyme E2 S","1","7AHF"
"7AHJ",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, HANGING DROP",,"0.1M TRIS pH8
0.92-1.2M Sodium Citrate 
0.1mM TCEP
0.5 micro molar Farglitazar.",293,,,"7AHJ",63.4,"2.1","2.1","Crystal structure of PPARgamma V290M mutant ligand binding domain in complex with farglitazar","ALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSMEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","7AHJ"
"7AHS",,"X-RAY DIFFRACTION",2.39,48.5,"VAPOR DIFFUSION, SITTING DROP",,"25 % w/v Polyethylene glycol 3,350, 100 mM BIS-TRIS pH 5.5, 200 mM lithium sulfate",293.15,"10.1085/jgp.202012766",,"7AHS",128.1,"2.05","2.05","titin-N2A Ig81-Ig83","GAMPVTLIKDIENQTVLKDNDAVFEIDIKINYPEIKLSWYKGTEKLEPSDKFEISIDGDRHTLRVKNCQLKDQGNYRLVCGPHIASAKLTVIEPAWERHLQDVTLKEGQTCTMTCQFSVPNVKSEWFRNGRILKPQGRHKTEVEHKVHKLTIADVRAEDQGQYTCKYEDLETSAELRIEAEPIQFTKRIQNIVVSEHQSATFECEVSFDDAIVTWYKGPTELTESQKYNFRNDGRCHYMTIHNVTPDDEGVYSVIARLEPRGEARSTAELYLT","Homo sapiens","TTN","Isoform 5 of Titin","1","7AHS"
"7AI4",,"X-RAY DIFFRACTION",2.54,51.53,"VAPOR DIFFUSION, HANGING DROP",,"1.1 M sodium formate and 0.1 M Hepes pH 7.9",290,,,"7AI4",66.55,"2.795","2.795","Crystal structure of the KLC1-TPR domain truncated from its nonTPR region ([A1-B6]-Delta-nonTPR fragment)","MRSETMSYYHHHHHHDYDIPTTENLYFQGAMGYEIPARLRTLHNLVIQYASQGRYEVAVPLCKQALEDLEKTSGHDHPDVATMLNILALVYRDQNKYKDAANLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKDHPDVAKQLNNLALLCQNQGKYEEVEYYYQRALEIYQTKLGPDDPNVAKTKNNLASCYLKQGKFKQAETLYKEILTRAHEREFGSGGGGSDSPTVTTTLKNLGALYRRQGKFEAAETLEEAAMRSRKQGLDNVH","Homo sapiens","KLC1, KLC, KNS2","Isoform C of Kinesin light chain 1,Isoform C of Kinesin light chain 1","1","7AI4"
,,,,,,,,,,,,,,,,,"Homo sapiens","KLC1, KLC, KNS2"
"7AIA",,"X-RAY DIFFRACTION",3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Lithium sulfate, 0.1 M bis-Tris pH 5.5, 25% w/v PEG 3350",277,"10.3389/fmolb.2020.631232",,"7AIA",66.66,"2.2","2.2","Complex of human GDAP1 with hexadecanedioic acid","EVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPRVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILIS","Homo sapiens","GDAP1","Ganglioside-induced differentiation-associated protein 1","1","7AIA"
"7AIE",,"X-RAY DIFFRACTION",2.52,51.21,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG8000, 0.6M magnesium acetate, 50mM sodium cacodylate pH 6.5",290,,,"7AIE",114.36,"3.287","3.287","Crystal structure of a truncated form of the KLC1-TPR domain ([A1-B5] fragment) - Monoclinic crystal form","MGSSHHHHHHSSGLVPRGSHMDDPGQGIQQQHSSAAAAAQQGGYEIPARLRTLHNLVIQYASQGRYEVAVPLCKQALEDLEKTSGHDHPDVATMLNILALVYRDQNKYKDAANLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKDHPDVAKQLNNLALLCQNQGKYEEVEYYYQRALEIYQTKLGPDDPNVAKTKNNLASCYLKQGKFKQAETLYKEILTRAHEREFGS","Homo sapiens","KLC1, KLC, KNS2","Kinesin light chain 1","1","7AIE"
"7AIN","3.2","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"7AIN",246.48,"3.2",,"Structure of Human Potassium Chloride Transporter KCC3 S45D/T940D/T997D in NaCl (Reference Map)","MPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNDITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERDLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMDWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYS","Homo sapiens","SLC12A6, KCC3","Isoform 2 of Solute carrier family 12 member 6","1","7AIN"
"7AIO","3.31","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"7AIO",246.16,"3.31",,"Structure of Human Potassium Chloride Transporter KCC3 S45D/T940D/T997D in NaCl (Subclass)","MPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNDITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERDLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMDWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYS","Homo sapiens","SLC12A6, KCC3","Solute carrier family 12 member 6","1","7AIO"
"7AIP","3.12","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"7AIP",242.63,"3.12",,"Structure of Human Potassium Chloride Transporter KCC1 in NaCl (Reference Map)","MLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSAENLYFQ","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","7AIP"
"7AIQ","3.72","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"7AIQ",241.85,"3.72",,"Structure of Human Potassium Chloride Transporter KCC1 in NaCl (Subclass 1)","MLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSAENLYFQ","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","7AIQ"
"7AIR","3.66","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107294",,"7AIR",242.13,"3.66",,"Structure of Human Potassium Chloride Transporter KCC1 in NaCl (Subclass 2)","MLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSAENLYFQ","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","7AIR"
,,,,,,,,,,,,,,,,"MLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSAENLYFQ","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","2","7AIR"
"7AIY",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",7.4,"250 mM ammonium acetate
20% polyethylene glycol 4000",293,"10.1021/acs.jmedchem.0c01775",,"7AIY",137.57,"2.937","2.937","Crystal structure of human butyrylcholinesterase in complex with 2-{1-[4-(12-Amino-3-chloro-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinolin-9-yl)butyl]-1H-1,2,3-triazol-4-yl}-N-[4-hydroxy-3-methoxybenzyl]acetamide","MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYTSKKESCVGL","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7AIY"
"7AJ2",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5; 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJ2",41.92,"2.1","2.1","Structure of DYRK1A in complex with compound 3","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJ2"
"7AJ4",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJ4",41.95,"2","2","Structure of DYRK1A in complex with compound 5","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJ4"
"7AJ5",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJ5",41.94,"2","2","Structure of DYRK1A in complex with compound 10","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJ5"
"7AJ6",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7
30%(v/v) jeffamine M-600 reagent pH 7.0",298,,,"7AJ6",46.1,"1.9","1.9","LN02 Fab","YVLGQSSSMSVAPGQTAKISCWGYYMGTKPVNWYQLKPGRAPSLIISYDDERASGTPARFSGSHSGSTATLTISNVVPADEADYFCQVWDSKYEEIYFGGGTALTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAP","Homo sapiens",,"LN02","1","7AJ6"
,,,,,,,,,,,,,,,,"APLPESGPGVVRPTGTLSLTCTAAYGSISRHFWGWVRQSPQGTLEWIAHMHHLGVKYVNPSLKNRVSISMDTSKNQMSLTLKTVTATDAAKYHCVRMGARMSDIAFFSFGDWGPGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"LN02 heavy chain","2","7AJ6"
"7AJ7",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJ7",41.96,"2.9","2.9","Structure of DYRK1A in complex with compound 16","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJ7"
"7AJ8",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJ8",41.93,"2","2","Structure of DYRK1A in complex with compound 25","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJ8"
"7AJA",,"X-RAY DIFFRACTION",2.49,50.54,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJA",42,"2.2","2.2","Structure of DYRK1A in complex with compound 28","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJA"
"7AJM",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJM",82.9,"2.4","2.4","Structure of DYRK1A in complex with compound 32","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFAA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJM"
"7AJN",,"X-RAY DIFFRACTION",2.17,43.47,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG1000
0.1M MIB pH 7.0",277,,,"7AJN",15.71,"1.48","1.48","Crystal Structure of the first bromodomain of BRD4 in complex with a BzD ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7AJN"
"7AJS",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJS",82.88,"2.15","2.15","Structure of DYRK1A in complex with compound 33","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFAA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJS"
"7AJV",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, SITTING DROP",5.6,"12% PEG3350, 0.2M ammonium sulphate, 0.05M Mg sulphate, 0.05M Na citrate buffer pH 5.6",293,"10.1021/acs.jmedchem.1c00023",,"7AJV",84.04,"2.1","2.1","Structure of DYRK1A in complex with compound 38","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJV"
"7AJW",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH 6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AJW",42.08,"2.8","2.8","Structure of DYRK1A in complex with compound 46","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJW"
"7AJY",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PegMME 5k, 0.1M ammonium sulphate, 0.1M ADA buffer pH 6.5",293,"10.1021/acs.jmedchem.1c00023",,"7AJY",84.15,"2.2","2.2","Structure of DYRK1A in complex with compound 51","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AJY"
"7AK0",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris pH 5.5, 0.3 M Magnesium Formate",298,"10.1021/acs.jmedchem.0c01245",,"7AK0",92.31,"2.316","2.316","Human MALT1(329-729) in complex with a chromane urea containing inhibitor","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","7AK0"
"7AK1",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, SITTING DROP",,"12.2 mg/ml, 25mM HEPES pH7.5, 50mM NaCL, 1mM TCEP",294,"10.1021/acs.jmedchem.0c01245",,"7AK1",46.16,"2.507","2.507","Human MALT1(329-729) in complex with a chromane urea containing inhibitor","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","7AK1"
"7AK2",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG 4K, 0.2M ammonium sulphate, 0.1M sodium DL-malate buffer pH 5.5",293,"10.1021/acs.jmedchem.1c00023",,"7AK2",84.19,"2.1","2.1","Structure of DYRK1A in complex with compound 53","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AK2"
"7AK3",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, SITTING DROP",9.3,"23% PEG 6000, 0.1 M bicine",278,"10.3390/ijms21217953",,"7AK3",39.99,"2.5","2.5","CLK1 bound with CAF052","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","7AK3"
"7AKA",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG4k, 0.2M Mg chloride, 0.1M MES buffer pH 6.5",293,"10.1021/acs.jmedchem.1c00023",,"7AKA",84.25,"1.9","1.9","Structure of DYRK1A in complex with compound 54","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AKA"
"7AKB",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8k, 0.15M Ca acetate, 16% ethylene glycol, 0.1M MES buffer pH 6.5",293,"10.1021/acs.jmedchem.1c00023",,"7AKB",84.17,"2.8","2.8","Structure of DYRK1A in complex with compound 56","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AKB"
"7AKE",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 0.1M Hepes buffer pH 7.5, 0.2M ammonium acetate",293,"10.1021/acs.jmedchem.1c00023",,"7AKE",84.24,"2.3","2.3","Structure of DYRK1A in complex with compound 58","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AKE"
"7AKF",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG 4000, 0.1M TRIS buffer pH 8.5, 0.1M Li sulphate",293,"10.1021/acs.jmedchem.1c00023",,"7AKF",49.89,"2.6","2.6","Structure of DYRK2 in complex with compound 50","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","7AKF"
"7AKG",,"X-RAY DIFFRACTION",2.72,54.72,"VAPOR DIFFUSION, SITTING DROP",5.5,"10% PEG 3350, 0.2M NaCl and 0.1M bis-tris pH 5.5",277.15,"10.1021/acs.jmedchem.0c01174",,"7AKG",38.03,"2.08","2.08","Crystal structure of STK17B with bound dovitinib","MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS","Homo sapiens","STK17B, DRAK2","Serine/threonine-protein kinase 17B","1","7AKG"
"7AKH",,"X-RAY DIFFRACTION",2.68,54.17,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG 4k, 0.1M Tris buffer pH 8.5, 0.1M Li sulphate",293,"10.1021/acs.jmedchem.1c00023",,"7AKH",50.09,"2.85","2.85","Structure of DYRK2 in complex with compound 58","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","7AKH"
"7AKI",,"X-RAY DIFFRACTION",1.84,33.3,"VAPOR DIFFUSION, SITTING DROP",7,"1.541M ammonium sulfate, 564mM potassium bromide",300.15,"10.1073/pnas.2007213117",,"7AKI",14.04,"1.36","1.36","ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-1]-NH2","GSMSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVL","Homo sapiens","ENAH, MENA","Protein enabled homolog","1","7AKI"
"7AKL",,"X-RAY DIFFRACTION",2.5,50.75,"VAPOR DIFFUSION",6.5,"12% PEG3350, 0.1M MES buffer pH6.5, 0.2M MgCl2",293,"10.1021/acs.jmedchem.1c00023",,"7AKL",41.94,"2","2","Structure of DYRK1A in complex with compound 50","MGSSHHHHHHSSGLVPRGSHMIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","7AKL"
"7AKM",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"200 mM Sodium citrate tribasic dihydrate, 100 mM Bis-Tris propane pH 8.5 and 20% w/v PEG 3350",287.15,"10.1016/j.str.2021.03.007",,"7AKM",69.77,"1.93","1.93","Crystal structure of CHK1 kinase domain in complex with ATPyS","GPGSAVPFVEDWRLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7AKM"
"7AKR",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, SITTING DROP",,"100 mM TrisHCl (pH 8.5), 20% (w/v) PEG4000 and 200 mM MgCl2",293.15,"10.1038/s41467-021-24723-3",,"7AKR",157.04,"1.95","1.95","Human ADP-ribosylserine hydrolase ARH3 mutant E41A in complex with ADP-ribose dimer","GPGSSLSRFRGCLAGALLGDCVGSFYAAHDTVDLTSVLRHVQSLEPDPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGVVTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQLTHASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEERPYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNSLQRTLIYSISLGGDTDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVFQKS","Homo sapiens","ADPRS, ADPRHL2, ARH3","ADP-ribose glycohydrolase ARH3","1","7AKR"
"7AL9",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M NaCit pH 5.0; 20% w/v PEG 8000 (Proplex E11)",293.15,,,"7AL9",101.97,"1.745","1.745","human GTP cyclohydrolase I feedback regulatory protein (GFRP) in complex with phenylalanine","GSHMPYLLISTQIRMEVGPTMVGDEQSDPELMQHLGASKRRALGNNFYEYYVDDPPRIVLDKLERRGFRVLSMTGVGQTLVWCLHKE","Homo sapiens","GCHFR, GFRP","GTP cyclohydrolase 1 feedback regulatory protein","1","7AL9"
"7ALE",,"X-RAY DIFFRACTION",2.74,55.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES/imidazole pH 6.5, 10% w/v PEG 8000, 20% v/v ethylene glycol, 0.02 M 1,6-hexanediol, 0.02 M 1-butanol, 0.02 M (RS)-1,2-propanediol, 0.02 M 2-propanol, 0.02 M 1,4-butanediol, and 0.02 M 1,3-propanediol",294,,,"7ALE",96.21,"2.95","2.95","Crystal structure of human PAICS in complex with inhibitor 69","MATAEVLNIGKKLYEGKTKEVYELLDSPGKVLLQSKDQITAGNAARKNHLEGKAAISNKITSCIFQLLQEAGIKTAFTRKCGETAFIAPQCEMIPIEWVCRRIATGSFLKRNPGVKEGYKFYPPKVELFFKDDANNDPQWSEEQLIAAKFCFAGLLIGQTEVDIMSHATQAIFEILEKSWLPQNCTLVDMKIEFGVDVTTKEIVLADVIDNDSWRLWPSGDRSQQKDKQSYRDLKEVTPEGLQMVKKNFEWVAERVELLLKSESQCRVVVLMGSTSDLGHCEKIKKACGNFGIPCELRVTSAHKGPDETLRIKAEYEGDGIPTVFVAVAGRSNGLGPVMSGNTAYPVISCPPLTPDWGVQDVWSSLRLPSGLGCSTVLSPEGSAQFAAQIFGLSNHLVWSKLRASILNTWISLKQADKKIRECNL","Homo sapiens","PAICS, ADE2, AIRC, PAIS","Multifunctional protein ADE2","1","7ALE"
"7ALM",,"X-RAY DIFFRACTION",4.32,71.56,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Magnesium formate, 20 % PEG3350",277,"10.3389/fmolb.2020.631232",,"7ALM",65.55,"2.8","2.8","Crystal structure of human GDAP1 at 2.8 Angstrom resolution.","EVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPRVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILIS","Homo sapiens","GDAP1","Ganglioside-induced differentiation-associated protein 1","1","7ALM"
"7ALS",,"X-RAY DIFFRACTION",2.13,42.35,"VAPOR DIFFUSION, SITTING DROP",8,"24% (w/v) PEG 2000 MME",293.5,,,"7ALS",36.52,"1.35","1.35","Alpha and beta Lactose isomer structure of Galectin 8, N-terminal domain","SLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSDLQ","Homo sapiens","LGALS8","Galectin-8","1","7ALS"
"7ALV",,"X-RAY DIFFRACTION",3.4,54.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Hepes pH 7.5, 1.4M SodiumCitrate",298,"10.1016/j.jmb.2021.167309",,"7ALV",65.03,"2.835","2.835","Crystal Structure of NLRP3 NACHT domain in complex with a potent inhibitor","GKMKKDYRKKYRKYVRSRFQCIEDRNARLGESVSLNKRYTRLRLIKEHRSQQEREQELLAIGKTKTCESPVSPIKMELLFDPDDEHSEPVHTVVFQGAAGIGKTILARKMMLDWASGTLYQDRFDYLFYIHCREVSLVTQRSLGDLIMSCCPDPNPPIHKIVRKPSRILFLMDGFDELQGAFDEHIGPLCTDWQKAERGDILLSSLIRKKLLPEASLLITTRPVALEKLQHLLDHPRHVEILGFSEAKRKEYFFKYFSDEAQARAAFSLIQENEVLFTMCFIPLVCWIVCTGLKQQMESGKSLAQTSKTTTAVYVFFLSSLLQPRGGSQEHGLCAHLWGLCSLAADGIWNQKILFEESDLRNHGLQKADVSAFLRMNLFQKEVDCEKFYSFIHMTFQEFFAAMYYLLEEEKEGRTNVPGSRLKLPSRDVTVLLENYGKFEKGYLIFVVRFLFGLVNQERTSYLEKKLSCKISQQIRLELLKWIEVKAKAKKLQIQPSQLELFYCLYEMQEEDFVQRAMDYFPKIEINLSTRMDHMVSSFCIENCHRVESL","Homo sapiens","NLRP3, C1orf7, CIAS1, NALP3, PYPAF1","NACHT, LRR and PYD domains-containing protein 3","1","7ALV"
"7AM9",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",8,"Crystallization: 100 mM Tris/HCl pH 8.0, 1.9 - 2.1 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol
Soaking: 100 mM Tris/HCl pH 8.0, 2.0 M Ammonium sulfate, 10 mM Glutathion, 5% (v/v) Glycerol, 50 mM OMP",293,,,"7AM9",29.73,"0.99","0.99","OMPD-domain of human UMPS in complex with the substrate OMP at 0.99 Angstroms resolution","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","7AM9"
"7AMA",,"X-RAY DIFFRACTION",3.35,63.29,"VAPOR DIFFUSION, SITTING DROP",,"PEG 10 000, isopropanol, sodium citrate",293,"10.1021/acs.jmedchem.2c00422",,"7AMA",25.79,"2.48","2.48","IL-17A in complex with small molecule modulators","PRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPI","Homo sapiens","IL17A, CTLA8, IL17","Interleukin-17A","1","7AMA"
"7AMD",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"10% (w/v) PEG 3350, 0.1M tris-HCl pH 8.5",293,"10.1002/anie.202011989","RMW","7AMD",69.17,"2.25","2.25","In situ assembly of choline acetyltransferase ligands by a hydrothiolation reaction reveals key determinants for inhibitor design","AAAKTPSSEESGLPKLPVPPLQQTLATYLQCMRHLVSEEQFRKSQAIVQQFGAPGGLGETLQQKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSSPAVIFARQHFPGTDDQLRFAASLISGVLSYKALLDSHSIPTDCAKGQLSGQPLCMKQYYGLFSSYRLPGHTQDTLVAQNSSIMPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNAAARLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLDAPGGVELSDTHRALQLLHGGGYSKNGANRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLLKHMTQPELVRSPMVPLPAPRRLRWKCSPEIQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDAFIQVALQLAFYRLHRRLVPTYESASIRRFQEGRVDNIRSATPEALAFVRAVTDHKAAVPASEKLLLLKDAIRAQTAYTVMAITGMAIDNHLLALRELARAMCAALPEMFMDETYLMSNRFVLSTSQVPTTTEMFCCYGPVVPNGYGACYNPQPETILFCISSFHSCAATSSSKFAKAVEESLIDMRDLCSLLPPTESKPL","Homo sapiens","CHAT","Choline O-acetyltransferase","1","7AMD"
"7AMG",,"X-RAY DIFFRACTION",5.63,78.16,"VAPOR DIFFUSION, SITTING DROP",,"PEG 10000, isopropanol, sodium citrate",293,"10.1021/acs.jmedchem.2c00422",,"7AMG",52.29,"3.18","3.18","IL-17A in complex with small molecule modulators","PRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPI","Homo sapiens","IL17A, CTLA8, IL17","Interleukin-17A","1","7AMG"
"7AMP",,"X-RAY DIFFRACTION",3.38,63.63,"VAPOR DIFFUSION, SITTING DROP",,"11.2 mg/ml complex in PBS buffer. 0.1 M sodium cacodylate pH 6.0, 3% PEG 8000, 5 mM Zn acetate, 4% benzamidine.",295,,,"7AMP",99.07,"2.64","2.64","Crystal structure of the complex of HuJovi-1 Fab with the human A6 T-cell receptor TRBC1","MQKEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"Alpha chain of A6 T-cell receptor","1","7AMP"
,,,,,,,,,,,,,,,,"MNAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Beta chain 1 of A6 T-cell receptor TRBC1","2","7AMP"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYVMHWVRQAPGQGLEWMGFINPYNDDIQSNERFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGAGYNFDGAYRFFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"HuJovi-1 Fab heavy chain","3","7AMP"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQRLVHSNGNTYLHWYLQKPGQSPRLLIYRVSNRFPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"HuJovi-1 Fab light chain","4","7AMP"
"7AMQ",,"X-RAY DIFFRACTION",3.36,63.37,"VAPOR DIFFUSION, SITTING DROP",7.4,"Equimolar amounts of A6 TCR C2 and Fab were mixed in PBS to 10.4 mg/ml. 5% PEG 8000, 0.1M sodium cacodylate pH 7.4, 5 mM ZnCl2, 4% benzamidine HCl. Crystals from the Hu-Jovi1-TRBC1 complex were used as seeds.",295,,,"7AMQ",98.45,"2.353","2.353","Crystal structure of the complex of HuJovi-1 Fab with the human TRBC2","KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human A6 T-cell receptor alpha chain","1","7AMQ"
,,,,,,,,,,,,,,,,"MNAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human A6 T-cell receptor beta chain TRBC1","2","7AMQ"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYVMHWVRQAPGQGLEWMGFINPYNDDIQSNERFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGAGYNFDGAYRFFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Human Jovi-1 Fab heavy chain","3","7AMQ"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQRLVHSNGNTYLHWYLQKPGQSPRLLIYRVSNRFPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Human Jovi-1 Fab light chain","4","7AMQ"
"7AMR",,"X-RAY DIFFRACTION",3.28,62.47,"VAPOR DIFFUSION, SITTING DROP",,"Equimolar amounts of A6 TCR C1 and Fab were mixed in PBS) to 10.8 mg/ml. 9% PEG 8000, 0.1M sodium cacodylate pH 6.6, 5 mM ZnCl2, 2% benzamidine HCl. Crystals from the complex with huJovi-1 Fab were used as seeds.",295,,,"7AMR",99.34,"1.949","1.949","Crystal structure of the complex of the KFN mutant of Jovi-1 Fab with human TRBC1","MNAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T-cell receptor beta chain TRBC2","2","7AMR"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYKFTGFVMHWVRQAPGQGLEWMGFINPYNDDIQSNERFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGNGYNFDGAYRFFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Human Jovi-1 Fab fragment, KFN mutant, heavy chain","3","7AMR"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQRLVHSNGNTYLHWYLQKPGQSPRLLIYRVSNRFPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Human Jovi-1 Fab fragment, KFN mutant, light chain","4","7AMR"
,,,,,,,,,,,,,,,,"MQKEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"Human T-cell receptor alpha chain","1","7AMR"
"7AMS",,"X-RAY DIFFRACTION",3.27,62.35,"VAPOR DIFFUSION, HANGING DROP",6.2,"Equimolar amounts of A6 TCR C2 and Fab in PBS. Concentration of complex 9.3 mg/ml. 9% PEG 8000, 0.1M sodium cacodylate pH 6.2, 5 mM ZnCl2, 2% benzamidine HCl.",295,,,"7AMS",98.9,"2.419","2.419","Crystal structure of the complex of the KFN mutant of HuJovi-1 Fab with human TRBC2","KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"Human A6 T-cell receptor alpha chain","1","7AMS"
,,,,,,,,,,,,,,,,"MNAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human A6 T-cell receptor beta chain TRBC2","2","7AMS"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYKFTGFVMHWVRQAPGQGLEWMGFINPYNDDIQSNERFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGNGYNFDGAYRFFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Human Jovi-1 Fab, KFN mutant, heavy chain","3","7AMS"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQRLVHSNGNTYLHWYLQKPGQSPRLLIYRVSNRFPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Human Jovi-1 Fab, KFN mutant, light chain","4","7AMS"
"7AMZ",,"X-RAY DIFFRACTION",3.19,61.48,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1016/j.ejmech.2021.113397",,"7AMZ",63.65,"2.25","2.25","Crystal structure of human Butyrylcholinesterase in complex with N-((2S,3R)-4-((2,2-dimethylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)-2,2-diphenylacetamide","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7AMZ"
"7ANW","2.68","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.62021",,"7ANW",644.03,"2.68, 2.68",,"hSARM1 NAD+ complex","SYHHHHHHDYDIPTTENLYFQGAMGSERLAVPGPDGGGGTGPWWAAGGRGPREVSPGAGTEVQDALERALPELQQALSALKQAGGARAVGAGLAEVFQLVEEAWLLPAVGREVAQGLCDAIRLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQAVQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNRLEAQCIGAFYLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKQIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAPMGPT","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","NAD(+) hydrolase SARM1","1","7ANW"
"7AOM",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris pH 8.5, 0.2M sodium acetate, 34% PEG 4000",277,"10.1016/j.chembiol.2021.06.001",,"7AOM",38.31,"1.95","1.95","Structure of NUDT15 in complex with Ganciclovir triphosphate","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7AOM"
"7AOP",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.0, 0.2 M sodium acetate, 29.5% PEG 4000",277,"10.1016/j.chembiol.2021.06.001",,"7AOP",19.01,"2.35","2.35","Structure of NUDT15 in complex with inhibitor TH8321","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7AOP"
"7AOT",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"38 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1002/anie.202017352",,"7AOT",14.66,"0.85","0.85","The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]-3,19-dioxa-10,13,16-triazatricyclo[18.3.1.0-5,10]tetracosa- 1(24),20,22-triene-4,11,14,17-tetrone","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7AOT"
"7AOU",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"32% PEG-3350, 0.2 M NH4-acetate and HEPES-NaOH pH 7.5",293,"10.1002/anie.202017352",,"7AOU",14.69,"1.16","1.16","The Fk1 domain of FKBP51 in complex with (2'R,5'S,12'R)-12'-cyclohexyl-2'-[2-(3,4-dimethoxyphenyl)ethyl]-3',19'-dioxa-10',13',16'-triazaspiro[cyclopropane-1,15'- tricyclo[18.3.1.0-5,10]tetracosane]-1'(24'),20',22'-triene-4',11',14',17'-tetrone","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7AOU"
"7AP7",,"X-RAY DIFFRACTION",1.86,33.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.25M (NH4)2SO4, 0.1M cacodylate pH 6.5, 10 mM Tris pH 7, 14.4 TP buffer",293,"10.1016/j.bpc.2021.106563",,"7AP7",14.98,"1.15","1.15","Structure of the W64R amyloidogenic variant of human lysozyme","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYRCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","7AP7"
"7APF",,"X-RAY DIFFRACTION",1.98,37.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.1-0.2 M MgCl2, 0.1 M MES, pH 5.5",277.15,"10.3390/ijms21239269",,"7APF",68.22,"1.95","1.95","Crystal structure of JAK3 in complex with FM601 (compound 10a)","SMQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","7APF"
"7APG",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.1-0.2 M MgCl2 and 0.1 M MES, pH 5.5",277.15,"10.3390/ijms21239269",,"7APG",136.39,"2.4","2.4","Crystal structure of JAK3 in complex with FM587 (compound 9a)","SMQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","7APG"
"7API",,"X-RAY DIFFRACTION",4.76,74.16,,,,,"10.1093/protein/2.6.407",,"7API",45.34,"3","3","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","DTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPM","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","ALPHA 1-ANTITRYPSIN","1","7API"
,,,,,,,,,,,,,,,,"SIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","ALPHA 1-ANTITRYPSIN","2","7API"
"7APQ",,"X-RAY DIFFRACTION",2.3,46.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"36% PEG-3350, 0.2 M NH4-acetate and HEPES-NaOH pH 7.5",293,"10.1039/d1sc04638a",,"7APQ",14.51,"1.09","1.09","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylmethyl)-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7APQ"
"7APS",,"X-RAY DIFFRACTION",1.96,37.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"38% PEG-3350, 0.2 M NH4-acetate and HEPES-NaOH, pH 7.5",293,"10.1039/d1sc04638a",,"7APS",28.98,"0.94","0.94","The Fk1 domain of FKBP51 in complex with (2S)-2-((1S,5R,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-vinyl-3,10-diazabicyclo[4.3.1]decan-3-yl)propanoic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7APS"
"7APT",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"38% PEG-3340, 0.2 M NH4-acetate and HEPES-NaOH, pH 7.5",293,"10.1039/d1sc04638a",,"7APT",14.47,"1.131","1.131","The Fk1 domain of FKBP51 in complex with ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-vinyl-3,10-diazabicyclo[4.3.1]decan-3-yl)acetic acid","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7APT"
"7APV",,"X-RAY DIFFRACTION",1.87,34.1,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG3350 and 0.2 M Ammonium chloride",277.15,"10.1093/nar/gkab693",,"7APV",42.76,"1.95","1.95","Structure of Artemis/DCLRE1C/SNM1C in complex with Ceftriaxone","SMSSFEGQMAEYPTISIDRFDRENLRARAYFLSHCHKDHMKGLRAPTLKRRLECSLKVYLYCSPVTKELLLTSPKYRFWKKRIISIEIETPTQISLVDEASGEKEEIVVTLLPAGHCPGSVMFLFQGNNGTVLYTGDFRLAQGEAARMELLHSGGRVKDIQSVYLDTTFCDPRFYQIPSREECLSGVLELVRSWITRSPYHVVWLNCKAAYGYEYLFTNLSEELGVQVHVNKLDMFRNMPEILHHLTTDRNTQIHACRHPKAEEYFQWSKLPCGITSRNRIPLHIISIKPSTMWFGERSRKTNVIVRTGESSYRACFSFHSSYSEIKDFLSYLCPVNAYPNVIPVGTTMDKVVEILKPLCRS","Homo sapiens","DCLRE1C, ARTEMIS, ASCID, SCIDA, SNM1C","Protein artemis","1","7APV"
"7APW",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"36 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1039/d1sc04638a",,"7APW",14.53,"0.89","0.89","The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymethyl)-3-(pyridin-2-ylethyl)-3,10-diazabicyclo[4.3.1]decan-2-one","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7APW"
"7AQ1",,"X-RAY DIFFRACTION",2.92,57.9,"VAPOR DIFFUSION, SITTING DROP",7.6,"Protein was mixed with inhibitor in a molar ratio of 1 to 1.2 to a final protein concentration of 8 mg/mL in 30 mM Tris, 100 mM sodium chloride, pH 7.6.
200 nL protein/inhibitor was mixed with 200 nL praezipitation buffer and equilibrated against 55 micro Liter of praezipitation buffer, containing 25 percent (w/v) PEG 4000 and 30 percent (v/v) ethylene glycol.",286,"10.3390/ijms22115651",,"7AQ1",127.88,"2.413","2.413","Crystal structure of human mature meprin beta in complex with the specific inhibitor MWT-S-270","NSIIGEKYRWPHTIPYVLEDSLEMNAKGVILNAFERYRLKTCIDFKPWAGETNYISVFKGSGCWSSVGNRRVGKQELSIGANCDRIATVQHEFLHALGFWHEQSRSDRDDYVRIMWDRILSGREHNFNTYSDDISDSLNVPYDYTSVMHYSKTAFQNGTEPTIVTRISDFEDVIGQRMDFSDSDLLKLNQLYNCSSSLSFMDSCSFELENVCGMIQSSGDNADWQRVSQVPRGPESDHSNMGQCQGSGFFMHFDSSSVNVGATAVLESRTLYPKRGFQCLQFYLYNSGSESDQLNIYIREYSADNVDGNLTLVEEIKEIPTGSWQLYHVTLKVTKKFRVVFEGRKGSGASLGGLSIDDINLSETRCPHHIWHIRNFTQFIGSPNGTLYSPPFYSSKGYAFQIYLNLAHVTNAGIYFHLISGANDDQLQWPCPWQQATMTLLDQNPDIRQRMSNQRSITTDPFMTTDNGNYFWDRPSKVGTVALFSNGTQFRRGGGYGTSAFITHERLKSRDFIKGDDVYILLTVEDISHLNSTQ","Homo sapiens","MEP1B","Meprin B subunit beta","1","7AQ1"
"7AQB",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION, SITTING DROP",6.7,"1.8M MgSO4; 0.1M MES",277,"10.3390/ijms21217953",,"7AQB",72.65,"2.25","2.25","Crystal structure of human mitogen activated protein kinase 6 (MAPK6)","SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI","Homo sapiens","MAPK6, ERK3, PRKM6","Mitogen-activated protein kinase 6","1","7AQB"
"7AQF",,"X-RAY DIFFRACTION",2.42,49.15,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.2 M TRISODIUM CITRATE, 10% w/v PEG 3350",293,"10.3390/ijms22031482",,"7AQF",85.89,"1.77","1.77","Crystal Structure of Small Molecule Inhibitor TM5484 Bound to Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-stab)","VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRPFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","SERPINE1, PAI1, PLANH1","Plasminogen activator inhibitor 1","1","7AQF"
"7AQT",,"SOLUTION NMR",,,,,,,"10.1021/acs.jmedchem.1c01703",,"7AQT",13.17,,,"NMR2 structure of BRD4-BD2 in complex with iBET-762","SEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPD","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7AQT"
"7ARG",,"X-RAY DIFFRACTION",1.92,35.92,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citric, pH4.6",296,"10.1021/acs.jmedchem.1c00701",,"7ARG",44.99,"1.24","1.24","Notum in complex with ARUK3002704","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7ARG"
"7ARN",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, SITTING DROP",7,"30% Jeffamine ED-2001 Reagent pH 7.0
0.1M HEPES pH 7.0
8% 2,5 hexanediol",298,,,"7ARN",56.18,"1.57","1.57","Crystal Structure of the Fab Fragment of a Glycosylated Lymphoma Antibody","MGILPSPGMPALLSLVSLLSVLLMGCVAETGEVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMTWVRQAPGKGLEWVSNISSSSNTAFYADSVKGRFTISRDNVKNSLYLQMHSLRDEDTAVYFCARDRNGYNFFDYWGQGTLVTVSSGTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCKHHHHHH","Homo sapiens",,"Antibody Fab Fragment Heavy Chain","1","7ARN"
,,,,,,,,,,,,,,,,"MGILPSPGMPALLSLVSLLSVLLMGCVAETGDIEMTQSPSSLSASIGDRLTITCRASQAIRESVQWYQQKPGKAPKLLMFSTSILESGVPSRFSGSGFGTHFTLTISSLQPEDFATYSCQQNYSGPFTFGPGTKVEMRAAATVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody Fab Fragment Light Chain","2","7ARN"
"7ARW",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",4.5,"100 mM ammonium acetate (pH 4.5) and 9% (w/v) PEG10000",292,"10.1038/s41467-021-24723-3",,"7ARW",77.88,"1.31","1.31","Structure of human ARH3 E41A bound to alpha-NAD+ and magnesium","GPGSSLSRFRGCLAGALLGDCVGSFYAAHDTVDLTSVLRHVQSLEPDPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGVVTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQLTHASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEERPYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNSLQRTLIYSISLGGDTDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVFQKS","Homo sapiens","ADPRS, ADPRHL2, ARH3","ADP-ribose glycohydrolase ARH3","1","7ARW"
"7AS7",,"X-RAY DIFFRACTION",2.99,58.8,"VAPOR DIFFUSION",7,"0.1 M DL-Malic acid pH 7.0, 12% w/v PEG 3350",292,"10.1016/j.jbc.2021.100858",,"7AS7",65.08,"2.65","2.65","Crystal structure of the GCD-associated TGFBIp mutant R124H","GPNVCAVQKVIGTNRKYFTNCKQWYQRKICGKSTVISYECCPGYEKVPGEKGCPAALPLSNLYETLGVVGSTTTQLYTDHTEKLRPEMEGPGSFTIFAPSNEAWASLPAEVLDSLVSNVNIELLNALRYHMVGRRVLTDELKHGMTLTSMYQNSNIQIHHYPNGIVTVNCARLLKADHHATNGVVHLIDKVISTITNNIQQIIEIEDTFETLRAAVAASGLNTMLEGNGQYTLLAPTNEAFEKIPSETLNRILGDPEALRDLLNNHILKSAMCAEAIVAGLSVETLEGTTLEVGCSGDMLTINGKAIISNKDILATNGVIHYIDELLIPDSAKTLFELAAESDVSTAIDLFRQAGLGNHLSGSERLTLLAPLNSVFKDGTPPIDAHTRNLLRNHIIKDQLASKYLYHGQTLETLGGKKLRVFVYRNSLCIENSCIAAHDKRGRYGTLFTMDRVLTPPMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNEAFRALPPRERSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLHHHHHH","Homo sapiens","TGFBI, BIGH3","Transforming growth factor-beta-induced protein ig-h3","1","7AS7"
"7ASC",,"X-RAY DIFFRACTION",5.23,76.49,"VAPOR DIFFUSION",9,"25 mM BIS-TRIS propane pH 9.0, 5% v/v PEG-mme 550, 1% PEG 3350",292,"10.1016/j.jbc.2021.100858",,"7ASC",130.25,"4.8","4.8","TGFBIp mutant A546T","GPNVCAVQKVIGTNRKYFTNCKQWYQRKICGKSTVISYECCPGYEKVPGEKGCPAALPLSNLYETLGVVGSTTTQLYTDRTEKLRPEMEGPGSFTIFAPSNEAWASLPAEVLDSLVSNVNIELLNALRYHMVGRRVLTDELKHGMTLTSMYQNSNIQIHHYPNGIVTVNCARLLKADHHATNGVVHLIDKVISTITNNIQQIIEIEDTFETLRAAVAASGLNTMLEGNGQYTLLAPTNEAFEKIPSETLNRILGDPEALRDLLNNHILKSAMCAEAIVAGLSVETLEGTTLEVGCSGDMLTINGKAIISNKDILATNGVIHYIDELLIPDSAKTLFELAAESDVSTAIDLFRQAGLGNHLSGSERLTLLAPLNSVFKDGTPPIDAHTRNLLRNHIIKDQLASKYLYHGQTLETLGGKKLRVFVYRNSLCIENSCIAAHDKRGRYGTLFTMDRVLTPPMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNETFRALPPRERSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLQHHHHH","Homo sapiens","TGFBI, BIGH3","Transforming growth factor-beta-induced protein ig-h3","1","7ASC"
"7ASG",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION",7,"0.5 M Succinic acid pH 7.0, 0.1 M BIS-TRIS propane pH 7.0",292,"10.1016/j.jbc.2021.100858",,"7ASG",65.13,"2","2","TGFBIp mutant R555W","GPNVCAVQKVIGTNRKYFTNCKQWYQRKICGKSTVISYECCPGYEKVPGEKGCPAALPLSNLYETLGVVGSTTTQLYTDRTEKLRPEMEGPGSFTIFAPSNEAWASLPAEVLDSLVSNVNIELLNALRYHMVGRRVLTDELKHGMTLTSMYQNSNIQIHHYPNGIVTVNCARLLKADHHATNGVVHLIDKVISTITNNIQQIIEIEDTFETLRAAVAASGLNTMLEGNGQYTLLAPTNEAFEKIPSETLNRILGDPEALRDLLNNHILKSAMCAEAIVAGLSVETLEGTTLEVGCSGDMLTINGKAIISNKDILATNGVIHYIDELLIPDSAKTLFELAAESDVSTAIDLFRQAGLGNHLSGSERLTLLAPLNSVFKDGTPPIDAHTRNLLRNHIIKDQLASKYLYHGQTLETLGGKKLRVFVYRNSLCIENSCIAAHDKRGRYGTLFTMDRVLTPPMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNEAFRALPPREWSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLHHHHHH","Homo sapiens","TGFBI, BIGH3","Transforming growth factor-beta-induced protein ig-h3","1","7ASG"
"7ASJ",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, HANGING DROP",8,"1.5 M sodium citrate, Tris 50 mM",298,"10.1021/acs.jmedchem.1c01906",,"7ASJ",29.8,"1.43","1.43","Crystal structure for the complex of human carbonic anhydrase II and 3-(3-methyl-3-phenethylureido)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7ASJ"
"7ASQ",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris/HCl pH 7.0, 1.7 - 1.9 M Ammonium sulfate, 10 mM Glutathion, 5% (w/v) Glycerol",293,,,"7ASQ",28.84,"0.95","0.95","Orotidine 5'-monophosphate decarboxylase-domain of human UMPS in complex with the reaction product UMP at 0.95 Angstrom resolution","MELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","7ASQ"
"7ASU",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"3.2 M NaCl, 100 mM Sodium Acetate pH 4.6 and 10 mM ZnCl2",277,"10.1038/s41467-020-20262-5",,"7ASU",80.27,"2.23","2.23","Crystal structure of tWHD1 of Rpc5 subunit of human RNA Polymerase III","MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDTLNPNYCRSKGEQIALNVDGACADETSTYSSKLMDKQTFCSSQTTSNTSRYAAALYRQGELHLTPLHGILQLRPSFSYLDKADAKHREREAANEAGDSSQDEAEDDVKQITVRFSRPESEQARQRRVQSYEFLQKKHAEEPWVHLHYYGLRDSRSEHERQYLLCPGSSGVENTELVKSPSEYLMMLMPPSQEEEKDKPVAPSNVLSMAQLRTLPLADQIKILMKNVKVMPFANLMSLLGPSIDSVAVLRGIQKVAMLVQGNWVVKSDILYPKDSSSPHSGVPAEVLCRGRDFVMWKFTQSRWVVRKEVATVTKLCAEDVKDFLEHMAVVRINKGWEFILPYDGEFIKKHPDVVQRQHMLWTGIQAKLEKVYNLVKETMPKKPDAQSGPAGLVCGDQRIQVAKTKAQQNHALLERELQRRKEQLRVPAVPPGVRIKEEPVSEEGEEDEEQEAEEEPMDTSPSGLHSKLANGLPLGRAAGTDSFNGHPPQGCASTPVARELKAFVEATFQRQFVLTLSELKRLFNLHLASLPPGHTLFSGISDRMLQDTVLAAGCKQILVPFPPQTAASPDEQKVFALWESGDMSDQHRQVLLEIFSKNYRVRRNMIQSRLTQECGEDLSKQEVDKVLKDCCVSYGGMWYLKGTVQS","Homo sapiens","POLR3E, KIAA1452","DNA-directed RNA polymerase III subunit RPC5","1","7ASU"
"7ASV",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"3.2-3.8 M Ammonium Acetate and 100 mM Bis-Tris Propane pH 6.5-7",277,"10.1038/s41467-020-20262-5",,"7ASV",162.27,"1.55","1.55","Crystal structure of tWHD2 of Rpc5 subunit of human RNA Polymerase III","MANEEDDPVVQEIDVYLAKSLAEKLYLFQYPVRPASMTYDDIPHLSAKIKPKQQKVELEMAIDTLNPNYCRSKGEQIALNVDGACADETSTYSSKLMDKQTFCSSQTTSNTSRYAAALYRQGELHLTPLHGILQLRPSFSYLDKADAKHREREAANEAGDSSQDEAEDDVKQITVRFSRPESEQARQRRVQSYEFLQKKHAEEPWVHLHYYGLRDSRSEHERQYLLCPGSSGVENTELVKSPSEYLMMLMPPSQEEEKDKPVAPSNVLSMAQLRTLPLADQIKILMKNVKVMPFANLMSLLGPSIDSVAVLRGIQKVAMLVQGNWVVKSDILYPKDSSSPHSGVPAEVLCRGRDFVMWKFTQSRWVVRKEVATVTKLCAEDVKDFLEHMAVVRINKGWEFILPYDGEFIKKHPDVVQRQHMLWTGIQAKLEKVYNLVKETMPKKPDAQSGPAGLVCGDQRIQVAKTKAQQNHALLERELQRRKEQLRVPAVPPGVRIKEEPVSEEGEEDEEQEAEEEPMDTSPSGLHSKLANGLPLGRAAGTDSFNGHPPQGCAPTPVARELKAFVEATFQRQFVLTLSELKRLFNLHLASLPPGHTLFSGISDRMLQDTVLAAGCKQILVPFPPQTAASPDEQKVFALWESGDMSDQHRQVLLEIFSKNYRVRRNMIQSRLTQECGEDLSKQEVDKVLKDCCVSYGGMWYLKGTVQS","Homo sapiens","POLR3E, KIAA1452","DNA-directed RNA polymerase III subunit RPC5","1","7ASV"
"7ASY",,"SOLUTION NMR",,,,,,,"10.1016/j.isci.2020.101775",,"7ASY",3.7,,,"Transmembrane helix of tumor necrosis factor alpha in trifluorethanol","RRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQR","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","7ASY"
"7AT5",,"X-RAY DIFFRACTION",3.19,61.49,"VAPOR DIFFUSION, SITTING DROP",,"reservoir composition: 30 % (w/v) PEG8000, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5; crystallization drop composition before equilibration: 0.01 ml reservoir solution plus 0.02 ml enzyme stock solution (6 mg/ml enzyme, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5); the bivalent inhibitor KN2 was introduced by extensive soaking",293,"10.1021/acs.jmedchem.1c00063",,"7AT5",85.88,"1.77","1.77","Structure of protein kinase ck2 catalytic subunit (csnk2a1 gene product) in complex with the bivalent inhibitor KN2","MGSSHHHHHHSQDPMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7AT5"
"7AT7",,"SOLUTION NMR",,,,,,,"10.1016/j.isci.2020.101775",,"7AT7",3.71,,,"Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, S34P mutant","RRCLFLPLFSFLIVAGATTLFCLLHFGVIGPQR","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","7AT7"
"7AT9",,"X-RAY DIFFRACTION",2.41,48.86,"VAPOR DIFFUSION, SITTING DROP",8.5,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser)/inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the alphaD-pocket ligand 3,4-dichlorophenethylamine was introduced by extensive soaking.",293,"10.1021/acs.jmedchem.1c00063",,"7AT9",44.3,"1.05","1.05","Structure of protein kinase ck2 catalytic subunit (csnk2a2 gene product) in complex with the ATP-competitive inhibitor MB002 and the alphaD-pocket ligand 3,4-dichlorophenethylamine","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7AT9"
"7ATB",,"SOLUTION NMR",,,,,,,"10.1016/j.isci.2020.101775",,"7ATB",3.84,,,"Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, AGALLL mutant","RRCLFLSLFSFLIVLLLTTLFCLLHFGVIGPQR","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","7ATB"
"7ATS",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350
0.1 M bis-tris-propane pH 7.5
0.2 M potassium thiocyanate
10% ethylene glycol",293,,,"7ATS",36.52,"2.8","2.8","The LIMK1 Kinase Domain Bound To LIJTF500127","SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES","Homo sapiens","LIMK1, LIMK","LIM domain kinase 1","1","7ATS"
"7ATU",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M citrate pH 5.9
0.2 M NaCl
8% jeffamine M-600
0.005 M iron chloride",277,,,"7ATU",145.9,"2.8","2.8","The LIMK1 Kinase Domain Bound To LIJTF500025","SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES","Homo sapiens","LIMK1, LIMK","LIM domain kinase 1","1","7ATU"
"7ATV",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, SITTING DROP",8.5,"Reservoir composition: 28 % (w/v) PEG6000, 0.9 M LiCl, 0.1 M, Tris/HCl, pH 8.5; drop composition prior to equilibration: 0.01 ml reservoir solution + 0.02 ml CK2alpha' (mutant Cys336Ser) /inhibitor MB002 mixture (0.180 ml 6 mg/ml CK2alpha'Cys336Ser, 0.5 M NaCl, 25 mM Tris/HCl, pH 8.5, mixed and pre-equilibrated with 0.02 ml 10 mM MB002 in dimethyl sulfoxide); the initial inhibitor MB002 was replaced by the bivalent inhibitor KN2 by extensive crystal soaking.",293,"10.1021/acs.jmedchem.1c00063",,"7ATV",43.75,"0.98","0.98","Structure of protein kinase ck2 catalytic subunit (csnk2a2 gene product) in complex with the bivalent inhibitor KN2","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","7ATV"
"7ATY",,"SOLUTION NMR",,,,,,,"10.3390/cells10010173",,"7ATY",7.46,,,"Solution NMR structure of the SH3 domain of human Caskin1","GSHMLQVRATKDYCNNYDLTSLNVKAGDIITVLEQHPDGRWKGCIHDNRTGNDRVGYFPSSLGEAIV","Homo sapiens","CASKIN1, KIAA1306","Caskin-1","1","7ATY"
"7AU2","2.43","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-022-31048-2",,"7AU2",205.76,"2.43",,"Cryo-EM structure of human exostosin-like 3 (EXTL3)","APQLHHHHHHDLYENLYFQGKLTTLDEADEAGKRIFGPRVGNELCEVKHVLDLCRIRESVSEELLQLEAKRQELNSEIAKLNLKIEACKKSIENAKQDLLQLKNVISQTEHSYKELMAQNQPKLSLPIRLLPEKDDAGLPPPKATRGCRLHNCFDYSRCPLTSGFPVYVYDSDQFVFGSYLDPLVKQAFQATARANVYVTENADIACLYVILVGEMQEPVVLRPAELEKQLYSLPHWRTDGHNHVIINLSRKSDTQNLLYNVSTGRAMVAQSTFYTVQYRPGFDLVVSPLVHAMSEPNFMEIPPQVPVKRKYLFTFQGEKIESLRSSLQEARSFEEEMEGDPPADYDDRIIATLKAVQDSKLDQVLVEFTCKNQPKPSLPTEWALCGEREDRLELLKLSTFALIITPGDPRLVISSGCATRLFEALEVGAVPVVLGEQVQLPYQDMLQWNEAALVVPKPRVTEVHFLLRSLSDSDLLAMRRQGRFLWETYFSTADSIFNTVLAMIRTRIQIPAAPIREEAAAEIPHRSGKAAGTDPNMADNGDLDLGPVETEPPYASPRYLRNFTLTVTDFYRSWNCAPGPFHLFPHTPFDPVLPSEAKFLGSGTGFRPIGGGAGGSGKEFQAALGGNVPREQFTVVMLTYEREEVLMNSLERLNGLPYLNKVVVVWNSPKLPSEDLLWPDIGVPIMVVRTEKNSLNNRFLPWNEIETEAILSIDDDAHLRHDEIMFGFRVWREARDRIVGFPGRYHAWDIPHQSWLYNSNYSCELSMVLTGAAFFHKYYAYLYSYVMPQAIRDMVDEYINCEDIAMNFLVSHITRKPPIKVTSRWTFRCPGCPQALSHDDSHFHERHKCINFFVKVYGYMPLLYTQFRVDSVLFKTRLPHDKTKCFKFI","Homo sapiens","EXTL3, EXTL1L, EXTR1, KIAA0519","Exostosin-like 3","1","7AU2"
"7AUA","2.93","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-022-31048-2",,"7AUA",206.67,"2.93",,"Cryo-EM structure of human exostosin-like 3 (EXTL3) in complex with UDP","APQLHHHHHHDLYENLYFQGKLTTLDEADEAGKRIFGPRVGNELCEVKHVLDLCRIRESVSEELLQLEAKRQELNSEIAKLNLKIEACKKSIENAKQDLLQLKNVISQTEHSYKELMAQNQPKLSLPIRLLPEKDDAGLPPPKATRGCRLHNCFDYSRCPLTSGFPVYVYDSDQFVFGSYLDPLVKQAFQATARANVYVTENADIACLYVILVGEMQEPVVLRPAELEKQLYSLPHWRTDGHNHVIINLSRKSDTQNLLYNVSTGRAMVAQSTFYTVQYRPGFDLVVSPLVHAMSEPNFMEIPPQVPVKRKYLFTFQGEKIESLRSSLQEARSFEEEMEGDPPADYDDRIIATLKAVQDSKLDQVLVEFTCKNQPKPSLPTEWALCGEREDRLELLKLSTFALIITPGDPRLVISSGCATRLFEALEVGAVPVVLGEQVQLPYQDMLQWNEAALVVPKPRVTEVHFLLRSLSDSDLLAMRRQGRFLWETYFSTADSIFNTVLAMIRTRIQIPAAPIREEAAAEIPHRSGKAAGTDPNMADNGDLDLGPVETEPPYASPRYLRNFTLTVTDFYRSWNCAPGPFHLFPHTPFDPVLPSEAKFLGSGTGFRPIGGGAGGSGKEFQAALGGNVPREQFTVVMLTYEREEVLMNSLERLNGLPYLNKVVVVWNSPKLPSEDLLWPDIGVPIMVVRTEKNSLNNRFLPWNEIETEAILSIDDDAHLRHDEIMFGFRVWREARDRIVGFPGRYHAWDIPHQSWLYNSNYSCELSMVLTGAAFFHKYYAYLYSYVMPQAIRDMVDEYINCEDIAMNFLVSHITRKPPIKVTSRWTFRCPGCPQALSHDDSHFHERHKCINFFVKVYGYMPLLYTQFRVDSVLFKTRLPHDKTKCFKFI","Homo sapiens","EXTL3, EXTL1L, EXTR1, KIAA0519","Exostosin-like 3","1","7AUA"
"7AUC",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"Morpheus-HT, condition A8, Molecular Dimensions
0.06 M divalents, 37.5% Buffer System 2 and 37.5% Precipitant Mix 4
Divalents = 0.3M magnesium chloride, 0.3M calcium chloride
Buffer system 2 = 1M sodium HEPES, MOPS (acid) pH 7.5
75% Precipitant Mix 4 = 25% w/v MPD, 25% v/v PEG1000, 25% w/v PEG 3350",277.15,"10.7554/eLife.65339",,"7AUC",65.59,"1.53","1.53","Crystal structure of an engineered helicase domain construct for human Bloom syndrome protein (BLM)","MGSAWSHPQFEKSSGLEVLFQGPHMSRNLKHERFQSLSFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSPGVTVVISPLRSLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLARFVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYYVLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDGCQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFYTYHDVTRLKRLIMMEKDGNHHTRETHFNNLYSMVHYCENITECRRIQLLAYFGENGFNPDFCKKHPDVSCDNCCKTKGSGGSKALVAKVSQREEMVKKCLGELTEVCKSLGKVFGVHYFNIFNTVTLKKLAESLSSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPAEDSSPG","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein,Bloom syndrome protein","1","7AUC"
,,,,,,,,,,,,,,,,,"Homo sapiens","BLM, RECQ2, RECQL3"
"7AUV",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.2M (NH4)2SO4
32% MPEG 2000
.02M Mercaptoethanol
.1M pH=7.2 HEPES/NaOH",291,"10.1158/1535-7163.MCT-20-0909",,"7AUV",43.5,"1.76","1.76","The structure of ERK2 in complex with dual inhibitor ASTX029","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","7AUV"
"7AUZ",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1 SODIUM ACETATE, 0.005 M YBCL3",298,"10.1021/acs.jmedchem.0c01955",,"7AUZ",70.62,"1.9","1.9","LTA4 hydrolase in complex with compound LYS006","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","7AUZ"
"7AV0",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1 SODIUM ACETATE, 0.005 M YBCL3",298,"10.1021/acs.jmedchem.0c01955",,"7AV0",70.6,"1.9","1.9","LTA4 hydrolase in complex with compound R(13)","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","7AV0"
"7AV1",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1 SODIUM ACETATE, 0.005 M YBCL3",298,"10.1021/acs.jmedchem.0c01955",,"7AV1",70.27,"1.79","1.79","LTA4 hydrolase in complex with fragment2","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","7AV1"
"7AV2",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1 SODIUM ACETATE, 0.005 M YBCL3",298,"10.1021/acs.jmedchem.0c01955",,"7AV2",70.25,"1.95","1.95","LTA4 hydrolase in complex with fragment1","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","7AV2"
"7AV8",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",,"0.1M HEPES pH 7.5, 0.15M magnesium chloride, 32% PEG3350",277,,,"7AV8",15.16,"1.63","1.63","Crystal Structure of the second bromodomain of Pleckstrin homology domain interacting protein (PHIP) in space group P21212","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","7AV8"
"7AV9",,"X-RAY DIFFRACTION",2,38.43,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG8000, 0.04M potassium phosphate monobasic",277,,,"7AV9",15.47,"1.23","1.23","Crystal Structure of the second bromodomain of Pleckstrin homology domain interacting protein (PHIP) in space group C2","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","7AV9"
"7AVC",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",,"10% glycerol, 4M sodium formate",293,"10.3390/v13020190",,"7AVC",17.12,"1.2","1.2","DoBi scaffold based on PIH1D1 N-terminal domain","MAHHHHHHSAALEVLFQGPGQPGFCIKTNSSEGKVFINICHSPSIPPPADVTEEELLQMLEEDQAGFRIPMSLGEPHAELDAKGQGCTAYDVAVNSDFYRRMQNSDFLRLLVIRIARQGLEYKYDLRLAPPWDMMKNRPFMGSISQQNIR","Homo sapiens","PIH1D1, NOP17","PIH1 domain-containing protein 1","1","7AVC"
"7AVI",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 4000, 60 mM Tris, 2 mM DTT",277,"10.1021/acs.jmedchem.0c01949",,"7AVI",114.98,"1.93","1.93","Crystal structure of SOS1 in complex with compound 2","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVI"
"7AVL",,"X-RAY DIFFRACTION",2.58,52.34,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 8000, 60 mM Tris, 2mM DTT",277,"10.1021/acs.jmedchem.0c01949",,"7AVL",115.34,"1.718","1.718","Crystal structure of SOS1 in complex with compound 4","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVL"
"7AVQ",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, SITTING DROP",,"63% MPD and 0.1 M SPG, pH 6.5",277.15,"10.1080/14756366.2020.1825408","S1Z","7AVQ",41.36,"1.65","1.65","Crystal structure of haspin in complex with disubstituted imidazo[1,2- b]pyridazine inhibitor (compound 12)","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","7AVQ"
"7AVS",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 8000, 2 mM DTT, 60 mM Tris",277,"10.1021/acs.jmedchem.0c01949",,"7AVS",115.27,"2.28","2.28","Crystal structure of SOS1 in complex with compound 6","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVS"
"7AVT",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 8000, 2 mM DTT, 60 mM Tris",277,"10.1021/acs.jmedchem.0c01949",,"7AVT",115.16,"1.88","1.88","Crystal structure of SOS1 in complex with compound 7","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVT"
"7AVU",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 8000, 2 mM DTT, 60 mM Tris",277,"10.1021/acs.jmedchem.0c01949",,"7AVU",115.09,"2.1","2.1","Crystal structure of SOS1 in complex with compound 8","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVU"
"7AVV",,"X-RAY DIFFRACTION",2.26,45.53,"VAPOR DIFFUSION, HANGING DROP",,"6-11 % PEG 8000, 2 mM DTT, 60 mM Tris",277,"10.1021/acs.jmedchem.0c01949",,"7AVV",57.52,"2.12","2.12","Crystal structure of SOS1 in complex with compound 9","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","7AVV"
"7AVX",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION",8.5,"co-crystallisation of 0.3 mM protein with 0.5 mM compound (1 % DMSO) in 4.0 M sodium chloride, 0.1 M Tris pH 8.5",293,"10.1021/acs.jmedchem.0c01904",,"7AVX",72.88,"2.44","2.44","MerTK kinase domain in complex with NPS-1034","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AVX"
"7AVY",,"X-RAY DIFFRACTION",3.58,65.62,"VAPOR DIFFUSION",6.5,"co-crystallisation of 0.3 mM protein with 0.5 mM compound (1 % DMSO) in 1.8 M lithium sulfate, 0.1 M PCTP pH 6.5",293,"10.1021/acs.jmedchem.0c01904",,"7AVY",34.74,"2.31","2.31","MerTK kinase domain in complex with quinazoline-based inhbitor","GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AVY"
"7AVZ",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION",8.5,"4.0-4.5 M sodium chloride, 0.1 M Tris pH 8.5: 16 h soak with 20 % DMSO and 20 mM compound",293,"10.1021/acs.jmedchem.0c01904",,"7AVZ",34.86,"2.04","2.04","MerTK kinase domain in complex with a bisaminopyrimidine inhibitor","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AVZ"
"7AW0",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION",8.5,"4.0-4.5 M sodium chloride, 0.1 M Tris pH 8.5: 16 h soak with 20 % DMSO and 20 mM compound",293,"10.1021/acs.jmedchem.0c01904",,"7AW0",34.74,"1.893","1.893","MerTK kinase domain in complex with purine inhibitor","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AW0"
"7AW1",,"X-RAY DIFFRACTION",2.33,47.23,"VAPOR DIFFUSION",8.5,"4.0-4.5 M sodium chloride, 0.1 M Tris pH 8.5: 32 h soak with 20 % DMSO and 20 mM compound",293,"10.1021/acs.jmedchem.0c01904",,"7AW1",34.97,"1.98","1.98","MerTK kinase domain in complex with a type 2 inhibitor","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AW1"
"7AW2",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION",8.5,"0.5 mM protein was crystallised in 4.3 M sodium chloride, 0.1 M Tris pH 8.5 and soaked for 24 h  with 20 mM compound and 20 % DMSO",293,"10.1021/acs.jmedchem.0c01904",,"7AW2",34.8,"2.1","2.1","MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AW2"
"7AW3",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION",8.5,"0.5 mM protein was crystallised in 4.3 M sodium chloride, 0.1 M Tris pH 8.5 and crystal soaked for 24 h  with 20 mM compound and 20 % DMSO",293,"10.1021/acs.jmedchem.0c01904",,"7AW3",34.88,"1.99","1.99","MerTK kinase domain with type 1 inhibitor from a DNA-encoded library","GSHMEELQNKLEDVVIDRNLLILGRILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPRHIPLQTLLRFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLERLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AW3"
"7AW4",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION",7.5,"0.3 mM protein co-crystallised with 0.5 mM compound (1 % DMSO) in 25 % PEG3350, 0.2 M MgCl2, 0.1 M PCTP pH 7.5",293,"10.1021/acs.jmedchem.0c01904",,"7AW4",73.49,"1.98","1.98","MerTK kinase domain with type 3 inhibitor from a DNA-encoded library","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","7AW4"
"7AW6",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1M citrate/phosphate, 6.5% PEG 400, 6.5% PEG 500 MME, 6.5% PEG 600, 6.5% PEG 1000",293,,,"7AW6",59.99,"1.95","1.95","The extracellular region of CD33 with bound sialoside analogue P22","MGILPSPGMPALLSLVSLLSVLLMGCVAETGFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTHRPKILIPGTLEPGHSKNLTCSVSWACEQGTPPIFSWLSAAPTSLGPRTTHSSVLIITPRPQDHGTNLTCQVKFAGAGVTTERTIQLNVTGTKHHHHHH","Homo sapiens","CD33, SIGLEC3","Myeloid cell surface antigen CD33","1","7AW6"
"7AWC",,"X-RAY DIFFRACTION",2.66,53.75,"VAPOR DIFFUSION, SITTING DROP",,"1.4 M ammonium sulfate, 0.1 M tris, pH 7.5",293.15,"10.1016/j.chembiol.2021.04.019",,"7AWC",32.49,"1.74","1.74","Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG)in complex with rosiglitazone","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","7AWC"
"7AWD",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",,"1.2 M ammonium sulfate, 0.1 M tris, pH 8.0",293.15,"10.1016/j.chembiol.2021.04.019",,"7AWD",32.99,"1.93","1.93","Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG)in complex with garcinoic acid","SMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","7AWD"
"7AWF",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG3350 
0.1M HEPES pH 7.5
0.2M ammonium thiocyanate NH4 SCN",293,"10.1002/anie.202017352",,"7AWF",14.68,"1.4","1.4","The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]-15,15,16-trimethyl-3,19-dioxa-10,13,16-triazatricyclo[18.3.1.0^5,^10]tetracosa-1(24),20,22-triene-4,11,14,17-tetrone","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7AWF"
"7AWG",,"X-RAY DIFFRACTION",3.2,61.58,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1016/j.ejmech.2021.113792",,"7AWG",63.98,"2","2","Crystal structure of human butyrylcholinesterase in complex with (2-((1-(benzenesulfonyl)-1H-indol-4-yl)oxy)ethyl)(benzyl)amine","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7AWG"
"7AWH",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",295,"10.1016/j.ejmech.2021.113792",,"7AWH",63.28,"2.3","2.3","Crystal structure of human butyrylcholinesterase in complex with tert-butyl 3-(((2-((1-(benzenesulfonyl)-1H-indol-4-yl)oxy)ethyl)amino)methyl)piperidine-1-carboxylate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7AWH"
"7AWI",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",295,"10.1016/j.ejmech.2021.113792",,"7AWI",63.02,"2.3","2.3","Crystal structure of human butyrylcholinesterase in complex with tert-butyl 3-(((2-((1-benzyl-1H-indol-4-yl)oxy)ethyl)amino)methyl]piperidine-1-carboxylate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7AWI"
"7AWL",,"X-RAY DIFFRACTION",3.67,66.5,"VAPOR DIFFUSION, HANGING DROP",8.2,"32% PEG400, 100 mM Tris pH 8.2, 50 mM Calcium chloride, 50 mM Barium chloride",277,"10.15252/embj.2021108341",,"7AWL",57.16,"3.7","3.7","Structure of the thermostabilized EAAT1 cryst-II mutant in complex with barium and the allosteric inhibitor UCPH101","MTKSNGEEPKMGGRMERFQQGVSKRTLLAKKKVQNITKEDVKSFLRRNALLLLTVLAVILGVVLGFLLRPYPLSPREVKYFAFPGELLMRMLKMLILPLIVSSLITGLASLDAKASGRLGMRAVVYYMSTTIIAVVLGIILVLIIHPGAASAAITASVGAAGSAENAPSKEVLDCFLDLARNIFPSNLVSAAFRSYSTTYEERTITGTRVKVPVGQEVEGMNILGLVVFSIVFGIALGKMGEQGQLLVDFFNSLNEATMKLVAIIMWYAPLGILFLIAGKIVEMEDLEVLGGQLGMYMVTVIVGLVIHGLIVLPLIYFLITRKNPFVFIAGILQALITALGTSSSSATLPITFKCLEENNGVDKRITRFVLPVGATINMDGTALYEAVAAIFIAQVNNYELDFGQIITISITATAASIGAAGIPQAGLVTMVIVLTAVGLPTDDITLIIAVDWLLDRFRTMVNVLGDALGAGIVEHLSRKELEKQDAELGNSVIEENEMKKPYQLIAQDNETEKPIDSETKM","Homo sapiens","SLC1A3, EAAT1, GLAST, GLAST1, SLC1A5, ASCT2, M7V1, RDR, RDRC","Excitatory amino acid transporter 1, Neutral amino acid transporter, Excitatory amino acid transporter, Transporter protein","1","7AWL"
"7AWX",,"X-RAY DIFFRACTION",2.25,45.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"40% PEG3350 
0.1 M HEPES-NaOH pH 7.5
0.2M ammonium thiocyanate",293,"10.1021/acs.jmedchem.0c02195",,"7AWX",29.41,"2.2","2.2","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 55","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7AWX"
"7AX3","3.74","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-25741-x",,"7AX3",3530.95,"3.74",,"CryoEM structure of the super-constricted two-start dynamin 1 filament","MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGNINTTTVSTPMPPPVDDSWLQVQSVPAGRRSPTSSPTPQRRAPAVPPARPGSRGPAPGPPPAGSALGGAPPVPSRPGASPDPFGPPPQVPSRPNRAPPGVPSRSGQASPSRPESPRPPFDL","Homo sapiens","DNM1, DNM","Dynamin-1","1","7AX3"
"7AX4",,"X-RAY DIFFRACTION",2.25,45.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"25.5% w/v PEG 4000, 0.21 M calcium chloride, 0.10 M Tris pH 8.5",293,"10.1177/24725552211002472",,"7AX4",66.62,"2.12","2.12","Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.","NLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","7AX4"
"7AX8",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AX8",36.34,"2.15","2.15","Crystal structure of the hPXR-LBD in apo form (P43212 SG)","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AX8"
"7AX9",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AX9",36.96,"2.25","2.25","Crystal structure of the hPXR-LBD in complex with cis-chlordane","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AX9"
"7AXA",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXA",37.09,"2.26","2.26","Crystal structure of the hPXR-LBD in complex with clotrimazole","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSLVPR","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXA"
"7AXB",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXB",36.99,"2.55","2.55","Crystal structure of the hPXR-LBD in complex with endosulfan","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXB"
"7AXC",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXC",36.97,"2.05","2.05","Crystal structure of the hPXR-LBD in complex with ferutinine","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXC"
"7AXD",,"X-RAY DIFFRACTION",2.52,51.28,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXD",37.02,"2.65","2.65","Crystal structure of the hPXR-LBD in complex with fipronil","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXD"
"7AXE",,"X-RAY DIFFRACTION",2.47,50.15,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXE",36.78,"1.9","1.9","Crystal structure of the hPXR-LBD in complex with oxadiazon","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXE"
"7AXF",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXF",37.21,"2.45","2.45","Crystal structure of the hPXR-LBD in complex with pretilachlor","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXF"
"7AXG",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXG",37.33,"2.7","2.7","Crystal structure of the hPXR-LBD in complex with tributyltin","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSLVPR","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXG"
"7AXH",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXH",36.84,"2.55","2.55","Crystal structure of the hPXR-LBD in complex with alpha-zearalanol","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXH"
"7AXI",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXI",37.55,"2.15","2.15","Crystal structure of the hPXR-LBD in complex with estradiol and cis-chlordane","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXI"
"7AXJ",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXJ",37.36,"2.3","2.3","Crystal structure of the hPXR-LBD in complex with estradiol and clotrimazole","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSLVPR","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXJ"
"7AXK",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXK",37.17,"2","2","Crystal structure of the hPXR-LBD in complex with estradiol and endosulfan","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXK"
"7AXL",,"X-RAY DIFFRACTION",2.41,49.07,"VAPOR DIFFUSION, HANGING DROP",,"50 - 100 mM imidazole
8 - 14% isopropanol",291,"10.1073/pnas.2020551118",,"7AXL",37.53,"2.5","2.5","Crystal structure of the hPXR-LBD in complex with estradiol and heptachlor endo-epoxide","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSLVPR","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","7AXL"
"7AXR",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION, SITTING DROP",7,"35% Tacsimate pH 7.0",293,"10.1021/acs.jmedchem.1c01119",,"7AXR",15.81,"1.5","1.5","Crystal structure of BRD4(1) bound to the dual BET-HDAC inhibitor LSH24","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7AXR"
"7AXU",,"X-RAY DIFFRACTION",2.04,39.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"10% (w/v) PEG20000, 20% (v/v) PEG550 MME, 0.02 M sodium formate, 0.02 M ammonium acetate, 0.02 M trisodium citrate, 0.02 M sodium potassium L-tartrate, 0.02 M sodium oxamate",277.15,"10.1021/acscentsci.1c00434",,"7AXU",36.64,"1.68","1.68","Structure of WDR5:CS-VIP8 cocrystal after illumination in situ","MATEEKKPETEAARAQPTPSSSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","7AXU"
"7AY6",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Magnesium Chloride, Hepes",293,"10.1016/j.ejmech.2021.113638",,"7AY6",81.25,"1.66","1.66","Crystal structure of the PDE4D catalytic domain in complex with GEBR-41b","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7AY6"
"7AY9",,"X-RAY DIFFRACTION",3.09,60.23,"VAPOR DIFFUSION",,"22-26% PEG 6000 ( w/v ), 0.2 M ammonium sulfate and 0.1 M MES (pH 6.5).",293,,,"7AY9",85.45,"2.25","2.25","Crystal structure of CK2 bound by compound 7","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7AY9"
"7AYA",,"X-RAY DIFFRACTION",3.08,60,"VAPOR DIFFUSION",,"22-26% PEG 6000 ( w/v ), 0.2 M ammonium sulfate and 0.1 M MES (pH 6.5).",293,,,"7AYA",85.37,"2.45","2.45","Crystal structure of CK2 bound by compound 9","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSHHHHHH","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7AYA"
"7AYB",,"X-RAY DIFFRACTION",2.8,56.05,"VAPOR DIFFUSION, SITTING DROP",4.5,"1M NaCl, 16.82% (w/v) Polyethylene glycol 6000, 100mM Acetic Acid pH:4.5",277,,,"7AYB",38.83,"1.85","1.85","Crystal Structure of wild type human mitochondrial 2-Enoyl Thioester Reductase (MECR)","MASSYSASAEPARVRALVYGHHGDPAKVVELKNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLGTWRTEAVFSEEALIQVPSDIPLQSAATLGVNPCTAYRMLMDFEQLQPGDSVIQNASNSGVGQAVIQIAAALGLRTINVVRDRPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGKSSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKKDHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISSKQILTMLEHHHHHH","Homo sapiens","MECR, NBRF1, CGI-63","Enoyl-[acyl-carrier-protein] reductase, mitochondrial","1","7AYB"
"7AYC",,"X-RAY DIFFRACTION",2.77,55.62,"VAPOR DIFFUSION, SITTING DROP",4.5,"1M NaCl, 16.82%w/v Polyethylene glycol 6000, 100mM Acetic Acid pH:4.5",277,,,"7AYC",38.47,"2.02","2.02","Crystal Structure of human mitochondrial 2-Enoyl Thioester Reductase (MECR) with single mutation G165Q","MASSYSASAEPARVRALVYGHHGDPAKVVELKNLELAAVRGSDVRVKMLAAPINPSDINMIQGNYGLLPELPAVGGNEGVAQVVAVGSNVTGLKPGDWVIPANAGLGTWRTEAVFSEEALIQVPSDIPLQSAATLQVNPCTAYRMLMDFEQLQPGDSVIQNASNSGVGQAVIQIAAALGLRTINVVRDRPDIQKLSDRLKSLGAEHVITEEELRRPEMKNFFKDMPQPRLALNCVGGKSSTELLRQLARGGTMVTYGGMAKQPVVASVSLLIFKDLKLRGFWLSQWKKDHSPDQFKELILTLCDLIRRGQLTAPACSQVPLQDYQSALEASMKPFISSKQILTMLEHHHHHH","Homo sapiens","MECR, NBRF1, CGI-63","Enoyl-[acyl-carrier-protein] reductase, mitochondrial","1","7AYC"
"7AYH",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG 3350, 0.2 M sodium malonate pH 7",277.15,"10.3390/molecules26061611",,"7AYH",33.31,"2.8","2.8","Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one derivative (compound 2c)","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","7AYH"
"7AYI",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG 3350 and 5% Tacsimate pH 7",277.15,"10.3390/molecules26061611",,"7AYI",33.28,"2.86","2.86","Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one derivative (compound 2a)","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","7AYI"
"7AYQ",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, HANGING DROP",,"0.46 mM Na citrate",277,"10.1002/anie.202210498",,"7AYQ",208.49,"2.45","2.45","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, B114","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7AYQ"
"7AYR",,"X-RAY DIFFRACTION",4.21,70.76,"VAPOR DIFFUSION, HANGING DROP",,"0.46 mM Na citrate",277,"10.1002/anie.202210498",,"7AYR",208.31,"2.69","2.69","Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, B115","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","7AYR"
"7AYY",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.12 M Alcohols, 0.1 M Buffer System 2 pH 7.5 and 48 % v/v Precipitant Mix 4 (Morpheus screen, Molecular Dimensions)",293.15,"10.1126/science.abf8980",,"7AYY",191.72,"2","2","Structure of the human 8-oxoguanine DNA Glycosylase hOGG1 in complex with activator TH10785","MGSSHHHHHHSSGLVPRGSHMGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","1","7AYY"
"7AZP","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.isci.2020.102022",,"7AZP",408.15,"3.5",,"Structure of the human mitochondrial HSPD1 single ring","SNAAKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKLSDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAGDFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF","Homo sapiens","HSPD1, HSP60","60 kDa heat shock protein, mitochondrial","1","7AZP"
"7AZW",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION",,"PEG 4000, sodium acetate",293,"10.1016/j.str.2021.06.005",,"7AZW",26.65,"2.1","2.1","Crystal structure of the MIZ1-BTB-domain","GGSMASMDFPQHSQHVLEQLNQQRQLGLLCDCTFVVDGVHFKAHKAVLAACSEYFKMLFVDQKDVVHLDISNAAGLGQVLEFMYTAKLSLSPENVDDVLAVATFLQMQDIITACHALKSLA","Homo sapiens","ZBTB17, MIZ1, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17 isoform X1","1","7AZW"
"7B0T",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"28% PEG 3350, 0.2M NaOAc, 0.1M Bis-Tris, pH6.0",293,"10.1021/acschembio.0c00960",,"7B0T",18.83,"2.05","2.05","Crystal structure of MLLT1 YEATS domain T3 mutant in complex with benzimidazole-amide based compound 1","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGKVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","7B0T"
"7B0V",,"X-RAY DIFFRACTION",2.64,53.47,"VAPOR DIFFUSION",6.5,"PEG 4000, lithium sulphate, ADA buffer",277,"10.1021/acsmedchemlett.1c00238",,"7B0V",120.66,"2.3","2.3","Crystal Structure of human monoamine oxidase B in complex with (E)-3-phenyl-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-one","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","7B0V"
"7B0Z",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION",6.5,"PEG 4000, lithium sulphate, ADA buffer",277,"10.1021/acsmedchemlett.1c00238",,"7B0Z",120.66,"2.1","2.1","Crystal Structure of human monoamine oxidase B in complex with (E)-3-phenyl-1-(4-(trifluoromethyl)phenyl)prop-2-en-1-one","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","7B0Z"
"7B10",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% w/v PEG 3350, 0.1M Bis-Tris, pH 5.5",293,"10.1021/acschembio.0c00960",,"7B10",19.87,"1.92","1.92","Crystal structure of MLLT1 YEATS domain T1 mutant in complex with benzimidazole-amide based compound 1","MDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","7B10"
"7B1E",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",5.2,"15% PEG 1,500 in water",292,"10.1021/acs.jmedchem.0c02143",,"7B1E",45.18,"1.62","1.62","BACE1 IN COMPLEX WITH compound 3 (NB-641)","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","7B1E"
"7B1O",,"X-RAY DIFFRACTION",2.86,56.99,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 mM Tris pH 8.0, 18% (w/v) PEG6000, 0.2 M NaCl",293,"10.1021/acs.jmedchem.1c00679",,"7B1O",93.17,"2.58","2.58","Crystal structure of the indoleamine 2,3-dioxygenase 1 (IDO1) in complex with compound 22","HHHHHHSSGLVPRGSHMISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","7B1O"
"7B1P",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG 1,500 in water",292,"10.1021/acs.jmedchem.0c02143",,"7B1P",45.25,"1.77","1.77","Crystal Structure of Human BACE-1 in Complex with Compound 38a (NB-854)","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","7B1P"
"7B1Q",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG 1,500 in water",292,"10.1021/acs.jmedchem.0c02143",,"7B1Q",45.23,"1.94","1.94","Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54)","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","7B1Q"
"7B1T",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES, Sodium citrate tribasic dihydrate",293,,,"7B1T",15.54,"1.92","1.92","Crystal structure of BRD4(1) in complex with the inhibitor MPM6","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7B1T"
"7B2G",,"X-RAY DIFFRACTION",6.22,80.23,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Succinic acid; 15% w/v PEG 3350",277,,,"7B2G",35.25,"3","3","Crystal structure of R120Q GDAP1 mutant","MAERQEEQRGSPPLRAEGKADAEVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPQVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILIS","Homo sapiens","GDAP1","Ganglioside-induced differentiation-associated protein 1","1","7B2G"
"7B2R",,"X-RAY DIFFRACTION",1.88,34.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% Medium molecular weight PEG Smears, 0.1M MES pH 6.5",293.15,,,"7B2R",60.07,"1.6","1.6","Crystal structure of NHL domain of TRIM2","SMNPIEDDLIFRVGTKGRNKGEFTNLQGVAASTNGKILIADSNNQCVQIFSNDGQFKSRFGIRGRSPGQLQRPTGVAVHPSGDIIIADYDNKWVSIFSSDGKFKTKIGSGKLMGPKGVSVDRNGHIIVVDNKACCVFIFQPNGKIVTRFGSRGNGDRQFAGPHFAAVNSNNEIIITDFHNHSVKVFNQEGEFMLKFGSNGEGNGQFNAPTGVAVDSNGNIIVADWGNSRIQVFDGSGSFLSYINTSADPLYGPQGLALTSDGHVVVADSGNHCFKVY","Homo sapiens","TRIM2, KIAA0517, RNF86","Tripartite motif-containing protein 2","1","7B2R"
"7B2S",,"X-RAY DIFFRACTION",1.93,36.21,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 8000, 0.2 M Ammonium sulfate",293.15,,,"7B2S",20.05,"1.5","1.5","Crystal structure of SPRY domain of TRIM9","SMVAWFAFDPGSAHSDIILSNDNLTVTCSSYDDRVVLGKTGFSKGIHYWELTVDRYDNHPDPAFGVARMDVMKDVMLGKDDKAWAMYVDNNRSWFMHNNSHTNRTEGGITKGATIGVLLDFNRKNLTFFINDEQQGPIAFDNVEGLFFPAVSLNRNVQVTLHTGLPVPDFYSSRASIA","Homo sapiens","TRIM9, KIAA0282, RNF91","E3 ubiquitin-protein ligase TRIM9","1","7B2S"
"7B2V",,"X-RAY DIFFRACTION",1.92,36.07,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c00701",,"7B2V",45.03,"1.24","1.24","Notum complex with ARUK3003906","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B2V"
"7B2X",,"X-RAY DIFFRACTION",3.04,59.54,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG3350 -- 0.1M HEPES pH 7.0 -- 0.2M sodium formate",277,"10.1093/nar/gkab692",,"7B2X",38.2,"3.1","3.1","Crystal structure of human 5' exonuclease Appollo H61Y variant","SMGYGNGVLIPHTPIAVDFWSLRRAGTARLFFLSHMHSDHTVGLSSTWARPLYCSPITAHLLHRYLQVSKQWIQALEVGESHVLPLDEIGQETMTVTLLDANHCPGSVMFLFEGYFGTILYTGDFRYTPSMLKEPALTLGKQIHTLYLDNTNCNPALVLPSRQEAAHQIVQLIRKHPQHNIKIGLYSLGKESLLEQLALEFQTWVVLSPRRLELVQLLGLADVFTVEEKAGRIHAVDHMEICHSNMLRWNQTHPTIAILPTSRKIHSSHPDIHVIPYSDHSSYSELRAFVAALKPCQVVPIVSRRPCGGFQDSLSPRISVPLIPDSVQQYMSSSSRKPS","Homo sapiens","DCLRE1B, SNM1B","5' exonuclease Apollo","1","7B2X"
"7B2Y",,"X-RAY DIFFRACTION",1.92,36.01,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c00701",,"7B2Y",45.16,"1.23","1.23","Notum complex with ARUK3003910","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B2Y"
"7B2Z",,"X-RAY DIFFRACTION",1.93,36.11,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c00701",,"7B2Z",44.62,"1.24","1.24","Notum complex with ARUK3003907","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B2Z"
"7B30",,"X-RAY DIFFRACTION",2.6,52.74,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol and 0.5 mM TCEP.
Reservoir: 10% PEG 6000, 0.1M HEPES pH 7.0.",293,"10.1021/acs.jmedchem.0c02144",,"7B30",35.05,"2.1","2.1","MST3 in complex with compound G-5555","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B30"
"7B31",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 0.5 mM TCEP.
Reservoir: 16% PEG 6000, 0.1M HEPES pH 7.0.",293,"10.1021/acs.jmedchem.0c02144",,"7B31",35.06,"1.8","1.8","MST3 in complex with compound MRIA9","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B31"
"7B32",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 0.5mM TCEP.
Reservoir: 20% PEG 3350, 0.1M bis-tris pH 6.5.",293,"10.1021/acs.jmedchem.0c02144",,"7B32",35.14,"1.75","1.75","MST3 in complex with MRIA7","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B32"
"7B33",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 0.5 mM TCEP.
Reservoir: 19% PEG 3350, 0.1M bis-tris pH 6.8.",293,"10.1021/acs.jmedchem.0c02144",,"7B33",35.34,"1.9","1.9","MST3 in complex with MRIA11","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B33"
"7B34",,"X-RAY DIFFRACTION",2.97,58.61,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 0.5 mM TCEP.
Reservoir: 14% PEG 6000, 0.1M HEPES pH 7.2.",293,"10.1021/acs.jmedchem.0c02144",,"7B34",35.51,"2.1","2.1","MST3 in complex with compound MRIA12","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B34"
"7B35",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 10 mg/ml in buffer 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 0.5 mM TCEP.
reservoir: 24% PEG 3550, 0.1M citrate pH 5.6.",293,"10.1021/acs.jmedchem.0c02144",,"7B35",70.17,"2.40005138292","2.40005138292","MST3 in complex with compound MRIA13","MRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDAHHHHHH","Homo sapiens","STK24, MST3, STK3","Serine/threonine-protein kinase 24","1","7B35"
"7B36",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",,"solution: protein 12 mg/ml in buffer 25mM HEPES pH 7.5, 200 mM NaCl, 0.5mM TCEP, 5% glycerol
reservoir:
28% PEG6000, 0.1M HEPES pH 7.5",293,"10.1021/acs.jmedchem.0c02144",,"7B36",68.93,"2.10681078505","2.10681078505","MST4 in complex with compound G-5555","SMAHSPVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWKAEGHS","Homo sapiens","STK26, MASK, MST4","Serine/threonine-protein kinase 26","1","7B36"
"7B37",,"X-RAY DIFFRACTION",1.93,36.26,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c00701",,"7B37",44.75,"1.34","1.34","Notum complex with ARUK3003718","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B37"
"7B3F",,"X-RAY DIFFRACTION",1.93,36.31,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c00701",,"7B3F",44.73,"1.39","1.39","Notum S232A in complex with ARUK3003718","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSAAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3F"
"7B3G",,"X-RAY DIFFRACTION",1.93,36.3,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B3G",45.1,"1.28","1.28","Notum complex with ARUK3003902","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3G"
"7B3H",,"X-RAY DIFFRACTION",1.94,36.45,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B3H",44.74,"1.28","1.28","Notum complex with ARUK3003909","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3H"
"7B3I",,"X-RAY DIFFRACTION",1.93,36.38,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B3I",44.94,"1.34","1.34","Notum complex with ARUK3003776","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3I"
"7B3M",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, HANGING DROP",,"MEK1 was prepared in buffer containing 25 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol and 1 mM TCEP at a concentration of 10 mg/ml  mixed with 2 mM MgCl2 and 2 mM AMP-PNP, and incubated at room temperature for 30 minutes. Crystals were obtained from hanging drops by mixing a 1:1 ratio of protein solution with well solution containing 2 M AmSO4, 0.1 M NaCl and 0.1 M Bis-tris pH 6.1-6.2 at room temperature.",293,"10.1021/acsmedchemlett.0c00563",,"7B3M",74.72,"2.3","2.3","MEK1 in complex with compound 6","MAHHHHHHAAAENLYFQLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 1","1","7B3M"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP2K1, MEK1, PRKMK1"
"7B3P",,"X-RAY DIFFRACTION",1.93,36.42,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B3P",44.7,"1.28","1.28","Notum complex with ARUK3003775","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3P"
"7B3Q",,"X-RAY DIFFRACTION",2.59,52.53,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG3350, 0.2 M (NH4)2SO4, 0.1 M Na-HEPES pH 7.5",293,"10.1021/acsmedchemlett.0c00392",,"7B3Q",34.11,"1.75","1.75","Crystal structure of c-MET bound by compound 1","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B3Q"
"7B3T",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG8000, 0.2 M Li2SO4",273,"10.1021/acsmedchemlett.0c00392",,"7B3T",34.22,"2.23","2.23","Crystal structure of c-MET bound by compound 2","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B3T"
"7B3V",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG3350, 0.2 M (NH4)2SO4, PCPT pH 5.5",273,"10.1021/acsmedchemlett.0c00392",,"7B3V",34.04,"1.93","1.93","Crystal structure of c-MET bound by compound 3","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B3V"
"7B3W",,"X-RAY DIFFRACTION",3.12,60.53,"VAPOR DIFFUSION, SITTING DROP",,"8 % ethylene glycol, 10 % PEG8000, 0.1 M Na-HEPES pH 7.5",293,"10.1021/acsmedchemlett.0c00392",,"7B3W",34.1,"2.02","2.02","Crystal structure of c-MET bound by compound 4","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B3W"
"7B3X",,"X-RAY DIFFRACTION",1.93,36.36,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B3X",44.48,"1.34","1.34","Notum complex with ARUK3003748","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B3X"
"7B3Z",,"X-RAY DIFFRACTION",2.54,51.5,"VAPOR DIFFUSION, SITTING DROP",,"20 % PEG10000, 0.1 M Na-HEPES pH 7.5",293,"10.1021/acsmedchemlett.0c00392",,"7B3Z",34.19,"1.8","1.8","Crystal structure of c-MET bound by compound 5","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B3Z"
"7B40",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, SITTING DROP",,"20 % PEG4000, 10 % isopropanol, 0.1 M Na-HEPES pH 7.5",293,"10.1021/acsmedchemlett.0c00392",,"7B40",34.14,"1.76","1.76","Crystal structure of c-MET bound by compound 6","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B40"
"7B41",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 5.5",293,"10.1021/acsmedchemlett.0c00392",,"7B41",34.16,"1.97","1.97","Crystal structure of c-MET bound by compound 7","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B41"
"7B42",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG3350, 0.2 M MgCl2, 0.1 M bis-tris pH 6.5",293,"10.1021/acsmedchemlett.0c00392",,"7B42",34.16,"1.8","1.8","Crystal structure of c-MET bound by compound 8","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B42"
"7B43",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, SITTING DROP",,"28 % PEGMME2000, 0.1 M bis-tris pH 6.5",293,"10.1021/acsmedchemlett.0c00392",,"7B43",68.32,"1.87","1.87","Crystal structure of c-MET bound by compound 9","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B43"
"7B44",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, SITTING DROP",,"25 % PEG3350, 0.2 M (NH4)2SO4, 0.1 M Na-HEPES pH 7.5",293,"10.1021/acsmedchemlett.0c00392",,"7B44",34.47,"1.76","1.76","Crystal structure of c-MET bound by compound S1","GNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","7B44"
"7B45",,"X-RAY DIFFRACTION",1.94,36.46,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c01735",,"7B45",45.05,"1.38","1.38","Notum complex with ARUK3003934","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B45"
"7B47",,"X-RAY DIFFRACTION",2.32,46.97,"EVAPORATION",6.1,"0.1M Li Acetate, 16% w/v PEG 3350",292,"10.1038/s41467-021-27142-6",,"7B47",91.6,"1.8","1.8","Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R273H mutant bound to MQ: R273H-MQ (I)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","7B47"
"7B48",,"X-RAY DIFFRACTION",2.46,50.01,"EVAPORATION",6.1,"0.2M Li Acetate, 2.0% w/v Agarose, 20% w/v PEG 3350",292,"10.1038/s41467-021-27142-6",,"7B48",91.3,"2.05","2.05","Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R273H mutant bound to MQ: R273H-MQ (II)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVHVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","7B48"
"7B4B",,"X-RAY DIFFRACTION",2.3,46.57,"EVAPORATION",6.1,"PROTEIN/DNA RATIO 1:2.4, 0.2M Sodium Fluoride, 20% w/v PEG 3350",292,"10.1038/s41467-021-27142-6",,"7B4B",91.92,"1.76","1.76","Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R273C mutant bound to MQ: R273C-MQ (I)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","7B4B"
"7B4C",,"X-RAY DIFFRACTION",2.32,46.87,"EVAPORATION",6.1,"0.2M Sodium Fluoride, 20% w/v PEG 3350",292,"10.1038/s41467-021-27142-6",,"7B4C",91.5,"1.71","1.71","Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Human p53DBD-R273C mutant bound to MQ: R273C-MQ (II)","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVCVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","7B4C"
"7B4L","3.1","ELECTRON MICROSCOPY",,,,,,,,,"7B4L",121.06,"3.1",,"CryoEM structure of the human sodium proton exchanger NHA2","MGDEDKRITYEDSEPSTGMNYTPSMHQEAQEETVMKLKGIDANEPTEGSILLKSSEKKLQETPTEANHVQRLRQMLACPPHGLLDRVITNVTIIVLLWAVVWSITGSECLPGGNLFGIIILFYCAIIGGKLLGLIKLPTLPPLPSLLGMLLAGFLIRNIPVINDNVQIKHKWSSSLRSIALSIILVRAGLGLDSKALKKLKGVCVRLSMGPCIVEACTSALLAHYLLGLPWQWGFILGFVLGAVSPAVVVPSMLLLQGGGYGVEKGVPTLLMAAGSFDDILAITGFNTCLGIAFSTGSTVFNVLRGVLEVVIGVATGSVLGFFIQYFPSRDQDKLVCKRTFLVLGLSVLAVFSSVHFGFPGSGGLCTLVMAFLAGMGWTSEKAEVEKIIAVAWDIFQPLLFGLIGAEVSIASLRPETVGLCVATVGIAVLIRILTTFLMVCFAGFNLKEKIFISFAWLPKATVQAAIGSVALDTARSHGEKQLEDYGMDVLTVAFLSILITAPIGSLLIGLLGPRLLQKVEHQNKDEEVQGETSVQV","Homo sapiens","SLC9B2, NHA2, NHEDC2","Sodium/hydrogen exchanger 9B2","1","7B4L"
"7B4M","7.2","ELECTRON MICROSCOPY",,,,,,,,,"7B4M",115.22,"7.2",,"CryoEM structure of the human sodium proton exchanger NHA2 in nanodisc","MGDEDKRITYEDSEPSTGMNYTPSMHQEAQEETVMKLKGIDANEPTEGSILLKSSEKKLQETPTEANHVQRLRQMLACPPHGLLDRVITNVTIIVLLWAVVWSITGSECLPGGNLFGIIILFYCAIIGGKLLGLIKLPTLPPLPSLLGMLLAGFLIRNIPVINDNVQIKHKWSSSLRSIALSIILVRAGLGLDSKALKKLKGVCVRLSMGPCIVEACTSALLAHYLLGLPWQWGFILGFVLGAVSPAVVVPSMLLLQGGGYGVEKGVPTLLMAAGSFDDILAITGFNTCLGIAFSTGSTVFNVLRGVLEVVIGVATGSVLGFFIQYFPSRDQDKLVCKRTFLVLGLSVLAVFSSVHFGFPGSGGLCTLVMAFLAGMGWTSEKAEVEKIIAVAWDIFQPLLFGLIGAEVSIASLRPETVGLCVATVGIAVLIRILTTFLMVCFAGFNLKEKIFISFAWLPKATVQAAIGSVALDTARSHGEKQLEDYGMDVLTVAFLSILITAPIGSLLIGLLGPRLLQKVEHQNKDEEVQGETSVQV","Homo sapiens","SLC9B2, NHA2, NHEDC2","Sodium/hydrogen exchanger 9B2","1","7B4M"
"7B4X",,"X-RAY DIFFRACTION",1.93,36.18,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acschemneuro.2c00325",,"7B4X",44.98,"1.24","1.24","Notum complex with ARUK3002697","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B4X"
"7B50",,"X-RAY DIFFRACTION",1.93,36.37,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,"10.1021/acs.jmedchem.1c01735",,"7B50",44.6,"1.33","1.33","Notum complex with ARUK3003778","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B50"
"7B63",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.0, 0.2 M sodium acetate, 38% PEG 4000",294,"10.1016/j.jbc.2021.100568",,"7B63",38.2,"1.6","1.6","Structure of NUDT15 in complex with TH7755","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Probable 8-oxo-dGTP diphosphatase NUDT15","1","7B63"
"7B64",,"X-RAY DIFFRACTION",2.1,41.52,"VAPOR DIFFUSION, SITTING DROP",,"0.12 M Monosaccharide mix (Morpheus Screen), 0.1 M Imidazole/MES pH 6.5, 20% PEG 500 MME,  20% PEG 2000",294,"10.1016/j.jbc.2021.100568",,"7B64",19.1,"1.5","1.5","Structure of NUDT15 V18I Mutant in complex with TH7755","MTASAQPRGRRPGVGVGIVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7B64"
"7B65",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, SITTING DROP",,"0.12 M Monosaccharide mix (Morpheus Screen) 0.1 M Imidazole/MES pH 6,5, 12.5% MPD, 12.5% PEG 1000,  12.5 % PEG 3350",294,"10.1016/j.jbc.2021.100568",,"7B65",38.07,"1.6","1.6","Structure of NUDT15 R139C Mutant in complex with TH7755","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLCCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7B65"
"7B66",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MMT pH 5.0, 25.4% PEG 1500",294,"10.1016/j.jbc.2021.100568",,"7B66",76.28,"1.6","1.6","Structure of NUDT15 R139H Mutant in complex with TH7755","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLHCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7B66"
"7B67",,"X-RAY DIFFRACTION",2.45,49.77,"VAPOR DIFFUSION, SITTING DROP",,"0.09 M SPG pH 5.0, 22.25% PEG 1500, 0.01 M sodium phosphate, 2.75% 1,2 propandiol, 1.0% glycerol",294,"10.1016/j.jbc.2021.100568",,"7B67",38.61,"1.45","1.45","Structure of NUDT15 V18_V19insGV Mutant in complex with TH7755","MTASAQPRGRRPGVGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Nucleotide triphosphate diphosphatase NUDT15","1","7B67"
"7B6F",,"X-RAY DIFFRACTION",2.87,57.08,"VAPOR DIFFUSION, SITTING DROP",,"protein solution: 10 mg/ml in buffer 25mM HEPES, pH 7.5, 200mM NaCl, 5% glycerol, 0.5mM TCEP
reservoir:12% PEG 8000, 1 mM MgCl2, 0.5M NaCl and 0.1M Tris pH 8.0",293,,,"7B6F",42.37,"2.05","2.05","GSK3-beta in complex with compound (S)-5c","MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARAHHHHHH","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","7B6F"
"7B75","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-021-27693-8",,"7B75",621.04,"3.2",,"Cryo-EM Structure of Human Thyroglobulin","MALVLEIFTLLASICWVSANIFEYQVDAQPLRPCELQRETAFLKQADYVPQCAEDGSFQTVQCQNDGRSCWCVGANGSEVLGSRQPGRPVACLSFCQLQKQQILLSGYINSTDTSYLPQCQDSGDYAPVQCDVQQVQCWCVDAEGMEVYGTRQLGRPKRCPRSCEIRNRRLLHGVGDKSPPQCSAEGEFMPVQCKFVNTTDMMIFDLVHSYNRFPDAFVTFSSFQRRFPEVSGYCHCADSQGRELAETGLELLLDEIYDTIFAGLDLPSTFTETTLYRILQRRFLAVQSVISGRFRCPTKCEVERFTATSFGHPYVPSCRRNGDYQAVQCQTEGPCWCVDAQGKEMHGTRQQGEPPSCAEGQSCASERQQALSRLYFGTSGYFSQHDLFSSPEKRWASPRVARFATSCPPTIKELFVDSGLLRPMVEGQSQQFSVSENLLKEAIRAIFPSRGLARLALQFTTNPKRLQQNLFGGKFLVNVGQFNLSGALGTRGTFNFSQFFQQLGLASFLNGGRQEDLAKPLSVGLDSNSSTGTPEAAKKDGTMNKPTVGSFGFEINLQENQNALKFLASLLELPEFLLFLQHAISVPEDVARDLGDVMETVLSSQTCEQTPERLFVPSCTTEGSYEDVQCFSGECWCVNSWGKELPGSRVRGGQPRCPTDCEKQRARMQSLMGSQPAGSTLFVPACTSEGHFLPVQCFNSECYCVDAEGQAIPGTRSAIGKPKKCPTPCQLQSEQAFLRTVQALLSNSSMLPTLSDTYIPQCSTDGQWRQVQCNGPPEQVFELYQRWEAQNKGQDLTPAKLLVKIMSYREAASGNFSLFIQSLYEAGQQDVFPVLSQYPSLQDVPLAALEGKRPQPRENILLEPYLFWQILNGQLSQYPGSYSDFSTPLAHFDLRNCWCVDEAGQELEGMRSEPSKLPTCPGSCEEAKLRVLQFIRETEEIVSASNSSRFPLGESFLVAKGIRLRNEDLGLPPLFPPREAFAEQFLRGSDYAIRLAAQSTLSFYQRRRFSPDDSAGASALLRSGPYMPQCDAFGSWEPVQCHAGTGHCWCVDEKGGFIPGSLTARSLQIPQCPTTCEKSRTSGLLSSWKQARSQENPSPKDLFVPACLETGEYARLQASGAGTWCVDPASGEELRPGSSSSAQCPSLCNVLKSGVLSRRVSPGYVPACRAEDGGFSPVQCDQAQGSCWCVMDSGEEVPGTRVTGGQPACESPRCPLPFNASEVVGGTILCETISGPTGSAMQQCQLLCRQGSWSVFPPGPLICSLESGRWESQLPQPRACQRPQLWQTIQTQGHFQLQLPPGKMCSADYADLLQTFQVFILDELTARGFCQIQVKTFGTLVSIPVCNNSSVQVGCLTRERLGVNVTWKSRLEDIPVASLPDLHDIERALVGKDLLGRFTDLIQSGSFQLHLDSKTFPAETIRFLQGDHFGTSPRTWFGCSEGFYQVLTSEASQDGLGCVKCPEGSYSQDEECIPCPVGFYQEQAGSLACVPCPVGRTTISAGAFSQTHCVTDCQRNEAGLQCDQNGQYRASQKDRGSGKAFCVDGEGRRLPWWETEAPLEDSQCLMMQKFEKVPESKVIFDANAPVAVRSKVPDSEFPVMQCLTDCTEDEACSFFTVSTTEPEISCDFYAWTSDNVACMTSDQKRDALGNSKATSFGSLRCQVKVRSHGQDSPAVYLKKGQGSTTTLQKRFEPTGFQNMLSGLYNPIVFSASGANLTDAHLFCLLACDRDLCCDGFVLTQVQGGAIICGLLSSPSVLLCNVKDWMDPSEAWANATCPGVTYDQESHQVILRLGDQEFIKSLTPLEGTQDTFTNFQQVYLWKDSDMGSRPESMGCRKDTVPRPASPTEAGLTTELFSPVDLNQVIVNGNQSLSSQKHWLFKHLFSAQQANLWCLSRCVQEHSFCQLAEITESASLYFTCTLYPEAQVCDDIMESNAQGCRLILPQMPKALFRKKVILEDKVKNFYTRLPFQKLMGISIRNKVPMSEKSISNGFFECERRCDADPCCTGFGFLNVSQLKGGEVTCLTLNSLGIQMCSEENGGAWRILDCGSPDIEVHTYPFGWYQKPIAQNNAPSFCPLVVLPSLTEKVSLDSWQSLALSSVVVDPSIRHFDVAHVSTAATSNFSAVRDLCLSECSQHEACLITTLQTQPGAVRCMFYADTQSCTHSLQGQNCRLLLREEATHIYRKPGISLLSYEASVPSVPISTHGRLLGRSQAIQVGTSWKQVDQFLGVPYAAPPLAERRFQAPEPLNWTGSWDASKPRASCWQPGTRTSTSPGVSEDCLYLNVFIPQNVAPNASVLVFFHNTMDREESEGWPAIDGSFLAAVGNLIVVTASYRVGVFGFLSSGSGEVSGNWGLLDQVAALTWVQTHIRGFGGDPRRVSLAADRGGADVASIHLLTARATNSQLFRRAVLMGGSALSPAAVISHERAQQQAIALAKEVSCPMSSSQEVVSCLRQKPANVLNDAQTKLLAVSGPFHYWGPVIDGHFLREPPARALKRSLWVEVDLLIGSSQDDGLINRAKAVKQFEESRGRTSSKTAFYQALQNSLGGEDSDARVEAAATWYYSLEHSTDDYASFSRALENATRDYFIICPIIDMASAWAKRARGNVFMYHAPENYGHGSLELLADVQFALGLPFYPAYEGQFSLEEKSLSLKIMQYFSHFIRSGNPNYPYEFSRKVPTFATPWPDFVPRAGGENYKEFSELLPNRQGLKKADCSFWSKYISSLKTSADGAKGGQSAESEEEELTAGSGLREDLLSLQEPGSKTYSK","Homo sapiens","TG","Thyroglobulin","1","7B75"
"7B7B",,"X-RAY DIFFRACTION",1.98,37.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1021/acsmedchemlett.2c00173",,"7B7B",12.59,"1.4","1.4","BAZ2A bromodomain in complex with triazole compound MS04","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7B7B"
"7B7G",,"X-RAY DIFFRACTION",2.02,39.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1021/acsmedchemlett.2c00173",,"7B7G",12.9,"1.428","1.428","BAZ2A bromodomain in complex with compounds MS04 and B11","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7B7G"
"7B7I",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1021/acsmedchemlett.2c00173",,"7B7I",12.8,"1.15","1.15","BAZ2A bromodomain in complex with triazole compound MS04-TN02","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7B7I"
"7B7R",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were obtained from hanging drops by mixing a 1:1 ratio of protein solution with well solution containing 2 M AmSO4, 0.1 M NaCl and 0.1 M Bis-tris pH 6.1-6.2",293,"10.1021/acsmedchemlett.0c00563",,"7B7R",75,"1.7","1.7","MEK1 in complex with compound 4","MAHHHHHHAAAENLYFQLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 1","1","7B7R"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP2K1, MEK1, PRKMK1"
"7B7V",,"X-RAY DIFFRACTION",2.08,40.81,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris pH 8.5, 0.2 M MgCl2, 34% PEG 4000 in a 1:2 ratio",277,"10.1038/s41467-021-24509-7",,"7B7V",38.05,"1.6","1.6","Structure of NUDT15 in complex with Acyclovir monophosphate","MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL","Homo sapiens","NUDT15, MTH2","Probable 8-oxo-dGTP diphosphatase NUDT15","1","7B7V"
"7B7W",,"X-RAY DIFFRACTION",1.96,37.37,"EVAPORATION",4.2,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate",296,,,"7B7W",44.34,"1.6","1.6","Notum-Fragment049","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B7W"
"7B7X",,"X-RAY DIFFRACTION",2,38.5,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7B7X",44.56,"2.41","2.41","Notum-Fragment063","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B7X"
"7B7Y",,"X-RAY DIFFRACTION",2,38.5,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7B7Y",44.89,"1.48","1.48","Notum-Fragment064","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B7Y"
"7B82",,"X-RAY DIFFRACTION",1.97,37.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1021/acsmedchemlett.2c00173",,"7B82",12.85,"1.25","1.25","BAZ2A bromodomain in complex with triazole compound MS04-TN03","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7B82"
"7B84",,"X-RAY DIFFRACTION",1.98,37.82,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B84",45.7,"1.36","1.36","Notum-Fragment065","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B84"
"7B85",,"X-RAY DIFFRACTION",3.3,62.77,"VAPOR DIFFUSION, HANGING DROP",,"1.6 K-Na-tartrate, 100 mM Na-MES (pH 7.0),
6.2 mg/mL EGFR-WT (im 100 mM NaCl, 25 mM Tris-HCl, 10 % glycerol, 1 mM TCEP, pH 8.0, 1 ul reservoir + 1 ul solution

Soaking-Experiment",293,"10.1021/acs.jmedchem.1c02080",,"7B85",38.66,"2.5","2.5","Crystal Structure of EGFR-WT in Complex with TAK-788","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","7B85"
"7B86",,"X-RAY DIFFRACTION",1.98,37.97,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B86",45.31,"1.4","1.4","Notum-Fragment067","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B86"
"7B87",,"X-RAY DIFFRACTION",1.98,37.72,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B87",44.91,"1.58","1.58","Notum-Fragment074","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B87"
"7B89",,"X-RAY DIFFRACTION",1.98,37.84,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B89",45,"1.84","1.84","Notum-Fragment077","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B89"
"7B8A",,"X-RAY DIFFRACTION",1.99,38.11,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7B8A",44.82,"1.23","1.23","Notum-Fragment 110","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8A"
"7B8C",,"X-RAY DIFFRACTION",1.98,37.99,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8C",44.83,"1.43","1.43","Notum-Fragment 147","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8C"
"7B8D",,"X-RAY DIFFRACTION",1.98,37.93,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8D",44.6,"1.62","1.62","Notum-Fragment 151","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8D"
"7B8F",,"X-RAY DIFFRACTION",1.97,37.47,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8F",44.59,"1.62","1.62","Notum-Fragment 154","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8F"
"7B8G",,"X-RAY DIFFRACTION",1.98,37.93,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8G",44.56,"1.58","1.58","Notum-Fragment 159","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8G"
"7B8H",,"X-RAY DIFFRACTION",1.98,38,"VAPOR DIFFUSION, SITTING DROP",,"1 microliter protein stock solution (8 mg/ml CK2alpha, 2 mM Heparin dodecasaccharide, 285.7 mM NaCl, 15 mM Tris, pH 8.5) was mixed with 2.5 microliter reservoir solution (32 %(w/v) PEG4000, 0.2 M malonate, 0.1 M Tris, pH 7.5). The resulting drop was equilibrated against 800 microliter reservoir solution. After equilibration the crystallization process was initialized by addition of 150 nanoliter micro seeding suspension. CK2alpha/heparin crystals grown in this way were prepared for cryo diffractometry by soaking them into a cryo solution consisting of 32 % (w/v) PEG4000, 0.2 M NaCl, 0.5 mM Heparin dodecasaccharide.",293.15,"10.1016/j.ejmech.2021.113223",,"7B8H",41.71,"1.34","1.34","Monoclinic structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo saccharide","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7B8H"
"7B8I",,"X-RAY DIFFRACTION",3.22,61.78,"VAPOR DIFFUSION, SITTING DROP",,"Prior to crystallization, the enzyme was incubated with heparin decasaccharide; the composition of this preincubation solution was 5 mg/ml CK2alpha1-335, 1.4 mM Heparin decasaccharide, 340 mM NaCl, 25 mM Tris/HCl, pH 8.5. 4 microliter of this enzyme/heparin mixture was mixed with 1 microliter reservoir solution. The composition of the reservoir solution was 32 % (w/v) PEG4000, 0.2 M Lithium sulfate, 0.1 M Tris/HCl, pH 7.5. As a preparation of X-ray diffraction data collection, the crystals were transferred to a cryo solution composed of 32 % (w/v) PEG4000, 10 % (v/v) glycerol, 0.2 M lithium sulfate, 0.5 mM Heparin decasaccharide, 0.1 M Tris/HCl, pH 7.5.",293.15,"10.1016/j.ejmech.2021.113223",,"7B8I",82.84,"2.55","2.55","Tetragonal structure of human protein kinase CK2 catalytic subunit in complex with a heparin oligo saccharide","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","7B8I"
"7B8J",,"X-RAY DIFFRACTION",1.98,37.72,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8J",44.48,"1.75","1.75","Notum-Fragment 163","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8J"
"7B8K",,"X-RAY DIFFRACTION",2,38.36,"EVAPORATION",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8K",44.3,"1.6","1.6","Notum-Fragment 173","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8K"
"7B8L",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8L",44.75,"1.45","1.45","Notum-Fragment 174","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8L"
"7B8M",,"X-RAY DIFFRACTION",2,38.39,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8M",44.42,"1.48","1.48","Notum-Fragment 193","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8M"
"7B8N",,"X-RAY DIFFRACTION",1.98,37.75,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8N",44.95,"1.56","1.56","Notum-Fragment 197","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8N"
"7B8O",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8O",44.92,"1.5","1.5","Notum-Fragment 199","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8O"
"7B8U",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8U",44.53,"1.54","1.54","Notum-Fragment 201","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8U"
"7B8W",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350",277.15,,,"7B8W",146.59,"2.8","2.8","Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470","SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES","Homo sapiens","LIMK1, LIMK","LIM domain kinase 1","1","7B8W"
"7B8X",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8X",44.35,"1.51","1.51","Notum-Fragment 210","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8X"
"7B8Y",,"X-RAY DIFFRACTION",1.99,38.05,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8Y",44.55,"1.57","1.57","Notum-Fragment 276","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8Y"
"7B8Z",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B8Z",44.78,"1.73","1.73","Notum-Fragment 277","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B8Z"
"7B94",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were obtained from hanging drops by mixing a 1:1 ratio of protein solution with well solution containing 2 M AmSO4, 0.1 M NaCl and 0.1 M Bis-tris pH 6.1-6.2",293,"10.1021/acsmedchemlett.0c00563",,"7B94",75.04,"2","2","MEK1 in complex with compound 6","MAHHHHHHAAAENLYFQLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 1","1","7B94"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP2K1, MEK1, PRKMK1"
"7B96",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mg/mL protein in 20mM Tris pH 7.5, 150mM NaCl, 20% (v/v) glycerol and 1mM DTT was added at a 1:1 ratio to the reservoir buffer: 0.2M potassium chloride and 24% (w/v) polyethylene glycol 3350 pH 7.5",293,,,"7B96",60.24,"1.8","1.8","NHL domain of human TRIM2","GPMGEDDLIFRVGTKGRNKGEFTNLQGVAASTNGKILIADSNNQCVQIFSNDGQFKSRFGIRGRSPGQLQRPTGVAVHPSGDIIIADYDNKWVSIFSSDGKFKTKIGSGKLMGPKGVSVDRNGHIIVVDNKACCVFIFQPNGKIVTRFGSRGNGDRQFAGPHFAAVNSNNEIIITDFHNHSVKVFNQEGEFMLKFGSNGEGNGQFNAPTGVAVDSNGNIIVADWGNSRIQVFDGSGSFLSYINTSADPLYGPQGLALTSDGHVVVADSGNHCFKVYRYLQ","Homo sapiens","TRIM2, KIAA0517, RNF86","Isoform 2 of Tripartite motif-containing protein 2","1","7B96"
"7B98",,"X-RAY DIFFRACTION",1.99,38.28,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B98",44.76,"1.53","1.53","Notum Fragment 282","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B98"
"7B99",,"X-RAY DIFFRACTION",2.01,38.86,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B99",44.96,"1.81","1.81","Notum Fragment 283","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B99"
"7B9B",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, SITTING DROP",,"6% PEG20K -- 0.1M bicine pH 7.3",278,"10.1093/nar/gkab692",,"7B9B",38.67,"2.8","2.8","Crystal structure of human 5' exonuclease Appollo APO form","MNGVLIPHTPIAVDFWSLRRAGTARLFFLSHMHSDHTVGLSSTWARPLYCSPITAHLLHRHLQVSKQWIQALEVGESHVLPLDEIGQETMTVTLLDANHCPGSVMFLFEGYFGTILYTGDFRYTPSMLKEPALTLGKQIHTLYLDNTNCNPALVLPSRQEAAHQIVQLIRKHPQHNIKIGLYSLGKESLLEQLALEFQTWVVLSPRRLELVQLLGLADVFTVEEKAGRIHAVDHMEICHSNMLRWNQTHPTIAILPTSRKIHSSHPDIHVIPYSDHSSYSELRAFVAALKPCQVVPIVSRRPCGGFQDSLSPRISVPLIPDSVQQYMSSSSRKPSAENLYFQ","Homo sapiens","DCLRE1B, SNM1B","5' exonuclease Apollo","1","7B9B"
"7B9D",,"X-RAY DIFFRACTION",2.03,39.26,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B9D",44.38,"1.93","1.93","Notum Fragment 290","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B9D"
"7B9H",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Magnesium Chloride, Hepes",293,"10.1016/j.ejmech.2021.113638",,"7B9H",82.09,"1.5","1.5","Crystal structure of the PDE4D catalytic domain in complex with GEBR-42a","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","7B9H"
"7B9I",,"X-RAY DIFFRACTION",2,38.42,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B9I",44.91,"1.34","1.34","Notum Fragment 297","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B9I"
"7B9L",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were obtained from hanging drops by mixing a 1:1 ratio of protein solution with well solution containing 2 M AmSO4, 0.1 M NaCl and 0.1 M Bis-tris pH 6.1-6.2",293,"10.1021/acsmedchemlett.0c00563",,"7B9L",74.93,"1.7","1.7","MEK1 in complex with compound 23","MAHHHHHHAAAENLYFQLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 1","1","7B9L"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP2K1, MEK1, PRKMK1"
"7B9N",,"X-RAY DIFFRACTION",1.99,38.06,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B9N",44.93,"1.38","1.38","Notum Fragment 588","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B9N"
"7B9U",,"X-RAY DIFFRACTION",1.99,38.22,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7B9U",44.72,"1.5","1.5","Notum Fragment 609","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7B9U"
"7B9X",,"SOLUTION NMR",,,,,,,"10.1021/acs.jmedchem.1c01703",,"7B9X",13.19,,,"NMR2 structure of TRIM24-BD in complex with a precursor of IACS-9571","TPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYP","Homo sapiens","TRIM24, RNF82, TIF1, TIF1A","Transcription intermediary factor 1-alpha","1","7B9X"
"7B9Y",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG 3350, 0.1 M HEPES pH 7.5, 0.2M ammonium acetate",293,"10.1021/acs.jmedchem.0c02195",,"7B9Y",15.04,"1.35","1.35","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 64a","HMGAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7B9Y"
"7B9Z",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG3350, 0.1 M HEPES pH 7.5, 0.2 M ammoniumthiocyanat",293,"10.1021/acs.jmedchem.0c02195",,"7B9Z",15.18,"1.44","1.44","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 35-(E)","HMGAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7B9Z"
"7BA0",,"X-RAY DIFFRACTION",1.76,30.04,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG3350, 0.1 M HEPES pH 7.5, 0.2 M ammonium thiocyanate",293,"10.1021/acs.jmedchem.0c02195",,"7BA0",15.04,"1.14","1.14","Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 63","HMGAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEIAHLLIKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","7BA0"
"7BA1",,"X-RAY DIFFRACTION",1.98,38,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BA1",44.5,"1.93","1.93","Notum Fragment 634","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BA1"
"7BAC",,"X-RAY DIFFRACTION",1.97,37.57,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BAC",44.82,"1.54","1.54","Notum Fragment 646","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BAC"
"7BAM","3.5","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107505",,"7BAM",442.1,"3.5",,"human Teneurin4 WT C2","METACGDSKDNDGDGLVDCMDPDCCLQPLCHINPLCLGSPNPLDIIQETQVPVSQQNLHSFYDRIKFLVGRDSTHIIPGENPFDGGHACVIRGQVMTSDGTPLVGVNISFVNNPLFGYTISRQDGSFDLVTNGGISIILRFERAPFITQEHTLWLPWDRFFVMETIIMRHEENEIPSCDLSNFARPNPVVSPSPLTSFASSCAEKGPIVPEIQALQEEISISGCKMRLSYLSSRTPGYKSVLRISLTHPTIPFNLMKVHLMVAVEGRLFRKWFAAAPDLSYYFIWDKTDVYNQKVFGLSEAFVSVGYEYESCPDLILWEKRTTVLQGYEIDASKLGGWSLDKHHALNIQSGILHKGNGENQFVSQQPPVIGSIMGNGRRRSISCPSCNGLADGNKLLAPVALTCGSDGSLYVGDFNYIRRIFPSGNVTNILELRNKDFRHSHSPAHKYYLATDPMSGAVFLSDSNSRRVFKIKSTVVVKDLVKNSEVVAGTGDQCLPFDDTRCGDGGKATEATLTNPRGITVDKFGLIYFVDGTMIRRIDQNGIISTLLGSNDLTSARPLSCDSVMDISQVHLEWPTDLAINPMDNSLYVLDNNVVLQISENHQVRIVAGRPMHCQVPGIDHFLLSKVAIHATLESATALAVSHNGVLYIAETDEKKINRIRQVTTSGEISLVAGAPSGCDCKNDANCDCFSGDDGYAKDAKLNTPSSLAVCADGELYVADLGNIRIRFIRKNKPFLNTQNMYELSSPIDQELYLFDTTGKHLYTQSLPTGDYLYNFTYTGDGDITLITDNNGNMVNVRRDSTGMPLWLVVPDGQVYWVTMGTNSALKSVTTQGHELAMMTYHGNSGLLATKSNENGWTTFYEYDSFGRLTNVTFPTGQVSSFRSDTDSSVHVQVETSSKDDVTITTNLSASGAFYTLLQDQVRNSYYIGADGSLRLLLANGMEVALQTEPHLLAGTVNPTVGKRNVTLPIDNGLNLVEWRQRKEQARGQVTVFGRRLRVHNRNLLSLDFDRVTRTEKIYDDHRKFTLRILYDQAGRPSLWSPSSRLNGVNVTYSPGGYIAGIQRGIMSERMEYDQAGRITSRIFADGKTWSYTYLEKSMVLLLHSQRQYIFEFDKNDRLSSVTMPNVARQTLETIRSVGYYRNIYQPPEGNASVIQDFTEDGHLLHTFYLGTGRRVIYKYGKLSKLAETLYDTTKVSFTYDETAGMLKTINLQNEGFTCTIRYRQIGPLIDRQIFRFTEEGMVNARFDYNYDNSFRVTSMQAVINETPLPIDLYRYDDVSGKTEQFGKFGVIYYDINQIITTAVMTHTKHFDAYGRMKEVQYEIFRSLMYWMTVQYDNMGRVVKKELKVGPYANTTRYSYEYDADGQLQTVSINDKPLWRYSYDLNGNLHLLSPGNSARLTPLRYDIRDRITRLGDVQYKMDEDGFLRQRGGDIFEYNSAGLLIKAYNRAGSWSVRYRYDGLGRRVSSKSSHSHHLQFFYADLTNPTKVTHLYNHSSSEITSLYYDLQGHLFAMELSSGDEFYIACDNIGTPLAVFSGTGLMIKQILYTAYGEIYMDTNPNFQIIIGYHGGLYDPLTKLVHMGRRDYDVLAGRWTSPDHELWKHLSSSNVMPFNLYMFKNNNPISNSQDIKCFMTDVNSWLLTFGFQLHNVIPGYPKPDMDAMEPSYELIHTQMKTQEWDNSKSILGVQCEVQKQLKAFVTLERFDQLYGSTITSCQQAPKTKKFASSGSVFGKGVKFALKDGRVTTDIISVANEDGRRVAAILNHAHYLENLHFTIDGVDTHYFVKPGPSEGDLAILGLSGGRRTLENGVNVTVSQINTVLNGRTRRYTDIQLQYGALCLNTRYGTTLDEEKARVLELARQRAVRQAWAREQQRLREGEEGLRAWTEGEKQQVLSTGRVQGYDGFFVISVEQYPELSDSANNIHFMRQSE","Homo sapiens","TENM4, KIAA1302, ODZ4, TNM4","Teneurin-4","1","7BAM"
"7BAN","2.7","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107505",,"7BAN",442.13,"2.7",,"human Teneurin4 Mut C2","METACGDSKDNDGDGLVDCMDPDCCLQPLCHINPLCLGSPNPLDIIQETQVPVSQQNLHSFYDRIKFLVGRDSTHIIPGENPFDGGHACVIRGQVMTSDGTPLVGVNISFVNNPLFGYTISRQDGSFDLVTNGGISIILRFERAPFITQEHTLWLPWDRFFVMETIIMRHEENEIPSCDLSNFARPNPVVSPSPLTSFASSCAEKGPIVPEIQALQEEISISGCKMRLSYLSSRTPGYKSVLRISLTHPTIPFNLMKVHLMVAVEGRLFRKWFAAAPDLSYYFIWDKTDVYNQKVFGLSEAFVSVGYEYESCPDLILWEKRTTVLQGYEIDASKLGGWSLDKHHALNIQSGILHKGNGENQFVSQQPPVIGSIMGNGRRRSISCPSCNGLADGNKLLAPVALTCGSDGSLYVGDFNYIRRIFPSGNVTNILELRNKDFRHSHSPAHKYYLATDPMSGAVFLSDSNSRRVFKIKSTVVVKDLVKNSEVVAGTGDQCLPFDDTRCGDGGKATEATLTNPRGITVDKFGLIYFVDGTMIRRIDQNGIISTLLGSNDLTSARPLSCDSVMDISQVHLEWPTDLAINPMDNSLYVLDNNVVLQISENHQVRIVAGRPMHCQVPGIDHFLLSKVAIHATLESATALAVSHNGVLYIAETDEKKINRIRQVTTSGEISLVAGAPSGCDCKNDANCDCFSGDDGYAKDAKLNTPSSLAVCADGELYVADLGNIRIRFIRKNKPFLNTQNMYELSSPIDQELYLFDTTGKHLYTQSLPTGDYLYNFTYTGDGDITLITDNNGNMVNVRRDSTGMPLWLVVPDGQVYWVTMGTNSALKSVTTQGHELAMMTYHGNSGLLATKSNENGWTTFYEYDSFGRLTNVTFPTGQVSSFRSDTDSSVHVQVETSSKDDVTITTNLSASGAFYTLLQDQVRNSYYIGADGSLRLLLANGMEVALQTEPHLLAGTVNPTVGKRNVTLPIDNGLNLVEWRQRKEQARGQVTVFGRRLRVHNRNLLSLDFDRVTRTEKIYDDHRKFTLRILYDQAGRPSLWSPSSRLNGVNVTYSPGGYIAGIQRGIMSERMEYDQAGRITSRIFADGKTWSYTYLEKSMVLLLHSQRQYIFEFDKNDRLSSVTMPNVARQTLETIRSVGYYRNIYQPPEGNASVIQDFTEDGHLLHTFYLGTGRRVIYKYGKLSKLAETLYDTTKVSFTYDETAGMLKTINLQNEGFTCTIRYRQIGPLIDRQIFRFTEEGMVNARFDYNYDNSFRVTSMQAVINETPLPIDLYRYDDVSGKTEQFGKFGVIYYDINQIITTAVMTHTKHFDAYGRMKEVQYEIFRSLMYWMTVQYDNMGRVVKKELKVGPYANTTRYSYEYDADGQLQTVSINDKPLWRYSYDLNGNLHLLSPGNSARLTPLRYDIRDRITRLGDVQYKMDEDGFLRQRGGDIFEYNSAGLLIKAYNRAGSWSVRYRYDGLGRRVSSKSSHSHHLQFFYADLTNPTKVTHLYNHSSSEITSLYYDLQGHLFAMELSSGDEFYIACDNIGTPLAVFSGTGLMIKQILYTAYGEIYMDTNPNFQIIIGYHGGLYDPLTKLVHMGRRDYDVLAGRWTSPDHELWKHLSSSNVMPFNLYMFKNNNPISNSQDIKCFMTDVNSWLLTFGFQLHNVIPGYPKPDMDAMEPSYELIHTQMKTQEWDNSKSILGVQCEVQKQLKAFVTLERFDQLYGSTITSCQQAPKTKKFASSGSVFGKGVKFALKDGRVTTDIICVANEDGRRVAAILNHAHYLENLHFTIDGVDTHYFVKPGPSEGDLAILGLSGGRRTLENGVNVTVSQINTVLNGRTRRYTDIQLQYGALCLNTRYGTTLDEEKARVLELARQRAVRQAWAREQQRLREGEEGLRAWTEGEKQQVLSTGRVQGYDGFFVISVEQYPELSDSANNIHFMRQSE","Homo sapiens","TENM4, KIAA1302, ODZ4, TNM4","Teneurin-4","1","7BAN"
"7BAO","2.7","ELECTRON MICROSCOPY",,,,,,,"10.15252/embj.2020107505",,"7BAO",221.07,"2.7",,"human Teneurin4 Mut C1","METACGDSKDNDGDGLVDCMDPDCCLQPLCHINPLCLGSPNPLDIIQETQVPVSQQNLHSFYDRIKFLVGRDSTHIIPGENPFDGGHACVIRGQVMTSDGTPLVGVNISFVNNPLFGYTISRQDGSFDLVTNGGISIILRFERAPFITQEHTLWLPWDRFFVMETIIMRHEENEIPSCDLSNFARPNPVVSPSPLTSFASSCAEKGPIVPEIQALQEEISISGCKMRLSYLSSRTPGYKSVLRISLTHPTIPFNLMKVHLMVAVEGRLFRKWFAAAPDLSYYFIWDKTDVYNQKVFGLSEAFVSVGYEYESCPDLILWEKRTTVLQGYEIDASKLGGWSLDKHHALNIQSGILHKGNGENQFVSQQPPVIGSIMGNGRRRSISCPSCNGLADGNKLLAPVALTCGSDGSLYVGDFNYIRRIFPSGNVTNILELRNKDFRHSHSPAHKYYLATDPMSGAVFLSDSNSRRVFKIKSTVVVKDLVKNSEVVAGTGDQCLPFDDTRCGDGGKATEATLTNPRGITVDKFGLIYFVDGTMIRRIDQNGIISTLLGSNDLTSARPLSCDSVMDISQVHLEWPTDLAINPMDNSLYVLDNNVVLQISENHQVRIVAGRPMHCQVPGIDHFLLSKVAIHATLESATALAVSHNGVLYIAETDEKKINRIRQVTTSGEISLVAGAPSGCDCKNDANCDCFSGDDGYAKDAKLNTPSSLAVCADGELYVADLGNIRIRFIRKNKPFLNTQNMYELSSPIDQELYLFDTTGKHLYTQSLPTGDYLYNFTYTGDGDITLITDNNGNMVNVRRDSTGMPLWLVVPDGQVYWVTMGTNSALKSVTTQGHELAMMTYHGNSGLLATKSNENGWTTFYEYDSFGRLTNVTFPTGQVSSFRSDTDSSVHVQVETSSKDDVTITTNLSASGAFYTLLQDQVRNSYYIGADGSLRLLLANGMEVALQTEPHLLAGTVNPTVGKRNVTLPIDNGLNLVEWRQRKEQARGQVTVFGRRLRVHNRNLLSLDFDRVTRTEKIYDDHRKFTLRILYDQAGRPSLWSPSSRLNGVNVTYSPGGYIAGIQRGIMSERMEYDQAGRITSRIFADGKTWSYTYLEKSMVLLLHSQRQYIFEFDKNDRLSSVTMPNVARQTLETIRSVGYYRNIYQPPEGNASVIQDFTEDGHLLHTFYLGTGRRVIYKYGKLSKLAETLYDTTKVSFTYDETAGMLKTINLQNEGFTCTIRYRQIGPLIDRQIFRFTEEGMVNARFDYNYDNSFRVTSMQAVINETPLPIDLYRYDDVSGKTEQFGKFGVIYYDINQIITTAVMTHTKHFDAYGRMKEVQYEIFRSLMYWMTVQYDNMGRVVKKELKVGPYANTTRYSYEYDADGQLQTVSINDKPLWRYSYDLNGNLHLLSPGNSARLTPLRYDIRDRITRLGDVQYKMDEDGFLRQRGGDIFEYNSAGLLIKAYNRAGSWSVRYRYDGLGRRVSSKSSHSHHLQFFYADLTNPTKVTHLYNHSSSEITSLYYDLQGHLFAMELSSGDEFYIACDNIGTPLAVFSGTGLMIKQILYTAYGEIYMDTNPNFQIIIGYHGGLYDPLTKLVHMGRRDYDVLAGRWTSPDHELWKHLSSSNVMPFNLYMFKNNNPISNSQDIKCFMTDVNSWLLTFGFQLHNVIPGYPKPDMDAMEPSYELIHTQMKTQEWDNSKSILGVQCEVQKQLKAFVTLERFDQLYGSTITSCQQAPKTKKFASSGSVFGKGVKFALKDGRVTTDIICVANEDGRRVAAILNHAHYLENLHFTIDGVDTHYFVKPGPSEGDLAILGLSGGRRTLENGVNVTVSQINTVLNGRTRRYTDIQLQYGALCLNTRYGTTLDEEKARVLELARQRAVRQAWAREQQRLREGEEGLRAWTEGEKQQVLSTGRVQGYDGFFVISVEQYPELSDSANNIHFMRQSE","Homo sapiens","TENM4, KIAA1302, ODZ4, TNM4","Teneurin-4","1","7BAO"
"7BAP",,"X-RAY DIFFRACTION",1.99,38.1,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BAP",44.78,"1.53","1.53","Notum Fragment 648","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BAP"
"7BBO",,"X-RAY DIFFRACTION",2.04,39.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG6000 -- 10% ethylene glycol -- 0.1M tris pH 7.5 -- 0.1M calcium chloride",277,,,"7BBO",30.99,"1.32","1.32","Crystal Structure of the second bromodomain of Pleckstrin homology domain interacting protein (PHIP) in space group P212121","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","7BBO"
"7BBU",,"X-RAY DIFFRACTION",2.04,39.59,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M NH4NO3, 5 mM L-Pro, 2mM NCP26",293.15,,,"7BBU",59.66,"2.19","2.19","Crystal Structure of human Prolyl-tRNA synthetase in complex with NCP26 and L-Proline","SMSGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS1, EPRS, GLNS, PARS, QARS, QPRS, PIG32","Bifunctional glutamate/proline--tRNA ligase","1","7BBU"
"7BC2",,"X-RAY DIFFRACTION",3.42,64.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1021/acsmedchemlett.2c00173",,"7BC2",12.72,"2","2","BAZ2A bromodomain in complex with triazole compound MS04-TN04","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BC2"
"7BC8",,"X-RAY DIFFRACTION",1.97,37.67,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BC8",44.73,"1.74","1.74","Notum Fragment 658","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BC8"
"7BC9",,"X-RAY DIFFRACTION",1.97,37.68,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BC9",44.69,"1.73","1.73","Notum Fragment 690","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BC9"
"7BCC",,"X-RAY DIFFRACTION",1.98,38.02,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCC",44.5,"1.58","1.58","Notum Fragment 705","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCC"
"7BCD",,"X-RAY DIFFRACTION",1.99,38.05,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCD",44.5,"1.51","1.51","Notum Fragment 714","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCD"
"7BCF",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCF",44.52,"1.86","1.86","Notum Fragment 722","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCF"
"7BCH",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCH",44.35,"1.7","1.7","Notum Fragment 772","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCH"
"7BCI",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCI",44.63,"1.94","1.94","Notum Fragment 784","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCI"
"7BCK",,"X-RAY DIFFRACTION",2,38.55,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCK",43.99,"1.7","1.7","Notum Fragment 791","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCK"
"7BCL",,"X-RAY DIFFRACTION",2.01,38.83,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BCL",44.25,"1.84","1.84","Notum Fragment 792","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BCL"
"7BCM",,"X-RAY DIFFRACTION",2.74,55.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG10,000
0.1 M HEPES pH 7.5",277,"10.1021/acs.jmedchem.1c00868",,"7BCM",72.75,"2.3","2.3","The DDR1 Kinase Domain Bound To SR302","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","7BCM"
"7BCQ","3.43","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2104093118",,"7BCQ",170.85,"3.43",,"ASCT2 in the presence of the inhibitor Lc-BPE (position ""up"") in the outward-open conformation.","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","7BCQ"
"7BCS","3.43","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2104093118",,"7BCS",170.85,"3.43",,"ASCT2 in the presence of the inhibitor Lc-BPE (position ""down"") in the outward-open conformation.","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","7BCS"
"7BCT","3.37","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2104093118",,"7BCT",169.92,"3.37",,"ASCT2 in the presence of the inhibitor ERA-21 in the outward-open conformation.","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","7BCT"
"7BD2",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD2",44.45,"1.52","1.52","Notum Fragment 810","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD2"
"7BD3",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION, SITTING DROP",,"ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRW
LLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFI
PYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLL
NVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNG
VVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGL
RLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHD
SHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH",296,"10.1021/acschemneuro.2c00325",,"7BD3",44.47,"1.91","1.91","Notum Fragment 823","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD3"
"7BD4",,"X-RAY DIFFRACTION",1.97,37.55,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD4",44.42,"1.8","1.8","Notum Fragment 828","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD4"
"7BD5",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, SITTING DROP",,".5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD5",44.16,"1.69","1.69","Notum Fragment 830","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD5"
"7BD6",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD6",44.5,"1.7","1.7","Notum Fragment 863","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD6"
"7BD8",,"X-RAY DIFFRACTION",1.99,38.28,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD8",44.63,"1.42","1.42","Notum Fragment 872","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD8"
"7BD9",,"X-RAY DIFFRACTION",2,38.44,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BD9",44.38,"1.59","1.59","Notum Fragment 886","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BD9"
"7BDA",,"X-RAY DIFFRACTION",1.99,38.07,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDA",44.69,"1.47","1.47","Notum Fragment 900","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDA"
"7BDB",,"X-RAY DIFFRACTION",1.97,37.64,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDB",44.39,"1.46","1.46","Notum Fragment 916","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDB"
"7BDC",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDC",44.59,"1.32","1.32","Notum Fragment 923","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDC"
"7BDD",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDD",44.4,"1.47","1.47","Notum Fragment 924","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDD"
"7BDE",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, Glycerol, BisTris Propane",293,"10.1016/j.jbc.2021.100928",,"7BDE",16.1,"2.044","2.044","HUMAN BCL6 BTB-DOMAIN IN COMPLEX WITH GSK137","GSADSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASEDYKDDDDK","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","Isoform 2 of B-cell lymphoma 6 protein","1","7BDE"
"7BDF",,"X-RAY DIFFRACTION",1.98,37.93,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDF",44.39,"1.4","1.4","Notum Fragment 927","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDF"
"7BDG",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDG",44.55,"1.6","1.6","Notum Fragment 934","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDG"
"7BDH",,"X-RAY DIFFRACTION",1.98,37.79,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,"10.1021/acschemneuro.2c00325",,"7BDH",44.54,"1.54","1.54","Notum Fragment 955","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BDH"
"7BE3",,"X-RAY DIFFRACTION",2.07,40.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"32% PEG 4000, 100 mM Tris-HCl pH 7.5, 100 mM Magnesium chloride, 8 mM beta-mercaptoethanol",277,"10.1002/chem.202100800",,"7BE3",16.29,"1.25","1.25","Human Galectin-3 in complex with LacdiNAc","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","7BE3"
"7BE6",,"X-RAY DIFFRACTION",2.55,51.71,"VAPOR DIFFUSION",,"20% PEG 3350, 10% ethylene glycol, 0.1 M BisTrisPropane pH 6.5, 0.2 M sodium sulfate (50 nL protein and 100 nL reservoir)",293,"10.1021/acs.jmedchem.1c00868",,"7BE6",37.04,"1.87081933411","1.87081933411","Structure of DDR1 receptor tyrosine kinase in complex with inhibitor SR159","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","7BE6"
"7BEA",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2 M Sodium citrate tribasic dihydrate
0.01 M Sodium borate, pH 8.5",298,"10.1021/acsmedchemlett.1c00033",,"7BEA",29.82,"2.45","2.45","Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","7BEA"
"7BED",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"26% PEG 3350, 100mM Bis-Tris pH 5.5, 50mM (NH4)2SO4,WDR5 at 14,65 mg/ml with 2:1 (protein:well) drop ratio.",294,"10.1093/nar/gkab1094",,"7BED",73.37,"1.26","1.26","X-ray structure of WDR5 bound to the WDR5 win motif peptide","MATEEKKPETEAARAQPTPSSSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","7BED"
"7BEQ",,"ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1038/s41467-021-22590-6",,"7BEQ",17.83,"3","3","MicroED structure of the MyD88 TIR domain higher-order assembly","MGHMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLPLEHHHHHH","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","7BEQ"
"7BER",,"X-RAY DIFFRACTION",2.31,46.65,"BATCH MODE",,"MAL TIR (0.5-3 mM) incubated with MyD88 TIR (60-100 mM) in 10 mM HEPES pH 7.5-8, 150 mM NaCl at 310K",310,"10.1038/s41467-021-22590-6",,"7BER",17.83,"2.3","2.3","SFX structure of the MyD88 TIR domain higher-order assembly (solved, rebuilt and refined using an identical protocol to the MicroED structure of the MyD88 TIR domain higher-order assembly)","MGHMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLPLEHHHHHH","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","7BER"
"7BEU",,"X-RAY DIFFRACTION",2.23,44.92,"VAPOR DIFFUSION, HANGING DROP",7.2,"HEPES 0.1 M (pH: 7.2), PEG 6000 18% (w/v) and ammonium chloride 0.2 M",289,"10.3390/ijms23073606",,"7BEU",103.15,"1.59","1.59","Human glutathione transferase M1-1","MPMILGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQTMDNHMQLGMICYNPEFEKLKPKYLEELPEKLKLYSEFLGKRPWFAGNKITFVDFLVYDVLDLHRIFEPKCLDAFPNLKDFISRFEGLEKISAYMKSSRFLPRPVFSKMAVWGNK","Homo sapiens","GSTM1, GST1","Glutathione S-transferase Mu 1","1","7BEU"
"7BEV",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.1c00052",,"7BEV",14.53,,,"NMR structure of an optimized version of the first TPR domain of the human SPAG1 protein","GPHMDYLATREKEKGNEAFNSGDYEEAVMYYTRSISALPTVVAYNNRAQAYIKLQNWNSAEQDCEKVLELEPGNVKALLRRATAYKHQNKLREAREDLKKVLKVEPDNDLAKKTLSEVERDLKNSE","Homo sapiens","SPAG1","Sperm-associated antigen 1","1","7BEV"
"7BFA",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, HANGING DROP",8,"1.5-1.7 M sodium citrate
0.1 M Tris pH 8.0",296,"10.1021/acs.jmedchem.1c00840",,"7BFA",29.91,"1.6","1.6","4-(2-(3-(4-iodophenyl)thioureido)ethyl)benzenesulfonamide in complex with Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7BFA"
"7BFZ",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, HANGING DROP",8,"34% (v/v) pentaerythritol propoxylate PO/OH 5/4
1 % (w/v) PEG 3350 
100 mM Tris-HCl, pH 8.0",293,"10.1038/s41467-021-25746-6",,"7BFZ",84.54,"1.73","1.73","X-ray structure of human prostate-specific membrane antigen(PSMA) in complex with a inhibitor Glu-490","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","7BFZ"
"7BG5",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M sodium citrate, 0.1 M Tris pH 8.0",296,"10.1021/acs.jmedchem.1c00840",,"7BG5",29.89,"1.428","1.428","4-(2-(3-(4-iodophenyl)ureido)ethyl)benzenesulfonamide in complex with Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7BG5"
"7BGC",,"X-RAY DIFFRACTION",3.2,61.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES PH 6.5, 2.1 M AMMONIUM SULFATE",293,"10.1021/acs.jmedchem.1c00048",,"7BGC",64.04,"2.4","2.4","human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7BGC"
"7BHH",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, HANGING DROP",8,"1.5-1.7 M sodium citrate, 0.1 M Tris pH 8.0",296,"10.1021/acs.jmedchem.1c00840",,"7BHH",29.95,"1.4","1.4","4-(2-(3-(4-iodophenyl)selenoureido)ethyl)benzenesulfonamide in complex with Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7BHH"
"7BHR",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHR",44.52,"1.08","1.08","Crystal structure of MAT2a with triazinone fragment 1 bound in the allosteric site","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHR"
"7BHS",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHS",44.6,"1.05","1.05","Crystal structure of MAT2a with quinazoline fragment 2 bound in the allosteric site","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHS"
"7BHT",,"X-RAY DIFFRACTION",2.12,42.02,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHT",44.67,"1.052","1.052","Crystal structure of MAT2a with quinazolinone fragment 5 bound in the allosteric site","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHT"
"7BHU",,"X-RAY DIFFRACTION",2.14,42.65,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHU",44.66,"1.15","1.15","Crystal structure of MAT2a with elaborated fragment 26 bound in the allosteric site","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHU"
"7BHV",,"X-RAY DIFFRACTION",2.13,42.28,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHV",44.63,"1.16","1.16","Crystal structure of MAT2a bound to allosteric inhibitor and in vivo tool compound 28","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHV"
"7BHW",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHW",44.65,"1.15","1.15","Crystal structure of MAT2a bound to allosteric inhibitor (compound 29)","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHW"
"7BHX",,"X-RAY DIFFRACTION",2.13,42.27,"VAPOR DIFFUSION",8,"8-12 % PEG8000, 8-12 % ethylene glycol, 0.1 M HEPES pH 8.0; soaked with 0.01 M compound (10 % DMSO)",293,"10.1021/acs.jmedchem.1c00067",,"7BHX",44.75,"1.08","1.08","Crystal structure of MAT2a bound to allosteric inhibitor (compound 31)","QSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","7BHX"
"7BI5",,"X-RAY DIFFRACTION",2.08,40.94,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 0.1 M Tris-HCl",293,"10.1016/j.bbrc.2021.02.067",,"7BI5",29.46,"1.74","1.74","Human CA II in complex with benzyl alcohol","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","7BI5"
"7BIA",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MES pH 6.0, 25% PEG8000, 0.02M CaCl2, 5mM DTT",293,"10.1016/j.foodchem.2022.132798",,"7BIA",47.92,"1.73","1.73","Crystal structure of human GSTP1 bound to iberin","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","7BIA"
"7BIB",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, HANGING DROP",,"Tris-HCl 0.1M pH 7.5, PEG4000 18%",293,"10.1016/j.foodchem.2022.132798",,"7BIB",52.24,"2.03","2.03","Crystal structure of human GSTA1-1 bound to the glutathione adduct of hexyl-isothiocyanate","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","7BIB"
"7BIC",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"Tris-HCl 0.1M pH 7.5, PEG4000 18%",293,"10.1016/j.foodchem.2022.132798",,"7BIC",102.78,"2.46","2.46","Crystal structure of human GSTA1-1 bound to allyl-isothiocyanate","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","7BIC"
"7BIK",,"X-RAY DIFFRACTION",2.89,57.41,"VAPOR DIFFUSION, HANGING DROP",5.6,"2 M ammonium sulphate, 0.1 M 
Sodium citrate tribasic pH 5.6",277.15,,,"7BIK",39.98,"2.1","2.1","Crystal structure of YTHDF2 in complex with m6Am","MGSSYHHHHHHSSGENLYFQHMKHGRVFIIKSYSEDDIHRSIKYNIWCSTEHGNKRLDAAYRSMNGKGPVYLLFSVNGSGHFCGVAEMKSAVDYNTCAGVWSQDKWKGRFDVRWIFVKDVPNSQLRHIRLENNENKPVTNSRDTQEVPLEKAKQVLKIIASYKHTTS","Homo sapiens","YTHDF2, HGRG8","YTH domain-containing family protein 2","1","7BIK"
"7BIR",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"2M (NH4)2SO4
5% PEG 400
.1M pH=6.5 Na MES/HCl",277,"10.1021/acs.jmedchem.0c02188",,"7BIR",11.93,"2.02","2.02","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BIR"
"7BIT",,"X-RAY DIFFRACTION",2.87,57.16,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5M (NH4)2SO4
15% Glycerol
.1M pH=8.5 Tris Cl/NaOH",277,"10.1021/acs.jmedchem.0c02188",,"7BIT",13.46,"2.13","2.13","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BIT"
"7BIV",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION, SITTING DROP",6,"2.4M (NH4)2SO4
.1M pH=6 MES/NaOH",277,"10.1021/acs.jmedchem.0c02188",,"7BIV",12.13,"1.64","1.64","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BIV"
"7BJ0",,"X-RAY DIFFRACTION",3.81,67.7,"VAPOR DIFFUSION, SITTING DROP",,"2.2M (NH4)2SO4",277,"10.1021/acs.jmedchem.0c02188",,"7BJ0",26.8,"2","2","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMAEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BJ0"
"7BJ1",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, HANGING DROP",8.25,"Protein: 50 mM Tris, 150 mM NaCl, 1 mM (S)-diperodon, 10% DMSO, pH 8.0; reservoir: 100 mM Tris, 50 mM magnesium acetate, 11% PEG3350, pH 8.25",293,,,"7BJ1",50.75,"1.61","1.61","Crystal structure of SMYD3 with diperodon S enantiomer bound to allosteric site","GSHMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","7BJ1"
"7BJ6",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION, SITTING DROP",6,"2.4M (NH4)2SO4
.1M pH=6 MES/NaOH",277,"10.1021/acs.jmedchem.0c02188",,"7BJ6",12.22,"1.59","1.59","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BJ6"
"7BJD",,"X-RAY DIFFRACTION",2.3,46.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJD",34.5,"2","2","Crystal structure of CHK1-10pt-mutant complex with compound 3","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJD"
"7BJE",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJE",34.26,"1.8","1.8","Crystal structure of CHK1-10pt-mutant complex with adenine","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJE"
"7BJH",,"X-RAY DIFFRACTION",2.33,47.1,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJH",34.29,"1.8","1.8","Crystal structure of CHK1-10pt-mutant complex with compound 8","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJH"
"7BJJ",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJJ",34.26,"1.8","1.8","Crystal structure of CHK1-10pt-mutant complex with compound 9","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJJ"
"7BJM",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJM",34.39,"2.3","2.3","Crystal structure of CHK1-10pt-mutant complex with compound 10","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJM"
"7BJO",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJO",34.38,"2.3","2.3","Crystal structure of CHK1-10pt-mutant complex with compound 13","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJO"
"7BJR",,"X-RAY DIFFRACTION",2.33,47.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJR",34.35,"1.9","1.9","Crystal structure of CHK1-10pt-mutant complex with compound 18","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJR"
"7BJX",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BJX",68.89,"2.4","2.4","Crystal structure of CHK1-10pt-mutant complex with compound 26","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BJX"
"7BJY",,"X-RAY DIFFRACTION",3.6,65.79,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M NaCl, 0.1 M Bis-Tris pH5.5, 25% w/v PEG 3,350",291,"10.1021/acs.jmedchem.1c01096",,"7BJY",27.85,"2.22","2.22","Crystal structure of the first bromodomain (BD1) of human BRDT bound to Ro3280","GAASTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Isoform 2 of Bromodomain testis-specific protein","1","7BJY"
"7BK1",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BK1",34.53,"2","2","Crystal structure of CHK1-10pt-mutant complex with compound 32","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BK1"
"7BK2",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BK2",34.59,"2","2","Crystal structure of CHK1-10pt-mutant complex with compound 44","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BK2"
"7BK3",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"7% PEG 8000, 0.1 M MES buffer pH 6.5, 20% ethylene glycol",293,"10.1021/acs.jmedchem.1c00720",,"7BK3",34.59,"2","2","Crystal structure of CHK1-10pt-mutant complex with compound 45","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICILKMLNHENVIKFYGHRREGNIQYLFMELASGGSLFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPHNLLLDERDNLKIADYSLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BK3"
"7BKG",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",,"Human NNMT was crystallized using the following conditions: A protein solution with 6 mg/ml NNMT, 50 mM Tris/HCL, pH 8.0, 1 mM DTT, 86uM S-Adenosyl-L-Homocysteine (SAH), 0.95mM ligand and 5% v/v glycerol was equilibrated at room temperature in a hanging drop setup against 2.2 M ammonium sulfate with 0.1 M HEPES/Na, pH 7.6. Small crystal appeared after 1-2 weeks.",293,"10.3390/molecules26040991",,"7BKG",128.16,"2.326","2.326","Co-crystal structure of Human Nicotinamide N-methyltransferase (NNMT) with the tricyclic inhibitor (2)","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","7BKG"
"7BKN",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-30% PEG8K
0.1M HEPES pH 7.5
15% isopropanol",298,"10.1021/acs.jmedchem.1c00720",,"7BKN",34.38,"2.74","2.74","Crystal structure of CHK1 complex with adenine","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BKN"
"7BKO",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-30% PEG8K
0.1M HEPES pH 7.5
15% isopropanol",298,"10.1021/acs.jmedchem.1c00720",,"7BKO",34.28,"2.3","2.3","Crystal structure of CHK1 complex with compound 9","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","7BKO"
"7BL8",,"X-RAY DIFFRACTION",3.48,64.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BL8",12.74,"2.5","2.5","BAZ2A bromodomain in complex with the chemical probe BAZ2-ICR","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BL8"
"7BL9",,"X-RAY DIFFRACTION",1.95,36.77,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BL9",12.81,"1.3","1.3","BAZ2A bromodomain in complex with GSK2801 chemical probe","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BL9"
"7BLA",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BLA",12.82,"1.086","1.086","BAZ2A bromodomain in complex with TP-238 chemical probe","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BLA"
"7BLB",,"X-RAY DIFFRACTION",3.45,64.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BLB",12.74,"2.3","2.3","BAZ2A bromodomain in complex with GSK4027 chemical probe","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRHRLSRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BLB"
"7BLC",,"X-RAY DIFFRACTION",3.4,63.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BLC",13.32,"2.3","2.3","BAZ2A bromodomain in complex with compound UP39","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BLC"
"7BLD",,"X-RAY DIFFRACTION",3.41,63.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,,,"7BLD",12.94,"2.35","2.35","BAZ2A bromodomain in complex with compound UZH23","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","7BLD"
"7BLE",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, HANGING DROP",,"Human NNMT was crystallized using the following conditions: A protein solution with 6 mg/ml NNMT, 50 mM Tris/HCL, pH 8.0, 1 mM DTT, 86uM S-Adenosyl-L-Homocysteine (SAH), 0.95mM inhibitor and 5% v/v glycerol was equilibrated at room temperature in a hanging drop setup against 2.2 M ammonium sulfate with 0.1 M HEPES/Na, pH 7.6. Small crystal appeared after 1-2 weeks.",293,"10.3390/molecules26040991",,"7BLE",128.21,"2.809","2.809","Co-crystal structure of Human Nicotinamide N-methyltransferase (NNMT) with the tricyclic inhibitor (3)","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","7BLE"
"7BLI",,"X-RAY DIFFRACTION",2.01,38.84,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BLI",44.79,"1.47","1.47","Notum-Bepridil complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BLI"
"7BLS",,"X-RAY DIFFRACTION",1.94,36.51,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BLS",44.73,"1.19","1.19","Notum-maybridge_18","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BLS"
"7BLT",,"X-RAY DIFFRACTION",1.94,36.5,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BLT",44.53,"1.2","1.2","Notum_Maybridge_4","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BLT"
"7BLU",,"X-RAY DIFFRACTION",1.95,36.8,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BLU",44.73,"1.21","1.21","Notum_Maybridge_56","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BLU"
"7BLW",,"X-RAY DIFFRACTION",2,38.52,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BLW",44.71,"1.45","1.45","Notum_Piperine complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BLW"
"7BM1",,"X-RAY DIFFRACTION",2.02,39.1,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BM1",45.41,"1.37","1.37","Notum_Valsartan complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BM1"
"7BM3",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BM3",45.98,"1.4","1.4","Notum Rosmarinic acid complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BM3"
"7BM5",,"X-RAY DIFFRACTION",2.77,55.55,"VAPOR DIFFUSION, SITTING DROP",6,"0.16 M lithium chloride, 22% (w/v) PEG6000, 0.1 M MES pH 6.0",293,"10.1038/s41467-021-24432-x",,"7BM5",288.86,"2.95","2.95","Crystal structure of Fab1, the Fab fragment of the anti-BamA monoclonal antibody MAB1","DIQMTQSPASLSASLGETVTIECRASEDIHSRLAWYQQKPGKSPQLLIYNANSLHTGVPSRFSGSGSGTQFSLKINSLQSEDVASYFCLQYYNYPPYTFGAGAKLELRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab1 light chain","1","7BM5"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGRSLKLSCVASRFTFSNYGMNWIRQTPGKGLEWVAYIGSTSSHIYYAETVKGRFTISRDNAKNTLYLQMTGLRSEDTALYYCVGHVRKLGAFFDYWGQGAMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"Fab1 heavy chain","2","7BM5"
"7BM7",,"X-RAY DIFFRACTION",1.92,36.01,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BM7",44.56,"1.87","1.87","Notum fragment 5e","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BM7"
"7BMB",,"X-RAY DIFFRACTION",1.93,36.33,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BMB",44.76,"1.83","1.83","Notum PPOH complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BMB"
"7BMD",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BMD",45.51,"1.45","1.45","Notum TDZD8 complex","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BMD"
"7BMG",,"X-RAY DIFFRACTION",3.32,62.91,"VAPOR DIFFUSION, SITTING DROP",,"2.2M (NH4)2SO4",277,"10.1021/acs.jmedchem.0c02188",,"7BMG",11.88,"1.83","1.83","Inhibitor of MDM2-p53 Interaction","GPLGSSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDAAQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","7BMG"
"7BMK",,"X-RAY DIFFRACTION",3.01,59.16,"VAPOR DIFFUSION",6,"10.00  %v/v  2-PropOH
 13.00  %w/v  PEG 4K
  0.10   M  Na3 Cit",279,"10.1038/s41589-021-00852-0",,"7BMK",102.92,"1.85","1.85","ATP-Competitive Partial Antagonists-'PAIR's-Rheostatically Modulate IRE1alpha's Kinase Helix-alphaC to Segregate its RNase-Mediated Biological Outputs","GAMGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","7BMK"
"7BN5",,"X-RAY DIFFRACTION",1.92,35.97,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BN5",44.39,"2.22","2.22","Notum fragment_1 (2-(isoquinolin-1-ylsulfanyl)acetic acid)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BN5"
"7BN8",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BN8",44.4,"1.78","1.78","Notum fragment_3 (4H,5H-naphtho[1,2-b]thiophene-2-carboxylic acid)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BN8"
"7BNB",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNB",44.83,"1.16","1.16","Notum fragment_50 (3-(quinazolin-4-ylsulfanyl)propanoic acid)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNB"
"7BNC",,"X-RAY DIFFRACTION",1.92,36.04,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNC",44.8,"1.86","1.86","Notum fragment_126 (2-(1,2-dihydroacenaphthylen-5-ylsulfanyl)acetic acid)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNC"
"7BND",,"X-RAY DIFFRACTION",1.95,36.78,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BND",44.7,"2.1","2.1","Notum_Fragment41 (N-methyl-4,5-dihydronaphtho,2-bthiophene-2-carboxamide)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BND"
"7BNE",,"X-RAY DIFFRACTION",1.94,36.56,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNE",44.33,"1.7","1.7","Notum Nicotine","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNE"
"7BNF",,"X-RAY DIFFRACTION",1.95,36.79,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNF",45.28,"1.45","1.45","Notum Cotinine","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNF"
"7BNJ",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNJ",45.43,"1.49","1.49","Notum Riluzole","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNJ"
"7BNL",,"X-RAY DIFFRACTION",1.93,36.13,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BNL",45.04,"1.23","1.23","Notum ARUK3003710","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BNL"
"7BO1",,"X-RAY DIFFRACTION",2,38.49,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BO1",44.96,"1.4","1.4","Notum Fragment_274 [(4-fluorophenyl)amino]thiourea","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BO1"
"7BO2",,"X-RAY DIFFRACTION",2.01,38.71,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BO2",45.14,"1.21","1.21","Notum Fragment_130 (4H-thieno[3,2-c]chromene-2-carboxylic acid)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BO2"
"7BO3",,"X-RAY DIFFRACTION",3.19,61.42,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1016/j.ejmech.2022.114248",,"7BO3",63.05,"2.2","2.2","Human Butyrylcholinesterase in complex with N-(2-(1H-Indol-3-yl)ethyl)-2-cycloheptyl-N-methylethan-1-amine","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7BO3"
"7BO4",,"X-RAY DIFFRACTION",3.19,61.41,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1016/j.ejmech.2022.114248",,"7BO4",63.66,"2.401","2.401","Human Butyrylcholinesterase in complex with 3-(2-(butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-6-ol","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","7BO4"
"7BO5",,"X-RAY DIFFRACTION",1.93,36.39,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Ammonium Sulphate
0.1 M Sodium Citrate, pH4.2",296,,,"7BO5",44.73,"1.38","1.38","Notum Fragment_130_methyEster (methyl 4H-thieno[3,2-c]chromene-2-carboxylate)","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","7BO5"
"7BOL",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, SITTING DROP",,"0.5 M Ammonium sulfate
0.1 M Sodium citrate  pH 5.6
1.0 M Lithium sulfate",291,"10.1111/febs.16360",,"7BOL",16.84,"1.797","1.797","ubiquitin-conjugating enzyme, Ube2D2","SMALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM","Homo sapiens","UBE2D2, PUBC1, UBC4, UBC5B, UBCH4, UBCH5B","Ubiquitin-conjugating enzyme E2 D2","1","7BOL"
"7BP3","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16334-1",,"7BP3",107.84,"3.8",,"Cryo-EM structure of the human MCT2","MPPMPSAPPVHPPPDGGWGWIVVGAAFISIGFSYAFPKAVTVFFKEIQQIFHTTYSEIAWISSIMLAVMYAGGPVSSVLVNKYGSRPVVIAGGLLCCLGMVLASFSSSVVQLYLTMGFITGLGLAFNLQPALTIIGKYFYRKRPMANGLAMAGSPVFLSSLAPFNQYLFNTFGWKGSFLILGSLLLNACVAGSLMRPLGPNQTTSKSKNKTGKTEDDSSPKKIKTKKSTWEKVNKYLDFSLFKHRGFLIYLSGNVIMFLGFFAPIIFLAPYAKDQGIDEYSAAFLLSVMAFVDMFARPSVGLIANSKYIRPRIQYFFSFAIMFNGVCHLLCPLAQDYTSLVLYAVFFGLGFGSVSSVLFETLMDLVGAPRFSSAVGLVTIVECGPVLLGPPLAGKLVDLTGEYKYMYMSCGAIVVAASVWLLIGNAINYRLLAKERKEENARQKTRESEPLSKSKHSEDVNVKVSNAQSVTSERETNIVEGGSSGGWSHPQFEK","Homo sapiens","SLC16A7, MCT2","Monocarboxylate transporter 2","1","7BP3"
"7BP8","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41418-022-01000-4",,"7BP8",541.57,"3.9, 3.9",,"Human AAA+ ATPase VCP mutant - T76A, ADP-bound form","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDACSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","7BP8"
"7BP9","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41418-022-01000-4",,"7BP9",541.92,"3.6, 3.6",,"Human AAA+ ATPase VCP mutant - T76E, ADP-bound form","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDECSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","7BP9"
"7BPA","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41418-022-01000-4",,"7BPA",542.04,"3.3, 3.3",,"Human AAA+ ATPase VCP mutant - T76A, AMP-PNP-bound form, Conformation I","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDACSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","7BPA"
"7BPB","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41418-022-01000-4",,"7BPB",542.39,"4.3, 4.3",,"Human AAA+ ATPase VCP mutant - T76E, AMP-PNP bound form, Conformation I","MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDECSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","7BPB"
"7BPI",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes (pH 7.5), 0.2 M MgCl2, 18% PEG 3350, 50 mM 2-mercaptoethanol",277,"10.1016/j.apsb.2020.04.003",,"7BPI",75.28,"2.40008632403","2.40008632403","The crystal structue of PDE10A complexed with 14","SICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","7BPI"
"7BPR",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION",,"27% (w/v) PEG3350, 0.1 M MES pH 6.3, 0.2 M potassium iodide",293,"10.1002/1873-3468.13875",,"7BPR",46.71,"1.95","1.95","Crystal structure of human TEX101","RSPWLYCQKGLSMTVEADPANMFNWTTEEVETCDKGALCQETILIIKAGTETAILATKGCIPEGEEAITIVQHSSPPGLIVTSYSNYCEDSFCNDKDSLSQFWEFSETTASTVSTTLHCPTCVALGTCFSAPSLPCPNGTTRCYQGKLEITGGGIESSVEVKGCTAMIGCRLMSGILAVGPMFVREACPHQLLTQPRKTENEFLEVLFQ","Homo sapiens","TEX101, SGRG, UNQ867/PRO1884","Testis-expressed protein 101","1","7BPR"
"7BQI",,"X-RAY DIFFRACTION",1.98,37.83,"VAPOR DIFFUSION, SITTING DROP",,"20% (w/v) PEG 3350, 180mM tri-ammonium citrate",277,"10.1107/S2053230X20009012",,"7BQI",20.87,"1.3","1.3","Crystal structure of FYCO1 RUN domain","GPLGSMASTNAESQLQRIIRDLQDAVTELSKEFQEAGEPITDDSTSLHKFSYKLEYLLQFDQKEKATLLGNKKDYWDYFCACLAKVKGANDGIRFVKSISELRTSLGKGRAFIRYSLVHQRLADTLQQCFMNTKVTSDWYYARSPFLQPKLSSDIVGQLYELTEVQFDLASRGFDLDAAWPTF","Homo sapiens","FYCO1, ZFYVE7","FYVE and coiled-coil domain-containing protein 1","1","7BQI"
"7BSJ",,"X-RAY DIFFRACTION",2.57,52.1,"EVAPORATION",,"8.64% PEG 20000, 2.4% MPD, 100mM MES",293,"10.1016/j.isci.2021.102034",,"7BSJ",130.24,"2.48","2.48","Crystal structure of human ME2 R484W","MHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIETQDIQALRFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLACSQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIPVGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMKAITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISKPISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALSNPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVILCNTWHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMAFRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE","Homo sapiens","ME2","NAD-dependent malic enzyme, mitochondrial","1","7BSJ"
"7BSK",,"X-RAY DIFFRACTION",2.62,53,"EVAPORATION",6.5,"PEG20000 6.575%
MPD(v/v) 5%
MES (pH=6.5)",293,"10.1016/j.isci.2021.102034",,"7BSK",129.61,"2.55","2.55","Crystal structure of human ME2 R67Q mutant","MHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIETQDIQALQFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLACSQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIPVGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMKAITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISKPISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALSNPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVILCNTRHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMAFRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE","Homo sapiens","ME2","NAD-dependent malic enzyme, mitochondrial","1","7BSK"
"7BSL",,"X-RAY DIFFRACTION",2.63,53.26,"EVAPORATION",6.5,"PEG20000 7%
MPD(v/v) 5%
MES",293,"10.1016/j.isci.2021.102034",,"7BSL",129.49,"2.55","2.55","Crystal Structure of human ME2 R67A mutant","MHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIETQDIQALAFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLACSQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIPVGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMKAITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISKPISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALSNPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVILCNTRHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMAFRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE","Homo sapiens","ME2","NAD-dependent malic enzyme, mitochondrial","1","7BSL"
"7BSO",,"X-RAY DIFFRACTION",1.66,25.95,"VAPOR DIFFUSION, HANGING DROP",,"20%(w/v) PEG MME 2,000
0.1M Tris pH 8.5
0.2M Trimethylamine n-oxide",295,"10.1002/1873-3468.13866",,"7BSO",12.81,"2.08","2.08","Crystal structure of the human NLRP9 pyrin domain","MAESFFSDFGLLWYLKELRKEEFWKFKELLKQPLEKFELKPIPWAELKKASKEDVAKLLDKHYPGKQAWEVTLNLFLQINRKDLWTKAQEEMRNKLLEHHHHHH","Homo sapiens","NLRP9, NALP9, NOD6, PAN12","NACHT, LRR and PYD domains-containing protein 9","1","7BSO"
"7BT2",,"X-RAY DIFFRACTION",3.64,66.24,"VAPOR DIFFUSION, HANGING DROP",7.2,"5% glycerol, 20-23% PEG1500, 5 mM MgSO4, 6 mM EGTA, 6% 2-methyl-2,4-pentanediol (MPD) and 100 mM MOPS pH 7.2",283,"10.1073/pnas.2006027117",,"7BT2",113.61,"3.00002849524","3.00002849524","Crystal structure of the SERCA2a in the E2.ATP state","MENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPAILE","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","7BT2"
"7BTA",,"X-RAY DIFFRACTION",1.82,32.3,"EVAPORATION",8,"0.2 M NaH2PO4: 16% PEG 3350",290,"10.1093/jmcb/mjaa025",,"7BTA",41.4,"2.6","2.6","Crystal structure of Rheb D60K mutant bound to GDP","MPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSYDPTIENTFTKLITVNGQEYHLQLVKTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLEHHHHHH","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","7BTA"
"7BTC",,"X-RAY DIFFRACTION",2.17,43.21,"EVAPORATION",5.5,"0.10% n-Octyl-beta-D-glucoside: 0.1 M Sodium citrate tribasic, pH 5.5: 22% PEG 3350",290,"10.1093/jmcb/mjaa025",,"7BTC",82.17,"2.101","2.101","Crystal structure of Rheb Y35N mutant bound to GDP","MPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSNDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLEHHHHHH","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","7BTC"
"7BTD",,"X-RAY DIFFRACTION",2.98,58.77,"EVAPORATION",7.5,"0.2 M Ammonium acetate: 0.1 M HEPES, pH 7.5: 25% PEG 3350.",290,"10.1093/jmcb/mjaa025",,"7BTD",20.65,"2","2","Crystal structure of Rheb Y35N mutant bound to GppNHp","MPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSNDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLEHHHHHH","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","7BTD"
"7BTN",,"X-RAY DIFFRACTION",2.79,55.91,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG4000, 50mM magnesium acetate, pH 5.5",289,"10.1016/j.bbrc.2020.09.139",,"7BTN",35.16,"2.382","2.382","Crystal structure of human inorganic pyrophosphatase with metal ions","HHHHHHGPNTEFALSLLREFMSGFSTEERAAPFSLEYRVFLKNEKGQYISPFHDIPIYADKDVFHMVVEVPRWSNAKMEIATKDPLNPIKQDVKKGKLRYVANLFPYKGYIWNYGAIPQTWEDPGHNDKHTGCCGDNDPIDVCEIGSKVCARGEIIGVKVLGILAMIDEGETDWKVIAINVDDPDAANYNDINDVKRLKPGYLEATVDWFRRYKVPDGKPENEFAFNAEFKDKDFAIDIIKSTHDHWKALVTKKTNGKGISCMNTTLSESPFKCDPDAARAIVDALPPPCESACTVPTDVDKWFHHQKN","Homo sapiens","PPA1, IOPPP, PP","Inorganic pyrophosphatase","1","7BTN"
"7BTT",,"X-RAY DIFFRACTION",2.17,43.33,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodium chloride, 25% w/v Polyethylene glycol 3,350, 0.1 M Tris pH 8.5",277.15,,,"7BTT",36.5,"1.86","1.86","A X-ray cocrystal structure of XMU-MP-5 bound to the ALK kinase domain","QGNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","7BTT"
"7BTV",,"X-RAY DIFFRACTION",2.48,50.43,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium acetate, 20% PEG 3350",293,"10.1016/j.bmcl.2020.127475","N47","7BTV",67.27,"2","2","Crystal structure of EHMT2 SET domain in complex with compound 5.","GSNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","7BTV"
"7BU4",,"X-RAY DIFFRACTION",1.95,37.05,"VAPOR DIFFUSION, SITTING DROP",,"Ethylene glycol",277,,,"7BU4",40.85,"1.7022731752","1.7022731752","Crystal structure of CK2a1 complexed with KY49","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein Kinase 2 subunit alpha","1","7BU4"
"7BUC",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M magnesium acetate, 20% polyethyleneglycol 3350",293,"10.1016/j.bmcl.2020.127475",,"7BUC",67.21,"2.6","2.6","Crystal structure of EHMT2 SET domain in complex with compound 13","GSNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","7BUC"
"7BUL",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa1045",,"7BUL",18.35,,,"Solution structure of the tandem PH and BSD1 domains of TFIIH p62","GSHMATSSEEVLLIVKKVRQKKQDGALYLMAERIAWAPEGKDRFTISHMYADIKCQKISPEGKAKIQLQLVLHAGDTTNFHFSNESTAVKERDAVKDLLQQLLPKFKRKANKELEEKNRMLQEDPVLFQLYKDLVVSQVISAEEFWANRLNVNATDSSSTS","Homo sapiens","GTF2H1, BTF2","General transcription factor IIH subunit 1","1","7BUL"
"7BV9",,"SOLUTION NMR",,,,,,,"10.3390/biomedicines8120608",,"7BV9",18.64,,,"The NMR structure of the BEN domain from human NAC1","LPEQVAPESRNRIRVRQDLASLPAELINQIGNRCHPKLYDEGDPSEKLELVTGTNVYITRAQLMNCHVSAGTRHKVLLRRLLASFFDRNTLANSCGTGIRSSTNDPRRKPLDSRVLHAVKYYCQNFAPNFKESEMNAIAADMCTNARRVVRKSWMPKVKVLKAE","Homo sapiens","NACC1, BTBD14B, NAC1","Nucleus accumbens-associated protein 1","1","7BV9"
"7BW1",,"X-RAY DIFFRACTION",3,59.02,"LIPIDIC CUBIC PHASE",,"30% v/v PEG600, 100mM tris-sodium citrate ph5.0, 100mM sodium chloride, 100mM Lithium sulfate",293,"10.21203/rs.3.rs-40159/v1",,"7BW1",30.36,"2.8","2.8","Crystal structure of Steroid 5-alpha-reductase 2 in complex with Finasteride","GGGTMQVQCQQSPVLAGSATLVALGALALYVAKPSGYGKHTESLKPAATRLPARAAWFLQELPSFAVPAGILARQPLSLFGPPGTVLLGLFCVHYFHRTFVYSLLNRGRPYPAILILRGTAFCTGNGVLQGYYLIYCAEYPDGWYTDIRFSLGVFLFILGMGINIHSDYILRQLRKPGEISYRIPQGGLFTYVSGANFLGEIIEWIGYALATWSLPALAFAFFSLCFLGLRAFHHHRFYLKMFEDYPKSRKALIPFIF","Homo sapiens","SRD5A2","3-oxo-5-alpha-steroid 4-dehydrogenase 2","1","7BW1"
"7BX7","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20227-8",,"7BX7",78.49,"2.8",,"Cryo-EM structure of amyloid fibril formed by hnRNPA1 low complexity domain","MASASSSQRGRSGSGNFGGGRGGGFGGNDNFGRGGNFSGRGGFGGSRGGGGYGGSGDGYNGFGNDGSNFGGGGSYNDFGNYNNQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGYGGSSSSSSYGSGRRF","Homo sapiens","HNRNPA1, HNRPA1","Heterogeneous nuclear ribonucleoprotein A1","1","7BX7"
"7BYI",,"X-RAY DIFFRACTION",3.56,65.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Sodium dihydrogen phosphate pH 6.5, 16% PEG 2000,2.5mM Carbenoxolone Sodium",293,,,"7BYI",108.14,"2.76","2.76","Structure of SHMT2 in complex with CBX","MAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAGKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQAATPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","7BYI"
,,,,,,,,,,,,,,,,"MAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYGLAPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREAPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGGYLVSGGTDNHLVLVDLRPKGGGGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","2","7BYI"
"7BYJ",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, SITTING DROP",,"Lithium citrate tribasic tetrahydrate, Polyethylene glycol 3350",289,"10.1042/BCJ20200857",,"7BYJ",38.56,"2.49","2.49","Crystal structure of the FERM domain of FRMPD4","GPGSTVKDNSLLFMPNVLKVYLENGQTKSFRFDCSTSIKDVILTLQEKLSIKGIEHFSLMLEQRTEGAGTKLLLLHEQETLTQVTQRPSSHKMRCLFRISFVPKDPIDLLRRDPVAFEYLYVQSCNDVVQERFGPELKYDIALRLAALQMYIATVTTKQTQKISLKYIEKEWGLETFLPSAVLQSMKEKNIKKALSHLVKANQNLVPPGKKLSALQAKVHYLKFLSDLRLYGGRVFKATLVQAEKRSEVTLLVGPRYGISHVINTKTNLVALLADFSHVNRIEMFSEEESLVRVELHVLDVKPITLLMESSDAMNLACLTAGYYRLLVDSRRSIFNMAN","Homo sapiens","FRMPD4, KIAA0316, PDZD10, PDZK10","FERM and PDZ domain-containing protein 4","1","7BYJ"
"7C00",,"X-RAY DIFFRACTION",2.51,51.05,"VAPOR DIFFUSION",8,"40% (w/v) polyethylene glycol 400, 0.2M sodium chloride, 0.1M Tacsimate (pH 8.0)",293,"10.1074/jbc.RA120.014690",,"7C00",13.46,"1.7","1.7","Crystal structure of the SRCR domain of human SCARA5.","MDFTMIRLVNGSGPHEGRVEVYHDRRWGTVCDDGWDKKDGDVVCRMLGFRGVEEVYRTARFGQGTGRIWMDDVACKGTEETIFRCSFSKWGVTNCGHAEDASVTCNRHHHHHHH","Homo sapiens","SCARA5, UNQ2938/PRO28700","Scavenger receptor class A member 5","1","7C00"
"7C04",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Citrate pH 5.5, 31% PEG 4000",293,"10.1016/j.bioorg.2020.103901","FEU","7C04",26.14,"1.7","1.7","Crystal structure of human Trap1 with DN203492","STQTAEDKEEPLHSIISSTESVQGSTSKHEFQAETKKLLDIVARSLYSEKEVFIRELISNASDALEKLRHKLVSDGQALPEMEIHLQTNAEKGTITIQDTGIGMTQEELVSNLGTIARSGSKAFLDALQNQAEASSKIIGQFGVGFYSAFMVADRVEVYSRSAAPGSLGYQWLSDGSGVFEIAEASGVRTGTKIIIHLKSDCKEFSSEARVRDVVTKYSNFVSFPLYLNGRRMNT","Homo sapiens","TRAP1, HSP75","Heat shock protein 75 kDa, mitochondrial","1","7C04"
"7C05",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, HANGING DROP",6.76,"0.1M Cacodylate pH 6.76, 0.1M Ca-acetate, 14% PEG 20000",293,"10.1016/j.bioorg.2020.103901",,"7C05",57.78,"2.59","2.59","Crystal structure of human Trap1 with DN203495","STQTAEDKEEPLHSIISSTESVQGSTSKHEFQAETKKLLDIVARSLYSEKEVFIRELISNASDALEKLRHKLVSDGQALPEMEIHLQTNAEKGTITIQDTGIGMTQEELVSNLGTIARSGSKAFLDALQNQAEASSKIIGQFGVGFYSAFMVADRVEVYSRSAAPGSLGYQWLSDGSGVFEIAEASGVRTGTKIIIHLKSDCKEFSSEARVRDVVTKYSNFVSFPLYLNGRRMNTLQAIWMMDPKDVREWQHEEFYRYVAQAHDKPRYTLHYKTDAPLNIRSIFYVPDMKPSMFDVSRELGSSVALYSRKVLIQTKATDILPKWLRFIRGVVDSEDIPLNLSRELLQESALIRKLRDVLQQRLIKFFIDQSKKDAEKYAKFFEDYGLFMREGIVTATEQEVKEDIAKLLRYESSALPSGQLTSLSEYASRMRAGTRNIYYLCAPNRHLAEHSPYYEAMKKKDTEVLFCFEQFDELTLLHLREFDKKKLISVETDIVVDHYKE","Homo sapiens","TRAP1, HSP75","Heat shock protein 75 kDa, mitochondrial","1","7C05"
"7C1D","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.2012435118",,"7C1D",86.86,"3.8",,"Cryo-EM structure of the hE46K cross-seeded hWT alpha-synuclein fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","7C1D"
"7C2V",,"X-RAY DIFFRACTION",2.54,51.5,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.1 M sodium acetate pH 5.4, 2.3 M sodium malonate",298,"10.1021/acsmedchemlett.0c00255","FJ0","7C2V",137.39,"2.44","2.44","Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948","SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","7C2V"
"7C2W",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.1 M sodium acetate pH 5.4, 2.3 M sodium malonate",298,"10.1021/acsmedchemlett.0c00255",,"7C2W",135.27,"3.2","3.2","Crystal Structure of IRAK4 kinase in complex with a small molecule inhibitor","TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","7C2W"
"7C2Z",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",,"4.0M Sodium Formate",295,"10.1080/14756366.2021.1906663",,"7C2Z",15.34,"1.3","1.3","Bromodomain-containing 4 BD1 in complex with 3',4',7,8-Tetrahydroxyflavone","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","7C2Z"
"7C36",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkab363",,"7C36",18.08,,,"c-Myc DNA binding protein structure","GAMGTNLYIRGLPPHTTDQDLVKLCQPYGKIVSTKAILDKTTNKCKGYGFVDFDSPAAAQKAVSALKASGVQAQMAKQQEQDPTNLYISNLPLSMDEQELENMLKPFGQVISTRILRDSSGTSRGVGFARMESTEKCEAVIGHFNGKFIKTPPGVSAPTEPLLCKFS","Homo sapiens","RBMS1, C2orf12, MSSP, MSSP1, SCR2","RNA-binding motif, single-stranded-interacting protein 1","1","7C36"
"7C3G",,"X-RAY DIFFRACTION",2.56,51.9,"VAPOR DIFFUSION, SITTING DROP",,"100 mM HEPES pH 7.6-8.0, 1.5-1.6 M ammonium sulfate",293,"10.1016/j.bmcl.2021.127858",,"7C3G",71.88,"1.802","1.802","Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazole inhibitor RK-73134","SMQRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","7C3G"
"7C3M",,"X-RAY DIFFRACTION",3.62,66.02,"VAPOR DIFFUSION, HANGING DROP",,"3M sodium formate pH 7.0, 3% w/v xylitol, and 9% glycerol",286,"10.1371/journal.pbio.3000755",,"7C3M",229.39,"3.6","3.6","Structure of FERM protein","MAGMKTASGDYIDSSWELRVFVGEEDPEAESVTLRVTGESHIGGVLLKIVEQINRKQDWSDHAIWWEQKRQWLLQTHWTLDKYGILADARLFFGPQHRPVILRLPNRRALRLRASFSQPLFQAVAAICRLLSIRHPEELSLLRAPEKKEKKKKEKEPEEELYDLSKVVLAGGVAPALFRGMPAHFSDSAQTEACYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSSRCLMQQGIKAGDALWLRFKYYSFFDLDPKTDPVRLTQLYEQARWDLLLEEIDCTEEEMMVFAALQYHINKLSQSGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPELKDHLRIFRIPRRPRKLTLKGYRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGCEVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMAGCRLASKGRTMADSSYTSEVQAILAFLSLQRTGSGGPGNHPHGPDASAEGLNPYGLVAPRFQRKFKAKQLTPRILEAHQNVAQLSLAEAQLRFIQAWQSLPDFGISYVMVRFKGSRKDEILGIANNRLIRIDLAVGDVVKTWRFSNMRQWNVNWDIRQVAIEFDEHINVAFSCVSASCRIVHEYIGGYIFLSTRERARGEELDEDLFLQLTGGHEAFLEHHHHHH","Homo sapiens","FERMT3, KIND3, MIG2B, URP2","Fermitin family homolog 3,Fermitin family homolog 3,Fermitin family homolog 3","1","7C3M"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
,,,,,,,,,,,,,,,,,"Homo sapiens","FERMT3, KIND3, MIG2B, URP2"
"7C3N",,"X-RAY DIFFRACTION",2.05,40.06,"VAPOR DIFFUSION, HANGING DROP",6,"50mM Pipes pH6.0, 1.1M sodium malonate, 1.6% glycerol, 10mM DTT",277.15,"10.1021/acs.jmedchem.0c00450","FHX","7C3N",36.16,"1.98","1.98","Crystal structure of JAK3 in complex with Delgocitinib","GSQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","7C3N"
